Clustering O 0 0.031333353370428085
of O 0 0.01134430430829525
missense O 0 0.02595498040318489
mutations O 0 0.0065120733343064785
in O 0 0.004429228138178587
the O 0 0.09591229259967804
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999966621398926
telangiectasia I-Disease 1 0.9999988079071045
gene O 0 0.0076618497259914875
in O 0 0.003119618631899357
a O 0 0.007051334250718355
sporadic B-Disease 1 0.9569497108459473
T I-Disease 1 0.9999991655349731
- I-Disease 1 0.999098539352417
cell I-Disease 1 0.914406418800354
leukaemia I-Disease 1 0.9999865293502808
. O 0 0.024384183809161186

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999699592590332
telangiectasia I-Disease 1 0.9999996423721313
( O 1 0.8474430441856384
A B-Disease 1 0.9999425411224365
- I-Disease 1 0.9999799728393555
T I-Disease 1 0.9999781847000122
) O 0 0.003254456678405404
is O 0 0.0020217299461364746
a O 0 0.004609506577253342
recessive B-Disease 1 0.9976369142532349
multi I-Disease 1 0.9999927282333374
- I-Disease 1 0.9999935626983643
system I-Disease 1 0.9889365434646606
disorder I-Disease 1 0.9999997615814209
caused O 1 0.9655134677886963
by O 0 0.003395505016669631
mutations O 0 0.0044026849791407585
in O 0 0.002052673138678074
the O 0 0.004146811086684465
ATM O 0 0.014851399697363377
gene O 0 0.003885886399075389
at O 0 0.004411430563777685
11q22 O 0 0.19757702946662903
- O 0 0.017688371241092682
q23 O 0 0.19197574257850647
( O 0 0.008671598508954048
ref O 0 0.029222331941127777
. O 0 0.0035289123188704252
3 O 0 0.007356348447501659
) O 0 0.006861038506031036
. O 0 0.007999586872756481

The O 0 0.017445674166083336
risk O 0 0.07781969010829926
of O 1 0.8809228539466858
cancer B-Disease 1 1.0
, O 0 0.04709577187895775
especially O 0 0.13399602472782135
lymphoid B-Disease 1 0.9999979734420776
neoplasias I-Disease 1 0.9995254278182983
, O 0 0.003884993027895689
is O 0 0.003257607575505972
substantially O 0 0.006599445827305317
elevated O 1 0.9611369371414185
in O 0 0.006904201116412878
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 1 0.9966000914573669
and O 0 0.0018751990282908082
has O 0 0.0022703055292367935
long O 0 0.0032840645872056484
been O 0 0.0025955550372600555
associated O 0 0.004742561373859644
with O 0 0.007036828901618719
chromosomal O 1 0.9999955892562866
instability O 1 0.9999983310699463
. O 0 0.0415959358215332

By O 0 0.01085467729717493
analysing O 1 0.7611197829246521
tumour B-Disease 1 1.0
DNA O 0 0.012923112139105797
from O 0 0.003447143593803048
patients O 0 0.05130702629685402
with O 0 0.0028296378441154957
sporadic B-Disease 1 0.5341731905937195
T I-Disease 1 0.9999959468841553
- I-Disease 1 0.5811846256256104
cell I-Disease 0 0.03561472147703171
prolymphocytic I-Disease 1 0.9996905326843262
leukaemia I-Disease 1 0.9999998807907104
( O 1 0.9060932993888855
T B-Disease 1 0.9999898672103882
- I-Disease 1 0.9089346528053284
PLL I-Disease 1 0.9996236562728882
) O 0 0.003942428156733513
, O 0 0.002258826280012727
a O 0 0.0032313645351678133
rare O 0 0.009192178025841713
clonal B-Disease 1 0.9616816639900208
malignancy I-Disease 1 0.9999842643737793
with O 0 0.0026615748647600412
similarities O 0 0.005046018864959478
to O 0 0.0027178050950169563
a O 0 0.006225504446774721
mature B-Disease 1 0.7673379182815552
T I-Disease 1 0.9999889135360718
- I-Disease 1 0.867756724357605
cell I-Disease 0 0.05464661121368408
leukaemia I-Disease 1 0.9999797344207764
seen O 0 0.005305252969264984
in O 0 0.004711298272013664
A B-Disease 1 0.9999685287475586
- I-Disease 1 0.9999902248382568
T I-Disease 1 0.9999856948852539
, O 0 0.002004313515499234
we O 0 0.0010518206981942058
demonstrate O 0 0.002167171100154519
a O 0 0.0017421958036720753
high O 0 0.002977380994707346
frequency O 0 0.0022620309609919786
of O 0 0.002646937035024166
ATM O 0 0.02342844568192959
mutations O 0 0.008192069828510284
in O 0 0.009324153885245323
T B-Disease 1 0.9999905824661255
- I-Disease 1 0.9264954924583435
PLL I-Disease 1 0.9996476173400879
. O 0 0.019625965505838394

In O 0 0.00948488898575306
marked O 0 0.010323825292289257
contrast O 0 0.004981078673154116
to O 0 0.002350446069613099
the O 0 0.0037500872276723385
ATM O 0 0.02108333818614483
mutation O 0 0.005236677825450897
pattern O 0 0.005349844228476286
in O 0 0.004076810088008642
A B-Disease 1 0.9999779462814331
- I-Disease 1 0.9999829530715942
T I-Disease 1 0.9999088048934937
, O 0 0.0016838264418765903
the O 0 0.0013691963395103812
most O 0 0.0010873563587665558
frequent O 0 0.0028662262484431267
nucleotide O 0 0.0038605183362960815
changes O 0 0.0016985523980110884
in O 0 0.002139829332008958
this O 0 0.003440818516537547
leukaemia B-Disease 1 0.9999914169311523
were O 0 0.009031402878463268
missense O 0 0.12608925998210907
mutations O 0 0.027112599462270737
. O 0 0.016580531373620033

These O 0 0.006158295087516308
clustered O 0 0.01277287770062685
in O 0 0.0040540024638175964
the O 0 0.003626392688602209
region O 0 0.004850741941481829
corresponding O 0 0.003867395455017686
to O 0 0.0023718124721199274
the O 0 0.004243726376444101
kinase O 0 0.010012025013566017
domain O 0 0.003681439207866788
, O 0 0.0019440499600023031
which O 0 0.0012441249564290047
is O 0 0.001514908974058926
highly O 0 0.002900548744946718
conserved O 0 0.004350929521024227
in O 0 0.0035269458312541246
ATM O 0 0.04584449529647827
- O 0 0.008549247868359089
related O 0 0.004075321368873119
proteins O 0 0.003107147989794612
in O 0 0.003048711223527789
mouse O 0 0.009758449159562588
, O 0 0.004939463920891285
yeast O 0 0.014405774883925915
and O 0 0.006459396798163652
Drosophila O 0 0.036573171615600586
. O 0 0.014399757608771324

The O 0 0.012370086275041103
resulting O 0 0.013796960934996605
amino O 0 0.012678563594818115
- O 0 0.016674678772687912
acid O 0 0.008225440979003906
substitutions O 0 0.0049346922896802425
are O 0 0.0012592647690325975
predicted O 0 0.0035465306136757135
to O 0 0.0015898047713562846
interfere O 0 0.0043670302256941795
with O 0 0.0030543021857738495
ATP O 1 0.9994062185287476
binding O 0 0.006259189452975988
or O 0 0.0050169541500508785
substrate O 0 0.0165857020765543
recognition O 0 0.015422438271343708
. O 0 0.015072032809257507

Two O 0 0.006024301052093506
of O 0 0.008835839107632637
seventeen O 0 0.08522533625364304
mutated O 1 0.9904933571815491
T B-Disease 1 0.9999665021896362
- I-Disease 0 0.24757516384124756
PLL I-Disease 1 0.8988537192344666
samples O 0 0.005637376103550196
had O 0 0.003572421381250024
a O 0 0.00372595083899796
previously O 0 0.006292078178375959
reported O 0 0.010497388429939747
A B-Disease 1 0.9994966983795166
- I-Disease 1 0.9997957348823547
T I-Disease 1 0.9999697208404541
allele O 0 0.030235186219215393
. O 0 0.012425691820681095

In O 0 0.010188957676291466
contrast O 0 0.009052458219230175
, O 0 0.004529495723545551
no O 0 0.0036731725558638573
mutations O 0 0.003673126921057701
were O 0 0.002267773961648345
detected O 0 0.004290097858756781
in O 0 0.001958859385922551
the O 0 0.004154513124376535
p53 O 0 0.013128953985869884
gene O 0 0.004108797293156385
, O 0 0.0019763908348977566
suggesting O 0 0.004060681909322739
that O 0 0.0020028825383633375
this O 0 0.005396544933319092
tumour B-Disease 1 1.0
suppressor O 1 0.9968516230583191
is O 0 0.0029003415256738663
not O 0 0.0014080969849601388
frequently O 0 0.0030086294282227755
altered O 0 0.005349704064428806
in O 0 0.00423433305695653
this O 0 0.007869101129472256
leukaemia B-Disease 1 0.9999970197677612
. O 0 0.021923748776316643

Occasional O 0 0.03503597155213356
missense O 0 0.04264726862311363
mutations O 0 0.012023563496768475
in O 0 0.005202312953770161
ATM O 0 0.018137525767087936
were O 0 0.0027908177580684423
also O 0 0.0025448035448789597
found O 0 0.0033001017291098833
in O 0 0.004111762624233961
tumour B-Disease 1 0.9999995231628418
DNA O 0 0.006304021459072828
from O 0 0.002263728529214859
patients O 0 0.007570503279566765
with O 0 0.0026462345849722624
B B-Disease 1 0.9971778392791748
- I-Disease 0 0.14060024917125702
cell I-Disease 0 0.014358663000166416
non I-Disease 0 0.08232153952121735
- I-Disease 1 0.9995388984680176
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999977350234985
( O 0 0.012001684866845608
B B-Disease 0 0.41733142733573914
- I-Disease 0 0.009180247783660889
NHL I-Disease 0 0.00944112241268158
) O 0 0.0018128390656784177
and O 0 0.001225931802764535
a O 0 0.0037558332551270723
B B-Disease 1 0.8502842783927917
- I-Disease 0 0.030542436987161636
NHL I-Disease 0 0.03297135606408119
cell O 0 0.016002636402845383
line O 0 0.013928616419434547
. O 0 0.010973913595080376

The O 0 0.008668950758874416
evidence O 0 0.004883848130702972
of O 0 0.003956393804401159
a O 0 0.0039007579907774925
significant O 0 0.00293533131480217
proportion O 0 0.00371186644770205
of O 0 0.0032567561138421297
loss O 1 0.9392015337944031
- O 0 0.40208372473716736
of O 0 0.010200143791735172
- O 0 0.4894070327281952
function O 0 0.004223866853863001
mutations O 0 0.002734463894739747
and O 0 0.0011076079681515694
a O 0 0.0018656851025298238
complete O 0 0.003375120460987091
absence O 0 0.004943379200994968
of O 0 0.0031373880337923765
the O 0 0.003838019445538521
normal O 0 0.0038365712389349937
copy O 0 0.0034898638259619474
of O 0 0.0024601148907095194
ATM O 0 0.006902372930198908
in O 0 0.001474445452913642
the O 0 0.0018935204716399312
majority O 0 0.002040792489424348
of O 0 0.004475087858736515
mutated O 1 0.9657771587371826
tumours B-Disease 1 0.9999991655349731
establishes O 1 0.9357382655143738
somatic O 0 0.13950590789318085
inactivation O 0 0.23363493382930756
of O 0 0.003220454091206193
this O 0 0.00180235190782696
gene O 0 0.002348882146179676
in O 0 0.0015078879659995437
the O 0 0.003059050999581814
pathogenesis O 1 0.9993808269500732
of O 0 0.02083473652601242
sporadic B-Disease 1 0.9998533725738525
T I-Disease 1 0.9999997615814209
- I-Disease 1 0.9903407692909241
PLL I-Disease 1 0.9998146891593933
and O 0 0.0027630235999822617
suggests O 0 0.00448291189968586
that O 0 0.0021297652274370193
ATM O 0 0.012585854157805443
acts O 0 0.004356659483164549
as O 0 0.004872843623161316
a O 0 0.06747201085090637
tumour B-Disease 1 1.0
suppressor O 1 0.9996460676193237
. O 0 0.024997496977448463

As O 0 0.008925043046474457
constitutional O 0 0.009946898557245731
DNA O 0 0.009010016918182373
was O 0 0.004401807207614183
not O 0 0.0010453086579218507
available O 0 0.001308534643612802
, O 0 0.001583187491632998
a O 0 0.0038562812842428684
putative O 1 0.6973564624786377
hereditary O 1 0.9999918937683105
predisposition O 1 0.9999966621398926
to O 0 0.47584274411201477
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9970180988311768
PLL I-Disease 1 0.9986214637756348
will O 0 0.00263177789747715
require O 0 0.002290013711899519
further O 0 0.0030102618038654327
investigation O 0 0.008342738263309002
. O 0 0.0050035761669278145
. O 0 0.00943308137357235

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.6832741498947144
kinase O 0 0.019923647865653038
is O 0 0.0028636325150728226
involved O 0 0.0020812111906707287
in O 0 0.0018538886215537786
the O 0 0.002880661515519023
modulation O 0 0.006628560833632946
of O 0 0.0033835163339972496
the O 0 0.012267334386706352
Ca2 O 1 0.9995996356010437
+ O 0 0.26774680614471436
homeostasis O 1 0.9456643462181091
in O 0 0.014471132308244705
skeletal O 1 0.9999994039535522
muscle O 1 0.9999971389770508
cells O 0 0.34124186635017395
. O 0 0.02077171951532364

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999969005584717
DM B-Disease 1 1.0
) O 0 0.008106598630547523
, O 0 0.0027747589629143476
the O 0 0.003401349764317274
most O 0 0.004170095548033714
prevalent O 1 0.9999560117721558
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9482403993606567
adults O 1 0.5859078764915466
, O 0 0.003685127943754196
is O 0 0.002427943516522646
caused O 0 0.005172567442059517
by O 0 0.002558666979894042
( O 0 0.007766891736537218
CTG O 1 0.9996132254600525
) O 0 0.004221613518893719
n O 0 0.0085027189925313
- O 0 0.007125613745301962
repeat O 0 0.005097205750644207
expansion O 0 0.003159481566399336
in O 0 0.0016262726858258247
a O 0 0.0028663461562246084
gene O 0 0.0037567378021776676
encoding O 0 0.0040695504285395145
a O 0 0.004101309925317764
protein O 0 0.009287219494581223
kinase O 0 0.017777658998966217
( O 0 0.013358679600059986
DM B-Disease 1 0.9999984502792358
protein O 0 0.010707952082157135
kinase O 0 0.013178533874452114
; O 0 0.00462964316830039
DMPK O 1 0.851811408996582
) O 0 0.003281728597357869
and O 0 0.0019004389178007841
involves O 0 0.004193949047476053
changes O 0 0.0033049974590539932
in O 0 0.005627449136227369
cytoarchitecture O 1 0.9706027507781982
and O 0 0.012829606421291828
ion O 1 0.9875389337539673
homeostasis O 1 0.9994972944259644
. O 0 0.02193545177578926

To O 0 0.007652576547116041
obtain O 0 0.005681595299392939
clues O 0 0.007079796399921179
to O 0 0.0023842519149184227
the O 0 0.0029397248290479183
normal O 0 0.00363763514906168
biological O 0 0.004474743735045195
role O 0 0.004481080919504166
of O 0 0.004775702487677336
DMPK O 1 0.9998875856399536
in O 0 0.006702678743749857
cellular O 0 0.08318252861499786
ion O 0 0.4610210061073303
homeostasis O 1 0.9496290683746338
, O 0 0.0022837675642222166
we O 0 0.0013438264140859246
have O 0 0.0008385677356272936
compared O 0 0.0024592559784650803
the O 0 0.0034074103459715843
resting O 1 0.9901654124259949
[ O 1 0.7682649493217468
Ca2 O 1 0.9889828562736511
+ O 0 0.055116206407547
] O 0 0.008928890340030193
i O 0 0.0034232421312481165
, O 0 0.001849386841058731
the O 0 0.002338864840567112
amplitude O 0 0.0052901082672178745
and O 0 0.002158585237339139
shape O 0 0.006782006472349167
of O 0 0.008766751736402512
depolarization O 1 0.9999740123748779
- O 1 0.9999501705169678
induced O 1 0.999976634979248
Ca2 O 1 0.9987755417823792
+ O 0 0.08667635172605515
transients O 0 0.015828870236873627
, O 0 0.0023302065674215555
and O 0 0.0014999362174421549
the O 0 0.0024501685984432697
content O 0 0.002590195508673787
of O 0 0.004784377291798592
ATP O 1 0.9999548196792603
- O 0 0.09553483873605728
driven O 0 0.012857961468398571
ion O 0 0.021346835419535637
pumps O 0 0.021446285769343376
in O 0 0.006461872719228268
cultured O 1 0.810505747795105
skeletal O 1 0.9999890327453613
muscle O 1 0.9988666772842407
cells O 0 0.004635767079889774
of O 0 0.0031366138719022274
wild O 0 0.00680855056270957
- O 0 0.009468381293118
type O 0 0.006041025277227163
and O 0 0.003931744024157524
DMPK O 1 0.9999654293060303
[ O 1 0.7458507418632507
- O 1 0.912796676158905
/ O 1 0.9608759880065918
- O 0 0.1275218427181244
] O 0 0.03044324740767479
knockout O 0 0.3703624904155731
mice O 0 0.03307909891009331
. O 0 0.014907057397067547

In O 0 0.013230003416538239
vitro O 0 0.04006340354681015
- O 0 0.061548687517642975
differentiated O 0 0.17803022265434265
DMPK O 1 0.9999679327011108
[ O 1 0.9427608847618103
- O 1 0.990097165107727
/ O 1 0.99181067943573
- O 0 0.030587563291192055
] O 0 0.011774512939155102
myotubes O 0 0.018395166844129562
exhibit O 0 0.006718570366501808
a O 0 0.0053994967602193356
higher O 0 0.007333972491323948
resting O 1 0.9809050559997559
[ O 0 0.38688716292381287
Ca2 O 1 0.8639054894447327
+ O 0 0.020592208951711655
] O 0 0.006857867352664471
i O 0 0.0027412530034780502
than O 0 0.0011287432862445712
do O 0 0.0016235921066254377
wild O 0 0.0052041239105165005
- O 0 0.01475787814706564
type O 0 0.011469212360680103
myotubes O 0 0.03055289201438427
because O 0 0.0016652500489726663
of O 0 0.0017324273940175772
an O 0 0.0017796801403164864
altered O 0 0.0033114308025687933
open O 0 0.0020714823622256517
probability O 0 0.0026056128554046154
of O 0 0.0033160625025629997
voltage O 0 0.012138308957219124
- O 0 0.01569191925227642
dependent O 0 0.009598812088370323
l O 0 0.06226338818669319
- O 0 0.016560403630137444
type O 0 0.018936729058623314
Ca2 O 0 0.12357853353023529
+ O 0 0.024157224223017693
and O 0 0.007360680960118771
Na O 1 0.9992313385009766
+ O 0 0.032134778797626495
channels O 0 0.012121402658522129
. O 0 0.013410072773694992

The O 0 0.023182310163974762
mutant O 0 0.05535641312599182
myotubes O 1 0.5260523557662964
exhibit O 0 0.011891933158040047
smaller O 0 0.004639997612684965
and O 0 0.004041512031108141
slower O 0 0.013087230734527111
Ca2 O 0 0.03553507849574089
+ O 0 0.009256785735487938
responses O 0 0.003179827006533742
upon O 0 0.003378121182322502
triggering O 0 0.009149166755378246
by O 0 0.003560123033821583
acetylcholine O 0 0.14344878494739532
or O 0 0.005308421794325113
high O 0 0.011716862209141254
external O 0 0.0234945360571146
K O 1 0.9341495633125305
+ O 0 0.03903897851705551
. O 0 0.012396901845932007

In O 0 0.00821409747004509
addition O 0 0.005965054035186768
, O 0 0.00329414545558393
we O 0 0.0015633568400517106
observed O 0 0.002092731883749366
that O 0 0.0010981702944263816
these O 0 0.0021586318034678698
Ca2 O 0 0.4541507065296173
+ O 0 0.03929822891950607
transients O 0 0.02545318752527237
partially O 0 0.00840382557362318
result O 0 0.0025693729985505342
from O 0 0.0018508362118154764
an O 0 0.002254119608551264
influx O 0 0.00775973591953516
of O 0 0.0049886396154761314
extracellular O 0 0.20111198723316193
Ca2 O 0 0.14382842183113098
+ O 0 0.007748494390398264
through O 0 0.0023814744781702757
the O 0 0.0064776064828038216
l O 1 0.9412184953689575
- O 0 0.09816142916679382
type O 0 0.1283435970544815
Ca2 O 1 0.7505854964256287
+ O 0 0.030125126242637634
channel O 0 0.017072293907403946
. O 0 0.012661002576351166

Neither O 0 0.019417600706219673
the O 0 0.006200812757015228
content O 0 0.0043441057205200195
nor O 0 0.004477293696254492
the O 0 0.0031626312993466854
activity O 0 0.004072307143360376
of O 0 0.008192035369575024
Na O 1 0.9999983310699463
+ O 1 0.9443662762641907
/ O 1 0.7498400211334229
K O 0 0.34764906764030457
+ O 0 0.03942521661520004
ATPase O 0 0.054356276988983154
and O 0 0.01203326415270567
sarcoplasmic O 1 0.9999115467071533
reticulum O 1 0.9999464750289917
Ca2 O 1 0.9993202686309814
+ O 1 0.9078060388565063
- O 0 0.0335843600332737
ATPase O 0 0.03383886441588402
are O 0 0.0028258031234145164
affected O 0 0.005946418736129999
by O 0 0.005877269431948662
DMPK O 1 0.9991958737373352
absence O 0 0.12192539125680923
. O 0 0.016884619370102882

In O 0 0.009317513555288315
conclusion O 0 0.00997012760490179
, O 0 0.0038666294422000647
our O 0 0.0026599497068673372
data O 0 0.0019407470244914293
suggest O 0 0.003156776539981365
that O 0 0.0023450437001883984
DMPK O 1 0.9526742100715637
is O 0 0.0030861422419548035
involved O 0 0.0028770125936716795
in O 0 0.0025234916247427464
modulating O 0 0.009889398701488972
the O 0 0.00267617660574615
initial O 0 0.003242796054109931
events O 0 0.0024835967924445868
of O 0 0.003315871814265847
excitation O 0 0.034850459545850754
- O 0 0.13519376516342163
contraction O 0 0.25700515508651733
coupling O 0 0.02165510505437851
in O 0 0.012995180673897266
skeletal O 1 0.9999998807907104
muscle O 1 0.9999748468399048
. O 0 0.008306343108415604
. O 0 0.013443688862025738

Constitutional O 0 0.08764410763978958
RB1 O 1 0.9999881982803345
- O 1 0.5123464465141296
gene O 0 0.013512366451323032
mutations O 0 0.006523070391267538
in O 0 0.0033651343546807766
patients O 0 0.4383274018764496
with O 0 0.005192568991333246
isolated O 1 0.8532816171646118
unilateral B-Disease 1 0.9374709129333496
retinoblastoma I-Disease 1 0.9999992847442627
. O 0 0.029101263731718063

In O 0 0.009205385111272335
most O 0 0.005341889802366495
patients O 0 0.07933108508586884
with O 0 0.003664777847006917
isolated O 1 0.8068850040435791
unilateral B-Disease 1 0.9906553626060486
retinoblastoma I-Disease 1 1.0
, O 1 0.9722442626953125
tumor B-Disease 1 0.9999990463256836
development O 0 0.008009916171431541
is O 0 0.0033955001272261143
initiated O 0 0.007529421243816614
by O 0 0.0023759573232382536
somatic O 0 0.012474464252591133
inactivation O 0 0.01997106522321701
of O 0 0.0038575984071940184
both O 0 0.0027561448514461517
alleles O 0 0.0068981158547103405
of O 0 0.006200260482728481
the O 0 0.09535124897956848
RB1 O 1 0.9999974966049194
gene O 0 0.027292484417557716
. O 0 0.01755695231258869

However O 0 0.008096927776932716
, O 0 0.0030557531863451004
some O 0 0.001662121620029211
of O 0 0.0029006728436797857
these O 0 0.0027370445895940065
patients O 1 0.8846141695976257
can O 0 0.0039147124625742435
transmit O 0 0.029070736840367317
retinoblastoma B-Disease 1 0.9998698234558105
predisposition O 1 0.8607859015464783
to O 0 0.0041338661685585976
their O 0 0.005136549938470125
offspring O 0 0.020179251208901405
. O 0 0.012016535736620426

To O 0 0.006263342685997486
determine O 0 0.005127116106450558
the O 0 0.0031496258452534676
frequency O 0 0.0028486575465649366
and O 0 0.0013175085186958313
nature O 0 0.002632319927215576
of O 0 0.004016804974526167
constitutional O 0 0.176902174949646
RB1 O 1 0.9999998807907104
- O 1 0.9057338237762451
gene O 0 0.007040092255920172
mutations O 0 0.004002001602202654
in O 0 0.0026653390377759933
patients O 0 0.022674813866615295
with O 0 0.003130105324089527
isolated O 0 0.02353786490857601
unilateral B-Disease 0 0.03843925520777702
retinoblastoma I-Disease 1 0.999864935874939
, O 0 0.003549468470737338
we O 0 0.001936586806550622
analyzed O 0 0.004166018683463335
DNA O 0 0.005119778215885162
from O 0 0.003858778392896056
peripheral O 1 0.9997237324714661
blood O 1 0.9846308827400208
and O 0 0.008832448162138462
from O 1 0.5367347598075867
tumor B-Disease 1 0.9999998807907104
tissue O 1 0.9998793601989746
. O 0 0.019133299589157104

The O 0 0.0077628567814826965
analysis O 0 0.004851303994655609
of O 0 0.006623269058763981
tumors B-Disease 1 0.9994489550590515
from O 0 0.004211698658764362
54 O 0 0.009556690230965614
( O 0 0.00430341949686408
71 O 0 0.006914864294230938
% O 0 0.002151346066966653
) O 0 0.0017731611151248217
of O 0 0.002692923881113529
76 O 0 0.012696925550699234
informative O 0 0.010466299951076508
patients O 0 0.03973936662077904
showed O 0 0.00646270252764225
loss O 0 0.006696573458611965
of O 0 0.005110164172947407
constitutional O 0 0.026998301967978477
heterozygosity O 1 0.9999961853027344
( O 1 0.9575515985488892
LOH O 1 0.9999997615814209
) O 0 0.00967127550393343
at O 0 0.013560797087848186
intragenic O 1 0.968303382396698
loci O 0 0.05245384946465492
. O 0 0.015641402453184128

Three O 0 0.009193042293190956
of O 0 0.011838334612548351
13 O 0 0.02398393675684929
uninformative O 1 0.9993436932563782
patients O 1 0.9973154664039612
had O 0 0.01528129167854786
constitutional O 0 0.02734890580177307
deletions O 0 0.10611314326524734
. O 0 0.021845106035470963

For O 0 0.007784207817167044
39 O 0 0.012310168705880642
randomly O 0 0.007227622903883457
selected O 0 0.011089753359556198
tumors B-Disease 1 0.9999003410339355
, O 0 0.00928313098847866
SSCP O 1 0.9999305009841919
, O 0 0.013513256795704365
hetero O 1 0.9994208812713623
- O 0 0.02714512124657631
duplex O 0 0.024159610271453857
analysis O 0 0.003705048467963934
, O 0 0.002818409586325288
sequencing O 0 0.005174967460334301
, O 0 0.0021958870347589254
and O 0 0.001986659364774823
Southern O 0 0.006159174256026745
blot O 0 0.015090178698301315
analysis O 0 0.002289779717102647
were O 0 0.0018209055997431278
used O 0 0.002008870244026184
to O 0 0.0022504122462123632
identify O 0 0.007976810447871685
mutations O 0 0.013868473470211029
. O 0 0.010133041068911552

Mutations O 0 0.015113754197955132
were O 0 0.004621498286724091
detected O 0 0.006562346126884222
in O 0 0.0025403473991900682
21 O 0 0.004485109355300665
( O 0 0.003140497487038374
91 O 0 0.005997378379106522
% O 0 0.002500704489648342
) O 0 0.0019807317294180393
of O 0 0.0038493468891829252
23 O 0 0.4417506754398346
tumors B-Disease 1 0.9999998807907104
with O 1 0.7522522211074829
LOH O 1 1.0
. O 0 0.030009977519512177

In O 0 0.01118765864521265
6 O 0 0.01153542846441269
( O 0 0.005114820785820484
38 O 0 0.005767339840531349
% O 0 0.0027687724214047194
) O 0 0.002013671211898327
of O 0 0.003225058550015092
16 O 0 0.017443310469388962
tumors B-Disease 1 0.9999996423721313
without O 0 0.015934718772768974
LOH O 1 1.0
, O 0 0.004110071808099747
one O 0 0.003035332076251507
mutation O 0 0.004831433761864901
was O 0 0.004673377610743046
detected O 0 0.004054272547364235
, O 0 0.0015689536230638623
and O 0 0.001356063294224441
in O 0 0.0017497777007520199
9 O 0 0.003998684696853161
( O 0 0.0025969096459448338
56 O 0 0.003795021679252386
% O 0 0.0020960455294698477
) O 0 0.0018550748936831951
of O 0 0.002903600689023733
the O 0 0.03282288461923599
tumors B-Disease 1 1.0
without O 1 0.7672930955886841
LOH O 1 1.0
, O 0 0.005360725335776806
both O 0 0.002895486308261752
mutations O 0 0.005284526851028204
were O 0 0.004534452222287655
found O 0 0.009759540669620037
. O 0 0.012711260467767715

Thus O 0 0.01123925019055605
, O 0 0.004358331207185984
a O 0 0.0031910508405417204
total O 0 0.0028385156765580177
of O 0 0.0027463261503726244
45 O 0 0.0039016695227473974
mutations O 0 0.0031287958845496178
were O 0 0.001912793260999024
identified O 0 0.004223750438541174
in O 0 0.004318524152040482
tumors B-Disease 1 0.9999575614929199
of O 0 0.07765655219554901
36 O 1 0.9320045709609985
patients O 1 0.9996089339256287
. O 0 0.014365128241479397

Thirty O 0 0.03099212422966957
- O 0 0.012970837764441967
nine O 0 0.0043495455756783485
of O 0 0.0037789158523082733
the O 0 0.005027676932513714
mutations O 0 0.0054237316362559795
- O 0 0.005026145838201046
including O 0 0.0020930275786668062
34 O 0 0.004369867034256458
small O 0 0.0024313454050570726
mutations O 0 0.0036226592492312193
, O 0 0.002117679687216878
2 O 0 0.0035392967984080315
large O 0 0.002633667318150401
structural O 1 0.6374880075454712
alterations O 0 0.026250222697854042
, O 0 0.0032819313928484917
and O 0 0.0030040573328733444
hypermethylation O 1 0.9987836480140686
in O 0 0.007875041104853153
3 O 1 0.6742994785308838
tumors O 1 0.9999995231628418
- O 0 0.014215012080967426
were O 0 0.0019318322883918881
not O 0 0.0011145895114168525
detected O 0 0.00342511641792953
in O 0 0.0018627651734277606
the O 0 0.0042244186624884605
corresponding O 0 0.016020718961954117
peripheral O 1 0.9999644756317139
blood O 1 0.9986245632171631
DNA O 0 0.033309344202280045
. O 0 0.017103208228945732

In O 0 0.010536023415625095
6 O 0 0.01151101291179657
( O 0 0.0046174596063792706
17 O 0 0.00441537331789732
% O 0 0.002295413054525852
) O 0 0.0013696318492293358
of O 0 0.001519524957984686
the O 0 0.0031005970668047667
36 O 0 0.00709671713411808
patients O 0 0.0958414077758789
, O 0 0.0020905467681586742
a O 0 0.0030577892903238535
mutation O 0 0.004393068607896566
was O 0 0.004188190214335918
detected O 0 0.003916430287063122
in O 0 0.00145826512016356
constitutional O 0 0.002804588060826063
DNA O 0 0.0029735194984823465
, O 0 0.0011851810850203037
and O 0 0.0010469660628587008
1 O 0 0.002096937270835042
of O 0 0.0012745375279337168
these O 0 0.0009840736165642738
mutations O 0 0.0024194642901420593
is O 0 0.0014089327305555344
known O 0 0.002302722539752722
to O 0 0.0013658114476129413
be O 0 0.001485841115936637
associated O 0 0.00330971903167665
with O 0 0.0036379718221724033
reduced O 0 0.023687541484832764
expressivity O 1 0.9983136653900146
. O 0 0.020287029445171356

The O 0 0.011280860751867294
presence O 0 0.006822044495493174
of O 0 0.004177517723292112
a O 0 0.004894645418971777
constitutional O 0 0.009822200052440166
mutation O 0 0.008652574382722378
was O 0 0.005523357540369034
not O 0 0.0011111721396446228
associated O 0 0.001666510128416121
with O 0 0.0010441819904372096
an O 0 0.0018366466974839568
early O 0 0.004752010107040405
age O 0 0.009661215357482433
at O 0 0.04711925983428955
treatment O 1 0.9997254014015198
. O 0 0.01631271280348301

In O 0 0.01585346832871437
1 O 0 0.023795442655682564
patient O 1 0.5659582018852234
, O 0 0.010191318579018116
somatic O 0 0.4131055176258087
mosaicism O 1 0.9989954829216003
was O 0 0.011093745008111
demonstrated O 0 0.00501536438241601
by O 0 0.0012666807742789388
molecular O 0 0.003200813662260771
analysis O 0 0.0017806258983910084
of O 0 0.0023609809577465057
DNA O 0 0.0049688867293298244
and O 0 0.0028780947905033827
RNA O 0 0.012803127989172935
from O 0 0.007546244654804468
peripheral O 1 0.999810516834259
blood O 1 0.9922892451286316
. O 0 0.018577978014945984

In O 0 0.011027057655155659
2 O 0 0.012454262934625149
patients O 0 0.01013137772679329
without O 0 0.0024925237521529198
a O 0 0.00389601057395339
detectable O 0 0.07106772065162659
mutation O 0 0.007909865118563175
in O 0 0.0052727581933140755
peripheral O 1 0.9999955892562866
blood O 1 0.9995858073234558
, O 0 0.011601012200117111
mosaicism O 1 0.9990623593330383
was O 0 0.009686194360256195
suggested O 0 0.0036247395910322666
because O 0 0.0016600925009697676
1 O 0 0.002547110430896282
of O 0 0.0021150107495486736
the O 0 0.0070640929043293
patients O 1 0.9998787641525269
showed O 1 0.9995179176330566
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.005154700484126806
the O 0 0.004813568666577339
other O 0 0.002025468274950981
later O 0 0.006186314392834902
developed O 0 0.02475210838019848
bilateral B-Disease 1 0.8679125308990479
retinoblastoma I-Disease 1 0.9999935626983643
. O 0 0.02335444465279579

In O 0 0.010532330721616745
conclusion O 0 0.010002519935369492
, O 0 0.004595176316797733
our O 0 0.0035591181367635727
results O 0 0.003071720013394952
emphasize O 0 0.006139986217021942
that O 0 0.0016979509964585304
the O 0 0.003698555752635002
manifestation O 1 0.9842180013656616
and O 0 0.005690416321158409
transmissibility O 1 0.9990411400794983
of O 0 0.05412427708506584
retinoblastoma B-Disease 1 0.9999756813049316
depend O 0 0.003431289456784725
on O 0 0.0018244582461193204
the O 0 0.001618908136151731
nature O 0 0.002097407355904579
of O 0 0.0018291666638106108
the O 0 0.002314747078344226
first O 0 0.002632164629176259
mutation O 0 0.002601378131657839
, O 0 0.001019488787278533
its O 0 0.0008523291326127946
time O 0 0.001067840843461454
in O 0 0.0012649254640564322
development O 0 0.0025568765122443438
, O 0 0.0012568035162985325
and O 0 0.000928218534681946
the O 0 0.00147715350612998
number O 0 0.0012578346068039536
and O 0 0.0010758809512481093
types O 0 0.0018580385949462652
of O 0 0.0034274691715836525
cells O 0 0.004843906499445438
that O 0 0.0015211505815386772
are O 0 0.0017078111413866282
affected O 0 0.005686197895556688
. O 0 0.005125217139720917
. O 0 0.010158470831811428

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9399383664131165
the I-Disease 1 0.9836693406105042
fifth I-Disease 1 0.9999792575836182
component I-Disease 0 0.41131454706192017
of I-Disease 0 0.007404870819300413
complement I-Disease 0 0.012378642335534096
in O 0 0.0075098066590726376
man O 0 0.032770801335573196
. O 0 0.016220256686210632

I O 1 0.5313988924026489
. O 0 0.034111425280570984

Clinical O 1 0.991367518901825
, O 0 0.01816747523844242
immunochemical O 1 0.9993088245391846
, O 0 0.007382904179394245
and O 0 0.004889575764536858
family O 0 0.012784897349774837
studies O 0 0.01671777293086052
. O 0 0.01778394542634487

The O 0 0.011176777072250843
first O 0 0.007879539392888546
recognized O 0 0.009544312953948975
human O 0 0.012821925804018974
kindred O 1 0.9999629259109497
with O 1 0.5234026908874512
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9975674152374268
the I-Disease 1 0.9779618978500366
fifth I-Disease 1 0.9985687732696533
component I-Disease 0 0.012336112558841705
of I-Disease 0 0.004983296152204275
complement I-Disease 0 0.045899633318185806
( O 0 0.01858919858932495
C5 O 1 0.9995799660682678
) O 0 0.0049683465622365475
is O 0 0.00526761868968606
described O 0 0.014534185640513897
. O 0 0.01367214322090149

The O 0 0.013937361538410187
proband O 0 0.060050852596759796
, O 0 0.004348273854702711
a O 0 0.0038516365457326174
20 O 0 0.00437304237857461
- O 0 0.006981383077800274
year O 0 0.0034145971294492483
- O 0 0.00780857726931572
old O 0 0.009986289776861668
black O 0 0.015610859729349613
female O 1 0.5275771021842957
with O 1 0.9929383397102356
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.999988317489624
age O 1 0.9994891881942749
11 O 0 0.2581566274166107
, O 0 0.009156189858913422
lacked O 1 0.9353986978530884
serum O 1 0.9999834299087524
hemolytic O 1 0.9999997615814209
complement O 0 0.016659462824463844
activity O 0 0.004785607103258371
, O 0 0.0032538350205868483
even O 0 0.003696874249726534
during O 0 0.013952148146927357
remission O 1 0.9993637204170227
. O 0 0.016714928671717644

C5 O 1 0.9998425245285034
was O 0 0.11611466109752655
undetectable O 1 0.9675768613815308
in O 0 0.00682385079562664
her O 0 0.04724881052970886
serum O 1 0.9645866751670837
by O 0 0.0031622308306396008
both O 0 0.004980811849236488
immunodiffusion O 1 0.9996836185455322
and O 0 0.01759467087686062
hemolytic O 1 0.9999998807907104
assays O 0 0.39012986421585083
. O 0 0.02398945391178131

Other O 0 0.00631842901930213
complement O 0 0.009032503701746464
components O 0 0.005366051569581032
were O 0 0.0032877949997782707
normal O 0 0.005304649472236633
during O 0 0.00897280965000391
remission O 1 0.9999053478240967
of O 1 0.9886642098426819
lupus O 1 1.0
, O 0 0.14849801361560822
but O 0 0.005288789048790932
C1 O 1 0.9999980926513672
, O 0 0.006787992548197508
C4 O 1 0.9998857975006104
, O 0 0.00620736088603735
C2 O 1 0.9999899864196777
, O 0 0.003925753757357597
and O 0 0.0048396047204732895
C3 O 1 0.9999895095825195
levels O 0 0.014334429055452347
fell O 1 0.5464208722114563
during O 0 0.043662019073963165
exacerbations O 1 0.9999833106994629
. O 0 0.022711673751473427

A O 0 0.02259325049817562
younger O 0 0.021000327542424202
half O 0 0.008640358224511147
- O 0 0.022249286994338036
sister O 0 0.016272971406579018
, O 0 0.002687961095944047
who O 0 0.0031590310391038656
had O 0 0.004022909794002771
no O 0 0.005899021867662668
underlying O 1 0.9999972581863403
disease O 1 1.0
, O 0 0.04801094904541969
was O 0 0.4792073667049408
also O 0 0.002504432573914528
found O 0 0.0027273783925920725
to O 0 0.003337988629937172
lack O 0 0.018319159746170044
immunochemically O 1 0.999849796295166
detectable O 1 0.9989853501319885
C5 O 1 0.9999759197235107
. O 0 0.02290322259068489

By O 0 0.021289605647325516
hemolytic O 1 0.9999996423721313
assay O 0 0.4872435927391052
, O 0 0.00723734637722373
she O 0 0.007725351955741644
exhibited O 0 0.013192414306104183
1 O 0 0.0074590896256268024
- O 0 0.005972746759653091
2 O 0 0.0030084275640547276
% O 0 0.0014530280604958534
of O 0 0.0015527530340477824
the O 0 0.003851504996418953
normal O 0 0.027459999546408653
serum O 1 0.9999160766601562
C5 O 1 0.9925001263618469
level O 0 0.0041812872514128685
and O 0 0.0020455610938370228
normal O 0 0.003395406762138009
concentrations O 0 0.0044127414003014565
of O 0 0.0023895155172795057
other O 0 0.0027207571547478437
complement O 0 0.01392005942761898
components O 0 0.016579341143369675
. O 0 0.014795391820371151

C5 O 1 0.998884379863739
levels O 0 0.00870404951274395
of O 0 0.0035356224980205297
other O 0 0.0016442567575722933
family O 0 0.0035239960998296738
members O 0 0.0012915977276861668
were O 0 0.0012106605572625995
either O 0 0.001651189522817731
normal O 0 0.0025175295304507017
or O 0 0.001430732780136168
approximately O 0 0.002651941729709506
half O 0 0.0030228388495743275
- O 0 0.006981337442994118
normal O 0 0.0031916878651827574
, O 0 0.00203136308118701
consistent O 0 0.004010575357824564
with O 0 0.002478472888469696
autosomal O 1 0.9326910972595215
codominant O 1 0.9990403056144714
inheritance O 0 0.06386809051036835
of O 0 0.010589567013084888
the O 0 0.38993605971336365
gene O 1 0.6501583456993103
determining O 1 0.9864200949668884
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.03418990969657898

Normal O 0 0.4093051552772522
hemolytic O 1 0.9999963045120239
titers O 1 0.9518560171127319
were O 0 0.00717603974044323
restored O 0 0.009453442879021168
to O 0 0.00258607417345047
both O 0 0.003353652311488986
homozygous O 0 0.27320870757102966
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999669790267944
deficient I-Disease 1 0.9999997615814209
( O 0 0.38225457072257996
C5D B-Disease 1 0.9999997615814209
) O 0 0.0056322673335671425
sera O 0 0.13290385901927948
by O 0 0.0017299947794526815
addition O 0 0.002591866534203291
of O 0 0.0035977265797555447
highly O 0 0.023077547550201416
purified O 1 0.9971266388893127
human O 1 0.6421862840652466
C5 O 1 0.9999659061431885
. O 0 0.021681929007172585

In O 0 0.013892739079892635
specific O 0 0.012811535969376564
C5 O 1 0.9998620748519897
titrations O 1 0.9393231868743896
, O 0 0.004754144232720137
however O 0 0.0029463262762874365
, O 0 0.0023226242046803236
it O 0 0.0014142130967229605
was O 0 0.004348973743617535
noted O 0 0.002755439840257168
that O 0 0.0010070926509797573
when O 0 0.0015293856849893928
limited O 0 0.0017573024379089475
amounts O 0 0.003045292804017663
of O 0 0.00546323461458087
C5 O 1 0.9983558058738708
were O 0 0.0032800473272800446
assayed O 0 0.011009307578206062
in O 0 0.0025116559118032455
the O 0 0.0027819459792226553
presence O 0 0.003003238933160901
of O 0 0.0032832983415573835
low O 0 0.008295261301100254
dilutions O 0 0.02714681811630726
of O 0 0.006214008666574955
either O 0 0.012042870745062828
C5D B-Disease 1 0.9999998807907104
serum O 1 0.9998378753662109
, O 0 0.003985727205872536
curving O 0 0.010075060650706291
rather O 0 0.0027282980736345053
than O 0 0.002355454722419381
linear O 0 0.008446728810667992
dose O 0 0.44395366311073303
- O 0 0.008640631102025509
response O 0 0.0028870240785181522
plots O 0 0.004075905773788691
were O 0 0.002275908598676324
consistently O 0 0.004263763781636953
obtained O 0 0.0034775894600898027
, O 0 0.003030861960723996
suggesting O 0 0.005887283012270927
some O 0 0.0033261466305702925
inhibitory O 0 0.02119550295174122
effect O 0 0.011012952774763107
. O 0 0.012499259784817696

Further O 0 0.00954411644488573
studies O 0 0.0051668682135641575
suggested O 0 0.0054555064998567104
that O 0 0.0021218389738351107
low O 0 0.0070903729647397995
dilutions O 0 0.04949801787734032
of O 0 0.014228095300495625
C5D B-Disease 1 1.0
serum O 1 0.9982861876487732
contain O 0 0.005736737512052059
a O 0 0.004676954820752144
factor O 0 0.007043166551738977
( O 0 0.003140707965940237
or O 0 0.0019153282046318054
factors O 0 0.0029891219455748796
) O 0 0.0025457271840423346
interfering O 0 0.004108260851353407
at O 0 0.002796665532514453
some O 0 0.0014795017195865512
step O 0 0.0036468321923166513
in O 0 0.0029166925232857466
the O 0 0.00674476008862257
hemolytic O 1 0.9999991655349731
assay O 0 0.11089696735143661
of O 0 0.020321326330304146
C5 O 1 0.9999239444732666
, O 0 0.0029113241471350193
rather O 0 0.0020714832935482264
than O 0 0.001526002073660493
a O 0 0.004469364415854216
true O 0 0.021142056211829185
C5 O 1 0.9999842643737793
inhibitor O 1 0.9977483153343201
or O 0 0.015550638549029827
inactivator O 1 0.9765787124633789
. O 0 0.02030855417251587

Of O 0 0.01370185799896717
clinical O 0 0.3097657561302185
interest O 0 0.004548170603811741
are O 0 0.0016651833429932594
( O 0 0.002646307460963726
a O 0 0.0024414139334112406
) O 0 0.002075563184916973
the O 0 0.002135063521564007
documentation O 0 0.007974592968821526
of O 0 0.014823591336607933
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.999990701675415
vasculitis B-Disease 1 1.0
, O 1 0.999900221824646
and O 1 0.9987188577651978
arthritis B-Disease 1 1.0
in O 0 0.08620130270719528
an O 0 0.004961473401635885
individual O 0 0.004301321692764759
lacking O 1 0.8781214356422424
C5 O 1 0.9999879598617554
( O 0 0.0038130159955471754
and O 0 0.0017236036946997046
its O 0 0.0025789213832467794
biologic O 1 0.6956345438957214
functions O 0 0.0030092215165495872
) O 0 0.0019525163806974888
, O 0 0.0017865754198282957
and O 0 0.001860039192251861
( O 0 0.004289442207664251
b O 0 0.006646424997597933
) O 0 0.0019561825320124626
a O 0 0.0020412744488567114
remarkable O 0 0.006926923990249634
propensity O 0 0.027379484847187996
to O 0 0.005486856680363417
bacterial B-Disease 1 0.9999998807907104
infections I-Disease 1 1.0
in O 0 0.009833588264882565
the O 0 0.05244734510779381
proband O 1 0.9943195581436157
, O 0 0.0020885169506073
even O 0 0.001344437012448907
during O 0 0.0024217211175709963
periods O 0 0.0035984034184366465
of O 0 0.004079329315572977
low O 0 0.012677931226789951
- O 0 0.013383098877966404
dose O 0 0.013192183338105679
or O 0 0.0030513708479702473
alternate O 0 0.009813115932047367
- O 0 0.02433095872402191
day O 0 0.02091905288398266
corticosteroid O 1 0.9999345541000366
therapy O 1 0.9993261098861694
. O 0 0.02209167554974556

Other O 0 0.005885904189199209
observations O 0 0.008043312467634678
indicate O 0 0.005334783345460892
that O 0 0.0022507591638714075
the O 0 0.004835521336644888
C5D B-Disease 1 0.9999910593032837
state O 0 0.003538647433742881
is O 0 0.002429940504953265
compatible O 0 0.0034298792015761137
with O 0 0.001778568490408361
normal O 0 0.006667017005383968
coagulation O 1 0.9494823217391968
function O 0 0.0035800135228782892
and O 0 0.0016634308267384768
the O 0 0.0025270343758165836
capacity O 0 0.004196949303150177
to O 0 0.0024018448311835527
mount O 0 0.10946094244718552
a O 0 0.014364467933773994
neutrophilic O 1 0.9999980926513672
leukocytosis O 1 0.9999971389770508
during O 1 0.998958945274353
pyogenic B-Disease 1 0.9999994039535522
infection I-Disease 1 0.9999997615814209
. O 0 0.013155721127986908
. O 0 0.015496348962187767

Susceptibility O 1 0.9976242184638977
to O 0 0.048177409917116165
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9618275761604309
twins O 1 0.9662184119224548
: O 0 0.004457294009625912
the O 0 0.0027332718018442392
role O 0 0.0036383105907589197
of O 0 0.003337468486279249
genes O 0 0.007270283531397581
, O 0 0.00844806432723999
HLA O 1 0.9999990463256836
, O 0 0.004497555550187826
and O 0 0.002882903441786766
the O 0 0.006513170897960663
environment O 0 0.01657131128013134
. O 0 0.013350863009691238

OBJECTIVE O 0 0.0220475010573864
To O 0 0.004011169541627169
determine O 0 0.0037277762312442064
the O 0 0.003270403016358614
relative O 0 0.0049108280800282955
effects O 0 0.004573076032102108
of O 0 0.003077344037592411
genetic O 0 0.005203013774007559
and O 0 0.0022862202022224665
environmental O 0 0.005297282710671425
factors O 0 0.004304890986531973
in O 0 0.004659825470298529
susceptibility O 1 0.9973697662353516
to O 0 0.22343195974826813
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999985694885254
AS B-Disease 1 0.9999934434890747
) O 0 0.015576720237731934
. O 0 0.010394257493317127

METHODS O 0 0.02040465921163559
Twins O 0 0.0198360625654459
with O 0 0.002782210474833846
AS B-Disease 0 0.00601613475009799
were O 0 0.0016522990772500634
identified O 0 0.00250525726005435
from O 0 0.001546809682622552
the O 0 0.0024309682194143534
Royal O 1 0.9129483699798584
National O 1 0.9997852444648743
Hospital O 1 1.0
for O 1 0.9999465942382812
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9987444877624512
. O 0 0.023687586188316345

Clinical O 1 0.6026775240898132
and O 0 0.009259155951440334
radiographic O 1 0.8059393763542175
examinations O 0 0.01574552431702614
were O 0 0.0027026860043406487
performed O 0 0.003499896265566349
to O 0 0.0016323536401614547
establish O 0 0.006955862510949373
diagnoses O 1 0.9999690055847168
, O 0 0.009304055012762547
and O 0 0.2074594497680664
disease O 1 1.0
severity O 1 0.9999986886978149
was O 1 0.9772400259971619
assessed O 0 0.006415524985641241
using O 0 0.0021573142148554325
a O 0 0.0025928309187293053
combination O 0 0.003997501451522112
of O 0 0.004300294443964958
validated O 0 0.010696189478039742
scoring O 0 0.008193576708436012
systems O 0 0.01613057777285576
. O 0 0.013673718087375164

HLA O 1 0.9998929500579834
typing O 0 0.05920863151550293
for O 0 0.01620934158563614
HLA O 1 0.9999992847442627
- O 0 0.25609061121940613
B27 O 1 0.5946698784828186
, O 0 0.012769078835844994
HLA O 1 0.9999990463256836
- O 0 0.03297017887234688
B60 O 0 0.03846092149615288
, O 0 0.005357334390282631
and O 0 0.007853413000702858
HLA O 1 0.9999998807907104
- O 1 0.9986473917961121
DR1 O 1 0.9999125003814697
was O 0 0.009711218997836113
performed O 0 0.006173629779368639
by O 0 0.002947245491668582
polymerase O 0 0.01212127786129713
chain O 0 0.006372483912855387
reaction O 0 0.0030573385301977396
with O 0 0.0016236084047704935
sequence O 0 0.0032443564850836992
- O 0 0.0047415620647370815
specific O 0 0.0019724108278751373
primers O 0 0.009416013024747372
, O 0 0.0027951300144195557
and O 0 0.0029959760140627623
zygosity O 0 0.05255600064992905
was O 0 0.009176379069685936
assessed O 0 0.010511832311749458
using O 0 0.006983267143368721
microsatellite O 0 0.13502494990825653
markers O 0 0.0502457469701767
. O 0 0.01781531795859337

Genetic O 0 0.024206561967730522
and O 0 0.005720965564250946
environmental O 0 0.008737802505493164
variance O 0 0.005694512743502855
components O 0 0.004728544037789106
were O 0 0.002261490561068058
assessed O 0 0.004346977919340134
with O 0 0.0017049852758646011
the O 0 0.003750592702999711
program O 0 0.007416600827127695
Mx O 1 0.5501441359519958
, O 0 0.0017739497125148773
using O 0 0.0011846619891002774
data O 0 0.0011768019758164883
from O 0 0.0009201127686537802
this O 0 0.0007210723124444485
and O 0 0.001108587603084743
previous O 0 0.0018095882842317224
studies O 0 0.002457177033647895
of O 0 0.0038336943835020065
twins O 1 0.6708650588989258
with O 0 0.005262000486254692
AS B-Disease 1 0.9956011772155762
. O 0 0.014791479334235191

RESULTS O 0 0.012629538774490356
Six O 0 0.005574799608439207
of O 0 0.005519428290426731
8 O 0 0.013187267817556858
monozygotic O 0 0.40633925795555115
( O 0 0.016838770359754562
MZ O 1 0.9999603033065796
) O 0 0.006147005595266819
twin O 0 0.011318620294332504
pairs O 0 0.005952005740255117
were O 0 0.005184624344110489
disease O 1 0.9999958276748657
concordant O 1 0.9731950759887695
, O 0 0.0039138528518378735
compared O 0 0.0027366685681045055
with O 0 0.0014046230353415012
4 O 0 0.0030544970650225878
of O 0 0.0027205038350075483
15 O 0 0.005678379908204079
B27 O 0 0.04772789776325226
- O 0 0.010648692958056927
positive O 0 0.006682996172457933
dizygotic O 0 0.09065290540456772
( O 0 0.009871304035186768
DZ O 1 0.999536395072937
) O 0 0.004343452397733927
twin O 0 0.00817115232348442
pairs O 0 0.003983486443758011
( O 0 0.0036892618518322706
27 O 0 0.00437846640124917
% O 0 0.002388967899605632
) O 0 0.0017860279185697436
and O 0 0.0015652402071282268
4 O 0 0.003562735626474023
of O 0 0.0034249327145516872
32 O 0 0.009944623336195946
DZ O 1 0.998566210269928
twin O 0 0.013591626659035683
pairs O 0 0.005376587621867657
overall O 0 0.006115182768553495
( O 0 0.0034725265577435493
12 O 0 0.0031983836088329554
. O 0 0.0018039648421108723
5 O 0 0.004425849765539169
% O 0 0.004359382204711437
) O 0 0.006488048005849123
. O 0 0.008247939869761467

Nonsignificant O 1 0.9260347485542297
increases O 0 0.009253610856831074
in O 0 0.0032207940239459276
similarity O 0 0.0039027335587888956
with O 0 0.0013960093492642045
regard O 0 0.0030290631111711264
to O 0 0.0018968784715980291
age O 0 0.007617074064910412
at O 1 0.8974021077156067
disease O 1 1.0
onset O 1 0.9999994039535522
and O 0 0.002811248879879713
all O 0 0.001565326121635735
of O 0 0.00397967454046011
the O 1 0.786289632320404
disease O 1 1.0
severity O 1 0.9996557235717773
scores O 0 0.004602537024766207
assessed O 0 0.004512527491897345
were O 0 0.0016408038791269064
noted O 0 0.00420683529227972
in O 0 0.006982559338212013
disease O 1 0.9999998807907104
- O 1 0.9988810420036316
concordant O 1 0.9996929168701172
MZ O 1 0.9999994039535522
twins O 0 0.1317186802625656
compared O 0 0.01099217776209116
with O 0 0.008574027568101883
concordant O 1 0.9929317235946655
DZ O 1 0.9999971389770508
twins O 1 0.9080073833465576
. O 0 0.023809345439076424

HLA O 1 0.9999988079071045
- O 0 0.3912408947944641
B27 O 0 0.04361803084611893
and O 0 0.0043763406574726105
B60 O 0 0.018132857978343964
were O 0 0.0022968659177422523
associated O 0 0.0025357045233249664
with O 0 0.0019519858760759234
the O 1 0.508032500743866
disease O 1 1.0
in O 0 0.05478803440928459
probands O 1 0.9998726844787598
, O 0 0.002179841510951519
and O 0 0.0016052520368248224
the O 0 0.0024081463925540447
rate O 0 0.003611278487369418
of O 0 0.006285098847001791
disease O 1 0.9999998807907104
concordance O 1 0.9605516195297241
was O 1 0.7487373948097229
significantly O 0 0.005391280632466078
increased O 0 0.0033356891945004463
among O 0 0.004250082653015852
DZ O 1 0.999940037727356
twin O 0 0.01273970678448677
pairs O 0 0.0029873065650463104
in O 0 0.0015063859755173326
which O 0 0.0015557671431452036
the O 0 0.004204956348985434
co O 1 0.9652596116065979
- O 0 0.07353926450014114
twin O 0 0.01618274860084057
was O 0 0.006811991333961487
positive O 0 0.0034183929674327374
for O 0 0.0024469178169965744
both O 0 0.004344557411968708
B27 O 0 0.4202178120613098
and O 0 0.013012207113206387
DR1 O 1 0.9997714161872864
. O 0 0.022559452801942825

Additive O 0 0.06885124742984772
genetic O 0 0.015899645164608955
effects O 0 0.00883402954787016
were O 0 0.00284403283149004
estimated O 0 0.0031213939655572176
to O 0 0.0017629400826990604
contribute O 0 0.003509349888190627
97 O 0 0.0075751906260848045
% O 0 0.0025880038738250732
of O 0 0.0025257235392928123
the O 0 0.004735683556646109
population O 0 0.005967514589428902
variance O 0 0.013345655985176563
. O 0 0.014532697387039661

CONCLUSION O 0 0.03397313132882118
Susceptibility O 0 0.10544714331626892
to O 0 0.004445384256541729
AS B-Disease 0 0.014390089549124241
is O 0 0.002479838440194726
largely O 0 0.0031862070318311453
genetically O 0 0.0027521413285285234
determined O 0 0.002630640286952257
, O 0 0.0014298026217147708
and O 0 0.0011706682853400707
the O 0 0.002315251622349024
environmental O 0 0.005943984724581242
trigger O 0 0.0061841970309615135
for O 0 0.002831608522683382
the O 0 0.491948664188385
disease O 1 1.0
is O 0 0.05787397176027298
probably O 0 0.01793503947556019
ubiquitous O 0 0.050911352038383484
. O 0 0.015460294671356678

HLA O 1 0.9999988079071045
- O 0 0.19853441417217255
B27 O 0 0.029571743682026863
accounts O 0 0.004121674224734306
for O 0 0.0020172419026494026
a O 0 0.002586999675258994
minority O 0 0.0026483938563615084
of O 0 0.002600576728582382
the O 0 0.005281704943627119
overall O 1 0.8105282187461853
genetic O 0 0.06324958056211472
susceptibility O 1 0.8724240064620972
to O 0 0.0053068711422383785
AS B-Disease 1 0.7533550262451172
. O 0 0.013064462691545486

Cell O 0 0.07577981054782867
cycle O 0 0.03798380866646767
- O 0 0.020009728148579597
dependent O 0 0.011431893333792686
colocalization O 0 0.04012631997466087
of O 0 0.010332876816391945
BARD1 O 1 0.9999762773513794
and O 0 0.008565304800868034
BRCA1 O 1 0.9805717468261719
proteins O 0 0.004887482617050409
in O 0 0.0041585396975278854
discrete O 0 0.011137436144053936
nuclear O 0 0.014866994693875313
domains O 0 0.021459398791193962
. O 0 0.014263257384300232

Germ O 1 0.9999481439590454
- O 0 0.08848067373037338
line O 0 0.011198941618204117
mutations O 0 0.006229543127119541
of O 0 0.004588006529957056
the O 0 0.012272379361093044
BRCA1 O 1 0.9998103976249695
gene O 0 0.009953583590686321
predispose O 0 0.013710856437683105
women O 0 0.0039227791130542755
to O 0 0.002435475355014205
early O 0 0.01072879321873188
- O 1 0.9995444416999817
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.999994158744812
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.008123156614601612
compromising O 1 0.9563494920730591
the O 0 0.007092632818967104
genes O 0 0.006123051512986422
presumptive O 1 0.9967781901359558
function O 0 0.005604421254247427
as O 0 0.006063996348530054
a O 0 0.045201532542705536
tumor B-Disease 1 0.9999997615814209
suppressor O 1 0.9996875524520874
. O 0 0.019790612161159515

Although O 0 0.009044607169926167
the O 0 0.00689711282029748
biochemical O 0 0.011490012519061565
properties O 0 0.007832175120711327
of O 0 0.012858746573328972
BRCA1 O 1 0.9999533891677856
polypeptides O 0 0.011706539429724216
are O 0 0.0017405867110937834
not O 0 0.001438142266124487
understood O 0 0.004375264048576355
, O 0 0.002162838587537408
their O 0 0.0019209168385714293
expression O 0 0.004055435303598642
pattern O 0 0.0061438921838998795
and O 0 0.0029646449256688356
subcellular O 0 0.015042359009385109
localization O 0 0.009630031883716583
suggest O 0 0.003742263885214925
a O 0 0.002951781963929534
role O 0 0.005144157912582159
in O 0 0.004627525806427002
cell O 0 0.08070135861635208
- O 0 0.058272331953048706
cycle O 0 0.01959163136780262
regulation O 0 0.015368500724434853
. O 0 0.01364488061517477

When O 0 0.016216710209846497
resting O 1 0.9503335952758789
cells O 0 0.01006939448416233
are O 0 0.00233260216191411
induced O 0 0.013438466005027294
to O 0 0.002907007234171033
proliferate O 0 0.007946469821035862
, O 0 0.002452509943395853
the O 0 0.0035647235345095396
steady O 0 0.009936455637216568
- O 0 0.005936373956501484
state O 0 0.001968440366908908
levels O 0 0.003432727884501219
of O 0 0.003376516280695796
BRCA1 O 1 0.756462574005127
increase O 0 0.0029088929295539856
in O 0 0.002716036280617118
late O 0 0.009497413411736488
G1 O 1 0.9897235631942749
and O 0 0.0020258876029402018
reach O 0 0.002758860355243087
a O 0 0.0026147346943616867
maximum O 0 0.005407133139669895
during O 0 0.009328797459602356
S O 1 0.9748275876045227
phase O 0 0.03645366057753563
. O 0 0.011608111672103405

Moreover O 0 0.018774274736642838
, O 0 0.006194909568876028
in O 0 0.00613338453695178
S O 1 0.9767343997955322
phase O 0 0.3365029990673065
cells O 0 0.008924609050154686
, O 0 0.004104209132492542
BRCA1 O 0 0.035902880132198334
polypeptides O 0 0.00961325503885746
are O 0 0.002281988738104701
hyperphosphorylated O 0 0.02114565297961235
and O 0 0.0028429836966097355
accumulate O 0 0.007412171922624111
into O 0 0.0038804765790700912
discrete O 0 0.010921363718807697
subnuclear O 0 0.24178309738636017
foci O 1 0.6665573120117188
termed O 1 0.9561383128166199
" O 0 0.14481939375400543
BRCA1 O 1 0.9993996620178223
nuclear O 0 0.02130075730383396
dots O 0 0.03913234919309616
. O 0 0.014849293977022171

" O 0 0.08964438736438751
BRCA1 O 1 0.9973247051239014
associates O 0 0.03025282360613346
in O 0 0.005395695101469755
vivo O 0 0.01261519268155098
with O 0 0.0027767044957727194
a O 0 0.005589643958956003
structurally O 0 0.16093461215496063
related O 0 0.012462797574698925
protein O 0 0.018179867416620255
termed O 0 0.376415491104126
BARD1 O 1 0.9998631477355957
. O 0 0.020308813080191612

Here O 0 0.00943500641733408
we O 0 0.0028811534866690636
show O 0 0.0028631396126002073
that O 0 0.0012839875416830182
the O 0 0.002328184200450778
steady O 0 0.00852543581277132
- O 0 0.005629055667668581
state O 0 0.0021607193630188704
levels O 0 0.0034597504418343306
of O 0 0.0034704154822975397
BARD1 O 1 0.9962517619132996
, O 0 0.0025798671413213015
unlike O 0 0.0029186068568378687
those O 0 0.0015876905526965857
of O 0 0.004146875813603401
BRCA1 O 1 0.9954612851142883
, O 0 0.003073229920119047
remain O 0 0.0032700374722480774
relatively O 0 0.0034273522906005383
constant O 0 0.0068652634508907795
during O 0 0.011991136707365513
cell O 0 0.22683657705783844
cycle O 0 0.11335106194019318
progression O 1 0.9626487493515015
. O 0 0.01705971360206604

However O 0 0.01496924553066492
, O 0 0.01016306970268488
immunostaining O 1 0.5430842638015747
revealed O 0 0.015615652315318584
that O 0 0.00455799326300621
BARD1 O 1 0.9947869777679443
resides O 0 0.01968652382493019
within O 0 0.005818061530590057
BRCA1 O 1 0.9443151950836182
nuclear O 0 0.008876798674464226
dots O 0 0.012675866484642029
during O 0 0.0075368573889136314
S O 0 0.09513161331415176
phase O 0 0.007269511930644512
of O 0 0.0035621465649455786
the O 0 0.004764691926538944
cell O 0 0.008319326676428318
cycle O 0 0.005557006224989891
, O 0 0.0018070791848003864
but O 0 0.001159148057922721
not O 0 0.0012294456828385592
during O 0 0.0051964824087917805
the O 0 0.009479881264269352
G1 O 1 0.9998369216918945
phase O 0 0.04828917607665062
. O 0 0.015140187926590443

Nevertheless O 0 0.038489241153001785
, O 0 0.015789004042744637
BARD1 O 1 0.9761729836463928
polypeptides O 0 0.014259998686611652
are O 0 0.0020403554663062096
found O 0 0.002612668788060546
exclusively O 0 0.002373031573370099
in O 0 0.001771524315699935
the O 0 0.0023194013629108667
nuclear O 0 0.002899310551583767
fractions O 0 0.0030458406545221806
of O 0 0.002426387509331107
both O 0 0.003489786060526967
G1 O 1 0.99996018409729
- O 0 0.019476426765322685
and O 0 0.005403070244938135
S O 1 0.997974693775177
- O 0 0.08073345571756363
phase O 0 0.057491205632686615
cells O 0 0.01522139273583889
. O 0 0.011179248802363873

Therefore O 0 0.015834195539355278
, O 0 0.008407537825405598
progression O 0 0.29741936922073364
to O 0 0.005237473174929619
S O 1 0.9808581471443176
phase O 0 0.011655871756374836
is O 0 0.0024144919589161873
accompanied O 0 0.004575635772198439
by O 0 0.001411436009220779
the O 0 0.0024260631762444973
aggregation O 0 0.005774360615760088
of O 0 0.0045683314092457294
nuclear O 0 0.01063473429530859
BARD1 O 1 0.8219826817512512
polypeptides O 0 0.021046960726380348
into O 0 0.008845072239637375
BRCA1 O 1 0.8476701378822327
nuclear O 0 0.019226569682359695
dots O 0 0.03988741710782051
. O 0 0.015825161710381508

This O 0 0.011200346052646637
cell O 0 0.020176202058792114
cycle O 0 0.019245781004428864
- O 0 0.01485223788768053
dependent O 0 0.006984868552535772
colocalization O 0 0.023740362375974655
of O 0 0.006527442019432783
BARD1 O 1 0.9999768733978271
and O 0 0.005816186312586069
BRCA1 O 1 0.9864913821220398
indicates O 0 0.005602763034403324
a O 0 0.0027874941006302834
role O 0 0.003787803230807185
for O 0 0.003128983546048403
BARD1 O 1 0.9995359182357788
in O 0 0.011650348082184792
BRCA1 O 1 0.9999973773956299
- O 1 0.9993380904197693
mediated O 1 0.9972215890884399
tumor B-Disease 1 0.9999991655349731
suppression O 1 0.9999042749404907
. O 0 0.024857522919774055

Ethnic O 0 0.010716436430811882
differences O 0 0.0070511833764612675
in O 0 0.005485155154019594
the O 0 0.010312149301171303
HFE O 1 0.9998257756233215
codon O 0 0.040290962904691696
282 O 0 0.31259724497795105
( O 0 0.026105783879756927
Cys O 1 0.9999675750732422
/ O 1 0.9981233477592468
Tyr O 1 0.9998446702957153
) O 0 0.01809505559504032
polymorphism O 0 0.03662586212158203
. O 0 0.01495518907904625

Recent O 0 0.009606689214706421
studies O 0 0.005211624316871166
have O 0 0.0023889143485575914
shown O 0 0.005141508765518665
that O 0 0.006362560670822859
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.02549685165286064
is O 0 0.002417605370283127
likely O 0 0.0019573671743273735
to O 0 0.0015439711278304458
be O 0 0.0016467258101329207
caused O 0 0.004170761443674564
by O 0 0.0022178019862622023
homozygosity O 0 0.019026685506105423
for O 0 0.0024004399310797453
a O 0 0.004219794180244207
Cys282Tyr O 1 0.5513265132904053
mutation O 0 0.005172839853912592
in O 0 0.0029730868991464376
the O 0 0.0075021120719611645
HFE O 1 0.9999836683273315
gene O 0 0.012719569727778435
located O 0 0.014207097701728344
4 O 0 0.01554947067052126
. O 0 0.012034907937049866

5 O 0 0.04011916741728783
Mb O 1 0.7891655564308167
telomeric O 1 0.8006852269172668
to O 0 0.01988881081342697
HLA O 1 0.9999995231628418
- O 0 0.4772025942802429
A O 0 0.03202861547470093
. O 0 0.020114319398999214

Population O 0 0.008549712598323822
studies O 0 0.005627996288239956
of O 0 0.0037572139408439398
this O 0 0.0026055248454213142
polymorphism O 0 0.005376575049012899
are O 0 0.0010818493319675326
facilitated O 0 0.004211191087961197
by O 0 0.0015388942556455731
the O 0 0.002648203633725643
fact O 0 0.0029755262657999992
that O 0 0.0016320054419338703
the O 0 0.00461479602381587
Cys282Tyr O 1 0.9876605272293091
mutation O 0 0.009585131891071796
creates O 0 0.008596954867243767
a O 0 0.008117296732962132
Rsal O 1 0.8930401802062988
restriction O 0 0.020431092008948326
site O 0 0.022318974137306213
. O 0 0.015446437522768974

We O 0 0.0064715174958109856
have O 0 0.0025239090900868177
studied O 0 0.006324599497020245
the O 0 0.005501626990735531
codon O 0 0.021635953336954117
282 O 0 0.1643480509519577
( O 0 0.024679098278284073
Cys O 1 0.9999814033508301
/ O 1 0.9985772371292114
Tyr O 1 0.9996674060821533
) O 0 0.005244918167591095
polymorphism O 0 0.005263033322989941
in O 0 0.0018831347115337849
different O 0 0.0015670888824388385
ethnic O 0 0.0046753608621656895
groups O 0 0.005869760178029537
. O 0 0.013116794638335705

In O 0 0.00671981880441308
agreement O 0 0.003994076047092676
with O 0 0.002040906110778451
previous O 0 0.003555070608854294
observations O 0 0.005566801410168409
the O 0 0.006531484890729189
Tyr O 1 0.9999812841415405
allele O 0 0.010909534059464931
appeared O 0 0.0035026012919843197
to O 0 0.0015021696453914046
be O 0 0.001342658419162035
rare O 0 0.0034511475823819637
or O 0 0.0022541109938174486
absent O 0 0.006995359901338816
in O 0 0.004213688895106316
Asiatic O 1 0.9990299940109253
( O 0 0.00519985007122159
Indian O 0 0.005026767961680889
, O 0 0.004069103393703699
Chinese O 0 0.01084416639059782
) O 0 0.0061202142387628555
populations O 0 0.007580848410725594
. O 0 0.010197747498750687

The O 0 0.01351961400359869
highest O 0 0.017597101628780365
allele O 0 0.010035933926701546
frequency O 0 0.004424950573593378
( O 0 0.0030906363390386105
7 O 0 0.0034825587645173073
. O 0 0.0017050447640940547
5 O 0 0.002779092639684677
% O 0 0.0023700350429862738
) O 0 0.002209470374509692
was O 0 0.003993600141257048
found O 0 0.0035689077340066433
in O 0 0.0050989375449717045
Swedes O 0 0.028683846816420555
. O 0 0.014516494236886501

Saamis O 1 0.7240328192710876
( O 0 0.014321970753371716
2 O 0 0.009042300283908844
% O 0 0.004208691883832216
) O 0 0.0028058537282049656
and O 0 0.0021863034926354885
Mordvinians O 0 0.05510460212826729
( O 0 0.0042578731663525105
1 O 0 0.004209491424262524
. O 0 0.0017096365336328745
8 O 0 0.00382917164824903
% O 0 0.0026997774839401245
) O 0 0.0024493762757629156
had O 0 0.0028341275174170732
significantly O 0 0.0034322645515203476
lower O 0 0.004431997425854206
frequencies O 0 0.002691716654226184
of O 0 0.003911775536835194
the O 0 0.01281201932579279
Tyr O 1 0.99996018409729
allele O 0 0.03847707808017731
. O 0 0.013713191263377666

Comparisons O 0 0.018823159858584404
with O 0 0.006109317298978567
allele O 0 0.010769407264888287
frequencies O 0 0.0037480818573385477
based O 0 0.003435244085267186
on O 0 0.00500911008566618
prevalence O 0 0.07948173582553864
estimates O 0 0.008308208547532558
of O 0 0.01036089938133955
HH B-Disease 1 0.9999996423721313
showed O 0 0.008539590053260326
some O 0 0.00210217060521245
disagreements O 0 0.005720623768866062
with O 0 0.002115800278261304
the O 0 0.005149236414581537
RFLP O 0 0.028303081169724464
data O 0 0.0035050418227910995
, O 0 0.003300710581243038
particularly O 0 0.004515589214861393
in O 0 0.007047049701213837
Finns O 0 0.04886993393301964
. O 0 0.017788419499993324

The O 0 0.020251398906111717
newly O 0 0.12649716436862946
described O 0 0.17707903683185577
HFE O 1 0.9999905824661255
marker O 0 0.05894210562109947
provides O 0 0.004963246174156666
a O 0 0.002406500745564699
new O 0 0.0017970605986192822
approach O 0 0.0020587281323969364
to O 0 0.0012054230319336057
the O 0 0.0022326260805130005
screening O 0 0.007261299062520266
of O 0 0.011331955902278423
HH B-Disease 1 1.0
as O 0 0.0033342167735099792
well O 0 0.0015291724121198058
as O 0 0.0012563965283334255
studies O 0 0.0016418523155152798
of O 0 0.0016159267397597432
the O 0 0.0022033657878637314
relationship O 0 0.002950882539153099
between O 0 0.00248787016607821
the O 0 0.015045568346977234
HFE O 1 0.9999998807907104
Tyr O 1 0.999996542930603
allele O 0 0.01505974866449833
and O 0 0.0035394916776567698
different O 0 0.004529483150690794
disorders O 1 0.9999998807907104
including O 1 0.999840497970581
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999947547912598
dominant I-Disease 1 0.9999915361404419
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.10242748260498047
with O 0 0.004940115846693516
a O 0 0.007518596947193146
missense O 0 0.020703531801700592
mutation O 0 0.008409621194005013
encoding O 0 0.012132924981415272
Gly23 O 1 0.9982629418373108
- O 1 0.7945979833602905
- O 0 0.15984469652175903
> O 0 0.03579796478152275
Val O 1 0.739467978477478
in O 0 0.011464445851743221
neurophysin O 1 0.9993892908096313
II O 1 0.9999942779541016
. O 0 0.025390135124325752

Autosomal B-Disease 1 0.999958872795105
dominant I-Disease 1 0.999915599822998
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999178647994995
ADNDI B-Disease 1 0.9999997615814209
) O 0 0.007087637670338154
is O 0 0.0037303678691387177
an O 0 0.060068368911743164
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999998807907104
by O 1 0.9966852068901062
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.999937891960144
the O 1 0.9994383454322815
magnocellular O 1 0.9999979734420776
neurons O 0 0.010724998079240322
of O 0 0.0044089555740356445
the O 0 0.008011705242097378
hypothalamus O 1 0.6853054761886597
leading O 0 0.007527365814894438
to O 0 0.0027060089632868767
decreased O 0 0.0062897889874875546
ability O 0 0.0019170846790075302
to O 0 0.0014234078116714954
produce O 0 0.002780962036922574
the O 0 0.005762671586126089
hormone O 1 0.9666298627853394
arginine O 0 0.20321492850780487
vasopressin O 1 0.8862269520759583
( O 0 0.021608304232358932
AVP O 1 0.9997881054878235
) O 0 0.015541335567831993
. O 0 0.013945752754807472

Affected O 0 0.014639855362474918
individuals O 0 0.0036710957065224648
are O 0 0.0019443766213953495
not O 0 0.0026744939386844635
symptomatic O 1 0.9998867511749268
at O 0 0.04468643665313721
birth O 0 0.39966145157814026
, O 0 0.002582549350336194
but O 0 0.0015361580299213529
usually O 0 0.0031741249840706587
develop O 0 0.0476871021091938
diabetes B-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999985694885254
at O 1 0.5101016163825989
1 O 0 0.03200128674507141
- O 0 0.018741413950920105
6 O 0 0.01124536618590355
yr O 0 0.05305333435535431
of O 0 0.007375768385827541
age O 0 0.01972219906747341
. O 0 0.015392505563795567

The O 0 0.013370751403272152
genetic O 0 0.01240879949182272
locus O 0 0.015854226425290108
of O 0 0.005673740524798632
the O 0 0.28318729996681213
disease O 1 0.9999997615814209
is O 0 0.005915222689509392
the O 0 0.011147312819957733
AVP O 1 0.9999996423721313
- O 1 0.9813747406005859
neurophysin O 1 0.9997078776359558
II O 1 0.9999977350234985
( O 0 0.01222989335656166
NPII O 1 0.9995452761650085
) O 0 0.0053732991218566895
gene O 0 0.0041880980134010315
, O 0 0.0019608871079981327
and O 0 0.0021187318488955498
mutations O 0 0.004601580556482077
that O 0 0.0020397265907377005
cause O 1 0.6961811184883118
ADNDI B-Disease 1 0.9999947547912598
have O 0 0.001802610233426094
been O 0 0.0015733293257653713
found O 0 0.0015229812124744058
in O 0 0.0013325816253200173
both O 0 0.001438253209926188
the O 0 0.0025185642298310995
signal O 0 0.0043598501943051815
peptide O 0 0.00419846223667264
of O 0 0.002185158198699355
the O 0 0.005078013055026531
prepro O 1 0.9996108412742615
- O 1 0.9813770651817322
AVP O 1 0.9999961853027344
- O 1 0.6311226487159729
NPII O 1 0.9937927722930908
precursor O 0 0.014208078384399414
and O 0 0.0031693459022790194
within O 0 0.005873991642147303
NPII O 1 0.999823272228241
itself O 0 0.0170708280056715
. O 0 0.012721091508865356

An O 0 0.014323290437459946
affected O 0 0.016731448471546173
girl O 0 0.024063756689429283
who O 0 0.004343598149716854
presented O 0 0.004878414329141378
at O 0 0.003936609253287315
9 O 0 0.00334426062181592
months O 0 0.0017482117982581258
of O 0 0.0017607025802135468
age O 0 0.0035982669796794653
and O 0 0.0021790305618196726
her O 0 0.011311662383377552
similarly O 0 0.03477638214826584
affected O 0 0.022734040394425392
younger O 0 0.1498526632785797
brother O 0 0.4244522452354431
and O 0 0.0021741033997386694
father O 0 0.04602848365902901
were O 0 0.0017184796743094921
all O 0 0.0008749309927225113
found O 0 0.0013844456989318132
to O 0 0.0008241863688454032
have O 0 0.0008298730244860053
a O 0 0.002466811565682292
novel O 0 0.008402284234762192
missense O 0 0.01577971689403057
mutation O 0 0.008452901616692543
( O 0 0.008661746047437191
G1758 O 1 0.9928383231163025
- O 1 0.9625183343887329
- O 1 0.5058596730232239
> O 0 0.03477684408426285
T O 0 0.02421257644891739
) O 0 0.0020986502058804035
encoding O 0 0.002451726235449314
the O 0 0.0023718485608696938
amino O 0 0.005137670785188675
acid O 0 0.008831220678985119
substitution O 0 0.015550031326711178
Gly23 O 1 0.9985383749008179
- O 1 0.8950099945068359
- O 0 0.14438574016094208
> O 0 0.043337155133485794
Val O 1 0.6585485339164734
within O 0 0.014926156960427761
NPII O 1 0.9991870522499084
. O 0 0.022032704204320908

The O 0 0.017304684966802597
mutation O 0 0.016872748732566833
was O 0 0.011073152534663677
confirmed O 0 0.00824424996972084
by O 0 0.004351950250566006
restriction O 0 0.0154502522200346
endonuclease O 0 0.05422430858016014
analysis O 0 0.014807761646807194
. O 0 0.014563404954969883

A O 0 0.2864246964454651
T1 O 1 0.9999732971191406
- O 0 0.027128664776682854
weighted O 0 0.01503828540444374
magnetic O 0 0.010913568548858166
resonance O 0 0.008311438374221325
imaging O 0 0.008377870544791222
of O 0 0.0051257614977657795
the O 0 0.014774270355701447
fathers O 1 0.9987797141075134
pituitary O 1 0.9999998807907104
gland O 1 0.9999988079071045
demonstrates O 1 0.9971323013305664
an O 0 0.20758943259716034
attenuated O 1 0.9999752044677734
posterior O 1 0.9999943971633911
pituitary O 1 0.9999997615814209
bright O 1 0.99936443567276
spot O 1 0.6458256244659424
. O 0 0.021504830569028854

This O 0 0.011736367829144001
mutation O 0 0.013768027536571026
may O 0 0.003684078808873892
be O 0 0.0015896388795226812
valuable O 0 0.0034442408941686153
for O 0 0.0020482761319726706
developing O 0 0.0036692789290100336
models O 0 0.004142374731600285
of O 0 0.007914013229310513
dominantly B-Disease 1 0.9999995231628418
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.008783308789134026
as O 0 0.002850685967132449
the O 0 0.002253544982522726
early O 0 0.002739384537562728
age O 0 0.0038158094976097345
of O 0 0.005208473186939955
onset O 1 0.9999998807907104
of O 1 0.9998512268066406
symptoms O 1 1.0
suggests O 1 0.9335965514183044
that O 0 0.001649600686505437
this O 0 0.0015933725517243147
mutation O 0 0.0032218503765761852
may O 0 0.0017383237136527896
be O 0 0.0012412191135808825
particularly O 0 0.002732281107455492
deleterious O 0 0.011223109439015388
to O 0 0.0033786925487220287
the O 0 0.011354897171258926
magnocellular O 1 0.9999783039093018
neuron O 1 0.9988316893577576
. O 0 0.008486807346343994
. O 0 0.011186330579221249

Frequent O 0 0.03999210521578789
inactivation O 1 0.9318758249282837
of O 0 0.31530413031578064
PTEN O 1 1.0
/ O 1 0.9999725818634033
MMAC1 O 1 0.9999932050704956
in O 0 0.25056788325309753
primary O 1 0.9999978542327881
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9197717308998108

Sporadic B-Disease 1 0.9999927282333374
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.050267208367586136
the O 0 0.005792697891592979
most O 0 0.002933122916147113
common O 0 0.053305525332689285
male B-Disease 1 0.9983868598937988
cancer I-Disease 1 0.9999995231628418
in O 0 0.0034817694686353207
the O 0 0.0036196070723235607
Western O 0 0.004230698104947805
world O 0 0.002989667933434248
, O 0 0.001108276192098856
yet O 0 0.0009246586123481393
many O 0 0.0005593091482296586
of O 0 0.0011695771245285869
the O 0 0.0019852067343890667
major O 0 0.003734084079042077
genetic O 0 0.0023757286835461855
events O 0 0.0016102041117846966
involved O 0 0.0016849731327965856
in O 0 0.0015334688359871507
the O 0 0.002868284936994314
progression O 1 0.7608402967453003
of O 0 0.0025606979615986347
this O 0 0.0021712295711040497
often O 0 0.005267636384814978
fatal O 1 0.9999998807907104
cancer B-Disease 1 1.0
remain O 0 0.03929812088608742
to O 0 0.004407078493386507
be O 0 0.004631357733160257
elucidated O 0 0.17977966368198395
. O 0 0.016377979889512062

Numerous O 0 0.02235146053135395
cytogenetic O 1 0.9222450256347656
and O 0 0.009096226654946804
allelotype O 1 0.9926885962486267
studies O 0 0.005560448858886957
have O 0 0.0020233364775776863
reported O 0 0.004516930785030127
frequent O 0 0.004988668020814657
loss O 0 0.012387202121317387
of O 0 0.008802992291748524
heterozygosity O 1 0.9999614953994751
on O 0 0.016148986294865608
chromosomal O 1 0.9996188879013062
arm O 1 0.9918420314788818
10q O 1 0.9972966313362122
in O 0 0.04925139620900154
sporadic B-Disease 1 0.9999972581863403
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9659149050712585

Deletion O 0 0.042595431208610535
mapping O 0 0.015926623716950417
studies O 0 0.005748258903622627
have O 0 0.0027180362958461046
unambiguously O 0 0.011146903969347477
identified O 0 0.00508688623085618
a O 0 0.003521092003211379
region O 0 0.005065571051090956
of O 0 0.005688036791980267
chromosome O 0 0.05198047310113907
10q23 O 0 0.020351160317659378
to O 0 0.0016576137859374285
be O 0 0.0012157978489995003
the O 0 0.0022552632726728916
minimal O 0 0.00597150344401598
area O 0 0.0052562677301466465
of O 0 0.008515367284417152
loss O 1 0.9899582266807556
. O 0 0.015558276325464249

A O 0 0.026385869830846786
new O 0 0.022170469164848328
tumor B-Disease 1 0.9999984502792358
suppressor O 1 0.9905630350112915
gene O 0 0.014270312152802944
, O 0 0.010336772538721561
PTEN O 1 0.999994158744812
/ O 1 0.9987616539001465
MMAC1 O 1 0.9998974800109863
, O 0 0.006342851556837559
was O 0 0.00904135126620531
isolated O 0 0.008536667563021183
recently O 0 0.00548391230404377
at O 0 0.0038370026741176844
this O 0 0.0015457849949598312
region O 0 0.003531285561621189
of O 0 0.0052991267293691635
chromosome O 0 0.15244989097118378
10q23 O 0 0.45626509189605713
and O 0 0.0017582144355401397
found O 0 0.001803571474738419
to O 0 0.0013334669638425112
be O 0 0.0014564464800059795
inactivated O 0 0.007150658406317234
by O 0 0.0013158696237951517
mutation O 0 0.0030186970252543688
in O 0 0.0025721448473632336
three O 0 0.045034416019916534
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999854564666748
lines O 0 0.039999108761548996
. O 0 0.013922043144702911

We O 0 0.012848732993006706
screened O 0 0.0365573987364769
80 O 0 0.21899442374706268
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999994039535522
by O 0 0.005139425862580538
microsatellite O 1 0.6789628863334656
analysis O 0 0.003729297546669841
and O 0 0.0024499038700014353
found O 0 0.004648764617741108
chromosome O 0 0.010109049268066883
10q23 O 0 0.014365670271217823
to O 0 0.002190596656873822
be O 0 0.001970065524801612
deleted O 0 0.005948028992861509
in O 0 0.0026156101375818253
23 O 0 0.0075887166894972324
cases O 0 0.008388620801270008
. O 0 0.010319256223738194

We O 0 0.008958365768194199
then O 0 0.005385913420468569
proceeded O 0 0.006930802948772907
with O 0 0.0018236151663586497
sequence O 0 0.0022120147477835417
analysis O 0 0.0016759653808549047
of O 0 0.0024969892110675573
the O 0 0.006122252903878689
entire O 1 0.7022573947906494
PTEN O 1 0.9999997615814209
/ O 1 0.9996013045310974
MMAC1 O 1 0.9998505115509033
coding O 0 0.022201310843229294
region O 0 0.004864946473389864
and O 0 0.002431393601000309
tested O 0 0.0052779181860387325
for O 0 0.0025986875407397747
homozygous O 0 0.0075132050551474094
deletion O 0 0.005581076256930828
with O 0 0.0018174095312133431
new O 0 0.0037065730430185795
intragenic O 1 0.942360520362854
markers O 0 0.008121098391711712
in O 0 0.0017719451570883393
these O 0 0.0011088611790910363
23 O 0 0.003728390671312809
cases O 0 0.0029004192911088467
with O 0 0.003156050108373165
10q23 O 1 0.9949443936347961
loss O 1 0.8076858520507812
of O 0 0.18744589388370514
heterozygosity O 1 0.9999886751174927
. O 0 0.021018246188759804

The O 0 0.011474782600998878
identification O 0 0.008254564367234707
of O 0 0.004235563334077597
the O 0 0.0047086202539503574
second O 0 0.007284524850547314
mutational O 0 0.024836506694555283
event O 0 0.004563075955957174
in O 0 0.0019521827343851328
10 O 0 0.0026530567556619644
( O 0 0.002665080362930894
43 O 0 0.005340013187378645
% O 0 0.004868743009865284
) O 0 0.008861532434821129
tumors B-Disease 1 0.9999960660934448
establishes O 1 0.9999735355377197
PTEN O 1 1.0
/ O 1 0.9999020099639893
MMAC1 O 1 0.9995662569999695
as O 0 0.0032234250102192163
a O 0 0.003590760752558708
main O 0 0.006078328005969524
inactivation O 0 0.028819357976317406
target O 0 0.0035500554367899895
of O 0 0.003693449078127742
10q O 0 0.3399139940738678
loss O 0 0.11195901036262512
in O 0 0.011994246393442154
sporadic B-Disease 1 0.9999957084655762
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.838813066482544
. O 0 0.01818535104393959

Risk O 0 0.04036514461040497
reversals O 0 0.040132079273462296
in O 0 0.010075950063765049
predictive O 0 0.022745441645383835
testing O 0 0.019244855269789696
for O 0 0.069403737783432
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.18151569366455078

The O 0 0.009224968031048775
first O 0 0.006850515026599169
predictive O 0 0.011265472508966923
testing O 0 0.008066393435001373
for O 0 0.010562382638454437
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9990605711936951
HD B-Disease 1 0.996775209903717
) O 0 0.002909354865550995
was O 0 0.0022347685880959034
based O 0 0.001007088809274137
on O 0 0.0012463785242289305
analysis O 0 0.001548399799503386
of O 0 0.0026591720525175333
linked O 0 0.008897691033780575
polymorphic O 0 0.016423584893345833
DNA O 0 0.006987520959228277
markers O 0 0.006645181216299534
to O 0 0.0018755622440949082
estimate O 0 0.0030925513710826635
the O 0 0.0027426511514931917
likelihood O 0 0.006099232938140631
of O 0 0.004254522267729044
inheriting O 0 0.1471998542547226
the O 0 0.009667672216892242
mutation O 0 0.013240452855825424
for O 0 0.007216566242277622
HD B-Disease 1 0.7699889540672302
. O 0 0.014261908829212189

Limits O 0 0.010540289804339409
to O 0 0.003123633796349168
accuracy O 0 0.004266939591616392
included O 0 0.003320427378639579
recombination O 0 0.005092821549624205
between O 0 0.002018406754359603
the O 0 0.0030843664426356554
DNA O 0 0.00528923561796546
markers O 0 0.0072215283289551735
and O 0 0.0017737435409799218
the O 0 0.003222427796572447
mutation O 0 0.0055388193577528
, O 0 0.002824255730956793
pedigree O 0 0.010113618336617947
structure O 0 0.005155311897397041
, O 0 0.0021826126612722874
and O 0 0.0017184746684506536
whether O 0 0.0019041633931919932
DNA O 0 0.0029543216805905104
samples O 0 0.002120928606018424
were O 0 0.0011970321647822857
available O 0 0.0013505520764738321
from O 0 0.0015808797907084227
family O 0 0.005032535642385483
members O 0 0.004915681667625904
. O 0 0.009010140784084797

With O 0 0.00584407290443778
direct O 0 0.004897632636129856
tests O 0 0.003839279990643263
for O 0 0.003048415994271636
the O 0 0.006440463475883007
HD B-Disease 1 0.8871774673461914
mutation O 0 0.006205916404724121
, O 0 0.0022036705631762743
we O 0 0.0014683768386021256
have O 0 0.0010305827017873526
assessed O 0 0.0032045587431639433
the O 0 0.002067204564809799
accuracy O 0 0.002928829286247492
of O 0 0.0020797825418412685
results O 0 0.002363716484978795
obtained O 0 0.002324674976989627
by O 0 0.0020156078971922398
linkage O 0 0.008211984299123287
approaches O 0 0.005497238133102655
when O 0 0.002083801431581378
requested O 0 0.002999190939590335
to O 0 0.0012761809630319476
do O 0 0.0013853757409378886
so O 0 0.0010863261995837092
by O 0 0.001153277582488954
the O 0 0.00270772073417902
test O 0 0.005891325417906046
individuals O 0 0.004536747466772795
. O 0 0.009862351231276989

For O 0 0.006697081029415131
six O 0 0.003745137481018901
such O 0 0.0018572764238342643
individuals O 0 0.0017656777054071426
, O 0 0.0026851121801882982
there O 0 0.0027260142378509045
was O 0 0.006853997707366943
significant O 0 0.004477101843804121
disparity O 0 0.012839610688388348
between O 0 0.004252100363373756
the O 0 0.007959245704114437
tests O 0 0.012486658990383148
. O 0 0.012618852779269218

Three O 0 0.00816263072192669
went O 0 0.009115364402532578
from O 0 0.003993704449385405
a O 0 0.0053366986103355885
decreased O 0 0.39930400252342224
risk O 0 0.005164574831724167
to O 0 0.001839306904003024
an O 0 0.0021224813535809517
increased O 0 0.0038063558749854565
risk O 0 0.0045175617560744286
, O 0 0.0017045203130692244
while O 0 0.0012657726183533669
in O 0 0.0011885946150869131
another O 0 0.0016670550685375929
three O 0 0.0013806071365252137
the O 0 0.0030515247490257025
risk O 0 0.33587273955345154
was O 1 0.9079887866973877
decreased O 1 0.8683897852897644
. O 0 0.012373518198728561

Knowledge O 0 0.013323456048965454
of O 0 0.006990473251789808
the O 0 0.005638929083943367
potential O 0 0.004417445044964552
reasons O 0 0.0028059124015271664
for O 0 0.001373380539007485
these O 0 0.0008972957148216665
changes O 0 0.0014869507867842913
in O 0 0.0014787002000957727
results O 0 0.0017621463630348444
and O 0 0.0012863378506153822
impact O 0 0.002388251945376396
of O 0 0.0017384662060067058
these O 0 0.001351317623630166
risk O 0 0.005156569182872772
reversals O 0 0.023446470499038696
on O 0 0.0032977485097944736
both O 0 0.0024602198973298073
patients O 1 0.7297793626785278
and O 0 0.002393481321632862
the O 0 0.004334460478276014
counseling O 0 0.3763847351074219
team O 0 0.003377368440851569
can O 0 0.0011213350808247924
assist O 0 0.0024144102353602648
in O 0 0.00120386085473001
the O 0 0.0016976026818156242
development O 0 0.00187781045679003
of O 0 0.0016152773750945926
strategies O 0 0.00376508804038167
for O 0 0.0018057550769299269
the O 0 0.0047804503701627254
prevention O 1 0.9999666213989258
and O 0 0.0017289714887738228
, O 0 0.0020878647919744253
where O 0 0.002240526955574751
necessary O 0 0.002675006166100502
, O 0 0.002159085590392351
management O 0 0.0044455802999436855
of O 0 0.003500271588563919
a O 0 0.005078499671071768
risk O 0 0.010238372720777988
reversal O 0 0.01032210048288107
in O 0 0.0030613262206315994
any O 0 0.002844069618731737
predictive O 0 0.009503677487373352
testing O 0 0.009108837693929672
program O 0 0.008014116436243057
. O 0 0.00583321787416935
. O 0 0.009577112272381783

A O 0 0.022421959787607193
novel O 0 0.022999903187155724
common O 0 0.012083198875188828
missense O 0 0.026295971125364304
mutation O 0 0.009868554770946503
G301C O 0 0.019748656079173088
in O 0 0.0038093875627964735
the O 0 0.005955718923360109
N O 0 0.07997109740972519
- O 0 0.026095345616340637
acetylgalactosamine O 1 0.9395325779914856
- O 0 0.07514435797929764
6 O 0 0.01984499767422676
- O 0 0.039330899715423584
sulfate O 1 0.9376431703567505
sulfatase O 1 0.9994946718215942
gene O 0 0.020432772114872932
in O 0 0.013083117082715034
mucopolysaccharidosis B-Disease 1 0.9999343156814575
IVA I-Disease 1 0.9999994039535522
. O 0 0.03577158972620964

Mucopolysaccharidosis B-Disease 1 0.9998196959495544
IVA I-Disease 1 0.9999997615814209
( O 1 0.7648661732673645
MPS B-Disease 1 0.9994457364082336
IVA I-Disease 1 1.0
) O 0 0.005457470193505287
is O 0 0.0030204656068235636
an O 0 0.004642974119633436
autosomal B-Disease 1 0.999990701675415
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999957084655762
by O 0 0.006199267692863941
a O 0 0.04039594531059265
genetic B-Disease 1 0.9970822930335999
defect I-Disease 1 0.9999822378158569
in O 0 0.005853114649653435
N O 1 0.7536637187004089
- O 0 0.020334789529442787
acetylgalactosamine O 1 0.7198838591575623
- O 0 0.018443867564201355
6 O 0 0.014814790338277817
- O 0 0.03816774860024452
sulfate O 1 0.9890831708908081
sulfatase O 1 0.9999426603317261
( O 0 0.055268533527851105
GALNS O 1 0.9998712539672852
) O 0 0.015622178092598915
. O 0 0.014675287529826164

In O 0 0.008442915976047516
previous O 0 0.00650205509737134
studies O 0 0.004623446613550186
, O 0 0.002373081399127841
we O 0 0.0012939433800056577
have O 0 0.0007342306198552251
found O 0 0.0011247338261455297
two O 0 0.0011889232555404305
common O 0 0.0030998678412288427
mutations O 0 0.004236770328134298
in O 0 0.0034142141230404377
Caucasians O 1 0.7290074825286865
and O 0 0.004270360805094242
Japanese O 0 0.22962751984596252
, O 0 0.008630892261862755
respectively O 0 0.018374629318714142
. O 0 0.012466483749449253

To O 0 0.010782482102513313
characterize O 0 0.02617694064974785
the O 0 0.009443973191082478
mutational O 0 0.100258968770504
spectrum O 0 0.005934286396950483
in O 0 0.0019954892341047525
various O 0 0.0016673090867698193
ethnic O 0 0.0026913429610431194
groups O 0 0.0016040814807638526
, O 0 0.0024678960908204317
mutations O 0 0.002943996340036392
in O 0 0.001947198063135147
the O 0 0.004647895693778992
GALNS O 1 0.9979630708694458
gene O 0 0.005414751823991537
in O 0 0.003176038386300206
Colombian O 0 0.027279941365122795
MPS B-Disease 1 0.9973315000534058
IVA I-Disease 1 1.0
patients O 1 0.9997569918632507
were O 0 0.004718351177871227
investigated O 0 0.040235087275505066
, O 0 0.002952128415927291
and O 0 0.0019679395481944084
genetic O 0 0.0036761085502803326
backgrounds O 0 0.0030151857063174248
were O 0 0.00184438971336931
extensively O 0 0.004054476507008076
analyzed O 0 0.0040356675162911415
to O 0 0.0016642998671159148
identify O 0 0.0029419339261949062
racial O 0 0.0045830137096345425
origin O 0 0.002041676314547658
, O 0 0.001747020403854549
based O 0 0.0021620679181069136
on O 0 0.0028382728341966867
mitochondrial O 0 0.008556651882827282
DNA O 0 0.007577765267342329
( O 0 0.0062372623942792416
mtDNA O 0 0.01140915509313345
) O 0 0.006361783016473055
lineages O 0 0.01417506393045187
. O 0 0.011777909472584724

Three O 0 0.011652208864688873
novel O 0 0.023085735738277435
missense O 0 0.04026394709944725
mutations O 0 0.010311000049114227
never O 0 0.0060528358444571495
identified O 0 0.00437550526112318
previously O 0 0.003716384992003441
in O 0 0.0018154416466131806
other O 0 0.001383243827149272
populations O 0 0.002321577165275812
and O 0 0.0015605057124048471
found O 0 0.00221834983676672
in O 0 0.0018975575221702456
16 O 0 0.002752684522420168
out O 0 0.0013517604675143957
of O 0 0.0024592585396021605
19 O 0 0.00806846097111702
Colombian O 0 0.02109363302588463
MPS B-Disease 1 0.7419601678848267
IVA I-Disease 1 0.9999994039535522
unrelated O 0 0.02743721939623356
alleles O 0 0.010373256169259548
account O 0 0.0050214119255542755
for O 0 0.005719262175261974
84 O 0 0.030464766547083855
. O 0 0.016266072168946266

2 O 0 0.014107145369052887
% O 0 0.004772671032696962
of O 0 0.0033336367923766375
the O 0 0.004681400489062071
alleles O 0 0.007078214082866907
in O 0 0.0028169439174234867
this O 0 0.0028754319064319134
study O 0 0.01041798572987318
. O 0 0.013565332628786564

The O 0 0.01838509365916252
G301C O 0 0.3129650354385376
and O 0 0.008042571134865284
S162F O 0 0.2595173120498657
mutations O 0 0.007510666269809008
account O 0 0.0057998946867883205
for O 0 0.006325911730527878
68 O 0 0.029671231284737587
. O 0 0.015153254382312298

4 O 0 0.023212099447846413
% O 0 0.008929443545639515
and O 0 0.007001530844718218
10 O 0 0.012177176773548126
. O 0 0.01283534336835146

5 O 0 0.015449773520231247
% O 0 0.005825269967317581
of O 0 0.004678845871239901
mutations O 0 0.005276726558804512
, O 0 0.0028371745720505714
respectively O 0 0.004370898008346558
, O 0 0.002064392203465104
whereas O 0 0.0027891674544662237
the O 0 0.002710469998419285
remaining O 0 0.0055130477994680405
F69V O 1 0.9967755675315857
is O 0 0.002263716422021389
limited O 0 0.0019482009811326861
to O 0 0.0016365054761990905
a O 0 0.004422212019562721
single O 0 0.008172438479959965
allele O 0 0.01835234835743904
. O 0 0.010514778085052967

The O 0 0.02098821848630905
skewed O 0 0.03214645758271217
prevalence O 0 0.04029544070363045
of O 0 0.008710474707186222
G301C O 0 0.28128907084465027
in O 0 0.004281299188733101
only O 0 0.003945578821003437
Colombian O 0 0.02186020463705063
patients O 0 0.3224722743034363
and O 0 0.003097303444519639
haplotype O 0 0.009228184819221497
analysis O 0 0.0026976882945746183
by O 0 0.001920306240208447
restriction O 0 0.0058672623708844185
fragment O 0 0.008962815627455711
length O 0 0.005162188783288002
polymorphisms O 0 0.007455461658537388
in O 0 0.0033172431867569685
the O 0 0.005781564861536026
GALNS O 1 0.9968370199203491
gene O 0 0.006194662302732468
suggest O 0 0.003418241860345006
that O 0 0.0021830694749951363
G301C O 0 0.017268523573875427
originated O 0 0.006257569883018732
from O 0 0.0032111790496855974
a O 0 0.005583080463111401
common O 0 0.009940181858837605
ancestor O 0 0.059506695717573166
. O 0 0.01790482923388481

Investigation O 0 0.01668679341673851
of O 0 0.007598353549838066
the O 0 0.0065216864459216595
genetic O 0 0.007153719663619995
background O 0 0.004599492531269789
by O 0 0.0019162874668836594
means O 0 0.002883597044274211
of O 0 0.003663919400423765
mtDNA O 0 0.008114144206047058
lineages O 0 0.004975744988769293
indicate O 0 0.0030106152407824993
that O 0 0.0012899056309834123
all O 0 0.0015093395486474037
our O 0 0.0035858729388564825
patients O 0 0.00869434978812933
are O 0 0.00197293097153306
probably O 0 0.0049819196574389935
of O 0 0.005639175418764353
native O 0 0.016041606664657593
American O 0 0.025493813678622246
descent O 0 0.06632682681083679

Low O 0 0.02247241511940956
frequency O 0 0.009509371593594551
of O 0 0.008587133139371872
BRCA1 O 1 0.9849997758865356
germline O 0 0.027013380080461502
mutations O 0 0.005126028787344694
in O 0 0.0035439245402812958
45 O 0 0.010210244916379452
German O 1 0.9999943971633911
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9471692442893982
. O 0 0.02319266088306904

In O 0 0.0066789803095161915
this O 0 0.0025691876653581858
study O 0 0.002793908817693591
we O 0 0.0017630886286497116
investigated O 0 0.007930036634206772
45 O 0 0.008608016185462475
German O 1 0.9998912811279297
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03161346912384033
for O 0 0.005194523371756077
germline O 0 0.4628392457962036
mutations O 0 0.005070059560239315
in O 0 0.003740724641829729
the O 0 0.009332606568932533
BRCA1 O 1 0.9998953342437744
gene O 0 0.018790751695632935
. O 0 0.012555917724967003

We O 0 0.007290408946573734
identified O 0 0.0076048728078603745
four O 0 0.004402875434607267
germline O 0 0.017442060634493828
mutations O 0 0.003970566671341658
in O 0 0.0025370963849127293
three O 0 0.005602125544101
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0035337815061211586
and O 0 0.0019446219084784389
in O 0 0.003776875324547291
one O 1 0.7270461916923523
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9929351210594177
. O 0 0.0019049791153520346
among O 0 0.0013271038187667727
these O 0 0.0007831688853912055
were O 0 0.0015224533854052424
one O 0 0.0023469096049666405
frameshift O 0 0.04121464863419533
mutation O 0 0.004565855488181114
, O 0 0.002187908859923482
one O 0 0.0026517650112509727
nonsense O 0 0.012093906290829182
mutation O 0 0.003937622532248497
, O 0 0.00196273741312325
one O 0 0.002030308824032545
novel O 0 0.009372835978865623
splice O 0 0.020800430327653885
site O 0 0.008542170748114586
mutation O 0 0.0064940908923745155
, O 0 0.0026759160682559013
and O 0 0.0028178547509014606
one O 0 0.0065533993765711784
missense O 0 0.042764805257320404
mutation O 0 0.026114149019122124
. O 0 0.0159018374979496

The O 0 0.017713211476802826
missense O 0 0.1165943369269371
mutation O 0 0.016269363462924957
was O 0 0.008381261490285397
also O 0 0.003592632943764329
found O 0 0.0037823442835360765
in O 0 0.005042057018727064
2 O 0 0.01336697954684496
. O 0 0.011239197105169296

8 O 0 0.012598110362887383
% O 0 0.004056401085108519
of O 0 0.002389162080362439
the O 0 0.0033681984059512615
general O 0 0.007217358332127333
population O 0 0.002097618067637086
, O 0 0.00200369069352746
suggesting O 0 0.0031572089064866304
that O 0 0.0011412844760343432
it O 0 0.0012442376464605331
is O 0 0.003024192526936531
not O 0 0.003906658384948969
disease O 1 0.9999966621398926
associated O 0 0.08506205677986145
. O 0 0.015838714316487312

The O 0 0.009819317609071732
average O 0 0.008871946483850479
age O 0 0.008483482524752617
of O 0 0.03461270406842232
disease O 1 1.0
onset O 1 0.9999998807907104
in O 0 0.006914706435054541
those O 0 0.0028634341433644295
families O 0 0.006350651383399963
harbouring O 1 0.9996925592422485
causative O 1 0.9995912909507751
mutations O 0 0.011193293146789074
was O 0 0.009901349432766438
between O 0 0.006596364546567202
32 O 0 0.015621320344507694
. O 0 0.012189515866339207

3 O 0 0.025732116773724556
and O 0 0.011418893001973629
37 O 0 0.029782140627503395
. O 0 0.01853252574801445

4 O 0 0.015337267890572548
years O 0 0.005382343661040068
, O 0 0.003993484657257795
whereas O 0 0.005388570483773947
the O 0 0.00460048858076334
family O 0 0.012644740752875805
harbouring O 1 0.9569942951202393
the O 0 0.006897779181599617
missense O 0 0.02437748573720455
mutation O 0 0.006141464225947857
had O 0 0.0031240626703947783
an O 0 0.0022290702909231186
average O 0 0.004449676722288132
age O 0 0.0045959968119859695
of O 0 0.005294494330883026
onset O 1 0.9999849796295166
of O 0 0.396388977766037
51 O 1 0.7952792644500732
. O 0 0.014172685332596302

2 O 0 0.03545963391661644
years O 0 0.02316024899482727
. O 0 0.02012259140610695

These O 0 0.006413948256522417
findings O 0 0.009156656451523304
show O 0 0.007884631864726543
that O 0 0.003927618730813265
BRCA1 O 1 0.9150671362876892
is O 0 0.0034398359712213278
implicated O 0 0.007906060665845871
in O 0 0.002288111252710223
a O 0 0.0024750398006290197
small O 0 0.0027233336586505175
fraction O 0 0.006675181910395622
of O 1 0.7436941862106323
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.013526128605008125
suggesting O 0 0.006262891925871372
the O 0 0.0026223284658044577
involvement O 0 0.004529835656285286
of O 0 0.0033478401601314545
another O 0 0.014182962477207184
susceptibility O 1 0.9997673630714417
gene O 0 0.034459784626960754
( O 0 0.012913712300360203
s O 0 0.06754501163959503
) O 0 0.018018942326307297

Paternal O 1 0.999868631362915
transmission O 1 0.9999175071716309
of O 1 0.9999958276748657
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999959468841553

We O 0 0.0073682875372469425
report O 0 0.005584923084825277
a O 0 0.003801788203418255
rare O 0 0.0060402946546673775
case O 0 0.007537656929343939
of O 0 0.04516866058111191
paternally O 1 0.9999992847442627
transmitted O 1 0.9999997615814209
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.4643554985523224
. O 0 0.018620667979121208

The O 0 0.015610962174832821
proband O 0 0.05065282806754112
is O 0 0.00359553936868906
a O 0 0.003209146438166499
23 O 0 0.00499233603477478
year O 0 0.003391711972653866
old O 0 0.26881706714630127
, O 0 0.011800196953117847
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999990463256836
male O 1 0.998890221118927
who O 1 0.9999532699584961
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9991864562034607

He O 0 0.015344484709203243
presented O 0 0.016934724524617195
with O 0 0.014224966056644917
respiratory O 1 1.0
and O 1 0.7561209201812744
feeding O 1 0.992358386516571
difficulties O 1 0.9999079704284668
at O 1 0.9837543368339539
birth O 1 0.9986996650695801
. O 0 0.015483718365430832

His O 0 0.017563218250870705
two O 0 0.009751186706125736
sibs O 1 0.9999866485595703
suffer O 1 0.9994577765464783
from O 0 0.45109325647354126
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.8410342931747437

Their O 0 0.006451219320297241
late O 0 0.009043979458510876
father O 0 0.012139053083956242
had O 0 0.0033716578036546707
the O 0 0.00287060160189867
adult O 0 0.0046574086882174015
type O 0 0.008195595815777779
of O 0 0.0630052238702774
DM B-Disease 1 1.0
, O 0 0.005180503707379103
with O 0 0.002964595565572381
onset O 1 0.9994134902954102
around O 0 0.006542691495269537
30 O 0 0.007482560817152262
years O 0 0.007475248072296381
. O 0 0.011679879389703274

Only O 0 0.005045444704592228
six O 0 0.0030944780446588993
other O 0 0.0016631007893010974
cases O 0 0.0032718018628656864
of O 0 0.007919492200016975
paternal O 1 0.999993085861206
transmission O 1 0.9999909400939941
of O 1 0.9999972581863403
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.012831767089664936
been O 0 0.006503748707473278
reported O 0 0.010262628085911274
recently O 0 0.015933239832520485
. O 0 0.0102152144536376

We O 0 0.006184253841638565
review O 0 0.005625373683869839
the O 0 0.0040551042184233665
sex O 0 0.006354052573442459
related O 0 0.005663145799189806
effects O 0 0.011961345560848713
on O 0 0.011119815520942211
transmission O 1 0.9994919300079346
of O 1 0.9998931884765625
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9879502058029175

Decreased O 0 0.2008172571659088
fertility O 0 0.16630540788173676
of O 0 0.007571975700557232
males O 0 0.006539481692016125
with O 0 0.004182406701147556
adult O 0 0.2410806268453598
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.006663932465016842
contraction O 0 0.015094629488885403
of O 0 0.003425030503422022
the O 0 0.004042041953653097
repeat O 0 0.010060209780931473
upon O 0 0.0043633366003632545
male O 0 0.009116006083786488
transmission O 0 0.006180453579872847
contribute O 0 0.0019996261689811945
to O 0 0.0010697029065340757
the O 0 0.0017235571285709739
almost O 0 0.002154463669285178
absent O 0 0.005827689543366432
occurrence O 0 0.007731619291007519
of O 0 0.009282349608838558
paternal O 1 0.9999569654464722
transmission O 1 0.9999611377716064
of O 1 0.9999806880950928
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9954912066459656

Also O 0 0.01020987331867218
the O 0 0.006906394846737385
fathers O 0 0.007435375824570656
of O 0 0.0040688542649149895
the O 0 0.006620464380830526
reported O 1 0.6517406702041626
congenitally O 1 0.9999366998672485
affected O 0 0.01177448034286499
children O 0 0.006412464659661055
showed O 0 0.005044272635132074
, O 0 0.0020090825855731964
on O 0 0.0019174752524122596
average O 0 0.003489011898636818
, O 0 0.002589291660115123
shorter O 0 0.007122655399143696
CTG O 1 0.7433891296386719
repeat O 0 0.010056981816887856
lengths O 0 0.008299530483782291
and O 0 0.0024682306684553623
hence O 0 0.006013226695358753
less O 0 0.004321679472923279
severe O 1 0.9999926090240479
clinical O 1 0.9999995231628418
symptoms O 1 0.9999998807907104
than O 0 0.002869590185582638
the O 0 0.004404641687870026
mothers O 0 0.06063022091984749
of O 0 0.006851446349173784
children O 1 0.9837110638618469
with O 1 0.9982563853263855
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9984560012817383

We O 0 0.006465909071266651
conclude O 0 0.009681666269898415
that O 0 0.003813566407188773
paternal O 1 0.9419209957122803
transmission O 1 0.9976949095726013
of O 1 0.9999582767486572
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.8983368277549744
rare O 0 0.11595948785543442
and O 0 0.0027154991403222084
preferentially O 0 0.006141083315014839
occurs O 0 0.002788594691082835
with O 0 0.0024310608860105276
onset O 1 0.9999730587005615
of O 1 0.9374939799308777
DM B-Disease 1 1.0
past O 0 0.005037776660174131
30 O 0 0.0029960491228848696
years O 0 0.0016926529351621866
in O 0 0.0016743970336392522
the O 0 0.004150869324803352
father O 0 0.4179898202419281
. O 0 0.005357095040380955
. O 0 0.008647201582789421

The O 0 0.03829079493880272
RB1 O 1 0.9999743700027466
gene O 0 0.011768866330385208
mutation O 0 0.005892085377126932
in O 0 0.0031006059143692255
a O 0 0.005761453416198492
child O 1 0.9490571618080139
with O 0 0.03343793749809265
ectopic B-Disease 1 0.9999998807907104
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.3414737284183502

The O 0 0.040182553231716156
RB1 O 1 0.9999798536300659
gene O 0 0.017777826637029648
mutation O 0 0.008608109317719936
was O 0 0.006398753263056278
investigated O 0 0.008229169063270092
in O 0 0.0031386481132358313
a O 0 0.005848258268088102
child O 1 0.8492859601974487
with O 0 0.010005537420511246
ectopic B-Disease 1 0.9999996423721313
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999964237213135
using O 0 0.005273663904517889
DNA O 0 0.004504598211497068
obtained O 0 0.002767532831057906
from O 0 0.0017297585727646947
both O 0 0.0016063519287854433
the O 0 0.005062257871031761
pineal B-Disease 1 0.9998425245285034
and I-Disease 0 0.04273704066872597
retinal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
of O 1 0.9906980395317078
the O 1 0.9996376037597656
patient O 1 0.9999963045120239
. O 0 0.019355639815330505

A O 0 0.025938749313354492
nonsense O 0 0.03134859725832939
mutation O 0 0.010676760226488113
in O 0 0.00529081653803587
exon O 0 0.021731974557042122
17 O 0 0.007355735171586275
( O 0 0.004964133724570274
codon O 0 0.009174198843538761
556 O 0 0.012491658329963684
) O 0 0.002417708747088909
of O 0 0.0023429926950484514
the O 0 0.009026401676237583
RB1 O 1 0.9999991655349731
gene O 0 0.006198768503963947
was O 0 0.003316376358270645
found O 0 0.0016755139222368598
to O 0 0.0010266408789902925
be O 0 0.0010738602140918374
present O 0 0.002428945619612932
homozygously O 0 0.014585585333406925
in O 0 0.0017501817783340812
both O 0 0.0019897560123354197
the O 0 0.007436677813529968
retinal B-Disease 1 0.9999953508377075
and I-Disease 0 0.010998399928212166
the I-Disease 1 0.9834991097450256
pineal I-Disease 1 0.9999995231628418
tumours I-Disease 1 0.9999998807907104
. O 0 0.033041518181562424

The O 0 0.01384204812347889
same O 0 0.005947980564087629
mutation O 0 0.00784583855420351
was O 0 0.006193230859935284
present O 0 0.004063326399773359
heterozygously O 0 0.043633121997117996
in O 0 0.002189707476645708
the O 0 0.0023905751295387745
DNA O 0 0.0028515115845948458
from O 0 0.001311499159783125
the O 0 0.0018261122750118375
constitutional O 0 0.003785656997933984
cells O 0 0.002589206676930189
of O 0 0.0023366070818156004
the O 0 0.006166586186736822
patient O 1 0.9980194568634033
, O 0 0.003302805358543992
proving O 0 0.007978553883731365
it O 0 0.0012081456370651722
to O 0 0.0012270204024389386
be O 0 0.0017599428538233042
of O 0 0.004626280628144741
germline O 0 0.044962890446186066
origin O 0 0.010544019751250744
. O 0 0.014894995838403702

The O 0 0.015574000775814056
initial O 0 0.014030368998646736
mutation O 0 0.01129024475812912
was O 0 0.006774446461349726
shown O 0 0.0029896649066358805
to O 0 0.0013186534633859992
have O 0 0.0011707022786140442
occurred O 0 0.0027925181202590466
in O 0 0.002032689983025193
the O 0 0.006344245746731758
paternally O 1 0.9932189583778381
derived O 0 0.06330878287553787
RB1 O 1 0.9999388456344604
allele O 0 0.03718468174338341
. O 0 0.015675446018576622

The O 0 0.014303987845778465
mutation O 0 0.01004768069833517
is O 0 0.002620215527713299
in O 0 0.0018374405335634947
an O 0 0.0017943392740562558
area O 0 0.002701727207750082
of O 0 0.0024703284725546837
the O 0 0.0030693437438458204
gene O 0 0.002718752482905984
that O 0 0.0010923424270004034
encodes O 0 0.0041457414627075195
the O 0 0.0028395012486726046
protein O 0 0.004886898677796125
- O 0 0.004615259822458029
binding O 0 0.002392577240243554
region O 0 0.0031358208507299423
known O 0 0.002917484613135457
as O 0 0.0023899769876152277
the O 0 0.003977383952587843
pocket O 1 0.633998692035675
region O 0 0.004548567812889814
and O 0 0.0015003192238509655
has O 0 0.0018056501867249608
been O 0 0.0016816300339996815
detected O 0 0.0025356959085911512
in O 0 0.0011451424797996879
other O 0 0.0008962207939475775
cases O 0 0.003129944670945406
of O 0 0.044717784970998764
retinoblastoma B-Disease 1 0.9999994039535522
. O 0 0.010307050310075283
. O 0 0.01348217111080885

Low O 0 0.021801868453621864
levels O 0 0.009043659083545208
of O 0 0.0067059434950351715
beta O 0 0.015012724325060844
hexosaminidase O 0 0.0437152162194252
A O 0 0.005893141031265259
in O 0 0.002965040970593691
healthy O 0 0.005708439741283655
individuals O 0 0.001704961876384914
with O 0 0.0030176180880516768
apparent O 1 0.9999768733978271
deficiency O 1 1.0
of O 1 0.9977878332138062
this O 0 0.055289797484874725
enzyme O 0 0.06253445893526077
. O 0 0.012666107155382633

Appreciable O 0 0.12763138115406036
beta O 0 0.044946204870939255
hexosaminidase O 0 0.4756350815296173
A O 0 0.015336151234805584
( O 0 0.009317290037870407
hex O 0 0.02084357477724552
A O 0 0.006685924716293812
) O 0 0.0028621815145015717
activity O 0 0.002004011068493128
has O 0 0.001506307045929134
been O 0 0.00180819071829319
detected O 0 0.004861969966441393
in O 0 0.0039685629308223724
cultured O 1 0.9980654120445251
skin O 1 0.9999995231628418
fibroblasts O 1 0.9999953508377075
and O 1 0.9983773231506348
melanoma B-Disease 1 1.0
tissue O 1 0.9999967813491821
from O 0 0.008401390165090561
healthy O 0 0.021535946056246758
individuals O 0 0.001443840330466628
previously O 0 0.0033114321995526552
reported O 0 0.0039163753390312195
as O 0 0.0033374556805938482
having O 0 0.34342917799949646
deficiency B-Disease 1 1.0
of I-Disease 0 0.09471787512302399
hex I-Disease 1 0.622066855430603
A I-Disease 0 0.005357095040380955
activity O 0 0.002510582096874714
indistinguishable O 0 0.0034675518982112408
from O 0 0.0010438199387863278
that O 0 0.0008093115757219493
of O 0 0.0024825504515320063
patients O 1 0.994408369064331
with O 1 0.9436275959014893
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9993340373039246
TSD B-Disease 1 0.9999998807907104
) O 0 0.016368195414543152
. O 0 0.01427651010453701

Identification O 0 0.0207882821559906
and O 0 0.008438710123300552
quantitation O 0 0.11975125968456268
of O 0 0.011208736337721348
hex O 0 0.4138089120388031
A O 0 0.012273997999727726
, O 0 0.005444457288831472
amounting O 0 0.014565209858119488
to O 0 0.0057658967562019825
3 O 0 0.014105195179581642
. O 0 0.014769509434700012

5 O 0 0.026062268763780594
% O 0 0.01836320385336876
- O 0 0.02659735642373562
6 O 0 0.02599160559475422
. O 0 0.01741844043135643

9 O 0 0.016052961349487305
% O 0 0.005093212705105543
of O 0 0.003930492792278528
total O 0 0.006939860060811043
beta O 0 0.03587790206074715
hexosaminidase O 1 0.9660454392433167
activity O 0 0.004252167418599129
, O 0 0.0021546233911067247
has O 0 0.0018347384175285697
been O 0 0.0019782502204179764
obtained O 0 0.002628829563036561
by O 0 0.0033663390204310417
cellulose O 1 0.9923185110092163
acetate O 1 0.9992850422859192
gel O 1 0.9836296439170837
electrophoresis O 0 0.12061037123203278
, O 0 0.010954621247947216
DEAE O 1 0.99994957447052
- O 1 0.8830295205116272
cellulose O 1 0.9176575541496277
ion O 0 0.09929416328668594
- O 0 0.01309443823993206
exchange O 0 0.008272978477180004
chromatography O 0 0.026835909113287926
, O 0 0.007757107727229595
radial O 0 0.4791020452976227
immunodiffusion O 1 0.9934145212173462
, O 0 0.009146494790911674
and O 0 0.008441494777798653
radioimmunoassay O 1 0.9955658316612244
. O 0 0.019259938970208168

Previous O 0 0.01687854900956154
family O 0 0.010518270544707775
studies O 0 0.005215319339185953
suggested O 0 0.0042334627360105515
that O 0 0.0013280280400067568
these O 0 0.001029316452331841
individuals O 0 0.0012548500671982765
may O 0 0.0020098048262298107
be O 0 0.0013862414052709937
compound O 0 0.007476543076336384
heterozygotes O 0 0.012777152471244335
for O 0 0.0017647275235503912
the O 0 0.0036920036654919386
common O 0 0.007491666823625565
mutant O 1 0.9034805297851562
TSD B-Disease 1 0.9999921321868896
gene O 0 0.005488698836416006
and O 0 0.0017488409066572785
a O 0 0.0030880384147167206
rare O 0 0.00778236985206604
( O 0 0.00946678128093481
allelic O 1 0.7537404298782349
) O 0 0.011265590786933899
mutant O 0 0.034411001950502396
gene O 0 0.018367668613791466
. O 0 0.013627307489514351

Thus O 0 0.009782896377146244
, O 0 0.004049354232847691
the O 0 0.00470741419121623
postulated O 0 0.02035965397953987
rate O 0 0.008392143994569778
mutant O 0 0.013536617159843445
gene O 0 0.003916326444596052
appears O 0 0.0024812922347337008
to O 0 0.0010299313580617309
code O 0 0.0017023051623255014
for O 0 0.0010592773323878646
the O 0 0.00193028652574867
expression O 0 0.0028076141607016325
of O 0 0.0027079631108790636
low O 0 0.00557848671451211
amounts O 0 0.0042428201995790005
of O 0 0.006314227357506752
hex O 0 0.04422667250037193
A O 0 0.02092057839035988
. O 0 0.01600947044789791

Heterozygotes O 0 0.06358268111944199
for O 0 0.00703170383349061
the O 0 0.006237091030925512
rare O 0 0.015501290559768677
mutant O 0 0.15752583742141724
may O 0 0.003002723678946495
be O 0 0.0019152972381561995
indistinguishable O 0 0.006279014982283115
from O 0 0.002749995794147253
heterozygotes O 0 0.015860360115766525
for O 0 0.0031244237907230854
the O 0 0.0076579563319683075
common O 0 0.33738085627555847
TSD B-Disease 1 0.9999997615814209
mutant O 1 0.9355466365814209
. O 0 0.017606468871235847

However O 0 0.011099908500909805
, O 0 0.006591351702809334
direct O 0 0.006062373053282499
visualization O 0 0.01620897650718689
and O 0 0.0046880217269063
quantitation O 0 0.360519140958786
of O 0 0.0078002773225307465
hex O 0 0.023914268240332603
A O 0 0.004304841626435518
by O 0 0.0013256382662802935
the O 0 0.0017499759560450912
methods O 0 0.0026046293787658215
described O 0 0.004608351271599531
may O 0 0.0029322875197976828
prevent O 0 0.005540417041629553
false O 0 0.009096179157495499
- O 0 0.15175560116767883
positive O 0 0.009135360829532146
prenatal O 1 0.998058021068573
diagnosis O 1 0.9993665814399719
of O 0 0.026820434257388115
TSD B-Disease 1 0.999998927116394
in O 0 0.006117604207247496
fetuses O 0 0.04827892407774925
having O 0 0.003830701345577836
the O 0 0.003486610483378172
incomplete O 0 0.011633360758423805
hex B-Disease 1 0.808597207069397
A I-Disease 1 0.676798403263092
deficiency I-Disease 1 0.9999983310699463
of O 0 0.006300545297563076
the O 0 0.006825712509453297
type O 0 0.014691957272589207
described O 0 0.005124108400195837
in O 0 0.0023798756301403046
the O 0 0.004238780587911606
four O 0 0.005930338520556688
healthy O 0 0.0220999363809824
individuals O 0 0.013217130675911903

The O 0 0.26689621806144714
tumor B-Disease 1 0.9999995231628418
suppressor O 1 0.9998792409896851
gene O 0 0.13177043199539185
Smad4 O 1 0.9998712539672852
/ O 1 0.9772657752037048
Dpc4 O 0 0.4766247868537903
is O 0 0.0030393663328140974
required O 0 0.0020835446193814278
for O 0 0.0024361126124858856
gastrulation O 1 0.8710407018661499
and O 0 0.0028112782165408134
later O 0 0.0045777494087815285
for O 0 0.003718941006809473
anterior O 1 0.9903056621551514
development O 0 0.007302636280655861
of O 0 0.007659199647605419
the O 0 0.031054997816681862
mouse O 0 0.1178814023733139
embryo O 0 0.02502562291920185
. O 0 0.01371146272867918

Mutations O 0 0.014269580133259296
in O 0 0.006619147956371307
the O 0 0.014497296884655952
SMAD4 O 1 0.9999994039535522
/ O 1 0.9999983310699463
DPC4 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.999669075012207
gene O 0 0.007576602976769209
, O 0 0.0027620713226497173
a O 0 0.003076150780543685
key O 0 0.006112508941441774
signal O 0 0.00694691576063633
transducer O 0 0.010075094178318977
in O 0 0.0022960191126912832
most O 0 0.0034282917622476816
TGFbeta O 1 0.9986384510993958
- O 0 0.06449655443429947
related O 0 0.00585644505918026
pathways O 0 0.006947012152522802
, O 0 0.0019515668973326683
are O 0 0.0008436755160801113
involved O 0 0.0016459045000374317
in O 0 0.0018137599108740687
50 O 0 0.0036727250553667545
% O 0 0.0038597281090915203
of O 0 0.0211970005184412
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.5868206024169922

Homozygous O 0 0.08405501395463943
Smad4 O 1 0.9948380589485168
mutant O 1 0.8324155807495117
mice O 0 0.3045646548271179
die O 0 0.04479116573929787
before O 0 0.007750511635094881
day O 0 0.012980977073311806
7 O 0 0.016960175707936287
. O 0 0.011490792967379093

5 O 0 0.028646498918533325
of O 0 0.022263405844569206
embryogenesis O 1 0.8851998448371887
. O 0 0.028443343937397003

Mutant O 0 0.05000429227948189
embryos O 0 0.014576438814401627
have O 0 0.0034112303983420134
reduced O 0 0.0053582643158733845
size O 0 0.00391777791082859
, O 0 0.002972841029986739
fail O 0 0.005102453287690878
to O 0 0.0025126677937805653
gastrulate O 0 0.09431346505880356
or O 0 0.0030253026634454727
express O 0 0.005307203158736229
a O 0 0.005647456739097834
mesodermal O 1 0.9968878626823425
marker O 1 0.7892795205116272
, O 0 0.00479143438860774
and O 0 0.004774653352797031
show O 0 0.013127879239618778
abnormal O 1 0.9924775958061218
visceral O 1 0.9998952150344849
endoderm O 1 0.9999755620956421
development O 0 0.10970358550548553
. O 0 0.022544290870428085

Growth B-Disease 1 0.9815223217010498
retardation I-Disease 1 0.9999595880508423
of O 0 0.03957173228263855
the O 1 0.9646040797233582
Smad4 O 1 0.9999997615814209
- O 1 0.9989749193191528
deficient O 1 0.8841193318367004
embryos O 0 0.0052585965022444725
results O 0 0.002608035458251834
from O 0 0.0026638817507773638
reduced O 0 0.006727375090122223
cell O 0 0.008575685322284698
proliferation O 0 0.009671705774962902
rather O 0 0.0036927564069628716
than O 0 0.003432796336710453
increased O 0 0.011162388138473034
apoptosis O 0 0.03843167796730995
. O 0 0.014758425764739513

Aggregation O 0 0.03129222244024277
of O 0 0.018661651760339737
mutant O 1 0.5860677361488342
Smad4 O 1 0.9996540546417236
ES O 1 0.9994865655899048
cells O 0 0.008749030530452728
with O 0 0.0030106594786047935
wild O 0 0.009267207235097885
- O 0 0.018977278843522072
type O 0 0.017923535779118538
tetraploid O 0 0.05591622740030289
morulae O 1 0.8704079389572144
rescues O 0 0.4881608784198761
the O 0 0.023806780576705933
gastrulation B-Disease 1 0.999988317489624
defect I-Disease 1 0.9999656677246094
. O 0 0.02276674285531044

These O 0 0.00685629528015852
results O 0 0.0066543882712721825
indicate O 0 0.006135936826467514
that O 0 0.003238172736018896
Smad4 O 0 0.2005665898323059
is O 0 0.0029881498776376247
initially O 0 0.003481840481981635
required O 0 0.0014928606105968356
for O 0 0.0013329178327694535
the O 0 0.0025940584018826485
differentiation O 0 0.004575737752020359
of O 0 0.003504315624013543
the O 0 0.009200820699334145
visceral O 1 0.9962880611419678
endoderm O 1 0.9953892230987549
and O 0 0.0030809652525931597
that O 0 0.002218538662418723
the O 0 0.005917384754866362
gastrulation B-Disease 1 0.9999046325683594
defect I-Disease 1 0.9981217980384827
in O 0 0.004230964463204145
the O 0 0.007741246372461319
epiblast O 1 0.9999481439590454
is O 0 0.0051561142317950726
secondary O 0 0.011862356215715408
and O 0 0.004985113628208637
non O 0 0.28744640946388245
- O 1 0.9430488348007202
cell O 0 0.019669508561491966
autonomous O 0 0.01885879971086979
. O 0 0.013693495653569698

Rescued O 0 0.3818798065185547
embryos O 0 0.0430448055267334
show O 0 0.04027247428894043
severe O 1 0.9999978542327881
anterior O 1 0.9999991655349731
truncations O 1 0.9999966621398926
, O 0 0.030732683837413788
indicating O 0 0.010593373328447342
a O 0 0.0034318992402404547
second O 0 0.003799967933446169
important O 0 0.0027195170987397432
role O 0 0.003535178955644369
for O 0 0.0034842153545469046
Smad4 O 1 0.9993645548820496
in O 0 0.011155769228935242
anterior O 1 0.9999709129333496
patterning O 1 0.9999397993087769
during O 1 0.9765616655349731
embryogenesis O 1 0.9993852376937866
. O 0 0.023567304015159607

Prevalence O 1 0.8258838653564453
of O 0 0.01709265448153019
p16 O 1 0.7114877700805664
and O 0 0.01049308106303215
CDK4 O 1 0.9999189376831055
germline O 1 0.8186507821083069
mutations O 0 0.008539783768355846
in O 0 0.006442947778850794
48 O 1 0.832653284072876
melanoma B-Disease 1 1.0
- O 1 0.9997311234474182
prone O 1 0.9502940773963928
families O 0 0.006886297836899757
in O 0 0.007514640688896179
France O 0 0.025643546134233475
. O 0 0.017811112105846405

The O 0 0.02408739924430847
French O 1 0.9887735247612
Familial B-Disease 1 0.9999997615814209
Melanoma I-Disease 1 1.0
Study O 1 0.9471498727798462
Group O 0 0.03199998289346695
. O 0 0.01900954730808735

Germline O 0 0.23486173152923584
mutations O 0 0.01254214532673359
in O 0 0.004359808750450611
the O 0 0.006678334437310696
p16 O 1 0.7687749862670898
and O 0 0.005777651909738779
CDK4 O 1 0.9999723434448242
genes O 0 0.004134015645831823
have O 0 0.0012220093049108982
been O 0 0.001768644666299224
reported O 0 0.0022733339574187994
in O 0 0.0013528370764106512
a O 0 0.002264054026454687
subset O 0 0.006691240705549717
of O 0 0.1711428016424179
melanoma B-Disease 1 1.0
pedigrees O 1 0.8529922366142273
, O 0 0.002683414379134774
but O 0 0.0014154103118926287
their O 0 0.0016986108385026455
prevalence O 1 0.7508018612861633
is O 0 0.0025015012361109257
not O 0 0.0019958652555942535
well O 0 0.003348812460899353
known O 0 0.009525814093649387
. O 0 0.01141718216240406

We O 0 0.006841435097157955
searched O 0 0.009859682060778141
for O 0 0.0029628172051161528
such O 0 0.0027956843841820955
germline O 0 0.022277159616351128
mutations O 0 0.004522024188190699
in O 0 0.0029899345245212317
48 O 0 0.011548505164682865
French O 1 0.9999364614486694
melanoma B-Disease 1 1.0
- O 1 0.9999632835388184
prone O 1 0.9397948384284973
families O 0 0.0025199446827173233
selected O 0 0.0022350640501827
according O 0 0.0012626673560589552
to O 0 0.0007085672114044428
two O 0 0.000690146058332175
major O 0 0.0018195834709331393
criteria O 0 0.0024040306452661753
families O 0 0.0012250988511368632
with O 0 0.0008238659356720746
at O 0 0.001667847391217947
least O 0 0.0008650300442241132
three O 0 0.0008487715967930853
affected O 0 0.0018073448445647955
members O 0 0.0011866716668009758
( O 0 0.002355216071009636
n O 0 0.004840367939323187
= O 0 0.0048469738103449345
20 O 0 0.0019287419272586703
) O 0 0.001322060008533299
or O 0 0.0009199344785884023
families O 0 0.0008876737556420267
with O 0 0.0007878442411310971
two O 0 0.001009237254038453
affected O 0 0.002079922240227461
members O 0 0.0009769678581506014
, O 0 0.0010541991796344519
one O 0 0.0010515704052522779
of O 0 0.0013738202396780252
them O 0 0.00108117435593158
affected O 0 0.00216634850949049
before O 0 0.001490757567808032
the O 0 0.0014388271374627948
age O 0 0.0020795937161892653
of O 0 0.0019333076197654009
50 O 0 0.0031218568328768015
( O 0 0.0028665887657552958
n O 0 0.005181394051760435
= O 0 0.006377778481692076
28 O 0 0.0031948951072990894
) O 0 0.0018864457961171865
, O 0 0.001422237022779882
and O 0 0.0013901585480198264
one O 0 0.0023133184295147657
additional O 0 0.00486377626657486
minor O 0 0.0724577084183693
criterion O 1 0.9708007574081421
. O 0 0.01837276667356491

Sixteen O 0 0.032020360231399536
different O 0 0.006988130044192076
p16 O 0 0.08187907189130783
germline O 0 0.08331658691167831
mutations O 0 0.006471612025052309
were O 0 0.002497138688340783
found O 0 0.00244193896651268
in O 0 0.001999845029786229
21 O 0 0.0033446960151195526
families O 0 0.0018944857874885201
, O 0 0.0015677184564992785
while O 0 0.0021197281312197447
one O 0 0.002869984833523631
germline O 0 0.022777704522013664
mutation O 0 0.006532870698720217
, O 0 0.0041364626958966255
Arg24His O 0 0.4484542906284332
, O 0 0.00430613337084651
was O 0 0.006750045344233513
detected O 0 0.007008907850831747
in O 0 0.003567393869161606
the O 0 0.008310290984809399
CDK4 O 1 0.9999417066574097
gene O 0 0.020475657656788826
. O 0 0.011800196953117847

The O 0 0.010961726307868958
frequency O 0 0.0068643465638160706
of O 0 0.005613085813820362
p16 O 0 0.05988407880067825
gene O 0 0.006196186877787113
mutation O 0 0.0034628668799996376
in O 0 0.0018626793753355742
our O 0 0.002398902550339699
sample O 0 0.003088131546974182
( O 0 0.0037270341999828815
44 O 0 0.004845501855015755
% O 0 0.0032298187725245953
) O 0 0.002113594440743327
is O 0 0.001592220738530159
among O 0 0.0017720885807648301
the O 0 0.0026327152736485004
highest O 0 0.00757650937885046
rates O 0 0.0036067632026970387
yet O 0 0.0021791779436171055
reported O 0 0.002993197413161397
and O 0 0.0017710017273202538
the O 0 0.003988750744611025
CDK4 O 1 0.9993733763694763
mutation O 0 0.0052477209828794
is O 0 0.0020547271706163883
the O 0 0.002437927760183811
second O 0 0.005085855722427368
mutation O 0 0.006114467978477478
detected O 0 0.005298898089677095
in O 0 0.002392581896856427
this O 0 0.00317373382858932
gene O 0 0.00777861475944519
worldwide O 0 0.009284542873501778
. O 0 0.011190286837518215

In O 0 0.01080038957297802
summary O 0 0.015180319547653198
, O 0 0.004603428300470114
our O 0 0.003153181867673993
results O 0 0.0032359014730900526
show O 0 0.0032108996529132128
frequent O 0 0.00398114463314414
involvement O 0 0.005374273285269737
of O 0 0.0034370042849332094
the O 0 0.007299263495951891
p16 O 1 0.893608033657074
gene O 0 0.007203428540378809
in O 0 0.004860234446823597
familial B-Disease 1 0.9999991655349731
melanoma I-Disease 1 1.0
and O 0 0.0050000352784991264
confirm O 0 0.003639306640252471
the O 0 0.002139259362593293
role O 0 0.002675674157217145
of O 0 0.0021697785705327988
the O 0 0.003941875416785479
CDK4 O 1 0.9999665021896362
gene O 0 0.0044163125567138195
as O 0 0.0027901383582502604
a O 0 0.012452978640794754
melanoma B-Disease 1 1.0
- O 1 0.999885082244873
predisposing O 1 0.9992662072181702
gene O 0 0.01625862903892994
. O 0 0.0068511939607560635
. O 0 0.012284709140658379

Progression O 0 0.4498686194419861
of O 0 0.027204278856515884
somatic O 1 0.9239403605461121
CTG O 1 0.999445378780365
repeat O 0 0.02009580284357071
length O 0 0.006274595856666565
heterogeneity O 0 0.010873831808567047
in O 0 0.003898539114743471
the O 0 0.007534569129347801
blood O 1 0.9993016719818115
cells O 1 0.524945855140686
of O 1 0.9958503246307373
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 1 0.5169793963432312

The O 0 0.010262647643685341
genetic O 0 0.008835822343826294
basis O 0 0.006875935010612011
of O 0 0.4619978368282318
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.004820005036890507
is O 0 0.001936724060215056
the O 0 0.0018102092435583472
expansion O 0 0.0032646439503878355
of O 0 0.0027672520373016596
an O 0 0.005486201029270887
unstable O 1 0.9998006224632263
CTG O 1 0.999943733215332
repeat O 0 0.010793064720928669
in O 0 0.002346143824979663
the O 0 0.0035183073487132788
34 O 0 0.0067390818148851395
UTR O 0 0.02428852953016758
of O 0 0.004994738381356001
the O 0 0.012049566954374313
DM B-Disease 1 0.9999996423721313
protein O 0 0.014194121584296227
kinase O 0 0.016743633896112442
gene O 0 0.007536313030868769
on O 0 0.005732311867177486
chromosome O 0 0.016554992645978928
19 O 0 0.013896620832383633
. O 0 0.01045367494225502

One O 0 0.0076155392453074455
of O 0 0.0050962623208761215
the O 0 0.004008518531918526
principal O 0 0.008951863273978233
features O 0 0.004084132146090269
of O 0 0.004785644356161356
the O 1 0.6020179986953735
DM B-Disease 1 1.0
mutation O 0 0.010017764754593372
is O 0 0.002651429735124111
an O 0 0.0027019339613616467
extraordinarily O 0 0.012605694122612476
high O 0 0.006120350211858749
level O 0 0.005278243217617273
of O 0 0.006087012123316526
somatic O 1 0.8903830051422119
mosaicism O 1 0.9986627101898193
, O 0 0.004222652409225702
due O 0 0.0040802787989377975
to O 0 0.0020369677804410458
an O 0 0.002554044360294938
extremely O 0 0.005355419125407934
high O 0 0.005120536778122187
degree O 0 0.005554587114602327
of O 0 0.006125692278146744
somatic O 1 0.9657189846038818
instability O 0 0.18928927183151245
both O 0 0.0018526925705373287
within O 0 0.0015787887386977673
and O 0 0.0017740534385666251
between O 0 0.0027534279506653547
different O 0 0.003662271425127983
tissues O 0 0.29366961121559143
. O 0 0.01246300246566534

This O 0 0.010247701779007912
instability O 0 0.20149342715740204
appears O 0 0.006886062677949667
to O 0 0.0020640052389353514
be O 0 0.0016409249510616064
biased O 0 0.0035352646373212337
towards O 0 0.002649985020980239
further O 0 0.0018568142550066113
expansion O 0 0.0029820618219673634
and O 0 0.0011601841542869806
continuous O 0 0.0031964473892003298
throughout O 0 0.0015871223295107484
the O 0 0.0015322063118219376
life O 0 0.0018361519323661923
of O 0 0.0013725424651056528
an O 0 0.0017115826485678554
individual O 0 0.0013824023772031069
, O 0 0.0014698024606332183
features O 0 0.0017520480323582888
that O 0 0.0008925828151404858
could O 0 0.0009617964387871325
be O 0 0.0007702572620473802
associated O 0 0.0014003110118210316
with O 0 0.0011785475071519613
the O 0 0.003102933056652546
progressive O 0 0.160984605550766
nature O 0 0.006510049570351839
of O 0 0.027093593031167984
the O 1 0.9984431862831116
disease O 1 1.0
. O 0 0.03095492348074913

Although O 0 0.01058484148234129
increasing O 0 0.008936341851949692
measured O 0 0.009267689660191536
allele O 0 0.008833800442516804
size O 0 0.004699844401329756
between O 0 0.0046134330332279205
patients O 0 0.12342700362205505
clearly O 0 0.005221431143581867
correlates O 0 0.0072797671891748905
with O 0 0.0017743345815688372
an O 0 0.002719376003369689
increased O 0 0.00528833270072937
severity O 1 0.9191802144050598
of O 0 0.060640789568424225
symptoms O 1 0.9999988079071045
and O 0 0.0027604796923696995
an O 0 0.002102670492604375
earlier O 0 0.00355102913454175
age O 0 0.004042208660393953
of O 0 0.004897823091596365
onset O 1 0.9999980926513672
, O 0 0.003214483615010977
this O 0 0.001546145649626851
correlation O 0 0.0034212011378258467
is O 0 0.0015632123686373234
not O 0 0.000992540386505425
precise O 0 0.0025201074313372374
and O 0 0.0019261542474851012
measured O 0 0.0051552727818489075
allele O 0 0.005152745172381401
length O 0 0.0028719091787934303
cannot O 0 0.0017392459558323026
be O 0 0.0008606479386799037
used O 0 0.0011363400844857097
as O 0 0.0012660572538152337
an O 0 0.001378804910928011
accurate O 0 0.0034421426244080067
predictor O 0 0.011187037453055382
of O 0 0.0034490805119276047
age O 0 0.009452232159674168
of O 0 0.018982812762260437
onset O 1 0.9999995231628418
. O 0 0.025171326473355293

In O 0 0.00835109781473875
order O 0 0.004602794535458088
to O 0 0.0027703435625880957
further O 0 0.0032616618555039167
characterize O 0 0.008396700024604797
the O 0 0.004226427525281906
dynamics O 0 0.013244953006505966
of O 0 0.21158331632614136
DM B-Disease 1 1.0
CTG O 1 0.9999996423721313
repeat O 1 0.995314359664917
somatic O 1 0.9475614428520203
instability O 0 0.21214856207370758
, O 0 0.002734737703576684
we O 0 0.0015235525788739324
have O 0 0.0010049915872514248
studied O 0 0.0037264551501721144
repeat O 0 0.005769527517259121
length O 0 0.00241631967946887
changes O 0 0.0011849264847114682
over O 0 0.0013618095545098186
time O 0 0.0022997481282800436
in O 0 0.004732922185212374
111 O 1 0.9998464584350586
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999985694885254
with O 0 0.005869757849723101
varying O 0 0.007932123728096485
clinical O 1 0.9993520379066467
severity O 1 0.9997009038925171
and O 0 0.010216154158115387
CTG O 1 0.9999527931213379
repeat O 0 0.009043299593031406
size O 0 0.002481088973581791
over O 0 0.0014227388892322779
time O 0 0.0012600901536643505
intervals O 0 0.0023606419563293457
of O 0 0.0026566251181066036
1 O 0 0.008260290138423443
- O 0 0.010995442979037762
7 O 0 0.00976103451102972
years O 0 0.007661301642656326
. O 0 0.01038915291428566

We O 0 0.006510925013571978
have O 0 0.002417747862637043
found O 0 0.0026420345529913902
a O 0 0.002757722046226263
direct O 0 0.003133389400318265
progression O 0 0.022647103294730186
of O 0 0.003686468815430999
the O 0 0.003940296359360218
size O 0 0.003792383475229144
heterogeneity O 0 0.006935721263289452
over O 0 0.002056295983493328
time O 0 0.001977012027055025
related O 0 0.002739580348134041
to O 0 0.0025992211885750294
initial O 0 0.007528221234679222
CTG O 1 0.9983934760093689
repeat O 0 0.010570578277111053
size O 0 0.0033025569282472134
and O 0 0.001575078465975821
the O 0 0.0023398161865770817
time O 0 0.002435601782053709
interval O 0 0.003959865774959326
and O 0 0.0019331566290929914
always O 0 0.0033077062107622623
biased O 0 0.006072822492569685
towards O 0 0.004857207648456097
further O 0 0.005921518430113792
expansion O 0 0.014685842208564281
. O 0 0.01164228469133377

Attempts O 0 0.0129090566188097
to O 0 0.0045133670791983604
mathematically O 0 0.009085624478757381
model O 0 0.0050880443304777145
the O 0 0.003457930637523532
dynamics O 0 0.007008296903222799
have O 0 0.0018766972934827209
proved O 0 0.005234850104898214
only O 0 0.0021291917655617
partially O 0 0.00648973323404789
successful O 0 0.003504987107589841
suggesting O 0 0.002698671305552125
that O 0 0.0009659118950366974
individual O 0 0.0011091063497588038
specific O 0 0.0017113561043515801
genetic O 0 0.0051439725793898106
and O 0 0.004530110862106085
/ O 1 0.9944802522659302
or O 0 0.0032002893276512623
environmental O 0 0.006234714761376381
factors O 0 0.003123390255495906
also O 0 0.0017720818286761642
play O 0 0.001687929150648415
a O 0 0.0022453386336565018
role O 0 0.005486481823027134
in O 0 0.005556521471589804
somatic O 1 0.9709521532058716
mosaicism O 1 0.999832272529602
. O 0 0.009164316579699516
. O 0 0.012628099881112576

Aspartylglucosaminuria B-Disease 1 0.9987589120864868
among O 0 0.02118910290300846
Palestinian O 0 0.03974083065986633
Arabs O 0 0.03306155651807785
. O 0 0.020369116216897964

Aspartylglucosaminuria B-Disease 1 0.9999984502792358
( O 1 0.9961710572242737
AGU B-Disease 1 0.9999998807907104
) O 0 0.007578252349048853
is O 0 0.0032747420482337475
a O 0 0.00416781147941947
rare O 0 0.318343847990036
disorder B-Disease 1 0.9999998807907104
of I-Disease 1 0.9999464750289917
glycoprotein I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.9992402791976929
caused O 0 0.03554672747850418
by O 0 0.0031767599284648895
the O 0 0.031084707006812096
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.10072103887796402
the I-Disease 1 0.7898058295249939
lysosomal I-Disease 1 0.9999998807907104
enzyme I-Disease 1 0.9968050718307495
aspartylglucosaminidase I-Disease 1 0.9999790191650391
( O 0 0.2060009241104126
AGA O 1 0.9999725818634033
) O 0 0.013813592493534088
. O 0 0.013735046610236168

AGU B-Disease 1 0.9999997615814209
is O 0 0.021861396729946136
inherited O 1 0.9998615980148315
as O 0 0.007676154375076294
an O 0 0.06751223653554916
autosomal O 1 0.9999998807907104
recessive O 1 0.9999998807907104
trait O 1 0.999994158744812
and O 0 0.20693275332450867
occurs O 0 0.007437287364155054
with O 0 0.0018275531474500895
a O 0 0.003331430722028017
high O 0 0.00491481414064765
frequency O 0 0.0019600631203502417
in O 0 0.0013581602834165096
Finland O 0 0.004476417787373066
because O 0 0.001430238364264369
of O 0 0.0026001003570854664
a O 0 0.0066380808129906654
founder O 1 0.9643943905830383
effect O 0 0.013181280344724655
. O 0 0.01238586101680994

While O 0 0.010070615448057652
very O 0 0.006109497044235468
few O 0 0.005489456467330456
patients O 1 0.8538950085639954
with O 0 0.007093566469848156
AGU B-Disease 1 1.0
have O 0 0.001880244817584753
been O 0 0.002238282235339284
reported O 0 0.00273716333322227
from O 0 0.0017693990375846624
non O 0 0.0045798951759934425
- O 0 0.005838731769472361
Finnish O 0 0.010794098488986492
origin O 0 0.002424798905849457
, O 0 0.002488671103492379
we O 0 0.0032820093911141157
diagnosed O 1 0.9999996423721313
the O 1 0.5156510472297668
disorder O 1 1.0
in O 0 0.2502584755420685
8 O 0 0.041735973209142685
patients O 0 0.043589238077402115
originating O 0 0.004662800580263138
from O 0 0.0022109171841293573
3 O 0 0.0035993780475109816
unrelated O 0 0.004216156899929047
families O 0 0.001961304107680917
, O 0 0.001712342258542776
all O 0 0.0011759042972698808
Palestinian O 0 0.003243742510676384
Arabs O 0 0.0034829971846193075
from O 0 0.0019100086065009236
the O 0 0.0034103160724043846
region O 0 0.0063190702348947525
of O 0 0.007686586119234562
Jerusalem O 1 0.5405586957931519
. O 0 0.01670004613697529

The O 0 0.02108297124505043
clinical O 1 0.9999253749847412
diagnosis O 1 0.9999997615814209
of O 1 0.9999417066574097
AGU B-Disease 1 1.0
is O 0 0.006516409106552601
often O 0 0.0021652872674167156
difficult O 0 0.0026836032047867775
, O 0 0.001326085301116109
in O 0 0.0009544689091853797
particular O 0 0.0011926741572096944
early O 0 0.0013664853759109974
in O 0 0.0009842179715633392
the O 0 0.001402245368808508
course O 0 0.002801108406856656
of O 0 0.0028881130274385214
the O 1 0.6437990069389343
disease O 1 1.0
, O 0 0.0020368038676679134
and O 0 0.0010624253191053867
most O 0 0.0008734666625969112
of O 0 0.001801824546419084
the O 0 0.004795369692146778
patients O 1 0.998768150806427
are O 0 0.002211126498878002
diagnosed O 1 0.9999998807907104
after O 0 0.005714917555451393
the O 0 0.0037021979223936796
age O 0 0.004981773439794779
of O 0 0.00426596449688077
5 O 0 0.007746790070086718
years O 0 0.007321069482713938
. O 0 0.008867893368005753

However O 0 0.00900087971240282
, O 0 0.005284345243126154
since O 0 0.003883506404235959
these O 0 0.002732302062213421
patients O 0 0.20671100914478302
excrete O 0 0.11738672107458115
early O 0 0.004213074687868357
large O 0 0.0022989832796156406
amounts O 0 0.002701084828004241
of O 0 0.003539222525432706
aspartylglucosamine O 1 0.9195213913917542
in O 0 0.004133002366870642
urine O 0 0.012876748107373714
, O 0 0.0036347273271530867
biochemical O 0 0.00956809800118208
screening O 0 0.00627135531976819
is O 0 0.0024349610321223736
easy O 0 0.004582034423947334
by O 0 0.0039049331098794937
urine O 0 0.020342040807008743
chromatography O 0 0.06810988485813141
. O 0 0.011723820120096207
. O 0 0.014936711639165878

Detection O 0 0.024547722190618515
of O 0 0.009214445017278194
heterozygous O 0 0.013303322717547417
carriers O 0 0.007819502614438534
of O 0 0.006279949564486742
the O 0 0.10162422060966492
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999985694885254
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.30541226267814636
ATM O 0 0.14836950600147247
) O 0 0.0038436283357441425
gene O 0 0.003702873596921563
by O 0 0.003243437735363841
G2 O 1 0.9977602958679199
phase O 0 0.0334399938583374
chromosomal O 1 0.8878296613693237
radiosensitivity O 1 0.9995125532150269
of O 1 0.9739832282066345
peripheral O 1 1.0
blood O 1 0.9999984502792358
lymphocytes O 1 0.9996234178543091
. O 0 0.022860625758767128

In O 0 0.03674722835421562
ataxia B-Disease 1 1.0
- I-Disease 1 0.99998939037323
telangiectasia I-Disease 1 0.9999998807907104
( O 1 0.9766510128974915
A B-Disease 1 0.9999914169311523
- I-Disease 1 0.9999985694885254
T I-Disease 1 0.9999996423721313
) O 0 0.006296337116509676
patients O 0 0.010631593875586987
, O 0 0.0023715891875326633
mutations O 0 0.0023438369389623404
in O 0 0.0012479301076382399
a O 0 0.0023837266489863396
single O 0 0.0033355150371789932
gene O 0 0.0034456339199095964
, O 0 0.0022687604650855064
ATM O 0 0.007587510626763105
, O 0 0.001832560752518475
result O 0 0.0020212882664054632
in O 0 0.002778085879981518
an O 0 0.04673192277550697
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.15173518657684326
embraces O 1 0.7439066171646118
a O 0 0.00379329826682806
variety O 0 0.003246583743020892
of O 0 0.003774267388507724
clinical O 1 0.9997046589851379
features O 0 0.007854633033275604
and O 0 0.0040282211266458035
manifests O 1 0.9339737892150879
extreme O 1 0.8626424074172974
radiosensitivity O 1 0.9989393353462219
and O 0 0.0026424468960613012
a O 0 0.0035936264321208
strong O 0 0.004756247159093618
pre O 0 0.24686969816684723
- O 0 0.06007979437708855
disposition O 0 0.06990976631641388
to O 0 0.00946697685867548
malignancy B-Disease 1 0.9998459815979004
. O 0 0.017208799719810486

Heterozygotes O 0 0.06042291224002838
for O 0 0.008180741220712662
the O 0 0.010769215412437916
ATM O 0 0.09508252888917923
gene O 0 0.005442386958748102
have O 0 0.0012030262732878327
no O 0 0.001852627145126462
clinical O 0 0.006696669384837151
expression O 0 0.0033847608137875795
of O 0 0.005646726116538048
A B-Disease 1 0.999997615814209
- I-Disease 1 0.9999984502792358
T I-Disease 1 0.9999946355819702
but O 0 0.0018377824453637004
may O 0 0.0025609435979276896
be O 0 0.0026967120356857777
cancer B-Disease 1 0.9999915361404419
prone O 1 0.9236975312232971
with O 0 0.0020456721540540457
a O 0 0.003820371348410845
moderate O 0 0.006992075126618147
increase O 0 0.002462850185111165
in O 0 0.0023236223496496677
in O 0 0.005552907474339008
vitro O 0 0.04739393666386604
radiosensitivity O 1 0.9830612540245056
. O 0 0.01974703185260296

We O 0 0.008383030071854591
performed O 0 0.009844722226262093
a O 0 0.006571940612047911
blind O 0 0.019975734874606133
chromosomal O 0 0.015326346270740032
analysis O 0 0.004565651994198561
on O 0 0.007376529276371002
G2 O 1 0.9999978542327881
- O 0 0.037734393030405045
phase O 0 0.013319977559149265
lymphocytes O 0 0.010005424730479717
from O 0 0.0023021060042083263
7 O 0 0.005167338531464338
unrelated O 0 0.00963536649942398
A B-Disease 1 0.9996941089630127
- I-Disease 1 0.9999843835830688
T I-Disease 1 0.999998927116394
patients O 0 0.32243087887763977
, O 0 0.003262854414060712
13 O 0 0.005941925570368767
obligate O 0 0.011531594209372997
A B-Disease 1 0.9946810603141785
- I-Disease 1 0.9996178150177002
T I-Disease 1 0.9999618530273438
heterozygotes O 0 0.05121080204844475
( O 0 0.003843557322397828
parents O 0 0.002562666777521372
of O 0 0.0025351536460220814
the O 0 0.006250795442610979
patients O 1 0.9992445707321167
) O 0 0.002726611914113164
, O 0 0.0016875241417437792
and O 0 0.0015819534892216325
14 O 0 0.0034024780616164207
normal O 0 0.003455263329669833
controls O 0 0.004186857491731644
following O 0 0.004667118191719055
X O 0 0.02037259005010128
- O 0 0.00846288725733757
irradiation O 0 0.009582731872797012
with O 0 0.0025725422892719507
1 O 0 0.006921206600964069
Gy O 0 0.0300433412194252
in O 0 0.0018201032653450966
order O 0 0.001426227274350822
to O 0 0.0012967712245881557
evaluate O 0 0.0038076217751950026
this O 0 0.0015214579179883003
cytogenetic O 0 0.010959968902170658
method O 0 0.0031713892240077257
as O 0 0.0017425182741135359
a O 0 0.0025957648176699877
tool O 0 0.006345466244965792
for O 0 0.0028727559838443995
detection O 0 0.00955974217504263
of O 0 0.009516702964901924
ATM O 1 0.6075024604797363
carriers O 0 0.027109211310744286
. O 0 0.012375260703265667

Both O 0 0.017780138179659843
A B-Disease 1 0.9999074935913086
- I-Disease 1 0.9999911785125732
T I-Disease 1 0.9999988079071045
homozygotes O 1 0.9969127178192139
and O 0 0.0067005641758441925
heterozygotes O 1 0.7301586866378784
showed O 0 0.007988130673766136
significantly O 0 0.004688550718128681
increased O 0 0.0029668882489204407
levels O 0 0.004704514518380165
of O 0 0.006031580734997988
radiation O 1 0.9999445676803589
- O 1 0.9992942810058594
induced O 1 0.9997935891151428
chromatid O 1 0.9999880790710449
damage O 0 0.4386748671531677
relative O 0 0.004399128723889589
to O 0 0.00160571513697505
that O 0 0.0011985747842118144
of O 0 0.003132967744022608
normal O 0 0.008328355848789215
controls O 0 0.01294240914285183
. O 0 0.012578846886754036

These O 0 0.006349610630422831
results O 0 0.006270205602049828
show O 0 0.004975164774805307
that O 0 0.0024004685692489147
the O 0 0.006433864124119282
G2 O 1 0.9999967813491821
- O 1 0.6703345775604248
phase O 0 0.1263018101453781
chromosomal O 1 0.8953530788421631
radiosensitivity O 1 0.9895749688148499
assay O 0 0.00867084413766861
can O 0 0.0011425632983446121
be O 0 0.0008761424105614424
used O 0 0.0010234504006803036
for O 0 0.0011291977716609836
the O 0 0.0023722583428025246
detection O 0 0.007060535252094269
of O 0 0.008016076870262623
A B-Disease 1 0.9999850988388062
- I-Disease 1 0.9999582767486572
T I-Disease 1 0.9999679327011108
heterozygotes O 1 0.6523630023002625
. O 0 0.016765441745519638

In O 0 0.009121007286012173
combination O 0 0.008894435130059719
with O 0 0.0031506288796663284
molecular O 0 0.008296394720673561
genetic O 0 0.005871079862117767
analyses O 0 0.004886662121862173
, O 0 0.0018859769916161895
this O 0 0.001060108537785709
test O 0 0.002081925282254815
may O 0 0.0013776171253994107
be O 0 0.0006076503777876496
of O 0 0.0009560702019371092
value O 0 0.0011015397030860186
in O 0 0.001069741789251566
studies O 0 0.0017652719980105758
of O 0 0.0032548278104513884
familial B-Disease 1 0.9999929666519165
and I-Disease 0 0.22141726315021515
sporadic I-Disease 1 0.9995858073234558
cancers I-Disease 1 0.9999957084655762
aimed O 0 0.008172554895281792
at O 0 0.0044003259390592575
determination O 0 0.005093377083539963
of O 0 0.002258756197988987
the O 0 0.0024787604343146086
potential O 0 0.003168869763612747
involvement O 0 0.004601790104061365
of O 0 0.004021314904093742
ATM O 1 0.8703356385231018
mutations O 0 0.009109069593250751
in O 0 0.008093398064374924
tumor B-Disease 1 0.9999998807907104
risk O 0 0.49619680643081665
or O 0 0.0045795864425599575
development O 0 0.011946703307330608
. O 0 0.006132454611361027
. O 0 0.009635454043745995

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999915361404419
telangiectasia I-Disease 1 0.9999995231628418
: O 0 0.0118340402841568
identification O 0 0.0073454296216368675
and O 0 0.0030082231387495995
detection O 0 0.007649307604879141
of O 0 0.0068315016105771065
founder O 1 0.9991391897201538
- O 0 0.01393280178308487
effect O 0 0.004291110206395388
mutations O 0 0.0030855031218379736
in O 0 0.001859353156760335
the O 0 0.003897994989529252
ATM O 0 0.041762933135032654
gene O 0 0.005041848868131638
in O 0 0.002511614002287388
ethnic O 0 0.0068703629076480865
populations O 0 0.012001775205135345
. O 0 0.015531394630670547

To O 0 0.00850188359618187
facilitate O 0 0.01001426950097084
the O 0 0.005995872430503368
evaluation O 0 0.011137353256344795
of O 0 0.0071655698120594025
ATM O 0 0.3133068084716797
heterozygotes O 0 0.04139850288629532
for O 0 0.0035577728413045406
susceptibility O 0 0.013125804252922535
to O 0 0.002330595860257745
other O 0 0.0027007870376110077
diseases O 1 0.9999914169311523
, O 0 0.0028948201797902584
such O 0 0.0026450343430042267
as O 1 0.9998015761375427
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.008003812283277512
we O 0 0.0015026223845779896
have O 0 0.0008256020955741405
attempted O 0 0.002743295393884182
to O 0 0.0013476572930812836
define O 0 0.0027224125806242228
the O 0 0.0019476606976240873
most O 0 0.001676023006439209
common O 0 0.0026710638776421547
mutations O 0 0.0024931037332862616
and O 0 0.0013085309183225036
their O 0 0.0015312808100134134
frequencies O 0 0.002563639311119914
in O 0 0.004183745477348566
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999829530715942
telangiectasia I-Disease 1 1.0
( O 1 0.7137717604637146
A B-Disease 1 0.9999783039093018
- I-Disease 1 0.999935507774353
T I-Disease 1 0.999980092048645
) O 0 0.004543583374470472
homozygotes O 0 0.01598503068089485
from O 0 0.002762331161648035
10 O 0 0.0040268669836223125
ethnic O 0 0.00574773084372282
populations O 0 0.009937357157468796
. O 0 0.012849966995418072

Both O 0 0.012697312980890274
genomic O 0 0.022394618019461632
mutations O 0 0.007184857036918402
and O 0 0.0028242692351341248
their O 0 0.002588087460026145
effects O 0 0.007330494467169046
on O 0 0.005353869870305061
cDNA O 0 0.020419957116246223
were O 0 0.005805713124573231
characterized O 0 0.021854247897863388
. O 0 0.014320733025670052

Protein O 0 0.03510040044784546
- O 0 0.023509593680500984
truncation O 0 0.02533739246428013
testing O 0 0.007764745969325304
of O 0 0.00497650308534503
the O 0 0.006007971242070198
entire O 0 0.010450243018567562
ATM O 0 0.022904686629772186
cDNA O 0 0.01745198294520378
detected O 0 0.009014254435896873
92 O 0 0.011533920653164387
( O 0 0.00504795927554369
66 O 0 0.009447992779314518
% O 0 0.004383102525025606
) O 0 0.003949692472815514
truncating O 0 0.01821262575685978
mutations O 0 0.005900486372411251
in O 0 0.004463052377104759
140 O 0 0.015049519017338753
mutant O 0 0.03240321949124336
alleles O 0 0.025481274351477623
screened O 0 0.028417516499757767
. O 0 0.016342950984835625

The O 0 0.017280414700508118
haplotyping O 1 0.7688252925872803
of O 0 0.01067360769957304
patients O 1 0.9493484497070312
with O 0 0.003959339577704668
identical O 0 0.009932235814630985
mutations O 0 0.006909921765327454
indicates O 0 0.00413551926612854
that O 0 0.001057450077496469
almost O 0 0.001342580420896411
all O 0 0.0007643022108823061
of O 0 0.0013775848783552647
these O 0 0.0008527847821824253
represent O 0 0.0020729447714984417
common O 0 0.0030467063188552856
ancestry O 0 0.005058114416897297
and O 0 0.002128901891410351
that O 0 0.0016813874244689941
very O 0 0.0025211721658706665
few O 0 0.003665932221338153
spontaneously O 0 0.0174189954996109
recurring O 1 0.9998834133148193
ATM O 1 0.9985137581825256
mutations O 0 0.01830212213099003
exist O 0 0.010261518880724907
. O 0 0.012660299427807331

Assays O 0 0.0339764729142189
requiring O 0 0.01087836641818285
minimal O 0 0.009522471576929092
amounts O 0 0.004733771085739136
of O 0 0.004422831814736128
genomic O 0 0.011524075642228127
DNA O 0 0.00590469827875495
were O 0 0.002119588665664196
designed O 0 0.0027717892080545425
to O 0 0.0014415646437555552
allow O 0 0.002104146871715784
rapid O 0 0.0067705754190683365
screening O 0 0.005514046177268028
for O 0 0.0024121077731251717
common O 0 0.0058445497415959835
ethnic O 0 0.009362366981804371
mutations O 0 0.017956553027033806
. O 0 0.012500590644776821

These O 0 0.008862592279911041
rapid O 0 0.01848055049777031
assays O 0 0.015267083421349525
detected O 0 0.010235974565148354
mutations O 0 0.00455645564943552
in O 0 0.002440130105242133
76 O 0 0.008506113663315773
% O 0 0.002623336622491479
of O 0 0.0031630820594727993
Costa O 0 0.02363121695816517
Rican O 0 0.40459638833999634
patients O 1 0.9475398063659668
( O 0 0.004969846457242966
3 O 0 0.0033241508062928915
) O 0 0.0014773701550439
, O 0 0.0011728202225640416
50 O 0 0.0015048790955916047
% O 0 0.0012947131181135774
of O 0 0.0018009379273280501
Norwegian O 0 0.010969562456011772
patients O 1 0.7585656642913818
( O 0 0.003849936183542013
1 O 0 0.0038106581196188927
) O 0 0.001499293721280992
, O 0 0.0012018007691949606
25 O 0 0.0017528245225548744
% O 0 0.0015379332471638918
of O 0 0.002576765837147832
Polish O 1 0.9997708201408386
patients O 1 0.9997031092643738
( O 0 0.006969057023525238
4 O 0 0.0043520620092749596
) O 0 0.001380317029543221
, O 0 0.001024980447255075
and O 0 0.0009986530058085918
14 O 0 0.002297420985996723
% O 0 0.0013819481246173382
of O 0 0.002195770386606455
Italian O 1 0.9913656711578369
patients O 1 0.999991774559021
( O 0 0.10328135639429092
1 O 0 0.00679833022877574
) O 0 0.001776046585291624
, O 0 0.0011965009616687894
as O 0 0.001108749769628048
well O 0 0.0011975475354120135
as O 0 0.0017189931822940707
in O 0 0.002230848651379347
patients O 0 0.0743328332901001
of O 0 0.011097877286374569
Amish O 1 0.9994865655899048
/ O 1 0.9749600291252136
Mennonite O 0 0.03688866272568703
and O 0 0.004494355991482735
Irish O 0 0.012314564548432827
English O 0 0.012284478172659874
backgrounds O 0 0.020084533840417862
. O 0 0.01589604839682579

Additional O 0 0.012968885712325573
mutations O 0 0.0080031119287014
were O 0 0.002683748956769705
observed O 0 0.003083476796746254
in O 0 0.0020503110717982054
Japanese O 0 0.007819424383342266
, O 0 0.0025985105894505978
Utah O 0 0.008432128466665745
Mormon O 0 0.009291463531553745
, O 0 0.0032557176891714334
and O 0 0.002930644666776061
African O 0 0.013501198962330818
American O 0 0.037763338536024094
patients O 1 0.9973861575126648
. O 0 0.016899077221751213

These O 0 0.006764561869204044
assays O 0 0.010618060827255249
should O 0 0.003103522816672921
facilitate O 0 0.004541135858744383
screening O 0 0.006037392187863588
for O 0 0.004298742860555649
A B-Disease 1 0.9992688298225403
- I-Disease 1 0.9998732805252075
T I-Disease 1 0.9999035596847534
heterozygotes O 0 0.019702119752764702
in O 0 0.0024786756839603186
the O 0 0.003408699296414852
populations O 0 0.004656993318349123
studied O 0 0.008855248801410198
. O 0 0.006543769966810942
. O 0 0.010150112211704254

The O 0 0.026686780154705048
von B-Disease 1 0.999757707118988
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
Lindau I-Disease 1 1.0
tumor I-Disease 1 1.0
suppressor O 1 0.9996542930603027
gene O 0 0.007332636043429375
is O 0 0.0023756155278533697
required O 0 0.0022332591470330954
for O 0 0.003183844033628702
cell O 0 0.008865093812346458
cycle O 0 0.012247919104993343
exit O 0 0.016546355560421944
upon O 0 0.011893988586962223
serum O 1 0.9541154503822327
withdrawal O 0 0.030235404148697853
. O 0 0.016545958817005157

The O 0 0.014005284756422043
inactivation O 0 0.027526099234819412
of O 0 0.005902553908526897
the O 0 0.009390229359269142
von B-Disease 1 0.9996726512908936
Hippel I-Disease 1 0.9999974966049194
- I-Disease 1 0.9995095729827881
Lindau I-Disease 1 0.9999963045120239
( I-Disease 0 0.4031773507595062
VHL I-Disease 1 0.9999996423721313
) I-Disease 1 0.5349312424659729
tumor I-Disease 1 0.9999991655349731
suppressor O 1 0.9992399215698242
gene O 0 0.01338981930166483
predisposes O 0 0.026594989001750946
affected O 0 0.004017779137939215
individuals O 0 0.0013514702441170812
to O 0 0.001632801489904523
the O 0 0.006144544575363398
human O 1 0.9999582767486572
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.30554696917533875
is O 0 0.004210428800433874
associated O 0 0.0046593495644629
with O 0 0.003908883780241013
sporadic B-Disease 1 0.9997339844703674
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999943971633911
RCC B-Disease 1 1.0
) O 0 0.02870301343500614
and O 0 0.008491074666380882
brain B-Disease 1 0.9998100399971008
hemangioblastomas I-Disease 1 0.9998249411582947
. O 0 0.020839717239141464

VHL O 1 0.9999232292175293
- O 0 0.061825189739465714
negative O 0 0.024872595444321632
786 O 1 0.9819937348365784
- O 0 0.3029959201812744
0 O 0 0.027514122426509857
RCC B-Disease 1 0.9999775886535645
cells O 0 0.007309767883270979
are O 0 0.0018780464306473732
tumorigenic O 0 0.019381040707230568
in O 0 0.0040583121590316296
nude O 1 0.9726005792617798
mice O 0 0.0248540211468935
which O 0 0.0018870652420446277
is O 0 0.002281104912981391
suppressed O 0 0.0072914655320346355
by O 0 0.0026054123882204294
the O 0 0.0065346695482730865
reintroduction O 0 0.039333321154117584
of O 0 0.021678214892745018
VHL B-Disease 1 0.999990701675415
. O 0 0.024524444714188576

Remarkably O 0 0.059684932231903076
, O 0 0.00708742905408144
this O 0 0.003263389226049185
occurs O 0 0.0038962471298873425
without O 0 0.0026824520900845528
affecting O 0 0.005573969800025225
the O 0 0.003891484811902046
growth O 0 0.005985465832054615
rate O 0 0.0036478962283581495
and O 0 0.0021720631048083305
cell O 0 0.006285789888352156
cycle O 0 0.006034269463270903
profile O 0 0.003962029702961445
of O 0 0.0025702298153191805
these O 0 0.0023094608914107084
cells O 0 0.0056169359013438225
in O 0 0.004685948137193918
culture O 0 0.019664864987134933
. O 0 0.014473505318164825

The O 0 0.020903320983052254
786 O 1 0.8811838626861572
- O 0 0.025262501090765
0 O 0 0.009955302812159061
cell O 0 0.006215457804501057
line O 0 0.0038089461158961058
, O 0 0.0022683998104184866
like O 0 0.0026896707713603973
many O 0 0.003527205903083086
cancer B-Disease 1 0.9999998807907104
cells O 0 0.011807527393102646
, O 0 0.0027850738260895014
fails O 0 0.004727709572762251
to O 0 0.0016944225644692779
exit O 0 0.005606646183878183
the O 0 0.004268621560186148
cell O 0 0.009248480200767517
cycle O 0 0.011614547111093998
upon O 0 0.010778688825666904
serum O 1 0.8757286071777344
withdrawal O 0 0.03225401043891907
. O 0 0.015614788979291916

Here O 0 0.01281214039772749
, O 0 0.004847438540309668
it O 0 0.0021823113784193993
is O 0 0.0021266713738441467
shown O 0 0.0023111184127628803
that O 0 0.001218529767356813
reintroduction O 0 0.005737101659178734
of O 0 0.002130843698978424
the O 0 0.004101995844393969
wild O 0 0.014971663244068623
- O 1 0.6284410953521729
type O 1 0.5317951440811157
VHL B-Disease 1 0.9999710321426392
gene O 0 0.00815043319016695
restores O 0 0.012738937512040138
the O 0 0.0028945766389369965
ability O 0 0.003427665214985609
of O 0 0.007728145457804203
VHL O 1 0.9999998807907104
- O 1 0.9997480511665344
negative O 1 0.8168120980262756
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
cells O 0 0.006223238538950682
to O 0 0.002678184537217021
exit O 0 0.007032852154225111
the O 0 0.0040601203218102455
cell O 0 0.007012030575424433
cycle O 0 0.006677734199911356
and O 0 0.003183090128004551
enter O 0 0.013093576766550541
G0 O 1 0.9999876022338867
/ O 1 0.7854574918746948
quiescence O 0 0.13904789090156555
in O 0 0.009026180021464825
low O 0 0.026738334447145462
serum O 1 0.915964663028717
. O 0 0.015481777489185333

Both O 0 0.02166498638689518
VHL O 1 0.9999780654907227
- O 0 0.04537651687860489
positive O 0 0.00853122491389513
and O 0 0.007020844146609306
VHL O 1 0.9999988079071045
- O 1 0.9592124223709106
negative O 0 0.017768854275345802
RCC B-Disease 1 0.9999955892562866
cells O 0 0.007026684936136007
exit O 0 0.00824449211359024
the O 0 0.0047883884981274605
cell O 0 0.009308099746704102
cycle O 0 0.008434705436229706
by O 0 0.0038355153519660234
contact O 0 0.014617015607655048
inhibition O 0 0.03914637118577957
. O 0 0.016991928219795227

The O 0 0.03432473912835121
cyclin O 1 0.9974678754806519
- O 1 0.5455701947212219
dependent O 0 0.022733207792043686
kinase O 0 0.03957805782556534
inhibitor O 0 0.12311024218797684
, O 0 0.007685690186917782
p27 O 0 0.36722174286842346
, O 0 0.005742664448916912
accumulates O 0 0.02384975552558899
upon O 0 0.006609732750803232
serum O 1 0.9921478629112244
withdrawal O 0 0.005971404258161783
, O 0 0.001408414333127439
only O 0 0.0009389011538587511
in O 0 0.0012329808669164777
the O 0 0.002104890998452902
presence O 0 0.002668046625331044
of O 0 0.005287692882120609
VHL B-Disease 1 0.9999977350234985
, O 0 0.00296681746840477
as O 0 0.0019182092510163784
a O 0 0.0018666915129870176
result O 0 0.0016774899559095502
of O 0 0.002291029319167137
the O 0 0.004159167874604464
stabilization O 0 0.023806320503354073
of O 0 0.005710296798497438
the O 0 0.008439423516392708
protein O 0 0.013633640483021736
. O 0 0.010116745717823505

We O 0 0.0071509163826704025
propose O 0 0.008047015406191349
that O 0 0.0021811279002577066
the O 0 0.003116915002465248
loss O 0 0.005571623332798481
of O 0 0.004512426443397999
wild O 0 0.020022524520754814
- O 1 0.737608015537262
type O 1 0.6884714365005493
VHL B-Disease 1 0.9999485015869141
gene O 0 0.004731399472802877
results O 0 0.001926311175338924
in O 0 0.0014795748284086585
a O 0 0.0023361314088106155
specific O 0 0.0031625109259039164
cellular O 0 0.010244172066450119
defect O 1 0.9943153262138367
in O 0 0.01108893845230341
serum O 1 0.9999972581863403
- O 1 0.8949039578437805
dependent O 0 0.005684332922101021
growth O 0 0.003760226536542177
control O 0 0.0032617596443742514
, O 0 0.00252936827018857
which O 0 0.002446601167321205
may O 0 0.005788316018879414
initiate O 0 0.404785692691803
tumor B-Disease 1 0.9999992847442627
formation O 1 0.8277118802070618
. O 0 0.01604624278843403

This O 0 0.007377877365797758
is O 0 0.005159833934158087
corrected O 0 0.010687191970646381
by O 0 0.0018002334982156754
the O 0 0.0025986405089497566
reintroduction O 0 0.009527524001896381
of O 0 0.003452600911259651
wild O 0 0.010024135932326317
- O 0 0.3836372196674347
type O 1 0.5528554320335388
VHL B-Disease 1 0.9999867677688599
, O 0 0.008738611824810505
implicating O 1 0.9983141422271729
VHL B-Disease 1 0.999972939491272
as O 0 0.004553238395601511
the O 0 0.0057089137844741344
first O 0 0.09081509709358215
tumor B-Disease 1 0.9999991655349731
suppressor O 0 0.26268160343170166
involved O 0 0.0020861567463725805
in O 0 0.0014702924527227879
the O 0 0.0022287352476269007
regulation O 0 0.002943559782579541
of O 0 0.0026374035514891148
cell O 0 0.024370096623897552
cycle O 0 0.007387189660221338
exit O 0 0.006158255040645599
, O 0 0.001832389971241355
which O 0 0.0009537820005789399
is O 0 0.0013419220922514796
consistent O 0 0.002345259999856353
with O 0 0.0010298147099092603
its O 0 0.0022060219198465347
gatekeeper O 1 0.9223742485046387
function O 0 0.0036848089657723904
in O 0 0.0031695805955678225
the O 0 0.3795517086982727
kidney O 1 1.0
. O 0 0.011883446015417576
. O 0 0.012493270449340343

Piebaldism B-Disease 1 0.9999815225601196
with O 0 0.0997590720653534
deafness B-Disease 1 1.0
: O 0 0.009428372606635094
molecular O 0 0.006242652423679829
evidence O 0 0.0035259556025266647
for O 0 0.0030451437924057245
an O 0 0.006745858583599329
expanded O 1 0.8641908168792725
syndrome O 1 1.0
. O 0 0.02933141216635704

In O 0 0.007543287705630064
a O 0 0.00669842679053545
South O 0 0.0084617268294096
African O 0 0.008412464521825314
girl O 0 0.01565728150308132
of O 0 0.005372552666813135
Xhosa O 1 0.9999608993530273
stock O 0 0.020220080390572548
with O 0 0.005101539194583893
severe O 1 0.9999998807907104
piebaldism B-Disease 1 1.0
and O 1 0.9997881054878235
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.8643495440483093
identified O 0 0.011524888686835766
a O 0 0.004327904433012009
novel O 0 0.009350743144750595
missense O 0 0.013081799261271954
substitution O 0 0.007191922049969435
at O 0 0.00457822997123003
a O 0 0.003466850146651268
highly O 0 0.005348610691726208
conserved O 0 0.006578624714165926
residue O 0 0.009649751707911491
in O 0 0.003170477692037821
the O 0 0.0053652371279895306
intracellular O 0 0.017812496051192284
kinase O 0 0.009760832414031029
domain O 0 0.004269399680197239
of O 0 0.0038277695421129465
the O 0 0.00854559801518917
KIT O 1 0.9999982118606567
proto O 1 0.9999723434448242
- O 1 0.9018580913543701
oncogene O 1 0.9730724096298218
, O 0 0.014141268096864223
R796G O 0 0.08835713565349579
. O 0 0.01914055459201336

Though O 0 0.02224644646048546
auditory B-Disease 1 0.6089233160018921
anomalies I-Disease 0 0.13028544187545776
have O 0 0.002939459402114153
been O 0 0.002332686446607113
observed O 0 0.003052180167287588
in O 0 0.0022366575431078672
mice O 0 0.004702057223767042
with O 0 0.0018626144155859947
dominant O 0 0.009775720536708832
white O 0 0.04848137125372887
spotting O 1 0.9979296922683716
( O 0 0.07089860737323761
W O 1 0.9990382194519043
) O 0 0.0031947039533406496
due O 0 0.003479384584352374
to O 0 0.0036938514094799757
KIT O 1 0.9999938011169434
mutations O 0 0.17401057481765747
, O 0 0.019696200266480446
deafness B-Disease 1 1.0
is O 0 0.0044479998759925365
not O 0 0.002083690371364355
typical O 0 0.0053590270690619946
in O 0 0.004543095827102661
human O 0 0.013552851043641567
piebaldism B-Disease 1 0.9959543943405151
. O 0 0.016930650919675827

Thus O 0 0.010185884311795235
, O 0 0.006031558383256197
the O 0 0.0065938993357121944
occurrence O 0 0.19580329954624176
of O 1 0.9921038150787354
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.9974364638328552
this O 0 0.01107860542833805
patient O 1 0.9963046312332153
extends O 0 0.008309347555041313
considerably O 0 0.004427467938512564
the O 0 0.002481442876160145
phenotypic O 0 0.006166118662804365
range O 0 0.0035506156273186207
of O 0 0.0038143889978528023
piebaldism B-Disease 0 0.09156762063503265
due O 0 0.005930624902248383
to O 0 0.003583031939342618
KIT O 1 0.999835729598999
gene O 0 0.0065426453948020935
mutation O 0 0.003281151410192251
in O 0 0.0018707195995375514
humans O 0 0.002862687921151519
and O 0 0.00267698522657156
tightens O 0 0.05336897820234299
the O 0 0.0033791100140661
clinical O 0 0.2599901258945465
similarity O 0 0.006375427823513746
between O 0 0.003003400284796953
piebaldism B-Disease 0 0.08220462501049042
and O 0 0.0016365303890779614
the O 0 0.0020949544850736856
various O 0 0.0021082027815282345
forms O 0 0.0062810624949634075
of O 1 0.9997687935829163
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9399478435516357
. O 0 0.019354816526174545

Cycloheximide O 1 0.8270416259765625
facilitates O 0 0.027273377403616905
the O 0 0.0086457384750247
identification O 0 0.007845570333302021
of O 0 0.005917160306125879
aberrant O 0 0.020822720602154732
transcripts O 0 0.00914477463811636
resulting O 0 0.005073683336377144
from O 0 0.0024299644865095615
a O 0 0.004047131631523371
novel O 0 0.015335971489548683
splice O 0 0.057549331337213516
- O 0 0.010130411013960838
site O 0 0.005867991130799055
mutation O 0 0.005291212350130081
in O 0 0.003077405272051692
COL17A1 O 1 0.9031605124473572
in O 0 0.003170291893184185
a O 0 0.006487746722996235
patient O 1 0.9781324863433838
with O 0 0.010338353924453259
generalized O 1 0.999981164932251
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.20485399663448334

Patients O 1 0.9945304989814758
with O 0 0.022525934502482414
generalized O 1 0.9999878406524658
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.018384478986263275
show O 0 0.01026148535311222
decreased O 0 0.011273299343883991
expression O 0 0.005327967926859856
of O 0 0.007759661879390478
type O 1 0.999982476234436
XVII O 1 1.0
collagen O 1 0.9999988079071045
, O 0 0.00826980173587799
a O 0 0.009410446509718895
transmembrane O 0 0.04779306426644325
hemidesmosomal O 0 0.27061405777931213
protein O 0 0.0072177378460764885
encoded O 0 0.0058176396414637566
by O 0 0.005622037686407566
COL17A1 O 1 0.8915974497795105
. O 0 0.016736021265387535

This O 0 0.006770809181034565
report O 0 0.005670356564223766
documents O 0 0.00474205706268549
a O 0 0.0050418796017766
novel O 0 0.015057495795190334
splice O 0 0.056236546486616135
- O 0 0.012770628556609154
site O 0 0.007197282277047634
mutation O 0 0.004976618103682995
in O 0 0.0032518005464226007
COL17A1 O 1 0.9850760102272034
in O 0 0.004123518243432045
a O 0 0.005309618078172207
patient O 1 0.8386788964271545
with O 0 0.007884863764047623
generalized O 1 0.9999855756759644
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.027917657047510147
and O 0 0.0032063457183539867
applies O 0 0.003988397307693958
a O 0 0.002505740849301219
new O 0 0.0021022059954702854
methodology O 0 0.004012716468423605
to O 0 0.0016558753559365869
define O 0 0.003830807050690055
and O 0 0.002588046947494149
characterize O 0 0.010900641791522503
the O 0 0.006067727692425251
resulting O 0 0.011812057346105576
mRNA O 0 0.01964758150279522
splice O 0 0.04247257858514786
variants O 0 0.024412985891103745
. O 0 0.0149230370298028

Mutational O 0 0.07050873339176178
analysis O 0 0.011265489272773266
of O 0 0.010714823380112648
COL17A1 O 1 0.9760623574256897
identified O 0 0.010606786236166954
a O 0 0.009125836193561554
maternally O 1 0.784365177154541
inherited O 1 0.9999353885650635
G O 1 0.9993240833282471
- O 0 0.020842893049120903
to O 0 0.005586364306509495
- O 0 0.33539435267448425
T O 0 0.40336140990257263
transversion O 0 0.015616833232343197
at O 0 0.004737346898764372
the O 0 0.0037290386389940977
- O 0 0.007465383969247341
1 O 0 0.004821987822651863
position O 0 0.004215025808662176
of O 0 0.005500794854015112
exon O 0 0.03809380531311035
32 O 0 0.01771259866654873
. O 0 0.013834211975336075

This O 0 0.012271582148969173
acceptor O 0 0.0638236254453659
splice O 1 0.8161324858665466
- O 0 0.020254643633961678
site O 0 0.00732492795214057
mutation O 0 0.004346766974776983
led O 0 0.0029645785689353943
to O 0 0.001677038031630218
the O 0 0.0027654198929667473
formation O 0 0.0052938638255000114
of O 0 0.003811380360275507
aberrant O 0 0.015309013426303864
transcripts O 0 0.007840045727789402
present O 0 0.004111848305910826
at O 0 0.005789098795503378
extremely O 0 0.008886881172657013
low O 0 0.01085860375314951
levels O 0 0.012164553627371788
. O 0 0.010419263504445553

Based O 0 0.010472030378878117
on O 0 0.0056373621337115765
our O 0 0.003759555285796523
recent O 0 0.0035611854400485754
finding O 0 0.0053862533532083035
that O 0 0.003841894445940852
cycloheximide O 1 0.9714859127998352
stabilized O 1 0.9698571562767029
mutant O 0 0.039721112698316574
COL17A1 O 1 0.8530243039131165
transcripts O 0 0.010692299343645573
in O 0 0.0049040368758141994
keratinocytes O 0 0.022526346147060394
homozygous O 0 0.008097306825220585
for O 0 0.002609737915918231
a O 0 0.005141576286405325
frameshift O 0 0.09414149075746536
mutation O 0 0.005624157376587391
, O 0 0.0022914709988981485
the O 0 0.002834706800058484
effects O 0 0.004052292089909315
of O 0 0.0028770698700100183
the O 0 0.006637177895754576
splice O 1 0.8815763592720032
- O 0 0.008515722118318081
site O 0 0.004642506595700979
mutation O 0 0.003525019157677889
on O 0 0.0022495717275887728
splicing O 0 0.0063720690086483955
of O 0 0.0043243104591965675
COL17A1 O 0 0.47869208455085754
transcripts O 0 0.00809138361364603
were O 0 0.0026809575501829386
determined O 0 0.004120300058275461
using O 0 0.0036804210394620895
reverse O 0 0.013026079162955284
transcriptase O 0 0.03857162967324257
polymerase O 0 0.01406820211559534
chain O 0 0.0072553763166069984
reaction O 0 0.003610061714425683
of O 0 0.002646906767040491
total O 0 0.0042655859142541885
RNA O 0 0.007920701988041401
from O 0 0.003889487124979496
keratinocytes O 0 0.018764253705739975
incubated O 0 0.014340803027153015
for O 0 0.005860953126102686
2 O 0 0.013693972490727901
. O 0 0.010806207545101643

5 O 0 0.020422575995326042
h O 0 0.018787791952490807
in O 0 0.003351921681314707
the O 0 0.0034001569729298353
presence O 0 0.0033722168300300837
or O 0 0.002436441835016012
absence O 0 0.005834868643432856
of O 0 0.005022765137255192
10 O 0 0.00858239270746708
microg O 1 0.862184464931488
cycloheximide O 1 0.8174558877944946
per O 0 0.014623638242483139
ml O 0 0.08084704726934433
. O 0 0.014012780971825123

Using O 0 0.0062972563318908215
this O 0 0.0025436116848140955
approach O 0 0.004000956658273935
, O 0 0.0025740577839314938
an O 0 0.0034373276866972446
abnormally O 0 0.3321704864501953
spliced O 0 0.020969152450561523
transcript O 0 0.014578700996935368
was O 0 0.007331077009439468
identified O 0 0.0036259826738387346
that O 0 0.0013318989658728242
contains O 0 0.0023324049543589354
an O 0 0.0018556383438408375
extra O 0 0.0041914647445082664
264 O 0 0.009541843086481094
bases O 0 0.005237293895334005
upstream O 0 0.007883637212216854
from O 0 0.0038801964838057756
exon O 0 0.01824124902486801
32 O 0 0.00676287105306983
, O 0 0.0034799003042280674
resulting O 0 0.0037847922649234533
in O 0 0.002962480764836073
a O 0 0.00674350094050169
premature O 0 0.08675510436296463
termination O 0 0.039720870554447174
codon O 0 0.016178255900740623
27 O 0 0.009390336461365223
bp O 0 0.011477443389594555
downstream O 0 0.007628332357853651
from O 0 0.003288924926891923
the O 0 0.00617004232481122
cryptic O 0 0.03870010003447533
splice O 0 0.07175629585981369
site O 0 0.026789359748363495
. O 0 0.01806284300982952

Three O 0 0.005903773475438356
other O 0 0.0038723584730178118
splice O 0 0.021416334435343742
variants O 0 0.005339466035366058
, O 0 0.001962136710062623
including O 0 0.0013511787401512265
one O 0 0.001404697191901505
derived O 0 0.001893123029731214
from O 0 0.0013129627332091331
the O 0 0.0023060357198119164
skipping O 0 0.008405297063291073
of O 0 0.004136550705879927
exon O 0 0.03833501785993576
32 O 0 0.005701147951185703
, O 0 0.0026203515008091927
were O 0 0.002740400843322277
also O 0 0.005499005317687988
identified O 0 0.013133872300386429
. O 0 0.011444317176938057

These O 0 0.006441248580813408
results O 0 0.004803247284144163
indicate O 0 0.004336011596024036
the O 0 0.0033319960348308086
usefulness O 0 0.010855056345462799
of O 0 0.006561914458870888
cycloheximide O 1 0.9998985528945923
treatment O 1 0.9959035515785217
in O 0 0.004154406487941742
evaluating O 0 0.00964746531099081
the O 0 0.004575710278004408
abnormal O 0 0.010271534323692322
processing O 0 0.004635654855519533
of O 0 0.0032598471734672785
mRNA O 0 0.005232203286141157
due O 0 0.0033777293283492327
to O 0 0.0025687350425869226
splice O 0 0.022051185369491577
- O 0 0.007854202762246132
site O 0 0.005629430059343576
mutations O 0 0.004736847709864378
, O 0 0.0026231559459120035
because O 0 0.0030767619609832764
( O 0 0.005235291551798582
i O 0 0.005868452601134777
) O 0 0.003947029821574688
aberrant O 0 0.011799022555351257
splicing O 0 0.008431877940893173
often O 0 0.002939277794212103
generates O 0 0.006268319208174944
a O 0 0.005710692144930363
premature O 0 0.023034410551190376
termination O 0 0.026813091710209846
codon O 0 0.018029293045401573
, O 0 0.005886049475520849
( O 0 0.007719881366938353
ii O 1 0.7314264178276062
) O 0 0.004905331414192915
transcripts O 0 0.007584933191537857
with O 0 0.003794592572376132
premature O 0 0.06312551349401474
termination O 0 0.02733045630156994
codons O 0 0.011868919245898724
can O 0 0.0019204160198569298
occur O 0 0.002285195514559746
at O 0 0.0037562453653663397
low O 0 0.006538676097989082
or O 0 0.004276368301361799
undetectable O 1 0.7534980177879333
levels O 0 0.005209113005548716
due O 0 0.0032100449316203594
to O 0 0.0029456187039613724
nonsense O 0 0.01626180112361908
- O 0 0.010056772269308567
mediated O 0 0.008024881593883038
mRNA O 0 0.006393976975232363
decay O 0 0.00730543676763773
, O 0 0.0026041162200272083
and O 0 0.0025631883181631565
( O 0 0.005569628905504942
iii O 1 0.8895837068557739
) O 0 0.0023102194536477327
the O 0 0.0017827496631070971
levels O 0 0.002418047981336713
of O 0 0.0017603429732844234
these O 0 0.001062055816873908
transcripts O 0 0.004017591010779142
can O 0 0.0014988246839493513
be O 0 0.001500455429777503
increased O 0 0.0037323248106986284
by O 0 0.0040858592838048935
cycloheximide O 1 0.8584919571876526
. O 0 0.01695016212761402

A O 0 0.025997113436460495
deletion O 0 0.03109695203602314
mutation O 0 0.011780740693211555
in O 0 0.004324211739003658
COL17A1 O 1 0.9199045896530151
in O 0 0.0030100529547780752
five O 0 0.0029753155540674925
Austrian O 0 0.0290098674595356
families O 0 0.004852063488215208
with O 0 0.00532501982524991
generalized O 1 0.999994158744812
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 0 0.1656918078660965
propagation O 0 0.031233370304107666
of O 0 0.009013108909130096
an O 0 0.010718261823058128
ancestral O 1 0.9120665192604065
allele O 0 0.037621114403009415
. O 0 0.01917572133243084

Patients O 1 0.9931498169898987
with O 0 0.019781507551670074
generalized O 1 0.999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.08262479305267334
a O 0 0.008296383544802666
usually O 0 0.005320027004927397
nonlethal O 0 0.02119823731482029
form O 0 0.005786335561424494
of O 0 0.01961204968392849
junctional B-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 0.010267665609717369
have O 0 0.004027906805276871
generalized O 0 0.39910635352134705
blistering B-Disease 1 0.999883770942688
, O 1 0.9962031245231628
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9986458420753479
patchy B-Disease 1 0.9999998807907104
alopecia I-Disease 1 1.0
, O 1 0.9973192811012268
and O 1 0.9903506636619568
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.4939601421356201

Skin B-Disease 1 0.9999997615814209
fragility I-Disease 1 0.9999897480010986
in O 0 0.008104797452688217
most O 0 0.003306255443021655
cases O 0 0.004156638402491808
is O 0 0.0024983719922602177
due O 0 0.002472796943038702
to O 0 0.0014325230149552226
mutations O 0 0.0022994603496044874
in O 0 0.001443029846996069
the O 0 0.0028023552149534225
gene O 0 0.0053181820549070835
encoding O 0 0.009754261001944542
type O 1 0.8966422080993652
XVII O 1 1.0
collagen O 1 0.9999998807907104
( O 1 0.7120417356491089
COL17A1 O 1 0.9999659061431885
) O 0 0.014448055997490883
. O 0 0.01226081233471632

Recently O 0 0.02481340803205967
, O 0 0.006167270243167877
we O 0 0.003138176864013076
reported O 0 0.004349587019532919
five O 0 0.0029020521324127913
Austrian O 0 0.02211529016494751
families O 0 0.006703034043312073
with O 0 0.007346250116825104
generalized O 1 0.9999865293502808
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.09261457622051239
share O 0 0.007399790920317173
the O 0 0.00732843391597271
same O 0 0.010507190600037575
COL17A1 O 1 0.9995328187942505
mutation O 0 0.027702251449227333
. O 0 0.015049688518047333

Affected O 0 0.012510341592133045
individuals O 0 0.002962062368169427
in O 0 0.0020374194718897343
three O 0 0.0015803152928128839
families O 0 0.0016737250844016671
are O 0 0.0008742243517190218
homozygous O 0 0.0039244708605110645
for O 0 0.002035178244113922
4003delTC O 1 0.9558734893798828
, O 0 0.0022851305548101664
whereas O 0 0.0022732396610081196
those O 0 0.001030120998620987
in O 0 0.0014459870290011168
two O 0 0.0015210798010230064
others O 0 0.0031906943768262863
are O 0 0.0030093174427747726
compound O 0 0.02942265383899212
heterozygotes O 1 0.6774850487709045
. O 0 0.018396766856312752

To O 0 0.006815086584538221
determine O 0 0.0052286554127931595
if O 0 0.002283817622810602
the O 0 0.002954519586637616
occurrence O 0 0.0069585838355124
of O 0 0.003839117242023349
4003delTC O 1 0.7075880169868469
in O 0 0.002212416846305132
these O 0 0.001399446278810501
unrelated O 0 0.006120616570115089
families O 0 0.003989889286458492
signifies O 0 0.01036216039210558
propagation O 0 0.007068391423672438
of O 0 0.003112094011157751
an O 0 0.0037532164715230465
ancestral O 0 0.20246627926826477
allele O 0 0.008968265727162361
or O 0 0.002742243930697441
a O 0 0.005625725723803043
mutational O 1 0.8196403980255127
hot O 0 0.07257424294948578
spot O 0 0.011786281131207943
, O 0 0.003893484827131033
haplotypes O 0 0.009083934128284454
were O 0 0.001999432221055031
determined O 0 0.002942112972959876
for O 0 0.0018767311703413725
polymorphisms O 0 0.00715548824518919
both O 0 0.0017817569896578789
within O 0 0.003064871998503804
and O 0 0.006735007744282484
flanking O 1 0.9987026453018188
COL17A1 O 1 0.9999958276748657
. O 0 0.028003986924886703

Five O 0 0.01647787168622017
intragenic O 0 0.19498686492443085
polymorphisms O 0 0.015110773965716362
were O 0 0.0030552914831787348
chosen O 0 0.003561723278835416
based O 0 0.0029491966124624014
on O 0 0.0036482084542512894
their O 0 0.004799959249794483
informativeness O 1 0.8975473642349243
. O 0 0.016480939462780952

One O 0 0.006060367450118065
of O 0 0.0039061775896698236
these O 0 0.0014715573051944375
, O 0 0.001620772760361433
not O 0 0.0011721948394551873
previously O 0 0.003001954173669219
reported O 0 0.0034302526619285345
, O 0 0.002625670749694109
was O 0 0.008947743102908134
2988 O 1 0.5596636533737183
A O 0 0.007466521114110947
or O 0 0.003240611171349883
C O 0 0.009504836052656174
that O 0 0.0015474476385861635
introduces O 0 0.005974034778773785
a O 0 0.0023717537987977266
new O 0 0.0027038969565182924
restriction O 0 0.005023885518312454
site O 0 0.00601428747177124
for O 0 0.005176689010113478
Eco0109 O 1 0.7090781927108765
I O 0 0.06720636785030365
. O 0 0.016511768102645874

All O 0 0.008562551811337471
the O 0 0.009998733177781105
4003delTC O 0 0.24951429665088654
alleles O 0 0.013300180435180664
showed O 0 0.006432083901017904
the O 0 0.003887250553816557
same O 0 0.0028659403324127197
haplotype O 0 0.007039272226393223
for O 0 0.001907719299197197
these O 0 0.0018732722382992506
five O 0 0.005076822824776173
polymorphic O 0 0.03369302302598953
markers O 0 0.06084384769201279
. O 0 0.016131691634655

Fourteen O 0 0.04434795677661896
microsatellite O 0 0.07096168398857117
polymorphisms O 0 0.01854334957897663
were O 0 0.003099344903603196
selected O 0 0.0032419299241155386
based O 0 0.0020270294044166803
on O 0 0.0023200467694550753
their O 0 0.0020598587580025196
high O 0 0.006615486927330494
heterozygosity O 0 0.02434306964278221
and O 0 0.0016956940526142716
their O 0 0.0014564048033207655
location O 0 0.004208824131637812
within O 0 0.004323957022279501
10q23 O 1 0.9306626915931702
- O 0 0.07790375500917435
q25 O 0 0.39392879605293274
near O 0 0.05523744225502014
COL17A1 O 1 0.9987685084342957
. O 0 0.021743854507803917

Three O 0 0.009680962190032005
families O 0 0.008215950801968575
shared O 0 0.011245070025324821
microsatellite O 0 0.1652608960866928
polymorphisms O 0 0.017453324049711227
covering O 0 0.009037354029715061
at O 0 0.005285940133035183
most O 0 0.002326542278751731
19 O 0 0.006171473767608404
cM O 0 0.007965467870235443
, O 0 0.0022818432189524174
whereas O 0 0.0024772046599537134
the O 0 0.0016763644525781274
others O 0 0.001692284713499248
shared O 0 0.0029565233271569014
smaller O 0 0.0018860838608816266
regions O 0 0.0018032488878816366
consistent O 0 0.003708935109898448
with O 0 0.002180480631068349
cross O 0 0.01022435910999775
- O 0 0.006544303614646196
over O 0 0.0019841259345412254
events O 0 0.002280404092743993
during O 0 0.002996289636939764
passage O 0 0.0035484887193888426
of O 0 0.002685142681002617
this O 0 0.0021082910243421793
mutation O 0 0.0038286063354462385
through O 0 0.002293126657605171
several O 0 0.003698407905176282
generations O 0 0.013835311867296696
. O 0 0.014274041168391705

These O 0 0.0057073310017585754
results O 0 0.005370089318603277
indicate O 0 0.0057229893282055855
that O 0 0.0029866101685911417
4003delTC O 0 0.021950064226984978
occurs O 0 0.0034027756191790104
on O 0 0.002714828820899129
a O 0 0.003716014791280031
single O 0 0.005960390903055668
ancestral O 0 0.02646343782544136
allele O 0 0.015788663178682327
. O 0 0.007001975085586309
. O 0 0.011007079854607582

The O 0 0.034553322941064835
haptoglobin O 1 0.9975491166114807
- O 0 0.13261932134628296
gene O 0 0.015452022664248943
deletion O 0 0.01777789182960987
responsible O 0 0.011272639967501163
for O 0 0.009524023160338402
anhaptoglobinemia B-Disease 1 0.9947740435600281
. O 0 0.021913817152380943

We O 0 0.007777099497616291
have O 0 0.0026358673349022865
found O 0 0.003765628207474947
an O 0 0.003257449483498931
allelic O 0 0.01834763027727604
deletion O 0 0.010790093801915646
of O 0 0.0050817797891795635
the O 0 0.010174295864999294
haptoglobin O 1 0.99978107213974
( O 0 0.010148943401873112
Hp O 0 0.048181939870119095
) O 0 0.00309665291570127
gene O 0 0.0024340299423784018
from O 0 0.0014604267198592424
an O 0 0.0019640258979052305
individual O 0 0.002887279260903597
with O 0 0.005852945614606142
anhaptoglobinemia B-Disease 1 0.993868887424469
. O 0 0.017871906980872154

The O 0 0.021307557821273804
Hp O 0 0.3514467179775238
gene O 0 0.011220168322324753
cluster O 0 0.008075219579041004
consists O 0 0.005143132992088795
of O 0 0.004445694386959076
coding O 0 0.009262646548449993
regions O 0 0.002562376670539379
of O 0 0.002671097172424197
the O 0 0.0047508785501122475
alpha O 0 0.015446032397449017
chain O 0 0.0065232692286372185
and O 0 0.002384056570008397
beta O 0 0.007376480847597122
chain O 0 0.005669072270393372
of O 0 0.0037145265378057957
the O 0 0.007379539776593447
haptoglobin O 1 0.9971283078193665
gene O 0 0.00914029125124216
( O 0 0.004357586149126291
Hp O 0 0.009338603354990482
) O 0 0.002062917221337557
and O 0 0.001109157339669764
of O 0 0.002294795121997595
the O 0 0.004084473475813866
alpha O 0 0.01093395333737135
chain O 0 0.005968877580016851
and O 0 0.0021531712263822556
beta O 0 0.0060769603587687016
chain O 0 0.004878058098256588
of O 0 0.0028835583943873644
the O 0 0.006856432184576988
haptoglobin O 1 0.9918540716171265
- O 0 0.013728715479373932
related O 0 0.006150383036583662
gene O 0 0.007403462193906307
( O 0 0.00613425113260746
Hpr O 1 0.5472244024276733
) O 0 0.0028269337490200996
, O 0 0.002098152879625559
in O 0 0.0023873341269791126
tandem O 0 0.00794568844139576
from O 0 0.003855266608297825
the O 0 0.0057031698524951935
5 O 0 0.01066138967871666
side O 0 0.011980719864368439
. O 0 0.013508262112736702

Southern O 0 0.040681302547454834
blot O 1 0.6624801158905029
and O 0 0.0081026004627347
PCR O 0 0.02134549804031849
analyses O 0 0.0062402416951954365
have O 0 0.0016885270597413182
indicated O 0 0.002940116450190544
that O 0 0.001109964563511312
the O 0 0.0016988501884043217
individual O 0 0.0015954182017594576
with O 0 0.001789688947610557
anhaptoglobinemia B-Disease 1 0.8383739590644836
was O 0 0.00752269709482789
homozygous O 0 0.004280494060367346
for O 0 0.001425934606231749
the O 0 0.0026699185837060213
gene O 0 0.0038457501213997602
deletion O 0 0.004740054253488779
and O 0 0.0011612909147515893
that O 0 0.0009688155259937048
the O 0 0.0023450457956641912
gene O 0 0.003851649584248662
deletion O 0 0.005582667421549559
was O 0 0.0036849735770374537
included O 0 0.0017733570421114564
at O 0 0.0025014253333210945
least O 0 0.0013528538402169943
from O 0 0.0014005090342834592
the O 0 0.003130965167656541
promoter O 1 0.7624770402908325
region O 0 0.004901900887489319
of O 0 0.004901462234556675
Hp O 0 0.14850285649299622
to O 0 0.004077148158103228
Hpr O 1 0.5441551804542542
alpha O 0 0.007024635560810566
but O 0 0.0012291236780583858
not O 0 0.001120304805226624
to O 0 0.0023568584583699703
Hpr O 0 0.274732768535614
beta O 0 0.027359897270798683
( O 0 0.014684462919831276
Hpdel O 1 0.8193715810775757
) O 0 0.013383615761995316
. O 0 0.013716822490096092

In O 0 0.008575567975640297
addition O 0 0.00598022760823369
, O 0 0.002846134128049016
we O 0 0.0017334471922367811
found O 0 0.0016538493800908327
seven O 0 0.001720982720144093
individuals O 0 0.0010759967844933271
with O 0 0.001493804156780243
hypohaptoglobinemia B-Disease 1 0.5025268793106079
in O 0 0.001968494849279523
three O 0 0.0014748533722013235
families O 0 0.0019872786942869425
, O 0 0.0015111456159502268
and O 0 0.0014010173035785556
the O 0 0.0022728226613253355
genotypes O 0 0.0065076351165771484
of O 0 0.0016984303947538137
six O 0 0.0015683051897212863
of O 0 0.0015819610562175512
the O 0 0.001717692706733942
seven O 0 0.0019108724081888795
individuals O 0 0.000952038390096277
were O 0 0.0012682622764259577
found O 0 0.002077277284115553
to O 0 0.0025474277790635824
be O 0 0.00441233953461051
Hp2 O 1 0.998939573764801
/ O 1 0.978567898273468
Hpdel O 1 0.9709793329238892
. O 0 0.020390236750245094

The O 0 0.01917644590139389
phenotypes O 0 0.024345537647604942
and O 0 0.0051161362789571285
genotypes O 0 0.015690049156546593
in O 0 0.002510125981643796
one O 0 0.001600966788828373
of O 0 0.0015403154538944364
these O 0 0.0008052560733631253
three O 0 0.0012651211582124233
families O 0 0.0016909947153180838
showed O 0 0.0023478541988879442
the O 0 0.0020817581098526716
father O 0 0.005076706875115633
to O 0 0.001519788522273302
be O 0 0.00201589148491621
hypohaptoglobinemic B-Disease 0 0.08048316836357117
( O 0 0.005381953436881304
Hp2 O 0 0.23935405910015106
) O 0 0.0037682983092963696
and O 0 0.0038764404598623514
Hp2 O 1 0.9983093738555908
/ O 1 0.9756193161010742
Hpdel O 1 0.8711647987365723
, O 0 0.0038299630396068096
the O 0 0.0035671668592840433
mother O 0 0.008239923045039177
to O 0 0.002044606488198042
be O 0 0.002416732721030712
Hp2 O 0 0.305085688829422
- O 0 0.01113828830420971
1 O 0 0.005655093118548393
and O 0 0.004072372801601887
Hp1 O 1 0.9991175532341003
/ O 1 0.9387617707252502
Hp2 O 1 0.6624656915664673
, O 0 0.002186190104112029
one O 0 0.0012398159597069025
of O 0 0.0013299556449055672
the O 0 0.0016413148259744048
two O 0 0.0011505524162203074
children O 0 0.0022914838045835495
to O 0 0.001654424937441945
be O 0 0.0020586338359862566
hypohaptoglobinemic B-Disease 0 0.384372353553772
( O 0 0.006143566220998764
Hp2 O 1 0.8840975761413574
) O 0 0.004182631149888039
and O 0 0.0037785046733915806
Hp2 O 1 0.9999041557312012
/ O 1 0.995841920375824
Hpdel O 1 0.9821478128433228
, O 0 0.0030368617735803127
and O 0 0.0016920585185289383
the O 0 0.002307129791006446
other O 0 0.0014614410465583205
child O 0 0.005048682913184166
to O 0 0.0017907064175233245
be O 0 0.002314663492143154
Hp1 O 0 0.47120484709739685
and O 0 0.005668576806783676
Hp1 O 1 0.9999676942825317
/ O 1 0.9951146841049194
Hpdel O 1 0.9636995196342468
, O 0 0.004155511502176523
showing O 0 0.005049352999776602
an O 0 0.0032197698019444942
anomalous O 0 0.20245490968227386
inheritance O 0 0.02199217490851879
of O 0 0.01065176259726286
Hp O 1 0.9974072575569153
phenotypes O 0 0.020367620512843132
in O 0 0.004016710910946131
the O 0 0.007068823557347059
child O 0 0.15850763022899628
with O 0 0.00858527421951294
Hp1 O 1 0.9990034699440002
. O 0 0.017940182238817215

The O 0 0.03163447976112366
Hp2 O 1 0.9999312162399292
/ O 1 0.9988849759101868
Hpdel O 1 0.9316307306289673
individuals O 0 0.003322561737149954
had O 0 0.0032925428822636604
an O 0 0.002223925432190299
extremely O 0 0.00517108291387558
low O 0 0.004219713155180216
level O 0 0.0031754886731505394
of O 0 0.0035899896174669266
Hp O 0 0.30046379566192627
( O 0 0.006305873394012451
mean O 0 0.006773198489099741
+ O 0 0.02144049108028412
/ O 0 0.025716865435242653
- O 0 0.013809220865368843
SD O 0 0.04459945857524872
= O 0 0.010340871289372444
0 O 0 0.005265325773507357
. O 0 0.0035658213309943676
049 O 0 0.06126555800437927
+ O 0 0.019538864493370056
/ O 0 0.015999918803572655
- O 0 0.008084651082754135
0 O 0 0.005715876817703247
. O 0 0.002928650239482522
043 O 0 0.05344846099615097
mg O 1 0.8313277959823608
/ O 0 0.08013563603162766
ml O 0 0.02707667462527752
; O 0 0.0032554499339312315
n O 0 0.009090482257306576
= O 0 0.008232546970248222
6 O 0 0.0045649586245417595
) O 0 0.0018455759854987264
, O 0 0.0012684011599048972
compared O 0 0.001781105762347579
with O 0 0.0009954499546438456
the O 0 0.002071751281619072
level O 0 0.004059952218085527
( O 0 0.0026989364996552467
1 O 0 0.0029498750809580088
. O 0 0.0016140046063810587
64 O 0 0.006347829941660166
+ O 0 0.013433726504445076
/ O 0 0.013554763980209827
- O 0 0.006575621198862791
1 O 0 0.004876511637121439
. O 0 0.002946393797174096
07 O 0 0.06663434207439423
mg O 1 0.9849799275398254
/ O 0 0.17944401502609253
ml O 0 0.020391182973980904
) O 0 0.001891635125502944
obtained O 0 0.0021012781653553247
from O 0 0.0022226255387067795
52 O 0 0.007664021570235491
healthy O 0 0.009140456095337868
volunteers O 0 0.008199566043913364
having O 0 0.006052726414054632
phenotype O 0 0.01768987812101841
Hp2 O 1 0.7828568816184998
, O 0 0.0042885662987828255
whereas O 0 0.004992885049432516
the O 0 0.0060035050846636295
serum O 1 0.8613636493682861
Hp O 0 0.012272563762962818
level O 0 0.0034952093847095966
of O 0 0.0020470251329243183
an O 0 0.0018880950519815087
individual O 0 0.0023183156736195087
with O 0 0.0033633550629019737
Hp1 O 1 0.9999144077301025
/ O 1 0.9979509711265564
Hpdel O 1 0.990653932094574
was O 0 0.03084712103009224
0 O 0 0.016036339104175568
. O 0 0.011030656285583973

50 O 0 0.038697198033332825
mg O 1 0.9994788765907288
/ O 1 0.9974871873855591
ml O 1 0.5874422788619995
, O 0 0.0034317392855882645
which O 0 0.0019655621144920588
was O 0 0.00391986221075058
approximately O 0 0.002265315502882004
half O 0 0.0015273832250386477
the O 0 0.0018171187257394195
level O 0 0.0028596161864697933
of O 0 0.0028017021249979734
Hp O 0 0.020482759922742844
in O 0 0.0024113687686622143
control O 0 0.004938514903187752
sera O 0 0.3585236072540283
from O 0 0.003040170995518565
the O 0 0.004438353702425957
Hp1 O 1 0.7166112065315247
phenotype O 0 0.007949755527079105
( O 0 0.0026216700207442045
1 O 0 0.0028090334963053465
. O 0 0.0016340174479410052
26 O 0 0.005577483680099249
+ O 0 0.012070240452885628
/ O 0 0.01031490322202444
- O 0 0.004956969525665045
0 O 0 0.003575036535039544
. O 0 0.0019715793896466494
33 O 0 0.008573917672038078
mg O 0 0.28658318519592285
/ O 0 0.028803596273064613
ml O 0 0.02176910638809204
; O 0 0.002977365627884865
n O 0 0.008408738300204277
= O 0 0.007945177145302296
9 O 0 0.003943381365388632
) O 0 0.0019033080898225307
, O 0 0.0017530565382912755
showing O 0 0.005122741684317589
a O 0 0.006412771996110678
gene O 0 0.012263803742825985
- O 0 0.0202957596629858
dosage O 0 0.04163830354809761
effect O 0 0.014109991490840912
. O 0 0.01324034109711647

The O 0 0.009031039662659168
other O 0 0.004551030229777098
allele O 0 0.013740330003201962
( O 0 0.0067259580828249454
Hp2 O 0 0.02833670563995838
) O 0 0.0028354187961667776
of O 0 0.0022195440251380205
individuals O 0 0.0019520751666277647
with O 0 0.003976332023739815
Hp2 O 1 0.9999982118606567
/ O 1 0.9999548196792603
Hpdel O 1 0.9996310472488403
was O 0 0.009954645298421383
found O 0 0.001965065486729145
to O 0 0.0009464933536946774
have O 0 0.000732061977032572
, O 0 0.0010885389056056738
in O 0 0.001374725834466517
all O 0 0.0014009851729497313
exons O 0 0.006876911967992783
, O 0 0.0022465523798018694
no O 0 0.002752853324636817
mutation O 0 0.004244726151227951
, O 0 0.0023612461518496275
by O 0 0.003198417369276285
DNA O 0 0.012755079194903374
sequencing O 0 0.017479658126831055
. O 0 0.011437003500759602

On O 0 0.006341504864394665
the O 0 0.0030316461343318224
basis O 0 0.0021168917883187532
of O 0 0.0019300320418551564
the O 0 0.0022047413513064384
present O 0 0.0024447038304060698
study O 0 0.0024880594573915005
, O 0 0.0017649997025728226
the O 0 0.00203660037368536
mechanism O 0 0.003962603397667408
of O 0 0.0033034393563866615
anhaptoglobinemia B-Disease 1 0.8118903040885925
and O 0 0.0023306235671043396
the O 0 0.0027438225224614143
mechanism O 0 0.004982207901775837
of O 0 0.0032508126460015774
anomalous O 0 0.1311122179031372
inheritance O 0 0.019187556579709053
of O 0 0.012029295787215233
Hp O 1 0.9996063113212585
phenotypes O 0 0.12320616841316223
were O 0 0.004358786623924971
well O 0 0.004586127121001482
explained O 0 0.017484882846474648
. O 0 0.010903422720730305

However O 0 0.010121569037437439
, O 0 0.005484920926392078
the O 0 0.005982603412121534
mechanism O 0 0.012115065939724445
of O 0 0.012184038758277893
hypohaptoglobinemia B-Disease 1 0.9992764592170715
remains O 0 0.1577664464712143
unknown O 0 0.04770079255104065

ATM O 0 0.08321923762559891
mutations O 0 0.013987583108246326
and O 0 0.005766924936324358
phenotypes O 0 0.03084825538098812
in O 0 0.09319693595170975
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
telangiectasia I-Disease 1 0.9999997615814209
families O 0 0.005622013472020626
in O 0 0.002584001747891307
the O 0 0.003154880367219448
British O 0 0.005490271840244532
Isles O 0 0.008777947165071964
: O 0 0.0032637352123856544
expression O 0 0.002804577350616455
of O 0 0.0035122742410749197
mutant O 0 0.01253044418990612
ATM O 0 0.009261875413358212
and O 0 0.0018488148925825953
the O 0 0.0025756533723324537
risk O 0 0.0070205386728048325
of O 1 0.8430413007736206
leukemia B-Disease 1 1.0
, O 1 0.9999979734420776
lymphoma B-Disease 1 1.0
, O 1 0.9999642372131348
and O 1 0.9999498128890991
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.12422642111778259

We O 0 0.007321998942643404
report O 0 0.00607203459367156
the O 0 0.004002678208053112
spectrum O 0 0.0055399672128260136
of O 0 0.004209703300148249
59 O 0 0.013474574312567711
ATM O 0 0.016277560964226723
mutations O 0 0.004983170889317989
observed O 0 0.004319127183407545
in O 0 0.006171784829348326
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999949932098389
telangiectasia I-Disease 1 1.0
( O 1 0.890568196773529
A B-Disease 1 0.999991774559021
- I-Disease 1 0.9999980926513672
T I-Disease 1 0.9999996423721313
) O 0 0.004834004212170839
patients O 0 0.00788283534348011
in O 0 0.002922436688095331
the O 0 0.006367035675793886
British O 0 0.014829314313828945
Isles O 0 0.04796824976801872
. O 0 0.015948986634612083

Of O 0 0.016693970188498497
51 O 0 0.0305582657456398
ATM O 0 0.10319063067436218
mutations O 0 0.007934311404824257
identified O 0 0.004172567743808031
in O 0 0.0021103424951434135
families O 0 0.0021443855948746204
native O 0 0.0025020630564540625
to O 0 0.001247542561031878
the O 0 0.0024940951261669397
British O 0 0.003928860649466515
Isles O 0 0.008303094655275345
, O 0 0.002902814419940114
11 O 0 0.003557841992005706
were O 0 0.002564979949966073
founder O 0 0.05308806523680687
mutations O 0 0.0043534524738788605
, O 0 0.002111602108925581
and O 0 0.0015047542983666062
2 O 0 0.0027496085967868567
of O 0 0.0016417244914919138
these O 0 0.0014141537249088287
11 O 0 0.004236010368913412
conferred O 0 0.0130888931453228
a O 0 0.005378187168389559
milder O 0 0.15813304483890533
clinical O 1 0.9972991347312927
phenotype O 0 0.010765507817268372
with O 0 0.0017797870095819235
respect O 0 0.0030917844269424677
to O 0 0.0027864696457982063
both O 0 0.007575247902423143
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.999932050704956
cellular O 1 0.9996448755264282
features O 0 0.16455376148223877
. O 0 0.01254645548760891

We O 0 0.0058196671307086945
report O 0 0.003779919119551778
, O 0 0.0019416653085500002
in O 0 0.0015953736146911979
two O 0 0.0018399899126961827
A B-Disease 1 0.9951868653297424
- I-Disease 1 0.9992927312850952
T I-Disease 1 0.9995355606079102
families O 0 0.0020994292572140694
, O 0 0.0016482881037518382
an O 0 0.0019611967727541924
ATM O 0 0.012720569968223572
mutation O 0 0.005952386651188135
( O 0 0.005715849809348583
7271T O 1 0.8920252323150635
- O 1 0.6685076951980591
- O 0 0.35793402791023254
> O 0 0.03921696916222572
G O 0 0.04966750368475914
) O 0 0.0023047151044011116
that O 0 0.0009266827255487442
may O 0 0.0012521961471065879
be O 0 0.0006887075142003596
associated O 0 0.0010775240371003747
with O 0 0.0007231057388707995
an O 0 0.0013947676634415984
increased O 0 0.002865597140043974
risk O 0 0.04353064298629761
of O 1 0.9970226883888245
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.006885090842843056
both O 0 0.0038213038351386786
homozygotes O 1 0.7851074934005737
and O 0 0.003376541892066598
heterozygotes O 0 0.36156564950942993
( O 0 0.004196911584585905
relative O 0 0.004722789395600557
risk O 0 0.004017605911940336
12 O 0 0.0026168019976466894
. O 0 0.0013607102446258068
7 O 0 0.0032735734712332487
; O 0 0.0028511362615972757
P O 0 0.017697082832455635
= O 0 0.00979975238442421
. O 0 0.003071039682254195
0025 O 1 0.6609995365142822
) O 0 0.0026041287928819656
, O 0 0.0013463270151987672
although O 0 0.0011056246003136039
there O 0 0.001165744150057435
is O 0 0.0013985529076308012
a O 0 0.002301472006365657
less O 0 0.003443668130785227
severe O 1 0.9999979734420776
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.999994158744812
phenotype O 0 0.0047720735892653465
in O 0 0.0012088363291695714
terms O 0 0.0011873506009578705
of O 0 0.0019534726161509752
the O 0 0.003380054607987404
degree O 0 0.01455072220414877
of O 1 0.9785428047180176
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9961651563644409

This O 0 0.009597606025636196
mutation O 0 0.015373221598565578
( O 0 0.013295513577759266
7271T O 1 0.9189738035202026
- O 1 0.8953741192817688
- O 0 0.43758997321128845
> O 0 0.03479481860995293
G O 0 0.021380191668868065
) O 0 0.002381534781306982
also O 0 0.0015963658224791288
allows O 0 0.0011891735484823585
expression O 0 0.002193501917645335
of O 0 0.0024325286503881216
full O 0 0.005003433208912611
- O 0 0.008699903264641762
length O 0 0.005085307639092207
ATM O 0 0.011129625141620636
protein O 0 0.0032048209104686975
at O 0 0.0026177854742854834
a O 0 0.0022585573606193066
level O 0 0.0032356956508010626
comparable O 0 0.0034998494666069746
with O 0 0.001544554135762155
that O 0 0.0017822744557633996
in O 0 0.00402124784886837
unaffected O 0 0.02434409409761429
individuals O 0 0.006943673361092806
. O 0 0.011323732323944569

In O 0 0.009045307524502277
addition O 0 0.0057662734761834145
, O 0 0.0029053755570203066
we O 0 0.0013891721609979868
have O 0 0.0009393923683091998
studied O 0 0.003888810984790325
18 O 0 0.005698899272829294
A B-Disease 1 0.9999268054962158
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999998807907104
patients O 1 0.5368057489395142
, O 0 0.001464547822251916
in O 0 0.0011716679437085986
15 O 0 0.0016240380937233567
families O 0 0.0012816136004403234
, O 0 0.0015641445061191916
who O 0 0.003540588542819023
developed O 1 0.9736653566360474
leukemia B-Disease 1 1.0
, O 1 0.9999229907989502
lymphoma B-Disease 1 1.0
, O 1 0.9984171390533447
preleukemic O 1 0.9999998807907104
T O 1 0.9999991655349731
- O 1 0.7599440813064575
cell O 0 0.01385634858161211
proliferation O 0 0.02431652322411537
, O 0 0.005643661133944988
or O 1 0.7156937122344971
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.891395628452301
mostly O 0 0.006717689801007509
in O 0 0.008801626972854137
childhood O 1 0.9999772310256958
. O 0 0.021050002425909042

A O 0 0.016458453610539436
wide O 0 0.006970442831516266
variety O 0 0.005772740114480257
of O 0 0.006948449183255434
ATM O 1 0.9279876351356506
mutation O 0 0.006485227029770613
types O 0 0.0025901561602950096
, O 0 0.0021431962959468365
including O 0 0.0023375232703983784
missense O 0 0.011687654070556164
mutations O 0 0.004652401898056269
and O 0 0.002430526539683342
in O 0 0.004252906423062086
- O 0 0.069126196205616
frame O 0 0.015329081565141678
deletions O 0 0.009261133149266243
, O 0 0.0030117330607026815
were O 0 0.0026314910501241684
seen O 0 0.0041964552365243435
in O 0 0.0034576975740492344
these O 0 0.004098845180124044
patients O 1 0.9212693572044373
. O 0 0.013959701173007488

We O 0 0.006106295622885227
also O 0 0.0031686979345977306
show O 0 0.002691857283934951
that O 0 0.0008503363933414221
25 O 0 0.0014728226233273745
% O 0 0.0009271251037716866
of O 0 0.001219994854182005
all O 0 0.0018038548296317458
A B-Disease 1 0.9999793767929077
- I-Disease 1 0.9999971389770508
T I-Disease 1 0.9999992847442627
patients O 0 0.34623000025749207
carried O 0 0.003923740703612566
in O 0 0.003181296167895198
- O 0 0.010492446832358837
frame O 0 0.009876861236989498
deletions O 0 0.008265865966677666
or O 0 0.003514411160722375
missense O 0 0.013835162855684757
mutations O 0 0.00407961243763566
, O 0 0.0017300976905971766
many O 0 0.001088159391656518
of O 0 0.0018353706691414118
which O 0 0.001709188218228519
were O 0 0.0019150619627907872
also O 0 0.001884058234281838
associated O 0 0.002124152146279812
with O 0 0.001662943046540022
expression O 0 0.004624044056981802
of O 0 0.007338958326727152
mutant O 1 0.6122710704803467
ATM O 0 0.42993271350860596
protein O 0 0.01737632229924202
. O 0 0.012798203155398369

The O 0 0.021484145894646645
DMPK O 1 0.9987425208091736
gene O 0 0.01622636802494526
of O 0 0.023091698065400124
severely O 1 0.9999980926513672
affected O 1 0.9999915361404419
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.997800886631012
hypermethylated O 1 0.9999822378158569
proximal O 1 0.9984277486801147
to O 0 0.003194626420736313
the O 0 0.004291214048862457
largely O 0 0.007961999624967575
expanded O 0 0.017535489052534103
CTG O 1 0.9983590245246887
repeat O 0 0.060009486973285675
. O 0 0.017195411026477814

Using O 0 0.016901738941669464
methylation O 0 0.02685835026204586
- O 0 0.02062317356467247
sensitive O 0 0.012839670293033123
restriction O 0 0.009484827518463135
enzymes O 0 0.006073730066418648
, O 0 0.0033068573102355003
we O 0 0.002365599386394024
characterized O 0 0.005703835282474756
the O 0 0.0038206647150218487
methylation O 0 0.006238609552383423
pattern O 0 0.004749133251607418
on O 0 0.0022099274210631847
the O 0 0.0025766261387616396
5 O 0 0.003123639849945903
side O 0 0.002842243295162916
of O 0 0.0024875756353139877
the O 0 0.005133194848895073
CTG O 1 0.9994909763336182
repeat O 0 0.007712006103247404
in O 0 0.002477372298017144
the O 0 0.004052417352795601
DMPK O 1 0.9985281229019165
gene O 0 0.0031219979282468557
of O 0 0.0016972649609670043
normal O 0 0.0024522370658814907
individuals O 0 0.0011057915398851037
and O 0 0.001495848991908133
of O 0 0.006593118887394667
patients O 1 0.9999865293502808
affected O 1 0.9922123551368713
with O 1 0.9889640808105469
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.6563857793807983
showing O 0 0.018227290362119675
expansions O 0 0.011229223571717739
of O 0 0.0050051333382725716
the O 0 0.006967430002987385
repetitive O 0 0.41498488187789917
sequence O 0 0.012658243998885155
. O 0 0.00973455049097538

The O 0 0.018999550491571426
gene O 0 0.015494944527745247
segment O 0 0.01233554258942604
analyzed O 0 0.00830446183681488
corresponds O 0 0.007228372152894735
to O 0 0.0032204019371420145
the O 0 0.006990548688918352
genomic O 0 0.02967243827879429
SacI O 1 0.9886838793754578
- O 0 0.02731957659125328
HindIII O 0 0.04740992188453674
fragment O 0 0.015093056485056877
carrying O 0 0.011172903701663017
exons O 0 0.020820001140236855
11 O 0 0.012254300527274609
- O 0 0.019252758473157883
15 O 0 0.011605815030634403
. O 0 0.01328473910689354

There O 0 0.008627122268080711
is O 0 0.006563136354088783
constitutive O 0 0.021559596061706543
methylation O 0 0.010325072333216667
in O 0 0.005385719705373049
intron O 0 0.05877240374684334
12 O 0 0.0053922259248793125
at O 0 0.003862677374854684
restriction O 0 0.003694379236549139
sites O 0 0.0022373897954821587
of O 0 0.003029300831258297
SacII O 0 0.4303891062736511
and O 0 0.0035804519429802895
HhaI O 0 0.0798499584197998
, O 0 0.0035845439415425062
localized O 0 0.009228401817381382
1 O 0 0.00476062810048461
, O 0 0.0028677270747721195
159 O 0 0.010095717385411263
- O 0 0.007293118163943291
1 O 0 0.003986318130046129
, O 0 0.0023243457544595003
232 O 0 0.010273066349327564
bp O 0 0.008025292307138443
upstream O 0 0.004953028634190559
of O 0 0.002844887785613537
the O 0 0.00652106199413538
CTG O 1 0.999848484992981
repeat O 0 0.026202255859971046
, O 0 0.0035150740295648575
whereas O 0 0.0032156938686966896
most O 0 0.0014012546744197607
, O 0 0.001747175119817257
if O 0 0.0010214380454272032
not O 0 0.000613685289863497
all O 0 0.0006294238264672458
, O 0 0.0009082300239242613
of O 0 0.001309444080106914
the O 0 0.0014882412506267428
other O 0 0.0007990493322722614
sites O 0 0.0014956973027437925
of O 0 0.0027637502644211054
SacII O 1 0.9989792704582214
, O 0 0.003959536552429199
HhaI O 1 0.9144610166549683
, O 0 0.0031708371825516224
and O 0 0.0024855684023350477
HpaII O 1 0.5282078981399536
in O 0 0.0021879859268665314
this O 0 0.0013314398238435388
region O 0 0.0025337901897728443
are O 0 0.0012930951779708266
unmethylated O 0 0.036499835550785065
, O 0 0.0022328386548906565
in O 0 0.0018992280820384622
normal O 0 0.0028342094738036394
individuals O 0 0.0010332365054637194
and O 0 0.0011732438579201698
most O 0 0.0015011265641078353
of O 0 0.004399494268000126
the O 0 0.22363850474357605
patients O 1 0.9996856451034546
. O 0 0.013709877617657185

In O 0 0.005847398657351732
a O 0 0.003941911738365889
number O 0 0.002303535584360361
of O 0 0.0036999229341745377
young O 0 0.08562818914651871
and O 0 0.03493177145719528
severely O 1 0.9999974966049194
affected O 1 0.9859226942062378
patients O 1 0.9988943934440613
, O 0 0.002711821347475052
however O 0 0.0018306516576558352
, O 0 0.001573330839164555
complete O 0 0.0025494785513728857
methylation O 0 0.0030838928651064634
of O 0 0.001337928930297494
these O 0 0.0007996213971637189
restriction O 0 0.0023522409610450268
sites O 0 0.0017203637398779392
was O 0 0.0026971737388521433
found O 0 0.0019756988622248173
in O 0 0.0024077831767499447
the O 0 0.0055096508003771305
mutated O 0 0.029318321496248245
allele O 0 0.020704204216599464
. O 0 0.010540707036852837

In O 0 0.005760858301073313
most O 0 0.002522129565477371
of O 0 0.0026071290485560894
these O 0 0.0017765952507033944
patients O 0 0.019612770527601242
, O 0 0.0020567423198372126
the O 0 0.0033174699638038874
onset O 1 0.9999850988388062
of O 1 0.9478163719177246
the O 1 0.999996542930603
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9953538179397583

Preliminary O 0 0.023644527420401573
in O 0 0.012058311142027378
vivo O 0 0.03787730261683464
footprinting O 0 0.05237645283341408
data O 0 0.0037214222829788923
gave O 0 0.0034852090757340193
evidence O 0 0.0024388094898313284
for O 0 0.0024901286233216524
protein O 0 0.0055166566744446754
- O 0 0.005726791452616453
DNA O 0 0.0035595817025750875
contact O 0 0.002725857077166438
in O 0 0.001850529806688428
normal O 0 0.0031738714314997196
genes O 0 0.0026380508206784725
at O 0 0.0032347054220736027
an O 0 0.0032170498743653297
Sp1 O 0 0.2135806828737259
consensus O 0 0.004975990857928991
binding O 0 0.002518681576475501
site O 0 0.004142795689404011
upstream O 0 0.004479602444916964
of O 0 0.0029175858944654465
the O 0 0.00576145900413394
CTG O 1 0.9999451637268066
repeat O 0 0.01134370919317007
and O 0 0.0020115163642913103
for O 0 0.0016354946419596672
a O 0 0.0023685020860284567
significant O 0 0.0023374254815280437
reduction O 0 0.0029976859223097563
of O 0 0.0014413613826036453
this O 0 0.000992300221696496
interaction O 0 0.0016289870254695415
in O 0 0.0017376091564074159
cells O 0 0.002093723975121975
with O 0 0.0016819501761347055
a O 0 0.0055395737290382385
hypermethylated O 1 0.9997902512550354
DMPK O 1 0.9999899864196777
gene O 0 0.011668122373521328
. O 0 0.004894124809652567
. O 0 0.008716496638953686

The O 1 0.7504817843437195
hemochromatosis B-Disease 1 1.0
gene O 0 0.02573821321129799
product O 0 0.007487852592021227
complexes O 0 0.010381542146205902
with O 0 0.0032869107089936733
the O 0 0.008502599783241749
transferrin O 1 0.9998341798782349
receptor O 0 0.01730732060968876
and O 0 0.004584279377013445
lowers O 0 0.030106185004115105
its O 0 0.003126569092273712
affinity O 0 0.006926547735929489
for O 0 0.0053508086130023
ligand O 0 0.025419320911169052
binding O 0 0.011952558532357216
. O 0 0.013199249282479286

We O 0 0.009483043104410172
recently O 0 0.011789674870669842
reported O 0 0.00612902594730258
the O 0 0.0036625387147068977
positional O 0 0.009878026321530342
cloning O 0 0.004899513907730579
of O 0 0.0030765864066779613
a O 0 0.004269383382052183
candidate O 0 0.009502134285867214
gene O 0 0.009893611073493958
for O 0 0.011563291773200035
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999992847442627
HFE O 1 1.0
. O 0 0.049269575625658035

The O 0 0.015444704331457615
gene O 0 0.00949818454682827
product O 0 0.004703831393271685
, O 0 0.002602888038381934
a O 0 0.0027414150536060333
member O 0 0.002933800918981433
of O 0 0.0025519777555018663
the O 0 0.004720178432762623
major O 0 0.2862667143344879
histocompatibility O 1 0.9999998807907104
complex O 1 0.8990963697433472
class O 1 0.9942243695259094
I O 1 0.9970281720161438
- O 0 0.13112610578536987
like O 0 0.0028381003066897392
family O 0 0.004053864628076553
, O 0 0.0021253009326756
was O 0 0.00394336087629199
found O 0 0.0016493825241923332
to O 0 0.001133618177846074
have O 0 0.0009931916138157248
a O 0 0.0025471975095570087
mutation O 0 0.005442861933261156
, O 0 0.005339253228157759
Cys O 1 0.9970784187316895
- O 0 0.028843751177191734
282 O 0 0.3698217570781708
- O 0 0.2082604467868805
- O 0 0.028886258602142334
> O 0 0.024942582473158836
Tyr O 1 0.9786900877952576
( O 0 0.00808811653405428
C282Y O 0 0.02134355530142784
) O 0 0.002594609512016177
, O 0 0.001554979244247079
in O 0 0.001816114061512053
85 O 0 0.005992786958813667
% O 0 0.0036299230996519327
of O 0 0.005503767170011997
patient O 1 0.9989068508148193
chromosomes O 0 0.027186818420886993
. O 0 0.013163709081709385

This O 0 0.014506509527564049
mutation O 0 0.01925177127122879
eliminates O 0 0.018350563943386078
the O 0 0.005860179662704468
ability O 0 0.004313293378800154
of O 0 0.005162705201655626
HFE O 1 0.9996165037155151
to O 0 0.003451272612437606
associate O 0 0.00794717762619257
with O 0 0.003769166534766555
beta2 O 1 0.9994674324989319
- O 1 0.7891549468040466
microglobulin O 1 0.9962525367736816
( O 0 0.00761466333642602
beta2m O 0 0.2121724784374237
) O 0 0.0044562676921486855
and O 0 0.0037571268621832132
prevents O 0 0.023564232513308525
cell O 0 0.22339235246181488
- O 0 0.05628857761621475
surface O 0 0.012481996789574623
expression O 0 0.013658183626830578
. O 0 0.012266341596841812

A O 0 0.025634771212935448
second O 0 0.01915198564529419
mutation O 0 0.00819267425686121
that O 0 0.001919076661579311
has O 0 0.002090481575578451
no O 0 0.0018123765476047993
effect O 0 0.0026935029309242964
on O 0 0.0035282988101243973
beta2m O 1 0.9547332525253296
association O 0 0.011075356975197792
, O 0 0.005525980144739151
H63D O 1 0.9999022483825684
, O 0 0.003498705569654703
was O 0 0.00436887564137578
found O 0 0.001680209068581462
in O 0 0.0010759710567072034
eight O 0 0.001409347401931882
out O 0 0.001260800869204104
of O 0 0.001866172649897635
nine O 0 0.0036893964279443026
patients O 0 0.01200438104569912
heterozygous O 0 0.005460457876324654
for O 0 0.0025286648888140917
the O 0 0.00643934728577733
C282Y O 1 0.7773041129112244
mutant O 0 0.044980380684137344
. O 0 0.014985334128141403

In O 0 0.007509067188948393
this O 0 0.00328568322584033
report O 0 0.003397427499294281
, O 0 0.0020058134105056524
we O 0 0.0015764650888741016
demonstrate O 0 0.0035338725429028273
in O 0 0.002727267798036337
cultured O 0 0.015819845721125603
293 O 0 0.029357779771089554
cells O 0 0.009507980197668076
overexpressing O 0 0.07078614830970764
wild O 0 0.009032410569489002
- O 0 0.013895275071263313
type O 0 0.009027307853102684
or O 0 0.004587575327605009
mutant O 0 0.0220761988312006
HFE O 1 0.9975207448005676
proteins O 0 0.0026714797131717205
that O 0 0.001054923515766859
both O 0 0.0010628164745867252
the O 0 0.002697638003155589
wild O 0 0.008068831637501717
- O 0 0.03404655680060387
type O 0 0.011554096825420856
and O 0 0.006289121229201555
H63D O 1 0.9999898672103882
HFE O 1 0.9999915361404419
proteins O 0 0.00566389225423336
form O 0 0.003851980436593294
stable O 0 0.009547844529151917
complexes O 0 0.007784116081893444
with O 0 0.002919611753895879
the O 0 0.009436258114874363
transferrin O 1 0.9996825456619263
receptor O 0 0.10404349118471146
( O 0 0.017713475972414017
TfR O 1 0.9990563988685608
) O 0 0.014163307845592499
. O 0 0.013954345136880875

The O 0 0.021341321989893913
C282Y O 1 0.6364128589630127
mutation O 0 0.012324532493948936
nearly O 0 0.006176840513944626
completely O 0 0.006988487206399441
prevents O 0 0.006203135009855032
the O 0 0.003014068119227886
association O 0 0.00447002612054348
of O 0 0.004091715440154076
the O 0 0.008234345354139805
mutant O 1 0.8355337977409363
HFE O 1 0.9998897314071655
protein O 0 0.008271547965705395
with O 0 0.004080365877598524
the O 0 0.012548773549497128
TfR O 1 0.9997432827949524
. O 0 0.021596523001790047

Studies O 0 0.014448544941842556
on O 0 0.009989633224904537
cell O 0 0.02268407680094242
- O 0 0.014712389558553696
associated O 0 0.007206105627119541
transferrin O 0 0.028765391558408737
at O 0 0.006463364697992802
37 O 0 0.007315866649150848
degrees O 0 0.00593879958614707
C O 0 0.007906760089099407
suggest O 0 0.0028813108801841736
that O 0 0.0012584133073687553
the O 0 0.0035843942314386368
overexpressed O 0 0.03193134069442749
wild O 0 0.010922960937023163
- O 0 0.12949278950691223
type O 0 0.10764098167419434
HFE O 1 0.9999499320983887
protein O 0 0.008065951056778431
decreases O 0 0.005678929388523102
the O 0 0.003126520197838545
affinity O 0 0.005586268845945597
of O 0 0.004998986609280109
the O 0 0.010847972705960274
TfR O 1 0.999826967716217
for O 0 0.01495510432869196
transferrin O 1 0.988440752029419
. O 0 0.021767200902104378

The O 0 0.03627537563443184
overexpressed O 1 0.9995502829551697
H63D O 1 0.9999704360961914
protein O 0 0.013998017646372318
does O 0 0.0031451566610485315
not O 0 0.0010851408587768674
have O 0 0.0009472223464399576
this O 0 0.001202637329697609
effect O 0 0.0020747454836964607
, O 0 0.00167144148144871
providing O 0 0.002010284923017025
the O 0 0.0017134429654106498
first O 0 0.001723747351206839
direct O 0 0.0016017785528674722
evidence O 0 0.001623916788958013
for O 0 0.001261283759959042
a O 0 0.0026145391166210175
functional O 0 0.005399898625910282
consequence O 0 0.008304351940751076
of O 0 0.005938754882663488
the O 0 0.014548016712069511
H63D O 1 0.9999614953994751
mutation O 0 0.0284884050488472
. O 0 0.015340067446231842

Addition O 0 0.013248778879642487
of O 0 0.009853811003267765
soluble O 1 0.7576479315757751
wild O 0 0.0850771814584732
- O 1 0.989410936832428
type O 1 0.9940791130065918
HFE O 1 0.9999997615814209
/ O 1 0.9985255599021912
beta2m O 1 0.9331682920455933
heterodimers O 1 0.867533266544342
to O 0 0.0044882227666676044
cultured O 0 0.46201062202453613
cells O 0 0.0068237739615142345
also O 0 0.0030590975657105446
decreased O 0 0.0070977583527565
the O 0 0.003741765860468149
apparent O 0 0.009608635678887367
affinity O 0 0.004579898901283741
of O 0 0.0029292406979948282
the O 0 0.005113579332828522
TfR O 1 0.9849556088447571
for O 0 0.0022379285655915737
its O 0 0.001924679847434163
ligand O 0 0.006191106513142586
under O 0 0.004918111953884363
steady O 0 0.012819983065128326
- O 0 0.0066726370714604855
state O 0 0.0019727130420506
conditions O 0 0.0026827738620340824
, O 0 0.0015750350430607796
both O 0 0.0012639113701879978
in O 0 0.00240507023409009
293 O 0 0.47504353523254395
cells O 0 0.005941916722804308
and O 0 0.0031565832905471325
in O 0 0.009768716990947723
HeLa O 1 0.9999798536300659
cells O 0 0.02491370216012001
. O 0 0.013361997902393341

Furthermore O 0 0.019664010033011436
, O 0 0.005928885191679001
at O 0 0.006259942892938852
4 O 0 0.0047941976226866245
degrees O 0 0.004688166081905365
C O 0 0.008598287589848042
, O 0 0.0022946628741919994
the O 0 0.0031102399807423353
added O 0 0.0062419455498456955
soluble O 0 0.013744079507887363
complex O 0 0.009473077952861786
of O 0 0.04898088797926903
HFE O 1 1.0
/ O 1 0.9999701976776123
beta2m O 1 0.9902746677398682
inhibited O 0 0.01501249149441719
binding O 0 0.003952267114073038
of O 0 0.004750770051032305
transferrin O 1 0.6873728036880493
to O 0 0.007405401207506657
HeLa O 1 0.9999080896377563
cell O 0 0.01715376414358616
TfR O 1 0.7732474207878113
in O 0 0.003661117749288678
a O 0 0.006943988613784313
concentration O 1 0.9522428512573242
- O 0 0.051747679710388184
dependent O 0 0.009969361126422882
manner O 0 0.011377885937690735
. O 0 0.013136531226336956

Scatchard O 0 0.058069877326488495
plots O 0 0.013924818485975266
of O 0 0.005190333351492882
these O 0 0.0020892901811748743
data O 0 0.00275172246620059
indicate O 0 0.0033644293434917927
that O 0 0.0019041255582123995
the O 0 0.004203968681395054
added O 0 0.009157252497971058
heterodimer O 0 0.33480462431907654
substantially O 0 0.008772356435656548
reduced O 0 0.005654651205986738
the O 0 0.00436181016266346
affinity O 0 0.009634079411625862
of O 0 0.010317259468138218
TfR O 1 0.9999815225601196
for O 0 0.014946278184652328
transferrin O 1 0.992258608341217
. O 0 0.020288115367293358

These O 0 0.0045496090315282345
results O 0 0.003802047809585929
establish O 0 0.004349224269390106
a O 0 0.0030060685239732265
molecular O 0 0.006163665093481541
link O 0 0.007346063386648893
between O 0 0.003585290163755417
HFE O 1 0.9993059635162354
and O 0 0.0021508662030100822
a O 0 0.003013951936736703
key O 0 0.004547622986137867
protein O 0 0.002949988702312112
involved O 0 0.002000480890274048
in O 0 0.002756864530965686
iron O 1 0.9998288154602051
transport O 0 0.03282773494720459
, O 0 0.004428527783602476
the O 0 0.007018687669187784
TfR O 1 0.999966025352478
, O 0 0.003394892206415534
and O 0 0.0023068124428391457
raise O 0 0.0032445304095745087
the O 0 0.0019891869742423296
possibility O 0 0.003029586048796773
that O 0 0.0015637618489563465
alterations O 0 0.00573933869600296
in O 0 0.0019761030562222004
this O 0 0.0017209008801728487
regulatory O 0 0.005792681127786636
mechanism O 0 0.0044417958706617355
may O 0 0.001823530299589038
play O 0 0.0012975698336958885
a O 0 0.001281249220483005
role O 0 0.0020177881233394146
in O 0 0.001562507008202374
the O 0 0.004340127110481262
pathogenesis O 1 0.9999995231628418
of O 1 0.9999626874923706
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9998807907104492
. O 0 0.031378328800201416

Genomic O 0 0.03115776553750038
organization O 0 0.01210204977542162
of O 0 0.009299792349338531
the O 0 0.02696216106414795
UBE3A O 1 0.9999998807907104
/ O 1 0.9999902248382568
E6 O 1 0.999984860420227
- O 1 0.8097112774848938
AP O 0 0.12029194086790085
gene O 0 0.008202056400477886
and O 0 0.005263768136501312
related O 0 0.012920375913381577
pseudogenes O 0 0.17945535480976105
. O 0 0.02003348246216774

The O 0 0.0315559022128582
UBE3A O 1 0.9995495676994324
gene O 0 0.01591191627085209
encodes O 0 0.014252077788114548
the O 0 0.009541005827486515
E6 O 1 0.9986220598220825
- O 0 0.035479843616485596
AP O 0 0.050317391753196716
ubiquitin O 0 0.05377122759819031
- O 0 0.020443519577383995
protein O 0 0.0061105163767933846
ligase O 0 0.01144417654722929
and O 0 0.002586952643468976
has O 0 0.0025927270762622356
recently O 0 0.003944492433220148
been O 0 0.0018419305561110377
shown O 0 0.0018165011424571276
to O 0 0.0013270342024043202
be O 0 0.0019923977088183165
mutated O 0 0.017507851123809814
in O 1 0.6468502879142761
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.9977176189422607
lack O 1 0.9952539205551147
15q11 O 1 0.9999580383300781
- O 1 0.8488426208496094
q13 O 0 0.3259885013103485
deletions O 0 0.018605390563607216
or O 0 0.007391246501356363
chromosome O 0 0.026410017162561417
15 O 0 0.016328245401382446
paternal O 1 0.9996616840362549
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999762773513794
. O 0 0.03624814748764038

Previous O 0 0.03582010790705681
UBE3A O 1 0.9994041919708252
cDNA O 0 0.031244764104485512
analysis O 0 0.0052299899980425835
has O 0 0.003461019601672888
shown O 0 0.0034245471470057964
a O 0 0.0031773417722433805
coding O 0 0.009199481457471848
region O 0 0.005092154256999493
of O 0 0.004846794065088034
approximately O 0 0.00931891892105341
2 O 0 0.013754579238593578
. O 0 0.011985670775175095

6 O 0 0.029530787840485573
kb O 0 0.03360828012228012
and O 0 0.004508298356086016
a O 0 0.006145831663161516
3 O 0 0.010579598136246204
- O 0 0.01541234739124775
untranslated O 0 0.034076027572155
region O 0 0.00906542781740427
( O 0 0.007453955244272947
UTR O 0 0.04008634015917778
) O 0 0.003470058785751462
of O 0 0.003808665322139859
< O 0 0.01626262441277504
50 O 0 0.004774592816829681
bp O 0 0.00722719170153141
, O 0 0.002270323922857642
whereas O 0 0.0031085561495274305
Northern O 0 0.0029058519285172224
analysis O 0 0.002486228011548519
has O 0 0.0019292468205094337
indicated O 0 0.003593452274799347
mRNA O 0 0.004253716208040714
sizes O 0 0.0028390150982886553
of O 0 0.003734815400093794
5 O 0 0.009930317290127277
- O 0 0.019129635766148567
8 O 0 0.0170760378241539
kb O 0 0.0639776885509491
. O 0 0.018092073500156403

We O 0 0.006994876079261303
have O 0 0.0029102545231580734
analyzed O 0 0.006958603858947754
additional O 0 0.006056071724742651
cDNA O 0 0.019219281151890755
clones O 0 0.012111837044358253
and O 0 0.0025871137622743845
provide O 0 0.002412548055872321
evidence O 0 0.00256515690125525
for O 0 0.0023410802241414785
an O 0 0.0034664892591536045
additional O 0 0.007027835585176945
0 O 0 0.015930097550153732
. O 0 0.009687995538115501

5 O 0 0.024903995916247368
kb O 0 0.03526652604341507
of O 0 0.008739111013710499
5 O 0 0.013561810366809368
- O 0 0.018992412835359573
UTR O 0 0.04080705717206001
and O 0 0.004878113511949778
> O 0 0.014552827924489975
2 O 0 0.008261297829449177
kb O 0 0.024289963766932487
of O 0 0.008671593852341175
3 O 0 0.0201832577586174
- O 0 0.04892735555768013
UTR O 1 0.6633428931236267
. O 0 0.017042681574821472

We O 0 0.006298205349594355
have O 0 0.0024864384904503822
established O 0 0.004728429950773716
the O 0 0.004141430836170912
genomic O 0 0.008610880933701992
organization O 0 0.005576698575168848
of O 0 0.005050507839769125
UBE3A O 1 0.9997441172599792
and O 0 0.0032049608416855335
the O 0 0.003249045694246888
sequence O 0 0.004338981118053198
of O 0 0.007154208142310381
intron O 1 0.9999227523803711
- O 0 0.2480749934911728
exon O 0 0.05382329225540161
borders O 0 0.019290614873170853
. O 0 0.017499011009931564

We O 0 0.006582720670849085
have O 0 0.002332341391593218
also O 0 0.0024077328853309155
mapped O 0 0.004753562156111002
two O 0 0.0015238638734444976
highly O 0 0.004582313355058432
homologous O 0 0.010616417042911053
processed O 0 0.008085744455456734
pseudogenes O 0 0.022553853690624237
, O 0 0.005997588858008385
UBE3AP1 O 1 0.9961961507797241
and O 0 0.004487681668251753
UBE3AP2 O 1 0.9948451519012451
, O 0 0.002357637509703636
to O 0 0.0014172837836667895
chromosomes O 0 0.0038149303290992975
2 O 0 0.0023033188190311193
and O 0 0.0012494452530518174
21 O 0 0.0027798989322036505
, O 0 0.001663161558099091
respectively O 0 0.002797258784994483
, O 0 0.0016952131409198046
and O 0 0.0016571087762713432
determined O 0 0.003362814662978053
their O 0 0.002529094461351633
genomic O 0 0.014091264456510544
organization O 0 0.01004751119762659
. O 0 0.010922796092927456

These O 0 0.005312426947057247
results O 0 0.0036317931953817606
will O 0 0.0017258261796087027
form O 0 0.001351972809061408
the O 0 0.0016378515865653753
basis O 0 0.0017632473027333617
for O 0 0.0016457870369777083
studies O 0 0.002748562954366207
of O 0 0.004067351575940847
mutation O 0 0.008346561342477798
and O 0 0.004940832499414682
imprinting O 0 0.36596813797950745
of O 0 0.13252417743206024
UBE3A O 1 0.9999959468841553
. O 0 0.027894610539078712

Mutation O 0 0.02678840607404709
spectrum O 0 0.01661222241818905
and O 0 0.008212419226765633
genotype O 0 0.043041955679655075
- O 0 0.015627553686499596
phenotype O 0 0.012107386253774166
analyses O 0 0.008151489309966564
in O 0 0.008196284994482994
Cowden B-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
and O 1 0.8186458349227905
Bannayan B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.010762552730739117
two O 0 0.009759988635778427
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 0.9999998807907104
with O 1 0.9893799424171448
germline O 1 0.9999994039535522
PTEN O 1 0.9999995231628418
mutation O 0 0.2274220585823059
. O 0 0.01993297040462494

The O 1 0.8890761733055115
tumour B-Disease 1 1.0
suppressor O 1 0.9999982118606567
gene O 1 0.6323675513267517
PTEN O 1 0.9986978769302368
, O 0 0.004830991383641958
which O 0 0.0029639487620443106
maps O 0 0.007595642935484648
to O 0 0.007501543965190649
10q23 O 0 0.07063499093055725
. O 0 0.017550257965922356

3 O 0 0.015548931434750557
and O 0 0.005128877237439156
encodes O 0 0.009649405255913734
a O 0 0.00490716565400362
403 O 0 0.01784648187458515
amino O 0 0.008339760825037956
acid O 0 0.010502411983907223
dual O 0 0.012792572379112244
specificity O 0 0.01570739410817623
phosphatase O 0 0.3858487904071808
( O 0 0.009381579235196114
protein O 0 0.010027563199400902
tyrosine O 0 0.01668993942439556
phosphatase O 0 0.04539698362350464
; O 0 0.005595813039690256
PTPase O 1 0.8721573352813721
) O 0 0.004794832319021225
, O 0 0.0032104100100696087
was O 0 0.005332460626959801
shown O 0 0.0028510382398962975
recently O 0 0.0033555703703314066
to O 0 0.0014522223500534892
play O 0 0.001727085211314261
a O 0 0.0024410050828009844
broad O 0 0.005826198495924473
role O 0 0.008634082041680813
in O 0 0.00862538069486618
human O 0 0.4431869089603424
malignancy B-Disease 1 0.9999988079071045
. O 0 0.026916027069091797

Somatic O 1 0.9971904158592224
PTEN O 1 0.9998196959495544
deletions O 0 0.02239023894071579
and O 0 0.004368581343442202
mutations O 0 0.004014211241155863
were O 0 0.0014650234952569008
observed O 0 0.0021047627087682486
in O 0 0.002199433743953705
sporadic B-Disease 1 0.6763578057289124
breast I-Disease 1 1.0
, I-Disease 1 0.8385852575302124
brain I-Disease 1 0.9999972581863403
, I-Disease 1 0.9931058287620544
prostate I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9989902377128601
lines O 0 0.003365827025845647
and O 0 0.0012221384095028043
in O 0 0.0013664958532899618
several O 0 0.0019411025568842888
primary O 0 0.448016494512558
tumours B-Disease 1 0.9999974966049194
such O 0 0.0038356538861989975
as O 1 0.6056320667266846
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9996386766433716

In O 0 0.009201189503073692
addition O 0 0.008846446871757507
, O 0 0.008370240218937397
PTEN O 1 0.9996516704559326
was O 0 0.01057774294167757
identified O 0 0.004362210165709257
as O 0 0.002705877646803856
the O 0 0.0034935222938656807
susceptibility O 0 0.015710124745965004
gene O 0 0.0034925893414765596
for O 0 0.0023619213607162237
two O 0 0.006041187793016434
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9995712637901306
CD B-Disease 1 0.999276340007782
; O 0 0.007987246848642826
MIM O 1 0.9999872446060181
158350 O 1 0.8337491750717163
) O 0 0.003633311716839671
and O 0 0.003441927256062627
Bannayan B-Disease 1 0.9992988109588623
- I-Disease 0 0.3426092267036438
Zonana I-Disease 1 0.9997007846832275
( I-Disease 0 0.013016322627663612
BZS I-Disease 1 0.9900493621826172
) I-Disease 0 0.005506521090865135
or I-Disease 0 0.005429319571703672
Ruvalcaba I-Disease 1 0.9995893836021423
- I-Disease 1 0.8582828044891357
Riley I-Disease 1 0.9996504783630371
- I-Disease 1 0.9991176724433899
Smith I-Disease 1 0.9997273087501526
syndrome I-Disease 1 1.0
( O 1 0.9982481002807617
MIM O 1 0.9999998807907104
153480 O 1 0.9999723434448242
) O 0 0.01447747740894556
. O 0 0.014161084778606892

Constitutive O 0 0.05642428249120712
DNA O 0 0.016891537234187126
from O 0 0.005209919065237045
37 O 0 0.007859858684241772
CD B-Disease 0 0.008765773847699165
families O 0 0.002968962537124753
and O 0 0.0024076502304524183
seven O 0 0.005636053159832954
BZS B-Disease 1 0.9977583885192871
families O 0 0.0056286766193807125
was O 0 0.010459131561219692
screened O 0 0.01592499576508999
for O 0 0.011065948754549026
germline O 1 0.9981166124343872
PTEN O 1 0.9999842643737793
mutations O 0 0.033862579613924026
. O 0 0.018810588866472244

PTEN O 1 0.999470055103302
mutations O 0 0.012368502095341682
were O 0 0.003584310645237565
identified O 0 0.0038096446078270674
in O 0 0.0016510377172380686
30 O 0 0.002311151474714279
of O 0 0.002134740585461259
37 O 0 0.005342257674783468
( O 0 0.0032804685179144144
81 O 0 0.007427430711686611
% O 0 0.003030395368114114
) O 0 0.0025782722514122725
CD B-Disease 0 0.005819490645080805
families O 0 0.0024262561928480864
, O 0 0.0021637955214828253
including O 0 0.0022439032327383757
missense O 0 0.010566149838268757
and O 0 0.003044963115826249
nonsense O 0 0.0232689268887043
point O 0 0.008170221000909805
mutations O 0 0.0060906363651156425
, O 0 0.0032032292801886797
deletions O 0 0.008373932912945747
, O 0 0.0037359418347477913
insertions O 0 0.01373942568898201
, O 0 0.0043742842972278595
a O 0 0.006748612970113754
deletion O 0 0.42684733867645264
/ O 1 0.7883455157279968
insertion O 0 0.02027909830212593
and O 0 0.0071794711984694
splice O 0 0.054663293063640594
site O 0 0.018462801352143288
mutations O 0 0.020146071910858154
. O 0 0.013845236971974373

These O 0 0.00672975555062294
mutations O 0 0.006366939749568701
were O 0 0.0025426126085221767
scattered O 0 0.003564144717529416
over O 0 0.0023605653550475836
the O 0 0.0031830116640776396
entire O 0 0.0060568153858184814
length O 0 0.0051318444311618805
of O 0 0.004866193514317274
PTEN O 1 0.9997256398200989
, O 0 0.0024587928783148527
with O 0 0.001189828384667635
the O 0 0.0017428675200790167
exception O 0 0.0023105402942746878
of O 0 0.0018615766894072294
the O 0 0.0025884739588946104
first O 0 0.003645962802693248
, O 0 0.003228542860597372
fourth O 0 0.00768274487927556
and O 0 0.003571677953004837
last O 0 0.009100017137825489
exons O 0 0.0317557118833065
. O 0 0.013900273479521275

A O 0 0.02216508984565735
hot O 0 0.0278178658336401
spot O 0 0.01732071302831173
for O 0 0.007583970669656992
PTEN O 1 0.9999146461486816
mutation O 0 0.006622120272368193
in O 0 0.003310263389721513
CD B-Disease 0 0.017891906201839447
was O 0 0.007178234402090311
identified O 0 0.004181983880698681
in O 0 0.0024826722219586372
exon O 0 0.011024784296751022
5 O 0 0.0028024110943078995
that O 0 0.0011299701873213053
contains O 0 0.0024654027074575424
the O 0 0.0033005517907440662
PTPase O 1 0.9625878930091858
core O 0 0.009926168248057365
motif O 0 0.007966644130647182
, O 0 0.0017427547136321664
with O 0 0.0011382608208805323
13 O 0 0.0024149916134774685
of O 0 0.0020391023717820644
30 O 0 0.002786858007311821
( O 0 0.002479536458849907
43 O 0 0.003774389624595642
% O 0 0.0024716316256672144
) O 0 0.0025939876213669777
CD B-Disease 0 0.007177724968641996
mutations O 0 0.003507821122184396
identified O 0 0.0030583576299250126
in O 0 0.002771939616650343
this O 0 0.004116865340620279
exon O 0 0.043515462428331375
. O 0 0.013567508198320866

Seven O 0 0.007865259423851967
of O 0 0.005348519422113895
30 O 0 0.005175434052944183
( O 0 0.00368671421892941
23 O 0 0.004284296650439501
% O 0 0.0021869370248168707
) O 0 0.0012922356836497784
were O 0 0.0011187242344021797
within O 0 0.0012987678637728095
the O 0 0.0031259122770279646
core O 0 0.00853393878787756
motif O 0 0.010803475975990295
, O 0 0.0024290704168379307
the O 0 0.0024317640345543623
majority O 0 0.001781600876711309
( O 0 0.0017553226789459586
five O 0 0.001211958471685648
of O 0 0.0016512381844222546
seven O 0 0.002262695925310254
) O 0 0.001439224579371512
of O 0 0.0013384910998865962
which O 0 0.001265512895770371
were O 0 0.0022323671728372574
missense O 0 0.014948377385735512
mutations O 0 0.0054727098904550076
, O 0 0.0029874115716665983
possibly O 0 0.0040620239451527596
pointing O 0 0.0055940537713468075
to O 0 0.0018139180028811097
the O 0 0.0027846749871969223
functional O 0 0.0047931852750480175
significance O 0 0.005765197332948446
of O 0 0.004312826320528984
this O 0 0.004480227828025818
region O 0 0.013088461942970753
. O 0 0.01215039100497961

Germline O 1 0.9997221827507019
PTEN O 1 0.999855637550354
mutations O 0 0.010083191096782684
were O 0 0.0027813478372991085
identified O 0 0.003174529178068042
in O 0 0.0014451092574745417
four O 0 0.0013282822910696268
of O 0 0.0021872546058148146
seven O 0 0.0035916173364967108
( O 0 0.003919569775462151
57 O 0 0.008157421834766865
% O 0 0.005303302779793739
) O 0 0.006318180356174707
BZS B-Disease 1 0.9330632090568542
families O 0 0.00969965010881424
studied O 0 0.019341440871357918
. O 0 0.012819958850741386

Interestingly O 0 0.034338343888521194
, O 0 0.00566568598151207
none O 0 0.0037907978985458612
of O 0 0.00291971443220973
these O 0 0.001956564374268055
mutations O 0 0.003803001483902335
was O 0 0.00434265797957778
observed O 0 0.002744365483522415
in O 0 0.00253965868614614
the O 0 0.006846665870398283
PTPase O 1 0.9997625946998596
core O 0 0.14807982742786407
motif O 0 0.09499098360538483
. O 0 0.016393188387155533

It O 0 0.006636402104049921
is O 0 0.00468351598829031
also O 0 0.003813068149611354
worthy O 0 0.0068794358521699905
of O 0 0.0034666932187974453
note O 0 0.0038379617035388947
that O 0 0.0014091540360823274
a O 0 0.0023673600517213345
single O 0 0.002860388485714793
nonsense O 0 0.009089678525924683
point O 0 0.004531741142272949
mutation O 0 0.004403115715831518
, O 0 0.002858631545677781
R233X O 0 0.07778431475162506
, O 0 0.002457368653267622
was O 0 0.003960926551371813
observed O 0 0.0020969852339476347
in O 0 0.001435665413737297
the O 0 0.002855605212971568
germline O 0 0.012976052239537239
DNA O 0 0.0030718455091118813
from O 0 0.001166260102763772
two O 0 0.0010007561650127172
unrelated O 0 0.0055551305413246155
CD B-Disease 0 0.010194599628448486
families O 0 0.0034871334210038185
and O 0 0.003002227284014225
one O 0 0.006818973459303379
BZS B-Disease 1 0.9998512268066406
family O 0 0.03150582313537598
. O 0 0.015939537435770035

Genotype O 1 0.942952036857605
- O 0 0.06845242530107498
phenotype O 0 0.01150946132838726
studies O 0 0.0034306745510548353
were O 0 0.001833767513744533
not O 0 0.0011156656546518207
performed O 0 0.0027029041666537523
on O 0 0.001855154288932681
this O 0 0.0014040091773495078
small O 0 0.002610359573736787
group O 0 0.0036060025449842215
of O 0 0.009655806235969067
BZS B-Disease 1 0.9998118281364441
families O 0 0.019296376034617424
. O 0 0.019463252276182175

However O 0 0.01277864445000887
, O 0 0.01061485055834055
genotype O 0 0.041890211403369904
- O 0 0.014334118925035
phenotype O 0 0.009227531030774117
analysis O 0 0.004032792057842016
inthe O 0 0.017536532133817673
group O 0 0.0032295500859618187
of O 0 0.003561939811334014
CD B-Disease 0 0.016701359301805496
families O 0 0.0033433709759265184
revealed O 0 0.0037457034923136234
two O 0 0.0010348501382395625
possible O 0 0.0017361885402351618
associations O 0 0.002211774466559291
worthy O 0 0.00571156432852149
of O 0 0.002989385975524783
follow O 0 0.0042404974810779095
- O 0 0.007473748177289963
up O 0 0.002682000631466508
in O 0 0.0025456740986555815
independent O 0 0.004760436248034239
analyses O 0 0.013579370453953743
. O 0 0.01413803081959486

The O 0 0.010585355572402477
first O 0 0.005701628979295492
was O 0 0.006934111472219229
an O 0 0.002383476123213768
association O 0 0.004833935759961605
noted O 0 0.0028462233021855354
in O 0 0.0014661693712696433
the O 0 0.0019174808403477073
group O 0 0.0018044576281681657
of O 0 0.0026330887340009212
CD B-Disease 0 0.07601858675479889
families O 0 0.006415387615561485
with O 0 0.04939928278326988
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.08723094314336777

A O 0 0.018478427082300186
correlation O 0 0.012215310707688332
was O 0 0.0064821187406778336
observed O 0 0.003723307279869914
between O 0 0.002427759114652872
the O 0 0.004148326814174652
presence O 0 0.007514335680752993
/ O 0 0.040018972009420395
absence O 0 0.005486182868480682
of O 0 0.004078201949596405
a O 0 0.009723538532853127
PTEN O 1 0.9999479055404663
mutation O 0 0.004355208016932011
and O 0 0.0014843314420431852
the O 0 0.002748197177425027
type O 0 0.011134234257042408
of O 0 0.06753573566675186
breast O 1 0.9999998807907104
involvement O 1 0.9954967498779297
( O 0 0.03095267526805401
unaffected O 1 0.8979092836380005
versus O 1 0.9953497648239136
benign O 1 0.9999966621398926
versus O 1 0.9999831914901733
malignant O 1 1.0
) O 0 0.025845758616924286
. O 0 0.016586098819971085

Specifically O 0 0.010284576565027237
and O 0 0.003384437644854188
more O 0 0.001896536210551858
directly O 0 0.0024086919147521257
, O 0 0.002289346419274807
an O 0 0.0022469288669526577
association O 0 0.008540021255612373
was O 0 0.006952200550585985
also O 0 0.0018808783497661352
observed O 0 0.0018920727306976914
between O 0 0.0011560461716726422
the O 0 0.0016324020689353347
presence O 0 0.0025950809940695763
of O 0 0.0035736726131290197
a O 0 0.013902352191507816
PTEN O 1 0.9999991655349731
mutation O 1 0.8110100626945496
and O 1 0.9295509457588196
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9328171014785767

Secondly O 0 0.12423139810562134
, O 0 0.0067933062091469765
there O 0 0.0034146299585700035
appeared O 0 0.004708284977823496
to O 0 0.0017783846706151962
be O 0 0.0014590172795578837
an O 0 0.002055676653981209
interdependent O 0 0.01908811554312706
association O 0 0.007183734327554703
between O 0 0.003564578015357256
mutations O 0 0.005787965375930071
upstream O 0 0.004969561472535133
and O 0 0.0012881438015028834
within O 0 0.0015698203351348639
the O 0 0.004062635358422995
PTPase O 1 0.999211311340332
core O 0 0.0253573227673769
motif O 0 0.01248337235301733
, O 0 0.002873605815693736
the O 0 0.0031256359070539474
core O 0 0.0063650235533714294
motif O 0 0.007462846580892801
containing O 0 0.003100300906226039
the O 0 0.002544758841395378
majority O 0 0.0021824194118380547
of O 0 0.0037591978907585144
missense O 0 0.02882939577102661
mutations O 0 0.004677059128880501
, O 0 0.0018742067040875554
and O 0 0.001474813325330615
the O 0 0.0019593057222664356
involvement O 0 0.0038818095345050097
of O 0 0.0021363969426602125
all O 0 0.0017596915131434798
major O 0 0.020133433863520622
organ O 1 0.999907374382019
systems O 0 0.26226723194122314
( O 0 0.007816044613718987
central O 0 0.01354539580643177
nervous O 1 0.9839709401130676
system O 0 0.02235230803489685
, O 0 0.04758791998028755
thyroid O 1 1.0
, O 1 0.9954588413238525
breast O 1 1.0
, O 1 0.9992932081222534
skin O 1 1.0
and O 1 0.9999346733093262
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9993516802787781
. O 0 0.01991906203329563

However O 0 0.010743227787315845
, O 0 0.003802427090704441
these O 0 0.0016247588209807873
observations O 0 0.003651607083156705
would O 0 0.0016606345307081938
need O 0 0.001745334011502564
to O 0 0.0010753654642030597
be O 0 0.0009400020353496075
confirmed O 0 0.001637627836316824
by O 0 0.0008134751697070897
studying O 0 0.002046973444521427
a O 0 0.0015963658224791288
larger O 0 0.0016247727908194065
number O 0 0.0016607579309493303
of O 0 0.004198103677481413
CD B-Disease 0 0.3105314075946808
families O 0 0.011070833541452885
. O 0 0.013320471160113811

Molecular O 0 0.25030022859573364
defects O 1 0.9993001222610474
leading O 0 0.013100823387503624
to O 0 0.0048162187449634075
human O 0 0.008460190147161484
complement B-Disease 1 0.5116016268730164
component I-Disease 1 0.9999954700469971
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.006058977451175451
an O 0 0.005217170342803001
African O 0 0.4275720715522766
- O 0 0.29019564390182495
American O 0 0.011478785425424576
family O 0 0.015847116708755493
. O 0 0.01214054599404335

Complement B-Disease 1 0.6520387530326843
component I-Disease 1 0.9999716281890869
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9971033930778503
C6D B-Disease 1 0.9999994039535522
) O 0 0.007761843968182802
was O 0 0.3318554759025574
diagnosed O 1 0.9999984502792358
in O 0 0.0023003180976957083
a O 0 0.0028680777177214622
16 O 0 0.00405435124412179
- O 0 0.005701255984604359
year O 0 0.0031109049450606108
- O 0 0.006537741050124168
old O 0 0.008601915091276169
African O 0 0.0076859742403030396
- O 0 0.009471029974520206
American O 0 0.005858304910361767
male O 0 0.012923738919198513
with O 0 0.017185017466545105
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.8846095204353333

The O 0 0.06423798948526382
patients O 1 0.9997484087944031
father O 1 0.7934463620185852
and O 0 0.00265261041931808
two O 0 0.002192928222939372
brothers O 0 0.016416193917393684
also O 0 0.0038705451879650354
had O 0 0.006871209014207125
C6D B-Disease 1 0.9999327659606934
, O 0 0.0023292244877666235
but O 0 0.001304341945797205
gave O 0 0.0026621618308126926
no O 0 0.0017632690723985434
history O 0 0.004689641296863556
of O 0 0.058502160012722015
meningitis B-Disease 1 1.0
or O 0 0.09885228425264359
other O 0 0.009046736173331738
neisserial B-Disease 1 0.9999978542327881
infection I-Disease 1 0.9999996423721313
. O 0 0.02407997101545334

By O 0 0.008594370447099209
using O 0 0.008549122139811516
exon O 0 0.029538031667470932
- O 0 0.010899561457335949
specific O 0 0.00396330701187253
polymerase O 0 0.014642945490777493
chain O 0 0.010508579201996326
reaction O 0 0.007605538237839937
( O 0 0.006873650010675192
PCR O 0 0.022256998345255852
) O 0 0.006811195053160191
/ O 0 0.01792820543050766
single O 0 0.006593312136828899
- O 0 0.011951882392168045
strand O 0 0.010531898587942123
conformation O 0 0.009384497068822384
polymorphism O 0 0.006029985845088959
as O 0 0.0022550122812390327
a O 0 0.002813632134348154
screening O 0 0.005547206848859787
step O 0 0.004091245122253895
and O 0 0.002068351721391082
nucleotide O 0 0.004896275699138641
sequencing O 0 0.003691586432978511
of O 0 0.0026274744886904955
target O 0 0.0042701419442892075
exons O 0 0.00756983645260334
, O 0 0.0022761740256100893
we O 0 0.0014754144940525293
determined O 0 0.002511592349037528
that O 0 0.0014151684008538723
the O 0 0.0030839014798402786
proband O 1 0.5964005589485168
was O 0 0.006606799550354481
a O 0 0.004142518155276775
compound O 0 0.011806471273303032
heterozygote O 0 0.02138325199484825
for O 0 0.003683545393869281
two O 0 0.006318351253867149
C6 O 1 0.9999871253967285
gene O 0 0.0204850472509861
mutations O 0 0.01613568514585495
. O 0 0.012028633616864681

The O 0 0.012530184350907803
first O 0 0.008861775510013103
, O 0 0.006070665083825588
1195delC O 0 0.02672499418258667
located O 0 0.007955022156238556
in O 0 0.004233939107507467
exon O 0 0.02605428919196129
7 O 0 0.006236129440367222
, O 0 0.0022114927414804697
is O 0 0.0018219484481960535
a O 0 0.002382680308073759
novel O 0 0.006771441083401442
mutation O 0 0.004348507151007652
, O 0 0.0017246912466362119
while O 0 0.0015940465964376926
the O 0 0.0018337746150791645
second O 0 0.0032535132486373186
, O 0 0.0025510941632092
1936delG O 0 0.015993477776646614
in O 0 0.002950916299596429
exon O 0 0.015445232391357422
12 O 0 0.0032309130765497684
, O 0 0.0021213667932897806
has O 0 0.0019250535406172276
been O 0 0.0018621082417666912
described O 0 0.0036290467251092196
before O 0 0.002440852113068104
to O 0 0.0022560583893209696
cause O 0 0.008983255364000797
C6D B-Disease 1 0.9975162744522095
in O 0 0.0025649883318692446
an O 0 0.0028824699111282825
unrelated O 0 0.012466907501220703
African O 0 0.0697757825255394
- O 0 0.02761034294962883
American O 0 0.0071326917968690395
individual O 0 0.005915166810154915
. O 0 0.010227852500975132

Both O 0 0.011669442988932133
mutations O 0 0.010834095068275928
result O 0 0.005307490471750498
in O 0 0.0066699134185910225
premature O 1 0.8047221302986145
termination O 1 0.8306481242179871
codons O 0 0.04125037044286728
and O 0 0.012572559528052807
C6 O 1 0.9999723434448242
null O 0 0.054355137050151825
alleles O 0 0.03689110279083252
. O 0 0.018915841355919838

Allele O 0 0.0590350478887558
- O 0 0.02240973897278309
specific O 0 0.006139951292425394
PCR O 0 0.015288173221051693
indicated O 0 0.005459512583911419
that O 0 0.0014985541347414255
the O 0 0.0029402507934719324
probands O 0 0.016626054421067238
two O 0 0.0026265475898981094
brothers O 0 0.01031408179551363
also O 0 0.00501887546852231
inherited O 1 0.9942004680633545
the O 0 0.009197326377034187
1195delC O 1 0.9947683811187744
mutation O 0 0.0056336564011871815
from O 0 0.0020982916466891766
their O 0 0.002013848628848791
heterozygous O 0 0.007191550452262163
mother O 0 0.007389963138848543
and O 0 0.002227079588919878
the O 0 0.0042522745206952095
1936delG O 1 0.5319969654083252
mutation O 0 0.004744241014122963
from O 0 0.0022016242146492004
their O 0 0.002530050929635763
homozygous O 0 0.014025779440999031
father O 0 0.05223427712917328
. O 0 0.0073403180576860905
. O 0 0.01052694022655487

PAX6 O 1 0.999901533126831
mutations O 0 0.0605088509619236
reviewed O 0 0.044857800006866455
. O 0 0.024793852120637894

Mutations O 0 0.02579864300787449
in O 0 0.009197712875902653
PAX6 O 1 0.998710036277771
are O 0 0.003017148934304714
responsible O 0 0.0051384312100708485
for O 0 0.0029918355867266655
human O 0 0.05233887955546379
aniridia B-Disease 1 0.9999967813491821
and O 0 0.0026381611824035645
have O 0 0.0011636351700872183
also O 0 0.0015595387667417526
been O 0 0.0014173208037391305
found O 0 0.0016428029630333185
in O 0 0.0019189943559467793
patients O 1 0.8561615943908691
with O 0 0.003483136184513569
Peters B-Disease 1 0.9999986886978149
anomaly I-Disease 1 0.9999990463256836
, O 1 0.7308543920516968
with O 1 0.999085545539856
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999986886978149
with O 1 0.9998846054077148
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999996423721313
keratitis I-Disease 1 1.0
, O 0 0.25595396757125854
and O 0 0.004971558693796396
with O 0 0.01168894860893488
isolated B-Disease 1 0.9999903440475464
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.37918978929519653

No O 0 0.014138509519398212
locus O 0 0.01956152729690075
other O 0 0.0029999285470694304
than O 0 0.003102912101894617
chromosome O 0 0.012607567943632603
11p13 O 0 0.06088247522711754
has O 0 0.003557436401024461
been O 0 0.0031813657842576504
implicated O 0 0.11872371286153793
in O 0 0.006390769965946674
aniridia B-Disease 1 0.9999994039535522
, O 0 0.007896121591329575
and O 0 0.005291165318340063
PAX6 O 1 0.9999960660934448
is O 0 0.0035012797452509403
clearly O 0 0.0033383662812411785
the O 0 0.002378062577918172
major O 0 0.004015160724520683
, O 0 0.0018570615211501718
if O 0 0.0010928056435659528
not O 0 0.0009521318133920431
only O 0 0.001516613643616438
, O 0 0.0040970658883452415
gene O 0 0.007789398077875376
responsible O 0 0.011693681590259075
. O 0 0.013887409120798111

Twenty O 0 0.02555917762219906
- O 0 0.010531898587942123
eight O 0 0.0038130267057567835
percent O 0 0.0035881223157048225
of O 0 0.003791324095800519
identified O 0 0.011863536201417446
PAX6 O 1 0.9998823404312134
mutations O 0 0.007206412963569164
are O 0 0.0026432008016854525
C O 0 0.2407667189836502
- O 0 0.025692453607916832
T O 0 0.023690922185778618
changes O 0 0.003223725128918886
at O 0 0.005926990881562233
CpG O 0 0.024278249591588974
dinucleotides O 0 0.02247869223356247
, O 0 0.00292284251190722
20 O 0 0.0029470871668308973
% O 0 0.0019169114530086517
are O 0 0.0012234620517119765
splicing O 0 0.005906307138502598
errors O 0 0.0046816798858344555
, O 0 0.0018345373682677746
and O 0 0.0012529154773801565
more O 0 0.0007610364118590951
than O 0 0.0009412029176019132
30 O 0 0.0022674568463116884
% O 0 0.0020006827544420958
are O 0 0.0014250624226406217
deletion O 0 0.009349187836050987
or O 0 0.005225209519267082
insertion O 0 0.021322065964341164
events O 0 0.012989678420126438
. O 0 0.015420554205775261

There O 0 0.008968274109065533
is O 0 0.005578787997364998
a O 0 0.006403022911399603
noticeably O 0 0.02703121304512024
elevated O 1 0.948350727558136
level O 0 0.0057198237627744675
of O 0 0.0036506878677755594
mutation O 0 0.004269651137292385
in O 0 0.001926630036905408
the O 0 0.0024489436764270067
paired O 0 0.005649462807923555
domain O 0 0.002911970252171159
compared O 0 0.002179587259888649
with O 0 0.001090118195861578
the O 0 0.002649411791935563
rest O 0 0.0036492659710347652
of O 0 0.0046568820253014565
the O 0 0.010640566237270832
gene O 0 0.014690161682665348
. O 0 0.010013248771429062

Increased O 0 0.01591932401061058
mutation O 0 0.00942829716950655
in O 0 0.0038019432686269283
the O 0 0.005752321798354387
homeodomain O 1 0.8312084674835205
is O 0 0.003950855694711208
accounted O 0 0.004896465688943863
for O 0 0.0022543342784047127
by O 0 0.002852535340934992
the O 0 0.008705995045602322
hypermutable O 1 0.9931364059448242
CpG O 1 0.5731670260429382
dinucleotide O 0 0.38960906863212585
in O 0 0.009750070981681347
codon O 0 0.03184400498867035
240 O 0 0.03111269511282444
. O 0 0.014850452542304993

Very O 0 0.010149603709578514
nearly O 0 0.006315956357866526
all O 0 0.002623853273689747
mutations O 0 0.004401405807584524
appear O 0 0.0030466108582913876
to O 0 0.002174127846956253
cause O 0 0.008068904280662537
loss O 0 0.007203172892332077
of O 0 0.0035163385327905416
function O 0 0.0034142988733947277
of O 0 0.0032495383638888597
the O 0 0.00588444247841835
mutant O 0 0.046098191291093826
allele O 0 0.004633459262549877
, O 0 0.0012863733572885394
and O 0 0.0008905644062906504
more O 0 0.0006104698404669762
than O 0 0.001005106489174068
80 O 0 0.0027579660527408123
% O 0 0.0022733500227332115
of O 0 0.003605377161875367
exonic O 0 0.03750558942556381
substitutions O 0 0.010152220726013184
result O 0 0.005223285872489214
in O 0 0.006262078415602446
nonsense O 0 0.11701218783855438
codons O 0 0.04123885929584503
. O 0 0.017075881361961365

In O 0 0.008916659280657768
a O 0 0.007574932649731636
gene O 0 0.006013144738972187
with O 0 0.0021603533532470465
such O 0 0.0020531865302473307
extraordinarily O 0 0.16739335656166077
high O 0 0.006215956062078476
sequence O 0 0.0035233530215919018
conservation O 0 0.003241449361667037
throughout O 0 0.0017878701910376549
evolution O 0 0.0027895865496248007
, O 0 0.0016202081460505724
there O 0 0.0014031040482223034
are O 0 0.0013591120950877666
presumed O 0 0.011422834359109402
undiscovered O 0 0.13964374363422394
missense O 0 0.025270486250519753
mutations O 0 0.0052093081176280975
, O 0 0.0018855121452361345
these O 0 0.00092842779122293
are O 0 0.0010856305016204715
hypothesized O 0 0.005086673889309168
to O 0 0.0013756505213677883
exist O 0 0.0017043482512235641
in O 0 0.001980561064556241
as O 0 0.0039644199423491955
- O 0 0.010483233258128166
yet O 0 0.005424169823527336
unidentified O 0 0.01883184351027012
phenotypes O 0 0.020842505618929863
. O 0 0.005796423181891441
. O 0 0.012369120493531227

Genetic O 0 0.032085660845041275
heterogeneity O 0 0.02859847992658615
and O 0 0.005976756568998098
penetrance O 0 0.019678909331560135
analysis O 0 0.003148576244711876
of O 0 0.0031140921637415886
the O 0 0.006072132382541895
BRCA1 O 1 0.9996198415756226
and O 0 0.005223316606134176
BRCA2 O 1 0.9996886253356934
genes O 0 0.010923238471150398
in O 0 0.13201265037059784
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.07584280520677567
. O 0 0.014332758262753487

The O 1 0.9981318116188049
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999129772186279
Consortium O 0 0.09824115037918091
. O 0 0.022083964198827744

The O 0 0.013903639279305935
contribution O 0 0.015252215787768364
of O 0 0.010170561261475086
BRCA1 O 1 0.999813973903656
and O 0 0.008045535534620285
BRCA2 O 1 0.9999829530715942
to O 0 0.3321355879306793
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9999966621398926
assessed O 0 0.24657538533210754
by O 0 0.0022879699245095253
linkage O 0 0.008902140893042088
and O 0 0.0015628039836883545
mutation O 0 0.002645899774506688
analysis O 0 0.001547374064102769
in O 0 0.001678479602560401
237 O 0 0.007692959625273943
families O 0 0.0019468637183308601
, O 0 0.0014047593576833606
each O 0 0.0007080922368913889
with O 0 0.0007871148991398513
at O 0 0.0015282515669241548
least O 0 0.0008321978966705501
four O 0 0.0011045060819014907
cases O 0 0.002058635698631406
of O 1 0.6593469977378845
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 0.0021466354373842478
collected O 0 0.0027510994113981724
by O 0 0.002343825763091445
the O 1 0.9661022424697876
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999744892120361
Consortium O 0 0.050185076892375946
. O 0 0.01412669662386179

Families O 0 0.010325842536985874
were O 0 0.003931223880499601
included O 0 0.003125979332253337
without O 0 0.0016245176084339619
regard O 0 0.0027193089481443167
to O 0 0.0013164699776098132
the O 0 0.0025393518153578043
occurrence O 0 0.020595261827111244
of O 1 0.9702450633049011
ovarian B-Disease 1 1.0
or I-Disease 1 0.9234211444854736
other I-Disease 0 0.0430586040019989
cancers I-Disease 1 0.9999986886978149
. O 0 0.027994561940431595

Overall O 1 0.8077025413513184
, O 0 0.4762309491634369
disease O 1 1.0
was O 1 0.9954564571380615
linked O 0 0.19738534092903137
to O 0 0.0026330258697271347
BRCA1 O 1 0.903836727142334
in O 0 0.001594304689206183
an O 0 0.001325276680290699
estimated O 0 0.002651924267411232
52 O 0 0.0032550739124417305
% O 0 0.001474199816584587
of O 0 0.0013288616901263595
families O 0 0.0018578616436570883
, O 0 0.001762279774993658
to O 0 0.0018784361891448498
BRCA2 O 0 0.021365655586123466
in O 0 0.0023959968239068985
32 O 0 0.00411100871860981
% O 0 0.0019040564075112343
of O 0 0.0018150233663618565
families O 0 0.0024684928357601166
, O 0 0.0017900398233905435
and O 0 0.0013362123863771558
to O 0 0.0014139498816803098
neither O 0 0.002835602033883333
gene O 0 0.0024543176405131817
in O 0 0.0013307222397997975
16 O 0 0.0028501900378614664
% O 0 0.002070085844025016
( O 0 0.002647747751325369
95 O 0 0.0038601423148065805
% O 0 0.0025668262969702482
confidence O 0 0.0063950554467737675
interval O 0 0.009421823546290398
[ O 0 0.013655421324074268
CI O 1 0.9997511506080627
] O 0 0.009616943076252937
6 O 0 0.0052932859398424625
% O 0 0.0032892709132283926
- O 0 0.005300506483763456
28 O 0 0.00418258598074317
% O 0 0.003123241476714611
) O 0 0.002587280236184597
, O 0 0.0025336765684187412
suggesting O 0 0.006454949267208576
other O 0 0.0037619811482727528
predisposition O 1 0.9931744933128357
genes O 0 0.019597580656409264
. O 0 0.01568196527659893

The O 0 0.008666631765663624
majority O 0 0.004417185205966234
( O 0 0.004372890572994947
81 O 0 0.006863556336611509
% O 0 0.002075057476758957
) O 0 0.0014751056442037225
of O 0 0.002132768975570798
the O 1 0.9110152125358582
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.007372082211077213
were O 0 0.0020808547269552946
due O 0 0.0030230253469198942
to O 0 0.0028041359037160873
BRCA1 O 1 0.990269660949707
, O 0 0.0015596902230754495
with O 0 0.0010705593740567565
most O 0 0.0011507394956424832
others O 0 0.0018848985200747848
( O 0 0.0025197744835168123
14 O 0 0.0032154140062630177
% O 0 0.0031941996421664953
) O 0 0.0030838078819215298
due O 0 0.00507412850856781
to O 0 0.007220034021884203
BRCA2 O 1 0.9995307922363281
. O 0 0.018017219379544258

Conversely O 0 0.026734642684459686
, O 0 0.003947481978684664
the O 0 0.0027979263104498386
majority O 0 0.0017929032910615206
of O 0 0.0019867548253387213
families O 0 0.00228673592209816
with O 0 0.0018647974357008934
male B-Disease 0 0.006942565552890301
and I-Disease 0 0.0049561369232833385
female I-Disease 1 0.9999505281448364
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.003914607688784599
due O 0 0.004854900762438774
to O 0 0.0036308406852185726
BRCA2 O 1 0.9995716214179993
( O 0 0.0063683753833174706
76 O 0 0.016412295401096344
% O 0 0.006740869954228401
) O 0 0.008380679413676262
. O 0 0.009748331271111965

The O 0 0.01235973834991455
largest O 0 0.011659020557999611
proportion O 0 0.007921556942164898
( O 0 0.005084834527224302
67 O 0 0.007323648780584335
% O 0 0.0028397010173648596
) O 0 0.0015886069741100073
of O 0 0.0012667706469073892
families O 0 0.001627270015887916
due O 0 0.0018558944575488567
to O 0 0.0011973298387601972
other O 0 0.0011821924708783627
genes O 0 0.0025460829492658377
was O 0 0.003465810790657997
found O 0 0.0016126243863254786
in O 0 0.001150712138041854
families O 0 0.001192512921988964
with O 0 0.0008232734980992973
four O 0 0.001305845333263278
or O 0 0.0013265286106616259
five O 0 0.001597880618646741
cases O 0 0.002798025030642748
of O 0 0.01806746982038021
female O 1 0.9999973773956299
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.012189377099275589
. O 0 0.012520949356257915

These O 0 0.006572033744305372
estimates O 0 0.0077746263705194
were O 0 0.00362497684545815
not O 0 0.0022776219993829727
substantially O 0 0.005198671482503414
affected O 0 0.0027480938006192446
either O 0 0.0015178504399955273
by O 0 0.0013088660780340433
changing O 0 0.0035160714760422707
the O 0 0.0035885008983314037
assumed O 0 0.014990881085395813
penetrance O 0 0.12811653316020966
model O 0 0.0059023830108344555
for O 0 0.003656207351014018
BRCA1 O 1 0.8437591791152954
or O 0 0.00187410949729383
by O 0 0.0013376525603234768
including O 0 0.002200647024437785
or O 0 0.0044591352343559265
excluding O 0 0.0509219616651535
BRCA1 O 1 0.9997987151145935
mutation O 0 0.013784081675112247
data O 0 0.00858242530375719
. O 0 0.01113315299153328

Among O 0 0.007138265296816826
those O 0 0.002762839663773775
families O 0 0.004053945187479258
with O 0 0.005438171327114105
disease O 1 1.0
due O 1 0.5067421197891235
to O 0 0.005084405653178692
BRCA1 O 1 0.9982845187187195
that O 0 0.0013505031820386648
were O 0 0.001572936773300171
tested O 0 0.002657939214259386
by O 0 0.000893584277946502
one O 0 0.0009711998864077032
of O 0 0.001463432563468814
the O 0 0.0025710929185152054
standard O 0 0.0036519679706543684
screening O 0 0.00370548153296113
methods O 0 0.0025916320737451315
, O 0 0.0019735610112547874
mutations O 0 0.0024052555672824383
were O 0 0.0016597952926531434
detected O 0 0.003096710192039609
in O 0 0.0017927830340340734
the O 0 0.003106737742200494
coding O 0 0.008152599446475506
sequence O 0 0.003136581275612116
or O 0 0.001741815940476954
splice O 0 0.0054145134054124355
sites O 0 0.001480938051827252
in O 0 0.001205691252835095
an O 0 0.0012323121773079038
estimated O 0 0.0026934081688523293
63 O 0 0.005270591005682945
% O 0 0.0025297077372670174
( O 0 0.002605055458843708
95 O 0 0.005112851038575172
% O 0 0.004387911409139633
CI O 1 0.9761491417884827
51 O 0 0.012805778533220291
% O 0 0.006687613669782877
- O 0 0.01238380279392004
77 O 0 0.015746749937534332
% O 0 0.008046821691095829
) O 0 0.00811246782541275
. O 0 0.009390455670654774

The O 0 0.011319926008582115
estimated O 0 0.00831204280257225
sensitivity O 0 0.010951516218483448
was O 0 0.0057589029893279076
identical O 0 0.0028786449693143368
for O 0 0.0017294182907789946
direct O 0 0.0026310330722481012
sequencing O 0 0.004479262046515942
and O 0 0.001930899336002767
other O 0 0.002678690245375037
techniques O 0 0.013132463209331036
. O 0 0.01343694981187582

The O 0 0.02220974862575531
penetrance O 0 0.2779639661312103
of O 0 0.019407300278544426
BRCA2 O 1 0.9998818635940552
was O 0 0.014759445562958717
estimated O 0 0.005293522495776415
by O 0 0.0022598537616431713
maximizing O 0 0.00928410328924656
the O 0 0.004434722941368818
LOD O 1 0.9748218059539795
score O 0 0.004711057059466839
in O 0 0.0051866560243070126
BRCA2 O 1 0.9996538162231445
- O 0 0.030004652217030525
mutation O 0 0.004415930714458227
families O 0 0.0020749696996062994
, O 0 0.0017417147755622864
over O 0 0.0017521522240713239
all O 0 0.001666250522248447
possible O 0 0.005474513862282038
penetrance O 0 0.12545093894004822
functions O 0 0.013056250289082527
. O 0 0.01445626001805067

The O 0 0.009213966317474842
estimated O 0 0.008871261961758137
cumulative O 0 0.01560510229319334
risk O 0 0.01100864913314581
of O 0 0.35868823528289795
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
reached O 0 0.014680743217468262
28 O 0 0.006121466867625713
% O 0 0.003100557718425989
( O 0 0.0029297415167093277
95 O 0 0.004866334609687328
% O 0 0.004135110881179571
CI O 1 0.9857404828071594
9 O 0 0.007109354715794325
% O 0 0.003298558760434389
- O 0 0.005300011020153761
44 O 0 0.0045016310177743435
% O 0 0.002311502117663622
) O 0 0.0014928841264918447
by O 0 0.0010906013194471598
age O 0 0.0026437188498675823
50 O 0 0.002046902198344469
years O 0 0.0015911342343315482
and O 0 0.0014040819369256496
84 O 0 0.00603653397411108
% O 0 0.002372214337810874
( O 0 0.002703413600102067
95 O 0 0.004262557253241539
% O 0 0.0038072820752859116
CI O 1 0.9947794675827026
43 O 0 0.007654000073671341
% O 0 0.00354102929122746
- O 0 0.0052544232457876205
95 O 0 0.004271581303328276
% O 0 0.002208518097177148
) O 0 0.0017290200339630246
by O 0 0.001488238456659019
age O 0 0.004751856904476881
70 O 0 0.007212569937109947
years O 0 0.007829559966921806
. O 0 0.012106667272746563

The O 0 0.03087610937654972
corresponding O 1 0.9991416931152344
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999568462371826
were O 0 0.02167419344186783
0 O 0 0.02407708391547203
. O 0 0.012009885162115097

4 O 0 0.015409491956233978
% O 0 0.006037226412445307
( O 0 0.0051490431651473045
95 O 0 0.0060471040196716785
% O 0 0.004745609126985073
CI O 1 0.9886627793312073
0 O 0 0.006980298552662134
% O 0 0.0031794763635843992
- O 0 0.004815830383449793
1 O 0 0.0036546860355883837
% O 0 0.0018698980566114187
) O 0 0.0012427830370143056
by O 0 0.0009221529471687973
age O 0 0.0024255348835140467
50 O 0 0.0022034193389117718
years O 0 0.0016245919978246093
and O 0 0.00162556825671345
27 O 0 0.004172195214778185
% O 0 0.002336881821975112
( O 0 0.002871133852750063
95 O 0 0.004774488043040037
% O 0 0.0042998287826776505
CI O 1 0.9739091992378235
0 O 0 0.006334519479423761
% O 0 0.003536455798894167
- O 0 0.004772549029439688
47 O 0 0.005005779210478067
% O 0 0.0025549386627972126
) O 0 0.0018797717057168484
by O 0 0.0016107085393741727
age O 0 0.005886557511985302
70 O 0 0.008247790858149529
years O 0 0.008853812702000141
. O 0 0.011511110700666904

The O 0 0.015455969609320164
lifetime O 0 0.09252896159887314
risk O 1 0.6279612183570862
of O 1 0.999643087387085
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.05527259409427643
similar O 0 0.0023267283104360104
to O 0 0.0017641009762883186
the O 0 0.0026964491698890924
risk O 0 0.00646536098793149
in O 0 0.0049423896707594395
BRCA1 O 1 0.9999741315841675
carriers O 0 0.006448530126363039
, O 0 0.001962037989869714
but O 0 0.001080745947547257
there O 0 0.001373249338939786
was O 0 0.002932629082351923
some O 0 0.0009471880039200187
suggestion O 0 0.004161490593105555
of O 0 0.0027006918098777533
a O 0 0.00414179265499115
lower O 0 0.009976041503250599
risk O 0 0.007813611067831516
in O 0 0.006162826903164387
BRCA2 O 1 0.9931132197380066
carriers O 0 0.011764640919864178
< O 0 0.014452129602432251
50 O 0 0.003999404609203339
years O 0 0.0036790717858821154
of O 0 0.005668174009770155
age O 0 0.01841990277171135
. O 0 0.013750944286584854

Eye B-Disease 1 0.9996411800384521
movement I-Disease 0 0.06846653670072556
abnormalities I-Disease 1 0.9880231618881226
correlate O 0 0.014418557286262512
with O 0 0.004798670299351215
genotype O 0 0.042572591453790665
in O 0 0.008365900255739689
autosomal O 1 0.9999947547912598
dominant O 1 0.9999967813491821
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999974966049194
. O 0 0.025811223313212395

We O 0 0.012296597473323345
compared O 0 0.01425428967922926
horizontal O 0 0.024615535512566566
eye O 0 0.466958612203598
movements O 0 0.007460834924131632
( O 0 0.006849467754364014
visually O 0 0.010593714192509651
guided O 0 0.01487750094383955
saccades O 1 0.9542004466056824
, O 0 0.006410502828657627
antisaccades O 0 0.14467789232730865
, O 0 0.0029388279654085636
and O 0 0.002265735762193799
smooth O 0 0.007041378878057003
pursuit O 0 0.008824177086353302
) O 0 0.001934591680765152
in O 0 0.001347816432826221
control O 0 0.0028266203589737415
subjects O 0 0.004453632049262524
( O 0 0.004198514390736818
n O 0 0.006309556309133768
= O 0 0.006983128376305103
14 O 0 0.003428567433729768
) O 0 0.0018468580674380064
and O 0 0.0013841195032000542
patients O 0 0.003808573354035616
with O 0 0.0012341599212959409
three O 0 0.0018386958399787545
forms O 0 0.003455893835052848
of O 0 0.014242141507565975
autosomal O 1 0.9999948740005493
dominant O 1 0.9999469518661499
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.999995231628418
I I-Disease 1 0.9997416138648987
spinocerebellar B-Disease 1 0.9999992847442627
ataxias I-Disease 1 0.9977182149887085
1 I-Disease 0 0.00710078701376915
and I-Disease 0 0.0027109573129564524
2 I-Disease 0 0.005438114050775766
( O 0 0.004129788838326931
SCA1 B-Disease 0 0.25480350852012634
, O 0 0.0035815394949167967
n O 0 0.007027097046375275
= O 0 0.006992789916694164
11 O 0 0.0030879166442900896
; O 0 0.002345152897760272
SCA2 B-Disease 0 0.024666540324687958
, O 0 0.0038443109951913357
n O 0 0.007460558786988258
= O 0 0.006206757854670286
10 O 0 0.0022867030929774046
) O 0 0.002557934494689107
and O 0 0.003607878927141428
SCA3 B-Disease 1 0.9999977350234985
/ O 1 0.9978092312812805
Machado B-Disease 1 0.9995811581611633
- I-Disease 1 0.9793218970298767
Joseph I-Disease 1 0.9999216794967651
disease I-Disease 1 0.9999998807907104
( O 0 0.13777872920036316
MJD B-Disease 1 0.9999979734420776
) O 0 0.00731549970805645
( O 0 0.006391566246747971
n O 0 0.012286894954741001
= O 0 0.015224117785692215
16 O 0 0.008599279448390007
) O 0 0.008781722746789455
. O 0 0.010073835030198097

In O 0 0.017957638949155807
SCA1 B-Disease 1 0.9975029826164246
, O 0 0.011288642883300781
saccade O 0 0.05993671715259552
amplitude O 0 0.016223596408963203
was O 0 0.011020495556294918
significantly O 0 0.005597457755357027
increased O 0 0.0042649139650166035
, O 0 0.004239877685904503
resulting O 0 0.008243762888014317
in O 0 0.009381030686199665
hypermetria B-Disease 1 0.9937268495559692
. O 0 0.018985789269208908

The O 0 0.017768684774637222
smooth O 0 0.030194967985153198
pursuit O 0 0.2701784670352936
gain O 0 0.019300252199172974
was O 1 0.6975486874580383
decreased O 0 0.43337273597717285
. O 0 0.016786843538284302

In O 0 0.019258547574281693
SCA2 B-Disease 1 0.9980599284172058
, O 0 0.012211331166327
saccade O 0 0.12451983988285065
velocity O 0 0.017749903723597527
was O 0 0.05488410219550133
markedly O 0 0.04807936027646065
decreased O 0 0.04832107201218605
. O 0 0.01905420981347561

The O 0 0.010868283919990063
percentage O 0 0.00865404773503542
of O 0 0.0038415947929024696
errors O 0 0.01034213975071907
in O 0 0.006406525149941444
antisaccades O 1 0.9999653100967407
was O 1 0.6151469945907593
greatly O 0 0.006160890217870474
increased O 0 0.0029320521280169487
and O 0 0.0021842080168426037
was O 0 0.00516620185226202
significantly O 0 0.003186750691384077
correlated O 0 0.0042549544014036655
with O 0 0.0019389117369428277
age O 0 0.2665174901485443
at O 1 0.9996979236602783
disease O 1 1.0
onset O 1 1.0
. O 0 0.2847282886505127

In O 0 0.009009753353893757
addition O 0 0.005919755902141333
, O 0 0.0035510628949850798
a O 0 0.0028338441625237465
correlation O 0 0.004633833654224873
between O 0 0.0021381520200520754
smooth O 0 0.005679252091795206
pursuit O 0 0.00778757780790329
gain O 0 0.0025675855576992035
and O 0 0.0011077640810981393
the O 0 0.001617210335098207
number O 0 0.0017341080820187926
of O 0 0.004258592613041401
trinucleotide O 1 0.9998014569282532
repeats O 0 0.039045460522174835
was O 0 0.014622949995100498
found O 0 0.009059779345989227
. O 0 0.012652970850467682

In O 0 0.023515257984399796
SCA3 B-Disease 1 0.9999983310699463
, O 0 0.018458005040884018
gaze B-Disease 1 0.9433631896972656
- I-Disease 1 0.6122893691062927
evoked I-Disease 1 0.7499416470527649
nystagmus I-Disease 1 0.9975558519363403
was O 0 0.01055467501282692
often O 0 0.002397046657279134
present O 0 0.003064558608457446
as O 0 0.0032461551018059254
was O 0 0.02792384847998619
saccade O 1 0.9773873686790466
hypometria O 1 0.7023134827613831
and O 0 0.003455759258940816
smooth O 0 0.011686976999044418
pursuit O 0 0.08131387829780579
gain O 0 0.012189309112727642
was O 0 0.3141937851905823
markedly O 0 0.11587367206811905
decreased O 0 0.04298124089837074
. O 0 0.017544133588671684

Three O 0 0.009801196865737438
major O 0 0.01179467048496008
criteria O 0 0.011535542085766792
, O 0 0.009037968702614307
saccade O 0 0.049681030213832855
amplitude O 0 0.01688217930495739
, O 0 0.006036580540239811
saccade O 0 0.030347099527716637
velocity O 0 0.007093237712979317
, O 0 0.003103977534919977
and O 0 0.002070767804980278
presence O 0 0.004539465997368097
of O 0 0.007226952351629734
gaze B-Disease 1 0.9969101548194885
- I-Disease 1 0.6745055317878723
evoked I-Disease 0 0.21640363335609436
nystagmus I-Disease 1 0.5901339054107666
, O 0 0.0034242363180965185
permitted O 0 0.0032786638475954533
the O 0 0.0034892521798610687
correct O 0 0.006428413558751345
assignment O 0 0.007787853945046663
of O 0 0.003153216326609254
90 O 0 0.003463140456005931
% O 0 0.0018647325923666358
of O 0 0.0019404863705858588
the O 0 0.004038350190967321
SCA1 B-Disease 1 0.9990322589874268
, O 0 0.002719567157328129
90 O 0 0.002818517154082656
% O 0 0.001718731364235282
of O 0 0.002009526127949357
the O 0 0.00404745526611805
SCA2 B-Disease 1 0.9961011409759521
, O 0 0.0027291669975966215
and O 0 0.0017893140902742743
93 O 0 0.006430943962186575
% O 0 0.0018082131864503026
of O 0 0.0017594435485079885
the O 0 0.003945444244891405
patients O 1 0.7056193351745605
with O 0 0.002991404850035906
SCA3 B-Disease 1 0.9999966621398926
to O 0 0.0016018417663872242
their O 0 0.0012080600718036294
genetically O 0 0.0030823745764791965
confirmed O 0 0.0050418796017766
patient O 1 0.5781887173652649
group O 0 0.0019684855360537767
and O 0 0.0014053641352802515
, O 0 0.0018108021467924118
therefore O 0 0.0023963386192917824
, O 0 0.002210007281973958
may O 0 0.002493862761184573
help O 0 0.0039018518291413784
orient O 0 0.016776081174612045
diagnoses O 1 0.5419091582298279
of O 0 0.011433812789618969
SCA1 B-Disease 1 0.999995231628418
, O 0 0.008697292767465115
SCA2 B-Disease 1 0.9983927607536316
, O 0 0.0036088440101593733
and O 0 0.0032454989850521088
SCA3 B-Disease 1 0.9998999834060669
at O 0 0.005436487030237913
early O 0 0.003412579419091344
clinical O 0 0.022967448458075523
stages O 0 0.008857296779751778
of O 0 0.012910431250929832
the O 1 0.9954286813735962
diseases O 1 1.0
. O 0 0.010753863491117954
. O 0 0.010815305635333061

Genetic O 0 0.014159088023006916
basis O 0 0.005311484448611736
and O 0 0.003699226537719369
molecular O 0 0.01155654713511467
mechanism O 0 0.23114557564258575
for O 1 0.686542809009552
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9995009899139404

Ventricular B-Disease 1 0.9999998807907104
fibrillation I-Disease 1 0.9999998807907104
causes O 1 0.9758884310722351
more O 0 0.0024751785676926374
than O 0 0.0019464634824544191
300 O 0 0.004717947915196419
, O 0 0.0033492071088403463
000 O 0 0.009257432073354721
sudden O 0 0.007797525729984045
deaths O 0 0.004243982490152121
each O 0 0.001645968877710402
year O 0 0.0022979893255978823
in O 0 0.002310720272362232
the O 0 0.006501820404082537
USA O 0 0.26844123005867004
alone O 0 0.01181593257933855
. O 0 0.010477229952812195

In O 0 0.008024850860238075
approximately O 0 0.0075690955854952335
5 O 0 0.007341807708144188
- O 0 0.006308548152446747
12 O 0 0.0032980963587760925
% O 0 0.0017689478117972612
of O 0 0.0015795172657817602
these O 0 0.0010004310170188546
cases O 0 0.0021729760337620974
, O 0 0.0015810845652595162
there O 0 0.0013758038403466344
are O 0 0.001169273629784584
no O 0 0.00294326595030725
demonstrable O 1 0.9998672008514404
cardiac O 1 1.0
or O 1 0.9917895793914795
non O 1 0.999995231628418
- O 1 0.9999979734420776
cardiac O 1 0.9999997615814209
causes O 0 0.30968761444091797
to O 0 0.0014098093379288912
account O 0 0.0016296453541144729
for O 0 0.0013462546048685908
the O 0 0.002203462179750204
episode O 0 0.007078309077769518
, O 0 0.0016566362464800477
which O 0 0.0010325915645807981
is O 0 0.0015040753642097116
therefore O 0 0.0028294657822698355
classified O 0 0.00978392269462347
as O 0 0.014996211044490337
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999998807907104
IVF B-Disease 1 1.0
) O 0 0.04172182083129883
. O 0 0.015901703387498856

A O 0 0.013231168501079082
distinct O 0 0.006567778997123241
group O 0 0.006180307362228632
of O 0 0.08384039252996445
IVF B-Disease 1 1.0
patients O 1 0.9999891519546509
has O 0 0.004079466685652733
been O 0 0.002113696886226535
found O 0 0.0014067072188481688
to O 0 0.001079375622794032
present O 0 0.0017723964992910624
with O 0 0.0017208976205438375
a O 0 0.004733499605208635
characteristic O 1 0.5422201752662659
electrocardiographic O 1 0.9999017715454102
pattern O 1 0.7690758109092712
. O 0 0.016034474596381187

Because O 0 0.0068653966300189495
of O 0 0.004029753617942333
the O 0 0.0036598120350390673
small O 0 0.00210201321169734
size O 0 0.0022541151847690344
of O 0 0.0016539704520255327
most O 0 0.0014714242424815893
pedigrees O 0 0.005978181958198547
and O 0 0.0016885021468624473
the O 0 0.0032747734803706408
high O 0 0.041196148842573166
incidence O 1 0.9990573525428772
of O 0 0.05054980143904686
sudden B-Disease 1 0.9999587535858154
death I-Disease 1 0.9964452385902405
, O 0 0.0026138569228351116
however O 0 0.0016632407205179334
, O 0 0.001516386168077588
molecular O 0 0.003070457372814417
genetic O 0 0.002972284099087119
studies O 0 0.0027584589552134275
of O 0 0.006255755666643381
IVF B-Disease 1 0.999998927116394
have O 0 0.0019611807074397802
not O 0 0.001700165681540966
yet O 0 0.003278361400589347
been O 0 0.005003951024264097
done O 0 0.00948804710060358
. O 0 0.010068172588944435

Because O 0 0.13519221544265747
IVF B-Disease 1 0.9999997615814209
causes O 1 0.999998927116394
cardiac O 1 1.0
rhythm O 1 0.9999998807907104
disturbance O 1 0.9999955892562866
, O 0 0.005365278106182814
we O 0 0.0024584466591477394
investigated O 0 0.006317273713648319
whether O 0 0.003817435586825013
malfunction O 1 0.9515194892883301
of O 0 0.005114534869790077
ion O 0 0.09622541069984436
channels O 0 0.0038663633167743683
could O 0 0.002183171221986413
cause O 0 0.005239649210125208
the O 0 0.004370721988379955
disorder O 1 0.9999517202377319
by O 0 0.002442157594487071
studying O 0 0.0057324692606925964
mutations O 0 0.003911002539098263
in O 0 0.0021974400151520967
the O 0 0.006812897976487875
cardiac O 1 0.9999988079071045
sodium O 1 0.7059346437454224
channel O 0 0.019444672390818596
gene O 0 0.01881122961640358
SCN5A O 1 0.8483208417892456
. O 0 0.016540084034204483

We O 0 0.008444501087069511
have O 0 0.0029118668753653765
now O 0 0.0034941965714097023
identified O 0 0.004316064529120922
a O 0 0.0037078093737363815
missense O 0 0.0131632499396801
mutation O 0 0.005481676198542118
, O 0 0.00322979548946023
a O 0 0.006031246390193701
splice O 1 0.9509642720222473
- O 0 0.40516412258148193
donor O 0 0.013634552247822285
mutation O 0 0.005237587261945009
, O 0 0.0024688025005161762
and O 0 0.0021046544425189495
a O 0 0.0039365398697555065
frameshift O 0 0.04615055397152901
mutation O 0 0.004593427758663893
in O 0 0.0022329066414386034
the O 0 0.0032670905347913504
coding O 0 0.008063905872404575
region O 0 0.004333233926445246
of O 0 0.003953217528760433
SCN5A O 1 0.9983578324317932
in O 0 0.0050823199562728405
three O 0 0.006314382888376713
IVF B-Disease 1 0.9999638795852661
families O 0 0.01403936930000782
. O 0 0.013228185474872589

We O 0 0.008268727920949459
show O 0 0.006203152239322662
that O 0 0.002427235944196582
sodium O 0 0.008039706386625767
channels O 0 0.002299452666193247
with O 0 0.0016991703305393457
the O 0 0.004224866162985563
missense O 0 0.023841172456741333
mutation O 0 0.009798643179237843
recover O 0 0.018608413636684418
from O 0 0.004062486346811056
inactivation O 1 0.7392181754112244
more O 0 0.0016663839342072606
rapidly O 0 0.0037836290430277586
than O 0 0.0011627787025645375
normal O 0 0.0022685800213366747
and O 0 0.0011781309731304646
that O 0 0.0012178682954981923
the O 0 0.0030843389686197042
frameshift O 0 0.3467772603034973
mutation O 0 0.0067917779088020325
causes O 0 0.005793729797005653
the O 0 0.004228470381349325
sodium O 0 0.008858212269842625
channel O 0 0.0037652957253158092
to O 0 0.0018869900377467275
be O 0 0.0023831543512642384
non O 0 0.010165199637413025
- O 0 0.020300311967730522
functional O 0 0.02152238041162491
. O 0 0.01694117859005928

Our O 0 0.010228296741843224
results O 0 0.005219343118369579
indicate O 0 0.004165192134678364
that O 0 0.001722977147437632
mutations O 0 0.0046738567762076855
in O 0 0.005283671896904707
cardiac O 1 1.0
ion O 1 0.9998446702957153
- O 0 0.24291077256202698
channel O 0 0.004878910258412361
genes O 0 0.0021943319588899612
contribute O 0 0.0017233463004231453
to O 0 0.0011569671332836151
the O 0 0.0022857068106532097
risk O 0 0.0046892366372048855
of O 0 0.005967434961348772
developing O 1 0.9916003942489624
IVF B-Disease 1 0.9999990463256836
. O 0 0.00908960122615099
. O 0 0.012586553581058979

Molecular O 0 0.027405209839344025
heterogeneity O 0 0.03383712098002434
in O 0 0.011860501021146774
mucopolysaccharidosis B-Disease 1 0.9999641180038452
IVA I-Disease 1 0.9999978542327881
in O 0 0.00455896882340312
Australia O 0 0.004690465517342091
and O 0 0.0016478504985570908
Northern O 0 0.0027770481538027525
Ireland O 0 0.003119292203336954
: O 0 0.0023227757774293423
nine O 0 0.0028361196164041758
novel O 0 0.005891085136681795
mutations O 0 0.0043412563391029835
including O 0 0.0027498386334627867
T312S O 1 0.6326959133148193
, O 0 0.003309231484308839
a O 0 0.004240779206156731
common O 0 0.0061675626784563065
allele O 0 0.011521506123244762
that O 0 0.003664572024717927
confers O 0 0.04553696885704994
a O 0 0.015427537262439728
mild O 1 0.9996371269226074
phenotype O 1 0.7134274840354919
. O 0 0.02141444757580757

Mucopolysaccharidosis B-Disease 1 0.9998869895935059
IVA I-Disease 1 0.9999994039535522
( O 1 0.6066175103187561
MPS B-Disease 1 0.99967360496521
IVA I-Disease 1 1.0
) O 0 0.00679134763777256
is O 0 0.0033217326272279024
an O 0 0.005543928127735853
autosomal B-Disease 1 0.9999949932098389
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999886751174927
by O 0 0.008230351842939854
a O 0 0.17476770281791687
genetic B-Disease 1 0.9954937696456909
defect I-Disease 1 0.9999474287033081
in O 0 0.008261313661932945
N O 0 0.34527748823165894
- O 0 0.018495038151741028
acetylgalactosamine O 1 0.8219954371452332
- O 0 0.027725949883461
6 O 0 0.017016874626278877
- O 0 0.09074927866458893
sulfate O 1 0.9957439303398132
sulfatase O 1 0.9999737739562988
( O 0 0.20094211399555206
GALNS O 1 0.9999573230743408
) O 0 0.017916280776262283
. O 0 0.012756461277604103

Previous O 0 0.010282688774168491
studies O 0 0.00543074868619442
of O 0 0.005513021722435951
patients O 0 0.16962739825248718
from O 0 0.002526425290852785
a O 0 0.0038652028888463974
British O 0 0.019881926476955414
- O 0 0.010938302613794804
Irish O 0 0.004855403210967779
population O 0 0.0019045440712943673
showed O 0 0.002857862738892436
that O 0 0.0011781399371102452
the O 0 0.00349916098639369
I113F O 1 0.5813888907432556
mutation O 0 0.004010667093098164
is O 0 0.0013538721250370145
the O 0 0.001491751754656434
most O 0 0.0011065290309488773
common O 0 0.0020333591382950544
single O 0 0.0028643161058425903
mutation O 0 0.0044386303052306175
among O 0 0.004631823860108852
MPS B-Disease 1 0.9999806880950928
IVA I-Disease 1 1.0
patients O 1 0.9999984502792358
and O 0 0.011640568263828754
produces O 0 0.021424556151032448
a O 0 0.015017285943031311
severe O 1 0.9999998807907104
clinical O 1 1.0
phenotype O 1 0.9996765851974487
. O 0 0.018239825963974

We O 0 0.007429571356624365
studied O 0 0.009700365364551544
mutations O 0 0.005907488986849785
in O 0 0.0030003846623003483
the O 0 0.006016562692821026
GALNS O 1 0.9981303811073303
gene O 0 0.004869653377681971
from O 0 0.0020137096289545298
23 O 0 0.004320230800658464
additional O 0 0.004458840470761061
MPS B-Disease 1 0.9449473023414612
IVA I-Disease 1 1.0
patients O 1 0.9984079003334045
( O 0 0.004313264507800341
15 O 0 0.0021317889913916588
from O 0 0.0012559430906549096
Australia O 0 0.0020013111643493176
, O 0 0.0012167402310296893
8 O 0 0.0019499142654240131
from O 0 0.0010232446948066354
Northern O 0 0.0021355231292545795
Ireland O 0 0.00292058102786541
) O 0 0.0014769749250262976
, O 0 0.0010218896204605699
with O 0 0.0008747276733629405
various O 0 0.002067321678623557
clinical O 1 0.9995146989822388
phenotypes O 1 0.9995232820510864
( O 0 0.30003952980041504
severe O 1 0.9999758005142212
, O 0 0.00538940355181694
16 O 0 0.004979183431714773
cases O 0 0.0029255535919219255
; O 0 0.0024218133185058832
intermediate O 0 0.00726545974612236
, O 0 0.002355828182771802
4 O 0 0.0042302715592086315
cases O 0 0.003025477984920144
; O 0 0.003122202819213271
mild O 0 0.017954334616661072
, O 0 0.005223360378295183
3 O 0 0.00802245270460844
cases O 0 0.007596268784254789
) O 0 0.00947835948318243
. O 0 0.009207195602357388

We O 0 0.005738598294556141
found O 0 0.0037576265167444944
two O 0 0.0018357463413849473
common O 0 0.0030585944186896086
mutations O 0 0.0030254749581217766
that O 0 0.0009457226260565221
together O 0 0.0012887781485915184
accounted O 0 0.003029031213372946
for O 0 0.0013855393044650555
32 O 0 0.0031831508968025446
% O 0 0.0016027946257963777
of O 0 0.0016094973543658853
the O 0 0.0028945780359208584
44 O 0 0.006156827788800001
unrelated O 0 0.008829518221318722
alleles O 0 0.007757070939987898
in O 0 0.004456889349967241
these O 0 0.005166397430002689
patients O 1 0.9507150650024414
. O 0 0.01829732023179531

One O 0 0.00769590912386775
is O 0 0.004844765644520521
the O 0 0.006132395938038826
T312S O 0 0.2204904854297638
mutation O 0 0.006234771106392145
, O 0 0.0022988596465438604
a O 0 0.0031461017206311226
novel O 0 0.007991800084710121
mutation O 0 0.004682124592363834
found O 0 0.002459164708852768
exclusively O 0 0.004784808494150639
in O 0 0.0060824379324913025
milder O 1 0.9897286891937256
patients O 1 0.9994338154792786
. O 0 0.01643730327486992

The O 0 0.00792467501014471
other O 0 0.002368155401200056
is O 0 0.0021828911267220974
the O 0 0.002299428917467594
previously O 0 0.004168242681771517
described O 0 0.00789025891572237
I113F O 0 0.4005914330482483
that O 0 0.0029306039214134216
produces O 0 0.008964316919445992
a O 0 0.013093809597194195
severe O 1 0.9999992847442627
phenotype O 1 0.99909508228302
. O 0 0.020382745191454887

The O 0 0.01910191960632801
I113F O 0 0.062169622629880905
and O 0 0.007706615142524242
T312S O 0 0.03634050115942955
mutations O 0 0.006650323513895273
accounted O 0 0.0054092747159302235
for O 0 0.00272693601436913
8 O 0 0.005006591323763132
( O 0 0.0030711388681083918
18 O 0 0.0024749210570007563
% O 0 0.0019545373506844044
) O 0 0.0016502338694408536
and O 0 0.001287910621613264
6 O 0 0.0039658755995333195
( O 0 0.0024261027574539185
14 O 0 0.0024889919441193342
% O 0 0.0017841571243479848
) O 0 0.001550103072077036
of O 0 0.0022534183226525784
44 O 0 0.006588354706764221
unrelated O 0 0.011901937425136566
alleles O 0 0.013039548881351948
, O 0 0.007570796646177769
respectively O 0 0.019946029409766197
. O 0 0.014939350076019764

The O 0 0.015970440581440926
relatively O 0 0.01454035472124815
high O 0 0.019909828901290894
residual O 1 0.7729100584983826
GALNS O 1 0.9994482398033142
activity O 0 0.006600043270736933
seen O 0 0.004808004479855299
when O 0 0.0023337341845035553
the O 0 0.004153416026383638
T312S O 0 0.054613664746284485
mutant O 0 0.020503997802734375
cDNA O 0 0.019436880946159363
is O 0 0.004860968329012394
overexpressed O 0 0.022018779069185257
in O 0 0.004740383010357618
mutant O 0 0.016002371907234192
cells O 0 0.0035312804393470287
provides O 0 0.002790572354570031
an O 0 0.0015198171604424715
explanation O 0 0.0030531729571521282
for O 0 0.002203043084591627
the O 0 0.005238558631390333
mild O 1 0.9876241683959961
phenotype O 0 0.03807639330625534
in O 0 0.004704457242041826
patients O 1 0.685106098651886
with O 0 0.003064363496378064
this O 0 0.005350833293050528
mutation O 0 0.014546600170433521
. O 0 0.009630321525037289

The O 0 0.010968459770083427
distribution O 0 0.005906553938984871
and O 0 0.003594932844862342
relative O 0 0.0051981243304908276
frequencies O 0 0.0029162766877561808
of O 0 0.0022971914149820805
the O 0 0.003969527315348387
I113F O 0 0.2416127771139145
and O 0 0.004065719433128834
T312S O 1 0.6681420207023621
mutations O 0 0.004800635855644941
in O 0 0.002102087950333953
Australia O 0 0.002805365715175867
corresponded O 0 0.004269436467438936
to O 0 0.0011642072349786758
those O 0 0.0009373003267683089
observed O 0 0.0016891628038138151
in O 0 0.001398488413542509
Northern O 0 0.002873137127608061
Ireland O 0 0.0027244824450463057
and O 0 0.0012393207289278507
are O 0 0.0007035498856566846
unique O 0 0.0013641162076964974
to O 0 0.0008754143491387367
these O 0 0.0007353888358920813
two O 0 0.0011582098668441176
populations O 0 0.002257975284010172
, O 0 0.001974462764337659
suggesting O 0 0.003174933372065425
that O 0 0.0012027284828945994
both O 0 0.0016624919371679425
mutations O 0 0.003204159438610077
were O 0 0.0020717771258205175
probably O 0 0.002631053328514099
introduced O 0 0.0023814269807189703
to O 0 0.0012544915080070496
Australia O 0 0.002399518620222807
by O 0 0.001151645788922906
Irish O 0 0.004457325208932161
migrants O 0 0.004572088364511728
during O 0 0.004470000974833965
the O 0 0.005014146212488413
19th O 0 0.02357746660709381
century O 0 0.02386287972331047
. O 0 0.017261017113924026

Haplotype O 0 0.04316668584942818
analysis O 0 0.008014305494725704
using O 0 0.005662092473357916
6 O 0 0.008795672096312046
RFLPs O 0 0.022686589509248734
provides O 0 0.004122213926166296
additional O 0 0.0021866769529879093
data O 0 0.0014220697339624166
that O 0 0.0010439552133902907
the O 0 0.0030090799555182457
I113F O 0 0.025434717535972595
mutation O 0 0.005850181914865971
originated O 0 0.005087296012789011
from O 0 0.002289076102897525
a O 0 0.004982028156518936
common O 0 0.009881721809506416
ancestor O 0 0.08263391256332397
. O 0 0.01667112112045288

The O 0 0.010605725459754467
other O 0 0.0038581148255616426
9 O 0 0.007543566171079874
novel O 0 0.008812016807496548
mutations O 0 0.004162196535617113
identified O 0 0.002708534710109234
in O 0 0.0014291021507233381
these O 0 0.0010789930820465088
23 O 0 0.004137028008699417
patients O 0 0.006266655866056681
were O 0 0.0012872846564278007
each O 0 0.0007669839542359114
limited O 0 0.0012847265461459756
to O 0 0.0012295205378904939
a O 0 0.0038405952509492636
single O 0 0.006588170304894447
family O 0 0.012121608480811119
. O 0 0.010932432487607002

These O 0 0.006004896480590105
data O 0 0.003855960676446557
provide O 0 0.0032133683562278748
further O 0 0.0023873886093497276
evidence O 0 0.0021076800767332315
for O 0 0.0019433217821642756
extensive O 0 0.007039152085781097
allelic O 0 0.0304449163377285
heterogeneity O 0 0.018271027132868767
in O 0 0.006091972813010216
MPS B-Disease 1 0.9704909324645996
IVA I-Disease 1 0.9999997615814209
in O 0 0.006290634628385305
British O 1 0.6100291013717651
- O 1 0.9750164747238159
Irish O 0 0.3444698750972748
patients O 0 0.3273209035396576
and O 0 0.001605261000804603
provide O 0 0.001916398759931326
evidence O 0 0.0018259533680975437
for O 0 0.0014315982116386294
their O 0 0.0014108488103374839
transmission O 0 0.003572323126718402
to O 0 0.0010050663258880377
Australia O 0 0.0019158809445798397
by O 0 0.0013728680787608027
British O 0 0.00593925267457962
- O 0 0.00979102123528719
Irish O 0 0.008690220303833485
migrants O 0 0.008746578358113766
. O 0 0.005809401627629995
. O 0 0.008822009898722172

Identification O 0 0.015534214675426483
of O 0 0.01098886039108038
constitutional O 0 0.028920883312821388
WT1 O 1 0.9999896287918091
mutations O 0 0.010650139302015305
, O 0 0.004340291954576969
in O 0 0.004079732578247786
patients O 1 0.5450571179389954
with O 0 0.006150536704808474
isolated O 1 0.9997062087059021
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.074574314057827
and O 0 0.0036469120532274246
analysis O 0 0.0038469925057142973
of O 0 0.008394917473196983
genotype O 1 0.7569687366485596
/ O 0 0.08178074657917023
phenotype O 0 0.007810397073626518
correlations O 0 0.00494752824306488
by O 0 0.0013694349909201264
use O 0 0.0015428615733981133
of O 0 0.0032703496981412172
a O 0 0.007219600025564432
computerized O 0 0.03589499741792679
mutation O 0 0.013854531571269035
database O 0 0.014240105636417866
. O 0 0.012932994402945042

Constitutional O 0 0.020377669483423233
mutations O 0 0.009879622608423233
of O 0 0.0060696229338645935
the O 0 0.010772736743092537
WT1 O 1 0.9999527931213379
gene O 0 0.00608431501314044
, O 0 0.0029801144264638424
encoding O 0 0.004800811409950256
a O 0 0.0058220564387738705
zinc O 1 0.9999799728393555
- O 0 0.45039480924606323
finger O 0 0.221791073679924
transcription O 0 0.012494122609496117
factor O 0 0.007227020803838968
involved O 0 0.004640322178602219
in O 0 0.016229107975959778
renal O 1 1.0
and O 1 0.9995502829551697
gonadal O 1 1.0
development O 0 0.4402827024459839
, O 0 0.0024397887755185366
are O 0 0.000822795438580215
found O 0 0.0013072529109194875
in O 0 0.0011492836056277156
most O 0 0.001534273731522262
patients O 0 0.1860097348690033
with O 0 0.00667111761868
Denys B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9992239475250244
DDS B-Disease 1 1.0
) O 0 0.008130243979394436
, O 0 0.005234536714851856
or O 0 0.009963597171008587
diffuse B-Disease 1 0.999987006187439
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999957084655762
DMS B-Disease 1 0.9999998807907104
) O 0 0.00504131056368351
associated O 0 0.0034031993709504604
with O 0 0.002587494207546115
pseudohermaphroditism B-Disease 1 0.9999942779541016
and O 0 0.015952467918395996
/ O 1 0.999969482421875
or O 1 0.6468977928161621
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.9993595480918884
WT B-Disease 1 0.9999996423721313
) O 0 0.014458033256232738
. O 0 0.012033808045089245

Most O 0 0.010650687851011753
mutations O 0 0.014176457189023495
in O 0 0.010615596547722816
DDS B-Disease 1 0.9999998807907104
patients O 1 0.9991372227668762
lie O 0 0.0353308841586113
in O 0 0.005184137262403965
exon O 0 0.02805129811167717
8 O 0 0.005504182074218988
or O 0 0.0029315741267055273
exon O 0 0.016208261251449585
9 O 0 0.006086939014494419
, O 0 0.0038694201502949
encoding O 0 0.009625712409615517
zinc O 1 0.7382137179374695
finger O 0 0.038223035633563995
2 O 0 0.010805015452206135
or O 0 0.005897327326238155
zinc O 1 0.9992671608924866
finger O 0 0.0956498309969902
3 O 0 0.005379358306527138
, O 0 0.00220570364035666
respectively O 0 0.0027234782464802265
, O 0 0.001340796472504735
with O 0 0.0010131881572306156
a O 0 0.0026086843572556973
hot O 0 0.012295273132622242
spot O 0 0.010956755839288235
( O 0 0.005319532472640276
R394W O 0 0.022088654339313507
) O 0 0.0030929630156606436
in O 0 0.003958775196224451
exon O 0 0.029026929289102554
9 O 0 0.01635514199733734
. O 0 0.01196374837309122

We O 0 0.006734455935657024
analyzed O 0 0.006399144418537617
a O 0 0.0036063657607883215
series O 0 0.0038422769866883755
of O 0 0.003496563294902444
24 O 0 0.006589353084564209
patients O 0 0.009187224321067333
, O 0 0.002423917641863227
10 O 0 0.0027302366215735674
with O 0 0.0026722673792392015
isolated B-Disease 0 0.11529052257537842
DMS I-Disease 1 0.9999995231628418
( O 0 0.16493231058120728
IDMS B-Disease 1 0.9999933242797852
) O 0 0.0034982815850526094
, O 0 0.0019255063962191343
10 O 0 0.0025568010751158
with O 0 0.0025858136359602213
DDS B-Disease 1 0.9999990463256836
, O 0 0.0032064022962003946
and O 0 0.002302188193425536
4 O 0 0.005802708212286234
with O 0 0.004900445695966482
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
and O 1 0.9941220879554749
/ O 1 0.9999979734420776
or O 0 0.28224867582321167
WT B-Disease 1 0.9999927282333374
. O 0 0.02165050245821476

We O 0 0.011369938030838966
report O 0 0.01319047063589096
WT1 O 1 0.6822812557220459
heterozygous O 0 0.013452230952680111
mutations O 0 0.005727296229451895
in O 0 0.0026482492685317993
16 O 0 0.005623656325042248
patients O 0 0.026992103084921837
, O 0 0.002742911921814084
4 O 0 0.00360699649900198
of O 0 0.0029204601887613535
whom O 0 0.006356968078762293
presented O 0 0.010763811878859997
with O 0 0.011019186116755009
IDMS B-Disease 1 0.9999974966049194
. O 0 0.024281123653054237

One O 0 0.00951298326253891
male O 0 0.008178981952369213
and O 0 0.003222914645448327
two O 0 0.0039342185482382774
female O 1 0.9222335815429688
IDMS B-Disease 1 1.0
patients O 1 0.999980092048645
with O 0 0.1448291689157486
WT1 O 1 0.9999995231628418
mutations O 1 0.7632875442504883
underwent O 1 0.9999974966049194
normal O 1 0.574375569820404
puberty O 1 0.9965922236442566
. O 0 0.018836531788110733

Two O 0 0.008126768283545971
mutations O 0 0.010659950785338879
associated O 0 0.005646559409797192
with O 0 0.00356171652674675
IDMS B-Disease 1 0.9999549388885498
are O 0 0.0012376874219626188
different O 0 0.0007688229088671505
from O 0 0.0014465400017797947
those O 0 0.001681379391811788
described O 0 0.009338374249637127
in O 0 0.02865132875740528
DDS B-Disease 1 1.0
patients O 1 0.9999712705612183
. O 0 0.01959908939898014

No O 0 0.031416479498147964
WT1 O 1 0.9989016056060791
mutations O 0 0.011730817146599293
were O 0 0.004052332136780024
detected O 0 0.005346185993403196
in O 0 0.0020148770418018103
the O 0 0.002813640283420682
six O 0 0.0029923063702881336
other O 0 0.0033919329289346933
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.9993736147880554
, O 0 0.0044027394615113735
suggesting O 0 0.007965234108269215
genetic O 0 0.007204004563391209
heterogeneity O 0 0.01611383445560932
of O 0 0.011010434478521347
this O 0 0.02308407425880432
disease O 1 0.9999998807907104
. O 0 0.028046930208802223

We O 0 0.010792428627610207
analyzed O 0 0.0210728757083416
genotype O 0 0.1198071539402008
/ O 0 0.06778695434331894
phenotype O 0 0.010622299276292324
correlations O 0 0.006579248234629631
, O 0 0.002033115364611149
on O 0 0.0016830499516800046
the O 0 0.0014836227055639029
basis O 0 0.0013376888819038868
of O 0 0.0017409216379746795
the O 0 0.0023908845614641905
constitution O 0 0.0029738813173025846
of O 0 0.003360648639500141
a O 0 0.00761274341493845
WT1 O 1 0.9880917072296143
mutation O 0 0.005700207315385342
database O 0 0.003958978224545717
of O 0 0.004500917624682188
84 O 0 0.3136749863624573
germ O 1 0.9999948740005493
- O 1 0.5406910181045532
line O 0 0.006841674912720919
mutations O 0 0.0034137521870434284
, O 0 0.0014274216955527663
to O 0 0.0012584374053403735
compare O 0 0.0029782846104353666
the O 0 0.002126146573573351
distribution O 0 0.002143251011148095
and O 0 0.002022144617512822
type O 0 0.005933746229857206
of O 0 0.0038058788049966097
mutations O 0 0.004434684757143259
, O 0 0.0018115401035174727
according O 0 0.001793739735148847
to O 0 0.0018873922526836395
the O 0 0.0036288988776504993
different O 0 0.004140243399888277
symptoms O 1 0.9999616146087646
. O 0 0.024013014510273933

This O 0 0.006872172001749277
demonstrated O 0 0.012122898362576962
( O 0 0.006813640706241131
1 O 0 0.006090047303587198
) O 0 0.0022092482540756464
the O 0 0.0023276915308088064
association O 0 0.004328839480876923
between O 0 0.0026655620895326138
mutations O 0 0.0035111592151224613
in O 0 0.002195099601522088
exons O 0 0.008468030020594597
8 O 0 0.0037664046976715326
and O 0 0.0019385888008400798
9 O 0 0.004809513222426176
and O 0 0.003078775480389595
DMS B-Disease 1 0.999893069267273
; O 0 0.003123087575659156
( O 0 0.0036354009062051773
2 O 0 0.003687152173370123
) O 0 0.002301147673279047
among O 0 0.002473648637533188
patients O 0 0.49451178312301636
with O 0 0.003814454423263669
DMS B-Disease 1 0.9999967813491821
, O 0 0.003308696672320366
a O 0 0.0027798539958894253
higher O 0 0.0026756231673061848
frequency O 0 0.001954263774678111
of O 0 0.002087866887450218
exon O 0 0.011383378878235817
8 O 0 0.0036837568040937185
mutations O 0 0.00262046093121171
among O 0 0.00191703368909657
46 O 0 0.006347842048853636
, O 0 0.005281419027596712
XY O 1 0.9999837875366211
patients O 1 0.8051463961601257
with O 0 0.0029133055359125137
female O 0 0.011016037315130234
phenotype O 0 0.005094483960419893
than O 0 0.0010581535752862692
among O 0 0.0017806265968829393
46 O 0 0.006182304583489895
, O 0 0.00535410875454545
XY O 1 0.9999827146530151
patients O 0 0.12782259285449982
with O 0 0.00205977656878531
sexual O 0 0.006075505632907152
ambiguity O 0 0.013351856730878353
or O 0 0.0044322628527879715
male O 0 0.009228464215993881
phenotype O 0 0.0105817262083292
; O 0 0.0018492215313017368
and O 0 0.0017448406433686614
( O 0 0.0033888795878738165
3 O 0 0.0031459045130759478
) O 0 0.0016671218909323215
statistically O 0 0.002632823074236512
significant O 0 0.0019471360137686133
evidence O 0 0.002526506781578064
that O 0 0.001779739512130618
mutations O 0 0.0038140916731208563
in O 0 0.0027835709042847157
exons O 0 0.010532196611166
8 O 0 0.004842596128582954
and O 0 0.0024388048332184553
9 O 0 0.006735887844115496
preferentially O 0 0.007264448329806328
affect O 0 0.003336848458275199
amino O 0 0.0035288874059915543
acids O 0 0.002154348650947213
with O 0 0.001180395483970642
different O 0 0.0014871348394080997
functions O 0 0.005014603026211262
. O 0 0.005361243616789579
. O 0 0.010733764618635178

The O 0 0.033170562237501144
185delAG O 1 0.998367965221405
BRCA1 O 1 0.9984877109527588
mutation O 0 0.014654163271188736
originated O 0 0.008626184426248074
before O 0 0.0029664593748748302
the O 0 0.002616634126752615
dispersion O 0 0.005467832554131746
of O 0 0.002389872446656227
Jews O 0 0.004309827461838722
in O 0 0.002290115226060152
the O 0 0.0032383985817432404
diaspora O 0 0.004357306752353907
and O 0 0.0018657438922673464
is O 0 0.0023083186242729425
not O 0 0.0013912965077906847
limited O 0 0.0033402324188500643
to O 0 0.004833811894059181
Ashkenazim O 0 0.0602618008852005
. O 0 0.01883968710899353

The O 0 0.01923586055636406
185delAG O 1 0.6576347947120667
mutation O 0 0.01416834257543087
in O 0 0.0058850450441241264
BRCA1 O 1 0.9955209493637085
is O 0 0.003598405048251152
detected O 0 0.005326164420694113
in O 0 0.002709341235458851
Ashkenazi O 0 0.011473063379526138
Jews O 0 0.0038485643453896046
both O 0 0.0020388395059853792
in O 0 0.005736025050282478
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8985896706581116
in O 0 0.006908243056386709
the O 0 0.006424476392567158
general O 0 0.02040894702076912
population O 0 0.007511626463383436
. O 0 0.008896177634596825

All O 0 0.012243269942700863
tested O 0 0.03295484930276871
Ashkenazi O 1 0.7525510787963867
mutation O 0 0.012632417492568493
carriers O 0 0.005811214447021484
share O 0 0.002871723612770438
the O 0 0.003617166308686137
same O 0 0.003971913363784552
allelic O 0 0.01956275664269924
pattern O 0 0.01092410460114479
at O 0 0.012266207486391068
the O 0 0.018411889672279358
BRCA1 O 1 0.9998682737350464
locus O 1 0.6334500312805176
. O 0 0.020998375490307808

Our O 0 0.008936903439462185
previous O 0 0.005893699359148741
study O 0 0.004127315245568752
showed O 0 0.004719412885606289
that O 0 0.001486711553297937
this O 0 0.001851976616308093
Ashkenazi O 1 0.5783848166465759
mutation O 0 0.0058806054294109344
also O 0 0.0024187187664210796
occurs O 0 0.0020582303404808044
in O 0 0.0018523151520639658
Iraqi O 0 0.00425739586353302
Jews O 0 0.0034251671750098467
with O 0 0.001669905032031238
a O 0 0.004263252019882202
similar O 0 0.007212348282337189
allelic O 0 0.10414884239435196
pattern O 0 0.05016620457172394
. O 0 0.021733682602643967

We O 0 0.007738924119621515
extended O 0 0.006449489388614893
our O 0 0.00274100573733449
analysis O 0 0.0018449514172971249
to O 0 0.0013760147849097848
other O 0 0.0016337872948497534
non O 0 0.005714701022952795
- O 0 0.009146110154688358
Ashkenazi O 0 0.013646457344293594
subsets O 0 0.008652246557176113
354 O 0 0.010794715955853462
of O 0 0.0030986524652689695
Moroccan O 0 0.010119662620127201
origin O 0 0.0033738405909389257
, O 0 0.0032290418166667223
200 O 0 0.006120591424405575
Yemenites O 0 0.02641376294195652
and O 0 0.00364542193710804
150 O 0 0.008430019952356815
Iranian O 0 0.011892166920006275
Jews O 0 0.018276631832122803
. O 0 0.013959751464426517

Heteroduplex O 0 0.08402200043201447
analysis O 0 0.00997230876237154
complemented O 0 0.014198824763298035
by O 0 0.00330365146510303
direct O 0 0.00444244546815753
DNA O 0 0.0070363362319767475
sequencing O 0 0.008091552183032036
of O 0 0.005269145593047142
abnormally O 0 0.10615275800228119
migrating O 0 0.0101992292329669
bands O 0 0.0070176804438233376
were O 0 0.005177923943847418
employed O 0 0.018700972199440002
. O 0 0.013300532475113869

Four O 0 0.006537634879350662
of O 0 0.005421592388302088
Moroccan O 0 0.013165566138923168
origin O 0 0.0043381331488490105
( O 0 0.0038704865146428347
1 O 0 0.0037984519731253386
. O 0 0.001616345252841711
1 O 0 0.003066470380872488
% O 0 0.001872637658379972
) O 0 0.0014157075202092528
and O 0 0.0009927669307217002
none O 0 0.0017496736254543066
of O 0 0.0021578408777713776
the O 0 0.004556567873805761
Yemenites O 1 0.9831872582435608
or O 0 0.003153464989736676
Iranians O 0 0.00461247842758894
was O 0 0.004263371229171753
a O 0 0.0029524376150220633
carrier O 0 0.007247891742736101
of O 0 0.004225580021739006
the O 0 0.01150704175233841
185delAG O 1 0.9971469044685364
mutation O 0 0.022381214424967766
. O 0 0.014829155057668686

BRCA1 O 1 0.9984368681907654
allelic O 0 0.048146482557058334
patterns O 0 0.008030775934457779
were O 0 0.002934884512796998
determined O 0 0.0028673589695245028
for O 0 0.0012382941786199808
four O 0 0.0010589684825390577
of O 0 0.0013550131116062403
these O 0 0.0007587831933051348
individuals O 0 0.0007896323222666979
and O 0 0.0010054291924461722
for O 0 0.0015162014169618487
12 O 0 0.0027454958762973547
additional O 0 0.0023670336231589317
non O 0 0.006385911721736193
- O 0 0.01343611627817154
Ashkenazi O 0 0.041224610060453415
185delAG O 0 0.047003231942653656
mutation O 0 0.0076898373663425446
carriers O 0 0.006493740249425173
who O 0 0.008473672904074192
had O 1 0.9956888556480408
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9850022196769714

Six O 0 0.01674742065370083
non O 0 0.031044892966747284
- O 0 0.05033578351140022
Ashkenazi O 0 0.03297106921672821
individuals O 0 0.0025495877489447594
shared O 0 0.00430999556556344
the O 0 0.004724004305899143
common O 0 0.009655345231294632
Ashkenazi O 1 0.9914831519126892
haplotype O 0 0.01850995235145092
, O 0 0.0029543484561145306
four O 0 0.0018135003047063947
had O 0 0.0022103944793343544
a O 0 0.0021494084503501654
closely O 0 0.0024821574334055185
related O 0 0.003017953597009182
pattern O 0 0.005925409961491823
, O 0 0.0022871820256114006
and O 0 0.0017922563711181283
the O 0 0.0031447382643818855
rest O 0 0.0060747116804122925
( O 0 0.004349397029727697
n O 0 0.008038376457989216
= O 0 0.008118055760860443
6 O 0 0.0044741323217749596
) O 0 0.0023215871769934893
displayed O 0 0.00470620347186923
a O 0 0.004868768621236086
distinct O 0 0.011921423487365246
BRCA1 O 1 0.9997895359992981
allelic O 1 0.9716773629188538
pattern O 0 0.3562479019165039
. O 0 0.022418593987822533

We O 0 0.007919642142951488
conclude O 0 0.008665844798088074
that O 0 0.002813121071085334
the O 0 0.007900913245975971
185delAG O 1 0.999452531337738
BRCA1 O 1 0.9998329877853394
mutation O 0 0.0065248203463852406
occurs O 0 0.0025031177792698145
in O 0 0.0018262818921357393
some O 0 0.0016900283517315984
non O 0 0.007509529124945402
- O 0 0.02565494179725647
Ashkenazi O 0 0.021233705803751945
populations O 0 0.0033999779261648655
at O 0 0.003519825404509902
rates O 0 0.0035985298454761505
comparable O 0 0.004109298810362816
with O 0 0.001953983213752508
that O 0 0.0029326474759727716
of O 0 0.010287203826010227
Ashkenazim O 1 0.912619411945343
. O 0 0.020783348008990288

The O 0 0.009850204922258854
majority O 0 0.004793972708284855
of O 0 0.005696562584489584
Jewish O 0 0.016425760462880135
185delAG O 1 0.9973516464233398
mutation O 0 0.009769879281520844
carriers O 0 0.00514574907720089
have O 0 0.0016170471208170056
a O 0 0.0033958200365304947
common O 0 0.004606960341334343
allelic O 0 0.12253159284591675
pattern O 0 0.013675391674041748
, O 0 0.003862536046653986
supporting O 0 0.005539492703974247
the O 0 0.004439953714609146
founder O 1 0.8901186585426331
effect O 0 0.003921284805983305
notion O 0 0.004767021629959345
, O 0 0.002047147834673524
but O 0 0.001535814255475998
dating O 0 0.004724051803350449
the O 0 0.002780067967250943
mutations O 0 0.003040406620129943
origin O 0 0.0017336343880742788
to O 0 0.0011897013755515218
an O 0 0.0015920813893899322
earlier O 0 0.0028535749297589064
date O 0 0.003650809172540903
than O 0 0.0019488550024107099
currently O 0 0.005659919232130051
estimated O 0 0.010306593030691147
. O 0 0.011490554548799992

However O 0 0.008251410908997059
, O 0 0.003343647113069892
the O 0 0.002853650599718094
different O 0 0.001644084812141955
allelic O 0 0.011665362864732742
pattern O 0 0.008450889028608799
at O 0 0.007353904657065868
the O 0 0.011758389882743359
BRCA1 O 1 0.9998237490653992
locus O 0 0.01373092457652092
even O 0 0.0021523304749280214
in O 0 0.0016675869701430202
some O 0 0.0015603097854182124
Jewish O 0 0.006087634712457657
mutation O 0 0.007148587144911289
carriers O 0 0.00567641481757164
, O 0 0.0023979065008461475
might O 0 0.0023124581202864647
suggest O 0 0.002882146742194891
that O 0 0.001316238660365343
the O 0 0.0030910405330359936
mutation O 0 0.00500542251393199
arose O 0 0.006613340228796005
independently O 0 0.005732800345867872
. O 0 0.0048295194283127785
. O 0 0.009608210064470768

Crystal O 0 0.042703624814748764
structure O 0 0.015382274985313416
of O 0 0.013068361207842827
the O 1 0.9586582779884338
hemochromatosis B-Disease 1 1.0
protein O 1 0.9957873225212097
HFE O 1 0.9999680519104004
and O 0 0.004829428158700466
characterization O 0 0.011375944130122662
of O 0 0.005028578452765942
its O 0 0.0035015596076846123
interaction O 0 0.007084812503308058
with O 0 0.0073548792861402035
transferrin O 1 0.9925796389579773
receptor O 0 0.03401932865381241
. O 0 0.01462414488196373

HFE O 1 0.9990924596786499
is O 0 0.011076713912189007
an O 0 0.009144222363829613
MHC O 1 0.9999417066574097
- O 0 0.18891474604606628
related O 0 0.006186255253851414
protein O 0 0.0037949909456074238
that O 0 0.001039551803842187
is O 0 0.0017763609066605568
mutated O 0 0.004525872878730297
in O 0 0.0027039814740419388
the O 0 0.03354359418153763
iron B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999141693115234

HFE O 1 0.999693751335144
binds O 0 0.03771501034498215
to O 0 0.012121950276196003
transferrin O 1 0.9500320553779602
receptor O 0 0.03204820677638054
( O 0 0.014953103847801685
TfR O 1 0.9979081153869629
) O 0 0.004789481870830059
and O 0 0.0026596614625304937
reduces O 0 0.005853977054357529
its O 0 0.002131920773535967
affinity O 0 0.0057052248157560825
for O 0 0.0045014177449047565
iron O 1 0.9999877214431763
- O 1 0.8187925219535828
loaded O 0 0.021392712369561195
transferrin O 1 0.6741117835044861
, O 0 0.009532160125672817
implicating O 1 0.9990612864494324
HFE O 1 0.9999983310699463
in O 0 0.09166283905506134
iron O 1 0.9999990463256836
metabolism O 1 0.99480801820755
. O 0 0.023520784452557564

The O 0 0.0318303257226944
2 O 0 0.03400680422782898
. O 0 0.024349883198738098

6 O 0 0.02406715601682663
A O 0 0.014577070251107216
crystal O 0 0.02334367297589779
structure O 0 0.011931784451007843
of O 0 0.012696643359959126
HFE O 1 0.9999910593032837
reveals O 0 0.027139263227581978
the O 0 0.004115917254239321
locations O 0 0.00499332882463932
of O 0 0.013412459753453732
hemochromatosis B-Disease 1 1.0
mutations O 0 0.024762799963355064
and O 0 0.0036025724839419127
a O 0 0.00930444709956646
patch O 1 0.9999768733978271
of O 0 0.03364454582333565
histidines O 1 0.9996875524520874
that O 0 0.0015506439376622438
could O 0 0.0011129623744636774
be O 0 0.0008877262589521706
involved O 0 0.0023366662207990885
in O 0 0.004271159879863262
pH O 1 0.9717870950698853
- O 0 0.049941327422857285
dependent O 0 0.010847082361578941
interactions O 0 0.01213480532169342
. O 0 0.014395372942090034

We O 0 0.008177082985639572
also O 0 0.004952211398631334
demonstrate O 0 0.00820967834442854
that O 0 0.004446633625775576
soluble O 1 0.6281171441078186
TfR O 1 0.9998639822006226
and O 0 0.008468138054013252
HFE O 1 0.9999613761901855
bind O 0 0.010703235864639282
tightly O 0 0.00647567305713892
at O 0 0.0035905407276004553
the O 0 0.003049140563234687
basic O 0 0.006831576116383076
pH O 0 0.009541217237710953
of O 0 0.0026322458870708942
the O 0 0.00373628456145525
cell O 0 0.0064948443323373795
surface O 0 0.00313450931571424
, O 0 0.0015675349859520793
but O 0 0.0009938423754647374
not O 0 0.0008631593664176762
at O 0 0.0031341088470071554
the O 0 0.004427846055477858
acidic O 0 0.02395801804959774
pH O 0 0.0324159674346447
of O 0 0.013506379909813404
intracellular O 1 0.9109682440757751
vesicles O 1 0.7964657545089722
. O 0 0.02002694644033909

TfR O 1 0.9995157718658447
HFE O 1 0.9993104934692383
stoichiometry O 0 0.058296531438827515
( O 0 0.012449894100427628
2 O 0 0.00819054339081049
1 O 0 0.006659552454948425
) O 0 0.003652009414508939
differs O 0 0.005207707639783621
from O 0 0.005389480385929346
TfR O 1 0.9906501173973083
transferrin O 1 0.5457817912101746
stoichiometry O 0 0.026573525741696358
( O 0 0.007212232332676649
2 O 0 0.006984411738812923
2 O 0 0.005364755634218454
) O 0 0.0023229194339364767
, O 0 0.0019172381144016981
implying O 0 0.004985589534044266
a O 0 0.0019676333758980036
different O 0 0.0010825120843946934
mode O 0 0.003718817373737693
of O 0 0.00233875447884202
binding O 0 0.0038253406528383493
for O 0 0.004681529477238655
HFE O 1 0.9999011754989624
and O 0 0.007811365183442831
transferrin O 1 0.8707314133644104
to O 0 0.005458480212837458
TfR O 1 0.999828577041626
, O 0 0.004165689926594496
consistent O 0 0.0041803321801126
with O 0 0.0016301155555993319
our O 0 0.0026005692780017853
demonstration O 0 0.007489553652703762
that O 0 0.0036664283834397793
HFE O 1 0.9999651908874512
, O 0 0.00619158148765564
transferrin O 1 0.9361047744750977
, O 0 0.004789631348103285
and O 0 0.004489437211304903
TfR O 1 0.9973862767219543
form O 0 0.005513419397175312
a O 0 0.0077780624851584435
ternary O 0 0.058624908328056335
complex O 0 0.029341448098421097
. O 0 0.01611975207924843

Identification O 0 0.010684388689696789
of O 0 0.0050339605659246445
three O 0 0.003770325565710664
novel O 0 0.012469754554331303
mutations O 0 0.005122669506818056
and O 0 0.0017780816415324807
a O 0 0.0033462352585047483
high O 0 0.005150636192411184
frequency O 0 0.0024256869219243526
of O 0 0.001775045762769878
the O 0 0.0034630894660949707
Arg778Leu O 1 0.5535707473754883
mutation O 0 0.004863483365625143
in O 0 0.003187350695952773
Korean O 1 0.9308775067329407
patients O 1 0.9885753989219666
with O 0 0.009304164908826351
Wilson B-Disease 1 0.9999973773956299
disease I-Disease 1 1.0
. O 0 0.01925148442387581

Four O 0 0.01406967081129551
mutations O 0 0.021572597324848175
- O 0 0.055820271372795105
- O 0 0.02016713283956051
R778L O 0 0.02896127849817276
, O 0 0.004988223314285278
A874V O 0 0.019598696380853653
, O 0 0.0042186761274933815
L1083F O 0 0.019601881504058838
, O 0 0.0030931190121918917
and O 0 0.0034754250664263964
2304delC O 1 0.9965624213218689
- O 0 0.0518142431974411
- O 0 0.005906133446842432
in O 0 0.0021394649520516396
the O 0 0.0036968549247831106
copper O 1 0.8845764398574829
- O 0 0.011286988854408264
transporting O 0 0.012383283115923405
enzyme O 0 0.00728693138808012
, O 0 0.004830785095691681
P O 0 0.21513736248016357
- O 0 0.014867539517581463
type O 0 0.015578154474496841
ATPase O 0 0.4465540051460266
( O 0 0.006985337473452091
ATP7B O 1 0.9557512998580933
) O 0 0.002032136544585228
, O 0 0.0011364358942955732
were O 0 0.0010728213237598538
identified O 0 0.002339303260669112
in O 0 0.002381592523306608
Korean O 1 0.992378830909729
Patients O 1 0.999554455280304
with O 0 0.02039811760187149
Wilson B-Disease 1 0.9999986886978149
disease I-Disease 1 1.0
. O 0 0.025945566594600677

Arg778Leu O 1 0.9489770531654358
, O 0 0.006852984428405762
the O 0 0.003977637272328138
most O 0 0.0022902698256075382
frequently O 0 0.0036050945054739714
reported O 0 0.004411627538502216
mutation O 0 0.0032158056274056435
of O 0 0.002667499938979745
this O 0 0.0022646000143140554
enzyme O 0 0.005010840483009815
, O 0 0.002228669822216034
was O 0 0.0035317856818437576
found O 0 0.0014680702006444335
in O 0 0.00105924136005342
six O 0 0.0011962468270212412
of O 0 0.001650287420488894
eight O 0 0.0030949015635997057
unrelated O 0 0.14379289746284485
patients O 1 0.7373719215393066
studied O 0 0.00783456303179264
, O 0 0.002610281575471163
an O 0 0.0026367201935499907
allele O 0 0.006891713012009859
frequency O 0 0.0031173236202448606
of O 0 0.004855260252952576
37 O 0 0.01696818694472313
. O 0 0.012395056895911694

5 O 0 0.017098920419812202
% O 0 0.006558654364198446
, O 0 0.0034306307788938284
which O 0 0.0018256509210914373
is O 0 0.0022524879314005375
considerably O 0 0.0032143553253263235
higher O 0 0.0020809576380997896
than O 0 0.0010244629811495543
those O 0 0.001013867906294763
in O 0 0.001705035800114274
other O 0 0.002545644761994481
Asian O 0 0.016373740509152412
populations O 0 0.010744606144726276
. O 0 0.012603318318724632

The O 0 0.011596455238759518
novel O 0 0.012829244136810303
single O 0 0.007026508450508118
nucleotide O 0 0.009065859951078892
deletion O 0 0.010717533528804779
, O 0 0.004840932786464691
2304delC O 1 0.5567320585250854
, O 0 0.003488884074613452
was O 0 0.0055266330018639565
found O 0 0.0028368670027703047
in O 0 0.0037031443789601326
one O 0 0.005641886964440346
patient O 1 0.9930179119110107
. O 0 0.014727783389389515

Since O 0 0.010107375681400299
a O 0 0.006170360837131739
mutation O 0 0.008531578816473484
at O 0 0.008858476765453815
cDNA O 0 0.025960460305213928
nucleotide O 0 0.01876719854772091
2302 O 1 0.6471841335296631
( O 0 0.009349939413368702
2302insC O 0 0.16598868370056152
) O 0 0.00370023213326931
had O 0 0.002619618782773614
been O 0 0.0019351044902577996
previously O 0 0.003194984747096896
described O 0 0.00394451105967164
, O 0 0.0017301329644396901
this O 0 0.0011337088653817773
region O 0 0.0024380055256187916
of O 0 0.0027760311495512724
the O 0 0.008686079643666744
ATP7B O 1 0.9999991655349731
gene O 0 0.007054940797388554
may O 0 0.002273246180266142
be O 0 0.0016547366976737976
susceptible O 0 0.007459951099008322
to O 0 0.003104331437498331
gene O 0 0.010693318210542202
rearrangements O 1 0.9665626883506775
causing O 1 0.9999634027481079
Wilson B-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
. O 0 0.06969620287418365

Disruption O 0 0.03399497643113136
of O 0 0.01020848099142313
splicing O 0 0.014508828520774841
regulated O 0 0.006029525771737099
by O 0 0.0027670932468026876
a O 0 0.007573620416224003
CUG O 1 0.9999550580978394
- O 0 0.02613917738199234
binding O 0 0.007654264569282532
protein O 0 0.012459617108106613
in O 0 0.015344621613621712
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.523835301399231

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.016506480053067207
is O 0 0.0040779635310173035
caused O 0 0.006208122242242098
by O 0 0.0024558354634791613
a O 0 0.005270912777632475
CTG O 1 0.9749769568443298
expansion O 0 0.0059118978679180145
in O 0 0.0025177618954330683
the O 0 0.00318081839941442
3 O 0 0.005177565384656191
untranslated O 0 0.0140750827267766
region O 0 0.004852727055549622
of O 0 0.006462023127824068
the O 0 0.4821246564388275
DM B-Disease 1 1.0
gene O 0 0.04029638692736626
. O 0 0.013181250542402267

One O 0 0.011241528205573559
model O 0 0.014236558228731155
of O 0 0.04428163915872574
DM B-Disease 1 1.0
pathogenesis O 1 0.999997615814209
suggests O 0 0.010483688674867153
that O 0 0.002364145824685693
RNAs O 0 0.00828274991363287
from O 0 0.0021441816352307796
the O 0 0.00222017546184361
expanded O 0 0.0040758210234344006
allele O 0 0.004304421134293079
create O 0 0.002102616475895047
a O 0 0.0028313070069998503
gain O 0 0.005399898625910282
- O 0 0.007697249297052622
of O 0 0.003984432201832533
- O 0 0.009222266264259815
function O 0 0.0031112113501876593
mutation O 0 0.002750279614701867
by O 0 0.0010307206539437175
the O 0 0.0021232946310192347
inappropriate O 0 0.004526932258158922
binding O 0 0.001856761984527111
of O 0 0.00233272323384881
proteins O 0 0.002638148609548807
to O 0 0.0027980515733361244
the O 0 0.008391937240958214
CUG O 1 0.9997450709342957
repeats O 0 0.04666721820831299
. O 0 0.015296483412384987

Data O 0 0.011118721216917038
presented O 0 0.01018038671463728
here O 0 0.005180093925446272
indicate O 0 0.004066594876348972
that O 0 0.0014195835683494806
the O 0 0.0028769029304385185
conserved O 0 0.0072822971269488335
heterogeneous O 0 0.011482108384370804
nuclear O 0 0.010811705142259598
ribonucleoprotein O 1 0.8206310272216797
, O 0 0.007179451175034046
CUG O 1 0.985532820224762
- O 0 0.009070534259080887
binding O 0 0.0038661393336951733
protein O 0 0.005528532899916172
( O 0 0.005670512560755014
CUG O 1 0.9979332685470581
- O 0 0.02906881831586361
BP O 0 0.01750197820365429
) O 0 0.002437097718939185
, O 0 0.0015352658228948712
may O 0 0.0022335464600473642
mediate O 0 0.006549836602061987
the O 0 0.005560015793889761
trans O 1 0.788320004940033
- O 0 0.012555629014968872
dominant O 0 0.006743112113326788
effect O 0 0.0034154870081692934
of O 0 0.003984635230153799
the O 0 0.009512911550700665
RNA O 0 0.02948690764605999
. O 0 0.0122847780585289

CUG O 1 0.9999796152114868
- O 1 0.8746963143348694
BP O 0 0.06505715101957321
was O 0 0.007129660341888666
found O 0 0.0024633468128740788
to O 0 0.0016597844660282135
bind O 0 0.00296605471521616
to O 0 0.0016237429808825254
the O 0 0.004516043700277805
human O 0 0.21815602481365204
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999943971633911
( O 0 0.010852695442736149
cTNT O 0 0.10656119138002396
) O 0 0.005456927232444286
pre O 0 0.017489463090896606
- O 0 0.017380613833665848
messenger O 0 0.01584884151816368
RNA O 0 0.0077733551152050495
and O 0 0.002541164169088006
regulate O 0 0.005463410634547472
its O 0 0.004115046001970768
alternative O 0 0.010446722619235516
splicing O 0 0.029363246634602547
. O 0 0.015548144467175007

Splicing O 0 0.028609314933419228
of O 0 0.011989284306764603
cTNT O 1 0.9884739518165588
was O 0 0.2156357318162918
disrupted O 1 0.7655016183853149
in O 1 0.7523804306983948
DM B-Disease 1 1.0
striated O 1 0.9999998807907104
muscle O 1 0.999945878982544
and O 0 0.0039729345589876175
in O 0 0.004753196612000465
normal O 0 0.007484819740056992
cells O 0 0.005307336803525686
expressing O 0 0.0061131552793085575
transcripts O 0 0.008259656839072704
that O 0 0.003376657608896494
contain O 0 0.010705557651817799
CUG O 1 0.9950026869773865
repeats O 0 0.04009366035461426
. O 0 0.01494110468775034

Altered O 0 0.021668819710612297
expression O 0 0.008723994717001915
of O 0 0.006183669902384281
genes O 0 0.006454330403357744
regulated O 0 0.007256667595356703
posttranscriptionally O 0 0.028803091496229172
by O 0 0.004698458593338728
CUG O 1 0.9999898672103882
- O 1 0.7473369836807251
BP O 0 0.020697832107543945
therefore O 0 0.0037114431615918875
may O 0 0.0036401264369487762
contribute O 0 0.006502621341496706
to O 0 0.010016596876084805
DM B-Disease 1 1.0
pathogenesis O 1 0.9999990463256836
. O 0 0.014831041917204857
. O 0 0.016078755259513855

Identification O 0 0.013424023054540157
of O 0 0.0066375331953167915
a O 0 0.007655630353838205
novel O 0 0.022468790411949158
nonsense O 0 0.10995485633611679
mutation O 0 0.007933586835861206
and O 0 0.0024003477301448584
a O 0 0.004410659894347191
missense O 0 0.011790941469371319
substitution O 0 0.007147923577576876
in O 0 0.0034950366243720055
the O 0 0.008181321434676647
vasopressin O 1 0.9924522042274475
- O 1 0.5260035395622253
neurophysin O 1 0.9953083395957947
II O 1 0.9998396635055542
gene O 0 0.004552939441055059
in O 0 0.0020216191187500954
two O 0 0.0018305558478459716
Spanish O 0 0.007423736620694399
kindreds O 0 0.05899755656719208
with O 0 0.010911823250353336
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 1 0.8405649065971375

Familial B-Disease 1 0.9999994039535522
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999759197235107
FNDI B-Disease 1 1.0
) O 0 0.006785520818084478
is O 0 0.0027539923321455717
an O 0 0.0038687936030328274
autosomal B-Disease 1 0.9999982118606567
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9998307228088379
deficiency O 1 1.0
in O 1 0.9501734375953674
the O 1 0.9702913165092468
antidiuretic O 1 0.9999990463256836
hormone O 1 0.9993188381195068
arginine O 1 0.552091121673584
vasopressin O 1 0.8204480409622192
( O 0 0.009673980064690113
AVP O 1 0.9593676328659058
) O 0 0.003173910779878497
encoded O 0 0.0023186795879155397
by O 0 0.0018207939574494958
the O 0 0.00671861506998539
AVP O 1 0.9999847412109375
- O 1 0.7202370166778564
neurophysin O 1 0.9995763897895813
II O 1 0.9999990463256836
( O 0 0.06325642764568329
AVP O 1 0.9999895095825195
- O 0 0.15042448043823242
NPII O 1 0.9962640404701233
) O 0 0.007980162277817726
gene O 0 0.008396084420382977
on O 0 0.007416474167257547
chromosome O 0 0.02690774016082287
20p13 O 0 0.09600052982568741
. O 0 0.019461242482066154

In O 0 0.008642387576401234
this O 0 0.0033925678580999374
study O 0 0.00407063402235508
, O 0 0.002441518707200885
we O 0 0.0015099560841917992
analyzed O 0 0.0026701067108660936
two O 0 0.001157024409621954
families O 0 0.0020166842732578516
with O 0 0.002302835462614894
FNDI B-Disease 1 0.9945772886276245
using O 0 0.002960055135190487
direct O 0 0.0032646781764924526
automated O 0 0.009595049545168877
fluorescent O 0 0.011361289769411087
, O 0 0.0029481127858161926
solid O 0 0.005619545932859182
phase O 0 0.007236510049551725
, O 0 0.0033371797762811184
single O 0 0.00470727076753974
- O 0 0.008309803903102875
stranded O 0 0.0089098596945405
DNA O 0 0.005935428664088249
sequencing O 0 0.006485381163656712
of O 0 0.005796758458018303
PCR O 0 0.03380318358540535
- O 0 0.028151510283350945
amplified O 0 0.030508408322930336
AVP O 1 0.9998873472213745
- O 0 0.4124487042427063
NPII O 1 0.9981468915939331
DNA O 0 0.024256423115730286
. O 0 0.015819594264030457

In O 0 0.006717870943248272
one O 0 0.003313036635518074
of O 0 0.003021970624104142
the O 0 0.004182484000921249
families O 0 0.003338245674967766
, O 0 0.002625011606141925
affected O 0 0.0028713643550872803
individuals O 0 0.001332689542323351
presented O 0 0.0036748789716511965
a O 0 0.0032816757448017597
novel O 0 0.00910414569079876
nonsense O 0 0.01663130149245262
mutation O 0 0.004415755160152912
in O 0 0.0028151359874755144
exon O 0 0.011162597686052322
3 O 0 0.003222955856472254
of O 0 0.002272407291457057
the O 0 0.003211267525330186
gene O 0 0.0032630013301968575
, O 0 0.0016051417915150523
consisting O 0 0.0026033089961856604
in O 0 0.002515561645850539
a O 0 0.004783380310982466
G O 0 0.01960267499089241
to O 0 0.003484774846583605
T O 0 0.02016844041645527
transition O 0 0.007480966858565807
at O 0 0.006864223163574934
nucleotide O 0 0.011413877829909325
2101 O 0 0.16843552887439728
, O 0 0.0026791642885655165
which O 0 0.001425733556970954
produces O 0 0.0027227920945733786
a O 0 0.002571528311818838
stop O 0 0.003764351597055793
signal O 0 0.003998373169451952
in O 0 0.002483905293047428
codon O 0 0.009994076564908028
82 O 0 0.0123729994520545
( O 0 0.01034894585609436
Glu O 1 0.9984951019287109
) O 0 0.006681359838694334
of O 0 0.010172403417527676
NPII O 1 0.9994049072265625
. O 0 0.021578624844551086

The O 0 0.027633914723992348
premature O 1 0.7449331879615784
termination O 0 0.16728048026561737
eliminates O 0 0.01632208190858364
part O 0 0.0037111665587872267
of O 0 0.003806887660175562
the O 0 0.007676429580897093
C O 1 0.9902374148368835
- O 0 0.012458549812436104
terminal O 0 0.01170275080949068
domain O 0 0.004114836920052767
of O 0 0.0038110888563096523
NPII O 1 0.9919549822807312
, O 0 0.0025121397338807583
including O 0 0.0015813601203262806
a O 0 0.002748411148786545
cysteine O 0 0.007085470482707024
residue O 0 0.00769635709002614
in O 0 0.0019386865897104144
position O 0 0.003665843280032277
85 O 0 0.004929546266794205
, O 0 0.0015879384009167552
which O 0 0.0009578558383509517
could O 0 0.0009159648907370865
be O 0 0.0007721452275291085
involved O 0 0.0014839859213680029
in O 0 0.002102786209434271
the O 0 0.0037401134613901377
correct O 0 0.011626575142145157
folding O 0 0.08396095782518387
of O 0 0.012498730793595314
the O 0 0.025599051266908646
prohormone O 1 0.9998773336410522
. O 0 0.022429827600717545

In O 0 0.008495648391544819
the O 0 0.006626438349485397
second O 0 0.007075613830238581
family O 0 0.006323442794382572
, O 0 0.002758490387350321
a O 0 0.0038806332740932703
G279A O 0 0.016053080558776855
substitution O 0 0.0056044794619083405
at O 0 0.004076989833265543
position O 0 0.004518544301390648
- O 0 0.0055074975825846195
1 O 0 0.002613899065181613
of O 0 0.0017847989220172167
the O 0 0.002985094441100955
signal O 0 0.005785217043012381
peptide O 0 0.006207551807165146
was O 0 0.004263213369995356
observed O 0 0.0026104655116796494
in O 0 0.0022067984100431204
all O 0 0.0023749081883579493
affected O 0 0.006678942125290632
individuals O 0 0.00621296651661396
. O 0 0.012349504977464676

This O 0 0.009294847957789898
missense O 0 0.028831707313656807
mutation O 0 0.009969018399715424
, O 0 0.0038832849822938442
which O 0 0.0037595725152641535
replaces O 1 0.9975691437721252
Ala O 1 0.9999963045120239
with O 0 0.008686158806085587
Thr O 1 0.9999958276748657
, O 0 0.003836193587630987
is O 0 0.0028037040028721094
frequent O 0 0.005797054618597031
among O 0 0.020920919254422188
FNDI B-Disease 1 1.0
patients O 1 0.9999788999557495
and O 0 0.0029353618156164885
is O 0 0.0020442127715796232
thought O 0 0.0019670622423291206
to O 0 0.0013401467585936189
reduce O 0 0.0029399737250059843
the O 0 0.002691802568733692
efficiency O 0 0.006964477710425854
of O 0 0.004988105036318302
cleavage O 0 0.3188561201095581
by O 0 0.004777278285473585
signal O 0 0.015459843911230564
peptidases O 0 0.06497900933027267
. O 0 0.0073744491674005985
. O 0 0.011880903504788876

Genetic O 0 0.024655325338244438
heterogeneity O 0 0.03380482643842697
of O 0 0.08726557344198227
Saethre B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999988079071045
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.008003437891602516
due O 0 0.0066842748783528805
to O 0 0.0043298774398863316
TWIST O 1 0.7473142147064209
and O 0 0.0103134885430336
FGFR O 1 0.9999642372131348
mutations O 0 0.02318667247891426
. O 0 0.011971737258136272

Thirty O 0 0.0352812297642231
- O 0 0.01588076539337635
two O 0 0.0032938166987150908
unrelated O 0 0.01099564041942358
patients O 0 0.02091355063021183
with O 0 0.0022599364165216684
features O 0 0.004919236991554499
of O 0 0.13914819061756134
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.006647016853094101
a O 0 0.006334610283374786
common O 0 0.03278310224413872
autosomal B-Disease 1 0.9999819993972778
dominant I-Disease 1 0.996193528175354
condition I-Disease 1 0.9999852180480957
of O 1 0.9999502897262573
craniosynostosis B-Disease 1 1.0
and O 1 0.9999966621398926
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999914169311523
, O 0 0.004303015302866697
were O 0 0.002252564998343587
screened O 0 0.004130589310079813
for O 0 0.0015393904177471995
mutations O 0 0.0029273787513375282
in O 0 0.002374633913859725
TWIST O 1 0.6482916474342346
, O 0 0.006270755548030138
FGFR2 O 1 0.9999731779098511
, O 0 0.00634584529325366
and O 0 0.00847217533737421
FGFR3 O 1 0.9997274279594421
. O 0 0.016499584540724754

Nine O 0 0.014523780904710293
novel O 0 0.014613115228712559
and O 0 0.004869596101343632
three O 0 0.00619102967903018
recurrent O 1 0.9999915361404419
TWIST O 1 0.9996597766876221
mutations O 0 0.00774433882907033
were O 0 0.0031792735680937767
found O 0 0.0033516751136630774
in O 0 0.0037129211705178022
12 O 0 0.007623846177011728
families O 0 0.007802101783454418
. O 0 0.010001854971051216

Seven O 0 0.010461940430104733
families O 0 0.004950524307787418
were O 0 0.0024547730572521687
found O 0 0.002295878017321229
to O 0 0.0015224468661472201
have O 0 0.001357267377898097
the O 0 0.004588773008435965
FGFR3 O 1 0.9999691247940063
P250R O 1 0.9956347346305847
mutation O 0 0.006881013046950102
, O 0 0.002189010614529252
and O 0 0.0014118622057139874
one O 0 0.0014993364457041025
individual O 0 0.0016773892566561699
was O 0 0.003373680403456092
found O 0 0.0018856145907193422
to O 0 0.0012606753734871745
have O 0 0.001415382488630712
an O 0 0.0036568602081388235
FGFR2 O 1 0.999650239944458
VV269 O 1 0.9870941042900085
- O 0 0.04151299223303795
270 O 0 0.027842266485095024
deletion O 0 0.03338242694735527
. O 0 0.017343485727906227

To O 0 0.007087577134370804
date O 0 0.0072623854503035545
, O 0 0.003938685171306133
our O 0 0.0033045888412743807
detection O 0 0.005863992962986231
rate O 0 0.0032289433293044567
for O 0 0.0021961817983537912
TWIST O 0 0.019419584423303604
or O 0 0.0045483410358428955
FGFR O 1 0.9971856474876404
mutations O 0 0.0042024096474051476
is O 0 0.0020812726579606533
68 O 0 0.004831305705010891
% O 0 0.0021021633874624968
in O 0 0.0019072054419666529
our O 0 0.005378039088100195
Saethre B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999951124191284
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999966621398926
, O 0 0.003107589902356267
including O 0 0.001964366063475609
our O 0 0.0025546785909682512
five O 0 0.0027899646665900946
patients O 1 0.5250214338302612
elsewhere O 0 0.004826431628316641
reported O 0 0.006236942484974861
with O 0 0.004311051219701767
TWIST O 1 0.953771710395813
mutations O 0 0.021289736032485962
. O 0 0.013665875419974327

More O 0 0.0037179552018642426
than O 0 0.002357291057705879
35 O 0 0.003380806418135762
different O 0 0.0015154255088418722
TWIST O 0 0.01555690448731184
mutations O 0 0.00348091428168118
are O 0 0.0011101262643933296
now O 0 0.002182107651606202
known O 0 0.0027966073248535395
in O 0 0.002422790275886655
the O 0 0.0048978328704833984
literature O 0 0.01284197811037302
. O 0 0.012196878902614117

The O 0 0.010520494543015957
most O 0 0.003956030588597059
common O 0 0.005132637917995453
phenotypic O 0 0.010584695264697075
features O 0 0.004550930578261614
, O 0 0.0020274112466722727
present O 0 0.0018397052772343159
in O 0 0.001128895441070199
more O 0 0.0004844914947170764
than O 0 0.0005103221628814936
a O 0 0.0011815957259386778
third O 0 0.002630164846777916
of O 0 0.0024198901373893023
our O 0 0.003372284583747387
patients O 0 0.018919996917247772
with O 0 0.0026402596849948168
TWIST O 1 0.9574287533760071
mutations O 0 0.0054488405585289
, O 0 0.0023517825175076723
are O 0 0.0019908291287720203
coronal B-Disease 0 0.04780491068959236
synostosis I-Disease 1 0.9769855737686157
, O 0 0.0071363262832164764
brachycephaly B-Disease 1 0.8574864268302917
, O 0 0.010130259208381176
low B-Disease 0 0.1541462540626526
frontal I-Disease 1 0.9999923706054688
hairline I-Disease 1 1.0
, O 1 0.9986005425453186
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.999997615814209
, O 1 0.9936768412590027
ptosis B-Disease 1 1.0
, O 0 0.0713331401348114
hypertelorism B-Disease 1 0.9997534155845642
, O 0 0.006880476139485836
broad B-Disease 0 0.012329083867371082
great I-Disease 0 0.2598251402378082
toes I-Disease 1 0.9985993504524231
, O 0 0.007560951169580221
and O 0 0.008836816065013409
clinodactyly B-Disease 1 0.9996721744537354
. O 0 0.016659798100590706

Significant O 0 0.02794582210481167
intra O 1 0.9936215281486511
- O 0 0.16567248106002808
and O 0 0.006660719867795706
interfamilial O 1 0.820742666721344
phenotypic O 0 0.01631174050271511
variability O 0 0.009288736619055271
is O 0 0.0029091835021972656
present O 0 0.0028812014497816563
for O 0 0.0022558942437171936
either O 0 0.0049791885539889336
TWIST O 0 0.45691466331481934
mutations O 0 0.013074993155896664
or O 0 0.00914531946182251
FGFR O 1 0.9999606609344482
mutations O 0 0.02751314267516136
. O 0 0.015095027163624763

The O 0 0.013021665625274181
overlap O 0 0.008900003507733345
in O 0 0.005445611663162708
clinical O 1 0.8877861499786377
features O 0 0.0051921457052230835
and O 0 0.002443126402795315
the O 0 0.0029161074198782444
presence O 0 0.0030532979872077703
, O 0 0.0016232049092650414
in O 0 0.0012311437167227268
the O 0 0.0016531429719179869
same O 0 0.0017530580516904593
genes O 0 0.001902886084280908
, O 0 0.001201197737827897
of O 0 0.0016501033678650856
mutations O 0 0.002034621313214302
for O 0 0.0009339720709249377
more O 0 0.0007668461184948683
than O 0 0.0010918581392616034
one O 0 0.0026530693285167217
craniosynostotic B-Disease 1 0.9968716502189636
condition I-Disease 1 0.9373306632041931
- O 0 0.005973735358566046
such O 0 0.0014546888414770365
as O 0 0.004008295945823193
Saethre B-Disease 1 0.9985673427581787
- I-Disease 0 0.047490961849689484
Chotzen I-Disease 1 0.7001745104789734
, I-Disease 0 0.00521881366148591
Crouzon I-Disease 1 0.6123719811439514
, I-Disease 0 0.0056391325779259205
and I-Disease 0 0.00792783871293068
Pfeiffer I-Disease 1 0.9999998807907104
syndromes I-Disease 1 1.0
- O 1 0.9930098056793213
support O 0 0.004183888901025057
the O 0 0.0033735428005456924
hypothesis O 0 0.006216883659362793
that O 0 0.0019579539075493813
TWIST O 0 0.012933407910168171
and O 0 0.003006619168445468
FGFRs O 0 0.022943124175071716
are O 0 0.0013379984302446246
components O 0 0.0024349645245820284
of O 0 0.002059735357761383
the O 0 0.002740690018981695
same O 0 0.0022342095617204905
molecular O 0 0.0053364732302725315
pathway O 0 0.004010823089629412
involved O 0 0.0019391480600461364
in O 0 0.0017977398820221424
the O 0 0.003161684377118945
modulation O 0 0.012725763022899628
of O 0 0.05848849564790726
craniofacial O 1 1.0
and O 1 0.9998321533203125
limb O 1 1.0
development O 0 0.453896701335907
in O 0 0.005526925902813673
humans O 0 0.006194360554218292
. O 0 0.004740414209663868
. O 0 0.009956893511116505

Mutation O 0 0.018461469560861588
analysis O 0 0.008502727374434471
of O 0 0.013401729986071587
UBE3A O 1 0.9999997615814209
in O 1 0.9999362230300903
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9329778552055359

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999773502349854
AS B-Disease 1 0.9999853372573853
) O 0 0.0074202800169587135
is O 0 0.0028621559031307697
caused O 0 0.005573864094913006
by O 0 0.003001430304720998
chromosome O 0 0.023851949721574783
15q11 O 1 0.9744315147399902
- O 0 0.01906052604317665
q13 O 0 0.030438410118222237
deletions O 0 0.008849923498928547
of O 0 0.004240300040692091
maternal O 1 0.6981859803199768
origin O 0 0.004252801649272442
, O 0 0.0031207306310534477
by O 0 0.0035613849759101868
paternal O 1 0.9982520937919617
uniparental B-Disease 1 0.9999998807907104
disomy I-Disease 1 0.9999979734420776
( O 1 0.923680305480957
UPD B-Disease 1 0.9999992847442627
) O 0 0.004725006874650717
15 O 0 0.0033075709361582994
, O 0 0.0023549338802695274
by O 0 0.0031112495344132185
imprinting O 1 0.9999339580535889
defects O 1 0.9999990463256836
, O 0 0.003819194855168462
and O 0 0.0023648771457374096
by O 0 0.0020141236018389463
mutations O 0 0.004624035209417343
in O 0 0.0036167707294225693
the O 0 0.013314781710505486
UBE3A O 1 0.9999978542327881
gene O 0 0.022586317732930183
. O 0 0.011399703100323677

UBE3A O 1 0.9967473745346069
encodes O 0 0.0338251069188118
a O 0 0.012249303981661797
ubiquitin O 0 0.04721559211611748
- O 0 0.020579012110829353
protein O 0 0.008846962824463844
ligase O 0 0.01808931492269039
and O 0 0.00518746767193079
shows O 0 0.012251819483935833
brain O 1 0.9927069544792175
- O 0 0.036777593195438385
specific O 0 0.00890433695167303
imprinting O 0 0.07888897508382797
. O 0 0.016222409904003143

Here O 0 0.017033416777849197
we O 0 0.007823368534445763
describe O 0 0.019963590428233147
UBE3A O 1 0.9998195767402649
coding O 0 0.2851928174495697
- O 0 0.028885897248983383
region O 0 0.008304743096232414
mutations O 0 0.006246620323508978
detected O 0 0.005722335074096918
by O 0 0.0021343750413507223
SSCP O 0 0.3531872630119324
analysis O 0 0.002493359846994281
in O 0 0.00224860361777246
13 O 0 0.003910146653652191
AS B-Disease 0 0.007008840795606375
individuals O 0 0.002602942520752549
or O 0 0.004378485027700663
families O 0 0.007418177090585232
. O 0 0.011112079955637455

Two O 0 0.009026700630784035
identical O 0 0.015149058774113655
de O 0 0.03462591394782066
novo O 0 0.0503489151597023
5 O 0 0.015710432082414627
- O 0 0.016815025359392166
bp O 0 0.015836825594305992
duplications O 0 0.016783522441983223
in O 0 0.005294968839734793
exon O 0 0.03141899034380913
16 O 0 0.009949523955583572
were O 0 0.006579696666449308
found O 0 0.0117561724036932
. O 0 0.016889700666069984

Among O 0 0.00863696914166212
the O 0 0.005589765962213278
other O 0 0.0026046661660075188
11 O 0 0.0042753820307552814
unique O 0 0.004215187858790159
mutations O 0 0.004576513543725014
, O 0 0.0024961577728390694
8 O 0 0.0037547519896179438
were O 0 0.0020396984182298183
small O 0 0.002838826272636652
deletions O 0 0.008340589702129364
or O 0 0.0033046987373381853
insertions O 0 0.01272598560899496
predicted O 0 0.0062508247792720795
to O 0 0.0027660971973091364
cause O 0 0.01957145519554615
frameshifts O 1 0.9836724400520325
, O 0 0.003774665528908372
1 O 0 0.005584562662988901
was O 0 0.0036004248540848494
a O 0 0.002258999040350318
mutation O 0 0.002458700444549322
to O 0 0.001133491168729961
a O 0 0.0022914118599146605
stop O 0 0.004333470482379198
codon O 0 0.006759969051927328
, O 0 0.0024025251623243093
1 O 0 0.004048685077577829
was O 0 0.003968965727835894
a O 0 0.003171108663082123
missense O 0 0.010572717525064945
mutation O 0 0.004605500027537346
, O 0 0.002306311158463359
and O 0 0.0019099434139207006
1 O 0 0.005196920596063137
was O 0 0.004448358900845051
predicted O 0 0.004588223993778229
to O 0 0.0018581305630505085
cause O 0 0.00443803146481514
insertion O 0 0.005463451612740755
of O 0 0.002750576473772526
an O 0 0.0032892520539462566
isoleucine O 1 0.9655877351760864
in O 0 0.0025714084040373564
the O 0 0.003389628604054451
hect O 0 0.025269752368330956
domain O 0 0.003942922223359346
of O 0 0.0035156437661498785
the O 0 0.006996098905801773
UBE3A O 1 0.9999932050704956
protein O 0 0.005544072482734919
, O 0 0.001977083273231983
which O 0 0.0012660740176215768
functions O 0 0.002420986071228981
in O 0 0.0034806246403604746
E2 O 1 0.5103467702865601
binding O 0 0.005768352188169956
and O 0 0.0050147357396781445
ubiquitin O 0 0.02685389295220375
transfer O 0 0.014702770859003067
. O 0 0.015021681785583496

Eight O 0 0.008455040864646435
of O 0 0.004507481120526791
the O 0 0.0052567715756595135
cases O 0 0.006115412339568138
were O 0 0.00428081164136529
familial O 1 0.9994804263114929
, O 0 0.005696451757103205
and O 0 0.003628226462751627
five O 0 0.00442914105951786
were O 0 0.005484358873218298
sporadic O 0 0.021329186856746674
. O 0 0.014400163665413857

In O 0 0.007810876239091158
two O 0 0.005033284891396761
familial O 1 0.9961517453193665
cases O 0 0.008976795710623264
and O 0 0.0038089461158961058
one O 0 0.003491856623440981
sporadic O 0 0.010168563574552536
case O 0 0.007620362099260092
, O 0 0.005074643529951572
mosaicism O 1 0.9846055507659912
for O 0 0.00671134190633893
UBE3A O 1 0.9999947547912598
mutations O 0 0.009183617308735847
was O 0 0.006358390208333731
detected O 0 0.004561293870210648
in O 0 0.001646870281547308
the O 0 0.0028047303203493357
mother O 0 0.0056934114545583725
of O 0 0.0022575980983674526
three O 0 0.002039712853729725
AS B-Disease 1 0.5452617406845093
sons O 0 0.19068168103694916
, O 0 0.0021357859950512648
in O 0 0.0020294259302318096
the O 0 0.003952201455831528
maternal O 1 0.9951934218406677
grandfather O 0 0.4077741801738739
of O 0 0.003316607791930437
two O 0 0.002033897442743182
AS B-Disease 0 0.1649029403924942
first O 0 0.003930040635168552
cousins O 0 0.006524140015244484
, O 0 0.0018494027899578214
and O 0 0.0012443851446732879
in O 0 0.001665159477852285
the O 0 0.0034344347659498453
mother O 0 0.021932434290647507
of O 0 0.00444849394261837
an O 0 0.007476825267076492
AS B-Disease 1 0.9995778203010559
daughter O 1 0.9996652603149414
. O 0 0.016969362273812294

The O 0 0.008960995823144913
frequencies O 0 0.0037251862231642008
with O 0 0.0016863918863236904
which O 0 0.0014778063632547855
we O 0 0.0016985638067126274
detected O 0 0.0042046173475682735
mutations O 0 0.002217278815805912
were O 0 0.0014487112639471889
5 O 0 0.002824314869940281
( O 0 0.0021923689637333155
14 O 0 0.002364348154515028
% O 0 0.0014410085277631879
) O 0 0.001178905600681901
of O 0 0.0013526142574846745
35 O 0 0.002515091560781002
in O 0 0.0016749078640714288
sporadic O 0 0.0042930664494633675
cases O 0 0.0024832519702613354
and O 0 0.002294339705258608
8 O 0 0.0038929807487875223
( O 0 0.0024311209563165903
80 O 0 0.002607528120279312
% O 0 0.001624667551368475
) O 0 0.0013094509486109018
of O 0 0.0015160705661401153
10 O 0 0.0024326667189598083
in O 0 0.003360910341143608
familial O 1 0.9989871382713318
cases O 0 0.047007281333208084
. O 0 0.00873209722340107
. O 0 0.014441621489822865

The O 0 0.07105588167905807
hemochromatosis B-Disease 1 1.0
845 O 1 0.9999994039535522
G O 1 0.9999974966049194
- O 1 0.9894311428070068
- O 0 0.017722373828291893
> O 0 0.010373314842581749
A O 0 0.0057642352767288685
and O 0 0.0035576713271439075
187 O 0 0.015288972295820713
C O 0 0.03713947534561157
- O 0 0.027222897857427597
- O 0 0.02268451824784279
> O 0 0.019565923139452934
G O 0 0.020181523635983467
mutations O 0 0.005301069933921099
: O 0 0.004271577578037977
prevalence O 0 0.04055440425872803
in O 0 0.005488964729011059
non O 0 0.38681164383888245
- O 1 0.9686508178710938
Caucasian O 1 0.9647696018218994
populations O 0 0.017203720286488533
. O 0 0.015924621373414993

Hemochromatosis B-Disease 1 0.9999991655349731
, O 0 0.02231205627322197
the O 1 0.9823094010353088
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999995231628418
, O 0 0.006662458181381226
leads O 0 0.012149492278695107
, O 0 0.0029990728944540024
if O 0 0.0023413095623254776
untreated O 1 0.9964883327484131
, O 0 0.0036840317770838737
to O 0 0.0042989677749574184
progressive O 1 0.9999629259109497
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
and O 1 0.7558692097663879
premature B-Disease 1 0.9999291896820068
death I-Disease 1 0.9990839958190918
. O 0 0.015738151967525482

The O 0 0.38451817631721497
hemochromatosis B-Disease 1 1.0
gene O 1 0.9598073959350586
, O 0 0.034013781696558
HFE O 1 0.9999995231628418
, O 0 0.005588679574429989
recently O 0 0.007578682620078325
has O 0 0.0022346642799675465
been O 0 0.002074020216241479
identified O 0 0.002837498439475894
, O 0 0.00156180199701339
and O 0 0.0015119776362553239
characterization O 0 0.005906632170081139
of O 0 0.0033662302885204554
this O 0 0.002564473543316126
gene O 0 0.0032682365272194147
has O 0 0.0013494971208274364
shown O 0 0.0014908469747751951
that O 0 0.0007706419564783573
it O 0 0.0007806245121173561
contains O 0 0.0015592670533806086
two O 0 0.001266407547518611
mutations O 0 0.0022647639270871878
that O 0 0.0008981904829852283
result O 0 0.0017736002337187529
in O 0 0.002402946585789323
amino O 0 0.005210223142057657
acid O 0 0.007386095821857452
substitutions O 0 0.009210353717207909
- O 0 0.011434944346547127
cDNA O 0 0.019419340416789055
nucleotides O 0 0.015186451375484467
845 O 0 0.07121340185403824
G O 1 0.8496960997581482
- O 0 0.03340282663702965
- O 0 0.012291016057133675
> O 0 0.010676422156393528
A O 0 0.005484426859766245
( O 0 0.004070636350661516
C282Y O 0 0.012244539335370064
) O 0 0.0020996350795030594
and O 0 0.0019491423154249787
187 O 0 0.009573160670697689
C O 0 0.029542816802859306
- O 0 0.025662090629339218
- O 0 0.023516196757555008
> O 0 0.027959492057561874
G O 0 0.18519474565982819
( O 0 0.013224676251411438
H63D O 1 0.997288703918457
) O 0 0.011164446361362934
. O 0 0.014483978040516376

Although O 0 0.20475593209266663
hemochromatosis B-Disease 1 1.0
is O 0 0.008876279927790165
common O 0 0.00691236974671483
in O 0 0.004988892935216427
Caucasians O 1 0.8962504267692566
, O 0 0.005777284968644381
affecting O 0 0.014199674129486084
> O 0 0.04367653653025627
= O 0 0.015727054327726364
1 O 0 0.007997631095349789
/ O 0 0.008724361658096313
300 O 0 0.002340331906452775
individuals O 0 0.0009573409333825111
of O 0 0.001622649491764605
northern O 0 0.0028039065655320883
European O 0 0.0024366015568375587
origin O 0 0.0022566604893654585
, O 0 0.0020686599891632795
it O 0 0.0012512970715761185
has O 0 0.0016106846742331982
not O 0 0.0009599947370588779
been O 0 0.0015032492810860276
recognized O 0 0.0028121606446802616
in O 0 0.002033368917182088
other O 0 0.002773192012682557
populations O 0 0.008351456373929977
. O 0 0.011240961030125618

The O 0 0.01056506298482418
present O 0 0.00616481015458703
study O 0 0.005259789060801268
used O 0 0.004231167491525412
PCR O 0 0.015210510231554508
and O 0 0.004394490737468004
restriction O 0 0.01239518541842699
- O 0 0.018394675105810165
enzyme O 0 0.007687443867325783
digestion O 0 0.008817941881716251
to O 0 0.00197037891484797
analyze O 0 0.0035527017898857594
the O 0 0.002202901290729642
frequency O 0 0.001893786247819662
of O 0 0.0019941849168390036
the O 0 0.004687353502959013
845 O 1 0.992522656917572
G O 1 0.9953267574310303
- O 0 0.02096017822623253
- O 0 0.008195658214390278
> O 0 0.006131722126156092
A O 0 0.0030634093564003706
and O 0 0.00211420189589262
187 O 0 0.01068112812936306
C O 0 0.0254870243370533
- O 0 0.01950850710272789
- O 0 0.014952885918319225
> O 0 0.017490077763795853
G O 0 0.01729033701121807
mutations O 0 0.006206598598510027
in O 0 0.005495564546436071
HLA O 1 0.9999476671218872
- O 0 0.013349230401217937
typed O 0 0.009272199124097824
samples O 0 0.004102437291294336
from O 0 0.003343072021380067
non O 0 0.010412381961941719
- O 0 0.021890824660658836
Caucasian O 0 0.09216807782649994
populations O 0 0.004246084485203028
, O 0 0.002731664339080453
comprising O 0 0.005670120008289814
Australian O 0 0.00976153276860714
Aboriginal O 0 0.012182490900158882
, O 0 0.004148941952735186
Chinese O 0 0.008664923720061779
, O 0 0.004578669089823961
and O 0 0.005251595284789801
Pacific O 0 0.023630602285265923
Islanders O 0 0.03890622407197952
. O 0 0.014396090991795063

Results O 0 0.009434827603399754
showed O 0 0.00656532496213913
that O 0 0.0023804588709026575
the O 0 0.005358371417969465
845 O 1 0.9892038702964783
G O 1 0.99937903881073
- O 0 0.46150001883506775
- O 0 0.017774013802409172
> O 0 0.011203411035239697
A O 0 0.00537630682811141
mutation O 0 0.004533152561634779
was O 0 0.003476320533081889
present O 0 0.001838932977989316
in O 0 0.0011460562236607075
these O 0 0.0009382805437780917
populations O 0 0.0020456071943044662
( O 0 0.0025392454117536545
allele O 0 0.0032638870179653168
frequency O 0 0.0018312818137928843
0 O 0 0.0023105842992663383
. O 0 0.0009835150558501482
32 O 0 0.0024319535586982965
% O 0 0.0020982488058507442
) O 0 0.0018628680845722556
, O 0 0.0015928379725664854
and O 0 0.001355741755105555
, O 0 0.0018948294455185533
furthermore O 0 0.0038070757873356342
, O 0 0.0018751259194687009
it O 0 0.0012467869091778994
was O 0 0.003386695170775056
always O 0 0.002284509828314185
seen O 0 0.002096017589792609
in O 0 0.0017069610767066479
conjunction O 0 0.007969930768013
with O 0 0.005768800154328346
HLA O 1 0.9999997615814209
haplotypes O 0 0.025187049061059952
common O 0 0.004930159077048302
in O 0 0.0036403718404471874
Caucasians O 0 0.021705299615859985
, O 0 0.00333257089368999
suggesting O 0 0.005729795899242163
that O 0 0.0031665193382650614
845 O 1 0.99856036901474
G O 1 0.9999473094940186
- O 1 0.9910703897476196
- O 0 0.170484259724617
> O 0 0.012979472987353802
A O 0 0.004502438940107822
may O 0 0.0020947211887687445
have O 0 0.0008959015249274671
been O 0 0.0014104580041021109
introduced O 0 0.0020369484554976225
into O 0 0.0012766709551215172
these O 0 0.0012329932069405913
populations O 0 0.0038532689213752747
by O 0 0.004782116040587425
Caucasian O 1 0.9020091891288757
admixture O 1 0.79471355676651
. O 0 0.021945863962173462

187 O 0 0.06113867089152336
C O 1 0.6414678692817688
- O 0 0.27881112694740295
- O 0 0.04185020551085472
> O 0 0.026027871295809746
G O 0 0.020545026287436485
was O 0 0.006006336770951748
present O 0 0.002826409414410591
at O 0 0.00383209902793169
an O 0 0.0025304178707301617
allele O 0 0.006157840136438608
frequency O 0 0.0031956727616488934
of O 0 0.004699953366070986
2 O 0 0.013802632689476013
. O 0 0.010180222801864147

68 O 0 0.024779751896858215
% O 0 0.005568390246480703
in O 0 0.0026744629722088575
the O 0 0.002531667472794652
two O 0 0.0016169932205229998
populations O 0 0.0027585166972130537
analyzed O 0 0.005641982890665531
( O 0 0.004431572277098894
Australian O 0 0.008118387311697006
Aboriginal O 0 0.012995134107768536
and O 0 0.004958865698426962
Chinese O 0 0.019618883728981018
) O 0 0.010310026817023754
. O 0 0.011174648068845272

In O 0 0.008784371428191662
the O 0 0.0067104739136993885
Australian O 0 0.009429972618818283
Aboriginal O 0 0.010495725087821484
samples O 0 0.00450194301083684
, O 0 0.0034289550967514515
187 O 0 0.012382479384541512
C O 0 0.17941831052303314
- O 0 0.1303476244211197
- O 0 0.031239844858646393
> O 0 0.021450860425829887
G O 0 0.017309825867414474
was O 0 0.004119905177503824
found O 0 0.002050429116934538
to O 0 0.0014076936058700085
be O 0 0.0015671782894060016
associated O 0 0.0033555831760168076
with O 0 0.004937556106597185
HLA O 1 0.9999996423721313
haplotypes O 0 0.057417143136262894
common O 0 0.004841690417379141
in O 0 0.004478033632040024
Caucasians O 1 0.9055543541908264
, O 0 0.003272735048085451
suggesting O 0 0.004067046567797661
that O 0 0.0012659425847232342
it O 0 0.0012194191804155707
was O 0 0.0037158646155148745
introduced O 0 0.0036088821943849325
by O 0 0.0025240445975214243
recent O 0 0.00794396735727787
admixture O 0 0.04449469596147537
. O 0 0.01689571887254715

In O 0 0.006200674921274185
the O 0 0.004100891761481762
Chinese O 0 0.005230456590652466
samples O 0 0.0031532386783510447
analyzed O 0 0.0036452559288591146
, O 0 0.0022713597863912582
187 O 0 0.009654177352786064
C O 0 0.029040448367595673
- O 0 0.03472427651286125
- O 0 0.0292920283973217
> O 0 0.02502923458814621
G O 0 0.02115928754210472
was O 0 0.004315054509788752
present O 0 0.0021006064489483833
in O 0 0.0015188277466222644
association O 0 0.0029006008990108967
with O 0 0.0012633432634174824
a O 0 0.0019950352143496275
wide O 0 0.0023914396297186613
variety O 0 0.0034259336534887552
of O 0 0.2898716330528259
HLA O 1 1.0
haplotypes O 1 0.9102066159248352
, O 0 0.0030606668442487717
showing O 0 0.004255708307027817
this O 0 0.001235677395015955
mutation O 0 0.0023921679239720106
to O 0 0.0009714154875837266
be O 0 0.001189935370348394
widespread O 0 0.002699862467125058
and O 0 0.0016849467065185308
likely O 0 0.0020354909356683493
to O 0 0.0014567667385563254
predate O 0 0.006628899369388819
the O 0 0.00201696646399796
more O 0 0.0012149544199928641
genetically O 0 0.004136246629059315
restricted O 0 0.006321650929749012
845 O 1 0.997713565826416
G O 1 0.9996870756149292
- O 1 0.7633053064346313
- O 0 0.04293552413582802
> O 0 0.019903255626559258
A O 0 0.013117565773427486
mutation O 0 0.017813729122281075
. O 0 0.011690166778862476

Genotype O 1 0.8501297235488892
- O 0 0.04815872758626938
phenotype O 0 0.025918977335095406
correlations O 0 0.02166229486465454
in O 0 0.017190109938383102
attenuated B-Disease 1 0.9998947381973267
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 1 0.7223204970359802

Germ O 1 0.9999048709869385
- O 0 0.03751351311802864
line O 0 0.010897243395447731
mutations O 0 0.007586239371448755
of O 0 0.005730067379772663
the O 1 0.6048691868782043
tumor B-Disease 1 1.0
suppressor O 1 0.9999785423278809
APC O 1 0.9894211292266846
are O 0 0.0027063810266554356
implicated O 0 0.020483043044805527
in O 0 0.012224233709275723
attenuated B-Disease 1 0.9999628067016602
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999699592590332
AAPC B-Disease 1 1.0
) O 0 0.00668436661362648
, O 0 0.002645426895469427
a O 0 0.0038567630108445883
variant O 0 0.02228708378970623
of O 0 0.12089797854423523
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.10744519531726837
. O 0 0.02103065513074398

AAPC B-Disease 1 0.9999574422836304
is O 0 0.009783866815268993
recognized O 0 0.006427752319723368
by O 0 0.0023938266094774008
the O 0 0.0031393198296427727
occurrence O 0 0.009731756523251534
of O 0 0.009053081274032593
< O 1 0.9773491024971008
100 O 0 0.01099145133048296
colonic B-Disease 1 0.9999191761016846
adenomas I-Disease 1 0.9981420040130615
and O 0 0.0031444525811821222
a O 0 0.003217903198674321
later O 0 0.009791704826056957
onset O 1 0.9999992847442627
of O 1 0.9999969005584717
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9982479810714722
age O 0 0.35971304774284363
> O 0 0.05696485936641693
40 O 0 0.005126232746988535
years O 0 0.005027256440371275
) O 0 0.007551402784883976
. O 0 0.00833778828382492

The O 0 0.011649918742477894
aim O 0 0.0090482197701931
of O 0 0.0037896926514804363
this O 0 0.0019301597494632006
study O 0 0.003163115354254842
was O 0 0.0051592267118394375
to O 0 0.002604349283501506
assess O 0 0.012330105528235435
genotype O 0 0.02396569401025772
- O 0 0.013665745966136456
phenotype O 0 0.013158271089196205
correlations O 0 0.014664136804640293
in O 0 0.010904256254434586
AAPC B-Disease 1 0.9999973773956299
families O 0 0.021698754280805588
. O 0 0.015278737992048264

By O 0 0.012927589938044548
protein O 0 0.014566689729690552
- O 0 0.012385662645101547
truncation O 0 0.022301767021417618
test O 0 0.008301285095512867
( O 0 0.0071696010418236256
PTT O 0 0.03105737455189228
) O 0 0.003243297105655074
assay O 0 0.005666838493198156
, O 0 0.001900392584502697
the O 0 0.002378757344558835
entire O 0 0.004345285706222057
coding O 0 0.006474890746176243
region O 0 0.0028084723744541407
of O 0 0.002629019320011139
the O 0 0.006238367408514023
APC B-Disease 1 0.9999440908432007
gene O 0 0.0057854559272527695
was O 0 0.0056098951026797295
screened O 0 0.005448858253657818
in O 0 0.0020649947691708803
affected O 0 0.0029565133154392242
individuals O 0 0.0015027942135930061
from O 0 0.003117138519883156
11 O 0 0.014695422723889351
AAPC B-Disease 1 0.9999997615814209
kindreds O 1 0.8511365056037903
, O 0 0.00431946711614728
and O 0 0.002481853822246194
their O 0 0.002283791545778513
phenotypic O 0 0.010518609546124935
differences O 0 0.007534679025411606
were O 0 0.008118746802210808
examined O 0 0.08786827325820923
. O 0 0.015397203154861927

Five O 0 0.015607958659529686
novel O 0 0.16010238230228424
germ O 1 0.9999895095825195
- O 1 0.9843819737434387
line O 0 0.03059454634785652
APC B-Disease 1 0.9801070690155029
mutations O 0 0.006303420756012201
were O 0 0.0028450151439756155
identified O 0 0.005306961480528116
in O 0 0.005408864002674818
seven O 0 0.010848070494830608
kindreds O 0 0.2524354159832001
. O 0 0.01744810864329338

Mutations O 0 0.015423380769789219
were O 0 0.004008739721029997
located O 0 0.005636304151266813
in O 0 0.00187071249820292
three O 0 0.0011982779251411557
different O 0 0.0006869094213470817
regions O 0 0.0013833795674145222
of O 0 0.0021588101517409086
the O 0 0.005758340936154127
APC B-Disease 1 0.9998131394386292
gene O 0 0.0056821019388735294
( O 0 0.003024356672540307
1 O 0 0.0028894052375108004
) O 0 0.0014694686979055405
at O 0 0.0016837863950058818
the O 0 0.0018413591897115111
5 O 0 0.002892001299187541
end O 0 0.003310071537271142
spanning O 0 0.0062758829444646835
exons O 0 0.009245321154594421
4 O 0 0.0037849396467208862
and O 0 0.0017697461880743504
5 O 0 0.0029623780865222216
, O 0 0.0021083252504467964
( O 0 0.0026616277173161507
2 O 0 0.002870724303647876
) O 0 0.0016102975932881236
within O 0 0.001632560626603663
exon O 0 0.01069430261850357
9 O 0 0.003941982053220272
, O 0 0.0019580621737986803
and O 0 0.0016495896270498633
( O 0 0.00266053038649261
3 O 0 0.002610092982649803
) O 0 0.0014838621718809009
at O 0 0.0022256230004131794
the O 0 0.0024936990812420845
3 O 0 0.005125236231833696
distal O 0 0.01991548389196396
end O 0 0.004864870570600033
of O 0 0.0061877151019871235
the O 0 0.014261058531701565
gene O 0 0.016747867688536644
. O 0 0.01186603307723999

Variability O 0 0.01837271638214588
in O 0 0.004829238634556532
the O 0 0.004763543140143156
number O 0 0.004783144220709801
of O 1 0.9843288660049438
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9999428987503052
most O 0 0.003493738593533635
apparent O 0 0.006983310449868441
in O 0 0.001966011943295598
individuals O 0 0.0011099897092208266
with O 0 0.001093236613087356
mutations O 0 0.002258989494293928
in O 0 0.0014286171644926071
region O 0 0.00379220861941576
1 O 0 0.004049863666296005
, O 0 0.002104593440890312
and O 0 0.0034312924835830927
upper O 1 0.9999867677688599
- O 1 0.9999935626983643
gastrointestinal O 1 1.0
manifestations O 1 0.9999890327453613
were O 0 0.010215695947408676
more O 0 0.0028015344869345427
severe O 1 0.9999096393585205
in O 0 0.006837683264166117
them O 0 0.00604882650077343
. O 0 0.011239366605877876

In O 0 0.0075789629481732845
individuals O 0 0.003175863064825535
with O 0 0.0023394080344587564
mutations O 0 0.0044102743268013
in O 0 0.0021875137463212013
either O 0 0.0024388304445892572
region O 0 0.003801325336098671
2 O 0 0.004247881006449461
or O 0 0.0019118438940495253
region O 0 0.003575777169317007
3 O 0 0.0032524617854505777
, O 0 0.001685769879259169
the O 0 0.00162569060921669
average O 0 0.0026134576182812452
number O 0 0.0019461835036054254
of O 0 0.003779714461416006
adenomas B-Disease 1 0.9996263980865479
tended O 0 0.008728258311748505
to O 0 0.0024424514267593622
be O 0 0.0016357220010831952
lower O 0 0.0032295987475663424
than O 0 0.001113843871280551
those O 0 0.0008440148667432368
in O 0 0.001242992701008916
individuals O 0 0.000999200390651822
with O 0 0.0011857337085530162
mutations O 0 0.002869086805731058
in O 0 0.0017922683618962765
region O 0 0.0035666751209646463
1 O 0 0.003487408859655261
, O 0 0.0016102408990263939
although O 0 0.0018683357629925013
age O 0 0.004747028462588787
at O 0 0.01212386880069971
diagnosis O 1 0.9999744892120361
was O 0 0.16021764278411865
similar O 0 0.008032317273318768
. O 0 0.01133393868803978

In O 0 0.014114109799265862
all O 0 0.011319936253130436
AAPC B-Disease 1 0.9999879598617554
kindreds O 0 0.4140211343765259
, O 0 0.005878381431102753
a O 0 0.005325555335730314
predominance O 0 0.09352956712245941
of O 0 0.09194483608007431
right O 1 0.9986498951911926
- O 1 0.9999994039535522
sided O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999955892562866
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999953508377075
was O 1 0.9890585541725159
observed O 0 0.017381248995661736
. O 0 0.010355355218052864

No O 0 0.03744598850607872
desmoid B-Disease 1 0.9999643564224243
tumors I-Disease 1 0.999997615814209
were O 0 0.005501999985426664
found O 0 0.005218314006924629
in O 0 0.004670694936066866
these O 0 0.005365710239857435
kindreds O 0 0.27247071266174316
. O 0 0.016997430473566055

Our O 0 0.008563474752008915
data O 0 0.004088618792593479
suggest O 0 0.0033951131626963615
that O 0 0.0014634756371378899
, O 0 0.002486786339432001
in O 0 0.0038571441546082497
AAPC B-Disease 1 0.9999977350234985
families O 0 0.003614781890064478
, O 0 0.002103125909343362
the O 0 0.0018557566218078136
location O 0 0.0034118141047656536
of O 0 0.0035280303563922644
the O 0 0.008287991397082806
APC B-Disease 1 0.9999638795852661
mutation O 0 0.011383336037397385
may O 0 0.0042069219052791595
partially O 0 0.008256095461547375
predict O 0 0.006552483886480331
specific O 0 0.004493069835007191
phenotypic O 0 0.018632207065820694
expression O 0 0.017916185781359673
. O 0 0.013711913488805294

This O 0 0.007181510794907808
should O 0 0.0038629435002803802
help O 0 0.0027369395829737186
in O 0 0.001672556740231812
the O 0 0.0021840669214725494
design O 0 0.004097606521099806
of O 0 0.004718364682048559
tailored O 0 0.22376945614814758
clinical O 1 0.9999324083328247
- O 0 0.47806382179260254
management O 0 0.006989241577684879
protocols O 0 0.004823510535061359
in O 0 0.0016987061826512218
this O 0 0.0016026708763092756
subset O 0 0.00812178198248148
of O 0 0.019862376153469086
FAP B-Disease 1 1.0
patients O 1 0.9999967813491821
. O 0 0.009005806408822536
. O 0 0.011812824755907059

Wilms B-Disease 1 0.9999984502792358
' I-Disease 1 0.9848697185516357
tumor I-Disease 1 0.9997484087944031
1 O 0 0.017110133543610573
and O 0 0.00844958983361721
Dax O 1 0.9998998641967773
- O 0 0.026177076622843742
1 O 0 0.009153265506029129
modulate O 0 0.011669249273836613
the O 0 0.007042475510388613
orphan O 1 0.9851100444793701
nuclear O 0 0.01713705062866211
receptor O 0 0.02124296873807907
SF O 1 0.9988620281219482
- O 0 0.011441566050052643
1 O 0 0.004735485650599003
in O 0 0.002634564181789756
sex O 0 0.006849940866231918
- O 0 0.011940019205212593
specific O 0 0.006460027303546667
gene O 0 0.013548949733376503
expression O 0 0.013936260715126991
. O 0 0.012088852934539318

Products O 0 0.01849254034459591
of O 0 0.013189464807510376
steroidogenic O 1 0.9997819066047668
factor O 0 0.019283352419734
1 O 0 0.011100789532065392
( O 0 0.009290413931012154
SF O 1 0.9996752738952637
- O 0 0.013075195252895355
1 O 0 0.007432272657752037
) O 0 0.0033865112345665693
and O 0 0.004966616630554199
Wilms B-Disease 1 0.9999995231628418
tumor I-Disease 1 0.999998927116394
1 O 0 0.1268940418958664
( O 0 0.014758509583771229
WT1 O 1 0.9994964599609375
) O 0 0.004677392076700926
genes O 0 0.002449186285957694
are O 0 0.0009355418151244521
essential O 0 0.00344848888926208
for O 0 0.0027357423678040504
mammalian O 0 0.01222034078091383
gonadogenesis O 0 0.04747263342142105
prior O 0 0.005888092797249556
to O 0 0.003852489637210965
sexual O 0 0.01659565232694149
differentiation O 0 0.08650808781385422
. O 0 0.020757215097546577

In O 0 0.011112257838249207
males O 0 0.013212360441684723
, O 0 0.012233343906700611
SF O 1 0.9999963045120239
- O 0 0.08204837143421173
1 O 0 0.008458215743303299
participates O 0 0.007406421005725861
in O 0 0.002670485060662031
sexual O 0 0.004046514630317688
development O 0 0.003601872595027089
by O 0 0.0021535451523959637
regulating O 0 0.005852434318512678
expression O 0 0.0036069878842681646
of O 0 0.0036445322912186384
the O 0 0.010702653788030148
polypeptide O 1 0.997810423374176
hormone O 1 0.9936052560806274
Mullerian O 1 0.9999654293060303
inhibiting O 1 0.9354323148727417
substance O 1 0.9768622517585754
( O 0 0.240032359957695
MIS O 1 0.9999790191650391
) O 0 0.014190886169672012
. O 0 0.011831776238977909

Here O 0 0.01158353965729475
, O 0 0.005157527979463339
we O 0 0.002838248386979103
show O 0 0.00537524651736021
that O 0 0.004533720668405294
WT1 O 1 0.999922513961792
- O 0 0.14031344652175903
KTS O 1 0.9937049746513367
isoforms O 0 0.011427228339016438
associate O 0 0.009527740068733692
and O 0 0.0034771065693348646
synergize O 0 0.34324726462364197
with O 0 0.008564174175262451
SF O 1 0.9999995231628418
- O 0 0.29531317949295044
1 O 0 0.008123379200696945
to O 0 0.0044532096944749355
promote O 0 0.01575418934226036
MIS O 1 0.9991426467895508
expression O 0 0.022413188591599464
. O 0 0.016723090782761574

In O 0 0.013576625846326351
contrast O 0 0.015096566639840603
, O 0 0.01132132951170206
WT1 O 1 0.9993563294410706
missense O 0 0.02865220420062542
mutations O 0 0.0077255419455468655
, O 0 0.002786240540444851
associated O 0 0.0024995270650833845
with O 0 0.001861689263023436
male B-Disease 0 0.011364676058292389
pseudohermaphroditism I-Disease 1 0.9999974966049194
in O 1 0.6702348589897156
Denys B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
Drash I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.006764372810721397
fail O 0 0.007909218780696392
to O 0 0.0032780575565993786
synergize O 1 0.7531313896179199
with O 0 0.010113240219652653
SF O 1 1.0
- O 1 0.9864755272865295
1 O 0 0.01921703666448593
. O 0 0.013073330745100975

Additionally O 0 0.017619885504245758
, O 0 0.005996957421302795
the O 0 0.007231298368424177
X O 1 0.6279134154319763
- O 0 0.010284212417900562
linked O 0 0.005090514663606882
, O 0 0.002848090138286352
candidate O 0 0.00609941128641367
dosage O 0 0.33129340410232544
- O 0 0.01069609820842743
sensitive O 0 0.00682663731276989
sex O 0 0.006639144383370876
- O 0 0.010036010295152664
reversal O 0 0.011446788907051086
gene O 0 0.005641982890665531
, O 0 0.003884008154273033
Dax O 1 0.9997531771659851
- O 0 0.01457239966839552
1 O 0 0.005138426087796688
, O 0 0.0035446719266474247
antagonizes O 0 0.05489373207092285
synergy O 0 0.018144117668271065
between O 0 0.007187183480709791
SF O 1 0.9999994039535522
- O 0 0.2753715217113495
1 O 0 0.008447668515145779
and O 0 0.0041005173698067665
WT1 O 1 0.9999147653579712
, O 0 0.003128739772364497
most O 0 0.001399570144712925
likely O 0 0.0017373345326632261
through O 0 0.0010221714619547129
a O 0 0.0018398872343823314
direct O 0 0.002389361150562763
interaction O 0 0.0040396274998784065
with O 0 0.005055388901382685
SF O 1 0.9999997615814209
- O 1 0.8808438181877136
1 O 0 0.01497170515358448
. O 0 0.009573268704116344

We O 0 0.009906535036861897
propose O 0 0.012972773984074593
that O 0 0.006016346160322428
WT1 O 1 0.9986599683761597
and O 0 0.009511302225291729
Dax O 1 0.9999970197677612
- O 0 0.2614979147911072
1 O 0 0.007781614549458027
functionally O 0 0.007219093851745129
oppose O 0 0.003024914301931858
each O 0 0.001309992396272719
other O 0 0.0013684493023902178
in O 0 0.0033961101435124874
testis O 1 0.9169193506240845
development O 0 0.006778750568628311
by O 0 0.003996967803686857
modulating O 1 0.9992757439613342
SF O 1 0.9999997615814209
- O 1 0.947758674621582
1 O 0 0.01587727852165699
- O 0 0.017679592594504356
mediated O 0 0.019494235515594482
transactivation O 0 0.16303510963916779
. O 0 0.008420626632869244
. O 0 0.01454518549144268

A O 0 0.02164260484278202
mouse O 0 0.01830831542611122
model O 0 0.012004443444311619
for O 0 0.01271103322505951
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999856948852539
centre O 1 0.9888733625411987
mutations O 0 0.028546836227178574
. O 0 0.013204889371991158

Imprinting O 0 0.0545189306139946
in O 0 0.009163589216768742
the O 0 0.011525660753250122
15q11 O 1 0.9926851987838745
- O 0 0.04432890936732292
q13 O 0 0.026239577680826187
region O 0 0.005090007092803717
involves O 0 0.004241772927343845
an O 0 0.0039032525382936
imprinting O 1 0.9210029244422913
centre O 1 0.8742872476577759
( O 0 0.044554561376571655
IC O 1 0.9999599456787109
) O 0 0.0029969094321131706
, O 0 0.0018340522656217217
mapping O 0 0.0034515990410000086
in O 0 0.001687706564553082
part O 0 0.0023893543984740973
to O 0 0.0015002033906057477
the O 0 0.003223754232749343
promoter O 0 0.0827057957649231
and O 0 0.0029464946128427982
first O 0 0.005330053623765707
exon O 0 0.03585676848888397
of O 0 0.013033083640038967
SNRPN O 1 0.9999443292617798
. O 0 0.019415194168686867

Deletion O 0 0.0364593043923378
of O 0 0.011414739303290844
this O 0 0.008151181042194366
IC O 1 0.9997501969337463
abolishes O 1 0.8854548335075378
local O 0 0.009132935665547848
paternally O 0 0.056115634739398956
derived O 0 0.007269071880728006
gene O 0 0.005007694009691477
expression O 0 0.0032708877697587013
and O 0 0.0022828246001154184
results O 0 0.005300310906022787
in O 0 0.012382023967802525
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999984502792358
PWS B-Disease 1 1.0
) O 0 0.22863982617855072
. O 0 0.014060016721487045

We O 0 0.005926685407757759
have O 0 0.0019211637554690242
created O 0 0.003396223299205303
two O 0 0.0021982851903885603
deletion O 0 0.010042896494269371
mutations O 0 0.0041997130028903484
in O 0 0.0027769897133111954
mice O 0 0.006747993174940348
to O 0 0.0023128145840018988
understand O 0 0.008633184246718884
PWS B-Disease 1 0.9999998807907104
and O 0 0.003440386848524213
the O 0 0.004454110283404589
mechanism O 0 0.006357061211019754
of O 0 0.004516930785030127
this O 0 0.006459598895162344
IC O 1 0.9993017911911011
. O 0 0.01688077114522457

Mice O 0 0.45163431763648987
harbouring O 1 0.8578541874885559
an O 0 0.01165933907032013
intragenic O 1 0.9637577533721924
deletion O 0 0.035907384008169174
in O 0 0.006385428365319967
Snrpn O 1 0.9623739719390869
are O 0 0.00285517075099051
phenotypically O 0 0.0671255812048912
normal O 0 0.005708710756152868
, O 0 0.00298252678476274
suggesting O 0 0.004698410164564848
that O 0 0.001796844182536006
mutations O 0 0.0036460389383137226
of O 0 0.004337127786129713
SNRPN O 1 0.9999651908874512
are O 0 0.002150231972336769
not O 0 0.0019584535621106625
sufficient O 0 0.006399065256118774
to O 0 0.006194844841957092
induce O 0 0.15487973392009735
PWS B-Disease 1 0.9999997615814209
. O 0 0.030156586319208145

Mice O 0 0.024681515991687775
with O 0 0.0036833477206528187
a O 0 0.004943233914673328
larger O 0 0.004423022735863924
deletion O 0 0.009874575771391392
involving O 0 0.005175989121198654
both O 0 0.003942117560654879
Snrpn O 1 0.8800268769264221
and O 0 0.005093584768474102
the O 0 0.013545254245400429
putative O 1 0.9999294281005859
PWS O 1 1.0
- O 1 0.9989551305770874
IC O 1 0.9956516623497009
lack O 0 0.008173699490725994
expression O 0 0.004213406704366207
of O 0 0.003411735873669386
the O 0 0.005914819426834583
imprinted O 1 0.520508885383606
genes O 0 0.007540489546954632
Zfp127 O 1 0.8151622414588928
( O 0 0.0065879616886377335
mouse O 0 0.008930330164730549
homologue O 0 0.019444206729531288
of O 0 0.005637552589178085
ZNF127 O 1 0.9999768733978271
) O 0 0.005559599492698908
, O 0 0.0053811646066606045
Ndn O 1 0.9869329333305359
and O 0 0.005295747425407171
Ipw O 1 0.9937388896942139
, O 0 0.003645538119599223
and O 0 0.0027235704474151134
manifest O 0 0.00954979658126831
several O 0 0.003303747158497572
phenotypes O 0 0.02586728148162365
common O 0 0.011627468280494213
to O 0 0.014456409960985184
PWS B-Disease 1 1.0
infants O 1 0.9999970197677612
. O 0 0.027483318001031876

These O 0 0.004962179344147444
data O 0 0.003827318549156189
demonstrate O 0 0.004093351773917675
that O 0 0.0012946034548804164
both O 0 0.0011746578384190798
the O 0 0.0021289894357323647
position O 0 0.003277350217103958
of O 0 0.003306125057861209
the O 0 0.006714531220495701
IC O 1 0.9994627833366394
and O 0 0.002768388483673334
its O 0 0.0017228254582732916
role O 0 0.003325312165543437
in O 0 0.002022399799898267
the O 0 0.0026430124416947365
coordinate O 0 0.004653740208595991
expression O 0 0.002507350407540798
of O 0 0.00237901764921844
genes O 0 0.002735914196819067
is O 0 0.001703678397461772
conserved O 0 0.0034539401531219482
between O 0 0.0023136597592383623
mouse O 0 0.006471931468695402
and O 0 0.0021534264087677
human O 0 0.0029920036904513836
, O 0 0.00263287965208292
and O 0 0.0018315815832465887
indicate O 0 0.0029811037238687277
that O 0 0.0013440798502415419
the O 0 0.0027415661606937647
mouse O 0 0.005325151141732931
is O 0 0.0015532402321696281
a O 0 0.0021573808044195175
suitable O 0 0.004023964516818523
model O 0 0.0035781969781965017
system O 0 0.0022440163884311914
in O 0 0.0011833010939881206
which O 0 0.0008960108389146626
to O 0 0.0009255131590180099
investigate O 0 0.003195592202246189
the O 0 0.0028117233887314796
molecular O 0 0.004614348988980055
mechanisms O 0 0.003911944571882486
of O 0 0.0030315248295664787
imprinting O 0 0.01879381388425827
in O 0 0.0019153228495270014
this O 0 0.0012542193289846182
region O 0 0.0023513820488005877
of O 0 0.0025340623687952757
the O 0 0.006123834755271673
genome O 0 0.012806677259504795
. O 0 0.005977944005280733
. O 0 0.009520426392555237

Mutations O 0 0.016748258844017982
of O 0 0.008323960937559605
the O 0 0.01117465365678072
ATM O 0 0.07207269966602325
gene O 0 0.0077792322263121605
detected O 0 0.006431066431105137
in O 0 0.00432237284258008
Japanese O 1 0.9989696741104126
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999816417694092
: O 0 0.004643996711820364
possible O 0 0.003460804233327508
preponderance O 0 0.0122764827683568
of O 0 0.0023586393799632788
the O 0 0.002941281069070101
two O 0 0.0028354807291179895
founder O 1 0.5363921523094177
mutations O 0 0.011291884817183018
4612del165 O 1 0.8411829471588135
and O 0 0.009984956122934818
7883del5 O 1 0.8949421644210815
. O 0 0.022502603009343147

The O 0 0.017133839428424835
ATM O 0 0.12851573526859283
( O 0 0.01338779553771019
A O 1 0.9808046221733093
- O 1 0.9985542893409729
T O 1 0.9998985528945923
, O 0 0.004350088536739349
mutated O 0 0.008793698623776436
) O 0 0.002810525707900524
gene O 0 0.003683597780764103
on O 0 0.00337348785251379
human O 0 0.010966711677610874
chromosome O 0 0.04161728173494339
11q22 O 0 0.20382475852966309
. O 0 0.022467361763119698

3 O 0 0.015343066304922104
has O 0 0.00505950627848506
recently O 0 0.005259400233626366
been O 0 0.0025264048017561436
identified O 0 0.0028152537997812033
as O 0 0.0017891336465254426
the O 0 0.0021761469542980194
gene O 0 0.0024105613119900227
responsible O 0 0.0020223890896886587
for O 0 0.0014768244000151753
the O 0 0.0036647876258939505
human O 1 0.9246401190757751
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9993628859519958
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999938011169434
T I-Disease 1 0.9999936819076538
) O 0 0.010660986416041851
. O 0 0.011429858393967152

In O 0 0.007027376908808947
order O 0 0.0033168320078402758
to O 0 0.0018177216406911612
define O 0 0.003663663286715746
the O 0 0.0026979907415807247
types O 0 0.003926070407032967
of O 0 0.1326875239610672
disease O 1 1.0
- O 1 0.9996435642242432
causing O 0 0.4932275116443634
ATM O 0 0.022539949044585228
mutations O 0 0.0032735406421124935
in O 0 0.0022388689685612917
Japanese O 1 0.929233193397522
A B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999995231628418
T I-Disease 1 0.9999997615814209
patients O 0 0.3805519640445709
as O 0 0.0018183040665462613
well O 0 0.0012998557649552822
as O 0 0.0014079147949814796
to O 0 0.001077692024409771
look O 0 0.0020425645634531975
for O 0 0.0017343532526865602
possible O 0 0.004796721041202545
mutational O 0 0.0809813141822815
hotspots O 0 0.02398427575826645
, O 0 0.004916866309940815
reverse O 0 0.010413424111902714
- O 0 0.00984340813010931
transcribed O 0 0.008894785307347775
RNA O 0 0.006072645075619221
derived O 0 0.003182639367878437
from O 0 0.0021738186478614807
ten O 0 0.004921889863908291
patients O 0 0.005684251897037029
belonging O 0 0.004430941306054592
to O 0 0.002052705967798829
eight O 0 0.0032543253619223833
unrelated O 0 0.008619319647550583
Japanese O 1 0.9419394135475159
A B-Disease 1 0.9999830722808838
- I-Disease 1 0.999925971031189
T I-Disease 1 0.9997860789299011
families O 0 0.0035141571424901485
was O 0 0.0045379530638456345
analyzed O 0 0.0038681342266499996
for O 0 0.0023271578829735518
mutations O 0 0.004063048399984837
by O 0 0.0026716955471783876
the O 0 0.005907741375267506
restriction O 0 0.019642796367406845
endonuclease O 0 0.06122368574142456
fingerprinting O 0 0.02700894884765148
method O 0 0.017151981592178345
. O 0 0.015162937343120575

As O 0 0.011191947385668755
has O 0 0.004852524492889643
been O 0 0.0034469945821911097
reported O 0 0.0041388156823813915
by O 0 0.0019175901543349028
others O 0 0.0026516744401305914
, O 0 0.0025891095865517855
mutations O 0 0.003428567433729768
that O 0 0.0011968188919126987
lead O 0 0.003263226244598627
to O 0 0.0028067906387150288
exon O 0 0.023517927154898643
skipping O 0 0.014853492379188538
or O 0 0.0048347339034080505
premature O 0 0.035533614456653595
protein O 0 0.008743652142584324
truncation O 0 0.017022842541337013
were O 0 0.003413870232179761
also O 0 0.003698495915159583
predominant O 0 0.011312809772789478
in O 0 0.005973927676677704
our O 0 0.009336980991065502
mutants O 0 0.04016299545764923
. O 0 0.013625397346913815

Six O 0 0.007846892811357975
different O 0 0.0024930397048592567
mutations O 0 0.004477540031075478
were O 0 0.0019129306310787797
identified O 0 0.0029087630100548267
on O 0 0.0018717607017606497
12 O 0 0.002658711513504386
of O 0 0.002441130578517914
the O 0 0.004280437715351582
16 O 0 0.008913346566259861
alleles O 0 0.014202777296304703
examined O 0 0.022992676123976707
. O 0 0.012023840099573135

Four O 0 0.00827731005847454
were O 0 0.005476734135299921
deletions O 0 0.00975028332322836
involving O 0 0.004559960216283798
a O 0 0.005170874763280153
loss O 0 0.016011236235499382
of O 0 0.003885007929056883
a O 0 0.00516005652025342
single O 0 0.006186097394675016
exon O 0 0.02482069842517376
exon O 0 0.01508184801787138
7 O 0 0.004178171046078205
, O 0 0.0028153688181191683
exon O 0 0.012372861616313457
16 O 0 0.00395434582605958
, O 0 0.003317224094644189
exon O 0 0.018368322402238846
33 O 0 0.009146987460553646
or O 0 0.00617255037650466
exon O 0 0.03344997763633728
35 O 0 0.01770870015025139
. O 0 0.01477013435214758

The O 0 0.010373588651418686
others O 0 0.004808477591723204
were O 0 0.0030725772958248854
minute O 0 0.005652351304888725
deletions O 0 0.009489095769822598
, O 0 0.004057836253196001
4649delA O 0 0.024434396997094154
in O 0 0.004463533405214548
exon O 0 0.02000257559120655
33 O 0 0.007834111340343952
and O 0 0.003666807897388935
7883del5 O 0 0.03218252956867218
in O 0 0.007959938608109951
exon O 0 0.05022316798567772
55 O 0 0.0260431170463562
. O 0 0.015872323885560036

The O 0 0.017044950276613235
mutations O 0 0.015779679641127586
4612del165 O 0 0.3836723566055298
and O 0 0.004797568544745445
7883del5 O 0 0.4327792525291443
were O 0 0.00251740962266922
found O 0 0.0016317794797942042
in O 0 0.0009859597776085138
more O 0 0.0005015339120291173
than O 0 0.000591122661717236
two O 0 0.0007575084455311298
unrelated O 0 0.0034297273959964514
families O 0 0.0022119663190096617
; O 0 0.0017725584330037236
44 O 0 0.003877081209793687
% O 0 0.002529245801270008
( O 0 0.002479701768606901
7 O 0 0.0027791867032647133
of O 0 0.0019086572574451566
16 O 0 0.0033600092865526676
) O 0 0.001723676105029881
of O 0 0.001954619074240327
the O 0 0.003536233911290765
mutant O 0 0.012220473028719425
alleles O 0 0.00492514343932271
had O 0 0.0026325625367462635
one O 0 0.00168300187215209
of O 0 0.0026485638227313757
the O 0 0.004417176824063063
two O 0 0.004662030376493931
mutations O 0 0.014197130687534809
. O 0 0.011064544320106506

The O 0 0.020330391824245453
4612del165 O 0 0.3388462960720062
mutations O 0 0.006712658796459436
in O 0 0.0019760411232709885
three O 0 0.0014378525083884597
different O 0 0.0008733223658055067
families O 0 0.0013618548400700092
were O 0 0.0009678017231635749
all O 0 0.0009323906851932406
ascribed O 0 0.0040532867424190044
to O 0 0.0013925357488915324
the O 0 0.0028924881480634212
same O 0 0.006063950713723898
T O 1 0.9999927282333374
- O 1 0.5374153256416321
- O 0 0.01122861448675394
> O 0 0.006424561608582735
A O 0 0.003317961934953928
substitution O 0 0.004644492175430059
at O 0 0.003913901746273041
the O 0 0.005219219718128443
splice O 0 0.025657638907432556
donor O 0 0.010715057142078876
site O 0 0.00854596309363842
in O 0 0.008969129994511604
intron O 1 0.971830427646637
33 O 0 0.03328139707446098
. O 0 0.02012018859386444

Microsatellite O 0 0.3672718405723572
genotyping O 0 0.04702765494585037
around O 0 0.008492491208016872
the O 0 0.008074249140918255
ATM O 1 0.8832882642745972
locus O 0 0.03371019661426544
also O 0 0.003980830777436495
indicated O 0 0.0042749010026454926
that O 0 0.0016535059548914433
a O 0 0.003019799245521426
common O 0 0.004463233519345522
haplotype O 0 0.01161698903888464
was O 0 0.00564585579559207
shared O 0 0.0034270607866346836
by O 0 0.001817743293941021
the O 0 0.004245216026902199
mutant O 0 0.014603918418288231
alleles O 0 0.007301478646695614
in O 0 0.0037537869065999985
both O 0 0.004762150812894106
mutations O 0 0.013440743088722229
. O 0 0.011214249767363071

This O 0 0.0071822586469352245
suggests O 0 0.006709901615977287
that O 0 0.0018478190759196877
these O 0 0.0014306906377896667
two O 0 0.002213128376752138
founder O 0 0.04008166864514351
mutations O 0 0.00695813586935401
may O 0 0.0033467630855739117
be O 0 0.0024207825772464275
predominant O 0 0.00980015005916357
among O 0 0.0058798640966415405
Japanese O 1 0.7244013547897339
ATM O 1 0.9876896142959595
mutant O 0 0.08850245177745819
alleles O 0 0.02703818865120411
. O 0 0.015627356246113777

W474C O 0 0.15082105994224548
amino O 0 0.02783772349357605
acid O 0 0.026092812418937683
substitution O 0 0.01771497167646885
affects O 0 0.009612083435058594
early O 0 0.004294956102967262
processing O 0 0.004233581013977528
of O 0 0.0028168901335448027
the O 0 0.004356895107775927
alpha O 0 0.010711601004004478
- O 0 0.004602794535458088
subunit O 0 0.004609786439687014
of O 0 0.002663861494511366
beta O 0 0.013172122649848461
- O 0 0.011796671897172928
hexosaminidase O 0 0.02872564271092415
A O 0 0.004775946959853172
and O 0 0.0020811192225664854
is O 0 0.0022053332068026066
associated O 0 0.003770633367821574
with O 0 0.004733305890113115
subacute O 1 1.0
G B-Disease 1 0.9999991655349731
( I-Disease 1 0.8575138449668884
M2 I-Disease 1 0.999985933303833
) I-Disease 0 0.012632286176085472
gangliosidosis I-Disease 0 0.10743813961744308
. O 0 0.01728994958102703

Mutations O 0 0.02057577110826969
in O 0 0.007628559600561857
the O 0 0.012470698915421963
HEXA O 1 0.9999842643737793
gene O 0 0.007636616937816143
, O 0 0.0031109435949474573
encoding O 0 0.004078476689755917
the O 0 0.0035545385908335447
alpha O 0 0.010356562212109566
- O 0 0.006218657363206148
subunit O 0 0.004932250827550888
of O 0 0.0035072641912847757
beta O 0 0.014027494005858898
- O 0 0.011772304773330688
hexosaminidase O 0 0.026830781251192093
A O 0 0.008217408321797848
( O 0 0.006886166986078024
Hex O 0 0.016632189974188805
A O 0 0.006466144695878029
) O 0 0.002847531111910939
, O 0 0.0018722328823059797
that O 0 0.001751253381371498
abolish O 0 0.012260455638170242
Hex O 0 0.018280375748872757
A O 0 0.009381087496876717
enzyme O 0 0.010075988247990608
activity O 0 0.008989684283733368
cause O 1 0.9985800981521606
Tay B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9834669232368469
TSD B-Disease 1 0.9999994039535522
) O 0 0.005219400394707918
, O 0 0.0033123439643532038
the O 0 0.005481496453285217
fatal O 1 0.9998979568481445
infantile B-Disease 1 0.999994158744812
form I-Disease 0 0.01008632406592369
of I-Disease 1 0.9612794518470764
G I-Disease 1 0.9999905824661255
( I-Disease 0 0.030485760420560837
M2 I-Disease 1 0.9972625970840454
) I-Disease 0 0.005419710651040077
gangliosidosis I-Disease 0 0.024630265310406685
, I-Disease 0 0.005586957558989525
Type I-Disease 0 0.020305095240473747
1 I-Disease 0 0.01634734310209751
. O 0 0.011353453621268272

Less O 0 0.022287629544734955
severe O 1 0.9997442364692688
, O 0 0.08848947286605835
subacute O 1 1.0
( O 1 0.9970065951347351
juvenile O 1 0.9999986886978149
- O 1 0.9996823072433472
onset O 1 0.9999991655349731
) O 0 0.009974412620067596
and O 0 0.007232492323964834
chronic O 1 1.0
( O 1 0.9990054965019226
adult O 1 0.99696284532547
- O 1 0.9999525547027588
onset O 1 0.9999994039535522
) O 0 0.005340497009456158
variants O 0 0.003774097189307213
are O 0 0.001098678563721478
characterized O 0 0.004148426465690136
by O 0 0.0015145341167226434
a O 0 0.003319555427879095
broad O 0 0.006133500952273607
spectrum O 0 0.0057380786165595055
of O 0 0.006097111385315657
clinical O 1 0.9999772310256958
manifestations O 1 0.9999566078186035
and O 0 0.004102326463907957
are O 0 0.0016223614802584052
associated O 0 0.00264403922483325
with O 0 0.002272414043545723
residual O 0 0.05146760493516922
levels O 0 0.00621970696374774
of O 0 0.005373121239244938
Hex O 0 0.17657223343849182
A O 0 0.017929663881659508
enzyme O 0 0.017034169286489487
activity O 0 0.010185452178120613
. O 0 0.010573850013315678

We O 0 0.009108238853514194
identified O 0 0.00909892562776804
a O 0 0.009259873069822788
1422 O 1 0.9982669353485107
G O 1 0.9963372945785522
- O 0 0.19358058273792267
- O 0 0.017938483506441116
> O 0 0.013957533985376358
C O 0 0.01246666070073843
( O 0 0.00427246605977416
amino O 0 0.004726975690573454
acid O 0 0.007330633699893951
W474C O 0 0.020482594147324562
) O 0 0.002730318810790777
substitution O 0 0.003458996070548892
in O 0 0.001520229852758348
the O 0 0.001895346213132143
first O 0 0.0020543301943689585
position O 0 0.0024640639312565327
of O 0 0.0024206892121583223
exon O 0 0.012100215069949627
13 O 0 0.0036352730821818113
of O 0 0.00415008096024394
HEXA O 1 0.999750554561615
of O 0 0.004050089046359062
a O 0 0.005046335514634848
non O 0 0.011462274938821793
- O 0 0.014274418354034424
Jewish O 0 0.00813116692006588
proband O 0 0.4229024648666382
who O 0 0.00684631522744894
manifested O 0 0.02598518878221512
a O 0 0.009849786758422852
subacute O 1 0.9999990463256836
variant O 1 0.8909664750099182
of O 1 0.533719539642334
G B-Disease 1 0.9999935626983643
( I-Disease 0 0.35274621844291687
M2 I-Disease 1 0.9999381303787231
) I-Disease 0 0.011368765495717525
gangliosidosis I-Disease 0 0.14346438646316528
. O 0 0.013731447979807854

On O 0 0.010756107047200203
the O 0 0.007829797454178333
second O 0 0.020158424973487854
maternally O 1 0.9983273148536682
inherited O 1 0.9999798536300659
allele O 0 0.011307301931083202
, O 0 0.002511603059247136
we O 0 0.0013889981200918555
identified O 0 0.003170478856191039
the O 0 0.004194789566099644
common O 1 0.8863778114318848
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999969005584717
causing O 1 0.9986253976821899
4 O 0 0.052716221660375595
- O 0 0.01620856672525406
bp O 0 0.011870949529111385
insertion O 0 0.011640182696282864
, O 0 0.0066827647387981415
+ O 0 0.028730444610118866
TATC O 1 0.947655975818634
1278 O 1 0.9430040717124939
, O 0 0.007004097104072571
in O 0 0.0070146480575203896
exon O 0 0.04280473291873932
11 O 0 0.015718117356300354
. O 0 0.014342879876494408

Pulse O 1 0.8857550621032715
- O 0 0.019751425832509995
chase O 0 0.011443723924458027
analysis O 0 0.003734428435564041
using O 0 0.004363241605460644
proband O 0 0.06962469220161438
fibroblasts O 0 0.015481822192668915
revealed O 0 0.006365741603076458
that O 0 0.0019298732513561845
the O 0 0.003842197125777602
W474C O 0 0.05688750743865967
- O 0 0.009224999696016312
containing O 0 0.006419510580599308
alpha O 0 0.012846012599766254
- O 0 0.00906912051141262
subunit O 0 0.008121920749545097
precursor O 0 0.010215706191956997
was O 0 0.005461090710014105
normally O 0 0.003172533353790641
synthesized O 0 0.004771747626364231
, O 0 0.0019274132791906595
but O 0 0.0009459092398174107
not O 0 0.0013246942544355989
phosphorylated O 0 0.006670646835118532
or O 0 0.0019629362504929304
secreted O 0 0.005822845734655857
, O 0 0.0020377414766699076
and O 0 0.002003670670092106
the O 0 0.004091738257557154
mature O 0 0.012786702252924442
lysosomal O 1 0.9999586343765259
alpha O 0 0.37843748927116394
- O 0 0.015265443362295628
subunit O 0 0.010606395080685616
was O 0 0.0074255503714084625
not O 0 0.003960593603551388
detected O 0 0.016756147146224976
. O 0 0.01008300669491291

When O 0 0.01033751480281353
the O 0 0.008586191572248936
W474C O 0 0.09683509916067123
- O 0 0.014325587078928947
containing O 0 0.008315163664519787
alpha O 0 0.015662308782339096
- O 0 0.008945501409471035
subunit O 0 0.009098096750676632
was O 0 0.0064472961239516735
transiently O 0 0.020006373524665833
co O 0 0.014847989194095135
- O 0 0.00620316993445158
expressed O 0 0.003229032503440976
with O 0 0.0016462665516883135
the O 0 0.00344928540289402
beta O 0 0.010504215955734253
- O 0 0.005488425958901644
subunit O 0 0.003474982688203454
to O 0 0.001304536359384656
produce O 0 0.002473176922649145
Hex O 0 0.011124378070235252
A O 0 0.005684354808181524
( O 0 0.004485270474106073
alphabeta O 0 0.02053905464708805
) O 0 0.003640582785010338
in O 0 0.0043637012131512165
COS O 1 0.9999992847442627
- O 0 0.026403630152344704
7 O 0 0.005694772116839886
cells O 0 0.0031385484617203474
, O 0 0.0018314978806301951
the O 0 0.0025726049207150936
mature O 0 0.006240614224225283
alpha O 0 0.012902945280075073
- O 0 0.00802712980657816
subunit O 0 0.006577050779014826
was O 0 0.004311534576117992
present O 0 0.0023538812529295683
, O 0 0.0018273245077580214
but O 0 0.0012254599714651704
its O 0 0.0014898208901286125
level O 0 0.0037266728468239307
was O 0 0.005083233583718538
much O 0 0.0018612833227962255
lower O 0 0.002530117053538561
than O 0 0.0008899705717340112
that O 0 0.0009744481067173183
from O 0 0.0017626405460759997
normal O 0 0.004989797715097666
alpha O 0 0.010839010588824749
- O 0 0.008445889689028263
subunit O 0 0.008319159969687462
transfections O 0 0.016445552930235863
, O 0 0.0023473496548831463
although O 0 0.0016861687181517482
higher O 0 0.0019485718803480268
than O 0 0.00094737479230389
in O 0 0.0015998961171135306
those O 0 0.0020247811917215586
cells O 0 0.004808380734175444
transfected O 0 0.014299115166068077
with O 0 0.0021023801527917385
an O 0 0.003523955587297678
alpha O 0 0.01629781350493431
- O 0 0.01104220561683178
subunit O 0 0.011370084248483181
associated O 0 0.00667297188192606
with O 0 0.008947092108428478
infantile O 1 0.9999996423721313
TSD B-Disease 1 0.9999997615814209
. O 0 0.03912830725312233

Furthermore O 0 0.022051943466067314
, O 0 0.006473366171121597
the O 0 0.004763911943882704
precursor O 0 0.010337348096072674
level O 0 0.003911812324076891
of O 0 0.002905139233916998
the O 0 0.005156084895133972
W474C O 1 0.8557509183883667
alpha O 0 0.01825079508125782
- O 0 0.007626415695995092
subunit O 0 0.0054197595454752445
was O 0 0.003644763957709074
found O 0 0.002047430258244276
to O 0 0.0015604174695909023
accumulate O 0 0.0039561716839671135
in O 0 0.0013703990262001753
comparison O 0 0.002441620687022805
to O 0 0.001597078749909997
the O 0 0.00317176291719079
normal O 0 0.007550423964858055
alpha O 0 0.016712678596377373
- O 0 0.013785143382847309
subunit O 0 0.015215633437037468
precursor O 0 0.022492969408631325
levels O 0 0.015989337116479874
. O 0 0.011970918625593185

We O 0 0.006331063341349363
conclude O 0 0.0073409248143434525
that O 0 0.002583156106993556
the O 0 0.007273925002664328
1422 O 1 0.999786913394928
G O 1 0.999669075012207
- O 1 0.8243129253387451
- O 0 0.02717086859047413
> O 0 0.015297042205929756
C O 0 0.011246598325669765
mutation O 0 0.004583206959068775
is O 0 0.0019433940760791302
the O 0 0.002424109261482954
cause O 0 0.005470410455018282
of O 0 0.00808357261121273
Hex B-Disease 1 0.9997355341911316
A I-Disease 1 0.9994055032730103
enzyme I-Disease 1 0.9999954700469971
deficiency I-Disease 1 1.0
in O 0 0.009655960835516453
the O 0 0.02069675922393799
proband O 1 0.9993207454681396
. O 0 0.016217024996876717

The O 0 0.017770541831851006
resulting O 0 0.015263929963111877
W474C O 0 0.3784041702747345
substitution O 0 0.014989507384598255
clearly O 0 0.008334694430232048
interferes O 0 0.013111517764627934
with O 0 0.003564460901543498
alpha O 0 0.016323866322636604
- O 0 0.009853996336460114
subunit O 0 0.007015235722064972
processing O 0 0.003944995813071728
, O 0 0.002211968647316098
but O 0 0.0011662495089694858
because O 0 0.0014416826888918877
the O 0 0.002175574656575918
base O 0 0.004530730191618204
substitution O 0 0.006702076178044081
falls O 0 0.009842288680374622
at O 0 0.0032775902654975653
the O 0 0.0022003152407705784
first O 0 0.002149849431589246
position O 0 0.00271912501193583
of O 0 0.0030503354500979185
exon O 0 0.01896592229604721
13 O 0 0.004450787790119648
, O 0 0.003159560030326247
aberrant O 0 0.013334378600120544
splicing O 0 0.007596653886139393
may O 0 0.0027767785359174013
also O 0 0.001967556541785598
contribute O 0 0.003585426602512598
to O 0 0.003013844368979335
Hex B-Disease 1 0.8324175477027893
A I-Disease 1 0.9156317710876465
deficiency I-Disease 1 0.9999998807907104
in O 0 0.00685916980728507
this O 0 0.005921254400163889
proband O 1 0.9854496717453003
. O 0 0.008169548586010933
. O 0 0.012061385437846184

Two O 0 0.009996331296861172
frequent O 0 0.018605442717671394
missense O 0 0.06812621653079987
mutations O 0 0.04251788929104805
in O 1 0.5383294224739075
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9484979510307312

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9869970083236694
an O 1 0.9999262094497681
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9993833303451538
early O 1 0.9999992847442627
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999997615814209
goiter B-Disease 1 1.0
. O 1 0.9982337951660156

A O 0 0.014073277823626995
century O 0 0.01113101001828909
after O 0 0.00462274020537734
its O 0 0.002238190732896328
recognition O 0 0.0038081412203609943
as O 0 0.0035556668881326914
a O 0 0.0396227091550827
syndrome O 1 1.0
by O 0 0.00454410957172513
Vaughan O 1 0.9990512728691101
Pendred O 1 0.9996472597122192
, O 0 0.004791088867932558
the O 0 0.01006058044731617
disease O 1 0.9999998807907104
gene O 0 0.05675602704286575
( O 0 0.01199764758348465
PDS O 1 0.9999324083328247
) O 0 0.0034264991991221905
was O 0 0.005804669577628374
mapped O 0 0.00812859833240509
to O 0 0.0044774254783988
chromosome O 0 0.02324521541595459
7q22 O 1 0.9867678284645081
- O 1 0.7768804430961609
q31 O 1 0.7813713550567627
. O 0 0.01828933134675026

1 O 0 0.019056199118494987
and O 0 0.004952507559210062
, O 0 0.004085861146450043
recently O 0 0.005327424965798855
, O 0 0.0024208156391978264
found O 0 0.0025830701924860477
to O 0 0.002406773157417774
encode O 0 0.007427687291055918
a O 0 0.009681684896349907
putative O 1 0.8847969770431519
sulfate O 1 0.9998979568481445
transporter O 1 0.9980930685997009
. O 0 0.028363468125462532

We O 0 0.009783330373466015
performed O 0 0.008393660187721252
mutation O 0 0.004932531621307135
analysis O 0 0.002400145633146167
of O 0 0.002875956706702709
the O 0 0.006659931968897581
PDS B-Disease 1 0.9999977350234985
gene O 0 0.00555987935513258
in O 0 0.002565203234553337
patients O 0 0.010084506124258041
from O 0 0.0026983581483364105
14 O 0 0.0052980687469244
Pendred B-Disease 0 0.15370795130729675
families O 0 0.0028129015117883682
originating O 0 0.0034826346673071384
from O 0 0.0015365398721769452
seven O 0 0.0017509059980511665
countries O 0 0.0011708702659234405
and O 0 0.0017820047214627266
identified O 0 0.005645616911351681
all O 0 0.004224288742989302
mutations O 0 0.013037473894655704
. O 0 0.010321877896785736

The O 0 0.012268506921827793
mutations O 0 0.007465072441846132
include O 0 0.0032689888030290604
three O 0 0.0023270249366760254
single O 0 0.004050129558891058
base O 0 0.005650571547448635
deletions O 0 0.0075143915601074696
, O 0 0.00286759901791811
one O 0 0.00329874106682837
splice O 0 0.017222393304109573
site O 0 0.007383354473859072
mutation O 0 0.006276736035943031
and O 0 0.0035008671693503857
10 O 0 0.008134863339364529
missense O 0 0.03884324058890343
mutations O 0 0.019860750064253807
. O 0 0.01441226340830326

One O 0 0.015924643725156784
missense O 0 0.03505435958504677
mutation O 0 0.016692379489541054
( O 0 0.010495991446077824
L236P O 0 0.4168590307235718
) O 0 0.0053589120507240295
was O 0 0.005392870865762234
found O 0 0.002171715022996068
in O 0 0.0018231943249702454
a O 0 0.002851382829248905
homozygous O 0 0.004714291077107191
state O 0 0.0017773930449038744
in O 0 0.0015704541001468897
two O 0 0.0017740912735462189
consanguineous O 0 0.05757594108581543
families O 0 0.0027756905183196068
and O 0 0.0018595708534121513
in O 0 0.002172374166548252
a O 0 0.002891906537115574
heterozygous O 0 0.00409814203158021
state O 0 0.0013639278477057815
in O 0 0.0012504708720371127
five O 0 0.002014027675613761
additional O 0 0.0033657150343060493
non O 0 0.01086887251585722
- O 0 0.030029350891709328
consanguineous O 1 0.5041459798812866
families O 0 0.012766937725245953
. O 0 0.013127810321748257

Another O 0 0.021347180008888245
missense O 0 0.04226089268922806
mutation O 0 0.01876233145594597
( O 0 0.010156701318919659
T416P O 1 0.9185386896133423
) O 0 0.003754465142264962
was O 0 0.004129085224121809
found O 0 0.0020722956396639347
in O 0 0.0017283206107094884
a O 0 0.002584621077403426
homozygous O 0 0.003628059523180127
state O 0 0.0013108360581099987
in O 0 0.0010619547683745623
one O 0 0.0014716638252139091
family O 0 0.0024741075467318296
and O 0 0.0012018821435049176
in O 0 0.0014772716676816344
a O 0 0.002193426014855504
heterozygous O 0 0.0038456914480775595
state O 0 0.0014917360385879874
in O 0 0.0020817203912883997
four O 0 0.0037883033510297537
families O 0 0.008325496688485146
. O 0 0.01031141821295023

Pendred B-Disease 1 0.9968054294586182
patients O 0 0.10815588384866714
in O 0 0.005341801326721907
three O 0 0.005289830267429352
non O 0 0.023753343150019646
- O 0 0.06588716804981232
consanguineous O 0 0.04254990816116333
families O 0 0.0038984499406069517
were O 0 0.0023723316844552755
shown O 0 0.0025069639086723328
to O 0 0.001489331480115652
be O 0 0.002146907150745392
compound O 0 0.00927693210542202
heterozygotes O 0 0.022038578987121582
for O 0 0.0049613178707659245
L236P O 1 0.8308857679367065
and O 0 0.008879988454282284
T416P O 1 0.8232547044754028
. O 0 0.018075937405228615

In O 0 0.007524007931351662
total O 0 0.005337878130376339
, O 0 0.003254661103710532
one O 0 0.0019035672303289175
or O 0 0.0013170191086828709
both O 0 0.0010018597822636366
of O 0 0.0013954391470178962
these O 0 0.0012801807606592774
mutations O 0 0.002343939384445548
were O 0 0.0011916010407730937
found O 0 0.0013479890767484903
in O 0 0.0012380477273836732
nine O 0 0.0018818373791873455
of O 0 0.0018530399538576603
the O 0 0.003422501962631941
14 O 0 0.005446889903396368
families O 0 0.004888520576059818
analyzed O 0 0.01364363543689251
. O 0 0.010825932025909424

The O 0 0.00899056252092123
identification O 0 0.007516647223383188
of O 0 0.00444437749683857
two O 0 0.0035629405174404383
frequent O 0 0.031232932582497597
PDS B-Disease 1 0.999997615814209
mutations O 0 0.006975649390369654
will O 0 0.0021564848721027374
facilitate O 0 0.004702595062553883
the O 0 0.00557254021987319
molecular O 0 0.020908832550048828
diagnosis O 1 0.9999740123748779
of O 1 0.9994816184043884
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.858301043510437

Insertional O 1 0.9591321349143982
mutation O 0 0.019879082217812538
by O 0 0.005777821410447359
transposable O 1 0.7068334221839905
element O 0 0.0163784921169281
, O 0 0.006177390459924936
L1 O 1 0.720521867275238
, O 0 0.003427879884839058
in O 0 0.0034588086418807507
the O 0 0.006396464072167873
DMD B-Disease 1 0.9999983310699463
gene O 0 0.005446580238640308
results O 0 0.0028036986477673054
in O 0 0.004543872084468603
X B-Disease 1 0.9997065663337708
- I-Disease 1 0.997338593006134
linked I-Disease 1 0.9926134347915649
dilated I-Disease 1 0.9999974966049194
cardiomyopathy I-Disease 1 1.0
. O 0 0.40801340341567993

X B-Disease 1 0.9993999004364014
- I-Disease 1 0.9691234827041626
linked I-Disease 1 0.9874070286750793
dilated I-Disease 1 0.9999986886978149
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999682903289795
XLDCM B-Disease 1 0.9999997615814209
) O 0 0.006003362126648426
is O 0 0.002621219027787447
a O 0 0.003708380041643977
clinical O 1 0.7943356037139893
phenotype O 0 0.014155254699289799
of O 0 0.006475262343883514
dystrophinopathy B-Disease 1 0.9995724558830261
which O 0 0.002683194587007165
is O 0 0.0030008312314748764
characterized O 0 0.009817026555538177
by O 0 0.0043509420938789845
preferential O 1 0.9927697777748108
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9107574224472046
without O 0 0.003325422527268529
any O 0 0.002630212577059865
overt O 0 0.015485935844480991
clinical O 1 0.9998712539672852
signs O 1 0.9994474053382874
of O 1 0.9999511241912842
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9351846575737

To O 0 0.005306879058480263
date O 0 0.0052263797260820866
, O 0 0.0026278395671397448
several O 0 0.0020067787263542414
mutations O 0 0.004218707792460918
in O 0 0.004099864978343248
the O 1 0.7582072019577026
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.999995231628418
, O 1 0.9443337321281433
DMD O 1 1.0
, O 0 0.003844351274892688
have O 0 0.0011982446303591132
been O 0 0.0018550679087638855
identified O 0 0.003302717348560691
in O 0 0.0031428018119186163
patients O 1 0.8466640114784241
with O 0 0.004222361370921135
XLDCM B-Disease 1 0.9999873638153076
, O 0 0.0036796696949750185
but O 0 0.0016159421065822244
a O 0 0.002583534922450781
pathogenic O 0 0.005833734758198261
correlation O 0 0.0029263184405863285
of O 0 0.001972031779587269
these O 0 0.0023498490918427706
cardiospecific O 0 0.45002609491348267
mutations O 0 0.006449446547776461
in O 0 0.0048654149286448956
DMD O 1 0.9999988079071045
with O 0 0.0047001224011182785
the O 0 0.02684229426085949
XLDCM B-Disease 1 0.9999972581863403
phenotype O 0 0.02656407095491886
has O 0 0.004118398763239384
remained O 0 0.008809905499219894
to O 0 0.003164489520713687
be O 0 0.005079280119389296
elucidated O 0 0.04679249972105026
. O 0 0.014818856492638588

We O 0 0.007216709665954113
report O 0 0.004978323820978403
here O 0 0.0031646008137613535
the O 0 0.0023767687380313873
identification O 0 0.002755021909251809
of O 0 0.002075976924970746
a O 0 0.002969516208395362
unique O 0 0.005903208628296852
de O 0 0.08032292127609253
novo O 1 0.5816762447357178
L1 O 1 0.8792321681976318
insertion O 0 0.011343085207045078
in O 0 0.003530458314344287
the O 0 0.005895736627280712
muscle O 1 0.9237151145935059
exon O 0 0.3130771517753601
1 O 0 0.00604954594746232
in O 0 0.0034963670186698437
DMD O 1 0.9999856948852539
in O 0 0.0031677375081926584
three O 0 0.003526245476678014
XLDCM B-Disease 1 0.9999884366989136
patients O 0 0.29612600803375244
from O 0 0.0024920650757849216
two O 0 0.0022891315165907145
unrelated O 0 0.014025607146322727
Japanese O 0 0.295192152261734
families O 0 0.013436672277748585
. O 0 0.014065385796129704

The O 0 0.01514121238142252
insertion O 0 0.01986096054315567
was O 0 0.010998918674886227
a O 0 0.0063735973089933395
5 O 0 0.007652338594198227
- O 0 0.008641628548502922
truncated O 0 0.009809252806007862
form O 0 0.0023983458522707224
of O 0 0.004121112637221813
human O 0 0.008688453584909439
L1 O 1 0.9831447601318359
inversely O 0 0.01211187057197094
integrated O 0 0.007096686400473118
in O 0 0.0024999789893627167
the O 0 0.004071950912475586
5 O 0 0.006574288010597229
- O 0 0.008590413257479668
untranslated O 0 0.014737416990101337
region O 0 0.004440249875187874
in O 0 0.0025204576086252928
the O 0 0.004689965862780809
muscle O 1 0.9982126951217651
exon O 1 0.8760349750518799
1 O 0 0.005324156489223242
, O 0 0.0018842096906155348
which O 0 0.0012812035856768489
affected O 0 0.0024046676699072123
the O 0 0.00229815230704844
transcription O 0 0.005675552878528833
or O 0 0.0018750010058283806
the O 0 0.002439656527712941
stability O 0 0.004860142711549997
of O 0 0.0033351026941090822
the O 0 0.02064095064997673
muscle O 1 0.9954401254653931
form O 0 0.004165781661868095
of O 0 0.011944655328989029
dystrophin O 1 0.9993416666984558
transcripts O 0 0.006191024091094732
but O 0 0.001268210238777101
not O 0 0.0007240242557600141
that O 0 0.0007568128639832139
of O 0 0.0019540453795343637
the O 0 0.014031992293894291
brain O 1 0.999920129776001
or O 0 0.022282812744379044
Purkinje O 1 0.9999986886978149
cell O 0 0.3525135815143585
form O 0 0.002993832342326641
, O 0 0.0023802854120731354
probably O 0 0.0030460620764642954
due O 0 0.0019847210496664047
to O 0 0.001350359176285565
its O 0 0.0013547181151807308
unique O 0 0.002762832911685109
site O 0 0.005196437705308199
of O 0 0.005805883090943098
integration O 0 0.021331634372472763
. O 0 0.014034010469913483

We O 0 0.00933152623474598
speculate O 0 0.009593155235052109
that O 0 0.0019149838481098413
this O 0 0.0017035098280757666
insertion O 0 0.0064277034252882
of O 0 0.0028542776126414537
an O 0 0.004325727466493845
L1 O 1 0.9680410623550415
sequence O 0 0.006863033398985863
in O 0 0.006487151142209768
DMD O 1 0.9999992847442627
is O 0 0.0030548919457942247
responsible O 0 0.0030365530401468277
for O 0 0.0013292187359184027
some O 0 0.000898731523193419
of O 0 0.0013993029715493321
the O 0 0.0015277555212378502
population O 0 0.0013470709091052413
of O 0 0.002817316446453333
Japanese O 1 0.9882301092147827
patients O 1 0.9924526810646057
with O 0 0.006165321450680494
XLDCM B-Disease 1 0.9999929666519165
. O 0 0.007647752296179533
. O 0 0.010226646438241005

Severe O 1 0.9999152421951294
early O 1 0.9957491159439087
- O 1 0.9999985694885254
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999942779541016
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999905824661255
red O 1 1.0
hair O 1 0.9999997615814209
pigmentation O 1 0.9999998807907104
caused O 1 0.9998593330383301
by O 0 0.09529680758714676
POMC O 1 0.9999998807907104
mutations O 0 0.01364122238010168
in O 0 0.00608073128387332
humans O 0 0.011014584451913834
. O 0 0.011081854812800884

Sequential O 0 0.03619644418358803
cleavage O 0 0.029880907386541367
of O 0 0.006355729419738054
the O 0 0.006426576990634203
precursor O 0 0.0202247966080904
protein O 0 0.007482794113457203
pre O 0 0.016350295394659042
- O 0 0.01647445559501648
pro O 0 0.01931028999388218
- O 0 0.09530871361494064
opiomelanocortin O 1 0.9875497221946716
( O 0 0.016418064013123512
POMC O 1 0.9982080459594727
) O 0 0.0070189437828958035
generates O 0 0.006902013439685106
the O 0 0.00783806573599577
melanocortin O 1 0.9843186736106873
peptides O 0 0.02405666932463646
adrenocorticotrophin O 1 0.8424320220947266
( O 0 0.020592806860804558
ACTH O 1 0.999681830406189
) O 0 0.007344727870076895
, O 0 0.00876354519277811
melanocyte O 1 0.9998366832733154
- O 1 0.8908300399780273
stimulating O 1 0.9197078943252563
hormones O 1 0.6864657998085022
( O 0 0.017336905002593994
MSH O 1 0.9999797344207764
) O 0 0.0069946288131177425
alpha O 0 0.009482769295573235
, O 0 0.002818882931023836
beta O 0 0.00600152462720871
and O 0 0.0017596964025869966
gamma O 0 0.005537404213100672
as O 0 0.0015224881935864687
well O 0 0.0013464385410770774
as O 0 0.0023495976347476244
the O 0 0.005603065714240074
opioid O 1 0.9957327246665955
- O 0 0.28102946281433105
receptor O 0 0.019848696887493134
ligand O 0 0.03450259566307068
beta O 0 0.08761163800954819
- O 0 0.07393697649240494
endorphin O 1 0.8205080032348633
. O 0 0.020803352817893028

While O 0 0.008873535320162773
a O 0 0.00452560605481267
few O 0 0.003272334113717079
cases O 0 0.004794914275407791
of O 0 0.02021278627216816
isolated O 1 0.9999973773956299
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.0030711388681083918
been O 0 0.0036271477583795786
reported O 0 0.008548945188522339
( O 0 0.00972981657832861
OMIM O 1 0.9998847246170044
201400 O 1 0.7918274998664856
) O 0 0.00450172508135438
, O 0 0.0033184983767569065
an O 0 0.005982053931802511
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.9999998807907104
has O 0 0.004211702384054661
not O 0 0.0015407407190650702
been O 0 0.0027324033435434103
described O 0 0.006082179024815559
so O 0 0.003657632041722536
far O 0 0.00565484119579196
. O 0 0.010157079435884953

Recent O 0 0.010966763831675053
studies O 0 0.006682154256850481
in O 0 0.00457695871591568
animal O 0 0.008490988984704018
models O 0 0.0055514113046228886
elucidated O 0 0.015522285364568233
a O 0 0.003244550433009863
central O 0 0.00519070727750659
role O 0 0.004811435472220182
of O 0 0.005505687557160854
alpha O 1 0.8661214709281921
- O 0 0.1681189239025116
MSH O 1 0.9982049465179443
in O 0 0.0025447080843150616
the O 0 0.0024591954424977303
regulation O 0 0.0031716665253043175
of O 0 0.002734306501224637
food O 0 0.005522245075553656
intake O 0 0.007453348487615585
by O 0 0.0017543688882142305
activation O 0 0.004273847211152315
of O 0 0.002863227156922221
the O 0 0.006545171607285738
brain O 1 0.9977055191993713
melanocortin O 1 0.9999918937683105
- O 0 0.15594804286956787
4 O 0 0.010599562898278236
- O 0 0.013557422906160355
receptor O 0 0.011577400378882885
( O 0 0.008867179974913597
MC4 O 1 0.9988425374031067
- O 0 0.017771698534488678
R O 0 0.017938736826181412
; O 0 0.0033211393747478724
refs O 0 0.013272951357066631
3 O 0 0.004599580075591803
- O 0 0.005383865442126989
5 O 0 0.002444043755531311
) O 0 0.0012247691629454494
and O 0 0.000916606280952692
the O 0 0.002152590546756983
linkage O 0 0.006753767840564251
of O 0 0.0037309685721993446
human O 0 0.4663075804710388
obesity B-Disease 1 0.9999997615814209
to O 0 0.003833990776911378
chromosome O 0 0.006814911961555481
2 O 0 0.0028714777436107397
in O 0 0.001231217524036765
close O 0 0.002459319308400154
proximity O 0 0.0031476423610001802
to O 0 0.0020509103778749704
the O 0 0.006184824742376804
POMC O 1 0.999996542930603
locus O 0 0.01851615123450756
, O 0 0.0028035789728164673
led O 0 0.0027676590252667665
to O 0 0.0013153395848348737
the O 0 0.0017087107989937067
proposal O 0 0.002376681426540017
of O 0 0.001958802342414856
an O 0 0.0026234688702970743
association O 0 0.008947446942329407
of O 0 0.014402065426111221
POMC O 1 0.9999995231628418
with O 0 0.014080788008868694
human O 1 0.960693359375
obesity B-Disease 1 0.9999997615814209
. O 0 0.03886605426669121

The O 0 0.010522302240133286
dual O 0 0.013196567073464394
role O 0 0.008188982494175434
of O 0 0.009692004881799221
alpha O 1 0.9782379865646362
- O 1 0.5279136300086975
MSH O 1 0.9996702671051025
in O 0 0.004376394674181938
regulating O 0 0.01006406731903553
food O 0 0.012529146857559681
intake O 0 0.02545066736638546
and O 0 0.006916665937751532
influencing O 0 0.3515404760837555
hair O 1 0.9997157454490662
pigmentation O 1 0.9999833106994629
predicts O 0 0.08123175799846649
that O 0 0.0027942887973040342
the O 0 0.0043869162909686565
phenotype O 0 0.00830578152090311
associated O 0 0.00354725681245327
with O 0 0.0021796049550175667
a O 0 0.005565982777625322
defect O 1 0.997494101524353
in O 0 0.008190794847905636
POMC O 1 0.9999850988388062
function O 0 0.0049790204502642155
would O 0 0.00241003162227571
include O 0 0.0052366554737091064
obesity B-Disease 1 0.9999997615814209
, O 0 0.008005773648619652
alteration O 1 0.9949098229408264
in O 0 0.48773932456970215
pigmentation O 1 1.0
and O 1 0.9999853372573853
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.08127189427614212

The O 0 0.010827003046870232
observation O 0 0.014022196643054485
of O 0 0.005181103479117155
these O 0 0.003028606530278921
symptoms O 1 0.9998204112052917
in O 0 0.0040433816611766815
two O 0 0.0030854265205562115
probands O 1 0.6560013294219971
prompted O 0 0.006724881008267403
us O 0 0.0026971788611263037
to O 0 0.0013707333710044622
search O 0 0.002899716142565012
for O 0 0.0020533869974315166
mutations O 0 0.0043561384081840515
within O 0 0.003113734070211649
their O 0 0.0053827292285859585
POMC O 1 0.9999725818634033
genes O 0 0.020476195961236954
. O 0 0.014277168549597263

Patient O 1 0.9977360963821411
1 O 0 0.016658291220664978
was O 0 0.0071179429069161415
found O 0 0.0028590967413038015
to O 0 0.0014154312666505575
be O 0 0.0012804887956008315
a O 0 0.002908901311457157
compound O 0 0.00840227585285902
heterozygote O 0 0.011997059918940067
for O 0 0.0016148099675774574
two O 0 0.0014580351999029517
mutations O 0 0.0028925032820552588
in O 0 0.0025246834848076105
exon O 0 0.01871132105588913
3 O 0 0.0060774702578783035
( O 0 0.004832986276596785
G7013T O 0 0.027882538735866547
, O 0 0.004682538099586964
C7133delta O 1 0.9461735486984253
) O 0 0.003073265077546239
which O 0 0.0013066851533949375
interfere O 0 0.0029149234760552645
with O 0 0.0015658097108826041
appropriate O 0 0.0036251661367714405
synthesis O 0 0.006421433761715889
of O 0 0.006449654698371887
ACTH O 1 0.9999749660491943
and O 0 0.01121084950864315
alpha O 1 0.8370345830917358
- O 1 0.6416861414909363
MSH O 1 0.9996020197868347
. O 0 0.023547548800706863

Patient O 1 0.940065324306488
2 O 0 0.011960196308791637
was O 0 0.007870616391301155
homozygous O 0 0.005253092385828495
for O 0 0.0018027561018243432
a O 0 0.0028960700146853924
mutation O 0 0.0044708456844091415
in O 0 0.002932222094386816
exon O 0 0.021052563562989235
2 O 0 0.007649191655218601
( O 0 0.006794049870222807
C3804A O 0 0.02972019650042057
) O 0 0.006414551753550768
which O 0 0.005906565114855766
abolishes O 1 0.8984311819076538
POMC O 1 0.9999758005142212
translation O 0 0.0384790413081646
. O 0 0.02189096249639988

These O 0 0.004410468973219395
findings O 0 0.005422718822956085
represent O 0 0.002985642058774829
the O 0 0.002284656511619687
first O 0 0.0023064613342285156
examples O 0 0.0029474080074578524
of O 0 0.0029910351149737835
a O 0 0.008406424894928932
genetic B-Disease 1 0.9952570796012878
defect I-Disease 1 0.999985933303833
within O 0 0.00478461803868413
the O 0 0.06921619921922684
POMC O 1 0.9999986886978149
gene O 0 0.005036290269345045
and O 0 0.0016219783574342728
define O 0 0.004040710162371397
a O 0 0.004076364450156689
new O 0 0.008590097539126873
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9880742430686951
in O 0 0.09569664299488068
early O 1 0.995617151260376
- O 1 0.9999970197677612
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.99998939037323
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999371767044067
red O 1 0.9999995231628418
hair O 1 0.999998927116394
pigmentation O 1 0.9999992847442627
. O 0 0.017426572740077972
. O 0 0.015978461131453514

A O 0 0.01764790154993534
European O 0 0.010549882426857948
multicenter O 0 0.44443395733833313
study O 0 0.009895788505673409
of O 0 0.34567052125930786
phenylalanine B-Disease 1 0.9999998807907104
hydroxylase I-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
: O 0 0.007887198589742184
classification O 0 0.011345888487994671
of O 0 0.004970421548932791
105 O 0 0.014936431311070919
mutations O 0 0.003797809826210141
and O 0 0.0017454262124374509
a O 0 0.002596912207081914
general O 0 0.005678484681993723
system O 0 0.004239281639456749
for O 0 0.003504592226818204
genotype O 0 0.014203010126948357
- O 0 0.0080751096829772
based O 0 0.004606719594448805
prediction O 0 0.01372390054166317
of O 0 0.013600260019302368
metabolic O 1 0.9997610449790955
phenotype O 0 0.18953163921833038
. O 0 0.021462222561240196

Phenylketonuria B-Disease 1 0.9999963045120239
( O 1 0.9701343178749084
PKU B-Disease 1 0.9999996423721313
) O 0 0.009750020690262318
and O 0 0.0053831301629543304
mild B-Disease 1 0.9999550580978394
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9999333620071411
MHP B-Disease 1 1.0
) O 0 0.008463387377560139
are O 0 0.0033098007552325726
allelic B-Disease 1 0.9998314380645752
disorders I-Disease 1 1.0
caused O 1 0.9995023012161255
by O 0 0.004926497116684914
mutations O 0 0.005423680879175663
in O 0 0.0028582538943737745
the O 0 0.0052870032377541065
gene O 0 0.010145897045731544
encoding O 0 0.013287327252328396
phenylalanine O 0 0.11492742598056793
hydroxylase O 1 0.9902847409248352
( O 0 0.12326489388942719
PAH O 1 0.9999954700469971
) O 0 0.022831415757536888
. O 0 0.018210968002676964

Previous O 0 0.012597113847732544
studies O 0 0.005429638084024191
have O 0 0.0017036653589457273
suggested O 0 0.003023094730451703
that O 0 0.0011688927188515663
the O 0 0.002704442013055086
highly O 0 0.005664348602294922
variable O 0 0.010388756170868874
metabolic O 1 0.992567777633667
phenotypes O 1 0.9972476363182068
of O 1 0.9999853372573853
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9996415376663208
with O 1 0.8928954601287842
PAH O 1 1.0
genotypes O 1 0.9983882904052734
. O 0 0.023703690618276596

We O 0 0.007048420142382383
identified O 0 0.007461081258952618
both O 0 0.0037540453486144543
causative O 1 0.8188480138778687
mutations O 0 0.007809613365679979
in O 0 0.004880961496382952
686 O 1 0.9997530579566956
patients O 1 0.9199276566505432
from O 0 0.0036092898808419704
seven O 0 0.004941719118505716
European O 0 0.00615416094660759
centers O 0 0.018239043653011322
. O 0 0.01318731065839529

On O 0 0.007990095764398575
the O 0 0.004229932092130184
basis O 0 0.0025349375791847706
of O 0 0.0025133490562438965
the O 0 0.0032768689561635256
phenotypic O 0 0.0075268992222845554
characteristics O 0 0.005517295096069574
of O 0 0.006446941755712032
297 O 1 0.997734785079956
functionally O 1 0.9977476000785828
hemizygous O 1 0.9996418952941895
patients O 0 0.22030331194400787
, O 0 0.002750202314928174
105 O 0 0.005665363743901253
of O 0 0.0021678402554243803
the O 0 0.0029040840454399586
mutations O 0 0.0026126636657863855
were O 0 0.0012248276034370065
assigned O 0 0.0030063230078667402
to O 0 0.000979122007265687
one O 0 0.0011721490882337093
of O 0 0.0019659765530377626
four O 0 0.0034890647511929274
arbitrary O 0 0.008581042289733887
phenotype O 0 0.021481294184923172
categories O 0 0.01471700705587864
. O 0 0.014645738527178764

We O 0 0.008052288554608822
proposed O 0 0.006177209783345461
and O 0 0.003118776250630617
tested O 0 0.005927746649831533
a O 0 0.0024927358608692884
simple O 0 0.0029635103419423103
model O 0 0.0036008700262755156
for O 0 0.002115469891577959
correlation O 0 0.005892448592931032
between O 0 0.004225931596010923
genotype O 0 0.012278136797249317
and O 0 0.004420608282089233
phenotypic O 0 0.019425496459007263
outcome O 0 0.0207402091473341
. O 0 0.015177874825894833

The O 0 0.016497580334544182
observed O 0 0.013650855980813503
phenotype O 0 0.015682237222790718
matched O 0 0.008641297928988934
the O 0 0.004925515037029982
predicted O 0 0.00925628561526537
phenotype O 0 0.007443241775035858
in O 0 0.0025375576224178076
79 O 0 0.008021997287869453
% O 0 0.0024108137004077435
of O 0 0.0018932238453999162
the O 0 0.002674971939995885
cases O 0 0.0030614600982517004
, O 0 0.0021093403920531273
and O 0 0.0013054896844550967
in O 0 0.0013603157131001353
only O 0 0.0012797119561582804
5 O 0 0.0022059606853872538
of O 0 0.002246960997581482
184 O 0 0.024945667013525963
patients O 0 0.2840036153793335
was O 0 0.008028542622923851
the O 0 0.003870839485898614
observed O 0 0.0039048923645168543
phenotype O 0 0.0037031937390565872
more O 0 0.000718054361641407
than O 0 0.0008908614399842918
one O 0 0.0016174351330846548
category O 0 0.00388978305272758
away O 0 0.002796452958136797
from O 0 0.0024607188533991575
that O 0 0.0029738913290202618
expected O 0 0.008790996856987476
. O 0 0.011468565091490746

Among O 0 0.009344164282083511
the O 0 0.00607386464253068
seven O 0 0.005466696806252003
contributing O 0 0.00864245742559433
centers O 0 0.006001930683851242
, O 0 0.002432240406051278
the O 0 0.002574399346485734
proportion O 0 0.0039498391561210155
of O 0 0.0037629783619195223
patients O 1 0.747614860534668
for O 0 0.0024162346962839365
whom O 0 0.004420650657266378
the O 0 0.003455767408013344
observed O 0 0.004396337550133467
phenotype O 0 0.005616453476250172
did O 0 0.0014614146202802658
not O 0 0.0009122811025008559
match O 0 0.002605969784781337
the O 0 0.0023083349224179983
predicted O 0 0.006103500723838806
phenotype O 0 0.005367395468056202
was O 0 0.004132295958697796
4 O 0 0.003803325118497014
% O 0 0.002667661989107728
- O 0 0.004707116633653641
23 O 0 0.004080174025148153
% O 0 0.0034685968421399593
( O 0 0.005519221071153879
P O 0 0.033157866448163986
< O 0 0.016189582645893097
. O 0 0.003411016194149852
0001 O 0 0.3253031075000763
) O 0 0.0028018567245453596
, O 0 0.0017840330256149173
suggesting O 0 0.0023174271918833256
that O 0 0.0008635074482299387
differences O 0 0.0014381229411810637
in O 0 0.0012738554505631328
methods O 0 0.0016893011052161455
used O 0 0.0016862144693732262
for O 0 0.0021474864333868027
mutation O 0 0.005072773899883032
detection O 0 0.0066032265312969685
or O 0 0.0032422628719359636
phenotype O 0 0.009198950603604317
classification O 0 0.009155422449111938
may O 0 0.002363331848755479
account O 0 0.0015896193217486143
for O 0 0.0013762186281383038
a O 0 0.002205322962254286
considerable O 0 0.005141064524650574
proportion O 0 0.005926230456680059
of O 0 0.007982607930898666
genotype O 1 0.9766077995300293
- O 1 0.516751229763031
phenotype O 0 0.026426328346133232
inconsistencies O 0 0.03475155308842659
. O 0 0.016409996896982193

Our O 0 0.010248911567032337
data O 0 0.004565171431750059
indicate O 0 0.005377577617764473
that O 0 0.0030325716361403465
the O 0 0.013947628438472748
PAH O 1 1.0
- O 1 0.8830814361572266
mutation O 0 0.009524617344141006
genotype O 0 0.008232397958636284
is O 0 0.0016314300009980798
the O 0 0.002630262402817607
main O 0 0.006448982283473015
determinant O 0 0.03646702691912651
of O 0 0.007877481169998646
metabolic O 1 0.999733030796051
phenotype O 0 0.043442513793706894
in O 0 0.0038723363541066647
most O 0 0.006622948683798313
patients O 1 0.9999878406524658
with O 1 0.9998881816864014
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.3159557580947876

In O 0 0.007098854519426823
the O 0 0.005072754342108965
present O 0 0.003440177533775568
study O 0 0.002824540948495269
, O 0 0.0017113089561462402
the O 0 0.002534684259444475
classification O 0 0.009104921482503414
of O 0 0.0134357875213027
105 O 1 0.9997778534889221
PAH O 1 1.0
mutations O 0 0.007747665513306856
may O 0 0.002063995460048318
allow O 0 0.001090789563022554
the O 0 0.0018211188726127148
prediction O 0 0.0044970642775297165
of O 0 0.0018698276253417134
the O 0 0.00367011409252882
biochemical O 0 0.01070776954293251
phenotype O 0 0.007814406417310238
in O 0 0.003014082321897149
> O 0 0.008710372261703014
10 O 0 0.002746407175436616
, O 0 0.0026538569945842028
000 O 0 0.010022731497883797
genotypes O 0 0.014341370202600956
, O 0 0.0023041877429932356
which O 0 0.0013401621254161
may O 0 0.0016012752894312143
be O 0 0.000884238921571523
useful O 0 0.0016357579734176397
for O 0 0.0014680945314466953
the O 0 0.0026741959154605865
management O 0 0.0077674719505012035
of O 0 0.009902727790176868
hyperphenylalaninemia B-Disease 1 0.9999977350234985
in O 0 0.03478001058101654
newborns O 1 0.9985143542289734
. O 0 0.018505582585930824

Somatic O 0 0.06924612075090408
instability O 0 0.02992061711847782
of O 0 0.010140749625861645
the O 0 0.01514996774494648
CTG O 1 0.9997772574424744
repeat O 0 0.016920756548643112
in O 0 0.004786393605172634
mice O 0 0.00897626206278801
transgenic O 0 0.010484638623893261
for O 0 0.0045501659624278545
the O 0 0.20403163135051727
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9996802806854248
is O 0 0.024739878252148628
age O 0 0.012802518904209137
dependent O 0 0.0037827950436621904
but O 0 0.001090435078367591
not O 0 0.0009253865573555231
correlated O 0 0.0028933833818882704
to O 0 0.0012803045101463795
the O 0 0.002614398719742894
relative O 0 0.008666477166116238
intertissue O 1 0.9266114830970764
transcription O 0 0.025100333616137505
levels O 0 0.011524108238518238
and O 0 0.009665618650615215
proliferative O 1 0.9999964237213135
capacities O 1 0.9557070732116699
. O 0 0.0219968780875206

A O 0 0.028428470715880394
( O 0 0.021189572289586067
CTG O 1 0.9879526495933533
) O 0 0.005214215721935034
nexpansion O 0 0.014095286838710308
in O 0 0.002304907888174057
the O 0 0.0035461916122585535
3 O 0 0.007712820079177618
- O 0 0.012748445384204388
untranslated O 0 0.02822902984917164
region O 0 0.0059488071128726006
( O 0 0.005487780552357435
UTR O 0 0.025982674211263657
) O 0 0.0024563181214034557
of O 0 0.0028837095014750957
the O 0 0.009469687938690186
DM O 1 1.0
protein O 0 0.012937505729496479
kinase O 0 0.01445221807807684
gene O 0 0.006572101730853319
( O 0 0.005765186157077551
DMPK O 1 0.649573028087616
) O 0 0.0030100042931735516
is O 0 0.0022645872086286545
responsible O 0 0.005660927854478359
for O 0 0.007307501044124365
causing O 1 0.9999836683273315
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.06640203297138214
. O 0 0.014602860435843468

Major O 1 0.5378029346466064
instability O 1 0.9496752619743347
, O 0 0.004695734474807978
with O 0 0.0021505921613425016
very O 0 0.002447515958920121
large O 0 0.002556467894464731
expansions O 0 0.006843894720077515
between O 0 0.0023544218856841326
generations O 0 0.004235174041241407
and O 0 0.0018393811769783497
high O 0 0.005205497145652771
levels O 0 0.0043337526731193066
of O 0 0.005233037285506725
somatic O 1 0.9977980852127075
mosaicism O 1 0.9998291730880737
, O 0 0.003340695984661579
is O 0 0.002825550502166152
observed O 0 0.004595080390572548
in O 0 0.005553026217967272
patients O 1 0.9497877359390259
. O 0 0.013270365074276924

There O 0 0.00724099250510335
is O 0 0.004049469251185656
a O 0 0.003065695520490408
good O 0 0.003082424635067582
correlation O 0 0.003369552781805396
between O 0 0.001839206088334322
repeat O 0 0.005817830096930265
size O 0 0.002758023561909795
( O 0 0.0023176984395831823
at O 0 0.002165753860026598
least O 0 0.0012939672451466322
in O 0 0.002398478100076318
leucocytes O 0 0.4446234405040741
) O 0 0.003367919474840164
, O 0 0.0029566220473498106
clinical O 0 0.32791611552238464
severity O 1 0.9770887494087219
and O 0 0.004645548295229673
age O 0 0.015465927310287952
of O 0 0.4118497669696808
onset O 1 0.9999998807907104
. O 0 0.035297393798828125

The O 0 0.0285545252263546
trinucleotide O 1 0.9997308850288391
repeat O 0 0.369850754737854
instability O 0 0.06840856373310089
mechanisms O 0 0.008307626470923424
involved O 0 0.00545243127271533
in O 0 0.008744239807128906
DM B-Disease 1 1.0
and O 0 0.0033959844149649143
other O 0 0.0025113774463534355
human O 0 0.33463144302368164
genetic B-Disease 1 0.9999850988388062
diseases I-Disease 1 1.0
are O 0 0.005363105330616236
unknown O 0 0.017653558403253555
. O 0 0.010919962078332901

We O 0 0.010857759974896908
studied O 0 0.018844248726963997
somatic O 0 0.02458111196756363
instability O 0 0.01728934794664383
by O 0 0.004722706042230129
measuring O 0 0.01695018634200096
the O 0 0.009430867619812489
CTG O 1 0.9990566372871399
repeat O 0 0.01085274200886488
length O 0 0.0035787750966846943
at O 0 0.002688600216060877
several O 0 0.001199590042233467
ages O 0 0.0027277711778879166
in O 0 0.0014841074589639902
various O 0 0.0019348447676748037
tissues O 0 0.007234345655888319
of O 0 0.004386191256344318
transgenic O 0 0.047168660908937454
mice O 0 0.006673920433968306
carrying O 0 0.004295328166335821
a O 0 0.004270307719707489
( O 0 0.007776112295687199
CTG O 1 0.9927615523338318
) O 0 0.005786220543086529
55expansion O 0 0.015454809181392193
surrounded O 0 0.006740831770002842
by O 0 0.0019493872532621026
45 O 0 0.0037867489736527205
kb O 0 0.013119394890964031
of O 0 0.003208951558917761
the O 0 0.006364013999700546
human O 1 0.7316479086875916
DM B-Disease 1 1.0
region O 0 0.007242576684802771
, O 0 0.002703435020521283
using O 0 0.0028108826372772455
small O 0 0.005039937794208527
- O 0 0.016930177807807922
pool O 0 0.027286207303404808
PCR O 0 0.03782357648015022
. O 0 0.01313499640673399

These O 0 0.008360330946743488
mice O 0 0.011908343993127346
have O 0 0.0018446837784722447
been O 0 0.0019891916308552027
shown O 0 0.0019464060897007585
to O 0 0.00143665901850909
reproduce O 0 0.0030592181719839573
the O 0 0.0031027484219521284
intergenerational O 0 0.3994017541408539
and O 0 0.0033257545437663794
somatic O 0 0.019049372524023056
instability O 0 0.01254214532673359
of O 0 0.004848286509513855
the O 0 0.0074806055054068565
55 O 0 0.014976361766457558
CTG O 1 0.9987953901290894
repeat O 0 0.012066652067005634
suggesting O 0 0.003915783949196339
that O 0 0.0011458073277026415
surrounding O 0 0.003132805461063981
sequences O 0 0.0025771947111934423
and O 0 0.0013642397243529558
the O 0 0.0027082336600869894
chromatin O 0 0.006841311696916819
environment O 0 0.00382820563390851
are O 0 0.0012837907997891307
involved O 0 0.0035477401688694954
in O 0 0.005800557788461447
instability O 1 0.9019765257835388
mechanisms O 0 0.04036514461040497
. O 0 0.017280641943216324

As O 0 0.00692560663446784
observed O 0 0.0033858937676995993
in O 0 0.001603887532837689
some O 0 0.0009483194444328547
of O 0 0.00197440548799932
the O 0 0.0045018685050308704
tissues O 1 0.983363151550293
of O 1 0.9982523322105408
DM B-Disease 1 1.0
patients O 1 0.9999957084655762
, O 0 0.003602401353418827
there O 0 0.001588767278008163
is O 0 0.0015186931705102324
a O 0 0.002013428835198283
tendency O 0 0.003516279859468341
for O 0 0.0022337737027555704
repeat O 0 0.009497109800577164
length O 0 0.004967694170773029
and O 0 0.003242964157834649
somatic O 0 0.020021460950374603
mosaicism O 0 0.23291358351707458
to O 0 0.0017740980256348848
increase O 0 0.001496527111157775
with O 0 0.0010910715209320188
the O 0 0.0023278610315173864
age O 0 0.004294083919376135
of O 0 0.0051427618600428104
the O 0 0.010497061535716057
mouse O 0 0.02815920300781727
. O 0 0.011259425431489944

Furthermore O 0 0.023102479055523872
, O 0 0.005842017941176891
we O 0 0.002569798147305846
observed O 0 0.002987229498103261
no O 0 0.0019766753539443016
correlation O 0 0.004275322891771793
between O 0 0.0022325729951262474
the O 0 0.004642176441848278
somatic O 0 0.027018893510103226
mutation O 0 0.009425763040781021
rate O 0 0.006549135781824589
and O 0 0.007093418389558792
tissue O 1 0.999336302280426
proliferation O 1 0.9140839576721191
capacity O 0 0.024612046778202057
. O 0 0.014679688028991222

The O 0 0.024766502901911736
somatic O 0 0.07814345508813858
mutation O 0 0.011077205650508404
rates O 0 0.004487396217882633
in O 0 0.0019882868509739637
different O 0 0.001780170015990734
tissues O 0 0.007088758982717991
were O 0 0.0018532993271946907
also O 0 0.0017106053419411182
not O 0 0.0008457925287075341
correlated O 0 0.0024261209182441235
to O 0 0.0009717047796584666
the O 0 0.0020822591613978148
relative O 0 0.00685042142868042
inter O 1 0.9920414090156555
- O 1 0.6728764176368713
tissue O 0 0.011656827293336391
difference O 0 0.002959582256153226
in O 0 0.0015427368925884366
transcriptional O 0 0.004379188176244497
levels O 0 0.0018922616727650166
of O 0 0.0012104795314371586
the O 0 0.0016406462527811527
three O 0 0.001726291375234723
genes O 0 0.0037426939234137535
( O 0 0.0036560753360390663
DMAHP O 1 0.8570018410682678
, O 0 0.003989916294813156
DMPK O 1 0.9851446151733398
and O 0 0.003116083797067404
59 O 0 0.009240522049367428
) O 0 0.0029177414253354073
surrounding O 0 0.005029461812227964
the O 0 0.005764196161180735
repeat O 0 0.02219333127140999
. O 0 0.0073327855207026005
. O 0 0.010875016450881958

A O 0 0.02010907605290413
novel O 0 0.023530608043074608
missense O 0 0.03268897533416748
mutation O 0 0.011605881154537201
in O 0 0.004617012571543455
patients O 0 0.4773261249065399
from O 0 0.0039868708699941635
a O 0 0.01079571433365345
retinoblastoma B-Disease 1 0.9999915361404419
pedigree O 1 0.5099117755889893
showing O 0 0.006340182851999998
only O 0 0.002535323379561305
mild O 0 0.02162300795316696
expression O 0 0.004801472183316946
of O 0 0.006449126172810793
the O 1 0.9497630000114441
tumor B-Disease 1 0.9999998807907104
phenotype O 1 0.9018574357032776
. O 0 0.014174602925777435

We O 0 0.0065860203467309475
have O 0 0.002418049145489931
used O 0 0.003225949127227068
single O 0 0.004939721897244453
strand O 0 0.00993394199758768
conformation O 0 0.007900726050138474
polymorphism O 0 0.004328923765569925
analysis O 0 0.0014731788542121649
to O 0 0.0010280346032232046
study O 0 0.0018999424064531922
the O 0 0.0026173570659011602
27 O 0 0.005080087576061487
exons O 0 0.006030768621712923
of O 0 0.0030007713939994574
the O 0 0.007360626012086868
RB1 O 1 0.9999330043792725
gene O 0 0.00391358882188797
in O 0 0.0014401854714378715
individuals O 0 0.0009400693234056234
from O 0 0.001396166393533349
a O 0 0.003235960379242897
family O 0 0.008105333894491196
showing O 0 0.010402231477200985
mild O 1 0.7901830077171326
expression O 0 0.006111662834882736
of O 0 0.008812815882265568
the O 1 0.596117377281189
retinoblastoma B-Disease 1 0.9999977350234985
phenotype O 1 0.8683683276176453
. O 0 0.0207295510917902

In O 0 0.007278358098119497
this O 0 0.003651475068181753
family O 0 0.0072632660157978535
affected O 0 0.005106374155730009
individuals O 0 0.0021890420466661453
developed O 1 0.5447863936424255
unilateral B-Disease 1 0.9999524354934692
tumors I-Disease 1 1.0
and O 0 0.08163361251354218
, O 0 0.0029046267736703157
as O 0 0.0016720241401344538
a O 0 0.0016728289192542434
result O 0 0.001625491539016366
of O 0 0.0023947295267134905
linkage O 0 0.009159330278635025
analysis O 0 0.002957432996481657
, O 0 0.0032149848993867636
unaffected O 0 0.0190932247787714
mutation O 0 0.006289392709732056
carriers O 0 0.004403466824442148
were O 0 0.0024111024104058743
also O 0 0.0024170808028429747
identified O 0 0.004049316048622131
within O 0 0.003133246209472418
the O 0 0.007909469306468964
pedigree O 0 0.051037050783634186
. O 0 0.014483392238616943

A O 0 0.016308916732668877
single O 0 0.00886455737054348
band O 0 0.007406638469547033
shift O 0 0.005579094868153334
using O 0 0.0033327576238662004
SSCP O 1 0.9923743605613708
was O 0 0.007009023800492287
identified O 0 0.0037949117831885815
in O 0 0.0026435856707394123
exon O 0 0.014209870249032974
21 O 0 0.003892594249919057
which O 0 0.0013389474479481578
resulted O 0 0.003174565266817808
in O 0 0.002216359367594123
a O 0 0.0038361044134944677
missense O 0 0.013099863193929195
mutation O 0 0.006012252531945705
converting O 0 0.006759227253496647
a O 0 0.009196456521749496
cys O 1 0.9999594688415527
- O 1 0.8084284067153931
- O 0 0.030243312940001488
> O 0 0.01848747581243515
arg O 0 0.021518684923648834
at O 0 0.005700207315385342
nucleotide O 0 0.004932751413434744
position O 0 0.003230377333238721
28 O 0 0.0040000746957957745
in O 0 0.002961138729006052
the O 0 0.007407223340123892
exon O 0 0.0644272193312645
. O 0 0.012917814776301384

The O 0 0.021361898630857468
mutation O 0 0.018538879230618477
destroyed O 0 0.019322499632835388
an O 0 0.0074675255455076694
NdeI O 1 0.9711354970932007
restriction O 0 0.020592421293258667
enzyme O 0 0.019006885588169098
site O 0 0.017768293619155884
. O 0 0.015149234794080257

Analysis O 0 0.00822693482041359
of O 0 0.00430516479536891
all O 0 0.0022449262905865908
family O 0 0.004274076782166958
members O 0 0.0022340668365359306
demonstrated O 0 0.004107679706066847
that O 0 0.001404918497428298
the O 0 0.003436798695474863
missense O 0 0.015251485630869865
mutation O 0 0.00916533824056387
co O 0 0.10536276549100876
- O 0 0.032189592719078064
segregated O 0 0.014687221497297287
with O 0 0.0031021363101899624
patients O 1 0.9996199607849121
with O 0 0.33523908257484436
tumors B-Disease 1 1.0
or O 0 0.2588061988353729
who O 0 0.01305078249424696
, O 0 0.001769550726749003
as O 0 0.0014835026813670993
a O 0 0.001991178607568145
result O 0 0.0018863487057387829
of O 0 0.0027685195673257113
linkage O 0 0.012729106470942497
analysis O 0 0.0029644856695085764
had O 0 0.0030196872539818287
been O 0 0.002115806331858039
predicted O 0 0.0035504973493516445
to O 0 0.0016948195407167077
carry O 0 0.003790855873376131
the O 0 0.0069861519150435925
predisposing O 1 0.8332644104957581
mutation O 0 0.02543402649462223
. O 0 0.014792578294873238

These O 0 0.004327891860157251
observations O 0 0.005905333440750837
point O 0 0.0036565582267940044
to O 0 0.001774777309037745
another O 0 0.0023552095517516136
region O 0 0.0031548114493489265
of O 0 0.003847248386591673
the O 0 0.02631893754005432
RB1 O 1 0.9999942779541016
gene O 0 0.007277162279933691
where O 0 0.0027901569847017527
mutations O 0 0.0024857171811163425
only O 0 0.0012420315761119127
modify O 0 0.0029613077640533447
the O 0 0.0019230481702834368
function O 0 0.0022431467659771442
of O 0 0.001974488142877817
the O 0 0.0034926426596939564
gene O 0 0.003169079078361392
and O 0 0.0013659101678058505
raise O 0 0.001962203998118639
important O 0 0.0014518641401082277
questions O 0 0.0019048777176067233
for O 0 0.0016921928618103266
genetic O 0 0.004312058445066214
counseling O 0 0.008966388180851936
in O 0 0.0018844535807147622
families O 0 0.0017358094919472933
with O 0 0.0012396961683407426
these O 0 0.0017254427075386047
distinctive O 0 0.06048154830932617
phenotypes O 0 0.3713688552379608
. O 0 0.008747149258852005
. O 0 0.011948831379413605

Maternal B-Disease 1 0.9992735981941223
disomy I-Disease 1 0.9993078708648682
and O 1 0.9274578094482422
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9870830774307251
with O 0 0.011271231807768345
gamete O 1 0.9998134970664978
complementation O 1 0.9997758269309998
in O 0 0.003037350019440055
a O 0 0.0030962065793573856
case O 0 0.003698439570143819
of O 0 0.00433151051402092
familial O 1 0.999861478805542
translocation O 1 0.7155306339263916
( O 0 0.004863750655204058
3 O 0 0.0035826133098453283
; O 0 0.001562365796416998
15 O 0 0.0024960157461464405
) O 0 0.0026303590275347233
( O 0 0.00380045548081398
p25 O 0 0.02394864894449711
; O 0 0.004186301492154598
q11 O 0 0.025453083217144012
. O 0 0.004076826851814985
2 O 0 0.00964572373777628
) O 0 0.007441667839884758
. O 0 0.01054654736071825

Maternal B-Disease 1 0.9999585151672363
uniparental I-Disease 1 0.9999991655349731
disomy I-Disease 1 0.9999966621398926
( I-Disease 1 0.9945498108863831
UPD I-Disease 1 0.9999996423721313
) I-Disease 0 0.0062141502276062965
for I-Disease 0 0.0033824904821813107
chromosome I-Disease 0 0.006779764778912067
15 I-Disease 0 0.0028582673985511065
is O 0 0.0014962898567318916
responsible O 0 0.00205858307890594
for O 0 0.0011069593019783497
an O 0 0.0013465796364471316
estimated O 0 0.0022280632983893156
30 O 0 0.002277992432937026
% O 0 0.001647103694267571
of O 0 0.001793260918930173
cases O 0 0.004593357443809509
of O 1 0.9818373322486877
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999997615814209
PWS B-Disease 1 1.0
) O 0 0.05218446999788284
. O 0 0.01808440312743187

We O 0 0.0060897525399923325
report O 0 0.004414862021803856
on O 0 0.0021631205454468727
an O 0 0.0017609338974580169
unusual O 0 0.003102407790720463
case O 0 0.004435067996382713
of O 0 0.007090182043612003
maternal B-Disease 1 0.9999507665634155
disomy I-Disease 1 0.9992233514785767
15 I-Disease 0 0.007377856411039829
in O 0 0.006569107994437218
PWS B-Disease 1 0.9999998807907104
that O 0 0.0021110998932272196
is O 0 0.0015994178829714656
most O 0 0.0011065717553719878
consistent O 0 0.0026231296360492706
with O 0 0.0016558864153921604
adjacent O 0 0.008798790164291859
- O 0 0.010967736132442951
1 O 0 0.005938456393778324
segregation O 0 0.010238555260002613
of O 0 0.0030744574032723904
a O 0 0.006474863737821579
paternal O 1 0.9831064939498901
t O 0 0.22359023988246918
( O 0 0.0035720786545425653
3 O 0 0.003306830767542124
; O 0 0.0014555701054632664
15 O 0 0.0027873986400663853
) O 0 0.002858150517567992
( O 0 0.003976617474108934
p25 O 0 0.021765530109405518
; O 0 0.003426583716645837
q11 O 0 0.015366076491773129
. O 0 0.002111756941303611
2 O 0 0.0038309891242533922
) O 0 0.0017958481330424547
with O 0 0.0014690575189888477
simultaneous O 0 0.007265786174684763
maternal O 1 0.9978668093681335
meiotic O 1 0.9999607801437378
nondisjunction O 1 0.9967443943023682
for O 0 0.010785370133817196
chromosome O 0 0.027238043025135994
15 O 0 0.014744523912668228
. O 0 0.014899810776114464

The O 0 0.020994389429688454
patient O 1 0.9973374009132385
( O 0 0.0166989304125309
J O 1 0.9990816116333008
. O 0 0.0029079830273985863
B O 0 0.011034433729946613
. O 0 0.0013068830594420433
) O 0 0.001294194022193551
, O 0 0.0010547030251473188
a O 0 0.00194854149594903
17 O 0 0.0035832636058330536
- O 0 0.004820711445063353
year O 0 0.0031723708380013704
- O 0 0.008079387247562408
old O 0 0.009656025096774101
white O 0 0.008516641333699226
male O 0 0.007112105842679739
with O 0 0.00456171203404665
PWS B-Disease 1 1.0
, O 0 0.008246200159192085
was O 0 0.00956917367875576
found O 0 0.0018429828342050314
to O 0 0.0010400519240647554
have O 0 0.000932541792280972
47 O 0 0.0038483780808746815
chromosomes O 0 0.0030110948719084263
with O 0 0.0014574730303138494
a O 0 0.003861194709315896
supernumerary O 1 0.9876165986061096
, O 0 0.007159940432757139
paternal O 1 0.9923681616783142
der O 1 0.999884843826294
( O 0 0.004997179377824068
15 O 0 0.0028395080007612705
) O 0 0.0015408883336931467
consisting O 0 0.001999227562919259
of O 0 0.0022056754678487778
the O 0 0.003684206632897258
short O 0 0.006265623029321432
arm O 0 0.03804571181535721
and O 0 0.002442215336486697
the O 0 0.0053871748968958855
proximal O 1 0.9998699426651001
long O 0 0.030141331255435944
arm O 0 0.2564373016357422
of O 0 0.005847102031111717
chromosome O 0 0.013985111378133297
15 O 0 0.004619507119059563
, O 0 0.0038518451619893312
and O 0 0.006514279171824455
distal O 1 0.9999834299087524
chromosome O 1 0.9997836947441101
arm O 1 0.9996199607849121
3p O 1 0.9990691542625427
. O 0 0.019322216510772705

The O 0 0.0227231252938509
t O 0 0.18610045313835144
( O 0 0.006255477201193571
3 O 0 0.004095093812793493
; O 0 0.001869933563284576
15 O 0 0.002822910901159048
) O 0 0.0019840411841869354
was O 0 0.0024128807708621025
present O 0 0.0014301129849627614
in O 0 0.0010718554258346558
the O 0 0.00167110248003155
balanced O 0 0.0026911983732134104
state O 0 0.0012791526969522238
in O 0 0.0014641588786616921
the O 0 0.0036349864676594734
patients O 1 0.9975577592849731
father O 1 0.9492661356925964
and O 0 0.004723405931144953
a O 0 0.013414565473794937
sister O 1 0.9885482788085938
. O 0 0.012376812286674976

Fluorescent O 0 0.046746451407670975
in O 0 0.009614817798137665
situ O 0 0.03992890566587448
hybridization O 0 0.008440564386546612
analysis O 0 0.0032651189249008894
demonstrated O 0 0.005612954962998629
that O 0 0.0020535422954708338
the O 0 0.005783428903669119
PWS B-Disease 1 0.9999998807907104
critical O 0 0.013562212698161602
region O 0 0.005561577156186104
resided O 0 0.011174200102686882
on O 0 0.0026602649595588446
the O 0 0.003226188477128744
derivative O 0 0.011532670818269253
chromosome O 0 0.0072239418514072895
3 O 0 0.002709789900109172
and O 0 0.0009993831627070904
that O 0 0.0008720895275473595
there O 0 0.0013261889107525349
was O 0 0.004165433347225189
no O 0 0.0027020075358450413
deletion O 0 0.006570370867848396
of O 0 0.0041329883970320225
the O 0 0.04377485066652298
PWS B-Disease 1 1.0
region O 0 0.009389418177306652
on O 0 0.004254941828548908
the O 0 0.0038006247486919165
normal O 0 0.004130566027015448
pair O 0 0.004200035706162453
of O 0 0.004043301101773977
15s O 0 0.4690345525741577
present O 0 0.009553770534694195
in O 0 0.011792837642133236
J O 1 0.9997170567512512
. O 0 0.019322877749800682

B O 1 0.9474307894706726
. O 0 0.03674774244427681

Methylation O 0 0.022096900269389153
analysis O 0 0.007872466929256916
at O 0 0.008313843980431557
exon O 0 0.02012513391673565
alpha O 0 0.007938290946185589
of O 0 0.0027986636850982904
the O 0 0.0035935277119278908
small O 0 0.004043811932206154
nuclear O 0 0.011787070892751217
ribonucleoprotein O 1 0.9312316179275513
- O 0 0.012570369057357311
associated O 0 0.006830867379903793
polypeptide O 0 0.03964503854513168
N O 0 0.027298754081130028
( O 0 0.00840428564697504
SNRPN O 1 0.9617812633514404
) O 0 0.005707947071641684
gene O 0 0.004477446433156729
showed O 0 0.00327148474752903
a O 0 0.0026394487358629704
pattern O 0 0.004618538077920675
characteristic O 0 0.005006691440939903
of O 0 0.0030413782224059105
only O 0 0.0024938604328781366
the O 0 0.005162605084478855
maternal O 1 0.9983497858047485
chromosome O 0 0.016439108178019524
15 O 0 0.007222834508866072
in O 0 0.008049470372498035
J O 1 0.9989131689071655
. O 0 0.015131830237805843

B O 1 0.9243190884590149
. O 0 0.03436481952667236

Maternal B-Disease 1 0.9998034834861755
disomy I-Disease 1 0.9969297051429749
was O 0 0.0231704693287611
confirmed O 0 0.008249523118138313
by O 0 0.0035311798565089703
polymerase O 0 0.013533510267734528
chain O 0 0.007059004157781601
reaction O 0 0.003247010987251997
analysis O 0 0.002203170908614993
of O 0 0.0035319654271006584
microsatellite O 0 0.019294822588562965
repeats O 0 0.008914138190448284
at O 0 0.004669905174523592
the O 0 0.004860048647969961
gamma O 0 0.019449234008789062
- O 0 0.01798095367848873
aminobutyric O 0 0.22263848781585693
acid O 0 0.013367166742682457
receptor O 0 0.012954220175743103
beta3 O 0 0.032370492815971375
subunit O 0 0.016020171344280243
( O 0 0.012481874786317348
GABRB3 O 1 0.9952653646469116
) O 0 0.012730849906802177
locus O 0 0.04087769612669945
. O 0 0.016298772767186165

A O 0 0.041219018399715424
niece O 1 0.999600350856781
( O 0 0.023420346900820732
B O 1 0.6501570343971252
. O 0 0.003865610109642148
B O 0 0.011468321084976196
. O 0 0.0018536653369665146
) O 0 0.001554151764139533
with O 0 0.0010355775011703372
45 O 0 0.00274067185819149
chromosomes O 0 0.0038593136705458164
and O 0 0.0016701205167919397
the O 0 0.002582813613116741
derivative O 0 0.00595158850774169
3 O 0 0.0033779155928641558
but O 0 0.0009759714594110847
without O 0 0.0011633126996457577
the O 0 0.003285342827439308
der O 1 0.9969630837440491
( O 0 0.004786066245287657
15 O 0 0.0033426841255277395
) O 0 0.002394761424511671
demonstrated O 0 0.004730849526822567
a O 0 0.003607287537306547
phenotype O 0 0.006521000526845455
consistent O 0 0.002895220648497343
with O 0 0.0010810601525008678
that O 0 0.0012455371906980872
reported O 0 0.0028376681730151176
for O 0 0.0022735900711268187
haploinsufficiency O 0 0.08010409772396088
of O 0 0.008377442136406898
distal O 1 0.9997754693031311
3 O 0 0.03510952368378639
p O 0 0.042583875358104706
. O 0 0.013347209431231022

Uniparental B-Disease 1 0.9999992847442627
disomy I-Disease 1 0.9999339580535889
associated O 0 0.012872106395661831
with O 0 0.005507544614374638
unbalanced O 1 0.9542717337608337
segregation O 1 0.9422632455825806
of O 0 0.01535196602344513
non O 1 0.9957960844039917
- O 1 0.9988492727279663
Robertsonian O 1 0.9998202919960022
translocations O 0 0.22210794687271118
has O 0 0.0028863130137324333
been O 0 0.0027125191409140825
reported O 0 0.003938112407922745
previously O 0 0.0032571107149124146
but O 0 0.0011784801026806235
has O 0 0.001463121036067605
not O 0 0.0009753447957336903
, O 0 0.001155915088020265
to O 0 0.0010821173200383782
our O 0 0.0015260266372933984
knowledge O 0 0.0025616565253585577
, O 0 0.0017551039345562458
been O 0 0.001692663412541151
observed O 0 0.0022221989929676056
in O 0 0.0019394635455682874
a O 0 0.004194383509457111
case O 0 0.011731323786079884
of O 0 0.07088787108659744
PWS B-Disease 1 1.0
. O 0 0.03257877752184868

Furthermore O 0 0.023786751553416252
, O 0 0.006794747896492481
our O 0 0.0035889102146029472
findings O 0 0.0030038345139473677
are O 0 0.001130352495238185
best O 0 0.0024511839728802443
interpreted O 0 0.0034177207853645086
as O 0 0.003183730412274599
true O 0 0.008834928274154663
gamete O 0 0.24400533735752106
complementation O 1 0.9928145408630371
resulting O 0 0.01888524927198887
in O 0 0.024020273238420486
maternal B-Disease 1 0.9999967813491821
UPD I-Disease 1 1.0
15 I-Disease 0 0.13333077728748322
and O 0 0.03590770810842514
PWS B-Disease 1 0.9999997615814209

Schwartz B-Disease 1 0.9995809197425842
- I-Disease 1 0.9997707009315491
Jampel I-Disease 1 0.9999963045120239
syndrome I-Disease 1 1.0
type I-Disease 1 0.9929943680763245
2 I-Disease 0 0.01841764524579048
and O 0 0.006956390105187893
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 0.999998927116394
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.0055895703844726086
a O 0 0.003379026660695672
case O 0 0.0050230179913342
for O 0 0.004057522397488356
" O 0 0.013049690052866936
lumping O 0 0.05066477879881859
" O 0 0.018724964931607246
. O 0 0.01307794637978077

Recent O 0 0.011880389414727688
studies O 0 0.006149304565042257
demonstrated O 0 0.006372679490596056
the O 0 0.0026392226573079824
existence O 0 0.003627137281000614
of O 0 0.0031329423654824495
a O 0 0.003440236672759056
genetically O 0 0.004091758280992508
distinct O 0 0.0021140510216355324
, O 0 0.0017564041772857308
usually O 0 0.001605530153028667
lethal O 0 0.003680141642689705
form O 0 0.0017465365817770362
of O 0 0.0026356845628470182
the O 0 0.008965163491666317
Schwartz B-Disease 1 0.9999674558639526
- I-Disease 1 0.9998871088027954
Jampel I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
( O 1 0.998532772064209
SJS B-Disease 1 0.9999998807907104
) O 0 0.0069808936677873135
of O 0 0.008812924847006798
myotonia B-Disease 1 1.0
and O 1 0.9902346134185791
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.027974238619208336
which O 0 0.0033741870429366827
we O 0 0.0040199169889092445
called O 0 0.02081708051264286
SJS B-Disease 1 0.9999974966049194
type I-Disease 0 0.04218844324350357
2 I-Disease 0 0.01994284987449646
. O 0 0.012275154702365398

This O 0 0.014206290245056152
disorder O 1 0.9999992847442627
is O 0 0.005720116198062897
reminiscent O 0 0.07703045755624771
of O 0 0.0050980448722839355
another O 0 0.009051358327269554
rare O 0 0.0521228052675724
condition O 1 0.9090718626976013
, O 0 0.0034177822526544333
the O 0 0.011026936583220959
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999974966049194
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9972136616706848
SWS B-Disease 1 0.999997615814209
) O 0 0.0035190533380955458
, O 0 0.0017209616489708424
which O 0 0.0014667389914393425
comprises O 0 0.005016154143959284
campomelia B-Disease 0 0.24281789362430573
at O 0 0.00803097989410162
birth O 1 0.8129076957702637
with O 0 0.06882272660732269
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.99901282787323
contractures B-Disease 1 1.0
, O 0 0.0148090161383152
and O 0 0.00478157214820385
early B-Disease 0 0.01140677835792303
death I-Disease 1 0.5292602777481079
. O 0 0.014324678108096123

To O 0 0.006783592980355024
test O 0 0.005354194901883602
for O 0 0.002652173861861229
possible O 0 0.00409433338791132
nosologic O 0 0.04292644187808037
identity O 0 0.004782855976372957
between O 0 0.0031902336049824953
these O 0 0.0033507419284433126
disorders O 1 0.9999998807907104
, O 0 0.005194517783820629
we O 0 0.0018768134759739041
reviewed O 0 0.0032037273049354553
the O 0 0.0018296596826985478
literature O 0 0.00230659288354218
and O 0 0.001367504708468914
obtained O 0 0.002278486965224147
a O 0 0.0026819889899343252
follow O 0 0.0031491643749177456
- O 0 0.004129314329475164
up O 0 0.0015282880049198866
of O 0 0.001277819275856018
the O 0 0.0013370270607993007
only O 0 0.0010072384029626846
two O 0 0.0012941159075126052
surviving O 0 0.0633387342095375
patients O 0 0.05240118131041527
, O 0 0.002246629213914275
one O 0 0.0021618916653096676
with O 0 0.0032797420863062143
SJS B-Disease 1 0.9999990463256836
type I-Disease 0 0.0070352740585803986
2 I-Disease 0 0.0029013322200626135
at O 0 0.002400356810539961
age O 0 0.0023629157803952694
10 O 0 0.0015855018282309175
years O 0 0.0013071408029645681
and O 0 0.001115483813919127
another O 0 0.002148493193089962
with O 0 0.0026356230955570936
SWS B-Disease 1 0.9997513890266418
at O 0 0.006121437530964613
age O 0 0.0069221374578773975
7 O 0 0.007848103530704975
years O 0 0.006945537868887186
. O 0 0.009918468073010445

Patients O 1 0.9220994710922241
reported O 0 0.011994266882538795
as O 0 0.005584472790360451
having O 0 0.01034289225935936
either O 0 0.07218539714813232
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.028269300237298012
SWS B-Disease 1 0.999636173248291
presented O 0 0.00612243078649044
a O 0 0.0029309054370969534
combination O 0 0.0041459109634160995
of O 0 0.003079272573813796
a O 0 0.009733079932630062
severe O 1 0.9999994039535522
, O 1 0.9985560774803162
prenatal O 1 1.0
- O 1 0.9999998807907104
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999977350234985
with O 1 0.9998582601547241
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9995943903923035
feeding O 1 0.9995007514953613
difficulties O 1 0.9999376535415649
, O 0 0.008563756942749023
tendency O 0 0.012880664318799973
to O 0 0.002937936456874013
hyperthermia B-Disease 1 0.9999920129776001
, O 0 0.0028045892249792814
and O 0 0.0020322450436651707
frequent O 0 0.004888382740318775
death O 0 0.18792112171649933
in O 0 0.0030804439447820187
infancy O 0 0.41555988788604736
) O 0 0.0017913688207045197
with O 0 0.0009448364726267755
a O 0 0.003007136518135667
distinct O 0 0.008654325269162655
campomelic B-Disease 1 0.9999957084655762
- I-Disease 1 0.999982476234436
metaphyseal I-Disease 1 0.9999988079071045
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.13393278419971466

The O 0 0.008716356009244919
similarity O 0 0.007726280018687248
of O 0 0.004115929361432791
the O 0 0.008155344985425472
clinical O 1 0.9999284744262695
and O 0 0.006860966328531504
radiographic O 1 0.9998175501823425
findings O 0 0.00930684246122837
is O 0 0.0028525758534669876
so O 0 0.0015777985099703074
extensive O 0 0.0034893734846264124
that O 0 0.0017720491159707308
these O 0 0.002252396894618869
disorders O 1 0.9999717473983765
appear O 0 0.0037604928947985172
to O 0 0.0020295409485697746
be O 0 0.0020064113195985556
a O 0 0.00421165069565177
single O 0 0.0072393473237752914
entity O 0 0.01608549989759922
. O 0 0.013439035974442959

The O 0 0.011088055558502674
follow O 0 0.007500336971133947
- O 0 0.008249804377555847
up O 0 0.0025141527876257896
observation O 0 0.0044839405454695225
of O 0 0.0022948726546019316
an O 0 0.0018355523934587836
identical O 0 0.002355914330109954
and O 0 0.0015785115538164973
unique O 0 0.002865927992388606
pattern O 0 0.007660272531211376
of O 1 0.5631790161132812
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.015158365480601788
the O 0 0.005854676477611065
two O 0 0.0023535352665930986
patients O 1 0.8574279546737671
( O 0 0.0026414997410029173
one O 0 0.0018627820536494255
with O 0 0.003303356235846877
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 0.00845240242779255
2 I-Disease 0 0.003274723654612899
, O 0 0.0011978955008089542
one O 0 0.0011649449588730931
with O 0 0.0019113700836896896
SWS B-Disease 1 0.9999560117721558
) O 0 0.003935190383344889
surviving O 0 0.008740106597542763
beyond O 0 0.004954763688147068
infancy O 0 0.035549357533454895
adds O 0 0.0045390259474515915
to O 0 0.0013483840739354491
the O 0 0.0018758239457383752
evidence O 0 0.0023619988933205605
in O 0 0.0017846947303041816
favor O 0 0.00327102467417717
of O 0 0.004424719605594873
identity O 0 0.013594062067568302
. O 0 0.012569396756589413

The O 0 0.016985898837447166
hypothesis O 0 0.021003786474466324
that O 0 0.008094538003206253
SWS B-Disease 1 0.9996063113212585
and O 0 0.015342163853347301
SJS B-Disease 1 0.9999973773956299
type I-Disease 0 0.014750225469470024
2 I-Disease 0 0.004749502521008253
are O 0 0.0012276810593903065
the O 0 0.0028783041052520275
same O 0 0.0045807864516973495
disorder O 1 0.999976634979248
should O 0 0.003439147723838687
be O 0 0.0020639558788388968
testable O 0 0.007065685000270605
by O 0 0.0022349408827722073
molecular O 0 0.0069488706067204475
methods O 0 0.007482039742171764
. O 0 0.006363778840750456
. O 0 0.012072418816387653

A O 0 0.021033577620983124
mouse O 0 0.015534371137619019
model O 0 0.007838417775928974
of O 0 0.009610704146325588
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999957084655762
defects O 1 1.0
in O 1 0.998291552066803
hemostasis O 1 1.0
and O 1 0.9996110796928406
thrombosis B-Disease 1 1.0
. O 0 0.2591785192489624

von B-Disease 1 0.9996918439865112
Willebrand I-Disease 1 0.9999998807907104
factor I-Disease 1 0.9957306981086731
( I-Disease 1 0.9769443869590759
vWf I-Disease 1 0.999994158744812
) I-Disease 1 0.9970629811286926
deficiency I-Disease 1 1.0
causes O 1 0.9999998807907104
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9997605681419373
humans O 1 0.5695867538452148
. O 0 0.013867312110960484

We O 0 0.006530169863253832
generated O 0 0.005068005993962288
a O 0 0.004216887056827545
mouse O 0 0.00705386558547616
model O 0 0.0034964634105563164
for O 0 0.002232828177511692
this O 0 0.0028652099426835775
disease O 1 0.9990168809890747
by O 0 0.00287707825191319
using O 0 0.005076909903436899
gene O 0 0.010979079641401768
targeting O 0 0.012833689339458942
. O 0 0.012144000269472599

vWf B-Disease 1 0.9998358488082886
- I-Disease 1 0.9984499216079712
deficient I-Disease 1 0.9995371103286743
mice O 0 0.012307288125157356
appeared O 0 0.0059939054772257805
normal O 0 0.0049356077797710896
at O 0 0.004981726408004761
birth O 0 0.010462681762874126
; O 0 0.0018310359446331859
they O 0 0.0012224569218233228
were O 0 0.0023389116395264864
viable O 0 0.007984496653079987
and O 0 0.006229634862393141
fertile O 0 0.14716647565364838
. O 0 0.017569376155734062

Neither O 0 0.05118461698293686
vWf O 1 0.5371901392936707
nor O 0 0.03348023444414139
vWf O 1 0.9838051199913025
propolypeptide O 1 0.9988179802894592
( O 0 0.03803661838173866
von B-Disease 1 0.999948263168335
Willebrand I-Disease 1 1.0
antigen O 1 0.9999880790710449
II O 1 0.9999997615814209
) O 0 0.0050807432271540165
were O 0 0.0026714298874139786
detectable O 0 0.008908520452678204
in O 0 0.0027936857659369707
plasma O 0 0.0119135407730937
, O 0 0.005631191655993462
platelets O 1 0.754306972026825
, O 0 0.004835555329918861
or O 0 0.0055326977744698524
endothelial O 0 0.4526126980781555
cells O 0 0.005429806187748909
of O 0 0.0045765978284180164
the O 0 0.00916136521846056
homozygous O 0 0.03308594599366188
mutant O 0 0.16926328837871552
mice O 0 0.031733136624097824
. O 0 0.014522744342684746

The O 0 0.026651998981833458
mutant O 1 0.9620723724365234
mice O 0 0.47858312726020813
exhibited O 1 0.9863485097885132
defects O 1 0.9999916553497314
in O 0 0.019461587071418762
hemostasis O 1 0.9999909400939941
with O 0 0.0032798543106764555
a O 0 0.008455876260995865
highly O 1 0.9209214448928833
prolonged O 1 0.9999997615814209
bleeding O 1 1.0
time O 0 0.014531482011079788
and O 0 0.004202812444418669
spontaneous O 0 0.11258918046951294
bleeding O 1 0.9999967813491821
events O 0 0.002742638112977147
in O 0 0.0019337991252541542
approximately O 0 0.0027217967435717583
10 O 0 0.00272856536321342
% O 0 0.0031174570322036743
of O 0 0.007171502336859703
neonates O 1 0.9381735920906067
. O 0 0.01642078161239624

As O 0 0.006999720819294453
in O 0 0.004551823250949383
the O 0 0.006692723836749792
human O 1 0.524470329284668
disease O 1 0.9999998807907104
, O 0 0.005336012691259384
the O 0 0.006044338457286358
factor O 0 0.012675794772803783
VIII O 1 0.9889955520629883
level O 0 0.0038366876542568207
in O 0 0.0017192534869536757
these O 0 0.0013516787439584732
mice O 0 0.005596106871962547
was O 0 0.0034577089827507734
reduced O 0 0.0025569177232682705
strongly O 0 0.00190842489246279
as O 0 0.0014583150623366237
a O 0 0.0015679671196267009
result O 0 0.001723246998153627
of O 0 0.0021587505470961332
the O 0 0.00378995924256742
lack O 0 0.006880377419292927
of O 0 0.006442380137741566
protection O 1 0.5209650993347168
provided O 0 0.010452915914356709
by O 0 0.00937753077596426
vWf O 1 0.8115365505218506
. O 0 0.01919957436621189

Defective O 1 0.9999970197677612
thrombosis B-Disease 1 0.9999998807907104
in O 1 0.5882654786109924
mutant O 1 0.999944806098938
mice O 1 0.8889773488044739
was O 0 0.01052241213619709
also O 0 0.002254626015201211
evident O 0 0.0033907899633049965
in O 0 0.0015509960940107703
an O 0 0.001552679925225675
in O 0 0.002970117377117276
vivo O 0 0.02905348688364029
model O 0 0.01075794268399477
of O 1 0.5088357925415039
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.4851173162460327

In O 0 0.006923468317836523
this O 0 0.003017253475263715
model O 0 0.004436851944774389
, O 0 0.0031193618196994066
the O 0 0.004702461417764425
exteriorized O 1 0.9496757984161377
mesentery O 1 0.998997151851654
was O 0 0.3479234576225281
superfused O 1 0.9936833381652832
with O 0 0.00955179426819086
ferric O 1 0.9999994039535522
chloride O 1 0.9972900152206421
and O 0 0.004751736763864756
the O 0 0.006270238664001226
accumulation O 0 0.1078701838850975
of O 0 0.018765831366181374
fluorescently O 1 0.999987006187439
labeled O 1 0.9981663823127747
platelets O 1 0.9946926236152649
was O 0 0.013011576607823372
observed O 0 0.008354103192687035
by O 0 0.0059482804499566555
intravital O 1 0.5369493365287781
microscopy O 0 0.04278451204299927
. O 0 0.01485287956893444

We O 0 0.00807174388319254
conclude O 0 0.00886994693428278
that O 0 0.0020151587668806314
these O 0 0.0017244481714442372
mice O 0 0.004960724618285894
very O 0 0.002085305517539382
closely O 0 0.004870370030403137
mimic O 1 0.65280681848526
severe O 1 0.9999994039535522
human O 1 0.9999985694885254
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9417113065719604
will O 0 0.0022545121610164642
be O 0 0.0011100844712927938
very O 0 0.0010532645974308252
useful O 0 0.0011646286584436893
for O 0 0.0008955311495810747
investigating O 0 0.003226416651159525
the O 0 0.00254823244176805
role O 0 0.0039058306720107794
of O 0 0.003244902240112424
vWf O 0 0.4690808653831482
in O 0 0.0029960419051349163
normal O 0 0.005606137681752443
physiology O 1 0.9912651181221008
and O 0 0.003760533407330513
in O 0 0.26600566506385803
disease O 1 1.0
models O 0 0.01702260971069336
. O 0 0.006260542199015617
. O 0 0.009880210272967815

Oral O 1 0.9903258085250854
contraceptives O 1 0.9742587804794312
and O 0 0.005939267110079527
the O 0 0.009810066781938076
risk O 1 0.9036527872085571
of O 1 0.9998444318771362
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997974038124084

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999998807907104
Study O 1 0.9924970865249634
Group O 0 0.04371579736471176
. O 0 0.015691714361310005

BACKGROUND O 0 0.02956276200711727
Women O 0 0.009317303076386452
with O 0 0.003090053331106901
mutations O 0 0.004737255163490772
in O 0 0.0025561030488461256
either O 0 0.00303346267901361
the O 0 0.0051335557363927364
BRCA1 O 1 0.9979246854782104
or O 0 0.003521471517160535
the O 0 0.005917039699852467
BRCA2 O 1 0.9984756112098694
gene O 0 0.0035629046615213156
have O 0 0.0010990507435053587
a O 0 0.001968883676454425
high O 0 0.0057225581258535385
lifetime O 0 0.2722572982311249
risk O 1 0.9050102829933167
of O 1 0.9999469518661499
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8881216049194336

Oral O 1 0.9933742880821228
contraceptives O 1 0.9998675584793091
protect O 1 0.9925658702850342
against O 1 0.9999568462371826
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9814498424530029
general O 1 0.9960483908653259
, O 0 0.0026862332597374916
but O 0 0.0009006602340377867
it O 0 0.0007830495596863329
is O 0 0.0010023067006841302
not O 0 0.0007533800671808422
known O 0 0.0015267650596797466
whether O 0 0.0011263851774856448
they O 0 0.0008228531223721802
also O 0 0.0017622109735384583
protect O 0 0.0039626541547477245
against O 0 0.004444784950464964
hereditary B-Disease 1 0.9999619722366333
forms I-Disease 1 0.9651323556900024
of I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9991625547409058

METHODS O 0 0.018608609214425087
We O 0 0.007026584818959236
enrolled O 0 0.017825551331043243
207 O 0 0.028730833902955055
women O 0 0.009669449180364609
with O 0 0.019088532775640488
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9763782024383545
161 O 1 0.7120679020881653
of O 0 0.004124732688069344
their O 0 0.001814721035771072
sisters O 0 0.008343270979821682
as O 0 0.0017969803884625435
controls O 0 0.0023950098548084497
in O 0 0.0016342524904757738
a O 0 0.0035216526594012976
case O 0 0.009160000830888748
- O 0 0.016162879765033722
control O 0 0.0071081300266087055
study O 0 0.008561507798731327
. O 0 0.01079628337174654

All O 0 0.006739031057804823
the O 0 0.007179926615208387
patients O 0 0.04534783214330673
carried O 0 0.004810928367078304
a O 0 0.0039626313373446465
pathogenic O 0 0.013263574801385403
mutation O 0 0.0046445829793810844
in O 0 0.002302558161318302
either O 0 0.004523889161646366
BRCA1 O 1 0.8553743362426758
( O 0 0.006126017309725285
179 O 0 0.011768355965614319
women O 0 0.006629778537899256
) O 0 0.00439184857532382
or O 0 0.005032727029174566
BRCA2 O 1 0.9569385051727295
( O 0 0.008968977257609367
28 O 0 0.01054337341338396
women O 0 0.012286589480936527
) O 0 0.009183918125927448
. O 0 0.011515897698700428

The O 0 0.012312952429056168
control O 0 0.010362992063164711
women O 0 0.006277729757130146
were O 0 0.003346505342051387
enrolled O 0 0.00928131490945816
regardless O 0 0.0034130821004509926
of O 0 0.0025485774967819452
whether O 0 0.0025286588352173567
or O 0 0.002162809716537595
not O 0 0.0012289374135434628
they O 0 0.001522165723145008
had O 0 0.0036273098085075617
either O 0 0.0058937082067132
mutation O 0 0.017107538878917694
. O 0 0.011358913034200668

Lifetime O 0 0.03836384415626526
histories O 0 0.02319803275167942
of O 0 0.02095344290137291
oral O 1 0.9999938011169434
- O 1 0.9988057613372803
contraceptive O 1 0.9579858779907227
use O 0 0.0027547781355679035
were O 0 0.001970395678654313
obtained O 0 0.0021183546632528305
by O 0 0.0012063059257343411
interview O 0 0.0038519897498190403
or O 0 0.0011554807424545288
by O 0 0.0009290847810916603
written O 0 0.0014566698810085654
questionnaire O 0 0.0033075083047151566
and O 0 0.0012254156172275543
were O 0 0.0015762338880449533
compared O 0 0.00287456507794559
between O 0 0.002718893578276038
patients O 1 0.9582920670509338
and O 0 0.002853306010365486
control O 0 0.014390935190021992
women O 0 0.006068191025406122
, O 0 0.00248671043664217
after O 0 0.003181049833074212
adjustment O 0 0.006764202378690243
for O 0 0.0017474794294685125
year O 0 0.0024212878197431564
of O 0 0.003425170434638858
birth O 0 0.23500940203666687
and O 0 0.006923429202288389
parity O 0 0.09050311893224716
. O 0 0.015925437211990356

RESULTS O 0 0.016007481142878532
The O 0 0.008792121894657612
adjusted O 0 0.013181386515498161
odds O 0 0.018539253622293472
ratio O 0 0.016365325078368187
for O 0 0.0887368693947792
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.011114919558167458
with O 0 0.0017993614310398698
any O 0 0.0011732494458556175
past O 0 0.0017891388852149248
use O 0 0.001347303157672286
of O 0 0.0035224491730332375
oral O 1 0.9980251789093018
contraceptives O 1 0.9999774694442749
was O 1 0.9328877925872803
0 O 0 0.018243949860334396
. O 0 0.012632494792342186

5 O 0 0.01795068569481373
( O 0 0.0072241611778736115
95 O 0 0.006650886964052916
percent O 0 0.004363492596894503
confidence O 0 0.004886143375188112
interval O 0 0.004533079452812672
, O 0 0.0021575388964265585
0 O 0 0.002938849851489067
. O 0 0.001066789380274713
3 O 0 0.0016869570827111602
to O 0 0.0012587670935317874
0 O 0 0.003503423649817705
. O 0 0.0022635941859334707
8 O 0 0.007032782770693302
) O 0 0.0065320758149027824
. O 0 0.008183651603758335

The O 0 0.020647656172513962
risk O 0 0.024055657908320427
decreased O 0 0.010233806446194649
with O 0 0.0024217211175709963
increasing O 0 0.0040635173209011555
duration O 0 0.006390818394720554
of O 0 0.003017402719706297
use O 0 0.002767926314845681
( O 0 0.004051830153912306
P O 0 0.009301302954554558
for O 0 0.0021632472053170204
trend O 0 0.005866461433470249
, O 0 0.0037974778097122908
< O 0 0.011753813363611698
0 O 0 0.005650190636515617
. O 0 0.002707001054659486
001 O 0 0.025475043803453445
) O 0 0.0025736475363373756
; O 0 0.0011533118085935712
use O 0 0.000742827367503196
for O 0 0.0008580450084991753
six O 0 0.0013136942870914936
or O 0 0.001134967664256692
more O 0 0.0007824104395695031
years O 0 0.0018599532777443528
was O 0 0.0032422628719359636
associated O 0 0.0018557477742433548
with O 0 0.0010394110577180982
a O 0 0.0026482264511287212
60 O 0 0.0044176168739795685
percent O 0 0.005173529498279095
reduction O 0 0.008205417543649673
in O 0 0.0061891996301710606
risk O 0 0.019195567816495895
. O 0 0.014511391520500183

Oral O 1 0.9992133378982544
- O 1 0.9853712320327759
contraceptive O 1 0.9880516529083252
use O 0 0.005659827962517738
protected O 0 0.16320018470287323
against O 1 0.9912551641464233
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.004198914859443903
for O 0 0.0028645750135183334
carriers O 0 0.004679030738770962
of O 0 0.002702331403270364
the O 0 0.00776353245601058
BRCA1 O 1 0.9996988773345947
mutation O 0 0.007164460141211748
( O 0 0.0036807081196457148
odds O 0 0.00862438976764679
ratio O 0 0.004841980524361134
, O 0 0.0020057382062077522
0 O 0 0.003385246731340885
. O 0 0.0013995663030073047
5 O 0 0.0024497152771800756
; O 0 0.0014684414491057396
95 O 0 0.003233138704672456
percent O 0 0.0025026537477970123
confidence O 0 0.003679879242554307
interval O 0 0.003978358581662178
, O 0 0.0018231691792607307
0 O 0 0.0027347495779395103
. O 0 0.0009331261971965432
3 O 0 0.001698796753771603
to O 0 0.0011312259593978524
0 O 0 0.0027436816599220037
. O 0 0.0012727148132398725
9 O 0 0.00322823622263968
) O 0 0.0015318503137677908
and O 0 0.0010436828015372157
for O 0 0.001266280421987176
carriers O 0 0.0030669807456433773
of O 0 0.0027948496863245964
the O 0 0.008310124278068542
BRCA2 O 1 0.9998219609260559
mutation O 0 0.007501401472836733
( O 0 0.004286846145987511
odds O 0 0.008225192315876484
ratio O 0 0.00462391646578908
, O 0 0.0022581168450415134
0 O 0 0.003297105897217989
. O 0 0.0013466195669025183
4 O 0 0.003299786476418376
; O 0 0.0018419587286189198
95 O 0 0.004400227684527636
percent O 0 0.0031806128099560738
confidence O 0 0.004666759632527828
interval O 0 0.004662867169827223
, O 0 0.0021547176875174046
0 O 0 0.003258025273680687
. O 0 0.001115481718443334
2 O 0 0.002195657230913639
to O 0 0.0013640018878504634
1 O 0 0.0031847457867115736
. O 0 0.0021273475140333176
1 O 0 0.007035966031253338
) O 0 0.0056528388522565365
. O 0 0.008543910458683968

CONCLUSIONS O 0 0.0445689782500267
Oral O 1 0.9990228414535522
- O 1 0.899874746799469
contraceptive O 1 0.7039818167686462
use O 0 0.0038393251597881317
may O 0 0.0037355339154601097
reduce O 0 0.003990731202065945
the O 0 0.0036529568023979664
risk O 0 0.16823986172676086
of O 1 0.9997850060462952
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.43941664695739746
women O 0 0.008154993876814842
with O 0 0.002426948631182313
pathogenic O 0 0.021974410861730576
mutations O 0 0.003883048892021179
in O 0 0.002661217702552676
the O 0 0.009305818937718868
BRCA1 O 1 0.9999686479568481
or O 0 0.02706155553460121
BRCA2 O 1 0.9998689889907837
gene O 0 0.05663353204727173

A O 0 0.021828899160027504
Japanese O 0 0.06497658044099808
family O 0 0.013824750669300556
with O 0 0.005026207305490971
adrenoleukodystrophy B-Disease 1 0.9999998807907104
with O 0 0.004557449836283922
a O 0 0.006143228150904179
codon O 0 0.01347918901592493
291 O 0 0.01610625721514225
deletion O 0 0.009734862484037876
: O 0 0.003182407934218645
a O 0 0.00319700688123703
clinical O 1 0.5907289981842041
, O 0 0.0053313071839511395
biochemical O 0 0.017588086426258087
, O 0 0.005481067579239607
pathological O 1 0.9841442108154297
, O 0 0.006434312555938959
and O 0 0.005912167485803366
genetic O 0 0.015139343217015266
report O 0 0.01415844913572073
. O 0 0.01293810922652483

We O 0 0.006347492802888155
report O 0 0.004328529350459576
a O 0 0.003903196891769767
Japanese O 0 0.01350376382470131
family O 0 0.009655400179326534
with O 0 0.008568997494876385
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999850988388062
ALD B-Disease 1 1.0
) O 0 0.003879944095388055
with O 0 0.0014105740701779723
a O 0 0.001800703932531178
three O 0 0.0016552300658077002
base O 0 0.003941333387047052
pair O 0 0.004943261854350567
deletion O 0 0.011564994230866432
( O 0 0.006049129646271467
delGAG O 0 0.07047691941261292
291 O 0 0.015340976417064667
) O 0 0.003275523893535137
in O 0 0.0038594475481659174
the O 0 0.01527218148112297
ALD B-Disease 1 1.0
gene O 0 0.0532822348177433
. O 0 0.016035661101341248

A O 0 0.013347911648452282
variety O 0 0.00637003593146801
of O 0 0.005448623094707727
phenotypes O 0 0.010547264479100704
were O 0 0.0031422071624547243
observed O 0 0.003647355828434229
within O 0 0.00244932365603745
this O 0 0.0029962381813675165
family O 0 0.014587532728910446
. O 0 0.011558388359844685

While O 0 0.009583380073308945
the O 0 0.008267570286989212
proband O 1 0.9659972190856934
( O 0 0.009765861555933952
patient O 1 0.8853320479393005
1 O 0 0.007475331891328096
) O 0 0.002582593820989132
was O 0 0.003505551489070058
classified O 0 0.003989775665104389
as O 0 0.0017971924971789122
having O 0 0.002516634063795209
a O 0 0.0023391677532345057
rare O 0 0.005767345428466797
intermediate O 0 0.02662334218621254
type O 0 0.006933422293514013
of O 0 0.0047294446267187595
adult O 0 0.10914957523345947
cerebral O 1 0.9999488592147827
and O 0 0.026348918676376343
cerebello O 1 0.9999997615814209
- O 1 0.9999750852584839
brain O 1 0.9985048770904541
stem O 0 0.006684503052383661
forms O 0 0.0024636443704366684
, O 0 0.0023577711544930935
his O 0 0.00536884181201458
younger O 0 0.16304738819599152
brother O 1 0.8733726143836975
( O 0 0.005589134991168976
patient O 0 0.3781466782093048
2 O 0 0.00412589218467474
) O 0 0.001722443150356412
and O 0 0.001519140088930726
nephew O 1 0.9951635599136353
( O 0 0.00803507212549448
patient O 1 0.8925793766975403
3 O 0 0.004389917943626642
) O 0 0.0023686375934630632
had O 0 0.003071362152695656
a O 0 0.008508076891303062
childhood O 1 0.9999997615814209
ALD B-Disease 1 1.0
type O 1 0.9999874830245972
. O 0 0.027015605941414833

Another O 0 0.018955036997795105
nephew O 1 0.9950575828552246
( O 0 0.014443827793002129
patient O 1 0.5488737225532532
4 O 0 0.005333864130079746
) O 0 0.001915516215376556
of O 0 0.002324699191376567
patient O 1 0.929079532623291
1 O 0 0.005538034252822399
was O 0 0.004401129670441151
classified O 0 0.004325016867369413
as O 0 0.002017214195802808
having O 0 0.003373165847733617
an O 0 0.004600008018314838
adolescent O 1 0.9995220899581909
form O 0 0.015552399680018425
. O 0 0.016750521957874298

The O 0 0.017632782459259033
tau O 0 0.039312154054641724
level O 0 0.006902916356921196
in O 0 0.003702912013977766
the O 0 0.008104156702756882
cerebrospinal O 1 0.9999911785125732
fluid O 1 0.9998175501823425
( O 0 0.33431464433670044
CSF O 1 0.999922513961792
) O 0 0.003723186906427145
in O 0 0.0027420383412390947
patient O 1 0.8240964412689209
1 O 0 0.004495926667004824
was O 0 0.003333736676722765
as O 0 0.0013306195614859462
high O 0 0.0017001201631501317
as O 0 0.0009804137516766787
that O 0 0.0008198696305043995
of O 0 0.002695085247978568
patients O 1 0.9979420304298401
with O 1 0.9522117972373962
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9993589520454407
AD B-Disease 1 0.9960152506828308
) O 0 0.009851711802184582
. O 0 0.008413841016590595

His O 0 0.04956367611885071
brain O 1 0.9062426686286926
magnetic O 0 0.01783674769103527
resonance O 0 0.016740990802645683
image O 0 0.04194176569581032
( O 0 0.010688673704862595
MRI O 1 0.9831534028053284
) O 0 0.005346926860511303
showed O 0 0.006522155832499266
abnormalities B-Disease 0 0.1277827024459839
in I-Disease 0 0.0028048132080584764
the I-Disease 0 0.007041005417704582
bilateral I-Disease 1 0.9984472393989563
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9998536109924316
and O 1 0.9875955581665039
brain O 1 0.9999994039535522
stem O 1 0.9738178253173828
, O 0 0.002170966938138008
but O 0 0.000843173242174089
not O 0 0.0007471111021004617
in O 0 0.0014945027651265264
the O 0 0.005434056743979454
cerebral O 1 0.9999794960021973
white O 0 0.07459665089845657
matter O 0 0.0034759605769068003
, O 0 0.001652455423027277
where O 0 0.0018317786743864417
marked O 0 0.00373454880900681
reductions O 0 0.004127992782741785
of O 0 0.003651631297543645
the O 1 0.6795675754547119
cerebral O 1 1.0
blood O 1 0.9999926090240479
flow O 0 0.01759670488536358
and O 0 0.0057822335511446
oxygen O 0 0.05364382266998291
metabolism O 0 0.009380246512591839
were O 0 0.0027796912472695112
clearly O 0 0.005083436146378517
demonstrated O 0 0.00554942712187767
by O 0 0.0036447555758059025
positron O 0 0.0217002984136343
emission O 0 0.011635015718638897
tomography O 0 0.018454205244779587
( O 0 0.012144938111305237
PET O 1 0.8631666898727417
) O 0 0.010025215335190296
. O 0 0.012062810361385345

In O 0 0.012994044460356236
patients O 0 0.3436434268951416
2 O 0 0.006687748711556196
and O 0 0.0024488461203873158
3 O 0 0.0038584524299949408
, O 0 0.0018377938540652394
the O 0 0.0030337306670844555
autopsy O 0 0.013032210990786552
findings O 0 0.0067594703286886215
showed O 0 0.008470908738672733
massive O 0 0.2192123681306839
demyelination B-Disease 1 0.9999995231628418
of I-Disease 1 0.7830408811569214
the I-Disease 1 0.9964991807937622
cerebral I-Disease 1 0.9999985694885254
white I-Disease 0 0.031930841505527496
matter I-Disease 0 0.002976953750476241
with O 0 0.0018528971122577786
sparing O 0 0.009100948460400105
of O 0 0.00499542523175478
the O 1 0.7327781915664673
U O 1 0.9999998807907104
- O 1 0.9991126656532288
fibers O 0 0.3312365412712097
, O 0 0.0026354375295341015
compatible O 0 0.002888641320168972
with O 0 0.0011826115660369396
the O 0 0.002752193482592702
findings O 0 0.005486425012350082
of O 0 0.01995173469185829
childhood O 1 0.9999998807907104
ALD B-Disease 1 1.0
. O 0 0.2696641683578491

Oleic O 1 0.9857045412063599
and O 0 0.014168502762913704
erucic O 1 0.9953228831291199
acids O 0 0.015791600570082664
( O 0 0.009665658697485924
Lorenzos O 0 0.09067365527153015
Oil O 0 0.007380577735602856
) O 0 0.0024806170258671045
were O 0 0.0014695771969854832
administered O 0 0.005020745098590851
to O 0 0.002170966938138008
patients O 0 0.12233045697212219
1 O 0 0.0050355116836726665
and O 0 0.0017641177400946617
4 O 0 0.0036377753131091595
, O 0 0.0018680673092603683
but O 0 0.0016144125256687403
sufficient O 0 0.00461063114926219
effectiveness O 0 0.009015404619276524
was O 0 0.006093696691095829
not O 0 0.0025165213737636805
obtained O 0 0.010035025887191296
. O 0 0.010058828629553318

The O 0 0.012001954019069672
findings O 0 0.007105586118996143
in O 0 0.0025598781649023294
this O 0 0.0019343106541782618
family O 0 0.004246217664331198
suggest O 0 0.0033599776215851307
that O 0 0.002009578747674823
delGAG291 O 0 0.027469074353575706
is O 0 0.002348417416214943
part O 0 0.002562094945460558
of O 0 0.002798243425786495
the O 0 0.00469566136598587
cause O 0 0.19670931994915009
of O 0 0.15166723728179932
Japanese O 1 0.9999730587005615
ALD B-Disease 1 1.0
with O 0 0.007352316752076149
phenotypic O 0 0.028390906751155853
variations O 0 0.018839959055185318
. O 0 0.017410747706890106

Moreover O 0 0.020703759044408798
, O 0 0.005769347306340933
although O 0 0.003092548344284296
the O 0 0.0024799704551696777
scale O 0 0.0034662948455661535
of O 0 0.0021742067765444517
the O 0 0.0025397830177098513
study O 0 0.0024900746066123247
is O 0 0.0015072165988385677
limited O 0 0.00162556825671345
, O 0 0.001505157328210771
there O 0 0.0013751448132097721
is O 0 0.0016480496851727366
a O 0 0.0020207075867801905
possibility O 0 0.003777420846745372
that O 0 0.002270251512527466
PET O 0 0.029003899544477463
can O 0 0.002060276223346591
detect O 0 0.007258363999426365
an O 0 0.005236352328211069
insidious B-Disease 1 0.9998469352722168
lesion I-Disease 1 0.9999914169311523
which O 0 0.0029051294550299644
is O 0 0.0031306499149650335
undetectable O 0 0.014489368535578251
by O 0 0.0021472300868481398
computed O 0 0.008943667635321617
tomogram O 1 0.9352028965950012
( O 0 0.013791966252028942
CT O 1 0.9999703168869019
) O 0 0.00439094565808773
or O 0 0.0027920922730118036
MRI O 0 0.10630319267511368
analysis O 0 0.0026017099153250456
, O 0 0.0016882383497431874
and O 0 0.0010178583906963468
that O 0 0.000917102035600692
the O 0 0.0019571136217564344
higher O 0 0.0028165930416435003
level O 0 0.0026434825267642736
of O 0 0.0028738270048052073
tau O 0 0.017752133309841156
reflects O 0 0.004810850601643324
the O 0 0.0024667999241501093
process O 0 0.002990055363625288
of O 0 0.008204422891139984
neuronal B-Disease 1 0.9987428784370422
degeneration I-Disease 1 1.0
in O 1 0.9983357787132263
ALD B-Disease 1 1.0
. O 0 0.04568072408437729

Lorenzos O 1 0.9474000930786133
Oil O 0 0.011589089408516884
should O 0 0.0027239809278398752
be O 0 0.0012844554148614407
given O 0 0.001504424144513905
in O 0 0.0014286116929724813
the O 0 0.0022917212918400764
early O 0 0.004216652829200029
stage O 0 0.014387210831046104
. O 0 0.0051343715749681
. O 0 0.008918040432035923

Nonsense O 0 0.05911737680435181
mutation O 0 0.014047371223568916
in O 0 0.005738473031669855
exon O 0 0.021849844604730606
4 O 0 0.006454520858824253
of O 0 0.0046118441969156265
human O 0 0.008167311549186707
complement O 0 0.022709522396326065
C9 O 1 0.999964714050293
gene O 0 0.007002352736890316
is O 0 0.00238858163356781
the O 0 0.002851916942745447
major O 0 0.0057051279582083225
cause O 0 0.015205633826553822
of O 0 0.11111035943031311
Japanese O 1 0.9999961853027344
complement B-Disease 1 0.9999674558639526
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.02972545102238655

Deficiency B-Disease 1 0.9999995231628418
of I-Disease 0 0.018905358389019966
the I-Disease 0 0.05175080522894859
ninth I-Disease 1 0.9948569536209106
component I-Disease 0 0.010607587173581123
of I-Disease 0 0.004191779065877199
human I-Disease 0 0.006353179458528757
complement I-Disease 0 0.021637558937072754
( O 0 0.014891189523041248
C9 O 1 0.9999740123748779
) O 0 0.0026917036157101393
is O 0 0.001693895785138011
the O 0 0.0020504312124103308
most O 0 0.0025148845743387938
common O 0 0.16599564254283905
complement B-Disease 1 0.9999949932098389
deficiency I-Disease 1 1.0
in O 0 0.06229874864220619
Japan O 1 0.7895123958587646
but O 0 0.0016332040540874004
is O 0 0.0018753615440800786
rare O 0 0.002843676134943962
in O 0 0.0020466253627091646
other O 0 0.0022332442458719015
countries O 0 0.003685908392071724
. O 0 0.009737713262438774

We O 0 0.00639575207605958
studied O 0 0.0067172786220908165
the O 0 0.0040521626360714436
molecular O 0 0.004792648367583752
basis O 0 0.003242731560021639
of O 0 0.00952652096748352
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
in O 0 0.0052098301239311695
four O 0 0.004922982770949602
Japanese O 1 0.9996817111968994
C9 B-Disease 1 1.0
- I-Disease 1 0.9999959468841553
deficient I-Disease 1 0.9999957084655762
patients O 1 0.9946699738502502
who O 0 0.021743647754192352
had O 1 0.5556004643440247
suffered O 1 1.0
from O 1 0.9998774528503418
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9135373830795288

Direct O 0 0.015937352553009987
sequencing O 0 0.02042458951473236
of O 0 0.011930592358112335
amplified O 0 0.03249283507466316
C9 O 1 0.9940898418426514
cDNA O 0 0.02288150228559971
and O 0 0.0035451839212328196
DNA O 0 0.005844959989190102
revealed O 0 0.005975507199764252
a O 0 0.0037613236345350742
nonsense O 0 0.013353126123547554
substitution O 0 0.011609288863837719
( O 0 0.008301139809191227
CGA O 1 0.8125708699226379
- O 0 0.11451847106218338
- O 0 0.02357030287384987
> O 0 0.020360086113214493
TGA O 1 0.7215700149536133
) O 0 0.0029922754038125277
at O 0 0.0031009921804070473
codon O 0 0.005265757907181978
95 O 0 0.003377376589924097
in O 0 0.0019994303584098816
exon O 0 0.008541535586118698
4 O 0 0.0030180958565324545
in O 0 0.001969114877283573
the O 0 0.003970624879002571
four O 0 0.009564666077494621
C9 B-Disease 1 0.9999994039535522
- I-Disease 1 0.9996935129165649
deficient I-Disease 1 0.9985287189483643
individuals O 0 0.009412722662091255
. O 0 0.014469853602349758

An O 0 0.01809278316795826
allele O 0 0.02973826415836811
- O 0 0.015819810330867767
specific O 0 0.006410724483430386
polymerase O 0 0.02038152515888214
chain O 0 0.01317700743675232
reaction O 0 0.006529476959258318
system O 0 0.004926618654280901
designed O 0 0.004842687863856554
to O 0 0.0019933327566832304
detect O 0 0.004201134666800499
exclusively O 0 0.0026380294002592564
only O 0 0.0011037634685635567
one O 0 0.001196211320348084
of O 0 0.0017118158284574747
the O 0 0.0024258324410766363
normal O 0 0.00343019375577569
and O 0 0.0022544669918715954
mutant O 0 0.010196196846663952
alleles O 0 0.004759751260280609
indicated O 0 0.0027645521331578493
that O 0 0.0008042966946959496
all O 0 0.0007714743842370808
the O 0 0.0015873383963480592
four O 0 0.0019810220692306757
patients O 0 0.0071408008225262165
were O 0 0.002189198974519968
homozygous O 0 0.003873384790495038
for O 0 0.0014993121149018407
the O 0 0.0027187420055270195
mutation O 0 0.004137683659791946
in O 0 0.0022998652420938015
exon O 0 0.01516500860452652
4 O 0 0.003144260263070464
and O 0 0.0011530437041074038
that O 0 0.0008790833526290953
the O 0 0.0020894790068268776
parents O 0 0.0034429708030074835
of O 0 0.0036416605580598116
patient O 1 0.9785086512565613
2 O 0 0.008934585377573967
were O 0 0.006119303405284882
heterozygous O 0 0.017554426565766335
. O 0 0.01050015352666378

The O 0 0.012590555474162102
common O 0 0.009293793700635433
mutation O 0 0.008089900016784668
at O 0 0.005085703916847706
codon O 0 0.008679653517901897
95 O 0 0.005373070482164621
in O 0 0.0031330035999417305
exon O 0 0.012811742722988129
4 O 0 0.0038020263891667128
might O 0 0.0016569626750424504
be O 0 0.0009585533407516778
responsible O 0 0.002193744294345379
for O 0 0.0020042583346366882
most O 0 0.004061379469931126
Japanese O 1 0.9999779462814331
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.013123666867613792
. O 0 0.011893652379512787

BRCA1 O 0 0.3570004105567932
required O 0 0.005537940189242363
for O 0 0.005664910655468702
transcription O 1 0.7465927004814148
- O 0 0.3546387255191803
coupled O 0 0.027687903493642807
repair O 1 0.99834144115448
of O 0 0.06853774935007095
oxidative O 1 0.9997543692588806
DNA O 1 0.7364794015884399
damage O 1 0.8266302347183228
. O 0 0.016295185312628746

The O 0 0.32451531291007996
breast B-Disease 1 1.0
and I-Disease 1 0.9999305009841919
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9998326301574707
BRCA1 O 1 0.9999556541442871
encodes O 0 0.01585550792515278
a O 0 0.007947097532451153
zinc O 1 0.9974225759506226
finger O 0 0.027389081194996834
protein O 0 0.005623568315058947
of O 0 0.004254748113453388
unknown O 0 0.010811450891196728
function O 0 0.01073135994374752
. O 0 0.011665082536637783

Association O 0 0.017541315406560898
of O 0 0.007884863764047623
the O 0 0.011508702300488949
BRCA1 O 1 0.9923391342163086
protein O 0 0.004895265679806471
with O 0 0.0020310364197939634
the O 0 0.0042176987044513226
DNA O 0 0.013603536412119865
repair O 1 0.9994557499885559
protein O 0 0.011236038990318775
Rad51 O 0 0.43334513902664185
and O 0 0.0022991092409938574
changes O 0 0.0018155452562496066
in O 0 0.0018085280898958445
the O 0 0.0027277013286948204
phosphorylation O 0 0.0038857015315443277
and O 0 0.0018376345979049802
cellular O 0 0.0038174702785909176
localization O 0 0.005373118910938501
of O 0 0.0022145609837025404
the O 0 0.002836790168657899
protein O 0 0.0036345343105494976
after O 0 0.0031874505802989006
exposure O 0 0.006001624278724194
to O 0 0.0026519743259996176
DNA O 0 0.011138403788208961
- O 0 0.012324509210884571
damaging O 0 0.0068055070005357265
agents O 0 0.0026509808376431465
are O 0 0.0009704344556666911
consistent O 0 0.002259845146909356
with O 0 0.001075192354619503
a O 0 0.002344981301575899
role O 0 0.005311940331012011
for O 0 0.0044492618180811405
BRCA1 O 1 0.9992414712905884
in O 0 0.00882524624466896
DNA O 0 0.03419818729162216
repair O 1 0.9941096305847168
. O 0 0.019257675856351852

Here O 0 0.012169093824923038
, O 0 0.004748198203742504
it O 0 0.002080452861264348
is O 0 0.0025546285323798656
shown O 0 0.0029128151945769787
that O 0 0.0019745370373129845
mouse O 0 0.010058140382170677
embryonic O 0 0.015710078179836273
stem O 0 0.031299740076065063
cells O 0 0.015330851078033447
deficient B-Disease 1 0.955048680305481
in I-Disease 0 0.005921720527112484
BRCA1 I-Disease 1 0.9979398846626282
are O 0 0.0026915832422673702
defective O 1 0.7152528166770935
in O 0 0.0021755641791969538
the O 0 0.0024137028958648443
ability O 0 0.0017333776922896504
to O 0 0.0009974208660423756
carry O 0 0.0016912419814616442
out O 0 0.002251181285828352
transcription O 0 0.014597276225686073
- O 0 0.014840171672403812
coupled O 0 0.01160349603742361
repair O 1 0.9586303234100342
of O 0 0.010617039166390896
oxidative O 1 0.9999126195907593
DNA O 1 0.7746213674545288
damage O 1 0.6720823049545288
, O 0 0.0030583820771425962
and O 0 0.0020389510318636894
are O 0 0.001726822229102254
hypersensitive O 0 0.04025275632739067
to O 0 0.0051436354406178
ionizing O 1 0.8599133491516113
radiation O 0 0.36644694209098816
and O 0 0.005682640243321657
hydrogen O 0 0.01789911277592182
peroxide O 0 0.06034591421484947
. O 0 0.01735512539744377

These O 0 0.005563740152865648
results O 0 0.0048185233026742935
suggest O 0 0.005778725724667311
that O 0 0.0034639108926057816
BRCA1 O 1 0.9757813811302185
participates O 0 0.009880741126835346
, O 0 0.002718794159591198
directly O 0 0.002425961662083864
or O 0 0.0020770886912941933
indirectly O 0 0.004850852768868208
, O 0 0.0027659039478749037
in O 0 0.0037966351956129074
transcription O 0 0.32111331820487976
- O 0 0.06124919280409813
coupled O 0 0.016115985810756683
repair O 1 0.942120373249054
of O 0 0.014524927362799644
oxidative O 1 0.9995521903038025
DNA O 1 0.6852489709854126
damage O 1 0.6548656821250916
. O 0 0.007024668622761965
. O 0 0.010624801740050316

Truncation O 0 0.15193285048007965
mutations O 0 0.014917570166289806
in O 0 0.004944031126797199
the O 0 0.006966731045395136
transactivation O 0 0.4552616775035858
region O 0 0.008257579989731312
of O 0 0.009577999822795391
PAX6 O 1 0.9999967813491821
result O 0 0.006713195238262415
in O 0 0.005485066678375006
dominant O 0 0.30287930369377136
- O 0 0.28898879885673523
negative O 0 0.014662413857877254
mutants O 0 0.03310611844062805
. O 0 0.010198122821748257

PAX6 O 1 0.9996943473815918
is O 0 0.008407879620790482
a O 0 0.00662502646446228
transcription O 0 0.00948354508727789
factor O 0 0.00438329391181469
with O 0 0.0013179503148421645
two O 0 0.0015716268680989742
DNA O 0 0.006348990835249424
- O 0 0.005483199842274189
binding O 0 0.0027306561823934317
domains O 0 0.005088650621473789
( O 0 0.004083221312612295
paired O 0 0.006447888445109129
box O 0 0.010506289079785347
and O 0 0.0042319996282458305
homeobox O 1 0.9952438473701477
) O 0 0.003491079667583108
and O 0 0.00256726355291903
a O 0 0.005871402099728584
proline O 1 0.7319015860557556
- O 0 0.1801971048116684
serine O 0 0.051012709736824036
- O 0 0.027516230940818787
threonine O 0 0.03527769446372986
( O 0 0.016024921089410782
PST O 1 0.9940213561058044
) O 0 0.013124332763254642
- O 0 0.019511917605996132
rich O 0 0.014554210007190704
transactivation O 0 0.18991290032863617
domain O 0 0.025407740846276283
. O 0 0.017408862709999084

PAX6 O 1 0.9999817609786987
regulates O 1 0.9804214835166931
eye O 1 0.9697191715240479
development O 0 0.0069258916191756725
in O 0 0.002856781240552664
animals O 0 0.0027455687522888184
ranging O 0 0.003905596910044551
from O 0 0.003167080692946911
jellyfish O 0 0.008234946057200432
to O 0 0.0033737539779394865
Drosophila O 0 0.01287373062223196
to O 0 0.004506997764110565
humans O 0 0.010112611576914787
. O 0 0.011644791811704636

Heterozygous O 0 0.030146881937980652
mutations O 0 0.009962232783436775
in O 0 0.004113500937819481
the O 0 0.00616058986634016
human O 0 0.012517731636762619
PAX6 O 1 0.9999921321868896
gene O 0 0.006983310449868441
result O 0 0.0023649828508496284
in O 0 0.0016202712431550026
various O 0 0.0018345400458201766
phenotypes O 0 0.008474575355648994
, O 0 0.0028802480082958937
including O 0 0.004619954153895378
aniridia B-Disease 1 0.9999994039535522
, O 0 0.02362201362848282
Peters B-Disease 1 0.9999946355819702
anomaly I-Disease 1 0.999994158744812
, O 0 0.2546810209751129
autosomal B-Disease 1 0.9999953508377075
dominant I-Disease 1 0.9999545812606812
keratitis I-Disease 1 1.0
, O 1 0.9936564564704895
and O 1 0.9938403367996216
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9757653474807739

It O 0 0.006584785878658295
is O 0 0.004973224364221096
believed O 0 0.004839899018406868
that O 0 0.0019091942813247442
the O 0 0.0036372339818626642
mutated O 0 0.009923595935106277
allele O 0 0.00732048787176609
of O 0 0.004410982597619295
PAX6 O 1 0.9997261166572571
produces O 0 0.0057427785359323025
an O 0 0.003593421308323741
inactive O 0 0.04326903074979782
protein O 0 0.0057280464097857475
and O 0 0.0036295815370976925
aniridia B-Disease 1 0.9996753931045532
is O 0 0.005261819809675217
caused O 0 0.010655728168785572
due O 0 0.006768940016627312
to O 0 0.005783746484667063
genetic O 0 0.13710536062717438
haploinsufficiency O 1 0.998602569103241
. O 0 0.016272254288196564

However O 0 0.008860381320118904
, O 0 0.004752190317958593
several O 0 0.0034956445451825857
truncation O 0 0.0851782038807869
mutations O 0 0.0058573223650455475
have O 0 0.0014790015993639827
been O 0 0.001622332027181983
found O 0 0.0016173520125448704
to O 0 0.001050953404046595
occur O 0 0.0009892592206597328
in O 0 0.0014636946143582463
the O 0 0.004073069430887699
C O 1 0.913699746131897
- O 0 0.010105886496603489
terminal O 0 0.00838453695178032
half O 0 0.0028657985385507345
of O 0 0.0036139264702796936
PAX6 O 1 0.9999668598175049
in O 0 0.0055679152719676495
patients O 1 0.7223275899887085
with O 0 0.004078472964465618
Aniridia B-Disease 1 0.9999879598617554
resulting O 0 0.008166732266545296
in O 0 0.003843474667519331
mutant O 0 0.009911722503602505
proteins O 0 0.002804873278364539
that O 0 0.0014354357263073325
retain O 0 0.004837401211261749
the O 0 0.004646571818739176
DNA O 0 0.010242286138236523
- O 0 0.007626534439623356
binding O 0 0.0031018827576190233
domains O 0 0.003681617323309183
but O 0 0.0013757802080363035
have O 0 0.0014350099954754114
lost O 0 0.0047958018258214
most O 0 0.001943515264429152
of O 0 0.004312013275921345
the O 0 0.010611671954393387
transactivation O 1 0.9841082096099854
domain O 0 0.025620875880122185
. O 0 0.01604517549276352

It O 0 0.005648696329444647
is O 0 0.003327667713165283
not O 0 0.0014422613894566894
clear O 0 0.0020864964462816715
whether O 0 0.0017879094230011106
such O 0 0.0016365725314244628
mutants O 0 0.01307632029056549
really O 0 0.0048283422365784645
behave O 0 0.004991208668798208
as O 0 0.00299011985771358
loss O 0 0.01083263847976923
- O 0 0.008540268056094646
of O 0 0.004544476047158241
- O 0 0.01241377368569374
function O 0 0.005334208253771067
mutants O 0 0.010971461422741413
as O 0 0.003421052126213908
predicted O 0 0.00839851051568985
by O 0 0.005441386252641678
haploinsufficiency O 1 0.5120846033096313
. O 0 0.01686093583703041

Contrary O 0 0.01607346720993519
to O 0 0.0035492931492626667
this O 0 0.0023799536284059286
theory O 0 0.004127781372517347
, O 0 0.0026985835283994675
our O 0 0.0020591060165315866
data O 0 0.0018676839536055923
showed O 0 0.0027388795278966427
that O 0 0.0008096356177702546
these O 0 0.0010762736201286316
mutants O 0 0.006051845848560333
are O 0 0.0013510293792933226
dominant O 0 0.007812795229256153
- O 0 0.010514713823795319
negative O 0 0.00470585934817791
in O 0 0.003912241663783789
transient O 0 0.049145203083753586
transfection O 1 0.8267149329185486
assays O 0 0.008108923211693764
when O 0 0.0026675809640437365
they O 0 0.0011733656283468008
are O 0 0.0013377964496612549
coexpressed O 0 0.015156678855419159
with O 0 0.003798708552494645
wild O 0 0.017549730837345123
- O 1 0.8779341578483582
type O 1 0.9638126492500305
PAX6 O 1 0.9999769926071167
. O 0 0.023616276681423187

We O 0 0.006062758155167103
found O 0 0.0035733450204133987
that O 0 0.0019151814049109817
the O 0 0.0042671337723731995
dominant O 0 0.04312910512089729
- O 0 0.029449302703142166
negative O 0 0.00571197597309947
effects O 0 0.004819551948457956
result O 0 0.0023944710846990347
from O 0 0.0021546378266066313
the O 0 0.003911062143743038
enhanced O 0 0.0076538268476724625
DNA O 0 0.005077333655208349
binding O 0 0.0022100021596997976
ability O 0 0.0020536966621875763
of O 0 0.0027382541447877884
these O 0 0.0036510208155959845
mutants O 0 0.027489153668284416
. O 0 0.013296728022396564

Kinetic O 0 0.024381978437304497
studies O 0 0.008119319565594196
of O 0 0.005101846065372229
binding O 0 0.005055239889770746
and O 0 0.004153262823820114
dissociation O 0 0.014637290500104427
revealed O 0 0.006781868636608124
that O 0 0.0017398238414898515
various O 0 0.002451180247589946
truncation O 0 0.021243643015623093
mutants O 0 0.013200775720179081
have O 0 0.002477525267750025
3 O 0 0.006148098036646843
- O 0 0.010033680126070976
5 O 0 0.005791368428617716
- O 0 0.007017189171165228
fold O 0 0.005722259636968374
higher O 0 0.0030499876011162996
affinity O 0 0.003161777276545763
to O 0 0.0014354233862832189
various O 0 0.002028870861977339
DNA O 0 0.006649605464190245
- O 0 0.005090975668281317
binding O 0 0.0016320599243044853
sites O 0 0.0013743375893682241
when O 0 0.001262791221961379
compared O 0 0.0016290111234411597
with O 0 0.001225709798745811
the O 0 0.0034797368571162224
wild O 0 0.018212780356407166
- O 1 0.9393783211708069
type O 1 0.8853163719177246
PAX6 O 1 0.9999523162841797
. O 0 0.021241452544927597

These O 0 0.00587862404063344
results O 0 0.005133738741278648
provide O 0 0.003361054230481386
a O 0 0.0028219979722052813
new O 0 0.002624914050102234
insight O 0 0.005202272906899452
into O 0 0.002018364379182458
the O 0 0.0023945984430611134
role O 0 0.004273970611393452
of O 0 0.005493185482919216
mutant O 1 0.9621744155883789
PAX6 O 1 0.9999896287918091
in O 0 0.010531132109463215
causing O 1 0.9780812859535217
aniridia B-Disease 1 0.9999921321868896
. O 0 0.01002406980842352
. O 0 0.012064152397215366

Reversal O 1 0.7371857166290283
of O 1 0.9983415603637695
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999958276748657
excellent O 1 0.9999221563339233
neuropsychologic O 1 0.9998148083686829
outcome O 0 0.005448964424431324
in O 0 0.0026110191829502583
very B-Disease 0 0.0031831960659474134
- I-Disease 0 0.010564455762505531
long I-Disease 0 0.007689750287681818
- I-Disease 0 0.01764705218374729
chain I-Disease 0 0.025111671537160873
acyl I-Disease 1 0.8215056657791138
- I-Disease 0 0.35611897706985474
coenzyme I-Disease 1 0.7962176203727722
A I-Disease 1 0.9990645051002502
dehydrogenase I-Disease 1 0.9999992847442627
deficiency I-Disease 1 1.0
. O 0 0.03209671005606651

Very B-Disease 0 0.01942591927945614
- I-Disease 0 0.03826485574245453
long I-Disease 0 0.014016173779964447
- I-Disease 0 0.022740403190255165
chain I-Disease 0 0.023550482466816902
acyl I-Disease 0 0.1387265920639038
- I-Disease 0 0.020541539415717125
coenzyme I-Disease 0 0.024610409513115883
A I-Disease 0 0.016377441585063934
dehydrogenase I-Disease 1 0.9910077452659607
( I-Disease 0 0.06975708156824112
VLCAD I-Disease 1 0.9999991655349731
) I-Disease 1 0.9343804717063904
deficiency I-Disease 1 0.9999997615814209
is O 0 0.005646430887281895
a O 0 0.05006833374500275
disorder O 1 0.9999998807907104
of O 1 0.9998667240142822
fatty O 1 0.9999995231628418
acid O 1 0.9985894560813904
beta O 0 0.029591435566544533
oxidation O 0 0.009674747474491596
that O 0 0.0023493270855396986
reportedly O 0 0.007046652026474476
has O 0 0.0027754134498536587
high O 0 0.005368994548916817
rates O 0 0.005037623457610607
of O 0 0.006336909718811512
morbidity O 1 0.9998353719711304
and O 0 0.013115444220602512
mortality O 1 0.9988884329795837
. O 0 0.02035895176231861

We O 0 0.00611012801527977
describe O 0 0.005546817556023598
the O 0 0.0028819304425269365
outcome O 0 0.002513718558475375
of O 0 0.001804170897230506
a O 0 0.0031202826648950577
5 O 0 0.004874448291957378
- O 0 0.006430941633880138
year O 0 0.0034672932233661413
- O 0 0.009465636685490608
old O 0 0.018822839483618736
girl O 1 0.9457463026046753
with O 0 0.05409235507249832
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.703986406326294
was O 0 0.1880398839712143
first O 0 0.0026343739591538906
seen O 0 0.00238610222004354
at O 0 0.002218495588749647
5 O 0 0.0018434093799442053
months O 0 0.0017240772722288966
of O 0 0.0022153554018586874
age O 0 0.009256365709006786
with O 0 0.06486565619707108
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 1 0.998820960521698
and O 1 0.8392989039421082
hypotonia B-Disease 1 0.9999910593032837
. O 0 0.022319667041301727

Biochemical O 0 0.06431908160448074
studies O 0 0.030314145609736443
indicated O 1 0.9991546869277954
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9993357062339783
by O 0 0.0046255518682301044
a O 0 0.008605672977864742
stable O 1 0.8137427568435669
yet O 0 0.00874275155365467
inactive O 0 0.20722386240959167
enzyme O 0 0.021129729226231575
. O 0 0.012983413413167

Molecular O 0 0.01884135790169239
genetic O 0 0.008493004366755486
analysis O 0 0.004154939204454422
of O 0 0.005341781303286552
her O 0 0.07714961469173431
VLCAD O 1 0.9999908208847046
gene O 0 0.008127599023282528
revealed O 0 0.007855691947042942
a O 0 0.006231707986444235
T1372C O 1 0.6016599535942078
( O 0 0.010581535287201405
F458L O 0 0.0505293533205986
) O 0 0.0063473936170339584
missense O 0 0.018144220113754272
mutation O 0 0.008800470270216465
and O 0 0.004838223103433847
a O 0 0.012260247021913528
1668 O 1 0.9999047517776489
ACAG O 1 0.9999738931655884
1669 O 1 0.9996042847633362
splice O 0 0.3563418686389923
site O 0 0.033717747777700424
mutation O 0 0.031211838126182556
. O 0 0.01766960509121418

After O 0 0.016387728974223137
initial O 0 0.015362802892923355
treatment O 1 0.9945525527000427
with O 0 0.009142614901065826
intravenous O 1 0.9999997615814209
glucose O 1 0.9987986087799072
and O 0 0.0090762535110116
carnitine O 1 0.9999351501464844
, O 0 0.004094008821994066
the O 0 0.0049392762593925
patient O 1 0.5854096412658691
has O 0 0.002581220818683505
thrived O 0 0.006833203602582216
on O 0 0.002048293361440301
a O 0 0.0030804791022092104
low O 0 0.008072890341281891
- O 0 0.01754332147538662
fat O 0 0.01070957351475954
diet O 0 0.009232180193066597
supplemented O 0 0.006413722410798073
with O 0 0.002597654704004526
medium O 0 0.009065375663340092
- O 0 0.012505524791777134
chain O 0 0.014312119223177433
triglyceride O 0 0.13983668386936188
oil O 0 0.009412999264895916
and O 0 0.006141406483948231
carnitine O 1 0.9993908405303955
and O 0 0.007413122802972794
avoidance O 1 0.9818375706672668
of O 0 0.22729229927062988
fasting O 1 0.9473382234573364
. O 0 0.02123914286494255

Her O 1 0.9977551102638245
ventricular O 1 0.9999995231628418
hypertrophy O 1 0.9999996423721313
resolved O 0 0.4776075482368469
significantly O 0 0.005893831141293049
over O 0 0.0025097127072513103
1 O 0 0.004114676732569933
year O 0 0.002273417543619871
, O 0 0.0021324038971215487
and O 0 0.0025062095373868942
cognitively O 1 0.5663593411445618
, O 0 0.003596656722947955
she O 0 0.0039827218279242516
is O 0 0.0018037825357168913
in O 0 0.001548990374431014
the O 0 0.0025932404678314924
superior O 0 0.007349255960434675
range O 0 0.003527846187353134
for O 0 0.004061559215188026
age O 0 0.010944629088044167
. O 0 0.012955743819475174

Clinical O 1 0.7183482646942139
recognition O 0 0.18446528911590576
of O 1 0.9999597072601318
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.3089231252670288
important O 0 0.003606886835768819
because O 0 0.0015424841549247503
it O 0 0.0007233649375848472
is O 0 0.0008091943454928696
one O 0 0.0007393815903924406
of O 0 0.0012249908177182078
the O 0 0.0019491701386868954
few O 0 0.002368657849729061
directly O 0 0.0048242537304759026
treatable O 1 0.9999995231628418
causes O 1 0.9991834759712219
of O 1 0.999945878982544
cardiomyopathy B-Disease 1 1.0
in O 1 0.9999805688858032
children O 1 0.9994717240333557
. O 0 0.00810209196060896
. O 0 0.010806860402226448

Cloning O 0 0.0174502395093441
of O 0 0.005260198377072811
a O 0 0.004034232348203659
novel O 0 0.0072652120143175125
member O 0 0.004300457425415516
of O 0 0.0037252181209623814
the O 0 0.0064103808254003525
low O 0 0.06610097736120224
- O 0 0.39288485050201416
density O 0 0.02001815475523472
lipoprotein O 1 0.9973589777946472
receptor O 0 0.028886714950203896
family O 0 0.02033032663166523
. O 0 0.016512714326381683

A O 0 0.020186083391308784
gene O 0 0.01026148535311222
encoding O 0 0.005460820626467466
a O 0 0.0047638327814638615
novel O 0 0.013242085464298725
transmembrane O 0 0.13750573992729187
protein O 0 0.007265467196702957
was O 0 0.005186821334064007
identified O 0 0.0030114452820271254
by O 0 0.0013373518595471978
DNA O 0 0.0025228599552065134
sequence O 0 0.0015676663024351
analysis O 0 0.0011182171292603016
within O 0 0.001486926805227995
the O 0 0.005098497495055199
insulin B-Disease 1 0.9999037981033325
- I-Disease 1 0.9994456171989441
dependent I-Disease 1 0.9940593242645264
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9980348944664001
IDDM B-Disease 1 0.9999918937683105
) O 0 0.011321469210088253
locus O 0 0.03886060416698456
IDDM4 O 1 0.9588245153427124
on O 0 0.01310204528272152
chromosome O 0 0.03932918608188629
11q13 O 0 0.17999088764190674
. O 0 0.020175499841570854

Based O 0 0.007278557401150465
on O 0 0.005026157945394516
its O 0 0.004184893798083067
chromosomal O 0 0.03550122305750847
position O 0 0.00708051398396492
, O 0 0.002740025520324707
this O 0 0.0018611008999869227
gene O 0 0.0028540792409330606
is O 0 0.0016119250794872642
a O 0 0.0023984070867300034
candidate O 0 0.004485027398914099
for O 0 0.00347247370518744
conferring O 0 0.18094146251678467
susceptibility O 1 0.9996821880340576
to O 0 0.021560169756412506
diabetes B-Disease 1 1.0
. O 0 0.029546217992901802

The O 0 0.01635330729186535
gene O 0 0.011750866658985615
, O 0 0.00559376971796155
termed O 0 0.019041510298848152
low O 0 0.01715908758342266
- O 0 0.021552883088588715
density O 0 0.01164911687374115
lipoprotein O 0 0.44366517663002014
receptor O 0 0.007143897470086813
related O 0 0.004011557903140783
protein O 0 0.004747368860989809
5 O 0 0.0050428989343345165
( O 0 0.005963112227618694
LRP5 O 1 0.989933431148529
) O 0 0.003374264342710376
, O 0 0.002526896307244897
encodes O 0 0.004976533818989992
a O 0 0.0030519815627485514
protein O 0 0.003867028048262
of O 0 0.0034709444735199213
1615 O 0 0.04927438870072365
amino O 0 0.005754765123128891
acids O 0 0.0034138381015509367
that O 0 0.0012719701044261456
contains O 0 0.002604983514174819
conserved O 0 0.004687583539634943
modules O 0 0.004254366736859083
which O 0 0.0010672438656911254
are O 0 0.0007862183265388012
characteristic O 0 0.0030240346677601337
of O 0 0.0024868077598512173
the O 0 0.0052736238576471806
low O 0 0.01458956953138113
- O 0 0.01874994859099388
density O 0 0.013740885071456432
lipoprotein O 1 0.9996706247329712
( O 0 0.04320022836327553
LDL O 1 0.9999767541885376
) O 0 0.011000609956681728
receptor O 0 0.017937082797288895
family O 0 0.016955874860286713
. O 0 0.014562481082975864

These O 0 0.005393290426582098
modules O 0 0.010336232371628284
include O 0 0.004750968422740698
a O 0 0.005814311560243368
putative O 0 0.03483365848660469
signal O 0 0.007892320863902569
peptide O 0 0.005783234257251024
for O 0 0.0017890585586428642
protein O 0 0.0036443329881876707
export O 0 0.0033658253960311413
, O 0 0.0024777844082564116
four O 0 0.003484937362372875
epidermal O 1 0.9909710884094238
growth O 0 0.008965197019279003
factor O 0 0.011167967692017555
( O 0 0.008843676187098026
EGF O 1 0.9825999140739441
) O 0 0.004052203148603439
repeats O 0 0.0060911038890480995
with O 0 0.0021290297154337168
associated O 0 0.005272097885608673
spacer O 0 0.024019647389650345
domains O 0 0.007482992019504309
, O 0 0.004514693282544613
three O 0 0.006535226944833994
LDL O 1 0.9999964237213135
- O 0 0.3975646197795868
receptor O 0 0.014088600873947144
( O 0 0.007515181787312031
LDLR O 1 0.8663380742073059
) O 0 0.004029680974781513
repeats O 0 0.006423404905945063
, O 0 0.0018056114204227924
a O 0 0.0025359238497912884
single O 0 0.003936676308512688
transmembrane O 0 0.01503060944378376
spanning O 0 0.009077904745936394
domain O 0 0.005854673683643341
, O 0 0.0027918480336666107
and O 0 0.0029357080347836018
a O 0 0.0064626834355294704
cytoplasmic O 0 0.02003285102546215
domain O 0 0.01703583635389805
. O 0 0.012121481820940971

The O 0 0.014611892402172089
encoded O 0 0.00903777964413166
protein O 0 0.005602139048278332
has O 0 0.0021606269292533398
a O 0 0.0021668144036084414
unique O 0 0.002697526477277279
organization O 0 0.0038922412786632776
of O 0 0.007797133643180132
EGF O 1 0.9999773502349854
and O 0 0.006762390490621328
LDLR O 1 0.9999399185180664
repeats O 0 0.01859116181731224
; O 0 0.0026442946400493383
therefore O 0 0.0033320134971290827
, O 0 0.004030672367662191
LRP5 O 1 0.9527825117111206
likely O 0 0.004034033510833979
represents O 0 0.003433621721342206
a O 0 0.0024607540108263493
new O 0 0.0027642652858048677
category O 0 0.0056943404488265514
of O 0 0.004146994091570377
the O 0 0.010315068066120148
LDLR O 1 0.999982476234436
family O 0 0.11447069048881531
. O 0 0.017402974888682365

Both O 0 0.01012825034558773
human O 0 0.009515894576907158
and O 0 0.008444988168776035
mouse O 1 0.6817135214805603
LRP5 O 1 0.9999899864196777
cDNAs O 1 0.9774559140205383
have O 0 0.002112584887072444
been O 0 0.002161906100809574
isolated O 0 0.004281256347894669
and O 0 0.0017888577422127128
the O 0 0.002762302290648222
encoded O 0 0.0031409866642206907
mature O 0 0.003185018664225936
proteins O 0 0.0014074990758672357
are O 0 0.0007745886105112731
95 O 0 0.0031589593272656202
% O 0 0.001708328491076827
identical O 0 0.002353962976485491
, O 0 0.0019846907816827297
indicating O 0 0.004514035768806934
a O 0 0.0025596749037504196
high O 0 0.004829625599086285
degree O 0 0.004876062739640474
of O 0 0.004851649049669504
evolutionary O 0 0.013425500132143497
conservation O 0 0.014296217821538448
. O 0 0.005440399516373873
. O 0 0.009686194360256195

The O 0 0.02336996980011463
APC B-Disease 1 0.9942207336425781
variants O 0 0.017738282680511475
I1307K O 0 0.19834493100643158
and O 0 0.003973452840000391
E1317Q O 0 0.03903583809733391
are O 0 0.0025159388314932585
associated O 0 0.009907115250825882
with O 1 0.9795812964439392
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.6880732774734497
but O 0 0.002079033525660634
not O 0 0.0011759625049307942
always O 0 0.001801084610633552
with O 0 0.001116150408051908
a O 0 0.0035303542390465736
family O 0 0.008346688002347946
history O 0 0.01487676054239273
. O 0 0.012147221714258194

Classical O 1 0.5105422139167786
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999995231628418
FAP B-Disease 1 1.0
) O 0 0.00960037112236023
is O 0 0.003712839912623167
a O 0 0.0052048154175281525
high O 0 0.16635076701641083
- O 1 0.997896671295166
penetrance O 1 0.9999818801879883
autosomal B-Disease 1 0.9999995231628418
dominant I-Disease 1 0.9999958276748657
disease I-Disease 1 1.0
that O 0 0.005038651637732983
predisposes O 1 0.8191777467727661
to O 0 0.0020151243079453707
hundreds O 0 0.002866365248337388
or O 0 0.0022490271367132664
thousands O 0 0.004509103484451771
of O 1 0.995387613773346
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
carcinoma I-Disease 1 1.0
and O 1 0.5624191164970398
that O 0 0.0021359529346227646
results O 0 0.0029257594142109156
from O 0 0.003109330777078867
truncating O 0 0.029393140226602554
mutations O 0 0.005482757929712534
in O 0 0.003740230342373252
the O 0 0.012162507511675358
APC B-Disease 1 0.9997852444648743
gene O 0 0.020767247304320335
. O 0 0.014412453398108482

A O 0 0.025239532813429832
variant O 0 0.056853778660297394
of O 0 0.04834338650107384
FAP B-Disease 1 0.9999998807907104
is O 1 0.8685821294784546
attenuated B-Disease 1 0.9999908208847046
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.006943785585463047
which O 0 0.0022181272506713867
results O 0 0.0028395403642207384
from O 0 0.003057921538129449
germ O 1 0.9999759197235107
- O 0 0.10176172107458115
line O 0 0.004179329611361027
mutations O 0 0.002356739481911063
in O 0 0.0014647834468632936
the O 0 0.0022058431059122086
5 O 0 0.002783458447083831
and O 0 0.0014157290570437908
3 O 0 0.002807457698509097
regions O 0 0.002420293167233467
of O 0 0.004663652274757624
the O 0 0.014853577129542828
APC B-Disease 1 0.9999500513076782
gene O 0 0.024738475680351257
. O 0 0.014797386713325977

Attenuated B-Disease 1 0.9999796152114868
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999994039535522
have O 0 0.006251287180930376
" O 0 0.020377349108457565
multiple O 0 0.22548621892929077
" O 1 0.9999552965164185
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.28637924790382385
typically O 0 0.0026046093553304672
fewer O 0 0.0020902585238218307
than O 0 0.0010550421429798007
100 O 0 0.002619463251903653
) O 0 0.002074497751891613
without O 0 0.001697467640042305
the O 0 0.004420809913426638
florid O 0 0.39474740624427795
phenotype O 0 0.020976942032575607
of O 0 0.012562925927340984
classical O 0 0.2841634154319763
FAP B-Disease 1 0.9999970197677612
. O 0 0.0325058288872242

Another O 0 0.011606307700276375
group O 0 0.00615008594468236
of O 0 0.007364493794739246
patients O 1 0.9857337474822998
with O 0 0.004414138849824667
multiple O 0 0.333886057138443
adenomas B-Disease 1 0.9999988079071045
has O 0 0.004793390166014433
no O 0 0.002996208146214485
mutations O 0 0.0030771316960453987
in O 0 0.0022015089634805918
the O 0 0.005098337773233652
APC B-Disease 1 0.9999790191650391
gene O 0 0.004336988087743521
, O 0 0.0016237915260717273
and O 0 0.0013126524863764644
their O 0 0.0015729115111753345
phenotype O 0 0.005728160496801138
probably O 0 0.002647249260917306
results O 0 0.0017735544824972749
from O 0 0.0015178835019469261
variation O 0 0.003164112102240324
at O 0 0.0036760231014341116
a O 0 0.0037533340509980917
locus O 0 0.016849927604198456
, O 0 0.0031713529024273157
or O 0 0.003177998587489128
loci O 0 0.00966246984899044
, O 0 0.0030378815717995167
elsewhere O 0 0.003981125541031361
in O 0 0.0034140227362513542
the O 0 0.007654203567653894
genome O 0 0.019987208768725395
. O 0 0.012968824245035648

Recently O 0 0.02234111912548542
, O 0 0.005579957272857428
however O 0 0.003082083072513342
, O 0 0.0028383000753819942
a O 0 0.003809058340266347
missense O 0 0.014503654092550278
variant O 0 0.01230090856552124
of O 0 0.0098807318136096
APC B-Disease 1 0.9999977350234985
( O 0 0.07034154236316681
I1307K O 1 0.9785881042480469
) O 0 0.0030608417000621557
was O 0 0.00344966072589159
described O 0 0.0034823750611394644
that O 0 0.0015085162594914436
confers O 0 0.00825820304453373
an O 0 0.002287005539983511
increased O 0 0.006719930097460747
risk O 1 0.8863338232040405
of O 1 0.9999923706054688
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.9222381114959717
including O 0 0.015515376813709736
multiple O 1 0.7504076361656189
adenomas B-Disease 1 0.9999971389770508
, O 0 0.009758182801306248
in O 0 0.01314872782677412
Ashkenazim O 1 0.9455627202987671
. O 0 0.021590398624539375

We O 0 0.006346994079649448
have O 0 0.002107851440086961
studied O 0 0.004589742515236139
a O 0 0.002154707442969084
set O 0 0.0023179210256785154
of O 0 0.00322885625064373
164 O 0 0.21662268042564392
patients O 1 0.6174068450927734
with O 0 0.003736646380275488
multiple O 1 0.999800980091095
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999996542930603
/ I-Disease 1 1.0
or I-Disease 1 0.9828318953514099
carcinoma I-Disease 1 1.0
and O 0 0.007052058819681406
analyzed O 0 0.013593914918601513
codons O 0 0.02468084543943405
1263 O 1 0.9864897727966309
- O 0 0.040498822927474976
1377 O 1 0.8683600425720215
( O 0 0.009594534523785114
exon O 0 0.025235021486878395
15G O 0 0.028101619333028793
) O 0 0.0029340474866330624
of O 0 0.0028379433788359165
the O 0 0.005875863134860992
APC B-Disease 1 0.9985525012016296
gene O 0 0.0061506363563239574
for O 0 0.004801080096513033
germ O 1 0.9999691247940063
- O 0 0.4669245481491089
line O 0 0.013587599620223045
variants O 0 0.016530966386198997
. O 0 0.012794709764420986

Three O 0 0.011365501210093498
patients O 0 0.018147755414247513
with O 0 0.0034577471669763327
the O 0 0.007695756386965513
I1307K O 1 0.7458988428115845
allele O 0 0.008256853558123112
were O 0 0.002319123363122344
detected O 0 0.004556810483336449
, O 0 0.0020806952379643917
each O 0 0.0017022101674228907
of O 0 0.00501026539131999
Ashkenazi O 1 0.9831324219703674
descent O 0 0.0684560239315033
. O 0 0.021531034260988235

Four O 0 0.013779647648334503
patients O 0 0.45826324820518494
had O 0 0.008672172203660011
a O 0 0.011825635097920895
germ O 1 0.9999963045120239
- O 0 0.4926319420337677
line O 0 0.008505944162607193
E1317Q O 0 0.02889672853052616
missense O 0 0.017748940736055374
variant O 0 0.01207998488098383
of O 0 0.006270992569625378
APC O 1 0.9999078512191772
that O 0 0.002131181536242366
was O 0 0.004321570508182049
not O 0 0.0010633963393047452
present O 0 0.00160890759434551
in O 0 0.0014031730825081468
controls O 0 0.0030293469317257404
; O 0 0.0013327694032341242
one O 0 0.0012173366267234087
of O 0 0.0013444108190014958
these O 0 0.0007537671481259167
individuals O 0 0.0011224424233660102
had O 0 0.0021756389178335667
an O 0 0.0017241750610992312
unusually O 0 0.0049434443935751915
large O 0 0.002186356345191598
number O 0 0.0019052603747695684
of O 0 0.0049313753843307495
metaplastic B-Disease 1 0.9998939037322998
polyps I-Disease 1 0.9951181411743164
of I-Disease 0 0.010531013831496239
the I-Disease 0 0.09321378916501999
colorectum I-Disease 1 0.9998223185539246
. O 0 0.01672990247607231

There O 0 0.008755024522542953
is O 0 0.004177277907729149
increasing O 0 0.0030790078453719616
evidence O 0 0.0024777257349342108
that O 0 0.0012374863727018237
there O 0 0.0017635033000260592
exist O 0 0.0031547965481877327
germ O 1 0.9984891414642334
- O 0 0.010088024660944939
line O 0 0.004205815494060516
variants O 0 0.0032406174577772617
of O 0 0.0029006577096879482
the O 0 0.007639678195118904
APC B-Disease 1 0.9998562335968018
gene O 0 0.0050735753029584885
that O 0 0.0016656051157042384
predispose O 0 0.006453573238104582
to O 0 0.0013675476657226682
the O 0 0.002244633622467518
development O 0 0.004050439223647118
of O 0 0.007801621221005917
multiple O 1 0.9999943971633911
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 1 0.7261456847190857
but O 0 0.0023637465201318264
without O 0 0.0019646016880869865
the O 0 0.003525623818859458
florid O 1 0.8940200209617615
phenotype O 0 0.009065615013241768
of O 0 0.004083744715899229
classical O 0 0.04453304037451744
FAP B-Disease 1 0.9999996423721313
, O 0 0.003661877941340208
and O 0 0.001965806121006608
possibly O 0 0.00266249873675406
with O 0 0.0016067627584561706
importance O 0 0.15003164112567902
for O 1 0.9963701963424683
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9996330738067627
in O 0 0.00403117761015892
the O 0 0.0045158034190535545
general O 0 0.009967200458049774
population O 0 0.004822475835680962
. O 0 0.004933097865432501
. O 0 0.009834079071879387

Genomic O 0 0.02740931510925293
structure O 0 0.010672107338905334
of O 0 0.007613383699208498
the O 0 0.060197751969099045
human O 1 0.9999754428863525
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 1 0.5502051115036011
gene O 0 0.017303388565778732
. O 0 0.010248336009681225

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.14031682908535004
is O 0 0.003290849970653653
caused O 0 0.0055571794509887695
by O 0 0.0016673821955919266
mutations O 0 0.002633990254253149
in O 0 0.0017333744326606393
a O 0 0.003276890842244029
gene O 0 0.004146432504057884
which O 0 0.002193072345107794
encodes O 0 0.010926175862550735
an O 0 0.010622921399772167
intestinal O 1 1.0
anion O 1 0.9999974966049194
transporter O 1 0.9998668432235718
. O 0 0.025202171877026558

We O 0 0.006525014992803335
report O 0 0.004784854594618082
here O 0 0.0028525812085717916
the O 0 0.002150721149519086
complete O 0 0.0031718111131340265
genomic O 0 0.005677262786775827
organization O 0 0.0024092933163046837
of O 0 0.0023556409869343042
the O 0 0.005306433420628309
human O 0 0.06143539398908615
CLD B-Disease 1 0.9999994039535522
gene O 0 0.00610498758032918
which O 0 0.0019639511592686176
spans O 0 0.007692391984164715
approximately O 0 0.004863691050559282
39kb O 0 0.07074356824159622
, O 0 0.003552073612809181
and O 0 0.0035880610812455416
comprises O 0 0.012461940757930279
21 O 0 0.016353992745280266
exons O 0 0.03795187920331955
. O 0 0.01574561931192875

All O 0 0.017309801653027534
exon O 0 0.18226993083953857
/ O 0 0.05011160299181938
intron O 0 0.04969130828976631
boundaries O 0 0.005756391678005457
conform O 0 0.008072259835898876
to O 0 0.003947149962186813
the O 0 0.011477930471301079
GT O 1 0.9999778270721436
/ O 1 0.9996589422225952
AG O 1 0.9997184872627258
rule O 0 0.025175627321004868
. O 0 0.01713533140718937

An O 0 0.006965071428567171
analysis O 0 0.004540452733635902
of O 0 0.004439240787178278
the O 0 0.007749909535050392
putative O 1 0.651509165763855
promoter O 1 0.6401845216751099
region O 0 0.006866921670734882
sequence O 0 0.004141697660088539
shows O 0 0.0032819437328726053
a O 0 0.004801449365913868
putative O 1 0.5883684754371643
TATA O 1 0.9999672174453735
box O 0 0.025117971003055573
and O 0 0.004471346270292997
predicts O 0 0.017038455232977867
multiple O 0 0.007458312902599573
transcription O 0 0.019528718665242195
factor O 0 0.011502394452691078
binding O 0 0.00657355273142457
sites O 0 0.0095540601760149
. O 0 0.012501167133450508

The O 0 0.016462035477161407
genomic O 0 0.020182348787784576
structure O 0 0.009930631145834923
was O 0 0.007742048241198063
determined O 0 0.004169577267020941
using O 0 0.002162068849429488
DNA O 0 0.0032265824265778065
from O 0 0.0011737562017515302
several O 0 0.0008876835345290601
sources O 0 0.001495275180786848
including O 0 0.0014941144036129117
multiple O 0 0.0030049544293433428
large O 0 0.005369550082832575
- O 0 0.3724435567855835
insert O 0 0.11577751487493515
libaries O 0 0.03130078315734863
and O 0 0.0037121877539902925
genomic O 0 0.010264226235449314
DNA O 0 0.008116512559354305
from O 0 0.005954231601208448
Finnish O 1 0.9997099041938782
CLD B-Disease 1 1.0
patients O 1 0.999947190284729
and O 0 0.01122003048658371
controls O 0 0.023814715445041656
. O 0 0.0168338380753994

Exon O 0 0.4955673813819885
- O 0 0.022554293274879456
specific O 0 0.006887105759233236
primers O 0 0.019035613164305687
developed O 0 0.0050619980320334435
in O 0 0.0021686626132577658
this O 0 0.0012136503355577588
study O 0 0.0020049146842211485
will O 0 0.0013063367223367095
facilitate O 0 0.0032103974372148514
mutation O 0 0.003094577929005027
screening O 0 0.003045766381546855
studies O 0 0.0023569087497889996
of O 0 0.0034408511128276587
patients O 1 0.9927951693534851
with O 0 0.005229821428656578
the O 1 0.9940871000289917
disease O 1 1.0
. O 0 0.027831409126520157

Genomic O 0 0.03398391231894493
sequencing O 0 0.012786594219505787
of O 0 0.006324862129986286
a O 0 0.014108034782111645
BAC O 1 0.9999970197677612
clone O 1 0.9997586607933044
H O 1 0.9999785423278809
_ O 0 0.006919571664184332
RG364P16 O 0 0.027655720710754395
revealed O 0 0.007833028212189674
the O 0 0.003140206215903163
presence O 0 0.00301380455493927
of O 0 0.00238790106959641
another O 0 0.003303329460322857
, O 0 0.002259670989587903
highly O 0 0.003957786131650209
homologous O 0 0.0075284745544195175
gene O 0 0.0036737758200615644
3 O 0 0.0028694812208414078
of O 0 0.0028001838363707066
the O 0 0.009026001207530499
CLD B-Disease 1 0.9999997615814209
gene O 0 0.005170648917555809
, O 0 0.0016155213816091418
with O 0 0.0010042134672403336
a O 0 0.0019893585704267025
similar O 0 0.0021926797926425934
genomic O 0 0.006212189793586731
structure O 0 0.0034162302035838366
, O 0 0.0019680731929838657
recently O 0 0.003675983054563403
identified O 0 0.0033057371620088816
as O 0 0.002509061247110367
the O 0 0.008711796253919601
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9994974136352539
( O 1 0.9659267067909241
PDS B-Disease 1 0.9999994039535522
) O 0 0.01054779626429081
. O 0 0.005887612234801054
. O 0 0.011535562574863434

The O 0 0.024783531203866005
APCI1307K O 1 0.9999397993087769
allele O 0 0.38353341817855835
and O 0 0.036801666021347046
cancer B-Disease 1 1.0
risk O 0 0.17954358458518982
in O 0 0.0031122094951570034
a O 0 0.003780542640015483
community O 0 0.003188899252563715
- O 0 0.004388792905956507
based O 0 0.001820787787437439
study O 0 0.0028353675734251738
of O 0 0.004762295633554459
Ashkenazi O 1 0.8046239018440247
Jews O 0 0.02250632829964161
. O 0 0.01538756862282753

Mutations O 0 0.025204941630363464
in O 0 0.01027243584394455
APC O 1 0.9654796719551086
are O 0 0.0035225260071456432
classically O 0 0.03296545147895813
associated O 0 0.007159622386097908
with O 0 0.00848205853253603
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999998807907104
FAP B-Disease 1 1.0
) O 0 0.007798226084560156
, O 0 0.003254819894209504
a O 0 0.004386537242680788
highly O 0 0.4621506333351135
penetrant O 1 0.9999997615814209
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999996423721313
disorder I-Disease 1 1.0
characterized O 1 0.9999995231628418
by O 1 0.9969043135643005
multiple O 1 0.9999997615814209
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9565616846084595
, O 0 0.02340008318424225
without O 0 0.004379511810839176
surgical O 1 0.9999963045120239
intervention O 0 0.18471212685108185
, O 0 0.0026510213501751423
the O 0 0.0031147017143666744
development O 0 0.008183218538761139
of O 1 0.9982537627220154
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999995231628418
CRC B-Disease 1 1.0
) O 0 0.016559861600399017
. O 0 0.013794845901429653

APC B-Disease 1 0.9978557229042053
is O 0 0.010550832375884056
a O 0 0.38384947180747986
tumour O 1 1.0
- O 1 0.9999916553497314
suppressor O 1 0.9991970658302307
gene O 0 0.005845469888299704
, O 0 0.002767553785815835
and O 0 0.0034154183231294155
somatic O 0 0.46029502153396606
loss O 1 0.9416791796684265
occurs O 0 0.010840892791748047
in O 0 0.01799418404698372
tumours B-Disease 1 0.9999998807907104
. O 0 0.027338244020938873

The O 0 0.03634348884224892
germline O 1 0.999755322933197
T O 1 0.9999159574508667
- O 0 0.013699511997401714
to O 0 0.003349671605974436
- O 0 0.009275678545236588
A O 0 0.007305706385523081
transversion O 0 0.035376641899347305
responsible O 0 0.004722526762634516
for O 0 0.002587351482361555
the O 0 0.006281639914959669
APC O 1 0.9918051958084106
I1307K O 0 0.04728104919195175
allele O 0 0.008404438383877277
converts O 0 0.0038422078359872103
the O 0 0.0030070277862250805
wild O 0 0.006145703140646219
- O 0 0.006220534909516573
type O 0 0.0042069656774401665
sequence O 0 0.0024162002373486757
to O 0 0.001667807693593204
a O 0 0.005498009268194437
homopolymer O 1 0.9999386072158813
tract O 1 0.9999997615814209
( O 1 0.9983848333358765
A8 O 1 0.9999992847442627
) O 0 0.004126738756895065
that O 0 0.001752002164721489
is O 0 0.0035087645519524813
genetically O 0 0.007700935937464237
unstable O 0 0.3473444879055023
and O 0 0.006092091090977192
prone O 1 0.8904606699943542
to O 0 0.010965553112328053
somatic O 1 0.5503714680671692
mutation O 0 0.026414779946208
. O 0 0.01527797058224678

The O 0 0.019440526142716408
I1307K O 1 0.6099675893783569
allele O 0 0.0175183042883873
was O 0 0.010115872137248516
found O 0 0.0055368212051689625
in O 0 0.0055017233826220036
6 O 0 0.018803223967552185
. O 0 0.01298394426703453

1 O 0 0.018849117681384087
% O 0 0.0076332688331604
of O 0 0.006242519244551659
unselected O 1 0.9541242718696594
Ashkenazi O 1 0.8992929458618164
Jews O 0 0.011287148110568523
and O 0 0.003562878118827939
higher O 0 0.0047313435934484005
proportions O 0 0.008947133086621761
of O 0 0.004940279293805361
Ashkenazim O 1 0.9190361499786377
with O 0 0.003706534393131733
family O 0 0.007902692072093487
or O 0 0.0031506302766501904
personal O 0 0.005344873294234276
histories O 0 0.014271531254053116
of O 0 0.23647883534431458
CRC B-Disease 1 1.0
( O 1 0.5829142928123474
ref O 1 0.9576764702796936
. O 0 0.00387983163818717
2 O 0 0.008357255719602108
) O 0 0.006641968619078398
. O 0 0.008507384918630123

To O 0 0.006900631356984377
evaluate O 0 0.008039692416787148
the O 0 0.003802131162956357
role O 0 0.004971464164555073
of O 0 0.005457721184939146
I1307K O 1 0.9996562004089355
in O 0 0.023055333644151688
cancer B-Disease 1 0.9999966621398926
, O 0 0.003648606827482581
we O 0 0.00257734302431345
genotyped O 0 0.02083423361182213
5 O 0 0.005462820176035166
, O 0 0.005112331826239824
081 O 1 0.7980663776397705
Ashkenazi O 0 0.04944303631782532
volunteers O 0 0.01017064694315195
in O 0 0.0039308578707277775
a O 0 0.005102066323161125
community O 0 0.007143376860767603
survey O 0 0.01542509626597166
. O 0 0.01316769327968359

Risk O 0 0.029339570552110672
of O 0 0.028232254087924957
developing O 1 0.9999783039093018
colorectal B-Disease 1 1.0
, I-Disease 1 0.999909520149231
breast I-Disease 1 1.0
and I-Disease 0 0.006907144095748663
other I-Disease 0 0.0034392490051686764
cancers I-Disease 1 0.9988940358161926
were O 0 0.002712768269702792
compared O 0 0.003566429717466235
between O 0 0.003597285831347108
genotyped O 1 0.988606870174408
I1307K O 1 0.8980292677879333
carriers O 0 0.006749418098479509
and O 0 0.00307270884513855
non O 0 0.012319750152528286
- O 0 0.012497601099312305
carriers O 0 0.003533237613737583
and O 0 0.0014390154974535108
their O 0 0.0014781046193093061
first O 0 0.0046982490457594395
- O 0 0.013908951543271542
degree O 0 0.011619770899415016
relatives O 0 0.019347673282027245
. O 0 0.013638348318636417

Sperm O 0 0.024812346324324608
DNA O 0 0.009572532959282398
analysis O 0 0.003975574392825365
in O 0 0.004483318887650967
a O 0 0.011000008322298527
Friedreich B-Disease 1 0.9999984502792358
ataxia I-Disease 1 1.0
premutation O 1 0.9999966621398926
carrier O 1 0.904306948184967
suggests O 0 0.011560906656086445
both O 0 0.0047967624850571156
meiotic O 1 0.9444908499717712
and O 0 0.005949156358838081
mitotic O 0 0.09661486744880676
expansion O 0 0.009260817430913448
in O 0 0.004874052945524454
the O 0 0.010790103115141392
FRDA B-Disease 1 0.9999394416809082
gene O 0 0.022214457392692566
. O 0 0.012406819500029087

Friedreich B-Disease 1 0.9999996423721313
ataxia I-Disease 1 0.9999998807907104
is O 1 0.5188941955566406
usually O 0 0.007747540716081858
caused O 0 0.010661308653652668
by O 0 0.0017731678672134876
an O 0 0.0023137431126087904
expansion O 0 0.00391998328268528
of O 0 0.0034892719704657793
a O 0 0.005534306634217501
GAA O 0 0.418247789144516
trinucleotide O 1 0.6458787322044373
repeat O 0 0.010979992337524891
in O 0 0.0037816076073795557
intron O 0 0.3986422121524811
1 O 0 0.00547041604295373
of O 0 0.0032010923605412245
the O 0 0.008785558864474297
FRDA B-Disease 1 0.9999752044677734
gene O 0 0.01984287053346634
. O 0 0.012882045470178127

Occasionally O 0 0.015163548290729523
, O 0 0.005083438474684954
a O 0 0.004331736825406551
fully O 0 0.005406958982348442
expanded O 0 0.005472917575389147
allele O 0 0.00603753887116909
has O 0 0.0018131360411643982
been O 0 0.0014887060970067978
found O 0 0.0015104220947250724
to O 0 0.0014011540915817022
arise O 0 0.0024685051757842302
from O 0 0.0018595230067148805
a O 0 0.003091119695454836
premutation O 0 0.020215420052409172
of O 0 0.003929585218429565
100 O 0 0.005068838130682707
or O 0 0.003198389895260334
less O 0 0.005886292550712824
triplet O 1 0.5735073089599609
repeats O 0 0.03441816195845604
. O 0 0.014515538699924946

We O 0 0.007167768198996782
have O 0 0.0031259285751730204
examined O 0 0.008879173547029495
the O 0 0.005519870202988386
sperm O 0 0.008224647492170334
DNA O 0 0.005456241313368082
of O 0 0.00479267630726099
a O 0 0.010822420008480549
premutation O 1 0.9942723512649536
carrier O 0 0.07206843793392181
. O 0 0.01636665314435959

This O 0 0.009881227277219296
mans O 0 0.05755157023668289
leucocyte O 1 0.7003797292709351
DNA O 0 0.01001858338713646
showed O 0 0.006025546696037054
one O 0 0.002570860553532839
normal O 0 0.004381259437650442
allele O 0 0.004758884664624929
and O 0 0.0016346282791346312
one O 0 0.002401631325483322
allele O 0 0.004936242010444403
of O 0 0.0032990698236972094
approximately O 0 0.005645649507641792
100 O 0 0.009353119879961014
repeats O 0 0.024478616192936897
. O 0 0.012438015080988407

His O 0 0.020020315423607826
sperm O 0 0.014056363143026829
showed O 0 0.007303320802748203
an O 0 0.002664148109033704
expanded O 0 0.005058886483311653
allele O 0 0.005770228337496519
in O 0 0.002198140835389495
a O 0 0.002767237601801753
tight O 0 0.005463286302983761
range O 0 0.0027828929014503956
centering O 0 0.007980517111718655
on O 0 0.0028071668930351734
a O 0 0.0027945281472057104
size O 0 0.004133234266191721
of O 0 0.004537134896963835
approximately O 0 0.009072668850421906
320 O 0 0.0346093624830246
trinucleotide O 1 0.9443246722221375
repeats O 0 0.05369886755943298
. O 0 0.02135683223605156

His O 0 0.08921720087528229
affected O 0 0.11558093875646591
son O 1 0.9851462244987488
has O 0 0.0054878974333405495
repeat O 0 0.011866079643368721
sizes O 0 0.006716807372868061
of O 0 0.007901518605649471
1040 O 1 0.8323835134506226
and O 0 0.010892556048929691
540 O 0 0.07382260262966156
. O 0 0.01699238270521164

These O 0 0.005790861323475838
data O 0 0.003898853901773691
suggest O 0 0.003468062961474061
that O 0 0.0013771114172413945
expansion O 0 0.003417711239308119
occurs O 0 0.0017181604634970427
in O 0 0.0012374547077342868
two O 0 0.0010123227257281542
stages O 0 0.00370066799223423
, O 0 0.001768895541317761
the O 0 0.0017531301127746701
first O 0 0.002108779503032565
during O 0 0.003773869713768363
meiosis O 0 0.00984953437000513
followed O 0 0.002850509947165847
by O 0 0.0015930937370285392
a O 0 0.004375862888991833
second O 0 0.011008081957697868
mitotic O 1 0.9090831875801086
expansion O 0 0.022473089396953583
. O 0 0.01298848632723093

We O 0 0.008061685599386692
also O 0 0.004546677228063345
show O 0 0.0031622822862118483
that O 0 0.0011646498460322618
in O 0 0.001545497914776206
all O 0 0.0014593064552173018
informative O 0 0.006823541130870581
carrier O 0 0.011509440839290619
father O 0 0.00964227132499218
to O 0 0.003445237409323454
affected O 0 0.007894657552242279
child O 0 0.4045824110507965
transmissions O 0 0.006330984644591808
, O 0 0.0017352220602333546
with O 0 0.0009974902495741844
the O 0 0.001985955750569701
notable O 0 0.0028613160829991102
exception O 0 0.003687345189973712
of O 0 0.0029488319996744394
the O 0 0.006731557194143534
premutation O 1 0.9996663331985474
carrier O 0 0.01919528655707836
, O 0 0.00293842819519341
the O 0 0.003855312243103981
expansion O 0 0.007785050664097071
size O 0 0.007347544189542532
decreases O 0 0.014933660626411438
. O 0 0.00730570312589407
. O 0 0.01118733175098896

The O 0 0.023340212181210518
R496H O 0 0.08574502915143967
mutation O 0 0.013263510540127754
of O 0 0.007086839526891708
arylsulfatase O 1 0.9461150765419006
A O 0 0.013845263049006462
does O 0 0.005059659946709871
not O 0 0.005245507694780827
cause O 1 0.6775907874107361
metachromatic B-Disease 1 0.9999988079071045
leukodystrophy I-Disease 1 0.9999998807907104
. O 0 0.03569228574633598

Deficiency B-Disease 1 0.9999984502792358
of I-Disease 0 0.06967451423406601
arylsulfatase I-Disease 1 0.999962329864502
A I-Disease 1 0.9073859453201294
( O 1 0.7400705814361572
ARSA O 1 0.9999971389770508
) O 0 0.010207194834947586
enzyme O 0 0.01149444468319416
activity O 0 0.0090482784435153
causes O 1 0.6620537638664246
metachromatic B-Disease 1 0.999998927116394
leukodystrophy I-Disease 1 1.0
( O 1 0.9998618364334106
MLD B-Disease 1 1.0
) O 0 0.022513139992952347
. O 0 0.015376606956124306

A O 0 0.013228397816419601
number O 0 0.005459509789943695
of O 0 0.009362800978124142
ARSA O 1 0.9999940395355225
gene O 0 0.012603212147951126
mutations O 0 0.006782455835491419
responsible O 0 0.005965212360024452
for O 0 0.006440616212785244
MLD B-Disease 1 0.9999998807907104
have O 0 0.003867031540721655
been O 0 0.005015878472477198
identified O 0 0.01148893591016531
. O 0 0.010842882096767426

Recently O 0 0.01877610944211483
, O 0 0.005684931296855211
the O 0 0.005940968170762062
R496H O 0 0.38088086247444153
mutation O 0 0.009315128438174725
of O 0 0.007961762137711048
ARSA O 1 0.9999759197235107
was O 0 0.008818361908197403
proposed O 0 0.003173578530550003
to O 0 0.0014380489010363817
be O 0 0.0012132496340200305
a O 0 0.0027167662046849728
cause O 0 0.00626788567751646
of O 0 0.0161917544901371
MLD B-Disease 1 1.0
( O 0 0.3641306757926941
Draghia O 1 0.9997188448905945
et O 1 0.8946422934532166
al O 0 0.012946861796081066
. O 0 0.002231140621006489
, O 0 0.004001860972493887
1997 O 0 0.011282630264759064
) O 0 0.008527474477887154
. O 0 0.009618433192372322

We O 0 0.0058532170951366425
have O 0 0.002608789596706629
investigated O 0 0.008076968602836132
the O 0 0.005164552479982376
R496H O 1 0.9066967964172363
mutation O 0 0.005588901694864035
and O 0 0.0016179403755813837
found O 0 0.0022280123084783554
this O 0 0.0016166898421943188
mutation O 0 0.003201209707185626
at O 0 0.0027553350664675236
a O 0 0.0020828102715313435
relatively O 0 0.00230814958922565
high O 0 0.00301896664313972
frequency O 0 0.0017981835408136249
in O 0 0.0011009585577994585
an O 0 0.0014876468339934945
African O 0 0.003697954583913088
American O 0 0.002868088660761714
population O 0 0.002244249451905489
( O 0 0.0037546681705862284
f O 0 0.007226753514260054
= O 0 0.006745107937604189
0 O 0 0.0039377836510539055
. O 0 0.0021018660627305508
09 O 0 0.013763612136244774
, O 0 0.0037818988785147667
n O 0 0.010038189589977264
= O 0 0.011371172964572906
61 O 0 0.00957465823739767
subjects O 0 0.011973908171057701
) O 0 0.010309544391930103
. O 0 0.011701530776917934

The O 0 0.04311072453856468
ARSA O 1 0.9999918937683105
enzyme O 0 0.017807407304644585
activity O 0 0.004456572234630585
in O 0 0.0024148470256477594
subjects O 0 0.003749279538169503
with O 0 0.0015987784136086702
and O 0 0.0017723019700497389
without O 0 0.00211907341144979
the O 0 0.0035778400488197803
R496H O 1 0.9502354264259338
mutation O 0 0.006314310245215893
was O 0 0.004531842190772295
determined O 0 0.0028741550631821156
and O 0 0.0012588929384946823
found O 0 0.0020703538320958614
to O 0 0.0017401501536369324
be O 0 0.002782226540148258
normal O 0 0.008753295987844467
. O 0 0.009046385996043682

It O 0 0.005760115571320057
is O 0 0.003594872774556279
therefore O 0 0.0034754816442728043
concluded O 0 0.005737210623919964
that O 0 0.002042117528617382
the O 0 0.004297988023608923
R496H O 1 0.5018511414527893
mutation O 0 0.009717925451695919
of O 0 0.008954865857958794
ARSA O 1 0.9999934434890747
does O 0 0.0036716964095830917
not O 0 0.001648691832087934
negatively O 0 0.0033813074696809053
influence O 0 0.0024161865003407
the O 0 0.0025760724674910307
activity O 0 0.003437578910961747
of O 0 0.006415849551558495
ARSA O 1 0.9999996423721313
and O 0 0.00294670183211565
is O 0 0.0025164473336189985
not O 0 0.001995109487324953
a O 0 0.00526556046679616
cause O 0 0.08482475578784943
of O 1 0.5989365577697754
MLD B-Disease 1 0.9999997615814209

Down O 0 0.030194761231541634
- O 0 0.01750563643872738
regulation O 0 0.009169192984700203
of O 0 0.0060471235774457455
transmembrane O 1 0.7552496790885925
carbonic O 1 0.9984112977981567
anhydrases O 1 0.9998788833618164
in O 1 0.9890667200088501
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999037504196167
lines O 0 0.005252559669315815
by O 0 0.0022301694843918085
wild O 0 0.007991649210453033
- O 0 0.0754665806889534
type O 0 0.06440519541501999
von B-Disease 1 0.9970038533210754
Hippel I-Disease 1 0.9999861717224121
- I-Disease 1 0.996236264705658
Lindau I-Disease 1 0.9995549321174622
transgenes O 1 0.7232012152671814
. O 0 0.032455924898386

To O 0 0.011490067467093468
discover O 0 0.0182952843606472
genes O 0 0.006503366865217686
involved O 0 0.0051363380625844
in O 0 0.005590964574366808
von B-Disease 1 0.9909233450889587
Hippel I-Disease 1 0.9999942779541016
- I-Disease 1 0.9997065663337708
Lindau I-Disease 1 0.9999972581863403
( O 0 0.23360657691955566
VHL B-Disease 1 0.9999978542327881
) O 0 0.009957287460565567
- O 0 0.01530634704977274
mediated O 0 0.014416476711630821
carcinogenesis O 1 0.9991266131401062
, O 0 0.003922521602362394
we O 0 0.004105421714484692
used O 0 0.037045568227767944
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 0.9985347986221313
lines O 0 0.01168202143162489
stably O 0 0.13566434383392334
transfected O 0 0.04292064905166626
with O 0 0.0035971691831946373
wild O 0 0.014248373918235302
- O 1 0.575881838798523
type O 1 0.9234617948532104
VHL O 1 0.9999980926513672
- O 0 0.37405917048454285
expressing O 0 0.04798475652933121
transgenes O 0 0.48423314094543457
. O 0 0.021091336384415627

Large O 0 0.02286006323993206
- O 0 0.02739744819700718
scale O 0 0.015121295116841793
RNA O 0 0.014039836823940277
differential O 0 0.008598247542977333
display O 0 0.005542779341340065
technology O 0 0.00369224208407104
applied O 0 0.002678090473636985
to O 0 0.00161221984308213
these O 0 0.0014635279076173902
cell O 0 0.004408214706927538
lines O 0 0.003114879596978426
identified O 0 0.003127639414742589
several O 0 0.0022139709908515215
differentially O 0 0.012475058436393738
expressed O 0 0.004712964873760939
genes O 0 0.003322396194562316
, O 0 0.0016873498680070043
including O 0 0.0018535992130637169
an O 0 0.004752601031213999
alpha O 0 0.04455862194299698
carbonic O 1 0.9719213247299194
anhydrase O 1 0.9969235062599182
gene O 0 0.015637468546628952
, O 0 0.00898901280015707
termed O 0 0.08979038894176483
CA12 O 1 0.9996955394744873
. O 0 0.022873105481266975

The O 0 0.011036493815481663
deduced O 0 0.016777094453573227
protein O 0 0.006001985631883144
sequence O 0 0.0038316550198942423
was O 0 0.003881209995597601
classified O 0 0.004169926047325134
as O 0 0.002176893875002861
a O 0 0.002825330477207899
one O 0 0.003595404326915741
- O 0 0.014368519186973572
pass O 0 0.006182914134114981
transmembrane O 0 0.06484498083591461
CA O 0 0.014021816663444042
possessing O 0 0.006603152025490999
an O 0 0.0038343972992151976
apparently O 0 0.00831426028162241
intact O 0 0.010620160028338432
catalytic O 0 0.010174872353672981
domain O 0 0.005685844458639622
in O 0 0.003982135560363531
the O 0 0.007345686666667461
extracellular O 0 0.07866498082876205
CA O 0 0.38282641768455505
module O 0 0.1087125614285469
. O 0 0.018771445378661156

Reintroduced O 0 0.06122145056724548
wild O 0 0.03608280047774315
- O 0 0.4074461758136749
type O 0 0.32660970091819763
VHL B-Disease 1 0.999907374382019
strongly O 0 0.010071433149278164
inhibited O 0 0.01222569402307272
the O 0 0.004519680980592966
overexpression O 0 0.009653691202402115
of O 0 0.0030162183102220297
the O 0 0.005754350684583187
CA12 O 1 0.9998102784156799
gene O 0 0.0038213233929127455
in O 0 0.0022100568749010563
the O 0 0.007884923368692398
parental O 1 0.9999743700027466
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.999992847442627
lines O 0 0.04144836217164993
. O 0 0.014401768334209919

Similar O 0 0.009639423340559006
results O 0 0.0048381127417087555
were O 0 0.002352307317778468
obtained O 0 0.0044180406257510185
with O 0 0.003885439829900861
CA9 O 1 0.9999285936355591
, O 0 0.004098443780094385
encoding O 0 0.006556591019034386
another O 0 0.005658725276589394
transmembrane O 0 0.03886337950825691
CA O 0 0.010311564430594444
with O 0 0.0022745123133063316
an O 0 0.003783181542530656
intact O 0 0.039676111191511154
catalytic O 0 0.022694414481520653
domain O 0 0.016876451671123505
. O 0 0.012891612015664577

Although O 0 0.00861976109445095
both O 0 0.0037461803294718266
domains O 0 0.00833066739141941
of O 0 0.005410867743194103
the O 0 0.014219938777387142
VHL B-Disease 1 0.999996542930603
protein O 0 0.006631977390497923
contribute O 0 0.0034873264376074076
to O 0 0.00158692745026201
regulation O 0 0.0036551200319081545
of O 0 0.004663517698645592
CA12 O 1 0.9998881816864014
expression O 0 0.0057722036726772785
, O 0 0.003143296344205737
the O 0 0.004095255397260189
elongin O 0 0.04066875949501991
binding O 0 0.004272206220775843
domain O 0 0.006296402309089899
alone O 0 0.005284391343593597
could O 0 0.0036373913753777742
effectively O 0 0.012200003489851952
regulate O 0 0.024130094796419144
CA9 O 1 0.9996399879455566
expression O 0 0.029489748179912567
. O 0 0.018154622986912727

We O 0 0.014779351651668549
mapped O 0 0.03523131459951401
CA12 O 1 0.9248404502868652
and O 0 0.015617147088050842
CA9 O 1 0.999574601650238
loci O 0 0.03473168984055519
to O 0 0.007421748246997595
chromosome O 0 0.019786287099123
bands O 0 0.012863753363490105
15q22 O 0 0.35911160707473755
and O 0 0.01371841598302126
17q21 O 1 0.9620205760002136
. O 0 0.022462895140051842

2 O 0 0.01994863897562027
respectively O 0 0.01135228667408228
, O 0 0.005001278128474951
regions O 0 0.005157251842319965
prone O 0 0.016752922907471657
to O 0 0.003408171236515045
amplification O 0 0.008376642130315304
in O 0 0.00308198481798172
some O 0 0.003949167672544718
human O 0 0.04812813922762871
cancers B-Disease 1 0.9999760389328003
. O 0 0.019410302862524986

Additional O 0 0.011687294580042362
experiments O 0 0.007955093868076801
are O 0 0.0016807625070214272
needed O 0 0.00254403636790812
to O 0 0.0013031529961153865
define O 0 0.0028056232258677483
the O 0 0.0022111728321760893
role O 0 0.005115145817399025
of O 0 0.006206387188285589
CA O 1 0.9983184337615967
IX O 1 0.9999990463256836
and O 0 0.007741165813058615
CA O 1 0.8548924922943115
XII O 1 0.9999755620956421
enzymes O 0 0.004426602274179459
in O 0 0.001974967308342457
the O 0 0.002511085942387581
regulation O 0 0.0032493933103978634
of O 0 0.0030369253363460302
pH O 0 0.012099645100533962
in O 0 0.0022978177294135094
the O 0 0.004033419769257307
extracellular O 0 0.012590317986905575
microenvironment O 0 0.046623293310403824
and O 0 0.0019526630640029907
its O 0 0.0016807335196062922
potential O 0 0.0038843548391014338
impact O 0 0.00603704946115613
on O 0 0.01268264651298523
cancer B-Disease 1 0.9999997615814209
cell O 1 0.9285138249397278
growth O 0 0.01604004204273224
. O 0 0.011412296444177628

A O 0 0.019418902695178986
gene O 0 0.009673687629401684
encoding O 0 0.006126833613961935
a O 0 0.005143703427165747
transmembrane O 0 0.015507775358855724
protein O 0 0.004730112385004759
is O 0 0.002520196605473757
mutated O 0 0.006668745074421167
in O 0 0.0034802639856934547
patients O 1 0.9985660910606384
with O 1 0.998536229133606
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.9758803844451904
. O 0 0.016823966056108475

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998916387557983
WFS B-Disease 1 0.9999998807907104
; O 0 0.03252199664711952
OMIM O 1 0.9999978542327881
222300 O 1 0.9987420439720154
) O 0 0.005127667915076017
is O 0 0.0033499777782708406
an O 0 0.006568554323166609
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9962027668952942
by O 0 0.09269856661558151
young O 1 0.9996503591537476
- O 1 0.9995369911193848
onset O 1 0.9999991655349731
non O 1 0.999320387840271
- O 1 0.9999392032623291
immune O 1 0.9999946355819702
insulin B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999759197235107
dependent I-Disease 1 0.9995777010917664
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.999996542930603
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9861115217208862

Linkage O 0 0.04096284136176109
to O 0 0.009029107168316841
markers O 0 0.023862628266215324
on O 0 0.009537779726088047
chromosome O 0 0.061150066554546356
4p O 1 0.9261502027511597
was O 0 0.010542119853198528
confirmed O 0 0.006420459598302841
in O 0 0.003548672655597329
five O 0 0.004386961460113525
families O 0 0.00803693849593401
. O 0 0.011954428628087044

On O 0 0.006459586322307587
the O 0 0.003539716824889183
basis O 0 0.003552819835022092
of O 0 0.007100252900272608
meiotic O 1 0.9999990463256836
recombinants O 1 0.9999997615814209
and O 1 0.9951796531677246
disease O 1 1.0
- O 1 0.9987372756004333
associated O 0 0.009470116347074509
haplotypes O 0 0.01829782873392105
, O 0 0.003965748939663172
the O 0 0.007456929888576269
WFS B-Disease 1 0.9999984502792358
gene O 0 0.0070897056721150875
was O 0 0.005001378245651722
localized O 0 0.00741823622956872
to O 0 0.0026717172004282475
a O 0 0.0084071084856987
BAC O 1 0.9999988079071045
/ O 1 0.9947736859321594
P1 O 1 0.8579287528991699
contig O 0 0.018692022189497948
of O 0 0.003339378396049142
less O 0 0.003173503326252103
than O 0 0.002986613195389509
250 O 0 0.012288261204957962
kb O 0 0.06556494534015656
. O 0 0.016565266996622086

Mutations O 0 0.01547231711447239
in O 0 0.004911693744361401
a O 0 0.005428603384643793
novel O 0 0.01651841215789318
gene O 0 0.010371381416916847
( O 0 0.0074186925776302814
WFS1 O 1 0.9344489574432373
) O 0 0.0031774064991623163
encoding O 0 0.00371184921823442
a O 0 0.003555210307240486
putative O 0 0.019432581961154938
transmembrane O 0 0.023576097562909126
protein O 0 0.004099923651665449
were O 0 0.0015944184269756079
found O 0 0.001533381175249815
in O 0 0.0014317197492346168
all O 0 0.0010665018344298005
affected O 0 0.001887237885966897
individuals O 0 0.000906182627659291
in O 0 0.0016211130423471332
six O 0 0.00448493380099535
WFS B-Disease 1 0.9999994039535522
families O 0 0.003296573180705309
, O 0 0.0018490419024601579
and O 0 0.0012092809192836285
these O 0 0.000984038459137082
mutations O 0 0.0021870555356144905
were O 0 0.0015686429105699062
associated O 0 0.0028275991789996624
with O 0 0.0033660205081105232
the O 1 0.9955755472183228
disease O 1 1.0
phenotype O 1 0.9998794794082642
. O 0 0.016500327736139297

WFS1 O 1 0.997837245464325
appears O 0 0.012933487072587013
to O 0 0.002679073717445135
function O 0 0.0033486373722553253
in O 0 0.0030190269462764263
survival O 0 0.013432777486741543
of O 0 0.006496746558696032
islet O 1 0.9995470643043518
beta O 1 0.9976966977119446
- O 1 0.8236689567565918
cells O 0 0.007989786565303802
and O 0 0.004528466612100601
neurons O 0 0.013054021634161472
. O 0 0.0055335876531898975
. O 0 0.010735809803009033

Stable O 0 0.02692030929028988
interaction O 0 0.005511537194252014
between O 0 0.002710409928113222
the O 0 0.0025958516635000706
products O 0 0.003791576251387596
of O 0 0.004159531090408564
the O 0 0.011839997954666615
BRCA1 O 1 0.9999639987945557
and O 0 0.05944489687681198
BRCA2 O 1 0.9999997615814209
tumor B-Disease 1 0.9999997615814209
suppressor O 1 0.9985135197639465
genes O 0 0.006999236065894365
in O 0 0.005767290946096182
mitotic O 1 0.8847982883453369
and O 0 0.012721330858767033
meiotic O 1 0.9999947547912598
cells O 0 0.12599226832389832
. O 0 0.016535386443138123

BRCA1 O 1 0.9998863935470581
and O 0 0.010489693842828274
BRCA2 O 1 0.9453698396682739
account O 0 0.0037731274496763945
for O 0 0.0017218941356986761
most O 0 0.001496202195994556
cases O 0 0.0020315719302743673
of O 0 0.003688693745061755
familial O 1 0.9999638795852661
, O 0 0.008616224862635136
early O 1 0.6216986179351807
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.999419093132019
/ I-Disease 1 0.9999997615814209
or I-Disease 1 0.9998866319656372
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.1352650374174118
encode O 0 0.006190117448568344
products O 0 0.0034807699266821146
that O 0 0.0015408194158226252
each O 0 0.0018043923191726208
interact O 0 0.003908027429133654
with O 0 0.0053520239889621735
hRAD51 O 1 0.9420239925384521
. O 0 0.015992023050785065

Results O 0 0.01330509502440691
presented O 0 0.00964481383562088
here O 0 0.006092408671975136
show O 0 0.006199555471539497
that O 0 0.0032878543715924025
BRCA1 O 1 0.9697928428649902
and O 0 0.004947109613567591
BRCA2 O 1 0.8824633359909058
coexist O 0 0.006694994401186705
in O 0 0.0028593686874955893
a O 0 0.0036197209265083075
biochemical O 0 0.008335107937455177
complex O 0 0.006124409381300211
and O 0 0.003297195304185152
colocalize O 0 0.20478296279907227
in O 0 0.0047666640020906925
subnuclear O 1 0.9334797859191895
foci O 0 0.3173910677433014
in O 0 0.005578332580626011
somatic O 0 0.3208751678466797
cells O 0 0.0032826957758516073
and O 0 0.001273610396310687
on O 0 0.00206790491938591
the O 0 0.0029050507582724094
axial O 0 0.006399129051715136
elements O 0 0.003348799655213952
of O 0 0.005886058323085308
developing O 0 0.21756112575531006
synaptonemal O 1 0.9996808767318726
complexes O 1 0.6881667375564575
. O 0 0.018475132063031197

Like O 0 0.0331382118165493
BRCA1 O 1 0.9992890357971191
and O 0 0.017403723672032356
RAD51 O 1 0.9999964237213135
, O 0 0.01712905615568161
BRCA2 O 1 0.9984520673751831
relocates O 0 0.08703906089067459
to O 0 0.010850397869944572
PCNA O 1 0.99925297498703
+ O 0 0.019430609419941902
replication O 0 0.007577069103717804
sites O 0 0.0030364273115992546
following O 0 0.004108440596610308
exposure O 0 0.008273902349174023
of O 0 0.007567659020423889
S O 1 0.9996354579925537
phase O 0 0.35560324788093567
cells O 0 0.00797070749104023
to O 0 0.0054552447982132435
hydroxyurea O 1 0.9799605011940002
or O 0 0.017461445182561874
UV O 1 0.9993711113929749
irradiation O 0 0.2280208021402359
. O 0 0.020536957308650017

Thus O 0 0.02112882025539875
, O 0 0.015228028409183025
BRCA1 O 1 0.9990955591201782
and O 0 0.006448810920119286
BRCA2 O 1 0.9844299554824829
participate O 0 0.003753578756004572
, O 0 0.0020037528593093157
together O 0 0.0016583659453317523
, O 0 0.0015103761106729507
in O 0 0.0016371539095416665
a O 0 0.0037685916759073734
pathway O 0 0.01205774862319231
( O 0 0.005929000210016966
s O 0 0.011231494136154652
) O 0 0.0019207085715606809
associated O 0 0.001384073868393898
with O 0 0.0009645724203437567
the O 0 0.002113090828061104
activation O 0 0.0039099738933146
of O 0 0.0031941935885697603
double O 0 0.031075024977326393
- O 0 0.11443302035331726
strand O 0 0.010520732961595058
break O 0 0.010323083959519863
repair O 1 0.9947654008865356
and O 0 0.009143038652837276
/ O 1 0.9842255115509033
or O 0 0.008985616266727448
homologous O 0 0.03553524613380432
recombination O 0 0.03544582799077034
. O 0 0.01603849045932293

Dysfunction O 1 0.9999954700469971
of O 0 0.07843635976314545
this O 0 0.007992999628186226
pathway O 0 0.15662863850593567
may O 0 0.002902200212702155
be O 0 0.0015055526746436954
a O 0 0.002139059826731682
general O 0 0.004581351764500141
phenomenon O 0 0.004239658359438181
in O 0 0.0013311848742887378
the O 0 0.0014056345680728555
majority O 0 0.0011229481315240264
of O 0 0.0016912795836105943
cases O 0 0.0029605659656226635
of O 0 0.3441963791847229
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999898672103882
/ I-Disease 1 1.0
or I-Disease 1 0.9999895095825195
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.3201577663421631
. O 0 0.017322279512882233

A O 0 0.022098630666732788
novel O 0 0.025643890723586082
Arg362Ser O 0 0.29509374499320984
mutation O 0 0.008225160650908947
in O 0 0.0033743809908628464
the O 0 0.005155124235898256
sterol O 0 0.03788021579384804
27 O 0 0.015884239226579666
- O 0 0.0278816856443882
hydroxylase O 0 0.08315987884998322
gene O 0 0.008436032570898533
( O 0 0.007390316110104322
CYP27 O 1 0.9088281989097595
) O 0 0.0031709037721157074
: O 0 0.0022079716436564922
its O 0 0.001691144541837275
effects O 0 0.0046370807103812695
on O 0 0.003968555014580488
pre O 0 0.02052989788353443
- O 0 0.013836059719324112
mRNA O 0 0.009516101330518723
splicing O 0 0.010363666340708733
and O 0 0.005481875967234373
enzyme O 0 0.015405778773128986
activity O 0 0.012132958509027958
. O 0 0.01564100570976734

A O 0 0.020510615780949593
novel O 0 0.021575607359409332
C O 0 0.016479680314660072
to O 0 0.0031781389843672514
A O 0 0.005643695592880249
mutation O 0 0.003649252001196146
in O 0 0.002035181038081646
the O 0 0.004172778222709894
sterol O 0 0.03936446085572243
27 O 0 0.011391151696443558
- O 0 0.017207840457558632
hydroxylase O 0 0.03800952434539795
gene O 0 0.010015982203185558
( O 0 0.007099851965904236
CYP27 O 1 0.9418916702270508
) O 0 0.003972453065216541
was O 0 0.004632909782230854
identified O 0 0.003073538653552532
by O 0 0.0019911807030439377
sequencing O 0 0.008256380446255207
amplified O 0 0.012776522897183895
CYP27 O 1 0.9746792316436768
gene O 0 0.004772503394633532
products O 0 0.00289109512232244
from O 0 0.002304251305758953
a O 0 0.004250713624060154
patient O 0 0.4318137466907501
with O 0 0.0049935197457671165
cerebrotendinous B-Disease 1 0.9999994039535522
xanthomatosis I-Disease 1 0.9999996423721313
( O 1 0.8579130172729492
CTX B-Disease 1 0.9999996423721313
) O 0 0.015036412514746189
. O 0 0.011912877671420574

The O 0 0.01655900850892067
mutation O 0 0.013489071279764175
changed O 0 0.008335628546774387
the O 0 0.007743568625301123
adrenodoxin O 1 0.8028857111930847
cofactor O 0 0.059474535286426544
binding O 0 0.0086270896717906
residue O 0 0.022662010043859482
362Arg O 0 0.03401525691151619
to O 0 0.005882986821234226
362Ser O 0 0.2407160997390747
( O 0 0.012694425880908966
CGT O 1 0.9960711002349854
362Arg O 1 0.7006832957267761
to O 0 0.008011939935386181
AGT O 1 1.0
362Ser O 1 0.9998099207878113
) O 0 0.003963617607951164
, O 0 0.0017515852814540267
and O 0 0.001559356227517128
was O 0 0.007084718439728022
responsible O 0 0.013355636969208717
for O 0 0.008389326743781567
deficiency O 1 0.9999998807907104
in O 0 0.005022565368562937
the O 0 0.008548596873879433
sterol O 1 0.9944077730178833
27 O 0 0.07007892429828644
- O 0 0.19683600962162018
hydroxylase O 0 0.021915940567851067
activity O 0 0.0032092719338834286
, O 0 0.0019733102526515722
as O 0 0.0016807080246508121
confirmed O 0 0.002244509756565094
by O 0 0.001062384806573391
expression O 0 0.0024093438405543566
of O 0 0.0032788801472634077
mutant O 0 0.012525094673037529
cDNA O 0 0.015012858435511589
into O 0 0.006852822843939066
COS O 1 0.9999911785125732
- O 0 0.3714739978313446
1 O 0 0.016209660097956657
cells O 0 0.014679226092994213
. O 0 0.01111546065658331

Quantitative O 0 0.018240351229906082
analysis O 0 0.005809071473777294
showed O 0 0.005307543557137251
that O 0 0.0015529475640505552
the O 0 0.0024715601466596127
expression O 0 0.003808280685916543
of O 0 0.004324203357100487
CYP27 O 1 0.9995359182357788
gene O 0 0.0058080581948161125
mRNA O 0 0.004210839048027992
in O 0 0.0019623180851340294
the O 0 0.003977648448199034
patient O 0 0.019239485263824463
represented O 0 0.00867424625903368
52 O 0 0.020967530086636543
. O 0 0.011982429772615433

5 O 0 0.01273219846189022
% O 0 0.004494467284530401
of O 0 0.003660924732685089
the O 0 0.00660691550001502
normal O 0 0.012849422171711922
level O 0 0.015189191326498985
. O 0 0.01080386433750391

As O 0 0.009823930449783802
the O 0 0.007811105810105801
mutation O 0 0.008029879070818424
occurred O 0 0.0052691129967570305
at O 0 0.004500787239521742
the O 0 0.004170444328337908
penultimate O 0 0.06893850117921829
nucleotide O 0 0.00651637464761734
of O 0 0.003914520610123873
exon O 0 0.018069801852107048
6 O 0 0.0074258106760680676
( O 0 0.00480377022176981
- O 0 0.004326466470956802
2 O 0 0.0027651358395814896
position O 0 0.0022792567033320665
of O 0 0.0035730935633182526
exon O 0 0.022068684920668602
6 O 0 0.009467022493481636
- O 0 0.013103388249874115
intron O 0 0.1675492376089096
6 O 0 0.008043650537729263
splice O 0 0.011643859557807446
site O 0 0.004144635517150164
) O 0 0.001805708627216518
of O 0 0.0017655894625931978
the O 0 0.003019856521859765
gene O 0 0.003836818737909198
, O 0 0.001965939300134778
we O 0 0.0016607248689979315
hypothesized O 0 0.005573472939431667
that O 0 0.0013446470256894827
the O 0 0.0032881891820579767
mutation O 0 0.0052971141412854195
may O 0 0.0029184932354837656
partially O 0 0.006277105305343866
affect O 0 0.002362642902880907
the O 0 0.0027959635481238365
normal O 0 0.004635634832084179
splicing O 0 0.006589116528630257
efficiency O 0 0.004759832751005888
in O 0 0.0030150897800922394
exon O 0 0.017533039674162865
6 O 0 0.005026947241276503
and O 0 0.0021884276065975428
cause O 0 0.0060244956985116005
alternative O 0 0.0051659271121025085
splicing O 0 0.0067140026949346066
elsewhere O 0 0.002894957782700658
, O 0 0.0019125337712466717
which O 0 0.0013030238915234804
resulted O 0 0.0034658729564398527
in O 0 0.0030405742581933737
decreased O 0 0.012214136309921741
transcript O 0 0.009761587716639042
in O 0 0.004067521542310715
the O 0 0.009307853877544403
patient O 1 0.98740154504776
. O 0 0.01444754097610712

Transfection O 1 0.6032117605209351
of O 0 0.011863150633871555
constructed O 1 0.601372480392456
minigenes O 1 0.9691402912139893
, O 0 0.0034392490051686764
with O 0 0.0015890939394012094
or O 0 0.0016067060641944408
without O 0 0.0013765364419668913
the O 0 0.002558317733928561
mutation O 0 0.003799354424700141
, O 0 0.002739210380241275
into O 0 0.005058800335973501
COS O 1 0.9999994039535522
- O 0 0.0662345141172409
1 O 0 0.0065407645888626575
cells O 0 0.0033284223172813654
confirmed O 0 0.0023944037966430187
that O 0 0.0011353067820891738
the O 0 0.00267031486146152
mutant O 0 0.015428412705659866
minigene O 1 0.8864941596984863
was O 0 0.005605584941804409
responsible O 0 0.003077346831560135
for O 0 0.0016162514220923185
a O 0 0.0029335704166442156
mRNA O 0 0.004405474290251732
species O 0 0.0018948824144899845
alternatively O 0 0.005297661758959293
spliced O 0 0.007734161801636219
at O 0 0.004666594788432121
an O 0 0.004064613487571478
activated O 0 0.01663312502205372
cryptic O 0 0.016511211171746254
5 O 0 0.0074362484738230705
splice O 0 0.015376121737062931
site O 0 0.008652271702885628
88 O 0 0.011501132510602474
bp O 0 0.009554325602948666
upstream O 0 0.005077141337096691
from O 0 0.0017959832912310958
the O 0 0.0025328032206743956
3 O 0 0.003953810315579176
end O 0 0.003866282058879733
of O 0 0.005847154650837183
exon O 0 0.11228977143764496
6 O 0 0.017835501581430435
. O 0 0.013452894985675812

Our O 0 0.009042762219905853
data O 0 0.0043925633653998375
suggest O 0 0.004175861831754446
that O 0 0.0016325977630913258
the O 0 0.0034404946491122246
C O 0 0.007660569157451391
to O 0 0.0019491534912958741
A O 0 0.004792043939232826
mutation O 0 0.004368051886558533
at O 0 0.004067401867359877
the O 0 0.003920867573469877
penultimate O 0 0.033625032752752304
nucleotide O 0 0.006820333190262318
of O 0 0.003362776478752494
exon O 0 0.013905313797295094
6 O 0 0.005070636980235577
of O 0 0.0028908206149935722
the O 0 0.005462804343551397
CYP27 O 1 0.9984239339828491
gene O 0 0.004923599306493998
not O 0 0.0014551155036315322
only O 0 0.0019092106958851218
causes O 0 0.010861078277230263
the O 0 0.07391580939292908
deficiency B-Disease 1 1.0
in I-Disease 0 0.005292464978992939
the I-Disease 0 0.012461718171834946
sterol I-Disease 1 0.9925578832626343
27 I-Disease 0 0.021023424342274666
- I-Disease 0 0.03526422753930092
hydroxylase I-Disease 0 0.025425918400287628
activity I-Disease 0 0.0034868521615862846
, O 0 0.00220290245488286
but O 0 0.0013974845642223954
also O 0 0.002010897034779191
partially O 0 0.005025411490350962
leads O 0 0.0033823521807789803
to O 0 0.0018602436175569892
alternative O 0 0.00440718699246645
pre O 0 0.012234929017722607
- O 0 0.010151242837309837
mRNA O 0 0.0074004982598125935
splicing O 0 0.0075460877269506454
of O 0 0.003935403190553188
the O 0 0.0079405028373003
gene O 0 0.014260193333029747
. O 0 0.013092626817524433

To O 0 0.0072186910547316074
our O 0 0.00514959217980504
knowledge O 0 0.004607218783348799
, O 0 0.0026026526466012
this O 0 0.0013339706929400563
is O 0 0.001607384067028761
the O 0 0.0018879638519138098
first O 0 0.002086775377392769
report O 0 0.0022233615163713694
regarding O 0 0.002740025520324707
effects O 0 0.004194245673716068
on O 0 0.003225211752578616
pre O 0 0.012083604000508785
- O 0 0.0068855020217597485
mRNA O 0 0.00460169417783618
splicing O 0 0.0037481633480638266
of O 0 0.001812832080759108
a O 0 0.00255570188164711
mutation O 0 0.0038219736889004707
at O 0 0.0036960295401513577
the O 0 0.003115510568022728
- O 0 0.005296626128256321
2 O 0 0.0026047430001199245
position O 0 0.0019616943318396807
of O 0 0.0017651442904025316
a O 0 0.003791936906054616
5 O 0 0.007654739078134298
splice O 0 0.028308145701885223
site O 0 0.012748428620398045
. O 0 0.011192175559699535

ATM O 0 0.29272234439849854
germline O 0 0.0905444547533989
mutations O 0 0.010864040814340115
in O 0 0.006189363542944193
classical O 1 0.8039231300354004
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999862909317017
in O 0 0.005615010391920805
the O 0 0.007012047339230776
Dutch O 0 0.02078198455274105
population O 0 0.00720116775482893
. O 0 0.009165668860077858

Germline O 1 0.5037663578987122
mutations O 0 0.010619043372571468
in O 0 0.004280969500541687
the O 0 0.004945326596498489
ATM O 0 0.017688700929284096
gene O 0 0.0026725560892373323
are O 0 0.0006692199385724962
responsible O 0 0.0021532196551561356
for O 0 0.002357188146561384
the O 0 0.14018775522708893
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999986886978149
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999986886978149
) O 0 0.01062190905213356
. O 0 0.01020361203700304

In O 0 0.007917165756225586
our O 0 0.0052535757422447205
study O 0 0.004479638300836086
, O 0 0.002190344501286745
we O 0 0.0012323861010372639
have O 0 0.0008858343353495002
determined O 0 0.0023223755415529013
the O 0 0.002704804763197899
ATM O 0 0.01130635291337967
mutation O 0 0.0036208252422511578
spectrum O 0 0.002726999344304204
in O 0 0.001666250522248447
19 O 0 0.0037162669468671083
classical O 0 0.006922481115907431
A B-Disease 1 0.999969482421875
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999998807907104
patients O 1 0.7534281611442566
, O 0 0.00183897337410599
including O 0 0.0013146380661055446
some O 0 0.0011943818535655737
immigrant O 0 0.004422195255756378
populations O 0 0.0029005641117691994
, O 0 0.001862133969552815
as O 0 0.001503111096099019
well O 0 0.0013938352931290865
as O 0 0.0015148223610594869
12 O 0 0.002132014138624072
of O 0 0.0022151824086904526
Dutch O 0 0.008797983638942242
ethnic O 0 0.0055160243064165115
origin O 0 0.010610478930175304
. O 0 0.012187769636511803

Both O 0 0.008519294671714306
the O 0 0.007641912437975407
protein O 0 0.009381911717355251
truncation O 0 0.020696796476840973
test O 0 0.00703349569812417
( O 0 0.006738539319485426
PTT O 0 0.028778869658708572
) O 0 0.0025616625789552927
and O 0 0.001723343855701387
the O 0 0.0027718511410057545
restriction O 0 0.007891260087490082
endonuclease O 0 0.04186469689011574
fingerprinting O 0 0.021368827670812607
( O 0 0.009419336915016174
REF O 1 0.7852743268013
) O 0 0.0023602929431945086
method O 0 0.0019055850571021438
were O 0 0.0014206219930201769
used O 0 0.0014089421601966023
and O 0 0.001331101288087666
compared O 0 0.0019647344015538692
for O 0 0.001322959316894412
their O 0 0.0014706013025715947
detection O 0 0.005629621911793947
efficiency O 0 0.004817379172891378
, O 0 0.0022339329589158297
identifying O 0 0.005344624165445566
76 O 0 0.007823827676475048
% O 0 0.00185442587826401
and O 0 0.0012917878339067101
60 O 0 0.0029027422424405813
% O 0 0.0019402630859985948
of O 0 0.0023880056105554104
the O 0 0.004956674762070179
mutations O 0 0.007683726958930492
, O 0 0.005828308407217264
respectively O 0 0.015596269629895687
. O 0 0.013142936863005161

Most O 0 0.01496350858360529
patients O 0 0.34682756662368774
were O 0 0.004570639692246914
found O 0 0.003786838846281171
to O 0 0.003814137075096369
be O 0 0.0046187350526452065
compound O 0 0.038845520466566086
heterozygote O 0 0.17431673407554626
. O 0 0.017105838283896446

Seventeen O 0 0.03153969720005989
mutations O 0 0.01042262651026249
were O 0 0.002893603639677167
distinct O 0 0.0028970229905098677
, O 0 0.002141447039321065
of O 0 0.0023029858712106943
which O 0 0.0018910770304501057
10 O 0 0.0026086261495947838
were O 0 0.002063046908006072
not O 0 0.001919902628287673
reported O 0 0.00706434715539217
previously O 0 0.011533644050359726
. O 0 0.010816209018230438

Mutations O 0 0.01895618997514248
are O 0 0.003637325717136264
small O 0 0.0051616523414850235
deletions O 0 0.012361468747258186
or O 0 0.0050788032822310925
point O 0 0.010062907822430134
mutations O 0 0.01034203264862299
frequently O 0 0.009221063926815987
affecting O 0 0.01576574333012104
splice O 0 0.056364756077528
sites O 0 0.01589464768767357
. O 0 0.0145111670717597

Moreover O 0 0.025720246136188507
, O 0 0.009933645837008953
a O 0 0.011420227587223053
16 O 0 0.01762964390218258
. O 0 0.013649140484631062

7 O 0 0.042289573699235916
- O 0 0.031324706971645355
kb O 0 0.040467552840709686
genomic O 0 0.014682033099234104
deletion O 0 0.009136077016592026
of O 0 0.00358980568125844
the O 0 0.004371680784970522
3 O 0 0.004855195991694927
end O 0 0.0032868674024939537
of O 0 0.0031588091515004635
the O 0 0.0044940682128071785
gene O 0 0.0039781248196959496
, O 0 0.0017595355166122317
most O 0 0.0012685655383393168
likely O 0 0.0018630098784342408
a O 0 0.0018538091098889709
result O 0 0.0021153450943529606
of O 0 0.0023582703433930874
recombination O 0 0.0046220687218010426
between O 0 0.0016011762199923396
two O 0 0.0013471556594595313
LINE O 0 0.006187981925904751
elements O 0 0.004083476960659027
, O 0 0.004422283265739679
was O 0 0.014690437354147434
identified O 0 0.01393248699605465
. O 0 0.011205101385712624

The O 0 0.009796167723834515
most O 0 0.0036317138001322746
frequently O 0 0.004686551168560982
found O 0 0.0037673995830118656
mutation O 0 0.004373283591121435
, O 0 0.001753973076120019
identified O 0 0.0021760675590485334
in O 0 0.0015988688683137298
three O 0 0.0016797962598502636
unrelated O 0 0.006837343331426382
Turkish O 0 0.041092757135629654
A B-Disease 1 0.9999933242797852
- I-Disease 1 0.9999908208847046
T I-Disease 1 0.9999866485595703
individuals O 0 0.001843701465986669
, O 0 0.0019181087845936418
was O 0 0.0033971499651670456
previously O 0 0.0026878665667027235
described O 0 0.0023210039362311363
to O 0 0.0008873363840393722
be O 0 0.0007735028630122542
a O 0 0.002026882953941822
Turkish O 0 0.008580210618674755
A B-Disease 1 0.9998953342437744
- I-Disease 1 0.9999740123748779
T I-Disease 1 0.999995231628418
founder O 1 0.9917649626731873
mutation O 0 0.025023769587278366
. O 0 0.010954868979752064

The O 0 0.010490406304597855
presence O 0 0.006399089936167002
of O 0 0.004505434539169073
a O 0 0.0077049341052770615
founder O 1 0.9862306714057922
mutation O 0 0.005952096078544855
among O 0 0.0021038223057985306
relatively O 0 0.001994587481021881
small O 0 0.0018045867327600718
ethnic O 0 0.002111139940097928
population O 0 0.0015271822921931744
groups O 0 0.0010813298868015409
in O 0 0.0015858005499467254
Western O 0 0.003648080164566636
Europe O 0 0.0034426420461386442
could O 0 0.0019105342216789722
indicate O 0 0.0031903365161269903
a O 0 0.003159085288643837
high O 0 0.006357913836836815
carrier O 0 0.008814586326479912
frequency O 0 0.0027358788065612316
in O 0 0.0018942324677482247
such O 0 0.002328964415937662
communities O 0 0.005993593949824572
. O 0 0.011134859174489975

In O 0 0.011382070370018482
patients O 0 0.019317567348480225
of O 0 0.0046393838711082935
Dutch O 0 0.00995483249425888
ethnic O 0 0.0033460059203207493
origin O 0 0.0031394974794238806
, O 0 0.0024573546834290028
however O 0 0.002117603085935116
, O 0 0.002029841300100088
no O 0 0.002235168358311057
significant O 0 0.004026878625154495
founder O 0 0.1447254866361618
effect O 0 0.004060901701450348
could O 0 0.002903970889747143
be O 0 0.0031904212664812803
identified O 0 0.0094689279794693
. O 0 0.008841156028211117

The O 0 0.012745248153805733
observed O 0 0.010409316048026085
genetic O 0 0.0096736503764987
heterogeneity O 0 0.011142206378281116
including O 0 0.002995138755068183
the O 0 0.003653491847217083
relative O 0 0.006044765468686819
high O 0 0.006301007233560085
percentage O 0 0.0047956425696611404
of O 0 0.0037009529769420624
splice O 1 0.8898226618766785
- O 0 0.022123094648122787
site O 0 0.006188994273543358
mutations O 0 0.00430310470983386
had O 0 0.0029872125014662743
no O 0 0.0024793208576738834
reflection O 0 0.007294295821338892
on O 0 0.0048090610653162
the O 0 0.0103606591001153
phenotype O 0 0.03689328581094742
. O 0 0.012448808178305626

All O 0 0.011782250367105007
patients O 0 0.06369543820619583
manifested O 0 0.1246321052312851
classical O 0 0.04827278479933739
A B-Disease 1 0.9999933242797852
- I-Disease 1 0.9999892711639404
T I-Disease 1 0.9999624490737915
and O 0 0.004999136086553335
increased O 0 0.006721791811287403
cellular O 0 0.018272683024406433
radioresistant O 1 0.7077823281288147
DNA O 0 0.017994699999690056
synthesis O 0 0.0203750841319561
. O 0 0.01383331511169672

Determination O 0 0.0193703081458807
of O 0 0.005645668599754572
the O 0 0.005297648720443249
genomic O 0 0.008593615144491196
structure O 0 0.00413557467982173
of O 0 0.0030537652783095837
the O 0 0.00566860381513834
COL4A4 O 1 0.999825656414032
gene O 0 0.003507544519379735
and O 0 0.0013748947530984879
of O 0 0.003255524206906557
novel O 1 0.6045558452606201
mutations O 0 0.2975955009460449
causing O 1 0.9997692704200745
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9997705817222595

Autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9972506165504456
a O 1 0.9646614193916321
progressive O 1 0.9999995231628418
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999862909317017
by O 1 0.821426510810852
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999510049819946
abnormalities I-Disease 1 0.9998570680618286
and O 0 0.002810051431879401
associated O 0 0.0029441951774060726
with O 0 0.0016151696909219027
mutations O 0 0.0023374545853585005
in O 0 0.0013685640878975391
either O 0 0.0020181857980787754
the O 0 0.0036967953201383352
COL4A3 O 1 0.9998281002044678
or O 0 0.0033179023303091526
the O 0 0.005551435519009829
COL4A4 O 1 0.999908447265625
gene O 0 0.005089606624096632
, O 0 0.0019549597054719925
which O 0 0.0014563866425305605
encode O 0 0.003682617796584964
the O 0 0.0038296955171972513
alpha3 O 0 0.03351432457566261
and O 0 0.006496813613921404
alpha4 O 1 0.9999699592590332
type O 1 0.9999809265136719
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9733057618141174
, O 0 0.01240421924740076
respectively O 0 0.024943040683865547
. O 0 0.017033258453011513

To O 0 0.00730035500600934
date O 0 0.008525842800736427
, O 0 0.004248788580298424
mutation O 0 0.004981863312423229
screening O 0 0.0039587863720953465
in O 0 0.0015148208476603031
the O 0 0.0023379914928227663
two O 0 0.0016263190191239119
genes O 0 0.0029913876205682755
has O 0 0.0022155768238008022
been O 0 0.0028280080296099186
hampered O 0 0.01202294509857893
by O 0 0.002034473465755582
the O 0 0.0038635176606476307
lack O 0 0.007017201744019985
of O 0 0.006996413692831993
genomic O 0 0.023591993376612663
structure O 0 0.014135530218482018
information O 0 0.009398559108376503
. O 0 0.014406649395823479

We O 0 0.009811091236770153
report O 0 0.006115809548646212
here O 0 0.003683289745822549
the O 0 0.0030227520037442446
complete O 0 0.004401728045195341
characterization O 0 0.006610800512135029
of O 0 0.0030657390598207712
the O 0 0.0033669723197817802
48 O 0 0.0049872929230332375
exons O 0 0.006832536775618792
of O 0 0.0030301506631076336
the O 0 0.0060416520573198795
COL4A4 O 1 0.9999881982803345
gene O 0 0.006015641614794731
, O 0 0.0018833659123629332
a O 0 0.0027521804440766573
comprehensive O 0 0.00815921276807785
gene O 0 0.003966570366173983
screen O 0 0.0029229314532130957
, O 0 0.0017175929388031363
and O 0 0.0012246823171153665
the O 0 0.0018594823777675629
subsequent O 0 0.0028481092303991318
detection O 0 0.003422983456403017
of O 0 0.001789391739293933
10 O 0 0.0020688765216618776
novel O 0 0.0037906651850789785
mutations O 0 0.0026223226450383663
in O 0 0.0019301431020721793
eight O 0 0.005644116085022688
patients O 1 0.9999936819076538
diagnosed O 1 1.0
with O 1 0.997488260269165
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998629093170166

Furthermore O 0 0.018647104501724243
, O 0 0.00501962099224329
we O 0 0.002748534083366394
identified O 0 0.003931626211851835
a O 0 0.0038779652677476406
glycine O 0 0.011327063664793968
to O 0 0.002625443274155259
alanine O 0 0.012205487117171288
substitution O 0 0.006481215823441744
in O 0 0.0031018340960144997
the O 0 0.005608120933175087
collagenous O 1 0.9994729161262512
domain O 0 0.0066759539768099785
that O 0 0.001844300888478756
is O 0 0.00243014725856483
apparently O 0 0.004230611491948366
silent O 0 0.006820252165198326
in O 0 0.0021685429383069277
the O 0 0.0036133993417024612
heterozygous O 0 0.008099907077848911
carriers O 0 0.005991082172840834
, O 0 0.003672512248158455
in O 0 0.004735695198178291
11 O 0 0.012490304186940193
. O 0 0.012024507857859135

5 O 0 0.011715373955667019
% O 0 0.004459795542061329
of O 0 0.00250516040250659
all O 0 0.001538136857561767
control O 0 0.0031863839831203222
individuals O 0 0.001444052206352353
, O 0 0.001835936913266778
and O 0 0.0013158400543034077
in O 0 0.001770747359842062
one O 0 0.002173360902816057
control O 0 0.0030813124030828476
individual O 0 0.0023120706900954247
homozygous O 0 0.005366249941289425
for O 0 0.002262037480250001
this O 0 0.004482955206185579
glycine O 0 0.03490131348371506
substitution O 0 0.023367032408714294
. O 0 0.013349656946957111

There O 0 0.008663060143589973
has O 0 0.00409013032913208
been O 0 0.0024409566540271044
no O 0 0.0018243766389787197
previous O 0 0.0019617341458797455
finding O 0 0.00278197112493217
of O 0 0.0027384937275201082
a O 0 0.005732906982302666
glycine O 0 0.1239253357052803
substitution O 0 0.006197350099682808
that O 0 0.0015552990371361375
is O 0 0.0015413498040288687
not O 0 0.0008981579449027777
associated O 0 0.001786803244613111
with O 0 0.0012014951789751649
any O 0 0.002010878873988986
obvious O 0 0.008742586709558964
phenotype O 0 0.011481351219117641
in O 0 0.004744886886328459
homozygous O 0 0.01671026647090912
individuals O 0 0.005523962900042534
. O 0 0.012071452103555202

Founder O 1 0.9982686042785645
BRCA1 O 1 0.9994657635688782
and O 0 0.011115003377199173
BRCA2 O 1 0.9652178287506104
mutations O 0 0.006801447365432978
in O 0 0.004363620653748512
French O 0 0.16421100497245789
Canadian O 1 0.9999510049819946
breast B-Disease 1 1.0
and I-Disease 1 0.9999971389770508
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.998424768447876
. O 0 0.02053188346326351

We O 0 0.005574897862970829
have O 0 0.0017004989786073565
identified O 0 0.002379859797656536
four O 0 0.001382889342494309
mutations O 0 0.00156178860925138
in O 0 0.0010057745967060328
each O 0 0.0008009196608327329
of O 0 0.00272343959659338
the O 1 0.9608296751976013
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9998964071273804
susceptibility O 1 0.9956881403923035
genes O 0 0.0055264439433813095
, O 0 0.004331306554377079
BRCA1 O 1 0.968525230884552
and O 0 0.0032789348624646664
BRCA2 O 1 0.8477663397789001
, O 0 0.0022821298334747553
in O 0 0.0023378680925816298
French O 0 0.09305107593536377
Canadian O 1 0.9998687505722046
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999972581863403
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.43928292393684387
from O 0 0.0095106465741992
Quebec O 1 0.7333450317382812
. O 0 0.014886701479554176

To O 0 0.00802587904036045
identify O 0 0.011067827232182026
founder O 1 0.979320764541626
effects O 0 0.030669312924146652
, O 0 0.0035062178503721952
we O 0 0.00210322393104434
examined O 0 0.006165271159261465
independently O 0 0.003402175847440958
ascertained O 0 0.010906261391937733
French O 0 0.013504602015018463
Canadian O 0 0.3227222263813019
cancer B-Disease 1 0.9999827146530151
families O 0 0.003045878140255809
for O 0 0.001624924479983747
the O 0 0.0021543281618505716
distribution O 0 0.0025293927174061537
of O 0 0.0033533477690070868
these O 0 0.002359265461564064
eight O 0 0.007473118603229523
mutations O 0 0.01390780508518219
. O 0 0.01212144736200571

Mutations O 0 0.016350433230400085
were O 0 0.004059906117618084
found O 0 0.004026411566883326
in O 0 0.0036791907623410225
41 O 0 0.009275336749851704
of O 0 0.007006123661994934
97 O 0 0.029152922332286835
families O 0 0.013919615186750889
. O 0 0.01318859588354826

Six O 0 0.008409152738749981
of O 0 0.005567408632487059
eight O 0 0.004743299912661314
mutations O 0 0.003983913920819759
were O 0 0.001919640228152275
observed O 0 0.0033951213117688894
at O 0 0.004241690039634705
least O 0 0.003978910390287638
twice O 0 0.009497539140284061
. O 0 0.0105361919850111

The O 0 0.032121945172548294
BRCA1 O 1 0.9994010925292969
C4446T O 1 0.9905856251716614
mutation O 0 0.012383423745632172
was O 0 0.005765678361058235
the O 0 0.0027057284023612738
most O 0 0.0017317018937319517
common O 0 0.0032559421379119158
mutation O 0 0.004324924200773239
found O 0 0.0023358981125056744
, O 0 0.0017881289822980762
followed O 0 0.0029261820018291473
by O 0 0.0025834240950644016
the O 0 0.010731988586485386
BRCA2 O 1 0.9998506307601929
8765delAG O 1 0.9991987347602844
mutation O 0 0.031160669401288033
. O 0 0.017504768446087837

Together O 0 0.008679850958287716
, O 0 0.004078976809978485
these O 0 0.0017305128276348114
mutations O 0 0.0031828023493289948
were O 0 0.0014127283357083797
found O 0 0.0014718263410031796
in O 0 0.0014287320664152503
28 O 0 0.0030591136310249567
of O 0 0.0025089536793529987
41 O 0 0.0050413054414093494
families O 0 0.0024016164243221283
identified O 0 0.0027976445853710175
to O 0 0.0014472149778157473
have O 0 0.0019021290354430676
a O 0 0.006698384881019592
mutation O 0 0.016332153230905533
. O 0 0.011797471903264523

The O 0 0.013959056697785854
odds O 0 0.017252152785658836
of O 0 0.004698365461081266
detection O 0 0.006080677267163992
of O 0 0.0030028934124857187
any O 0 0.0013254325604066253
of O 0 0.0020272887777537107
the O 0 0.0035595970693975687
four O 0 0.0049667321145534515
BRCA1 O 1 0.9984768033027649
mutations O 0 0.00801432877779007
was O 0 0.011909554712474346
18 O 0 0.011057280004024506
. O 0 0.01086918544024229

7x O 1 0.973625659942627
greater O 0 0.009352942928671837
if O 0 0.0023374934680759907
one O 0 0.001600686926394701
or O 0 0.0012962714536115527
more O 0 0.0010953409364446998
cases O 0 0.0036673450376838446
of O 1 0.9998000264167786
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.010969826020300388
also O 0 0.002311518881469965
present O 0 0.002101392252370715
in O 0 0.0019991714507341385
the O 0 0.005076721776276827
family O 0 0.015785664319992065
. O 0 0.009659088216722012

The O 0 0.012195558287203312
odds O 0 0.01519184559583664
of O 0 0.005106366705149412
detection O 0 0.0057015265338122845
of O 0 0.0023493559565395117
any O 0 0.0013427798403427005
of O 0 0.0023299772292375565
the O 0 0.00374619266949594
four O 0 0.0045594931580126286
BRCA2 O 1 0.9973485469818115
mutations O 0 0.010101599618792534
was O 0 0.01566723734140396
5 O 0 0.013450300320982933
. O 0 0.012960867024958134

3x O 1 0.5612411499023438
greater O 0 0.008502928540110588
if O 0 0.0023151899222284555
there O 0 0.0016675693914294243
were O 0 0.0014158827252686024
at O 0 0.0019616037607192993
least O 0 0.0009891772642731667
five O 0 0.001350230653770268
cases O 0 0.0025222075637429953
of O 1 0.9051318168640137
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.019090715795755386
the O 0 0.031182654201984406
family O 0 0.09257451444864273
. O 0 0.010970736853778362

Interestingly O 0 0.029385708272457123
, O 0 0.006227138452231884
the O 0 0.004355116747319698
presence O 0 0.003895063418895006
of O 0 0.005196368787437677
a O 1 0.9248949885368347
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 1 0.5507131814956665
< O 0 0.03808702901005745
36 O 0 0.004227838013321161
years O 0 0.001985826762393117
of O 0 0.0021194778382778168
age O 0 0.005040167365223169
was O 0 0.00583004392683506
strongly O 0 0.0027757883071899414
predictive O 0 0.0039269509725272655
of O 0 0.0017119916155934334
the O 0 0.0020718895830214024
presence O 0 0.0018326559802517295
of O 0 0.0014594835229218006
any O 0 0.0011265380308032036
of O 0 0.0021081846207380295
the O 0 0.0035370441619306803
eight O 0 0.0063693951815366745
mutations O 0 0.011087624356150627
screened O 0 0.017869798466563225
. O 0 0.010531590320169926

Carriers O 0 0.019512120634317398
of O 0 0.006484347861260176
the O 0 0.005665272008627653
same O 0 0.003620247356593609
mutation O 0 0.004155896138399839
, O 0 0.0015193591825664043
from O 0 0.0013063703663647175
different O 0 0.0007448319811373949
families O 0 0.0016767362831160426
, O 0 0.001659673755057156
shared O 0 0.0029278146103024483
similar O 0 0.0026230996008962393
haplotypes O 0 0.011385535821318626
, O 0 0.0026039776857942343
indicating O 0 0.004208084661513567
that O 0 0.0014891244936734438
the O 0 0.003168261144310236
mutant O 0 0.010514164343476295
alleles O 0 0.004663787316530943
were O 0 0.0014131009811535478
likely O 0 0.0014658133732154965
to O 0 0.0008355391910299659
be O 0 0.0007852239650674164
identical O 0 0.001644175499677658
by O 0 0.0011360201751813293
descent O 0 0.003356090048328042
for O 0 0.0016604703851044178
a O 0 0.003177638864144683
mutation O 0 0.0039057694375514984
in O 0 0.0026295247953385115
the O 0 0.005360353738069534
founder O 1 0.8831754326820374
population O 0 0.00831873994320631
. O 0 0.012859703972935677

The O 0 0.009736287407577038
identification O 0 0.007568397559225559
of O 0 0.006697874050587416
common O 0 0.15147267282009125
BRCA1 O 1 0.9999903440475464
and O 0 0.010754544287919998
BRCA2 O 1 0.9998656511306763
mutations O 0 0.006566737312823534
will O 0 0.002302652457728982
facilitate O 0 0.004501489922404289
carrier O 0 0.00684400787577033
detection O 0 0.004372587893158197
in O 0 0.0020523543935269117
French O 0 0.013704841956496239
Canadian O 1 0.9984512329101562
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999890327453613
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9760037660598755
. O 0 0.02179546281695366

Are O 0 0.012015084736049175
Dp71 O 1 0.8587009310722351
and O 0 0.01496875286102295
Dp140 O 1 0.999817430973053
brain O 1 0.999445378780365
dystrophin O 1 0.9081600308418274
isoforms O 0 0.012494529597461224
related O 0 0.007862127386033535
to O 0 0.007019159849733114
cognitive B-Disease 1 0.9998313188552856
impairment I-Disease 1 0.9999998807907104
in O 1 0.9999942779541016
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999250173568726

Molecular O 0 0.02023620903491974
study O 0 0.007419788744300604
and O 0 0.004060639068484306
neuropsychological O 0 0.01261196844279766
analysis O 0 0.002967796754091978
were O 0 0.002028999850153923
performed O 0 0.0034199366346001625
concurrently O 0 0.005573716014623642
on O 0 0.0029880418442189693
49 O 0 0.011077267117798328
patients O 1 0.9847599864006042
with O 1 0.6574515700340271
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.004337533842772245
in O 0 0.001825737883336842
order O 0 0.0016931446734815836
to O 0 0.0012603806098923087
find O 0 0.0019737817347049713
a O 0 0.002079235389828682
molecular O 0 0.003337741130962968
explanation O 0 0.0035227439366281033
for O 0 0.002273750491440296
the O 0 0.00505202729254961
cognitive B-Disease 1 0.5569737553596497
impairment I-Disease 1 0.999015212059021
observed O 0 0.00795868132263422
in O 0 0.006925704888999462
most O 0 0.016707444563508034
DMD B-Disease 1 1.0
patients O 1 0.9999889135360718
. O 0 0.024152550846338272

Complete O 0 0.011120985262095928
analysis O 0 0.004677735734730959
of O 0 0.005348166450858116
the O 0 0.008937802165746689
dystrophin O 1 0.999514102935791
gene O 0 0.008049394935369492
was O 0 0.005485889036208391
performed O 0 0.0035514882765710354
to O 0 0.001473338925279677
define O 0 0.003793060313910246
the O 0 0.003162611275911331
localization O 0 0.008462951518595219
of O 0 0.0038034114986658096
deletions O 0 0.009944706223905087
and O 0 0.00357817648909986
duplications O 0 0.014241095632314682
in O 0 0.0033988517243415117
relation O 0 0.005877490621060133
to O 0 0.002816405612975359
the O 0 0.005847793072462082
different O 0 0.0077176871709525585
DMD B-Disease 1 0.9999991655349731
promoters O 1 0.9270329475402832
. O 0 0.02072727307677269

Qualitative O 0 0.018572989851236343
analysis O 0 0.00582165876403451
of O 0 0.005047724582254887
the O 0 0.008144847117364407
Dp71 O 1 0.9823775291442871
transcript O 0 0.0123249851167202
and O 0 0.0026597068645060062
testing O 0 0.002864861162379384
for O 0 0.0015677798073738813
the O 0 0.0018919016001746058
specific O 0 0.001785939559340477
first O 0 0.0027646624948829412
exon O 0 0.010569536127150059
of O 0 0.0037578425835818052
Dp140 O 0 0.3175696134567261
were O 0 0.0032852867152541876
also O 0 0.003858822165057063
carried O 0 0.006561674643307924
out O 0 0.0071295322850346565
. O 0 0.00981641560792923

Neuropsychological O 0 0.0691671222448349
analysis O 0 0.013746470212936401
assessed O 0 0.016246207058429718
verbal O 0 0.017146386206150055
and O 0 0.007699515670537949
visuospatial O 1 0.9961620569229126
intelligence O 0 0.011652477085590363
, O 0 0.005090859718620777
verbal O 0 0.0248202346265316
memory O 1 0.9978228807449341
, O 0 0.005690092220902443
and O 0 0.00464259460568428
reading O 0 0.018082428723573685
skills O 0 0.03359539061784744
. O 0 0.018061833456158638

Comparison O 0 0.015932133421301842
of O 0 0.008783652447164059
molecular O 0 0.012625686824321747
and O 0 0.0050337486900389194
psychometric O 0 0.025222711265087128
findings O 0 0.00890087429434061
demonstrated O 0 0.007496135774999857
that O 0 0.0023469161242246628
deletions O 0 0.007657268550246954
and O 0 0.0029339641332626343
duplications O 0 0.013217507861554623
that O 0 0.0020259018056094646
were O 0 0.002138980431482196
localized O 0 0.006335684563964605
in O 0 0.002527155913412571
the O 0 0.0045016054064035416
distal O 1 0.9554380178451538
part O 0 0.0044612884521484375
of O 0 0.0039919521659612656
the O 0 0.007558224257081747
gene O 0 0.004076924175024033
seemed O 0 0.0028808878269046545
to O 0 0.001340333023108542
be O 0 0.001635169261135161
preferentially O 0 0.006991542875766754
associated O 0 0.005893308203667402
with O 0 0.005972398445010185
cognitive B-Disease 1 0.999881386756897
impairment I-Disease 1 0.999998927116394
. O 0 0.04120774194598198

Two O 0 0.009646718390285969
altered O 0 0.015866374596953392
Dp71 O 0 0.06299261003732681
transcripts O 0 0.010574120096862316
and O 0 0.0031726963352411985
two O 0 0.002642245963215828
deleted O 0 0.010112629272043705
Dp140 O 0 0.018272174522280693
DNA O 0 0.00452194269746542
sequences O 0 0.0020342206116765738
were O 0 0.0012952792458236217
found O 0 0.0014402404194697738
in O 0 0.001797366770915687
four O 0 0.0034635518677532673
patients O 1 0.999923825263977
with O 1 0.8516992926597595
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9997718930244446

These O 0 0.006310284603387117
findings O 0 0.007148783653974533
suggest O 0 0.0045962827280163765
that O 0 0.0012927564093843102
some O 0 0.001387708936817944
sequences O 0 0.0027177289593964815
located O 0 0.003577660070732236
in O 0 0.001998426392674446
the O 0 0.003640479175373912
distal O 0 0.2455589473247528
part O 0 0.003677369561046362
of O 0 0.003767639398574829
the O 0 0.008629724383354187
gene O 0 0.003777309088036418
and O 0 0.0013966450933367014
, O 0 0.0014972620410844684
in O 0 0.0014914419734850526
particular O 0 0.002564522437751293
, O 0 0.0026425649411976337
some O 0 0.002237760229036212
DMD B-Disease 1 0.9999959468841553
isoforms O 0 0.005394676700234413
expressed O 0 0.0027063176967203617
in O 0 0.002148217288777232
the O 0 0.006100232247263193
brain O 1 0.9874036312103271
may O 0 0.002093968214467168
be O 0 0.0009340552496723831
related O 0 0.001766534405760467
to O 0 0.0014795481692999601
the O 0 0.005755974445492029
cognitive B-Disease 1 0.9998026490211487
impairment I-Disease 1 0.9999990463256836
associated O 1 0.975030779838562
with O 1 0.8509982228279114
DMD B-Disease 1 1.0
. O 0 0.01542166993021965
. O 0 0.013522210530936718

I1307K O 1 0.9982157945632935
APC O 1 0.9986611604690552
and O 0 0.00804456789046526
hMLH1 O 0 0.4611609876155853
mutations O 0 0.006141406483948231
in O 0 0.0028379433788359165
a O 0 0.0035489590372890234
non O 0 0.006949992384761572
- O 0 0.008614269085228443
Jewish O 0 0.0049890680238604546
family O 0 0.004972582217305899
with O 0 0.0037661739625036716
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9998219609260559

We O 0 0.006330655422061682
describe O 0 0.006546951364725828
a O 0 0.004677012097090483
French O 0 0.014313814230263233
Canadian O 1 0.6324884295463562
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 0.9999998807907104
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.16978487372398376
kindred O 1 0.9598433971405029
which O 0 0.0021782303228974342
carries O 0 0.004442757461220026
a O 0 0.003542491467669606
novel O 0 0.015025188215076923
truncating O 1 0.6768569946289062
mutation O 0 0.01481131836771965
in O 0 0.00948979053646326
hMLH1 O 1 0.9700500965118408
. O 0 0.017574239522218704

Interestingly O 0 0.0364474356174469
, O 0 0.009463982656598091
the O 0 0.011461041867733002
I1307K O 1 0.9867419600486755
APC O 1 0.991353452205658
polymorphism O 0 0.010558565147221088
, O 0 0.002391856163740158
associated O 0 0.002234694082289934
with O 0 0.001175791141577065
an O 0 0.0017508409218862653
increased O 0 0.004646589979529381
risk O 1 0.9188365340232849
of O 1 0.9999926090240479
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9961821436882019
is O 0 0.0028893251437693834
also O 0 0.0015659715281799436
present O 0 0.0018147366354241967
in O 0 0.002062057377770543
this O 0 0.002418596763163805
family O 0 0.011389889754354954
. O 0 0.011408057995140553

The O 0 0.02104107290506363
I1307K O 0 0.4857845604419708
polymorphism O 0 0.0155876986682415
has O 0 0.003379103494808078
previously O 0 0.0030777654610574245
only O 0 0.0012588832760229707
been O 0 0.0013460955815389752
identified O 0 0.0019464448560029268
in O 0 0.0011286137159913778
individuals O 0 0.0010458724573254585
of O 0 0.0030473899096250534
self O 1 0.6838908195495605
- O 1 0.622484564781189
reported O 0 0.00968922208994627
Ashkenazi O 0 0.031751811504364014
Jewish O 0 0.017180396243929863
origins O 0 0.030284786596894264
. O 0 0.018712671473622322

In O 0 0.0069008274003863335
addition O 0 0.004927768371999264
, O 0 0.002692313166335225
in O 0 0.0018949185032397509
this O 0 0.0015205525560304523
family O 0 0.00337992119602859
, O 0 0.0018956945277750492
there O 0 0.0016512287547811866
appears O 0 0.0023286882787942886
to O 0 0.0009756237268447876
be O 0 0.0009161849156953394
no O 0 0.0011630821973085403
relationship O 0 0.0020969989709556103
between O 0 0.0015992549015209079
the O 0 0.0036168773658573627
I1307K O 0 0.4315386116504669
polymorphism O 0 0.0055714803747832775
and O 0 0.0016317919362336397
the O 0 0.0022016398143023252
presence O 0 0.0029624232556670904
or O 0 0.0026839759666472673
absence O 0 0.01665782928466797
of O 1 0.9797524213790894
cancer B-Disease 1 1.0
. O 0 0.01685035601258278
. O 0 0.012032595463097095

Identification O 0 0.013302458450198174
of O 0 0.005806684959679842
a O 0 0.005067483987659216
novel O 0 0.01116335578262806
mutation O 0 0.005222253501415253
of O 0 0.003927264362573624
the O 0 0.007324612233787775
CPO O 1 0.9893626570701599
gene O 0 0.003983293194323778
in O 0 0.0022309229243546724
a O 0 0.004725693259388208
Japanese O 1 0.641002357006073
hereditary B-Disease 1 0.9999873638153076
coproporphyria I-Disease 1 0.9999761581420898
family O 1 0.784467339515686
. O 0 0.01878450997173786

Hereditary B-Disease 1 0.9999829530715942
coproporphyria I-Disease 1 0.9999737739562988
( O 1 0.9673048853874207
HCP B-Disease 1 0.9999923706054688
) O 0 0.005868386942893267
is O 0 0.003441832261160016
an O 0 0.004477030131965876
autosomal B-Disease 1 0.9999849796295166
dominant I-Disease 1 0.9999964237213135
disease I-Disease 1 1.0
characterized O 1 0.999935507774353
by O 0 0.04782149940729141
a O 1 0.9970619082450867
deficiency B-Disease 1 1.0
of I-Disease 1 0.9995983242988586
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999653100967407
( O 0 0.04174104332923889
CPO O 1 0.9961733222007751
) O 0 0.0036711241118609905
caused O 0 0.003991751000285149
by O 0 0.0016244696453213692
a O 0 0.0032757073640823364
mutation O 0 0.005151757039129734
in O 0 0.004103153012692928
the O 0 0.009844914078712463
CPO O 1 0.9972023963928223
gene O 0 0.02082996256649494
. O 0 0.011424696072936058

Only O 0 0.007471590302884579
11 O 0 0.00678273243829608
mutations O 0 0.004494699649512768
of O 0 0.002731290413066745
the O 0 0.0042030722834169865
gene O 0 0.00416983850300312
have O 0 0.0010639780666679144
been O 0 0.0024168002419173717
reported O 0 0.0062309992499649525
in O 0 0.008958040736615658
HCP B-Disease 1 0.9999995231628418
patients O 1 0.9998437166213989
. O 0 0.017453454434871674

We O 0 0.00863579660654068
report O 0 0.00661182776093483
another O 0 0.006005041766911745
mutation O 0 0.006138958968222141
in O 0 0.0034691966138780117
a O 0 0.007275702897459269
Japanese O 0 0.24257738888263702
family O 0 0.026667218655347824
. O 0 0.016488494351506233

Polymerase O 0 0.08521093428134918
chain O 0 0.0409136638045311
reaction O 0 0.01983821950852871
- O 0 0.01953231543302536
single O 0 0.008393976837396622
strand O 0 0.011777598410844803
conformational O 0 0.009487809613347054
polymorphism O 0 0.006984974257647991
and O 0 0.0017576663522049785
direct O 0 0.002177994232624769
sequence O 0 0.0024602189660072327
analyses O 0 0.003955634776502848
demonstrated O 0 0.004823276307433844
a O 0 0.003863741410896182
C O 0 0.010785248130559921
to O 0 0.0028864173218607903
T O 0 0.0155256949365139
substitution O 0 0.004617608617991209
in O 0 0.002563954098150134
exon O 0 0.010235057212412357
1 O 0 0.003175109624862671
of O 0 0.002190931001678109
the O 0 0.004113075323402882
CPO O 0 0.15611280500888824
gene O 0 0.003938221372663975
at O 0 0.003170017385855317
nucleotide O 0 0.0036831460893154144
position O 0 0.0029658502899110317
85 O 0 0.003927965648472309
, O 0 0.0018228830303996801
which O 0 0.001509672962129116
lies O 0 0.003960531670600176
in O 0 0.0020603409502655268
the O 0 0.0040406095795333385
putative O 0 0.022169681265950203
presequence O 0 0.02678217738866806
for O 0 0.0032917819917201996
targeting O 0 0.007630025502294302
to O 0 0.00506543880328536
mitochondria O 0 0.020358650013804436
. O 0 0.012491350993514061

This O 0 0.009237187914550304
mutation O 0 0.008986694738268852
changes O 0 0.003422417677938938
the O 0 0.003823172068223357
codon O 0 0.007279933430254459
for O 0 0.002422675024718046
glutamine O 0 0.007622453849762678
to O 0 0.00183504493907094
a O 0 0.003971228841692209
termination O 0 0.011883838102221489
codon O 0 0.010485569015145302
at O 0 0.005398239474743605
amino O 0 0.005967359058558941
acid O 0 0.00987323373556137
position O 0 0.009555535390973091
29 O 0 0.01658625528216362
. O 0 0.011915233917534351

MaeI O 0 0.11624554544687271
restriction O 0 0.014943968504667282
analysis O 0 0.005598750431090593
showed O 0 0.005371867213398218
two O 0 0.0015915753319859505
other O 0 0.001549417502246797
carriers O 0 0.004602895583957434
in O 0 0.003458722960203886
the O 0 0.007540129125118256
family O 0 0.02108263596892357
. O 0 0.012018069624900818

The O 0 0.04960814118385315
C O 1 0.9999444484710693
- O 1 0.9996424913406372
T O 1 0.9986374974250793
mutation O 0 0.007767126429826021
is O 0 0.00252687931060791
located O 0 0.003333410480991006
within O 0 0.0016190821770578623
a O 0 0.0024415208026766777
recently O 0 0.005231195595115423
proposed O 0 0.004759308882057667
putative O 0 0.012445016764104366
alternative O 0 0.004787669982761145
translation O 0 0.007298893295228481
initiation O 0 0.013859418220818043
codon O 0 0.0190713033080101
( O 0 0.010719728656113148
TIC O 1 0.9993962049484253
- O 0 0.013613693416118622
1 O 0 0.00550158740952611
) O 0 0.002058087382465601
, O 0 0.001366422395221889
supporting O 0 0.002775260480120778
that O 0 0.0024155955761671066
TIC O 1 0.9999825954437256
- O 0 0.01002536155283451
1 O 0 0.0037643262185156345
is O 0 0.0018061005976051092
the O 0 0.002372932154685259
real O 0 0.005897052586078644
TIC O 1 0.9904382824897766
rather O 0 0.003892407286912203
than O 0 0.003846776904538274
TIC O 1 0.9999545812606812
- O 0 0.04136773943901062
2 O 0 0.010077272541821003
. O 0 0.0054607996717095375
. O 0 0.010720688849687576

Human B-Disease 0 0.031091634184122086
complement I-Disease 0 0.3216448128223419
factor I-Disease 1 0.999811589717865
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9999336004257202
with O 1 0.9999916553497314
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999946355819702

This O 0 0.005647218786180019
study O 0 0.004733243491500616
reports O 0 0.0033674973528832197
on O 0 0.00218233116902411
six O 0 0.0026061669923365116
cases O 0 0.004259591456502676
of O 0 0.21594958007335663
deficiency B-Disease 1 1.0
in I-Disease 0 0.0048646279610693455
the I-Disease 0 0.004200861323624849
human I-Disease 0 0.003839730052277446
complement I-Disease 0 0.0064520263113081455
regulatory I-Disease 0 0.00750805763527751
protein I-Disease 0 0.00617614109069109
Factor I-Disease 0 0.011079326272010803
H I-Disease 1 0.9996299743652344
( O 0 0.00817746203392744
FH O 1 0.9978394508361816
) O 0 0.0015421361895278096
in O 0 0.0009435904212296009
the O 0 0.001454823068343103
context O 0 0.002539697103202343
of O 0 0.005206072703003883
an O 1 0.999321460723877
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999966621398926

Five O 0 0.006181033328175545
of O 0 0.004163178615272045
the O 0 0.0035435776226222515
cases O 0 0.0027003528084605932
were O 0 0.0018998978193849325
observed O 0 0.0020939302630722523
in O 0 0.001737382379360497
children O 0 0.004608044866472483
presenting O 0 0.022549301385879517
with O 1 0.9013335108757019
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9996715784072876
. O 0 0.020829547196626663

Two O 0 0.00501238601282239
of O 0 0.004970223642885685
the O 0 0.005841730162501335
children O 0 0.017765073105692863
exhibited O 1 0.9522948265075684
a O 1 0.7995864748954773
homozygous O 1 0.9999501705169678
deficiency O 1 1.0
characterized O 1 0.9309828281402588
by O 0 0.0023876407649368048
the O 0 0.003753241617232561
absence O 0 0.0065965112298727036
of O 0 0.0039015128277242184
the O 0 0.0042002033442258835
150 O 0 0.00659007765352726
- O 0 0.00930753629654646
kD O 0 0.024952981621026993
form O 0 0.0025202527176588774
of O 0 0.004738064017146826
Factor O 0 0.4761747717857361
H O 1 0.9997190833091736
and O 0 0.0016656876541674137
the O 0 0.00201593991369009
presence O 0 0.002411969704553485
, O 0 0.0019472991116344929
upon O 0 0.0028899740427732468
immunoblotting O 0 0.012763428501784801
, O 0 0.0018718873616307974
of O 0 0.0022447044029831886
the O 0 0.0045142690651118755
42 O 0 0.01358573418110609
- O 0 0.05417202040553093
kD O 1 0.9669880867004395
Factor O 0 0.013281065039336681
H O 1 0.8520857691764832
- O 0 0.005590720567852259
like O 0 0.002188580809161067
protein O 0 0.003592963796108961
1 O 0 0.00440360838547349
( O 0 0.005441742017865181
FHL O 1 0.9840759634971619
- O 0 0.009509582072496414
1 O 0 0.004499327857047319
) O 0 0.0017840787768363953
and O 0 0.001205726875923574
other O 0 0.0024908941704779863
FH O 1 0.9999725818634033
- O 0 0.013801619410514832
related O 0 0.006682027596980333
protein O 0 0.00894185807555914
( O 0 0.008861989714205265
FHR O 1 0.9930927753448486
) O 0 0.008123601786792278
bands O 0 0.013092800974845886
. O 0 0.011605245992541313

Southern O 0 0.02982953190803528
blot O 0 0.05895337462425232
and O 0 0.00478798383846879
PCR O 0 0.008677470497786999
analysis O 0 0.0017931679030880332
of O 0 0.0019329857314005494
DNA O 0 0.00345415691845119
of O 0 0.002552608959376812
one O 0 0.002950986148789525
patient O 1 0.9460577368736267
with O 0 0.006519585847854614
homozygous O 1 0.999038577079773
deficiency O 1 1.0
ruled O 0 0.00970545131713152
out O 0 0.0025299773551523685
the O 0 0.002410382265225053
presence O 0 0.002303598914295435
of O 0 0.0017746082739904523
a O 0 0.0019614961929619312
large O 0 0.0023251615930348635
deletion O 0 0.005230332724750042
of O 0 0.003217060584574938
the O 0 0.01747063547372818
FH O 1 0.9999991655349731
gene O 0 0.003972320817410946
as O 0 0.0019100086065009236
the O 0 0.0032786496449261904
underlying O 1 0.9980681538581848
defect O 1 0.9999830722808838
for O 0 0.03691638261079788
the O 1 0.9994704127311707
deficiency O 1 1.0
. O 0 0.025732485577464104

The O 0 0.00794491358101368
other O 0 0.0027294140309095383
four O 0 0.0030416513327509165
children O 0 0.004492488224059343
presented O 0 0.005725097842514515
with O 0 0.005447667092084885
heterozygous O 1 0.8965225219726562
deficiency O 1 1.0
and O 0 0.004824265372008085
exhibited O 1 0.8348371982574463
a O 0 0.006160356570035219
normal O 0 0.008355801925063133
immunoblotting O 0 0.4515528678894043
pattern O 0 0.00534901162609458
of O 0 0.0027460847049951553
proteins O 0 0.0026279068551957607
of O 0 0.0037846285849809647
the O 0 0.016725314781069756
FH O 1 0.9999996423721313
family O 0 0.1384182721376419
. O 0 0.013868583366274834

Factor B-Disease 1 0.9999654293060303
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.006211777683347464
the O 0 0.0061380257830023766
only O 0 0.00661435816437006
complement B-Disease 1 0.9999711513519287
deficiency I-Disease 1 1.0
associated O 1 0.978486955165863
with O 1 0.5012844800949097
HUS B-Disease 1 1.0
. O 0 0.28662529587745667

These O 0 0.004017363768070936
observations O 0 0.005584202706813812
suggest O 0 0.0034306275192648172
a O 0 0.0026781056076288223
role O 0 0.004271023441106081
for O 0 0.004152875859290361
FH O 1 0.9999995231628418
and O 0 0.008528162725269794
/ O 1 0.999367892742157
or O 0 0.005930512212216854
FH O 1 0.9999316930770874
receptors O 0 0.005377919413149357
in O 0 0.002091611735522747
the O 0 0.005125678610056639
pathogenesis O 1 0.9999982118606567
of O 1 0.9996689558029175
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.8282127380371094
. O 0 0.020412463694810867

Further O 0 0.007733455393463373
evidence O 0 0.0039469096809625626
for O 0 0.0022050205152481794
a O 0 0.003247543703764677
major O 0 0.006741264835000038
ancient O 0 0.09687883406877518
mutation O 1 0.9595381617546082
underlying O 1 0.9999980926513672
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9983723759651184
linkage O 1 0.9999297857284546
disequilibrium O 1 0.9994723200798035
studies O 0 0.0055091227404773235
in O 0 0.003999197855591774
the O 0 0.006577427964657545
Japanese O 0 0.05648162588477135
population O 0 0.007600411307066679
. O 0 0.010564246214926243

The O 1 0.9521874785423279
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999990463256836
DM B-Disease 1 1.0
) O 0 0.010625878348946571
mutation O 0 0.005481795407831669
is O 0 0.0024790905881673098
an O 0 0.003610310610383749
unstable O 1 0.991397500038147
( O 0 0.012966613285243511
CTG O 1 0.9998446702957153
) O 0 0.004385329317301512
n O 0 0.005730197764933109
repeat O 0 0.005717296618968248
, O 0 0.0019355345284566283
present O 0 0.0020734260324388742
at O 0 0.0027243138756603003
a O 0 0.0021714619360864162
copy O 0 0.0032029340509325266
number O 0 0.0012299424270167947
of O 0 0.001964850351214409
5 O 0 0.004036559257656336
- O 0 0.0046893828548491
37 O 0 0.004567236173897982
repeats O 0 0.005158616695553064
on O 0 0.002465240890160203
normal O 0 0.003289226908236742
chromosomes O 0 0.0035086628049612045
but O 0 0.0012302427785471082
amplified O 0 0.0034434699919074774
to O 0 0.001725924899801612
50 O 0 0.0040507023222744465
- O 0 0.007979505695402622
3000 O 0 0.011726947501301765
copies O 0 0.0068888613022863865
on O 0 0.011730522848665714
DM B-Disease 1 0.9999986886978149
chromosomes O 0 0.03475015237927437
. O 0 0.017281200736761093

Previous O 0 0.011912787333130836
findings O 0 0.007618372328579426
in O 0 0.003921687137335539
Caucasian O 0 0.24235163629055023
populations O 0 0.003987870179116726
of O 0 0.005481332540512085
a O 1 0.9407118558883667
DM B-Disease 1 1.0
founder O 1 0.999964714050293
chromosome O 0 0.016558557748794556
raise O 0 0.004049898590892553
a O 0 0.0021068286150693893
question O 0 0.0018621304770931602
about O 0 0.0012796497903764248
the O 0 0.0016591839957982302
molecular O 0 0.0030932454392313957
events O 0 0.002334780525416136
involved O 0 0.00245493883267045
in O 0 0.002869264455512166
the O 0 0.0059274486266076565
expansion O 0 0.022063355892896652
mutation O 0 0.02103915810585022
. O 0 0.014125727117061615

To O 0 0.00833018310368061
investigate O 0 0.01029363926500082
whether O 0 0.005086441989988089
a O 0 0.00577044440433383
founder O 0 0.0313410721719265
chromosome O 0 0.009863859973847866
for O 0 0.0034919059835374355
the O 0 0.016443083062767982
DM B-Disease 1 1.0
mutation O 0 0.007449532859027386
exists O 0 0.0027002652641385794
in O 0 0.001514084287919104
the O 0 0.002341585699468851
Japanese O 0 0.007632351014763117
population O 0 0.0021309838630259037
, O 0 0.0017740946495905519
we O 0 0.0016472026472911239
genotyped O 0 0.009867650456726551
families O 0 0.0021406409796327353
using O 0 0.002085366751998663
polymorphic O 0 0.00997347105294466
markers O 0 0.010511132888495922
near O 0 0.00858338363468647
the O 0 0.0058547877706587315
( O 0 0.010041318833827972
CTG O 1 0.9988718628883362
) O 0 0.004834456834942102
n O 0 0.008503975346684456
repeat O 0 0.010070838034152985
region O 0 0.005858412943780422
and O 0 0.004866705741733313
constructed O 0 0.08256212621927261
haplotypes O 0 0.1086912676692009
. O 0 0.01755043864250183

Six O 0 0.008674525655806065
different O 0 0.0034804660826921463
haplotypes O 0 0.013873024843633175
were O 0 0.0035461108200252056
found O 0 0.005055638495832682
and O 0 0.008787316270172596
DM B-Disease 1 1.0
alleles O 0 0.01950613223016262
were O 0 0.004840537440031767
always O 0 0.007872109301388264
haplotype O 0 0.028827328234910965
A O 0 0.018113544210791588
. O 0 0.01647009700536728

To O 0 0.0061238957569003105
find O 0 0.004303211346268654
an O 0 0.0021754982881247997
origin O 0 0.0028976898174732924
of O 0 0.003528811503201723
the O 0 0.006338116712868214
( O 0 0.010458728298544884
CTG O 1 0.9985330104827881
) O 0 0.005031776148825884
n O 0 0.008089630864560604
repeat O 0 0.008694320917129517
mutation O 0 0.004218139220029116
and O 0 0.0014598652487620711
to O 0 0.001562147052027285
investigate O 0 0.004274137783795595
the O 0 0.0030114755500108004
mechanism O 0 0.003956098575145006
of O 0 0.00228401948697865
the O 0 0.0027540172450244427
expansion O 0 0.004829456098377705
mutation O 0 0.003046993166208267
in O 0 0.0014276786241680384
the O 0 0.002267897129058838
Japanese O 0 0.006052233278751373
population O 0 0.001271645538508892
we O 0 0.0008298655156977475
have O 0 0.0006238854839466512
studied O 0 0.0034184125252068043
90 O 0 0.004457985516637564
Japanese O 0 0.08572440594434738
DM B-Disease 1 0.9999996423721313
families O 0 0.0045524234883487225
comprising O 0 0.005467724055051804
190 O 0 0.009073389694094658
affected O 0 0.004543613642454147
and O 0 0.0030944482423365116
130 O 0 0.01021043211221695
unaffected O 0 0.02018810622394085
members O 0 0.007429684512317181
. O 0 0.011748330667614937

The O 0 0.010100855492055416
results O 0 0.00536287622526288
suggest O 0 0.003446637885645032
that O 0 0.001159567735157907
a O 0 0.0019751349464058876
few O 0 0.0018841056153178215
common O 0 0.003228131914511323
ancestral O 0 0.0168205127120018
mutations O 0 0.004286666866391897
in O 0 0.0023472090251743793
both O 0 0.002348503330722451
Caucasian O 1 0.9765626788139343
and O 0 0.0028829993680119514
Japanese O 0 0.09806177765130997
populations O 0 0.002533705672249198
have O 0 0.0010595794301480055
originated O 0 0.0027431310154497623
by O 0 0.001034880755469203
expansion O 0 0.0025421385653316975
of O 0 0.0019446578808128834
an O 0 0.0027576168067753315
ancestral O 0 0.01793813891708851
n O 0 0.009465627372264862
= O 0 0.006810297723859549
5 O 0 0.003179222345352173
repeat O 0 0.005090951453894377
to O 0 0.0020770300179719925
n O 0 0.007876579649746418
= O 0 0.010832590982317924
19 O 0 0.007120403461158276
- O 0 0.009446283802390099
37 O 0 0.010551276616752148
copies O 0 0.009865996427834034
. O 0 0.010043716989457607

These O 0 0.006467603612691164
data O 0 0.005015152972191572
support O 0 0.005355972796678543
multistep O 0 0.019222695380449295
models O 0 0.006531129125505686
of O 0 0.006771345157176256
triplet O 1 0.9885970950126648
repeat O 0 0.026840930804610252
expansion O 0 0.0047788312658667564
that O 0 0.0009743079426698387
have O 0 0.0006906967610120773
been O 0 0.001146324910223484
proposed O 0 0.001700831577181816
for O 0 0.0018231518333777785
both O 0 0.005006301682442427
DM B-Disease 1 1.0
and O 0 0.2058364748954773
Friedreichs B-Disease 1 0.999998927116394
ataxia I-Disease 1 0.9999995231628418
. O 0 0.01537964679300785
. O 0 0.01700209267437458

The O 0 0.009624576196074486
molecular O 0 0.008715330623090267
basis O 0 0.006182987708598375
of O 1 0.8987822532653809
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.007763436995446682
the O 0 0.0072276294231414795
western O 0 0.007369772996753454
Cape O 0 0.04877575859427452
, O 0 0.005883469246327877
South O 0 0.01300986297428608
Africa O 0 0.01784917153418064
. O 0 0.011819039471447468

Deficiency B-Disease 1 0.9999983310699463
of I-Disease 0 0.017425421625375748
the I-Disease 0 0.017764374613761902
sixth I-Disease 1 0.9733763337135315
component I-Disease 0 0.010250701569020748
of I-Disease 0 0.004160167183727026
human I-Disease 0 0.006981419399380684
complement I-Disease 0 0.1496490091085434
( O 0 0.1544228345155716
C6 O 1 0.9999960660934448
) O 0 0.0034351428039371967
has O 0 0.002108949236571789
been O 0 0.0019422197947278619
reported O 0 0.002689001616090536
in O 0 0.001400007400661707
a O 0 0.0015563121996819973
number O 0 0.0012189290719106793
of O 0 0.0015593931311741471
families O 0 0.002033765660598874
from O 0 0.0018419156549498439
the O 0 0.0030229189433157444
western O 0 0.005586098413914442
Cape O 0 0.0301643218845129
, O 0 0.006902399472892284
South O 0 0.014782587997615337
Africa O 0 0.019904479384422302
. O 0 0.01388393621891737

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.4284789562225342
endemic O 1 0.9985660910606384
in O 0 0.004441728815436363
the O 0 0.004979070276021957
Cape O 0 0.013343566097319126
and O 0 0.0019326885230839252
almost O 0 0.0016939821653068066
all O 0 0.0014909221790730953
pedigrees O 0 0.008428115397691727
of O 0 0.006400435697287321
total O 1 0.9879315495491028
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9997085928916931
C6Q0 O 1 0.9999984502792358
) O 0 0.0028051601257175207
have O 0 0.0010550754377618432
been O 0 0.0018735977355390787
ascertained O 0 0.008353285491466522
because O 0 0.00365250906907022
of O 0 0.23370447754859924
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.8755802512168884

We O 0 0.006228425074368715
have O 0 0.0025209852028638124
sequenced O 0 0.005440858658403158
the O 0 0.0023667721543461084
expressed O 0 0.0036223705392330885
exons O 0 0.006887432187795639
of O 0 0.0034971595741808414
the O 0 0.021854177117347717
C6 O 1 0.9999984502792358
gene O 0 0.004504833370447159
from O 0 0.0016765998443588614
selected O 0 0.0022810096852481365
cases O 0 0.0019672606140375137
and O 0 0.0012489394284784794
have O 0 0.0008194052497856319
found O 0 0.00144249910954386
three O 0 0.0017138230614364147
molecular O 0 0.009816971607506275
defects O 1 0.9999126195907593
leading O 0 0.264019250869751
to O 0 0.004454829264432192
total O 1 0.8611253499984741
deficiency O 1 1.0
879delG O 1 0.9999933242797852
, O 0 0.0023052841424942017
which O 0 0.0009046854684129357
is O 0 0.001187506248243153
the O 0 0.0020686620846390724
common O 0 0.004112918395549059
defect O 1 0.9906540513038635
in O 0 0.0024704893585294485
the O 0 0.004106948152184486
Cape O 0 0.45842689275741577
and O 0 0.002704748185351491
hitherto O 0 0.023782068863511086
unreported O 0 0.014698460698127747
, O 0 0.003182442858815193
and O 0 0.0030442047864198685
1195delC O 1 0.9512730240821838
and O 0 0.004260356072336435
1936delG O 1 0.9943205118179321
, O 0 0.002818972570821643
which O 0 0.0009625343955121934
have O 0 0.0008539886912330985
been O 0 0.0012339154491201043
previously O 0 0.002711790380999446
reported O 0 0.0033785433042794466
in O 0 0.00303248199634254
African O 0 0.04113253578543663
- O 0 0.030337799340486526
Americans O 0 0.01055583730340004
. O 0 0.010738925077021122

We O 0 0.007489043287932873
also O 0 0.004276941064745188
show O 0 0.004020743537694216
that O 0 0.0019366908818483353
the O 0 0.004900448489934206
879delG O 1 0.8842033743858337
and O 0 0.007421849761158228
1195delC O 1 0.9999659061431885
defects O 1 0.9998898506164551
are O 0 0.002182409167289734
associated O 0 0.0043380954302847385
with O 0 0.0046390448696911335
characteristic O 1 0.9999434947967529
C6 O 1 1.0
/ O 1 0.9999984502792358
C7 O 1 0.9999994039535522
region O 0 0.027266625314950943
DNA O 0 0.016138488426804543
marker O 0 0.11129142343997955
haplotypes O 0 0.015931017696857452
, O 0 0.003142469795420766
although O 0 0.0020218444988131523
small O 0 0.0021504671312868595
variations O 0 0.005019273143261671
were O 0 0.004854468163102865
observed O 0 0.011113074608147144
. O 0 0.012112748809158802

The O 0 0.02665700949728489
1936delG O 1 0.999922513961792
defect O 1 0.9998680353164673
was O 0 0.016161946579813957
observed O 0 0.003030720865353942
only O 0 0.001224128995090723
once O 0 0.0020901672542095184
in O 0 0.001497337594628334
the O 0 0.00298339338041842
Cape O 0 0.017688388004899025
, O 0 0.0022374633699655533
but O 0 0.0013603356201201677
its O 0 0.001952774589881301
associated O 0 0.004302001092582941
haplotype O 0 0.013399568386375904
could O 0 0.003164265537634492
be O 0 0.004172218963503838
deduced O 0 0.026528609916567802
. O 0 0.013131864368915558

The O 0 0.00914656464010477
data O 0 0.004201491829007864
from O 0 0.002716075163334608
the O 0 0.0034530439879745245
haplotypes O 0 0.009745786897838116
indicate O 0 0.002388599794358015
that O 0 0.0009106927900575101
these O 0 0.000807552132755518
three O 0 0.001760053331963718
molecular O 0 0.006982778199017048
defects O 1 0.9545854926109314
account O 0 0.002639944665133953
for O 0 0.002109565306454897
the O 0 0.005813149269670248
defects O 1 0.9996609687805176
in O 0 0.0024487038608640432
all O 0 0.0015017498517408967
the O 0 0.003027434926480055
38 O 0 0.007721638772636652
unrelated O 0 0.010557122528553009
C6Q0 O 1 0.9562557339668274
individuals O 0 0.002014992292970419
we O 0 0.00145050510764122
have O 0 0.0009801797568798065
studied O 0 0.003911117557436228
from O 0 0.0036091459915041924
the O 0 0.008982512168586254
Cape O 1 0.5025781989097595
. O 0 0.015648555010557175

We O 0 0.007098564878106117
have O 0 0.002600634703412652
also O 0 0.0026864937972277403
observed O 0 0.003233090043067932
the O 0 0.004043038468807936
879delG O 1 0.526409924030304
defect O 0 0.12459966540336609
in O 0 0.0031123561784625053
two O 0 0.003626561490818858
Dutch O 1 0.9997937083244324
C6 B-Disease 1 1.0
- I-Disease 1 0.9999853372573853
deficient I-Disease 1 0.999992847442627
kindreds O 0 0.03503837808966637
, O 0 0.003087468910962343
but O 0 0.0018219139892607927
the O 0 0.0037752825301140547
879delG O 1 0.9983388185501099
defect O 1 0.9963654279708862
in O 0 0.003364243544638157
the O 0 0.005792983807623386
Cape O 1 0.7794111371040344
probably O 0 0.0035439447965472937
did O 0 0.001533740432932973
not O 0 0.0006974124116823077
come O 0 0.0011519151739776134
from O 0 0.0016486271051689982
The O 0 0.004255843348801136
Netherlands O 0 0.012184315361082554
. O 0 0.005865124985575676
. O 0 0.010690528899431229

Complement B-Disease 1 0.9998780488967896
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.0124333081766963
seven O 0 0.006371067371219397
further O 0 0.0052251750603318214
molecular O 0 0.19985465705394745
defects O 1 0.9998492002487183
and O 0 0.003208454232662916
their O 0 0.0032817674800753593
associated O 0 0.015110517852008343
marker O 1 0.9955629110336304
haplotypes O 0 0.31261059641838074
. O 0 0.012652522884309292

Seven O 0 0.010102811269462109
further O 0 0.005304480902850628
molecular O 0 0.010356195271015167
bases O 0 0.012112588621675968
of O 1 0.9878807067871094
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.010119248181581497
described O 0 0.10180681943893433
. O 0 0.01679857447743416

All O 0 0.00490845600143075
these O 0 0.0026760229375213385
new O 0 0.004590622149407864
molecular O 0 0.013246235437691212
defects O 1 0.9752187132835388
involve O 0 0.008906841278076172
single O 0 0.009310747496783733
- O 0 0.014679158106446266
nucleotide O 0 0.006937373895198107
events O 0 0.002915679244324565
, O 0 0.0022526017855852842
deletions O 0 0.005994962062686682
and O 0 0.0021836047526448965
substitutions O 0 0.005068270489573479
, O 0 0.0020332334097474813
some O 0 0.001163546578027308
of O 0 0.002223879797384143
which O 0 0.0024236964527517557
alter O 0 0.009123352356255054
splice O 0 0.014914109371602535
sites O 0 0.0040116626769304276
, O 0 0.00327429105527699
and O 0 0.003558149328455329
others O 0 0.008107208646833897
codons O 0 0.03417132794857025
. O 0 0.014736849814653397

They O 0 0.00426067179068923
are O 0 0.002062068320810795
distributed O 0 0.003783091902732849
along O 0 0.0048214141279459
the O 0 0.008621317334473133
C7 O 1 0.9999992847442627
gene O 0 0.00617551151663065
, O 0 0.002140902914106846
but O 0 0.0012838250258937478
predominantly O 0 0.0025468291714787483
towards O 0 0.0036895805969834328
the O 0 0.004600944463163614
3 O 0 0.009712589904665947
end O 0 0.010658562183380127
. O 0 0.011266153305768967

All O 0 0.005103395786136389
were O 0 0.0034739128313958645
found O 0 0.003612242406234145
in O 0 0.004195486661046743
compound O 0 0.02232743613421917
heterozygous O 0 0.01677309162914753
individuals O 0 0.006608646363019943
. O 0 0.011040824465453625

The O 1 0.8211726546287537
C6 O 1 0.9999998807907104
/ O 1 0.9999845027923584
C7 O 1 0.9999943971633911
marker O 1 0.7785655856132507
haplotypes O 0 0.029019393026828766
associated O 0 0.0068878172896802425
with O 0 0.004573644604533911
most O 0 0.014441180042922497
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999959468841553
are O 0 0.004751394037157297
tabulated O 0 0.027906421571969986
. O 0 0.007308684755116701
. O 0 0.010517819784581661

A O 0 0.026572033762931824
genome O 0 0.020193317905068398
- O 0 0.010394561104476452
wide O 0 0.003838873002678156
search O 0 0.004161989316344261
for O 0 0.004024449735879898
chromosomal O 0 0.1502881944179535
loci O 0 0.09856899082660675
linked O 0 0.03745507448911667
to O 0 0.005751203279942274
mental O 1 0.9999997615814209
health O 1 0.9999773502349854
wellness O 1 0.9999523162841797
in O 0 0.0037976689636707306
relatives O 0 0.0059292814694345
at O 0 0.004299722611904144
high O 0 0.011778363958001137
risk O 0 0.4686688482761383
for O 0 0.3256073296070099
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.8914552330970764
the O 1 0.8969448208808899
Old O 1 0.9977364540100098
Order O 0 0.014449766837060452
Amish O 0 0.05761414021253586
. O 0 0.013598431833088398

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999997615814209
BPAD B-Disease 1 1.0
; O 1 0.999963641166687
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.38655102252960205
is O 0 0.0028964022640138865
characterized O 0 0.005772641394287348
by O 0 0.0017686707433313131
episodes O 0 0.006547757890075445
of O 0 0.12948451936244965
mania B-Disease 1 1.0
and O 1 0.9267854690551758
/ O 1 0.9999725818634033
or O 0 0.009562289342284203
hypomania B-Disease 1 0.9999933242797852
interspersed O 0 0.019579941406846046
with O 0 0.003951310180127621
periods O 0 0.018014268949627876
of O 1 0.9037563800811768
depression B-Disease 1 1.0
. O 0 0.26631399989128113

Compelling O 0 0.018053239211440086
evidence O 0 0.007716401480138302
supports O 0 0.0065634530037641525
a O 0 0.00348174967803061
significant O 0 0.003562610363587737
genetic O 0 0.004893154371529818
component O 0 0.007028607651591301
in O 0 0.003003794467076659
the O 0 0.006080069113522768
susceptibility O 1 0.5841500163078308
to O 0 0.00652419263496995
develop O 0 0.20025552809238434
BPAD B-Disease 1 0.9999974966049194
. O 0 0.026249093934893608

To O 0 0.008926802314817905
date O 0 0.009320243261754513
, O 0 0.004714071284979582
however O 0 0.0037116475868970156
, O 0 0.003538158256560564
linkage O 0 0.007873465307056904
studies O 0 0.002979196375235915
have O 0 0.0011682771146297455
attempted O 0 0.0035772076807916164
only O 0 0.0015736761270090938
to O 0 0.0018595654983073473
identify O 0 0.005811418406665325
chromosomal O 1 0.7289578914642334
loci O 0 0.019154902547597885
that O 0 0.0023173729423433542
cause O 0 0.007243495434522629
or O 0 0.002433421090245247
increase O 0 0.002799148205667734
the O 0 0.0043402258306741714
risk O 0 0.008501268923282623
of O 0 0.010698460042476654
developing O 1 0.9927954077720642
BPAD B-Disease 1 0.9999995231628418
. O 0 0.022774070501327515

To O 0 0.00618134718388319
determine O 0 0.004987737629562616
whether O 0 0.0026877974160015583
there O 0 0.0020367468241602182
could O 0 0.0018966681091114879
be O 0 0.002067317720502615
protective O 0 0.013246815651655197
alleles O 0 0.005379812326282263
that O 0 0.0016035333974286914
prevent O 0 0.004872034303843975
or O 0 0.0025741446297615767
reduce O 0 0.004362145904451609
the O 0 0.0031802256125956774
risk O 0 0.007602555677294731
of O 0 0.005151357036083937
developing O 1 0.9057305455207825
BPAD B-Disease 1 0.9999997615814209
, O 0 0.00208492623642087
similar O 0 0.0012044560862705112
to O 0 0.0010005001677200198
what O 0 0.0010417760349810123
is O 0 0.0010115312179550529
observed O 0 0.001301607466302812
in O 0 0.0012862324947491288
other O 0 0.002142455894500017
genetic B-Disease 1 0.9998195767402649
disorders I-Disease 1 1.0
, O 0 0.10999666154384613
we O 0 0.0033121174201369286
used O 0 0.0108611099421978
mental O 1 1.0
health O 1 0.999997615814209
wellness O 1 0.9999991655349731
( O 0 0.0074281408451497555
absence O 0 0.006303608883172274
of O 0 0.004988204222172499
any O 0 0.011433424428105354
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.0536377988755703
as O 0 0.002507355296984315
the O 0 0.003214182797819376
phenotype O 0 0.0056997560895979404
in O 0 0.0019439936149865389
our O 0 0.0033288178965449333
genome O 0 0.007712288293987513
- O 0 0.0066406275145709515
wide O 0 0.003459544852375984
linkage O 0 0.00824043806642294
scan O 0 0.005884883459657431
of O 0 0.002041138242930174
several O 0 0.0018680832581594586
large O 0 0.0038895225152373314
multigeneration O 0 0.4396398961544037
Old O 0 0.014962918125092983
Order O 0 0.006206531077623367
Amish O 0 0.019999895244836807
pedigrees O 0 0.016760868951678276
exhibiting O 0 0.01255747303366661
an O 0 0.004503033123910427
extremely O 0 0.013929487206041813
high O 0 0.020088113844394684
incidence O 1 0.997634768486023
of O 1 0.5942592620849609
BPAD B-Disease 1 0.9999998807907104
. O 0 0.030886705964803696

We O 0 0.0090099535882473
have O 0 0.002726432867348194
found O 0 0.0029306053183972836
strong O 0 0.002563439542427659
evidence O 0 0.0025862210895866156
for O 0 0.0019414712442085147
a O 0 0.004386770073324442
locus O 0 0.015868816524744034
on O 0 0.006052738521248102
chromosome O 0 0.016654761508107185
4p O 0 0.21920591592788696
at O 0 0.008385899476706982
D4S2949 O 0 0.04294202849268913
( O 0 0.007007182110100985
maximum O 0 0.009748570621013641
GENEHUNTER O 1 0.9988383650779724
- O 0 0.016079848632216454
PLUS O 0 0.013599325902760029
nonparametric O 0 0.024233952164649963
linkage O 0 0.012430468574166298
score O 0 0.005516185890883207
= O 0 0.009677539579570293
4 O 0 0.00468985503539443
. O 0 0.0025250292383134365
05 O 0 0.019543806090950966
, O 0 0.005152515135705471
P O 0 0.018067732453346252
= O 0 0.007682163733989
5 O 0 0.0029249584767967463
. O 0 0.001235569710843265
22 O 0 0.0028971622232347727
x O 0 0.004563308320939541
10 O 0 0.0032212284859269857
( O 0 0.0040381792932748795
- O 0 0.005894554778933525
4 O 0 0.00440689641982317
) O 0 0.003022808115929365
; O 0 0.002908339723944664
SIBPAL O 0 0.03906024619936943
Pempirical O 0 0.0259773638099432
value O 0 0.004850751720368862
< O 0 0.010608297772705555
3 O 0 0.0038441591896116734
x O 0 0.00431648688390851
10 O 0 0.0028945805970579386
( O 0 0.0038850191049277782
- O 0 0.006469355896115303
5 O 0 0.004199325572699308
) O 0 0.0024756016209721565
) O 0 0.0018876743270084262
and O 0 0.0014877446228638291
suggestive O 0 0.0066911508329212666
evidence O 0 0.0025130792055279016
for O 0 0.0021661752834916115
a O 0 0.004592342302203178
locus O 0 0.015079827979207039
on O 0 0.0056658582761883736
chromosome O 0 0.015332314185798168
4q O 0 0.3767116367816925
at O 0 0.01005653664469719
D4S397 O 0 0.1462172418832779
( O 0 0.0071585513651371
maximum O 0 0.009905590675771236
GENEHUNTER O 1 0.9895542860031128
- O 0 0.01568962261080742
PLUS O 0 0.012995071709156036
nonparametric O 0 0.020882420241832733
linkage O 0 0.010993162170052528
score O 0 0.004394152667373419
= O 0 0.006525222212076187
3 O 0 0.0028216224163770676
. O 0 0.001539140474051237
29 O 0 0.003919515758752823
, O 0 0.002978184027597308
P O 0 0.015205311588943005
= O 0 0.0065393890254199505
2 O 0 0.0029625892639160156
. O 0 0.001254269969649613
57 O 0 0.004405930172652006
x O 0 0.004247833508998156
10 O 0 0.002847043564543128
( O 0 0.0036055296659469604
- O 0 0.005232818890362978
3 O 0 0.0031533557921648026
) O 0 0.002080524107441306
; O 0 0.0021828939206898212
SIBPAL O 0 0.02996787056326866
Pempirical O 0 0.025738392025232315
value O 0 0.00477792602032423
< O 0 0.010976212099194527
1 O 0 0.004371747374534607
x O 0 0.004704184364527464
10 O 0 0.002934438409283757
( O 0 0.0034876808058470488
- O 0 0.005099847447127104
3 O 0 0.003268494503572583
) O 0 0.0019311134237796068
) O 0 0.0012510349042713642
that O 0 0.0008438873337581754
are O 0 0.001232272363267839
linked O 0 0.007268342189490795
to O 0 0.006708582863211632
mental O 1 0.9999998807907104
health O 1 0.9999995231628418
wellness O 1 0.9999998807907104
. O 0 0.07671330869197845

These O 0 0.005773128475993872
findings O 0 0.005838064476847649
are O 0 0.00207025115378201
consistent O 0 0.004333731718361378
with O 0 0.0016423934139311314
the O 0 0.0028681389521807432
hypothesis O 0 0.005250449758023024
that O 0 0.0015553004341199994
certain O 0 0.002071184804663062
alleles O 0 0.005013674963265657
could O 0 0.0017798428889364004
prevent O 0 0.0038860950153321028
or O 0 0.0020371144637465477
modify O 0 0.004662437364459038
the O 0 0.0032067634165287018
clinical O 1 0.9371286630630493
manifestations O 1 0.9982231259346008
of O 1 0.9796774983406067
BPAD B-Disease 1 1.0
and O 0 0.0051030321046710014
perhaps O 0 0.005454163532704115
other O 0 0.004030788782984018
related O 1 0.9356520175933838
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9859316349029541

Segregation O 1 0.9997316002845764
distortion O 1 0.9999372959136963
in O 1 0.9983689188957214
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9906257390975952

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999990463256836
DM B-Disease 1 1.0
) O 0 0.009778901934623718
is O 0 0.0036102745216339827
an O 0 0.005370305851101875
autosomal B-Disease 1 0.9999991655349731
dominant I-Disease 1 0.9999973773956299
disease I-Disease 1 1.0
which O 0 0.00439574895426631
, O 0 0.002792931394651532
in O 0 0.0020807478576898575
the O 0 0.00296131637878716
typical O 0 0.007532771676778793
pedigree O 0 0.009270657785236835
, O 0 0.002262911293655634
shows O 0 0.002438725670799613
a O 0 0.0025623447727411985
three O 0 0.003521023318171501
generation O 0 0.015642179176211357
anticipation O 0 0.026208143681287766
cascade O 0 0.10137995332479477
. O 0 0.016059620305895805

This O 0 0.005887762643396854
results O 0 0.006295251660048962
in O 0 0.00984306912869215
infertility B-Disease 1 1.0
and O 1 0.9999954700469971
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.0035660939756780863
with O 0 0.0014000422088429332
the O 0 0.002901438158005476
disappearance O 0 0.07297448813915253
of O 1 0.570772647857666
DM B-Disease 1 1.0
in O 0 0.009392274543642998
that O 0 0.006491359323263168
pedigree O 0 0.033255208283662796
. O 0 0.013099134899675846

The O 0 0.010933732613921165
concept O 0 0.010184328071773052
of O 0 0.008374211378395557
segregation O 1 0.9995229244232178
distortion O 1 0.9919785261154175
, O 0 0.004187780898064375
where O 0 0.002952407579869032
there O 0 0.002452429383993149
is O 0 0.0027704699896275997
preferential O 0 0.008313785307109356
transmission O 0 0.0055767567828297615
of O 0 0.0026107681915163994
the O 0 0.0035929724108427763
larger O 0 0.003543927799910307
allele O 0 0.005862602964043617
at O 0 0.005323462188243866
the O 0 0.01226434763520956
DM B-Disease 1 1.0
locus O 1 0.7200586199760437
, O 0 0.004271483514457941
has O 0 0.0025997997727245092
been O 0 0.002081636106595397
put O 0 0.0024125573690980673
forward O 0 0.0020147734321653843
to O 0 0.0012581892078742385
explain O 0 0.0038915311452001333
partially O 0 0.005490321200340986
the O 0 0.003953960724174976
maintenance O 1 0.9537815451622009
of O 1 0.5720911622047424
DM B-Disease 1 1.0
in O 0 0.005874465219676495
the O 0 0.006044402252882719
population O 0 0.006670462898910046
. O 0 0.009973743930459023

In O 0 0.007647383492439985
a O 0 0.005781899206340313
survey O 0 0.007335368078202009
of O 0 0.009255451150238514
DM B-Disease 1 0.9999998807907104
in O 0 0.004802776034921408
Northern O 0 0.005341381300240755
Ireland O 0 0.00531074358150363
, O 0 0.004589822608977556
59 O 0 0.013156749308109283
pedigrees O 0 0.020584968850016594
were O 0 0.00820513628423214
ascertained O 0 0.0401507243514061
. O 0 0.018693143501877785

Sibships O 0 0.34928902983665466
where O 0 0.0068435086868703365
the O 0 0.0042119622230529785
status O 0 0.003525610314682126
of O 0 0.002369154943153262
all O 0 0.001324786338955164
the O 0 0.002155449939891696
members O 0 0.0016001375624909997
had O 0 0.002412858186289668
been O 0 0.0018068368081003428
identified O 0 0.002175288973376155
were O 0 0.0011994197266176343
examined O 0 0.002835944527760148
to O 0 0.0008829860598780215
determine O 0 0.0015056824777275324
the O 0 0.0019204177660867572
transmission O 0 0.0039758882485330105
of O 0 0.0027645716909319162
the O 0 0.016629397869110107
DM B-Disease 1 1.0
expansion O 0 0.008320922963321209
from O 0 0.002611554227769375
affected O 0 0.004054388031363487
parents O 0 0.0031523830257356167
to O 0 0.0023916445206850767
their O 0 0.003873024135828018
offspring O 0 0.02130790613591671
. O 0 0.012416358105838299

Where O 0 0.013030960224568844
the O 0 0.011767735704779625
transmitting O 0 0.09581625461578369
parent O 0 0.025079654529690742
was O 0 0.02694331295788288
male O 0 0.011998280882835388
, O 0 0.00699028093367815
58 O 0 0.02340857870876789
. O 0 0.013393579050898552

3 O 0 0.012007509358227253
% O 0 0.004184889607131481
of O 0 0.0028957603499293327
the O 0 0.004125860519707203
offspring O 0 0.008475643582642078
were O 0 0.0029989092145115137
affected O 0 0.0037411032244563103
, O 0 0.0016868846723809838
and O 0 0.0011436946224421263
in O 0 0.0012329849414527416
the O 0 0.0018825683509930968
case O 0 0.00267540430650115
of O 0 0.0025598262436687946
a O 0 0.004632063675671816
female O 0 0.01408347673714161
transmitting O 0 0.2932739853858948
parent O 0 0.014097016304731369
, O 0 0.006352584343403578
68 O 0 0.023332322016358376
. O 0 0.012558773159980774

7 O 0 0.03303353115916252
% O 0 0.014445135369896889
were O 0 0.010222709737718105
affected O 0 0.020364589989185333
. O 0 0.018374286592006683

Studies O 0 0.014735756441950798
on O 0 0.010449114255607128
meiotic O 1 0.9979683756828308
drive O 0 0.018668370321393013
in O 0 0.014786089770495892
DM B-Disease 1 1.0
have O 0 0.0034031071700155735
shown O 0 0.0041546630673110485
increased O 0 0.003388829994946718
transmission O 0 0.00426106434315443
of O 0 0.002185640623793006
the O 0 0.0029771223198622465
larger O 0 0.002685736631974578
allele O 0 0.004598259460180998
at O 0 0.0044458042830228806
the O 0 0.006883695721626282
DM B-Disease 1 0.9999995231628418
locus O 0 0.02574293687939644
in O 0 0.005761333275586367
non O 1 0.8285040855407715
- O 1 0.9999141693115234
DM O 1 1.0
heterozygotes O 1 0.9794101715087891
for O 0 0.009622180834412575
CTGn O 1 0.9945151805877686
. O 0 0.016293656080961227

This O 0 0.005497128237038851
study O 0 0.005086485296487808
provides O 0 0.0035437389742583036
further O 0 0.002177746267989278
evidence O 0 0.0027978147845715284
that O 0 0.002236071275547147
the O 0 0.007543441839516163
DM B-Disease 1 0.9999998807907104
expansion O 0 0.011586500331759453
tends O 0 0.007792531978338957
to O 0 0.0026507109869271517
be O 0 0.003630423452705145
transmitted O 0 0.015293530188500881
preferentially O 0 0.022488126531243324
. O 0 0.012126816436648369

Diagnosis O 1 0.999997615814209
of O 1 0.9991415739059448
hemochromatosis B-Disease 1 1.0
. O 1 0.9064034223556519

If O 0 0.032507482916116714
untreated O 1 0.9999996423721313
, O 1 0.9820246696472168
hemochromatosis B-Disease 1 1.0
can O 0 0.2813286781311035
cause O 1 0.9999527931213379
serious O 1 0.9999980926513672
illness O 1 1.0
and O 0 0.07633265852928162
early B-Disease 0 0.03070366568863392
death I-Disease 1 0.6655257940292358
, O 0 0.0016712840879336
but O 0 0.0011831872398033738
the O 0 0.004643256310373545
disease O 1 0.9999996423721313
is O 0 0.003393340390175581
still O 0 0.0038855504244565964
substantially O 0 0.00904620997607708
under O 0 0.05156141519546509
- O 1 0.9999006986618042
diagnosed O 1 1.0
. O 0 0.018985513597726822

The O 0 0.016217175871133804
cornerstone O 1 0.7831971049308777
of O 0 0.010883046314120293
screening O 0 0.014713024720549583
and O 0 0.003973913379013538
case O 0 0.006684271618723869
detection O 0 0.008337796665728092
is O 0 0.003568669082596898
the O 0 0.004051347728818655
measurement O 0 0.010354896076023579
of O 0 0.010661217384040356
serum O 1 0.9996192455291748
transferrin O 1 0.8521808385848999
saturation O 0 0.01985265128314495
and O 0 0.005049089435487986
the O 0 0.011322339065372944
serum O 1 0.9957727789878845
ferritin O 1 0.9834746718406677
level O 0 0.02130073681473732
. O 0 0.015251241624355316

Once O 0 0.024774473160505295
the O 0 0.015159114263951778
diagnosis O 1 0.9999755620956421
is O 0 0.007358946371823549
suspected O 0 0.02250329591333866
, O 0 0.003853810951113701
physicians O 0 0.009733765386044979
must O 0 0.003653849009424448
use O 0 0.005390687845647335
serum O 1 0.9955995082855225
ferritin O 1 0.9989803433418274
levels O 0 0.011042429134249687
and O 0 0.00721342395991087
hepatic O 1 0.9999967813491821
iron O 1 0.9999961853027344
stores O 0 0.04052489995956421
on O 0 0.16247114539146423
liver O 1 0.9999996423721313
biopsy O 1 0.9998563528060913
specimens O 0 0.008369816467165947
to O 0 0.0026875161565840244
assess O 0 0.006936982274055481
patients O 0 0.005753745324909687
for O 0 0.001537242205813527
the O 0 0.0029265827033668756
presence O 0 0.005674170795828104
of O 0 0.023589033633470535
iron B-Disease 1 0.9999998807907104
overload I-Disease 1 0.9999973773956299
. O 0 0.023726539686322212

Liver O 1 1.0
biopsy O 1 0.9999978542327881
is O 0 0.008130359463393688
also O 0 0.002435883041471243
used O 0 0.001336898421868682
to O 0 0.0009719441877678037
establish O 0 0.0022349790669977665
the O 0 0.0017655560513958335
presence O 0 0.002700039418414235
or O 0 0.0019327887566760182
absence O 0 0.008640378713607788
of O 1 0.6503960490226746
cirrhosis B-Disease 1 1.0
, O 0 0.1948469877243042
which O 0 0.003263493301346898
can O 0 0.002816825872287154
affect O 0 0.009433054365217686
prognosis O 1 0.9999885559082031
and O 0 0.009852754883468151
management O 1 0.5726113319396973
. O 0 0.018173562362790108

A O 0 0.023560330271720886
DNA O 0 0.012861629016697407
- O 0 0.008091640658676624
based O 0 0.002712464891374111
test O 0 0.0029054181650280952
for O 0 0.002131171291694045
the O 0 0.005356099922209978
HFE O 1 0.9999809265136719
gene O 0 0.006212431471794844
is O 0 0.0021334774792194366
commercially O 0 0.0032172121573239565
available O 0 0.0015677213668823242
, O 0 0.0013538321945816278
but O 0 0.0008094689110293984
its O 0 0.0008991807699203491
place O 0 0.0017158768605440855
in O 0 0.001734484569169581
the O 0 0.004072132986038923
diagnosis O 1 0.9999912977218628
of O 1 0.9978334307670593
hemochromatosis B-Disease 1 1.0
is O 0 0.30809319019317627
still O 0 0.008220127783715725
being O 0 0.008531979285180569
evaluated O 0 0.023173565044999123
. O 0 0.013438417576253414

Currently O 0 0.01209085714071989
, O 0 0.0041542863473296165
the O 0 0.002844809554517269
most O 0 0.0016040167538449168
useful O 0 0.0025947813410311937
role O 0 0.002623399021103978
for O 0 0.001364109106361866
this O 0 0.0011605367762967944
test O 0 0.0018064944306388497
is O 0 0.0011604450410231948
in O 0 0.0011809364659711719
the O 0 0.0018993158591911197
detection O 0 0.006247751880437136
of O 0 0.009423640556633472
hemochromatosis B-Disease 1 1.0
in O 0 0.004488666541874409
the O 0 0.0035190817434340715
family O 0 0.003773708129301667
members O 0 0.0014765852829441428
of O 0 0.0023455580230802298
patients O 1 0.7639094591140747
with O 0 0.0014627304626628757
a O 0 0.003666793927550316
proven O 0 0.009121646173298359
case O 0 0.003704576753079891
of O 0 0.006688360124826431
the O 1 0.788240909576416
disease O 1 1.0
. O 0 0.01890360750257969

It O 0 0.006645633839070797
is O 0 0.005087504629045725
crucial O 0 0.008656910620629787
to O 0 0.00737743778154254
diagnose O 1 0.9999997615814209
hemochromatosis B-Disease 1 1.0
before O 1 0.9999879598617554
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999998807907104
because O 1 0.977354109287262
phlebotomy O 1 1.0
therapy O 1 0.9999967813491821
can O 0 0.006299261469393969
avert O 1 0.9999967813491821
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.915435791015625
can O 0 0.0017326270462945104
even O 0 0.001462453161366284
lead O 0 0.0020618769340217113
to O 0 0.001502672559581697
normal O 0 0.004162285476922989
life O 0 0.007152230013161898
expectancy O 0 0.4954785406589508
. O 0 0.004927174653857946
. O 0 0.009129746817052364

Prevalence O 0 0.41185262799263
of O 0 0.013951104134321213
the O 0 0.0216879453510046
I1307K O 1 0.9999022483825684
APC B-Disease 1 0.9999114274978638
gene O 0 0.008943548426032066
variant O 0 0.006968921050429344
in O 0 0.0023537043016403913
Israeli O 0 0.00360347842797637
Jews O 0 0.003064687130972743
of O 0 0.002047950401902199
differing O 0 0.0018960220040753484
ethnic O 0 0.0023634308017790318
origin O 0 0.0031404660549014807
and O 0 0.0037842204328626394
risk O 1 0.9866051077842712
for O 1 0.9993547797203064
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9901745319366455

BACKGROUND O 0 0.051825158298015594
& O 0 0.0790901929140091
AIMS O 0 0.017936870455741882
Israeli O 0 0.006744031328707933
Jews O 0 0.005063295364379883
of O 0 0.0033271522261202335
European O 0 0.004237482324242592
birth O 1 0.6972087025642395
, O 0 0.0034767133183777332
i O 0 0.003893469227477908
. O 0 0.0016146855195984244
e O 0 0.0034587557893246412
. O 0 0.0013766216579824686
, O 0 0.0018190606497228146
Ashkenazim O 0 0.008852210827171803
, O 0 0.002216099761426449
have O 0 0.0016827445942908525
the O 0 0.00665555102750659
highest O 1 0.9999985694885254
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999998807907104
of O 0 0.3070811927318573
any O 0 0.003271515481173992
Israeli O 0 0.0063962615095078945
ethnic O 0 0.005486289504915476
group O 0 0.008688313886523247
. O 0 0.009801307693123817

The O 0 0.027075419202446938
I1307K O 1 0.9921654462814331
APC B-Disease 1 0.9995586276054382
gene O 0 0.015552566386759281
variant O 0 0.01743328385055065
was O 0 0.008673870004713535
found O 0 0.004939707927405834
in O 0 0.006255204323679209
6 O 0 0.015684114769101143
. O 0 0.01129750907421112

1 O 0 0.013403269462287426
% O 0 0.004277191124856472
of O 0 0.0026908516883850098
American O 0 0.0033881792332977057
Jews O 0 0.003244402352720499
, O 0 0.0021231197752058506
28 O 0 0.0033894625958055258
% O 0 0.0015786896692588925
of O 0 0.0022338947746902704
their O 0 0.006859413348138332
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999978542327881
, O 0 0.020217766985297203
but O 0 0.001365313190035522
not O 0 0.001048230566084385
in O 0 0.0022698077373206615
non O 0 0.009739043191075325
- O 0 0.021093612536787987
Jews O 0 0.01357272919267416
. O 0 0.012704262509942055

We O 0 0.00951120350509882
assessed O 0 0.014593065716326237
the O 0 0.008766788989305496
I1307K O 1 0.9250985980033875
prevalence O 0 0.42783480882644653
in O 0 0.0032562636770308018
Israeli O 0 0.004685548134148121
Jews O 0 0.0033979604486376047
of O 0 0.0019855352584272623
differing O 0 0.00232378370128572
ethnic O 0 0.0026885876432061195
origin O 0 0.0037547177635133266
and O 0 0.005354247987270355
risk O 1 0.9950418472290039
for O 1 0.9993116855621338
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9473901987075806

METHODS O 0 0.021739259362220764
DNA O 0 0.012292111292481422
samples O 0 0.00556130800396204
from O 0 0.002517394255846739
500 O 0 0.004788029473274946
unrelated O 0 0.004049727227538824
Jews O 0 0.0031524309888482094
of O 0 0.0025281081907451153
European O 0 0.003616523463279009
or O 0 0.003130367025732994
non O 0 0.005685426760464907
- O 0 0.0047435336746275425
European O 0 0.0018763212719932199
origin O 0 0.0018595620058476925
, O 0 0.0015382437268272042
with O 0 0.0011467704316601157
or O 0 0.0015763944247737527
without O 0 0.0014041896210983396
a O 0 0.002398523734882474
personal O 0 0.009287526831030846
and O 0 0.006720935460180044
/ O 1 0.9941129088401794
or O 0 0.002115610521286726
family O 0 0.004043587017804384
history O 0 0.005493865814059973
of O 0 0.03853081911802292
neoplasia B-Disease 1 0.9999984502792358
, O 0 0.0031684283167123795
were O 0 0.0019365213811397552
examined O 0 0.004227631259709597
for O 0 0.0016564879333600402
the O 0 0.0035362071357667446
I1307K O 0 0.12905609607696533
variant O 0 0.006747824139893055
by O 0 0.0021325882989913225
the O 0 0.004671257920563221
allele O 0 0.009461612440645695
- O 0 0.007601569406688213
specific O 0 0.004101230297237635
oligonucleotide O 0 0.02879701741039753
( O 0 0.012536468915641308
ASO O 1 0.9998965263366699
) O 0 0.009113176725804806
method O 0 0.011492906138300896
. O 0 0.013144316151738167

RESULTS O 0 0.009383982978761196
In O 0 0.00340869277715683
persons O 0 0.0036213910207152367
at O 0 0.00411330908536911
average O 0 0.00511661171913147
risk O 0 0.009428363293409348
for O 0 0.06682460755109787
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.8716392517089844
I1307K O 1 0.9995356798171997
was O 0 0.018019182607531548
found O 0 0.004081594757735729
in O 0 0.004695034585893154
5 O 0 0.010217808187007904
. O 0 0.009297359734773636

0 O 0 0.018817130476236343
% O 0 0.005590669810771942
of O 0 0.004424534738063812
120 O 0 0.006809439975768328
European O 0 0.0054449839517474174
and O 0 0.005608552135527134
1 O 0 0.017566626891493797
. O 0 0.013865035958588123

6 O 0 0.018323970958590508
% O 0 0.006341390777379274
of O 0 0.005395715590566397
188 O 0 0.017620578408241272
non O 0 0.008542940951883793
- O 0 0.006564341951161623
European O 0 0.003842397592961788
Jews O 0 0.007258983328938484
( O 0 0.007192071061581373
P O 0 0.028023866936564445
= O 0 0.012984396889805794
0 O 0 0.006581087131053209
. O 0 0.003615087131038308
08 O 0 0.025023335590958595
) O 0 0.008966481313109398
. O 0 0.010078785009682178

It O 0 0.009660681709647179
occurred O 0 0.013789176940917969
in O 0 0.007880378514528275
15 O 0 0.01755291223526001
. O 0 0.015309632755815983

4 O 0 0.016455020755529404
% O 0 0.005810911767184734
of O 0 0.004173959139734507
52 O 0 0.010358463041484356
Ashkenazi O 0 0.02007438614964485
Israelis O 0 0.007477568928152323
with O 0 0.005157063715159893
familial O 1 0.9999921321868896
cancer B-Disease 1 1.0
( O 1 0.7864612936973572
P O 1 0.9578081369400024
= O 0 0.012655931524932384
0 O 0 0.005004559177905321
. O 0 0.002325387205928564
02 O 0 0.2441677749156952
) O 0 0.003030219580978155
and O 0 0.0016429313691332936
was O 0 0.003834872506558895
not O 0 0.0014877085341140628
detected O 0 0.003635955508798361
in O 0 0.0018377256346866488
51 O 0 0.005936914123594761
non O 0 0.00477797444909811
- O 0 0.005142377223819494
European O 0 0.002841708017513156
Jews O 0 0.0067115165293216705
at O 0 0.012174218893051147
increased O 0 0.09108351916074753
cancer B-Disease 1 0.9999994039535522
risk O 1 0.9073977470397949
. O 0 0.0188576839864254

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999992847442627
occurred O 0 0.4701996147632599
personally O 0 0.09522239863872528
or O 0 0.003544483333826065
in O 0 0.002381489146500826
the O 0 0.0023368874099105597
families O 0 0.0021673564333468676
of O 0 0.001990778837352991
13 O 0 0.0028377019334584475
of O 0 0.0025281982962042093
20 O 0 0.004709708504378796
Ashkenazi O 0 0.48263776302337646
I1307K O 0 0.38426581025123596
carriers O 0 0.0053685870952904224
, O 0 0.0024132851976901293
8 O 0 0.003475270001217723
of O 0 0.002307690680027008
whom O 0 0.004022573586553335
also O 0 0.002509252168238163
had O 0 0.0029151453636586666
a O 0 0.0025707080494612455
personal O 0 0.005742402747273445
or O 0 0.0031591663137078285
family O 0 0.005965885240584612
history O 0 0.009857695549726486
of O 0 0.07293829321861267
noncolonic O 1 0.9999978542327881
neoplasia B-Disease 1 0.9999986886978149
. O 0 0.030055014416575432

CONCLUSIONS O 0 0.026811402291059494
The O 0 0.014623034745454788
I1307K O 1 0.9934297204017639
APC O 1 0.9999098777770996
variant O 0 0.049459174275398254
may O 0 0.0030457417014986277
represent O 0 0.0028102281503379345
a O 0 0.004047539550811052
susceptibility O 1 0.8915730714797974
gene O 0 0.007125107105821371
for O 0 0.0053423685021698475
colorectal B-Disease 1 1.0
, I-Disease 0 0.0055181486532092094
or I-Disease 0 0.0025551989674568176
other I-Disease 0 0.0017325999215245247
, I-Disease 0 0.004278112668544054
cancers I-Disease 1 0.9973184466362
in O 0 0.0039694351144135
Ashkenazi O 1 0.9826708436012268
Jews O 0 0.0061345817521214485
, O 0 0.0031417859718203545
and O 0 0.002146539743989706
partially O 0 0.007633615285158157
explains O 0 0.006726434454321861
the O 0 0.003913611639291048
higher O 0 0.008191000670194626
incidence O 1 0.999904990196228
of O 1 0.9999822378158569
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.6251305341720581
European O 0 0.013104993849992752
Israelis O 0 0.016183340921998024
. O 0 0.010903041809797287

Systematic O 0 0.02150692045688629
analysis O 0 0.008376712910830975
of O 0 0.010211888700723648
coproporphyrinogen O 1 0.9999414682388306
oxidase O 1 0.9977237582206726
gene O 0 0.050668638199567795
defects O 1 0.9995716214179993
in O 0 0.012791361659765244
hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 0.9999984502792358
and O 0 0.13003303110599518
mutation O 0 0.20447051525115967
update O 0 0.03173282369971275
. O 0 0.012106413021683693

Hereditary B-Disease 1 0.9999970197677612
coproporphyria I-Disease 1 0.9999963045120239
( O 1 0.9939953684806824
HC B-Disease 1 1.0
) O 0 0.03333006426692009
is O 0 0.007151850499212742
an O 0 0.17014764249324799
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999967813491821
autosomal O 1 1.0
dominant O 1 0.9999996423721313
inheritance O 1 0.9999984502792358
caused O 1 0.9999849796295166
by O 0 0.06440053880214691
deficient B-Disease 1 0.9999392032623291
activity I-Disease 0 0.005882601719349623
of I-Disease 0 0.009394627064466476
coproporphyrinogen I-Disease 1 0.9999954700469971
III I-Disease 1 0.9999998807907104
oxidase I-Disease 1 0.9991387128829956
( O 0 0.022954950109124184
CPO O 1 0.9368733167648315
) O 0 0.015395612455904484
. O 0 0.014810414984822273

Clinical O 1 0.9430953860282898
manifestations O 1 0.9898882508277893
of O 1 0.7830964922904968
the O 1 0.9997084736824036
disease O 1 1.0
are O 0 0.002456597751006484
characterized O 1 0.7590846419334412
by O 0 0.003469947027042508
acute O 1 1.0
attacks O 1 0.9638716578483582
of O 1 0.9999914169311523
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9834966659545898
precipitated O 1 0.9999964237213135
by O 0 0.004730395507067442
drugs O 1 0.9501157402992249
, O 0 0.004377992358058691
fasting O 0 0.021331634372472763
, O 0 0.005538832861930132
cyclical O 1 0.9823509454727173
hormonal O 1 0.9944196343421936
changes O 0 0.005212440621107817
, O 0 0.006979076657444239
or O 0 0.3912912905216217
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.48255765438079834

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 0.0999097004532814
also O 0 0.007408797740936279
be O 0 0.0047415574081242085
present O 0 0.008712364360690117
. O 0 0.010632086545228958

The O 0 0.010373750701546669
seven O 0 0.00741308368742466
exons O 0 0.014317610301077366
, O 0 0.004375368356704712
the O 0 0.007748142350465059
exon O 1 0.7398718595504761
/ O 0 0.06486735492944717
intron O 0 0.031332388520240784
boundaries O 0 0.003032751614227891
and O 0 0.002024720422923565
part O 0 0.002919453429058194
of O 0 0.0030392103362828493
3 O 0 0.005144650116562843
noncoding O 0 0.01154407486319542
sequence O 0 0.002702767960727215
of O 0 0.0025008651427924633
the O 0 0.004645266104489565
CPO O 1 0.8649923205375671
gene O 0 0.0035073128528892994
were O 0 0.001683735055848956
systematically O 0 0.004497641231864691
analyzed O 0 0.0029907510615885258
by O 0 0.001766188070178032
an O 0 0.0032150184269994497
exon O 0 0.028461415320634842
- O 0 0.009312242269515991
by O 0 0.003956837113946676
- O 0 0.01811904087662697
exon O 0 0.03792267665266991
denaturing O 0 0.09263024479150772
gradient O 0 0.05153282359242439
gel O 1 0.9265246987342834
electrophoresis O 1 0.510970413684845
( O 0 0.015387844294309616
DGGE O 1 0.9864792227745056
) O 0 0.0043363929726183414
strategy O 0 0.004472365602850914
followed O 0 0.002652800874784589
by O 0 0.0013984139077365398
direct O 0 0.002245619660243392
sequencing O 0 0.0033437837846577168
in O 0 0.0019159172661602497
seven O 0 0.0033153421245515347
unrelated O 0 0.010668220929801464
heterozygous O 0 0.019495267421007156
HC B-Disease 1 0.9999998807907104
patients O 1 0.9999215602874756
from O 0 0.006499208975583315
France O 0 0.023252123966813087
, O 0 0.005138114560395479
Holland O 0 0.023922190070152283
, O 0 0.0032716032583266497
and O 0 0.0036857861559838057
Czech O 0 0.02814621478319168
Republic O 0 0.030811341479420662
. O 0 0.017036881297826767

Seven O 0 0.014620009809732437
novel O 0 0.018090955913066864
mutations O 0 0.007026324979960918
and O 0 0.003040733514353633
two O 0 0.0026068673469126225
new O 0 0.005329067353159189
polymorphisms O 0 0.015650611370801926
were O 0 0.006463425233960152
detected O 0 0.02051834762096405
. O 0 0.012847880832850933

Among O 0 0.007702481001615524
these O 0 0.0027620976325124502
mutations O 0 0.0037429321091622114
two O 0 0.0016156496712937951
are O 0 0.001611941261216998
missense O 0 0.013437608256936073
( O 0 0.007434559054672718
G197W O 0 0.04540213197469711
, O 0 0.004022170323878527
W427R O 0 0.05629737675189972
) O 0 0.0020334559958428144
, O 0 0.001142654218710959
two O 0 0.0008170097717083991
are O 0 0.001003699959255755
nonsense O 0 0.00976033415645361
( O 0 0.005267728585749865
Q306X O 0 0.05104503408074379
, O 0 0.003711656667292118
Q385X O 0 0.03183538839221001
) O 0 0.0020159934647381306
, O 0 0.0012544019846245646
two O 0 0.0006830223719589412
are O 0 0.0006327187875285745
small O 0 0.0016942257061600685
deletions O 0 0.007692297454923391
( O 0 0.0046942648477852345
662de14bp O 0 0.086552195250988
; O 0 0.0035328464582562447
1168del3bp O 0 0.025161487981677055
removing O 0 0.008120820857584476
a O 0 0.0037322293501347303
glycine O 0 0.009371260181069374
at O 0 0.003695547115057707
position O 0 0.003913544584065676
390 O 0 0.011671807616949081
) O 0 0.001757245510816574
, O 0 0.001143931527622044
and O 0 0.0009550928371027112
one O 0 0.0012672407319769263
is O 0 0.0015368734020739794
a O 0 0.003121466375887394
splicing O 0 0.009282376617193222
mutation O 0 0.00632054265588522
( O 0 0.007242593448609114
IVS1 O 1 0.9952988028526306
- O 0 0.05622146651148796
15c O 1 0.843686580657959
- O 0 0.4827518165111542
- O 0 0.0446883924305439
> O 0 0.021371275186538696
g O 0 0.01053251326084137
) O 0 0.0029643645975738764
which O 0 0.0013771515805274248
creates O 0 0.004284515976905823
a O 0 0.003977750428020954
new O 0 0.006393225863575935
acceptor O 0 0.028651760891079903
splice O 0 0.04745512083172798
site O 0 0.02052099071443081
. O 0 0.015136698260903358

The O 0 0.01714155822992325
pathological O 0 0.030075136572122574
significance O 0 0.010581215843558311
of O 0 0.005316575989127159
the O 0 0.005009944550693035
point O 0 0.00684222811833024
mutations O 0 0.006835793145000935
G197W O 0 0.14783823490142822
, O 0 0.0035355249419808388
W427R O 0 0.02389329858124256
, O 0 0.002217264147475362
and O 0 0.0014563673175871372
the O 0 0.0027388271410018206
in O 0 0.004179075360298157
- O 0 0.03527692332863808
frame O 0 0.012620371766388416
deletion O 0 0.010442149825394154
390delGly O 0 0.018595227971673012
were O 0 0.002332544419914484
assessed O 0 0.003548586741089821
by O 0 0.001058777212165296
their O 0 0.0010438956087455153
respective O 0 0.0026886232662945986
expression O 0 0.002557840896770358
in O 0 0.0017151550855487585
a O 0 0.0026131607592105865
prokaryotic O 0 0.007934854365885258
system O 0 0.003615898545831442
using O 0 0.002656180178746581
site O 0 0.00804045144468546
- O 0 0.014359499327838421
directed O 0 0.01464473269879818
mutagenesis O 0 0.040754955261945724
. O 0 0.017162354663014412

These O 0 0.007862893864512444
mutations O 0 0.00972778256982565
resulted O 0 0.007449120283126831
in O 0 0.0033891519997268915
the O 0 0.004141557030379772
absence O 0 0.010705861262977123
or O 0 0.0030727714765816927
a O 0 0.004564711824059486
dramatic O 0 0.01222640834748745
decrease O 0 0.013591011986136436
of O 0 0.024558503180742264
CPO O 1 0.9998514652252197
activity O 0 0.016018636524677277
. O 0 0.013257334008812904

The O 0 0.011284858919680119
two O 0 0.004947901237756014
polymorphisms O 0 0.013856531120836735
were O 0 0.0034410308580845594
localized O 0 0.009936957620084286
in O 0 0.0038745994679629803
noncoding O 0 0.015589624643325806
part O 0 0.0032777348533272743
of O 0 0.0024733920581638813
the O 0 0.003196547506377101
gene O 0 0.003630399238318205
1 O 0 0.003092927625402808
) O 0 0.002085563028231263
a O 0 0.0037157780025154352
C O 0 0.15093331038951874
/ O 0 0.05856024846434593
G O 0 0.015025519765913486
polymorphism O 0 0.0063113076612353325
in O 0 0.0024375130888074636
the O 0 0.004310093354433775
promotor O 1 0.9917437434196472
region O 0 0.007688375189900398
, O 0 0.005260252859443426
142 O 0 0.015136129222810268
bp O 0 0.011222162283957005
upstream O 0 0.006982143502682447
from O 0 0.0023875227198004723
the O 0 0.003574817208573222
transcriptional O 0 0.011927659623324871
initiation O 0 0.009420373477041721
site O 0 0.008640644140541553
( O 0 0.0075265574268996716
- O 0 0.014593798667192459
142C O 1 0.6486051082611084
/ O 1 0.7310492396354675
G O 0 0.06620223820209503
) O 0 0.0020588531624525785
, O 0 0.0013805727940052748
and O 0 0.0013414869317784905
2 O 0 0.0033632575068622828
) O 0 0.0017559562111273408
a O 0 0.0024199041072279215
6 O 0 0.005844361614435911
bp O 0 0.008711745962500572
deletion O 0 0.006965355481952429
polymorphism O 0 0.004941339138895273
in O 0 0.0018333365442231297
the O 0 0.002913951175287366
3 O 0 0.005453780759125948
noncoding O 0 0.01258035097271204
part O 0 0.003584970021620393
of O 0 0.003501347964629531
the O 0 0.007931253872811794
CPO O 1 0.9996520280838013
gene O 0 0.006420216057449579
, O 0 0.00396398501470685
574 O 0 0.02557835355401039
bp O 0 0.008873837999999523
downstream O 0 0.004147780127823353
of O 0 0.002004008274525404
the O 0 0.0022481349296867847
last O 0 0.0026951225008815527
base O 0 0.0030499000567942858
of O 0 0.002430494176223874
the O 0 0.003624038537964225
normal O 0 0.0072167497128248215
termination O 0 0.02295302413403988
codon O 0 0.02090371958911419
( O 0 0.011039596050977707
+ O 0 0.027487849816679955
574 O 0 0.07523822039365768
delATTCTT O 0 0.3706207275390625
) O 0 0.014337568543851376
. O 0 0.013871355913579464

Five O 0 0.01598438434302807
intragenic O 1 0.9924302697181702
dimorphisms O 1 0.917427122592926
are O 0 0.0031289388425648212
now O 0 0.0035980171523988247
well O 0 0.002746716607362032
characterized O 0 0.007428362034261227
and O 0 0.0024805201683193445
the O 0 0.004160366952419281
high O 0 0.00793020986020565
degree O 0 0.007085584569722414
of O 0 0.006364134605973959
allelic O 1 0.9553468227386475
heterogeneity O 0 0.312945693731308
in O 0 0.01006990298628807
HC B-Disease 1 1.0
is O 0 0.006013871170580387
demonstrated O 0 0.004720200784504414
with O 0 0.0012092434335500002
seven O 0 0.001486695953644812
new O 0 0.0012642232468351722
different O 0 0.0007353801047429442
mutations O 0 0.0016311588697135448
making O 0 0.0012124526547268033
a O 0 0.0016463183565065265
total O 0 0.0022596127819269896
of O 0 0.0038912834133952856
nineteen O 1 0.9509099125862122
CPO O 1 0.9999862909317017
gene B-Disease 0 0.2244122475385666
defects I-Disease 1 0.9997392296791077
reported O 0 0.009380410425364971
so O 0 0.0032504526898264885
far O 0 0.0043151057325303555
. O 0 0.005332819651812315
. O 0 0.009288988076150417

Coincidence O 0 0.020326217636466026
of O 0 0.005800947546958923
two O 0 0.0035447797272354364
novel O 0 0.01609787344932556
arylsulfatase O 1 0.7482736110687256
A O 0 0.010550210252404213
alleles O 0 0.01101972721517086
and O 0 0.004688550718128681
mutation O 0 0.014466604217886925
459 O 1 0.9904881715774536
+ O 1 0.6357534527778625
1G O 1 0.9849327206611633
> O 0 0.012268684804439545
A O 0 0.004430251661688089
within O 0 0.0019973721355199814
a O 0 0.002905711065977812
family O 0 0.006310087628662586
with O 0 0.005671266466379166
metachromatic B-Disease 1 0.9999988079071045
leukodystrophy I-Disease 1 0.9999996423721313
: O 0 0.007571771275252104
molecular O 0 0.006680521182715893
basis O 0 0.00425158254802227
of O 0 0.007478948682546616
phenotypic O 0 0.035260606557130814
heterogeneity O 0 0.14575721323490143
. O 0 0.02580977976322174

In O 0 0.006961068604141474
a O 0 0.005165897309780121
family O 0 0.004933551885187626
with O 0 0.0021498871501535177
three O 0 0.0032242217566818
siblings O 0 0.010492956265807152
, O 0 0.002790441270917654
one O 0 0.002280671149492264
developed O 0 0.004516026470810175
classical O 0 0.009357132017612457
late O 0 0.17849496006965637
infantile O 1 0.9999998807907104
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9997542500495911
MLD B-Disease 1 1.0
) O 0 0.006666035391390324
, O 0 0.003671901533380151
fatal O 1 0.8923438787460327
at O 0 0.005887885577976704
age O 0 0.005448887124657631
5 O 0 0.0032627531327307224
years O 0 0.002004416659474373
, O 0 0.002083920408040285
with O 0 0.0028028215747326612
deficient O 1 0.9998461008071899
arylsulfatase O 1 0.9974516034126282
A O 0 0.4341234266757965
( O 0 0.013472863472998142
ARSA O 1 0.9997854828834534
) O 0 0.004174942150712013
activity O 0 0.003049024846404791
and O 0 0.0025585845578461885
increased O 0 0.008061808533966541
galactosylsulfatide O 1 0.9989964365959167
( O 0 0.3432542085647583
GS O 1 0.9999995231628418
) O 0 0.0168176107108593
excretion O 0 0.04738355800509453
. O 0 0.017177948728203773

The O 0 0.007519821170717478
two O 0 0.002562478883191943
other O 0 0.002365094143897295
siblings O 0 0.008776063099503517
, O 0 0.0031574219465255737
apparently O 0 0.005269715562462807
healthy O 0 0.005527859553694725
at O 0 0.0038213564548641443
12 O 0 0.0033132508397102356
( O 0 0.0028822042513638735
1 O 0 0.0041436259634792805
/ O 0 0.007635673973709345
2 O 0 0.0024935093242675066
) O 0 0.001132049597799778
and O 0 0.0008176647243089974
15 O 0 0.001509578200057149
years O 0 0.0017594242235645652
, O 0 0.0016943468945100904
respectively O 0 0.0026667488273233175
, O 0 0.0014520674012601376
and O 0 0.0012259690556675196
their O 0 0.0014079255051910877
father O 1 0.6656146049499512
, O 0 0.0031602387316524982
apparently O 0 0.005935360211879015
healthy O 0 0.005717049818485975
as O 0 0.0016774324467405677
well O 0 0.0016646222211420536
, O 0 0.0031504507642239332
presented O 0 0.010380669496953487
ARSA O 1 0.9999681711196899
and O 0 0.007015415467321873
GS O 1 0.9999089241027832
values O 0 0.0033404864370822906
within O 0 0.00198247074149549
the O 0 0.00298125809058547
range O 0 0.006328711751848459
of O 0 0.024905165657401085
MLD B-Disease 1 1.0
patients O 1 0.999976634979248
. O 0 0.02352830395102501

Mutation O 0 0.025111332535743713
screening O 0 0.010739387013018131
and O 0 0.003232395276427269
sequence O 0 0.003340981900691986
analysis O 0 0.0023457936476916075
disclosed O 0 0.005100916139781475
the O 0 0.0021236813627183437
involvement O 0 0.003924385644495487
of O 0 0.0024730050936341286
three O 0 0.002108311979100108
different O 0 0.0025039431639015675
ARSA O 1 0.9998219609260559
mutations O 0 0.004892564378678799
being O 0 0.0023648771457374096
the O 0 0.0023986243177205324
molecular O 0 0.004360371734946966
basis O 0 0.003418542677536607
of O 0 0.006651526782661676
intrafamilial O 1 0.9857697486877441
phenotypic O 0 0.06299544125795364
heterogeneity O 1 0.6276313662528992
. O 0 0.022074954584240913

The O 0 0.019261451438069344
late O 0 0.16957710683345795
infantile O 1 0.9999996423721313
patient O 1 0.9999983310699463
inherited O 1 0.9999970197677612
from O 0 0.006245853845030069
his O 0 0.05463826283812523
mother O 1 0.5774194002151489
the O 0 0.0034841562155634165
frequent O 0 0.006193406414240599
0 O 0 0.007358716335147619
- O 0 0.009072900749742985
type O 0 0.007824861444532871
mutation O 0 0.008512984961271286
459 O 0 0.4442068636417389
+ O 0 0.06490403413772583
1G O 1 0.9908427000045776
> O 0 0.011708734557032585
A O 0 0.004117291886359453
, O 0 0.001877826638519764
and O 0 0.0012486991472542286
from O 0 0.0016418695449829102
his O 0 0.0032526382710784674
father O 0 0.11705300211906433
a O 0 0.0028085848316550255
novel O 0 0.0064201802015304565
, O 0 0.0025339729618281126
single O 0 0.003478187834843993
basepair O 0 0.06790193915367126
microdeletion O 0 0.01787758246064186
of O 0 0.003779955441132188
guanine O 0 0.008128021843731403
at O 0 0.003830710658803582
nucleotide O 0 0.00472534354776144
7 O 0 0.0031008641235530376
in O 0 0.002462447155267
exon O 0 0.016919085755944252
1 O 0 0.008008440025150776
( O 0 0.007759901229292154
7delG O 0 0.1697826087474823
) O 0 0.009682613424956799
. O 0 0.011343983002007008

The O 0 0.011352842673659325
two O 0 0.0064033265225589275
clinically O 1 0.9987472295761108
unaffected O 0 0.2282562553882599
siblings O 0 0.018892740830779076
carried O 0 0.006224635988473892
the O 0 0.006342926062643528
maternal O 1 0.9937979578971863
mutation O 0 0.022702030837535858
459 O 1 0.9988539218902588
+ O 1 0.7046166658401489
1G O 1 0.9938686490058899
> O 0 0.014943812973797321
A O 0 0.0055168974213302135
and O 0 0.0022312900982797146
, O 0 0.002305457601323724
on O 0 0.002503636758774519
their O 0 0.002513623097911477
paternal O 0 0.03333450108766556
allele O 0 0.00800277478992939
, O 0 0.002743742661550641
a O 0 0.0035862887743860483
novel O 0 0.009691099636256695
cytosine O 0 0.012371066026389599
to O 0 0.0027689768467098475
thymidine O 0 0.01608189381659031
transition O 0 0.008663790300488472
at O 0 0.007507347036153078
nucleotide O 0 0.011651072651147842
2435 O 0 0.04409237205982208
in O 0 0.0040626684203743935
exon O 0 0.015453733503818512
8 O 0 0.00442922580987215
, O 0 0.0016502047656103969
resulting O 0 0.002700475975871086
in O 0 0.002170289633795619
substitution O 0 0.005859924480319023
of O 0 0.004495479166507721
alanine O 0 0.029857894405722618
464 O 0 0.14028972387313843
by O 0 0.005488293245434761
valine O 1 0.9659155011177063
( O 0 0.017966024577617645
A464V O 1 0.8718733191490173
) O 0 0.012838594615459442
. O 0 0.013553551398217678

The O 0 0.020879151299595833
fathers O 0 0.029768535867333412
genotype O 0 0.028258470818400383
thus O 0 0.010223123244941235
was O 0 0.04173228144645691
7delG O 1 0.9994885921478271
/ O 1 0.997636079788208
A464V O 1 0.8056872487068176
. O 0 0.022721854969859123

Mutation O 0 0.037382543087005615
A464V O 0 0.15288878977298737
was O 0 0.009994755499064922
not O 0 0.001840499578975141
found O 0 0.00207225838676095
in O 0 0.002485622651875019
18 O 0 0.007183761801570654
unrelated O 1 0.9738789796829224
MLD B-Disease 1 1.0
patients O 1 0.999834418296814
and O 0 0.007398796733468771
50 O 0 0.010344259440898895
controls O 0 0.015662385150790215
. O 0 0.012556957080960274

A464V O 0 0.08770943433046341
, O 0 0.009068358689546585
although O 0 0.00550390500575304
clearly O 0 0.009826849214732647
modifying O 0 0.038347795605659485
ARSA O 1 0.9999959468841553
and O 0 0.02583903633058071
GS O 1 1.0
levels O 0 0.012408535927534103
, O 0 0.0034346794709563255
apparently O 0 0.005342637188732624
bears O 0 0.005932300817221403
little O 0 0.002985897473990917
significance O 0 0.0044656614772975445
for O 0 0.0025908141396939754
clinical O 1 0.9614644646644592
manifestation O 1 0.9999772310256958
of O 1 0.99866783618927
MLD B-Disease 1 1.0
, O 0 0.01507398672401905
mimicking O 0 0.08526521176099777
the O 0 0.011416235007345676
frequent O 0 0.04105577617883682
ARSA O 1 0.9999849796295166
pseudodeficiency O 1 0.9959723353385925
allele O 0 0.047395966947078705
. O 0 0.019452208653092384

Our O 0 0.01233290508389473
results O 0 0.0049966489896178246
demonstrate O 0 0.004454568959772587
that O 0 0.0012995796278119087
in O 0 0.0016939821653068066
certain O 0 0.002630780450999737
genetic O 0 0.009900742210447788
conditions O 1 0.9693759083747864
MLD B-Disease 1 1.0
- O 1 0.9994294047355652
like O 0 0.014959024265408516
ARSA O 1 0.9999922513961792
and O 0 0.007907336577773094
GS O 1 0.9999874830245972
values O 0 0.00417502922937274
need O 0 0.0023329462856054306
not O 0 0.0010618926025927067
be O 0 0.0013284757733345032
paralleled O 0 0.008130229078233242
by O 0 0.0032103273551911116
clinical O 1 0.9999971389770508
disease O 1 1.0
, O 0 0.005090822000056505
a O 0 0.0038505629636347294
finding O 0 0.004932054318487644
with O 0 0.003205888671800494
serious O 1 0.9753873348236084
diagnostic O 1 0.9999004602432251
and O 0 0.018712103366851807
prognostic O 1 0.9998418092727661
implications O 0 0.057040274143218994
. O 0 0.0178558100014925

Moreover O 0 0.025478854775428772
, O 0 0.009485703893005848
further O 0 0.010125420987606049
ARSA O 1 0.9999387264251709
alleles O 0 0.01417152676731348
functionally O 0 0.010744098573923111
similar O 0 0.00234963302500546
to O 0 0.002272039884701371
A464V O 0 0.022920265793800354
might O 0 0.001902350108139217
exist O 0 0.0011378357885405421
which O 0 0.0008080609259195626
, O 0 0.0010638822568580508
together O 0 0.0013164205010980368
with O 0 0.0017443507676944137
0 O 0 0.007814979180693626
- O 0 0.01128471177071333
type O 0 0.009453671053051949
mutations O 0 0.005405207630246878
, O 0 0.003226496744900942
may O 0 0.005641038995236158
cause O 0 0.38075998425483704
pathological O 1 0.9999959468841553
ARSA O 1 1.0
and O 1 0.8671364784240723
GS O 1 1.0
levels O 0 0.007733536884188652
, O 0 0.001630919985473156
but O 0 0.0009286166750825942
not O 0 0.0009548163507133722
clinical O 0 0.018897851929068565
outbreak O 1 0.9990954399108887
of O 0 0.2183220237493515
the O 1 0.9997721314430237
disease O 1 1.0
. O 0 0.010298375971615314
. O 0 0.010593838058412075

Human O 1 0.9994534850120544
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999786615371704
to O 0 0.024699075147509575
hematological B-Disease 1 0.9999997615814209
malignancy I-Disease 1 1.0
and O 1 0.9996166229248047
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999910593032837
1 I-Disease 1 0.5196366906166077
. O 0 0.01662353426218033

Heterozygous O 0 0.07079393416643143
germ O 1 0.9995220899581909
- O 0 0.033138491213321686
line O 0 0.009475423023104668
mutations O 0 0.004384127911180258
in O 0 0.0027496819384396076
the O 0 0.0050003863871097565
DNA O 0 0.021892892196774483
mismatch O 1 0.9997277855873108
repair O 1 0.998776376247406
genes O 0 0.006642584688961506
lead O 0 0.005482887849211693
to O 0 0.0066276127472519875
hereditary B-Disease 1 0.9999998807907104
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9994575381278992

The O 1 0.981259286403656
disease O 1 1.0
susceptibility O 1 0.9988775849342346
of O 0 0.010973835363984108
individuals O 0 0.0032050732988864183
who O 0 0.005456171464174986
constitutionally O 0 0.009344939142465591
lack O 0 0.004998099524527788
both O 0 0.002492823638021946
wild O 0 0.010965429246425629
- O 1 0.511165976524353
type O 0 0.027900509536266327
alleles O 0 0.010722075589001179
is O 0 0.005598875228315592
unknown O 0 0.011622712947428226
. O 0 0.011478212662041187

We O 0 0.005723903886973858
have O 0 0.001785410800948739
identified O 0 0.002963107544928789
three O 0 0.0018174785654991865
offspring O 0 0.004317011218518019
in O 0 0.0025598525535315275
a O 0 0.013856003060936928
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.999997615814209
who O 1 0.9978529214859009
developed O 1 0.9998607635498047
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 1 0.5167874693870544
a O 0 0.0037561950739473104
very O 0 0.002003720495849848
early O 0 0.0028893074486404657
age O 0 0.003250616602599621
, O 0 0.0018770117312669754
and O 0 0.00117710349150002
at O 0 0.0019670340698212385
least O 0 0.0008187469211407006
two O 0 0.0005056249210610986
of O 0 0.0010118985082954168
them O 0 0.0010941175278276205
displayed O 0 0.005196284968405962
signs O 0 0.009839212521910667
of O 0 0.012706552632153034
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.996911883354187
1 I-Disease 0 0.08365944772958755
( O 0 0.015403687953948975
NF1 B-Disease 1 0.9996525049209595
) O 0 0.01190277747809887
. O 0 0.011525269597768784

DNA O 0 0.017438840121030807
sequence O 0 0.006979888770729303
analysis O 0 0.004241738468408585
and O 0 0.003736231243237853
allele O 0 0.009579641744494438
- O 0 0.005528177134692669
specific O 0 0.002494094194844365
amplification O 0 0.005282245576381683
in O 0 0.0018841272685676813
two O 0 0.0018346990691497922
siblings O 0 0.008421598002314568
revealed O 0 0.006574854254722595
a O 0 0.005664316471666098
homozygous O 0 0.019177790731191635
MLH1 O 1 0.9998906850814819
mutation O 0 0.014848708175122738
( O 0 0.011499863117933273
C676T O 1 0.9957478642463684
- O 1 0.9506927728652954
- O 0 0.2557125985622406
> O 0 0.04460897669196129
Arg226Stop O 1 0.6769813299179077
) O 0 0.015214561484754086
. O 0 0.012913239188492298

Thus O 0 0.011799017898738384
, O 0 0.006659357342869043
a O 0 0.0094242412596941
homozygous O 0 0.04615174978971481
germ O 1 0.9999654293060303
- O 1 0.7178078889846802
line O 0 0.024674372747540474
MLH1 O 1 0.9998817443847656
mutation O 0 0.018912125378847122
and O 0 0.00901351310312748
consequent O 1 0.9999966621398926
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.008361264131963253
in O 0 0.004240973386913538
a O 0 0.007007659878581762
mutator O 1 0.9999643564224243
phenotype O 0 0.0284664798527956
characterized O 0 0.11938025057315826
by O 0 0.006837787572294474
leukemia B-Disease 1 1.0
and O 1 0.9988712668418884
/ O 1 0.9999997615814209
or O 1 0.9671071171760559
lymphoma B-Disease 1 1.0
associated O 1 0.9863103628158569
with O 1 0.6754012703895569
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999614953994751
1 I-Disease 0 0.07468467950820923
. O 0 0.006059471983462572
. O 0 0.009587748907506466

Missense O 0 0.05970865115523338
mutations O 0 0.010755092836916447
in O 0 0.0036081208381801844
the O 0 0.0031949072144925594
most O 0 0.002135269111022353
ancient O 0 0.006376364268362522
residues O 0 0.007860859856009483
of O 0 0.005352614913135767
the O 0 0.014105885289609432
PAX6 O 1 0.9999978542327881
paired O 0 0.021102819591760635
domain O 0 0.009262488223612309
underlie O 0 0.015086367726325989
a O 0 0.005159618798643351
spectrum O 0 0.01158431638032198
of O 1 0.6883671879768372
human O 1 0.9999991655349731
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9984752535820007

Mutations O 0 0.01699635572731495
of O 0 0.007601235527545214
the O 0 0.007989823818206787
human O 0 0.022150583565235138
PAX6 O 1 0.9999988079071045
gene O 0 0.3500184416770935
underlie O 1 0.9999353885650635
aniridia B-Disease 1 1.0
( O 1 0.9998041987419128
congenital B-Disease 1 1.0
absence I-Disease 1 0.9992955923080444
of I-Disease 1 0.9978241920471191
the I-Disease 1 0.9997310042381287
iris I-Disease 1 0.9999979734420776
) O 0 0.0037101423367857933
, O 0 0.0018778356024995446
a O 0 0.0031364960595965385
rare O 0 0.011791442520916462
dominant O 1 0.863199770450592
malformation B-Disease 1 0.9999997615814209
of I-Disease 1 0.9916654229164124
the I-Disease 1 0.9998745918273926
eye I-Disease 1 0.999998927116394
. O 0 0.028170309960842133

The O 0 0.01252803299576044
spectrum O 0 0.013550709933042526
of O 0 0.010574324987828732
PAX6 O 1 0.9999979734420776
mutations O 0 0.021381983533501625
in O 0 0.01196581032127142
aniridia B-Disease 1 0.9999998807907104
patients O 1 0.9994288086891174
is O 0 0.0036073497030884027
highly O 0 0.004712009336799383
biased O 0 0.0047869388945400715
, O 0 0.0019493947038426995
with O 0 0.001475036609917879
92 O 0 0.007212474476546049
% O 0 0.0019982154481112957
of O 0 0.0017288801027461886
all O 0 0.0016026931116357446
reported O 0 0.005107277538627386
mutations O 0 0.00406347680836916
leading O 0 0.004431658424437046
to O 0 0.002817178377881646
premature O 0 0.010844646953046322
truncation O 0 0.011778326705098152
of O 0 0.003583675716072321
the O 0 0.004990443121641874
protein O 0 0.006153607275336981
( O 0 0.00367200979962945
nonsense O 0 0.009185452945530415
, O 0 0.0034766660537570715
splicing O 0 0.007149223703891039
, O 0 0.0032524296548217535
insertions O 0 0.010398770682513714
and O 0 0.0030788688454777002
deletions O 0 0.009481861256062984
) O 0 0.0029202529694885015
and O 0 0.0020095319487154484
just O 0 0.0025826599448919296
2 O 0 0.0036885468289256096
% O 0 0.0018378131790086627
leading O 0 0.0028619084041565657
to O 0 0.0013884486397728324
substitution O 0 0.003917675465345383
of O 0 0.0024418022949248552
one O 0 0.002936762059107423
amino O 0 0.004316093400120735
acid O 0 0.004453966394066811
by O 0 0.0020206160843372345
another O 0 0.00591891398653388
( O 0 0.008397558704018593
missense O 0 0.0260027963668108
) O 0 0.010015632025897503
. O 0 0.010894736275076866

The O 0 0.013294374570250511
extraordinary O 0 0.01611175574362278
conservation O 0 0.009977501817047596
of O 0 0.005785019136965275
the O 0 0.008949583396315575
PAX6 O 1 0.9998844861984253
protein O 0 0.007365306373685598
at O 0 0.004675773903727531
the O 0 0.0038367656525224447
amino O 0 0.005347096361219883
acid O 0 0.006996635347604752
level O 0 0.005449298303574324
amongst O 0 0.00825565867125988
vertebrates O 0 0.013677378185093403
predicts O 0 0.012030569836497307
that O 0 0.002910387236624956
pathological O 1 0.9381397366523743
missense O 0 0.33674561977386475
mutations O 0 0.006143499165773392
should O 0 0.0017636242555454373
in O 0 0.001690703327767551
fact O 0 0.002362776780501008
be O 0 0.001379440538585186
common O 0 0.002019100356847048
even O 0 0.0015848013572394848
though O 0 0.0015051772352308035
they O 0 0.0009309062152169645
are O 0 0.0009631720022298396
hardly O 0 0.0052760508842766285
ever O 0 0.004221176262944937
seen O 0 0.005380888935178518
in O 0 0.007705105934292078
aniridia B-Disease 1 0.9999992847442627
patients O 1 0.9999164342880249
. O 0 0.02063896134495735

This O 0 0.007684731390327215
indicates O 0 0.008701692335307598
that O 0 0.0019117564661428332
there O 0 0.002187686040997505
is O 0 0.002183031989261508
a O 0 0.003549716668203473
heavy O 0 0.06140758469700813
ascertainment O 1 0.9990419745445251
bias O 0 0.007904965430498123
in O 0 0.002306846436113119
the O 0 0.002307564252987504
selection O 0 0.0033426813315600157
of O 0 0.004002469591796398
patients O 1 0.8922701478004456
for O 0 0.0052213240414857864
PAX6 O 1 0.9999908208847046
mutation O 0 0.005460178013890982
analysis O 0 0.0018502285238355398
and O 0 0.0014272741973400116
that O 0 0.0013471711426973343
the O 0 0.00397106446325779
missing O 0 0.01593618094921112
PAX6 O 1 0.9999475479125977
missense O 0 0.03708355501294136
mutations O 0 0.007809748873114586
frequently O 0 0.004961776547133923
may O 0 0.004425405990332365
underlie O 0 0.1714482456445694
phenotypes O 0 0.01826057955622673
distinct O 0 0.0063561489805579185
from O 0 0.007667383179068565
textbook O 1 0.999859094619751
aniridia B-Disease 1 0.9999979734420776
. O 0 0.027695992961525917

Here O 0 0.012413281947374344
we O 0 0.003954723943024874
present O 0 0.004268747288733721
four O 0 0.004439727868884802
novel O 0 0.019231202080845833
PAX6 O 1 0.9997681975364685
missense O 0 0.03291810303926468
mutations O 0 0.006380776409059763
, O 0 0.0022736445534974337
two O 0 0.0012182913487777114
in O 0 0.002296038903295994
association O 0 0.00643546786159277
with O 0 0.004291992634534836
atypical O 1 0.999990701675415
phenotypes O 1 0.9944031238555908
ectopia B-Disease 1 0.9999710321426392
pupillae I-Disease 1 0.9999463558197021
( O 0 0.011437193490564823
displaced B-Disease 0 0.01873668283224106
pupils I-Disease 0 0.073844775557518
) O 0 0.009738586843013763
and O 0 0.019432904198765755
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999998807907104
( O 1 0.8839952349662781
searching B-Disease 0 0.02103283256292343
gaze I-Disease 0 0.22935986518859863
) O 0 0.0027755878400057554
, O 0 0.0013805367052555084
and O 0 0.0010494525777176023
two O 0 0.0008667450165376067
in O 0 0.0014843052485957742
association O 0 0.0043438333086669445
with O 0 0.00209842249751091
more O 0 0.00288948742672801
recognizable O 1 0.9376975893974304
aniridia B-Disease 1 0.9999957084655762
phenotypes O 1 0.7482404112815857
. O 0 0.017496680840849876

Strikingly O 0 0.033454377204179764
, O 0 0.005681406706571579
all O 0 0.002284413203597069
four O 0 0.0024767357390373945
mutations O 0 0.0034297602251172066
are O 0 0.0011276917066425085
located O 0 0.003663586685433984
within O 0 0.0024170579854398966
the O 0 0.0051445188000798225
PAX6 O 1 0.9999955892562866
paired O 0 0.017514420673251152
domain O 0 0.005714131984859705
and O 0 0.002419479424133897
affect O 0 0.003195241093635559
amino O 0 0.003238566452637315
acids O 0 0.002077041892334819
which O 0 0.0009400092530995607
are O 0 0.0007726931944489479
highly O 0 0.0029356929007917643
conserved O 0 0.0035186398308724165
in O 0 0.0021620544139295816
all O 0 0.001874956302344799
known O 0 0.006390076130628586
paired O 0 0.015103083103895187
domain O 0 0.013439439237117767
proteins O 0 0.013475297018885612
. O 0 0.011792936362326145

Our O 0 0.011357168667018414
results O 0 0.005884409416466951
support O 0 0.003289358224719763
the O 0 0.003141556167975068
hypothesis O 0 0.004779248498380184
that O 0 0.0013155211927369237
the O 0 0.0024946765042841434
under O 0 0.003485080087557435
- O 0 0.005029074847698212
representation O 0 0.00268776947632432
of O 0 0.0032905074767768383
missense O 0 0.029273074120283127
mutations O 0 0.007632278371602297
is O 0 0.003590624313801527
caused O 0 0.012546551413834095
by O 0 0.004391183611005545
ascertainment O 1 0.9999794960021973
bias O 0 0.023272264748811722
and O 0 0.0026982990093529224
suggest O 0 0.00311695015989244
that O 0 0.0012660777429118752
a O 0 0.0030494946986436844
substantial O 0 0.005872947163879871
burden O 0 0.1597224473953247
of O 0 0.23633092641830444
PAX6 B-Disease 1 1.0
- I-Disease 1 0.99998939037323
related I-Disease 1 0.9979161620140076
disease I-Disease 1 1.0
remains O 0 0.18248708546161652
to O 0 0.002414178103208542
be O 0 0.0022735644597560167
uncovered O 0 0.01615956425666809
. O 0 0.0057761347852647305
. O 0 0.010431491769850254

The O 0 0.016741115599870682
chromosomal O 0 0.020841902121901512
order O 0 0.006030905991792679
of O 0 0.005501979496330023
genes O 0 0.005290720611810684
controlling O 0 0.0072641875594854355
the O 0 0.004879178944975138
major O 0 0.11327105015516281
histocompatibility O 1 0.9999997615814209
complex O 0 0.10696549713611603
, O 0 0.007279532961547375
properdin O 1 0.99891197681427
factor O 0 0.035608045756816864
B O 1 0.647528886795044
, O 0 0.0036505141761153936
and O 0 0.0050537777133286
deficiency B-Disease 1 0.9999990463256836
of I-Disease 0 0.006547838915139437
the I-Disease 0 0.018535463139414787
second I-Disease 0 0.02092362940311432
component I-Disease 0 0.01291526760905981
of I-Disease 0 0.007347168400883675
complement I-Disease 0 0.020471671596169472
. O 0 0.011398177593946457

The O 0 0.011018532328307629
relationship O 0 0.008089561946690083
of O 0 0.005408674478530884
the O 0 0.005745648872107267
genes O 0 0.006327914074063301
coding O 0 0.011311556212604046
for O 0 0.0045965141616761684
HLA O 1 0.9982483386993408
to O 0 0.0022044668439775705
those O 0 0.0017691716784611344
coding O 0 0.006149502005428076
for O 0 0.0030863273423165083
properdin O 0 0.32078081369400024
Factor O 0 0.01683703437447548
B O 0 0.07195018976926804
allotypes O 0 0.03798091411590576
and O 0 0.00346511066891253
for O 0 0.005072677042335272
deficiency B-Disease 1 0.999996542930603
of I-Disease 0 0.006911419797688723
the I-Disease 0 0.006110533606261015
second I-Disease 0 0.0064934357069432735
component I-Disease 0 0.006740869954228401
of I-Disease 0 0.0037059704773128033
complement I-Disease 0 0.011693207547068596
( O 0 0.011443745344877243
C2 O 1 0.9999902248382568
) O 0 0.0026240854058414698
was O 0 0.002590121468529105
studied O 0 0.0024885800667107105
in O 0 0.001376860192976892
families O 0 0.002308612922206521
of O 0 0.010145570151507854
patients O 1 0.9999983310699463
with O 1 0.9993394017219543
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9984569549560547

Patients O 1 0.6408458948135376
were O 0 0.004706145264208317
selected O 0 0.004524100571870804
because O 0 0.0018085971241816878
they O 0 0.0013244166038930416
were O 0 0.0022875701542943716
heterozygous O 0 0.0073667182587087154
or O 0 0.005166980903595686
homozygous O 0 0.024174897000193596
for O 0 0.161280557513237
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.6208153367042542

12 O 0 0.012426161207258701
families O 0 0.005116199608892202
with O 0 0.0030915727838873863
15 O 0 0.005996707361191511
matings O 0 0.01893855817615986
informative O 0 0.017001766711473465
for O 0 0.17690056562423706
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.06515344232320786
found O 0 0.018980367109179497
. O 0 0.016236113384366035

Of O 0 0.0152128329500556
57 O 0 0.020301632583141327
informative O 0 0.015494619496166706
meioses O 0 0.029765969142317772
, O 0 0.0031788430642336607
two O 0 0.001562035526148975
crossovers O 0 0.0042351046577095985
were O 0 0.0015478383284062147
noted O 0 0.0032906685955822468
between O 0 0.003432492958381772
the O 1 0.7467901110649109
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.05453084409236908
and O 0 0.0031229390297085047
the O 0 0.24868758022785187
HLA O 1 1.0
- O 1 0.9954786896705627
B O 0 0.4353480637073517
gene O 0 0.0038790376856923103
, O 0 0.0018163092900067568
with O 0 0.001401121960952878
a O 0 0.0038053831085562706
recombinant O 0 0.014276793226599693
fraction O 0 0.00813134666532278
of O 0 0.007600824814289808
0 O 0 0.019179150462150574
. O 0 0.011569834314286709

035 O 1 0.9898437261581421
. O 0 0.05581081286072731

A O 0 0.02490786276757717
lod O 0 0.055193156003952026
score O 0 0.00520913815125823
of O 0 0.0035132726188749075
13 O 0 0.004070995841175318
was O 0 0.0037487761583179235
calculated O 0 0.0029328230302780867
for O 0 0.0025202876422554255
linkage O 0 0.028497036546468735
between O 0 0.21802647411823273
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999725818634033
HLA O 1 1.0
- O 1 0.9997304081916809
B O 0 0.28427261114120483
at O 0 0.004371847026050091
a O 0 0.0025176298804581165
maximum O 0 0.003086553420871496
likelihood O 0 0.0035540235694497824
value O 0 0.0018919501453638077
of O 0 0.002317290287464857
the O 0 0.0040491498075425625
recombinant O 0 0.0148992370814085
fraction O 0 0.007645435631275177
of O 0 0.007726163603365421
0 O 0 0.020061548799276352
. O 0 0.013517833314836025

04 O 1 0.9647297859191895
. O 0 0.05501429736614227

18 O 0 0.014091112650930882
families O 0 0.006333366967737675
with O 0 0.003383226692676544
21 O 0 0.006064234767109156
informative O 0 0.007318900432437658
matings O 0 0.009626075625419617
for O 0 0.002486263634636998
both O 0 0.0036293973680585623
properdin O 1 0.8072489500045776
Factor O 0 0.02084415778517723
B O 1 0.6023305654525757
allotype O 1 0.856071412563324
and O 0 0.011383394710719585
HLA O 1 0.9999994039535522
- O 1 0.7948964238166809
B O 0 0.03554345667362213
were O 0 0.006213608663529158
found O 0 0.010587349534034729
. O 0 0.015459131449460983

Of O 0 0.014204273000359535
72 O 0 0.023112699389457703
informative O 0 0.016979625448584557
meioses O 0 0.03848519176244736
, O 0 0.0035369161050766706
three O 0 0.0026006929110735655
recombinants O 0 0.04390731826424599
were O 0 0.0024404991418123245
found O 0 0.002549944445490837
, O 0 0.002098951954394579
giving O 0 0.002798959147185087
a O 0 0.004064657725393772
recombinant O 0 0.01371433213353157
fraction O 0 0.007283303886651993
of O 0 0.006914546713232994
0 O 0 0.018310315907001495
. O 0 0.012832805514335632

042 O 1 0.9283266067504883
. O 0 0.058618079870939255

A O 0 0.025387680158019066
lod O 0 0.053393326699733734
score O 0 0.006742945406585932
of O 0 0.004947572480887175
16 O 0 0.00784221664071083
between O 0 0.007409387268126011
HLA O 1 0.9999996423721313
- O 0 0.42416059970855713
B O 0 0.024594852700829506
and O 0 0.0029456582851707935
Factor O 0 0.010794277302920818
B O 0 0.023479506373405457
allotypes O 0 0.020184271037578583
was O 0 0.005443852860480547
calculated O 0 0.0042042979039251804
at O 0 0.0032714661210775375
a O 0 0.0024347477592527866
maximum O 0 0.0030664356891065836
likelihood O 0 0.0035158174578100443
value O 0 0.0016442756168544292
of O 0 0.002086476655676961
the O 0 0.00367367803119123
recombinant O 0 0.012113319709897041
fraction O 0 0.006483233533799648
of O 0 0.006161428056657314
0 O 0 0.01676269993185997
. O 0 0.010038896463811398

04 O 1 0.9599395990371704
. O 0 0.04950046166777611

A O 0 0.021055305376648903
crossover O 0 0.015770861878991127
was O 0 0.008864369243383408
shown O 0 0.002854182617738843
to O 0 0.001153143821284175
have O 0 0.0007770493975840509
occurred O 0 0.0018379443790763617
between O 0 0.00116463762242347
genes O 0 0.0017174358945339918
for O 0 0.0017804260132834315
Factor O 0 0.007601001765578985
B O 0 0.29313966631889343
and O 0 0.005125260911881924
HLA O 1 0.9999997615814209
- O 0 0.20706689357757568
D O 0 0.038239412009716034
, O 0 0.0020029633305966854
in O 0 0.0018367550801485777
which O 0 0.0032948812004178762
HLA O 1 0.9999927282333374
- O 0 0.1962250918149948
D O 1 0.9553311467170715
segregared O 0 0.14558938145637512
with O 0 0.006213334854692221
HLA O 1 0.9999997615814209
- O 0 0.09970978647470474
A O 0 0.010460316203534603
and O 0 0.007186803035438061
B O 0 0.4397551119327545
. O 0 0.012578149326145649

These O 0 0.004733739886432886
studies O 0 0.004545934963971376
suggest O 0 0.0032507958821952343
that O 0 0.0011253355769440532
the O 0 0.002185971476137638
genes O 0 0.002195787848904729
for O 0 0.0020727275405079126
Factor O 0 0.03995789587497711
B O 1 0.9980997443199158
and O 0 0.15890654921531677
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00228669005446136
located O 0 0.005406207405030727
outside O 0 0.0029551759362220764
those O 0 0.0017180704744532704
for O 0 0.0038404599763453007
HLA O 1 0.9999984502792358
, O 0 0.0021516280248761177
that O 0 0.0009515840793028474
the O 0 0.0014003129908815026
order O 0 0.0017557254759594798
of O 0 0.0032789784017950296
genese O 1 0.9938203692436218
is O 0 0.009791307151317596
HLA O 1 0.9999951124191284
- O 0 0.008649274706840515
A O 0 0.005407961551100016
, O 0 0.003549017012119293
- O 0 0.009014029055833817
B O 0 0.011813700199127197
, O 0 0.003253006376326084
- O 0 0.009222989901900291
D O 0 0.02467774599790573
, O 0 0.0035216426476836205
Factor O 0 0.011517347767949104
B O 0 0.3452502191066742
allotype O 1 0.9976342916488647
, O 1 0.7981658577919006
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.004275741055607796
that O 0 0.001829328597523272
the O 0 0.0033000842668116093
genes O 0 0.005874008405953646
coding O 0 0.031956013292074203
for O 0 0.019219214096665382
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.018605047836899757
Factor O 0 0.4399353563785553
B O 0 0.04570355266332626
allotypes O 0 0.012050440534949303
are O 0 0.0011535579105839133
approximately O 0 0.002857457846403122
3 O 0 0.004256607498973608
- O 0 0.006712085567414761
- O 0 0.006075724959373474
5 O 0 0.0034623323008418083
centimorgans O 0 0.009146537631750107
from O 0 0.00263314601033926
the O 0 0.006531747058033943
HLA O 1 0.9999994039535522
- O 0 0.020804323256015778
A O 0 0.008224925957620144
and O 0 0.006523642223328352
HLA O 1 1.0
- O 1 0.9899101853370667
B O 1 0.9057376384735107
loci O 0 0.009925578720867634
, O 0 0.0020620066206902266
and O 0 0.0013925516977906227
that O 0 0.0012344303540885448
the O 0 0.0024918231647461653
apparent O 0 0.006971142254769802
lack O 0 0.0047830878756940365
of O 0 0.004790775012224913
recombinants O 1 0.8095582127571106
between O 0 0.0027356641367077827
the O 0 0.004759783390909433
Factor O 0 0.4066401422023773
B O 1 0.9937382936477661
gene O 0 0.013930496759712696
and O 0 0.04940730333328247
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.02516130357980728
suggests O 0 0.005118054337799549
that O 0 0.0012495189439505339
these O 0 0.0007738169515505433
two O 0 0.0014468231238424778
genes O 0 0.0029061036184430122
lie O 0 0.004788097459822893
in O 0 0.002455345122143626
close O 0 0.004194049164652824
proximity O 0 0.005004433449357748
to O 0 0.0031105370726436377
one O 0 0.004511991515755653
another O 0 0.009664947167038918
. O 0 0.01200826745480299

Distribution O 0 0.01313729677349329
of O 0 0.010706285946071148
emerin O 1 0.9797711968421936
and O 0 0.00569676561281085
lamins O 1 0.9951285123825073
in O 0 0.003762063104659319
the O 0 0.007055348716676235
heart O 1 0.9998815059661865
and O 0 0.003229859983548522
implications O 0 0.010928794741630554
for O 0 0.010053502395749092
Emery B-Disease 1 0.999997615814209
- I-Disease 1 0.9999974966049194
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9664818048477173

Emerin O 0 0.3716050982475281
is O 0 0.008477972820401192
a O 0 0.006482680328190327
nuclear O 0 0.008570173755288124
membrane O 0 0.008024923503398895
protein O 0 0.003948994912207127
which O 0 0.001249849796295166
is O 0 0.0019060058984905481
missing O 0 0.004393007606267929
or O 0 0.0039080409333109856
defective O 1 0.9781890511512756
in O 0 0.011124473065137863
Emery B-Disease 1 0.9999873638153076
- I-Disease 1 0.9999867677688599
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999979734420776
EDMD B-Disease 1 1.0
) O 0 0.02127681113779545
. O 0 0.014037995599210262

It O 0 0.004969337489455938
is O 0 0.003041314659640193
one O 0 0.001950684585608542
member O 0 0.0024679771158844233
of O 0 0.0018936401465907693
a O 0 0.0039762165397405624
family O 0 0.007889769971370697
of O 0 0.06191154196858406
lamina O 1 0.9999998807907104
- O 1 0.5977832674980164
associated O 0 0.004508821293711662
proteins O 0 0.0026067171711474657
which O 0 0.001371793681755662
includes O 0 0.003674345323815942
LAP1 O 1 0.9966781139373779
, O 0 0.00557189853861928
LAP2 O 1 0.9956892132759094
and O 0 0.007532315328717232
lamin O 1 0.999647855758667
B O 1 0.995573878288269
receptor O 0 0.04235118255019188
( O 0 0.021534333005547523
LBR O 1 0.9998183846473694
) O 0 0.015877071768045425
. O 0 0.014741572551429272

A O 0 0.015383574180305004
panel O 0 0.009280008263885975
of O 0 0.006642474792897701
16 O 0 0.011620954610407352
monoclonal O 0 0.10127129405736923
antibodies O 0 0.029038088396191597
( O 0 0.00986495427787304
mAbs O 0 0.43580517172813416
) O 0 0.0033233691938221455
has O 0 0.001800566096790135
been O 0 0.0017281988402828574
mapped O 0 0.003542075864970684
to O 0 0.001059453352354467
six O 0 0.001194183831103146
specific O 0 0.001159994164481759
sites O 0 0.0014566545141860843
throughout O 0 0.0019167637219652534
the O 0 0.0033238381147384644
emerin O 0 0.03483879566192627
molecule O 0 0.006338170263916254
using O 0 0.004694562871009111
phage O 0 0.12965981662273407
- O 0 0.010908772237598896
displayed O 0 0.00833200290799141
peptide O 0 0.007497001904994249
libraries O 0 0.003474239492788911
and O 0 0.0016914891311898828
has O 0 0.0014859047951176763
been O 0 0.0014715208671987057
used O 0 0.0018000827403739095
to O 0 0.0023194497916847467
localize O 0 0.021367814391851425
emerin O 0 0.20837357640266418
in O 0 0.004643842112272978
human O 0 0.007917413488030434
and O 0 0.010786235332489014
rabbit O 1 0.9999752044677734
heart O 1 0.9999953508377075
. O 0 0.01940416730940342

Several O 0 0.014669347554445267
mAbs O 0 0.058583974838256836
against O 0 0.008637135848402977
different O 0 0.004107845481485128
emerin O 1 0.5520006418228149
epitopes O 0 0.02785322442650795
did O 0 0.004554332233965397
not O 0 0.002206004923209548
recognize O 0 0.006168632302433252
intercalated O 0 0.047750625759363174
discs O 0 0.011391978710889816
in O 0 0.003762531094253063
the O 0 0.017106816172599792
heart O 1 0.999995231628418
, O 0 0.003511670045554638
though O 0 0.002103663282468915
they O 0 0.0014308091485872865
recognized O 0 0.004255795385688543
cardiomyocyte O 0 0.07099481672048569
nuclei O 0 0.006233603693544865
strongly O 0 0.0036848229356110096
, O 0 0.0017295073485001922
both O 0 0.0014282518532127142
at O 0 0.004143897444009781
the O 0 0.004309061914682388
rim O 0 0.012192323803901672
and O 0 0.0025673904456198215
in O 0 0.00490473723039031
intranuclear O 1 0.9607551693916321
spots O 0 0.01895044557750225
or O 0 0.007202839013189077
channels O 0 0.011232182383537292
. O 0 0.011745242401957512

A O 0 0.08036322146654129
polyclonal O 1 0.9976378679275513
rabbit O 1 0.9853063821792603
antiserum O 1 0.6630291938781738
against O 0 0.010671885684132576
emerin O 1 0.6678218841552734
did O 0 0.004476737231016159
recognize O 0 0.003885015146806836
both O 0 0.0023934540804475546
nuclear O 0 0.006155287381261587
membrane O 0 0.006270963232964277
and O 0 0.0027700604405254126
intercalated O 1 0.7817115783691406
discs O 0 0.010404072701931
but O 0 0.0017880353843793273
, O 0 0.00225662300363183
after O 0 0.0033242187928408384
affinity O 0 0.0058267065323889256
purification O 0 0.01669311709702015
against O 0 0.004199102520942688
a O 0 0.004847888834774494
pure O 0 0.015429201535880566
- O 0 0.01965651474893093
emerin O 0 0.03550593927502632
band O 0 0.004696606658399105
on O 0 0.00244105770252645
a O 0 0.0033123972825706005
western O 0 0.00555887445807457
blot O 0 0.3209457993507385
, O 0 0.004115571267902851
it O 0 0.003165503963828087
stained O 0 0.10185907036066055
only O 0 0.0028454032726585865
the O 0 0.00544922286644578
nuclear O 0 0.013611126691102982
membrane O 0 0.02194564789533615
. O 0 0.011695819906890392

These O 0 0.006717998068779707
results O 0 0.005892157554626465
would O 0 0.0022495687007904053
not O 0 0.0011777494801208377
be O 0 0.001172193675301969
expected O 0 0.002054597018286586
if O 0 0.0020640071015805006
immunostaining O 0 0.021292513236403465
at O 0 0.007418264169245958
intercalated O 1 0.8087084293365479
discs O 0 0.008469056338071823
were O 0 0.0023947113659232855
due O 0 0.0026891911402344704
to O 0 0.001466491841711104
a O 0 0.0021212820429354906
product O 0 0.0027807820588350296
of O 0 0.002693525981158018
the O 0 0.0066511924378573895
emerin O 1 0.9998916387557983
gene O 0 0.005381506402045488
and O 0 0.001801078557036817
, O 0 0.002470608102157712
therefore O 0 0.0021653634030371904
, O 0 0.0018666019896045327
cast O 0 0.0024736723862588406
some O 0 0.0012364620342850685
doubt O 0 0.0028938872274011374
upon O 0 0.0025085851084440947
the O 0 0.0037489538080990314
hypothesis O 0 0.011962192133069038
that O 0 0.005757756531238556
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999996423721313
in O 0 0.4870049059391022
EDMD B-Disease 1 0.9999998807907104
are O 0 0.0025207768194377422
caused O 0 0.006257937289774418
by O 0 0.002023808192461729
absence O 0 0.007982072420418262
of O 0 0.010001009330153465
emerin O 1 0.9996912479400635
from O 0 0.00969183910638094
intercalated O 1 0.9984942674636841
discs O 0 0.3211773931980133
. O 0 0.018685204908251762

Although O 0 0.017637431621551514
emerin O 1 0.9704118967056274
was O 0 0.009522895328700542
abundant O 0 0.005989827681332827
in O 0 0.0027664853259921074
the O 0 0.0034303455613553524
membranes O 0 0.007817626930773258
of O 0 0.006496622692793608
cardiomyocyte O 1 0.9999500513076782
nuclei O 0 0.007070634979754686
, O 0 0.002305544214323163
it O 0 0.0013515931786969304
was O 0 0.0033507400657981634
absent O 0 0.0036620935425162315
from O 0 0.0013836397556588054
many O 0 0.0016690752236172557
non O 0 0.013462941162288189
- O 1 0.9709330201148987
myocyte O 1 0.9999821186065674
cells O 0 0.006597595755010843
in O 0 0.004205855540931225
the O 0 0.01005179900676012
heart O 1 0.9998836517333984
. O 0 0.018438728526234627

This O 0 0.0059443251229822636
distribution O 0 0.006652790121734142
of O 0 0.0061622485518455505
emerin O 1 0.9922208189964294
was O 0 0.006027980241924524
similar O 0 0.0017997982213273644
to O 0 0.0011526934104040265
that O 0 0.001147097209468484
of O 0 0.002562756882980466
lamin O 1 0.969570517539978
A O 0 0.0058043417520821095
, O 0 0.0021722386591136456
a O 0 0.0022377304267138243
candidate O 0 0.004453268833458424
gene O 0 0.0024649209808558226
for O 0 0.0014146147295832634
an O 0 0.002876047044992447
autosomal O 1 0.5312538743019104
form O 0 0.009109740145504475
of O 1 0.9913443326950073
EDMD B-Disease 1 1.0
. O 0 0.06793798506259918

In O 0 0.014038999564945698
contrast O 0 0.017057625576853752
, O 0 0.015361396595835686
lamin O 1 0.9997796416282654
B1 O 1 0.9999935626983643
was O 0 0.02053871750831604
absent O 0 0.012232531793415546
from O 0 0.00447166059166193
cardiomyocyte O 1 0.7504560947418213
nuclei O 0 0.00910605676472187
, O 0 0.0038514649495482445
showing O 0 0.008707287721335888
that O 0 0.005096412729471922
lamin O 1 0.9999755620956421
B1 O 1 0.9999908208847046
is O 0 0.003190847812220454
not O 0 0.0013449506368488073
essential O 0 0.003251896006986499
for O 0 0.0021593032870441675
localization O 0 0.007456584367901087
of O 0 0.003828456625342369
emerin O 0 0.16216666996479034
to O 0 0.004267599433660507
the O 0 0.00815628096461296
nuclear O 0 0.029010580852627754
lamina O 1 0.9994438290596008
. O 0 0.021566130220890045

Lamin O 1 0.9999387264251709
B1 O 1 0.9999806880950928
is O 0 0.008756221272051334
also O 0 0.004267172422260046
almost O 0 0.00414904672652483
completely O 0 0.009333536960184574
absent O 0 0.0223549772053957
from O 0 0.014691784046590328
skeletal O 1 0.9999997615814209
muscle O 1 0.9999961853027344
nuclei O 1 0.8763381838798523
. O 0 0.02175852842628956

In O 0 0.022219665348529816
EDMD B-Disease 1 0.9999192953109741
, O 0 0.006143353413790464
the O 0 0.004341602325439453
additional O 0 0.0036548420321196318
absence O 0 0.008014479652047157
of O 0 0.013847775757312775
lamin O 1 0.9999990463256836
B1 O 1 1.0
from O 0 0.21622583270072937
heart O 1 0.9999997615814209
and O 1 0.9597341418266296
skeletal O 1 1.0
muscle O 1 0.9999991655349731
nuclei O 1 0.5763244032859802
which O 0 0.0028508107643574476
already O 0 0.005364509765058756
lack O 0 0.013160252943634987
emerin O 1 0.9961512684822083
may O 0 0.0025576255284249783
offer O 0 0.0014748795656487346
an O 0 0.0013042843202129006
alternative O 0 0.0024066611658781767
explanation O 0 0.003202926367521286
of O 0 0.0025935163721442223
why O 0 0.003925735130906105
these O 0 0.0017769851256161928
tissues O 0 0.008253846317529678
are O 0 0.001984778791666031
particularly O 0 0.006730113178491592
affected O 0 0.01104388851672411
. O 0 0.0065879239700734615
. O 0 0.011941931210458279

Genetic O 0 0.018021460622549057
mapping O 0 0.011107929982244968
of O 0 0.0067403847351670265
the O 0 0.015000946819782257
copper B-Disease 1 0.9999738931655884
toxicosis I-Disease 1 0.9999990463256836
locus O 1 0.793912947177887
in O 0 0.008429095149040222
Bedlington O 1 0.9998816251754761
terriers O 1 0.6499185562133789
to O 0 0.0037120571359992027
dog O 0 0.030042605474591255
chromosome O 0 0.006813866551965475
10 O 0 0.0022139560896903276
, O 0 0.001687689684331417
in O 0 0.0014583102893084288
a O 0 0.0028792456723749638
region O 0 0.005631324835121632
syntenic O 0 0.2561626732349396
to O 0 0.003175291232764721
human O 0 0.006971729453653097
chromosome O 0 0.01970650441944599
region O 0 0.016483962535858154
2p13 O 1 0.9980562925338745
- O 1 0.6919958591461182
p16 O 0 0.1904604285955429
. O 0 0.016539132222533226

Abnormal O 1 0.9999939203262329
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999990463256836
accumulation I-Disease 1 0.999906063079834
is O 0 0.005417156033217907
recognized O 0 0.004851409699767828
as O 0 0.002823726972565055
an O 0 0.013464600779116154
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999442100524902
man O 1 0.9999936819076538
, O 0 0.02147763967514038
mouse O 0 0.029989929869771004
, O 0 0.007133380509912968
rat O 1 0.689517617225647
and O 0 0.008578434586524963
dog O 1 0.5736165642738342
. O 0 0.016210900619626045

The O 0 0.013952522538602352
major O 0 0.024840837344527245
cause O 1 0.8959111571311951
of O 1 0.9997416138648987
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999949932098389
in O 0 0.04555158689618111
man O 0 0.0577675960958004
is O 0 0.0034233282785862684
a O 0 0.005582566373050213
dysfunctional O 1 0.9622406363487244
ATP7B O 1 0.9999415874481201
gene O 0 0.009312867186963558
, O 0 0.005311006214469671
causing O 1 0.6019482612609863
Wilson B-Disease 1 0.9999897480010986
disease I-Disease 1 1.0
( O 1 0.9998218417167664
WD B-Disease 1 0.9999996423721313
) O 0 0.014201241545379162
. O 0 0.012112676165997982

Mutations O 0 0.016186576336622238
in O 0 0.006189428269863129
the O 0 0.00909730140119791
ATP7B O 1 0.9998887777328491
genes O 0 0.005343425553292036
have O 0 0.0016026207013055682
also O 0 0.0019944051746279
been O 0 0.00209217332303524
demonstrated O 0 0.0052946521900594234
in O 0 0.004895978141576052
mouse O 0 0.06944353878498077
and O 0 0.008338636718690395
rat O 1 0.9864084720611572
. O 0 0.01658577285706997

The O 0 0.024994149804115295
ATP7B O 1 0.9998372793197632
gene O 0 0.010820413008332253
has O 0 0.002985701896250248
been O 0 0.0023491939064115286
excluded O 0 0.00358863384462893
in O 0 0.0020810586865991354
the O 0 0.003250786568969488
much O 0 0.004187649115920067
rarer O 1 0.5162478685379028
human O 0 0.15171903371810913
copper B-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9998681545257568
- I-Disease 1 0.9990519881248474
Indian I-Disease 0 0.03777123615145683
childhood I-Disease 1 0.9999918937683105
cirrhosis I-Disease 1 1.0
, O 0 0.07137402147054672
indicating O 0 0.28939419984817505
genetic O 0 0.030263422057032585
heterogeneity O 0 0.12840400636196136
. O 0 0.020334342494606972

By O 0 0.006769177503883839
investigating O 0 0.012442287057638168
the O 0 0.009469741024076939
common O 0 0.1986580789089203
autosomal O 1 0.9999967813491821
recessive O 1 0.9999996423721313
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9995998740196228
CT B-Disease 1 0.9999972581863403
) O 0 0.006048886105418205
in O 0 0.005390155594795942
Bedlington O 1 0.9998630285263062
terriers O 1 0.8369621634483337
, O 0 0.0029723872430622578
we O 0 0.0013716317480430007
have O 0 0.0009468765929341316
identified O 0 0.0020433927420526743
a O 0 0.0017250444507226348
new O 0 0.0025037964805960655
locus O 0 0.01102440059185028
involved O 0 0.004907696507871151
in O 0 0.11476077139377594
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.998272180557251

We O 0 0.008342316374182701
examined O 0 0.01120388600975275
whether O 0 0.00503454590216279
the O 0 0.00916271936148405
WD B-Disease 1 0.9999827146530151
gene O 0 0.011460836045444012
ATP7B O 1 0.9984488487243652
was O 0 0.008204314857721329
also O 0 0.0035619232803583145
causative O 0 0.019056666642427444
for O 0 0.0031864235643297434
CT B-Disease 1 0.5596451759338379
by O 0 0.002198657486587763
investigating O 0 0.006858757697045803
the O 0 0.006569754797965288
chromosomal O 1 0.9889028668403625
co O 1 0.7939717173576355
- O 0 0.01781913824379444
localization O 0 0.01266718003898859
of O 0 0.0053147305734455585
ATP7B O 1 0.9995076656341553
and O 0 0.004311118274927139
C04107 O 0 0.02161373756825924
, O 0 0.0034380301367491484
using O 0 0.0026327730156481266
fluorescence O 0 0.00861402414739132
in O 0 0.004085750784724951
situ O 0 0.04830741509795189
hybridization O 0 0.015224067494273186
( O 0 0.0095480652526021
FISH O 0 0.01790483668446541
) O 0 0.009674363769590855
. O 0 0.011225978843867779

C04107 O 0 0.07673851400613785
is O 0 0.0065916758030653
an O 0 0.005080022849142551
anonymous O 0 0.013641780242323875
microsatellite O 0 0.04920276626944542
marker O 0 0.0273733027279377
closely O 0 0.010354631580412388
linked O 0 0.01800195500254631
to O 0 0.010689329355955124
CT B-Disease 1 0.999915361404419
. O 0 0.017843889072537422

However O 0 0.015445060096681118
, O 0 0.012218994088470936
BAC O 1 0.9998327493667603
clones O 0 0.12652242183685303
containing O 0 0.013174857012927532
ATP7B O 1 0.9908497333526611
and O 0 0.004259595647454262
C04107 O 0 0.02196609415113926
mapped O 0 0.007184286136180162
to O 0 0.0026102059055119753
the O 0 0.005395658779889345
canine O 1 0.9703456163406372
chromosome O 0 0.012633119709789753
regions O 0 0.005481764208525419
CFA22q11 O 1 0.9626347422599792
and O 0 0.0043925633653998375
CFA10q26 O 1 0.9990357160568237
, O 0 0.004557196982204914
respectively O 0 0.005905036814510822
, O 0 0.0035685128532350063
demonstrating O 0 0.009706240147352219
that O 0 0.00461104279384017
WD B-Disease 1 0.9811182618141174
cannot O 0 0.0040008388459682465
be O 0 0.0035237332340329885
homologous O 0 0.01626772992312908
to O 0 0.00860383827239275
CT B-Disease 1 0.9992917776107788
. O 0 0.019686488434672356

The O 0 0.02331816777586937
copper O 1 0.997623860836029
transport O 0 0.14046017825603485
genes O 0 0.014777791686356068
CTR1 O 1 0.9998801946640015
and O 0 0.00525148818269372
CTR2 O 1 0.9997451901435852
were O 0 0.0028483120258897543
also O 0 0.002115121576935053
excluded O 0 0.004061472602188587
as O 0 0.0020859602373093367
candidate O 0 0.004363940097391605
genes O 0 0.003172779455780983
for O 0 0.002869176911190152
CT B-Disease 1 0.9979369640350342
since O 0 0.0022440506145358086
they O 0 0.0009735581115819514
both O 0 0.001456776517443359
mapped O 0 0.007248726207762957
to O 0 0.004460962023586035
canine O 1 0.9982606768608093
chromosome O 0 0.12009189277887344
region O 0 0.02301626466214657
CFA11q22 O 1 0.9950934648513794
. O 0 0.017708683386445045

2 O 0 0.04604880511760712
- O 0 0.04096696898341179
22 O 0 0.025640495121479034
. O 0 0.016089221462607384

5 O 0 0.056530456990003586
. O 0 0.03439579904079437

A O 0 0.01494880486279726
transcribed O 0 0.011542145162820816
sequence O 0 0.004310670308768749
identified O 0 0.0033886253368109465
from O 0 0.0019842565525323153
the O 0 0.003749360330402851
C04107 O 1 0.9201313853263855
- O 0 0.030937323346734047
containing O 0 0.008881306275725365
BAC O 1 0.9997726082801819
was O 0 0.00597212091088295
found O 0 0.0020120064727962017
to O 0 0.0011402892414480448
be O 0 0.0011626479681581259
homologous O 0 0.003536848584190011
to O 0 0.0011771197896450758
a O 0 0.002380231162533164
gene O 0 0.0025879566092044115
expressed O 0 0.002176556270569563
from O 0 0.0022272279020398855
human O 0 0.005844588857144117
chromosome O 0 0.04182635247707367
2p13 O 1 0.9915185570716858
- O 0 0.08978518843650818
p16 O 0 0.01988038420677185
, O 0 0.003055682172998786
a O 0 0.003259093966335058
region O 0 0.004643104039132595
devoid O 0 0.009102554991841316
of O 0 0.004336773883551359
any O 0 0.004064830020070076
positional O 0 0.021839218214154243
candidate O 0 0.0152548523619771
genes O 0 0.011490121483802795
. O 0 0.010716887190937996

Molecular O 0 0.013773700222373009
analysis O 0 0.005027600098401308
of O 0 0.00451325299218297
the O 0 0.00714695593342185
APC B-Disease 1 0.9916833639144897
gene O 0 0.004262120928615332
in O 0 0.002144933445379138
205 O 0 0.008706608787178993
families O 0 0.003327705664560199
: O 0 0.0034301811829209328
extended O 0 0.006904837675392628
genotype O 0 0.020131845027208328
- O 0 0.01154479943215847
phenotype O 0 0.009019725024700165
correlations O 0 0.008448654785752296
in O 0 0.00461485655978322
FAP B-Disease 1 0.9998629093170166
and O 0 0.0025745974853634834
evidence O 0 0.00218939408659935
for O 0 0.0014130801428109407
the O 0 0.0024106393102556467
role O 0 0.003680802183225751
of O 0 0.003999524284154177
APC B-Disease 1 0.9975770115852356
amino O 0 0.006607462652027607
acid O 0 0.009300434961915016
changes O 0 0.005494563840329647
in O 1 0.8487272262573242
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.5402425527572632

BACKGROUND O 0 0.19260770082473755
/ O 0 0.47081395983695984
AIMS O 0 0.019495122134685516
The O 0 0.006665188819169998
development O 0 0.039696719497442245
of O 1 0.9998968839645386
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.09696861356496811
a O 0 0.0052844262681901455
variable O 0 0.0036703255027532578
range O 0 0.0027781904209405184
of O 0 0.004030781798064709
extracolonic O 1 0.8656953573226929
manifestations O 1 0.9430877566337585
in O 0 0.08393682539463043
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999997615814209
FAP B-Disease 1 1.0
) O 0 0.006280562374740839
is O 0 0.0021513288374990225
the O 0 0.0016795459669083357
result O 0 0.0018246694235131145
of O 0 0.00222760415636003
the O 0 0.004668848123401403
dominant O 0 0.014479785226285458
inheritance O 0 0.12626251578330994
of O 1 0.9859874844551086
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999953508377075
APC B-Disease 1 0.9999997615814209
) O 0 0.017384929582476616
gene O 0 0.01739540882408619
mutations O 0 0.016279058530926704
. O 0 0.013262120075523853

In O 0 0.00667777843773365
this O 0 0.002317004604265094
study O 0 0.0029267347417771816
, O 0 0.0020481611136347055
direct O 0 0.001996363280341029
mutation O 0 0.0025799099821597338
analysis O 0 0.0018369491444900632
of O 0 0.0028603938408195972
the O 0 0.00743108382448554
APC B-Disease 1 0.9999631643295288
gene O 0 0.0054812184534966946
was O 0 0.0049951644614338875
performed O 0 0.003259425750002265
to O 0 0.0017671399982646108
determine O 0 0.004745902959257364
genotype O 0 0.013539910316467285
- O 0 0.008189111016690731
phenotype O 0 0.00750421779230237
correlations O 0 0.005191484931856394
for O 0 0.0021138377487659454
nine O 0 0.005257215350866318
extracolonic O 1 0.6516768336296082
manifestations O 0 0.027244621887803078
and O 0 0.002372094662860036
to O 0 0.0019377125427126884
investigate O 0 0.005429847165942192
the O 0 0.004480346571654081
incidence O 1 0.9531829953193665
of O 0 0.01365619245916605
APC B-Disease 1 0.9999451637268066
mutations O 0 0.006511012092232704
in O 0 0.0051171439699828625
non O 1 0.9987903237342834
- O 1 0.9999994039535522
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8491806983947754

METHODS O 0 0.022624611854553223
The O 0 0.015081380493938923
APC B-Disease 1 0.9964011907577515
gene O 0 0.007930810563266277
was O 0 0.005767148453742266
analysed O 0 0.008707189932465553
in O 0 0.003612024476751685
190 O 0 0.009933937340974808
unrelated O 0 0.012380531057715416
FAP B-Disease 1 0.9998441934585571
and O 0 0.005702737718820572
15 O 0 0.011928222142159939
non O 1 0.9873615503311157
- O 1 0.9999977350234985
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999980926513672
using O 0 0.016238488256931305
denaturing O 1 0.9997171759605408
gradient O 0 0.420798122882843
gel O 0 0.38653698563575745
electrophoresis O 0 0.019909903407096863
, O 0 0.004012156277894974
the O 0 0.0040664286352694035
protein O 0 0.006558604538440704
truncation O 0 0.01626608707010746
test O 0 0.0048496052622795105
, O 0 0.0030130124650895596
and O 0 0.003339880146086216
direct O 0 0.007812635973095894
sequencing O 0 0.019618721678853035
. O 0 0.013651279732584953

RESULTS O 0 0.026267968118190765
Chain O 0 0.02902650274336338
terminating O 0 0.022333092987537384
signals O 0 0.004865923430770636
were O 0 0.0017766824457794428
only O 0 0.0013536271871998906
identified O 0 0.002821010770276189
in O 0 0.0022439181338995695
patients O 0 0.008963215164840221
belonging O 0 0.00464486051350832
to O 0 0.0020591963548213243
the O 0 0.005143015645444393
FAP B-Disease 1 0.9999970197677612
group O 0 0.006209531798958778
( O 0 0.007316016126424074
105 O 0 0.02219473011791706
patients O 1 0.7975391149520874
) O 0 0.009587086737155914
. O 0 0.011066063307225704

Amino O 0 0.02488488331437111
acid O 0 0.013954751193523407
changes O 0 0.0031213657930493355
were O 0 0.0019234024221077561
identified O 0 0.003000667318701744
in O 0 0.0018773582996800542
four O 0 0.002391137182712555
patients O 0 0.06251797825098038
, O 0 0.0013235518708825111
three O 0 0.0010436479933559895
of O 0 0.0016753082163631916
whom O 0 0.003218755591660738
belonged O 0 0.004274470265954733
to O 0 0.0011870559537783265
the O 0 0.0027807001024484634
non O 0 0.01862436905503273
- O 1 0.9463131427764893
FAP O 1 0.9999992847442627
group O 0 0.009594044648110867
of O 1 0.9994699358940125
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 1 0.8914042711257935

Genotype O 1 0.9835855960845947
- O 0 0.11225923150777817
phenotype O 0 0.019851675257086754
correlations O 0 0.009970283135771751
identified O 0 0.005076591856777668
significant O 0 0.0027083544991910458
differences O 0 0.00241276016458869
in O 0 0.00203196844086051
the O 0 0.0024320208467543125
nature O 0 0.003299472387880087
of O 0 0.002552109071984887
certain O 0 0.0037670216988772154
extracolonic O 1 0.9972892999649048
manifestations O 1 0.9987265467643738
in O 0 0.4721400737762451
FAP B-Disease 1 1.0
patients O 1 0.9968308806419373
belonging O 0 0.008682007901370525
to O 0 0.0032426142133772373
three O 0 0.0048431940376758575
mutation O 0 0.013950697146356106
subgroups O 0 0.030819186940789223
. O 0 0.01645800657570362

CONCLUSIONS O 0 0.029691580682992935
Extended O 0 0.026467857882380486
genotype O 0 0.15243737399578094
- O 0 0.018543677404522896
phenotype O 0 0.010550040751695633
correlations O 0 0.006198286544531584
made O 0 0.002538063330575824
in O 0 0.0014767864486202598
this O 0 0.0012014185776934028
study O 0 0.002150162123143673
may O 0 0.001487426576204598
have O 0 0.0007313353708013892
the O 0 0.0015610171249136329
potential O 0 0.0019728660117834806
to O 0 0.0010153857292607427
determine O 0 0.002003417117521167
the O 0 0.0016854784917086363
most O 0 0.0016209379537031054
appropriate O 0 0.0037533484864979982
surveillance O 0 0.006173642352223396
and O 0 0.0037029350642114878
prophylactic O 1 0.9996945858001709
treatment O 1 0.9999840259552002
regimens O 1 0.9998760223388672
for O 0 0.00366158876568079
those O 0 0.002160674426704645
patients O 1 0.7803754210472107
with O 0 0.00228126160800457
mutations O 0 0.004503888543695211
associated O 0 0.0029958426021039486
with O 0 0.0023482071701437235
life O 0 0.3476632237434387
threatening O 1 0.9466367363929749
conditions O 1 0.871819019317627
. O 0 0.01535934116691351

This O 0 0.005921866744756699
study O 0 0.005178661551326513
also O 0 0.0022705625742673874
provided O 0 0.0022407113574445248
evidence O 0 0.0020501073449850082
for O 0 0.0017376007745042443
the O 0 0.002721973927691579
pathological O 0 0.10079129040241241
nature O 0 0.0042893667705357075
of O 0 0.003788382513448596
amino O 0 0.005689278244972229
acid O 0 0.006104683503508568
changes O 0 0.0022560337092727423
in O 0 0.003363298950716853
APC O 1 0.5032095313072205
associated O 0 0.0032808829564601183
with O 0 0.001990363933146
both O 0 0.004031313583254814
FAP B-Disease 1 0.9999988079071045
and O 0 0.03191034123301506
non O 1 0.9999806880950928
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.14487701654434204
. O 0 0.01669497974216938

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.999998927116394
cancer B-Disease 1 1.0
risk O 1 0.9996296167373657
of O 1 0.8462887406349182
the O 1 0.9932155609130859
APC O 1 0.9999972581863403
I1307K O 1 0.9980489015579224
polymorphism O 0 0.041700493544340134
. O 0 0.014511079527437687

Germ O 1 0.999983549118042
- O 0 0.17307579517364502
line O 0 0.011972080916166306
and O 0 0.005739436484873295
somatic O 0 0.021290212869644165
truncating O 0 0.04677717015147209
mutations O 0 0.006388799287378788
of O 0 0.004209543578326702
the O 0 0.01100089494138956
APC B-Disease 1 0.9999411106109619
gene O 0 0.003095487132668495
are O 0 0.0008157836855389178
thought O 0 0.002290287520736456
to O 0 0.0026601722929626703
initiate O 1 0.8475711941719055
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9998846054077148
in O 1 0.998356282711029
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999998807907104
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9964337348937988
respectively O 1 0.6949817538261414
. O 0 0.016079220920801163

Recently O 0 0.018900785595178604
, O 0 0.007053932640701532
an O 0 0.008966371417045593
isoleucine O 1 0.9999470710754395
- O 1 0.993994414806366
- O 0 0.0907638743519783
> O 0 0.021758634597063065
lysine O 0 0.017301345244050026
polymorphism O 0 0.01110913511365652
at O 0 0.008113469928503036
codon O 0 0.018196608871221542
1307 O 0 0.04150805249810219
( O 0 0.006872933823615313
I1307K O 0 0.016754860058426857
) O 0 0.0028410111553967
of O 0 0.002881626132875681
the O 0 0.0061923968605697155
APC B-Disease 1 0.9998512268066406
gene O 0 0.004142679739743471
has O 0 0.001568422419950366
been O 0 0.0014251179527491331
identified O 0 0.0021030486095696688
in O 0 0.001460819155909121
6 O 0 0.003973520826548338
% O 0 0.0024706057738512754
- O 0 0.004101613536477089
7 O 0 0.003077809466049075
% O 0 0.001693056896328926
of O 0 0.0019708850886672735
the O 0 0.00435723876580596
Ashkenazi O 1 0.8818101286888123
Jewish O 0 0.012917445041239262
population O 0 0.00807719025760889
. O 0 0.011092305183410645

To O 0 0.008957973681390285
assess O 0 0.011870093643665314
the O 0 0.005455115810036659
risk O 0 0.004666123539209366
of O 0 0.002518442226573825
this O 0 0.002292316872626543
common O 0 0.007029326166957617
APC B-Disease 1 0.9999099969863892
allelic O 1 0.9975128173828125
variant O 1 0.999562680721283
in O 1 0.8826438188552856
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.007953607477247715
we O 0 0.001809709588997066
have O 0 0.0008782180375419557
analyzed O 0 0.002875562757253647
a O 0 0.002214230829849839
large O 0 0.0033188676461577415
cohort O 0 0.018216822296380997
of O 0 0.005810633301734924
unselected O 1 0.668880045413971
Ashkenazi O 0 0.03506061062216759
Jewish O 0 0.011388386599719524
subjects O 0 0.010715358890593052
with O 0 0.008516624569892883
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999997615814209
and O 0 0.19367021322250366
. O 1 0.5460004210472107
or O 1 0.9998378753662109
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.4982103407382965
for O 0 0.007357977796345949
the O 0 0.01823681779205799
APC O 1 0.9996689558029175
I1307K O 1 0.889354407787323
polymorphism O 0 0.03796777129173279
. O 0 0.015843266621232033

The O 0 0.02752215601503849
APC O 1 0.999413013458252
I1307K O 1 0.8529794216156006
allele O 0 0.01232197880744934
was O 0 0.005686197895556688
identified O 0 0.003223994979634881
in O 0 0.0015024777967482805
48 O 0 0.003302045864984393
( O 0 0.0019956317264586687
10 O 0 0.0014483635313808918
. O 0 0.0010770540684461594
1 O 0 0.0031376222614198923
% O 0 0.002178844064474106
) O 0 0.0028489676769822836
of O 0 0.005057223606854677
476 O 1 0.9971854090690613
patients O 1 0.9989981055259705
. O 0 0.019793380051851273

Compared O 0 0.010904929600656033
with O 0 0.00306517630815506
the O 0 0.0030387970618903637
frequency O 0 0.0021648062393069267
in O 0 0.0012002894654870033
two O 0 0.0008430526359006763
separate O 0 0.0011260604951530695
population O 0 0.001361617585644126
control O 0 0.0021983706392347813
groups O 0 0.0012354830978438258
, O 0 0.0026445940602570772
the O 0 0.005927589721977711
APC O 1 0.9999468326568604
I1307K O 1 0.9837130308151245
allele O 0 0.007765611633658409
is O 0 0.0018034693785011768
associated O 0 0.0018542591715231538
with O 0 0.0010686839232221246
an O 0 0.0017374338349327445
estimated O 0 0.003438967978581786
relative O 0 0.005199325270950794
risk O 0 0.00675212312489748
of O 0 0.006118305493146181
1 O 0 0.017589887604117393
. O 0 0.011220474727451801

5 O 0 0.04083465412259102
- O 0 0.05113734304904938
1 O 0 0.026222435757517815
. O 0 0.01890878565609455

7 O 0 0.022838523611426353
for O 0 0.012034228071570396
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999997615814209
( O 0 0.01717800460755825
both O 0 0.006192549131810665
P O 1 0.9583854675292969
= O 0 0.019280891865491867
. O 0 0.004388259258121252
01 O 1 0.9526558518409729
) O 0 0.010544638149440289
. O 0 0.012031897902488708

Furthermore O 0 0.022366683930158615
, O 0 0.0060812621377408504
compared O 0 0.00624849135056138
with O 0 0.003967595752328634
noncarriers O 1 0.9966260194778442
, O 0 0.011559804901480675
APC O 1 0.9998353719711304
I1307K O 1 0.9949116110801697
carriers O 0 0.008057020604610443
had O 0 0.003538869321346283
increased O 0 0.002539834938943386
numbers O 0 0.00234864535741508
of O 0 0.004266858566552401
adenomas B-Disease 1 0.9999943971633911
and O 1 0.7926207184791565
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.11470796167850494
patient O 1 0.9998637437820435
( O 0 0.011909028515219688
P O 1 0.5774989128112793
= O 0 0.007544070016592741
. O 0 0.0018331968458369374
03 O 0 0.052524350583553314
) O 0 0.0018851569620892406
, O 0 0.0012895285617560148
as O 0 0.0010432989802211523
well O 0 0.0010595204075798392
as O 0 0.0016200598329305649
a O 0 0.002966927830129862
younger O 0 0.008048991672694683
age O 0 0.009312770329415798
at O 0 0.055679045617580414
diagnosis O 1 0.9999841451644897
. O 0 0.01890365034341812

We O 0 0.007678148802369833
conclude O 0 0.011017036624252796
that O 0 0.0032889130525290966
the O 0 0.007732680067420006
APC O 1 0.9977793097496033
I1307K O 1 0.9048120975494385
variant O 0 0.05665051192045212
leads O 0 0.00990730244666338
to O 0 0.004796523600816727
increased O 0 0.032646529376506805
adenoma B-Disease 1 1.0
formation O 1 0.7683804631233215
and O 0 0.003646170487627387
directly O 0 0.002963583916425705
contributes O 0 0.0050232443027198315
to O 0 0.0016742923762649298
3 O 0 0.003386302385479212
% O 0 0.0022661369293928146
- O 0 0.003872122848406434
4 O 0 0.0030000752303749323
% O 0 0.0013734276872128248
of O 0 0.0019302634755149484
all O 0 0.0032733262050896883
Ashkenazi O 1 0.9994401335716248
Jewish O 1 0.9997318387031555
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9666187167167664

The O 0 0.011885887943208218
estimated O 0 0.010444154031574726
relative O 0 0.00910111889243126
risk O 0 0.007219293154776096
for O 0 0.003165781730785966
carriers O 0 0.006677114404737949
may O 0 0.0032223344314843416
justify O 0 0.006358768790960312
specific O 0 0.002918659709393978
clinical O 0 0.025483127683401108
screening O 0 0.006607393268495798
for O 0 0.002297568367794156
the O 0 0.003070423612371087
360 O 0 0.0068048047833144665
, O 0 0.0023600736167281866
000 O 0 0.005421690177172422
Americans O 0 0.0020658487919718027
expected O 0 0.0016710724448785186
to O 0 0.001529234228655696
harbor O 0 0.008926413021981716
this O 0 0.0019726697355508804
allele O 0 0.005021833349019289
, O 0 0.0017098236130550504
and O 0 0.0016136688645929098
genetic O 0 0.002809992991387844
testing O 0 0.0027589756064116955
in O 0 0.001324209850281477
the O 0 0.0016667948802933097
setting O 0 0.0029265745542943478
of O 0 0.0030274318996816874
long O 0 0.007213337812572718
- O 0 0.010549244470894337
term O 0 0.006086572539061308
- O 0 0.004928863141685724
outcome O 0 0.0030187976080924273
studies O 0 0.0026062449906021357
may O 0 0.002683051861822605
impact O 0 0.004599095322191715
significantly O 0 0.007598944008350372
on O 1 0.9334554076194763
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.033197931945323944
this O 0 0.0043983981013298035
population O 0 0.006165172439068556
. O 0 0.009584547951817513

Localization O 0 0.0283291507512331
of O 0 0.008967620320618153
human O 0 0.014056792482733727
BRCA1 O 1 0.9886856079101562
and O 0 0.0020107526797801256
its O 0 0.0016892522107809782
loss O 0 0.005111473612487316
in O 0 0.0022328451741486788
high O 0 0.013019595295190811
- O 0 0.12476038932800293
grade O 0 0.4690482020378113
, O 0 0.004791142884641886
non B-Disease 0 0.3095954656600952
- I-Disease 1 0.999715268611908
inherited I-Disease 1 0.9999995231628418
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.328926146030426

Although O 0 0.008129804395139217
the O 0 0.0048743607476353645
link O 0 0.007460174150764942
between O 0 0.004317655693739653
the O 0 0.02090446837246418
BRCA1 O 1 0.9999998807907104
tumour B-Disease 1 1.0
- O 1 0.9999862909317017
suppressor O 1 0.9985377788543701
gene O 0 0.00808720476925373
and O 0 0.0052484204061329365
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.9789930582046509
established O 0 0.027665823698043823
, O 0 0.001962211448699236
the O 0 0.002224108437076211
role O 0 0.003349843667820096
, O 0 0.0015063815517351031
if O 0 0.0008232029504142702
any O 0 0.0008628256036899984
, O 0 0.0014984208391979337
of O 0 0.0035640292335301638
BRCA1 O 1 0.9956092238426208
in O 0 0.006620846688747406
non B-Disease 1 0.9886822700500488
- I-Disease 1 0.9999135732650757
familial I-Disease 1 0.9999995231628418
cancers I-Disease 1 0.9999996423721313
is O 0 0.02096140943467617
unclear O 0 0.020635858178138733
. O 0 0.015035961754620075

BRCA1 O 1 0.9984830021858215
mutations O 0 0.011179590597748756
are O 0 0.0024716730695217848
rare O 0 0.006442123558372259
in O 0 0.004843404982239008
sporadic B-Disease 1 0.969851553440094
cancers I-Disease 1 0.9999971389770508
, O 0 0.00551695516332984
but O 0 0.0023461205419152975
loss O 0 0.00802692398428917
of O 0 0.009033774957060814
BRCA1 O 1 0.9999520778656006
resulting O 0 0.006865256931632757
from O 0 0.003416405525058508
reduced O 0 0.0054633175022900105
expression O 0 0.003976983018219471
or O 0 0.00268869218416512
incorrect O 0 0.0075617022812366486
subcellular O 0 0.017285620793700218
localization O 0 0.012222729623317719
is O 0 0.0023066848516464233
postulated O 0 0.005405561067163944
to O 0 0.0011133108055219054
be O 0 0.0008855111082084477
important O 0 0.0014316356973722577
in O 0 0.002552082296460867
non B-Disease 0 0.0423271618783474
- I-Disease 1 0.999698281288147
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.994763970375061

Epigenetic O 1 0.7974510192871094
loss O 1 0.8154333829879761
, O 0 0.00598920276388526
however O 0 0.0037883282639086246
, O 0 0.0026907643768936396
has O 0 0.0020072467159479856
not O 0 0.0010914026061072946
received O 0 0.0036211346741765738
general O 0 0.005404782015830278
acceptance O 0 0.00615773256868124
due O 0 0.0036304695531725883
to O 0 0.002035244135186076
controversy O 0 0.00474023912101984
regarding O 0 0.004162083845585585
the O 0 0.004623933229595423
subcellular O 0 0.01919916272163391
localization O 0 0.01547249872237444
of O 0 0.00737742381170392
BRCA1 O 1 0.999468982219696
proteins O 0 0.0033361664973199368
, O 0 0.0021500017028301954
reports O 0 0.0021738880313932896
of O 0 0.0018304976401850581
which O 0 0.0013542640954256058
have O 0 0.0010046240640804172
ranged O 0 0.003788476111367345
from O 0 0.0017634679097682238
exclusively O 0 0.002818706911057234
nuclear O 0 0.003115507774055004
, O 0 0.0014401156222447753
to O 0 0.0013614712515845895
conditionally O 0 0.0071136788465082645
nuclear O 0 0.003316503716632724
, O 0 0.0017605776665732265
to O 0 0.00247521186247468
the O 0 0.010449257679283619
ER O 1 0.9999997615814209
/ O 1 0.9932600855827332
golgi O 1 0.8770666122436523
, O 0 0.004160194657742977
to O 0 0.0037577443290501833
cytoplasmic O 0 0.01117594912648201
invaginations O 0 0.02571764960885048
into O 0 0.005296561401337385
the O 0 0.008166578598320484
nucleus O 0 0.026723725721240044
. O 0 0.013461548835039139

In O 0 0.006376183126121759
an O 0 0.003597523318603635
attempt O 0 0.004293263889849186
to O 0 0.002342690946534276
resolve O 0 0.0054456195794045925
this O 0 0.001679884153418243
issue O 0 0.003016588045284152
, O 0 0.0018754417542368174
we O 0 0.00133893929887563
have O 0 0.0013448544777929783
comprehensively O 0 0.012018755078315735
characterized O 0 0.012307479046285152
19 O 0 0.025826916098594666
anti O 1 0.9994208812713623
- O 1 0.9998979568481445
BRCA1 O 1 0.999958872795105
antibodies O 0 0.048782069236040115
. O 0 0.015120186842978

These O 0 0.00734059838578105
reagents O 0 0.021131455898284912
detect O 0 0.011883355677127838
a O 0 0.007804814726114273
220 O 0 0.02238207869231701
- O 0 0.03590303659439087
kD O 1 0.8167256712913513
protein O 0 0.006334435660392046
localized O 0 0.005664080381393433
in O 0 0.0023966189473867416
discrete O 0 0.005604718811810017
nuclear O 0 0.005200441926717758
foci O 0 0.011278041638433933
in O 0 0.00252445787191391
all O 0 0.0025478575844317675
epithelial O 1 0.9997263550758362
cell O 0 0.014548110775649548
lines O 0 0.0034430823288857937
, O 0 0.0018160812323912978
including O 0 0.001631870400160551
those O 0 0.0018024336313828826
derived O 0 0.006881603039801121
from O 0 0.010802272707223892
breast B-Disease 1 0.9999982118606567
malignancies I-Disease 1 0.9999505281448364
. O 0 0.030447375029325485

Immunohistochemical O 1 0.9923257827758789
staining O 1 0.5956971049308777
of O 0 0.01843748800456524
human O 1 0.7680240869522095
breast O 1 0.9999984502792358
specimens O 0 0.03539285808801651
also O 0 0.005729328375309706
revealed O 0 0.039472270756959915
BRCA1 O 1 0.9860683679580688
nuclear O 0 0.007887564599514008
foci O 0 0.23180532455444336
in O 0 0.007975625805556774
benign O 1 0.999998927116394
breast O 1 1.0
, O 1 0.9731893539428711
invasive B-Disease 1 0.9999998807907104
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.8652958273887634
low B-Disease 1 0.999882698059082
- I-Disease 1 0.9999827146530151
grade I-Disease 1 0.9999897480010986
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.1405397355556488

Conversely O 0 0.053809959441423416
, O 0 0.013583995401859283
BRCA1 O 1 0.9705064296722412
expression O 0 0.009025276638567448
was O 0 0.011894268915057182
reduced O 0 0.006028614938259125
or O 0 0.0029428349807858467
undetectable O 0 0.017292024567723274
in O 0 0.0017408172134310007
the O 0 0.0020493154879659414
majority O 0 0.0020844880491495132
of O 0 0.0032063445542007685
high O 0 0.3493812084197998
- O 1 0.9940792322158813
grade O 1 0.9996657371520996
, O 0 0.02789924666285515
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.008352626115083694
suggesting O 0 0.007500677369534969
that O 0 0.0023043632972985506
absence O 0 0.007593587972223759
of O 0 0.010125836357474327
BRCA1 O 1 0.9999483823776245
may O 0 0.004551673773676157
contribute O 0 0.003672589547932148
to O 0 0.0018035818357020617
the O 0 0.003582919714972377
pathogenesis O 1 0.9936524629592896
of O 0 0.0034465244971215725
a O 0 0.003572907065972686
significant O 0 0.0031976206228137016
percentage O 0 0.004959573969244957
of O 0 0.0062245773151516914
sporadic B-Disease 1 0.9997290968894958
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 0.01586582325398922
. O 0 0.013958321884274483

